key: cord-325296-zrvykzof authors: zuhorn, frédéric; omaimen, hassan; ruprecht, bertram; stellbrink, christoph; rauch, michael; rogalewski, andreas; klingebiel, randolf; schäbitz, wolf-rüdiger title: parainfectious encephalitis in covid-19: “the claustrum sign” date: 2020-09-03 journal: j neurol doi: 10.1007/s00415-020-10185-y sha: doc_id: 325296 cord_uid: zrvykzof nan included positive serum antibody indices for sars-cov-2. on day 4, respiratory deterioration required endotracheal intubation and treatment of bacterial superinfection was started according to antibiogram. eight days later, the patient could be extubated and pcr tests were negative for sars-cov-2. yet, the patient continued to show concentration difficulties and delirious behavior. subsequent mri (fig. 1a c) revealed signal alterations within the claustrum/external capsule region, showing reduced diffusion. cerebrospinal fluid (csf) analysis disclosed a mild lymphocytic pleocytosis with negative test results for common neurotropic viruses. tests in serum and csf were also negative for various antineuronal antibodies. the patient recovered and was discharged with only mild cognitive impairment. follow-up has been carried out four months later showing a normalization in cell count of csf and improvement of mri findings, although the claustrum lesions persisted. clinically, his neurological and cognitive status was normal. our case is characterized by evidence of parainfectious autoimmune encephalitis in the context of severe covid-19 pneumonia. clinically, the patient presented with various neuropsychiatric symptoms, which were reported before in other covid-19 patients with encephalopathy [1] . neither sars-cov-2 itself nor antibodies against the virus were found positive in the csf, precluding direct viral cns infection. comprehensive laboratory tests ruled out antineuronal antibodies as well as common infectious causes of encephalitis, altogether supporting the diagnosis of parainfectious autoimmune encephalitis. in addition, the diagnostic criteria for possible autoimmune encephalitis as proposed by gaus et al. were met [2] . while immunological markers remained unspecific and imaging findings of acute necrotizing encephalitis were absent in our patient, brain mri disclosed a unique pattern, a.k.a. the claustrum sign. previously, this sign has been coined in mri studies of autoimmune epilepsy, where an immune-inflammatory-mediated encephalopathy is suspected [3] . the claustrum is known to play a crucial role in regulating consciousness [6] correlating well to the randolf klingebiel and wolf-rüdiger schäbitz both authors contributed equally to this work. clinical findings of impaired levels of consciousness in the presented case. in autoimmune epilepsy, the claustrum signals normalized in the majority but not in all patients [4] , suggesting a varying severity of claustrum damage. this is confirmed by reduced diffusion in the first mri scan of our patient, heralding irreversible tissue damage (as proven by the 4-month mri follow-up). at no point in time, there was evidence for other causes of diffusion reduction, i.e., hypoxemia or status epilepticus. comparable claustrum lesions have also been reported in the context of autoimmune encephalitis without epileptic or anoxic episodes, supporting inflammation as a decisive factor [5] . a particular vulnerability of claustral neurons to hypoxic stress has been shown [7] , without relating to the inflammatory pathogenesis of our mri findings. yet, astrocyte proliferations and microglia/macrophage infiltrations of the claustrum have been observed in non-herpetic encephalitis [8] . to which extent other pathomechanisms, such as encephalitic hypermetabolism as known from the striatum [9] . additionally, compromise the claustrum remains speculative. common mri findings in a recent study of covid-19 encephalopathy were cortical signal abnormalities on flair images (37%), accompanied by diffusion reduction, leptomeningeal enhancement and cortical blooming artifacts in some cases. these imaging findings, termed by the authors themselves as "rather unspecific", did not allow [10] . mri findings in covid-19 encephalitis, especially when suggesting autoimmune encephalopathy may imply therapeutic interventions, such as immunosuppressive therapy. recently, progressive clinical improvement along with a reduction of inflammatory csf parameters has been observed in covid-19 encephalitis, following high-dose steroid treatment [11] . in summary, a previously undescribed imaging pattern in parainfectious covid-19 encephalitis is presented that bears a strong resemblance to mri findings in autoimmune encephalitic syndromes, such as known from epileptic or encephalitis caused by antineuronal antibodies. this claustrum sign should be added to the still limited knowledge of encephalitic imaging patterns in covid-19, as it most probably represents an autoimmune phenomenon that might progress from reversible signal changes to permanent tissue damage and thus may trigger appropriate as well as timely therapy. author contributions fz is lead author, analyzed and interpreted the collected data and literature, designed and wrote the manuscript. ho&ar participated in the design and coordination of the manuscript. br&cs helped in drafting the manuscript. mr&rk provided figures and data and revised the manuscript for important intellectual content. imaging (d-e), the flair-hyperintensities persist (d) whereas tissue diffusion has normalized (e). csf-cytology (f) showed a slightly elevated cell count (9/µl) with a lymphocytic predominance (88% lymphocytes, 12% monocytes). a meaningful plasmacytic transformation was not observed, the monocytes being only slightly activated neurologic features in severe sars-cov-2 infection a clinical approach to diagnosis of autoimmune encephalitis new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome what is the function of the claustrum? voltage-gated potassium channel antibody-associated encephalitis with claustrum lesions claustral neurons are vulnerable to ischemic insults in cardiac arrest encephalopathy neuropathological studies of patients with possible non-herpetic acute limbic encephalitis and so-called acute juvenile female non-herpetic encephalitis striatal hypermetabolism in limbic encephalitis brain mri findings in patients in the intensive care unit with covid-19 infection steroidresponsive encephalitis in covid-19 disease key: cord-302015-z2k6wuhm authors: bonardel, claire; bonnerot, mathieu; ludwig, marie; vadot, wilfried; beaune, gaspard; chanzy, bruno; cornut, lucie; baysson, hélène; farines, magali; combes, isabelle; macheda, gabriel; bing, fabrice title: bilateral posterior infarction in a sars-cov-2 infected patient: discussion about an unusual case date: 2020-06-28 journal: j stroke cerebrovasc dis doi: 10.1016/j.jstrokecerebrovasdis.2020.105095 sha: doc_id: 302015 cord_uid: z2k6wuhm in time of sars-cov2 pandemic, neurologists need to be vigilant for cerebrovascular complications of covid-19. we present a case of bilateral occipito-temporal infarction revealed by a sudden cortical blindness with haemorrhagic transformation after intravenous thrombolysis in a diabetic patient infected by covid-19. differential diagnoses are discussed in front of this unusual presentation and evolution. bilateral posterior infarction in a sars-cov-2 infected patient: discussion about an unusual case abstract in time of sars-cov2 pandemic, neurologists need to be vigilant for cerebrovascular complications of covid-19. we present a case of bilateral occipito-temporal infarction revealed by a sudden cortical blindness with haemorrhagic transformation after intravenous thrombolysis in a diabetic patient infected by . differential diagnoses are discussed in front of this unusual presentation and evolution. a 51-year-old-man presented with one-week history of cough, dysgeusia and diarrhea. the patient complained of moderate headache without fever. the patient had a history of diabetes mellitus, hypertension and obesity. blood investigation showed a lymphocytopenia (1.08 giga/l), an increased fibrinogen (5.1 g/l), ferritin (1190 µg/l), creatin-kinase (749 ui/l), c-reactive protein (71 g/l), asat (54 ui/l) and glycated hemoglobin (9.1%) concentrations. prothrombin ratio was low (66%). antiphospholipid, platelets and partial thromboplastin time were normal. the rt-pcr for sars-cov-2 using a nasopharyngeal swab was positive. a chest scan showed bilateral ground glass opacities concerning more than 50% of the parenchymal lung ( figure 1 ). six days after arrival and 30 minutes after the fourth injection of remdesivir (loading dose: 200mg iv, 100mg iv per day thereafter), he presented an abrupt cortical blindness and disorientation (nihss score: 4). an atrial fibrillation (af) was recorded. a first brain mri performed one hour after clinical onset showed bilateral and asymmetric acute occipito-temporal infarction without visibility of the p3 segments of the posterior cerebral arteries (pca) (figure 2a to c). fluid-attenuated inversion recovery (flair), t2*, mr venography and mr angiography of the supra-aortic trunks were normal. no pathological enhancement in leptomeningeal spaces was observed. alteplase was injected 128 min after symptom onset. the following morning, blindness was unchanged and anterograde memory disorders with anosognosia were noticed. the 24-hour control multimodality mri showed a haemorrhagic transformation of the previous lesions ( figure 2e -f). dynamic susceptibilityweighted contrast-enhanced magnetic resonance perfusion imaging (dsc-mri perfusion) showed an increase of cerebral blood volume (cbv) and flow (cbf) in the right thalamus and an increase of the mean transit time (mtt) and cbv in the right hemisphere ( figure 1h ). distal segments of the pca were permeable ( figure 2d ). nine hours later, the patient died due to a rapid respiratory breakdown, without neurological worsening. this bilateral cerebral posterior stroke may be secondary to an embolic event (af). stroke could also be explained by the state of hypercoagulability induced by sars-cov-2 infection 1 . severe patients are more likely to have neurologic symptoms 2 and bilateral frontotemporal hypoperfusion 3 has been reported. in our case, mtt and cbv were increased in the right hemisphere which may reflect reduced cerebral perfusion pressure. the increase value of the cbf in the right thalamus may correspond to a post-recanalization hyperperfusion 4 . other stroke mechanisms can be suggested. infection may have induced cerebral vasculitis, explaining the stroke and the perfusion's anomalies. severe reversible cerebral vasoconstriction syndrome (rcvs) cases with cerebral infarction and intracranial haemorrhage have been reported but the absence of thunderclap headache is unusual in rcvs 5 . the absence of rapid increase in blood pressure and the presence of an initial cytotoxic oedema instead of vasogenic is less in favour of posterior reversible encephalopathy syndrome (pres) 6 . an adverse effect of remdesivir is also to be discussed, but no neurological adverse effect potentially related to remdesivir have been reported 7 . finally, the absence of thalamus involvement makes the diagnosis of acute necrotizing encephalitis unlikely 8 . in conclusion, the origin of the stroke is probably multifactorial: the cytokine storm syndrome and hypercoagulability may have induced blood flow dysregulation, associated with an embolic event that may finally induce arterial thrombosis. a cerebral artery vasculitis or a rvcs are not excluded. this unusual case confirms the increased risk of thrombotic events in sars-cov2 infected patients. figures legend figure 1 . axial ct scanner shows focal subpleural ground-glass opacities in the left and right lobes. the right lower lobe lesion is accompanied by air bronchogram (arrow). second mri (d to f). tof shows better visualisation of distal segments of bilateral pca (arrows) (d). fluid--attenuated inversion recovery (flair) shows a hypersignal in the initial ischemic lesions (initial flair was normal) (e). susceptibility-weighted imaging (swi) shows hypointensity (haemorrhage) concerning the totality of the ischemic lesion (f). mri perfusion shows an increase cerebral blood volume (cbv) in the right thalamus (arrow) (g) and an increase of mtt in the right hemisphere (h). annecy hospital annecy hospital * corresponding author: fabrice bing imaging unit, annecy hospital, 74374 metz-tessy, france email : fabricebing@yahoo.fr phone number author contact information: claire bonardel: cbonardel@chu-grenoble.fr mathieu bonnerot: mbonnerot@ch-annecygenevois.fr wilfried vadot: wvadot@ch-annecygenevois.fr gaspard beaune: gbeaune@ch-annecygenevois.fr lucie cornut : lcornut@ch-annecygenevois.fr hélène baysson : hbaysson@ch-annecygenevois.fr magali farines : mfarines@ch-annecygenevois.fr isabelle combes : icombes@ch-annecygenevois.fr gabriel macheda : gmacheda@ch-annecygenevois.fr keywords: infarction; mr perfusion; covid-19; visual loss; sars-cov2 running title: stroke in a sars-cov-2 infected patient conflict of interest: the authors report no disclosures difference of coagulation features between severe pneumonia induced by sars-cov2 and non-sars-cov2 neurologic manifestations of hospitalized patients with coronavirus disease neurologic features in severe sars-cov-2 infection diffusion-perfusion mri characterization of postrecanalization hyperperfusion in humans severe reversible cerebral vasoconstriction syndrome with large posterior cerebral infarction posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations controlled trial of ebola virus disease therapeutics covid-19-associated acute hemorrhagic necrotizing encephalopathy: ct and mri features key: cord-288158-6gicgsj8 authors: mahammedi, abdelkader; saba, luca; vagal, achala; leali, michela; rossi, andrea; gaskill, mary; sengupta, soma; zhang, bin; carriero, alessandro; bachir, suha; crivelli, paola; paschè, alessio; premi, enrico; padovani, alessandro; gasparotti, roberto title: imaging of neurologic disease in hospitalized patients with covid-19: an italian multicenter retrospective observational study date: 2020-05-21 journal: radiology doi: 10.1148/radiol.2020201933 sha: doc_id: 288158 cord_uid: 6gicgsj8 of 725 consecutive hospitalized patients with coronavirus disease 2019, 108 (15%) had acute neurologic symptoms necessitating neurologic imaging. all images were obtained as per standard of care protocols. mri scans of brain and spine were obtained with 1.5-t scanners with standardized protocols. gadopen-tetate dimeglumine (0.1 mmol/kg gadobutrol [gadovist; bayer, berlin, germany]) was used for contrast materialenhanced studies. the neurologic imaging characteristics that were evaluated are listed in table 1 . all scans were initially analyzed by the institution's own neuroradiologists. subsequently, all images were reviewed by three neuroradiologists in consensus (r.g., l.s., and a.c., with 30, 14, and 32 years of neuroradiology experience, respectively). continuous variables are presented as means 6 standard deviations and were compared between patients with altered mental status by using the student t test; categoric variables are presented as frequencies with percentages. all statistical analyses were performed by using software (stata, version 15; statacorp, college station, tex). p , .05 was indicative of a statistically significant difference. a total of 725 consecutive hospitalized patients with covid-19 were reviewed. of these 725 patients, 108 (15%) met the eligibility criteria (fig 1) . of the 108 patients, 107 (99%) were examined with unenhanced brain ct, 17 (16%) with head and neck ct angiography, and 20 (18%) with brain mri. of the 20 patients who underwent brain mri, 10 (50%) underwent mri with and without intravenous contrast material, 10 (50%) underwent head and neck mr angiography, and three underwent additional mri of the whole spine for evaluation of lower extremity weakness. table 2 summarizes the demographic characteristics, medical history, and neurologic characteristics. the most common neurologic symptoms were altered mental status in 64 of the 108 patients (59%) and ischemic stroke in 34 imaging of neurologic disease in hospitalized patients with covid-19: an italian multicenter retrospective observational study e271 10 had acute ischemic infarcts and two had intracranial hemorrhage. seventy-one of the 108 patients (66%) had no acute findings on brain ct scans; seven of the 20 patients who underwent mri (35%) had acute abnormalities on brain mri scans. there was a statistically significant association between the prevalence of altered mental status and patient age (mean age, 72 years 6 11 vs 64 years 6 18; p = .007). the main neurologic imaging hallmark was acute ischemic infarcts, which were present in 34 of the 108 patients (31%) (30 [28%] on ct scans and four [20%] on mri scans). of these infarcts, 19 (18%) were large (15 in the middle cerebral artery territory, two in the posterior cerebral artery territory, two in the anterior cerebral artery territory), 11 (10%) were small, three (3%) were cardioembolic, and one (1%) had an hypoxic-ischemic encephalopathy pattern. six of the 108 patients (6%) had intracranial hemorrhages, with subarachnoid hemorrhage being the most common (n = 3, 3%). additional neurologic imaging findings are shown in table 1 . (12) note.-numbers are numbers of patients (numerator/ denominator), with percentages in parentheses. flair = fluid-attenuated inversion recovery, iv = intravenous, ms = multiple sclerosis, pres = posterior reversible encephalopathy syndrome. * one patient with miller-fisher syndrome, a regional variant of guillain-barré syndrome, had both cranial nerve and cauda equina enhancement. a 62-year-old man presented with bilateral facial nerve palsy, ophthalmoplegia, areflexia, and polyradiculopathy. results of real-time reverse-transcriptase polymerase chain reaction assay of the cerebrospinal fluid were negative for severe acute respiratory syndrome coronavirus 2. † a 60-year-old man without history of seizures presented with first time convulsion (fig 2) . real-time reverse transcriptase polymerase chain reaction assay of the cerebrospinal fluid was negative for severe acute respiratory syndrome coronavirus 2. ‡ one patient, a 53-year-old woman, presented with seizures and altered mental status. (31%). of the 108 patients, 31 (29%) had no known past medical history and 77 (71%) had at least one of the following chronic disorders: coronary artery disease (n = 25, 23%), cerebrovascular disease (n = 15, 14%), hypertension (n = 55, 51%), and diabetes (n = 30, 28%). of the 31 patients without known past medical history (age range, 16-62 years) (29%), our study demonstrated that the neurologic imaging features of hospitalized patients with covid-19 were variable, without a specific pattern but dominated by acute ischemic infarcts and intracranial hemorrhages. we also showed that the neurologic mri spectrum may include posterior reversible encephalopathy syndrome, hypoxicischemic encephalopathy, exacerbation of demyelinating disease, and nonspecific cortical pattern of t2 fluid-attenuated inversion-recovery hyperintense signal with associated restriction diffusion that may be caused by systemic toxemia, viremia, and/or hypoxic effects (9) . currently, we have a poor mechanistic understanding of the neurologic symptoms in patients with covid-19, whether these are arising from critical illness or from direct central nervous system invasion of severe acute respiratory syndrome coronavirus 2 (10). accumulating evidence suggests that a subgroup of patients with severe covid-19 might have a cytokine storm syndrome that could be a trigger for ischemic strokes, probably related to the prothrombotic effect of the inflammatory response (3, 11) . our results showed a lower prevalence of central nervous system symptoms than the wuhan experience (8) (15% vs 25%, respectively); however, the prevalence of ischemic strokes was higher in our study (31% vs 11%). furthermore, our findings also support the suggested potential for co-vid-19-associated guillain-barré syndrome and variants (12) . none of our patients showed abnormal parenchymal or leptomeningeal enhancement. in conclusion, neurologists and neuroradiologists should be familiar with the broad spectrum of neurologic imaging patterns associated with covid-19. coronavirus disease 2019 (covid-19) situation report -115 ct imaging features of 2019 novel coronavirus (2019-ncov) acute cerebrovascular disease following co-vid-19: a single center covid-19-associated acute hemorrhagic necrotizing encephalopathy: ct and mri features neurological complications of coronavirus disease (covid-19): encephalopathy neurologic features in severe sars-cov-2 infection a first case of meningitis/encephalitis associated with sars-coronavirus-2 neurologic manifestations of hospitalized patients with coronavirus disease nervous system involvement after infection with cov-id-19 and other coronaviruses covid-19: consider cytokine storm syndromes and immunosuppression guillain-barré syndrome associated with sars-cov-2 infection: causality or coincidence? we thank all patients and their families involved in the study.author contributions: guarantors of integrity of entire study, a.m., r.g.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; key: cord-012651-7bllqwh1 authors: kalidindi, kalyan kumar varma; gupta, mayank; chhabra, harvinder singh title: a rare cause of neurological deterioration to complete paraplegia after surgery for thoracic myelopathy: a case report date: 2019-06-05 journal: spinal cord ser cases doi: 10.1038/s41394-019-0202-z sha: doc_id: 12651 cord_uid: 7bllqwh1 introduction: progressive deterioration of neurological status post-thoracic myelopathy surgery after a clinically stable period is rare and can pose a diagnostic dilemma. we present our experience with such a case where all known etiologies were ruled out and the cause of deterioration could not be conclusively identified. the course was found to be similar to sub-acute post-traumatic ascending myelopathy (spam). however, the condition has only been described for traumatic injuries so far. case presentation: our patient presented a history of back pain and associated gait instability for one and a half months. there was no history of trauma. investigations suggested an anderson-like lesion at t11–t12 with cord edema at the same level suggestive of instability. she underwent posterior stabilization t9 to l2 and laminectomy of t11 as well as t12 under neuromonitoring. the postoperative sequence of events included an episode of pyrexia on the fifth day of surgery, neurological deterioration from the seventh day of surgery proceeding to complete paraplegia by the fourteenth day, no response to steroid treatment and no signs of recovery till two years post surgery. mri findings were suggestive of spam, and there was no evidence of infection. discussion: ascending myelopathy is a potential but rare cause of delayed deterioration in neurological status after surgical intervention. mri findings of cord edema extending more than four levels above the involved segments is a characteristic finding of the condition. ascending myelopathy may lead to complete cord injury. the precise cause of the condition is unknown and prognosis remains poor. outcomes of surgical management of thoracic myelopathy have not been very promising. one of the main contributing factors to the poor outcome is the vulnerable spinal cord at the site of the lesion due to relative avascularity and reduced available space [1] . the deterioration of neurological status is a known complication of surgical decompression of thoracic myelopathy detected, either intraoperatively through neuromonitoring or in the immediate postoperative period on assessment of neurological status [2] . progressive deterioration of neurological status postoperatively is rare and can pose a diagnostic dilemma. we present our experience with one such case where all known etiologies were ruled out and the cause of progressive postoperative neurological deficit could not be conclusively identified. on thorough search of the available literature, the clinical course was found to most closely resemble an entity known as spam, which has so far been reported to occur only after significant trauma. the rarity of occurrence and lack of any published article till date warrants this case to be reported in the literature. a 43-year-old female was presented to our center with severe pain of 6 weeks' duration in the mid-back. the pain was insidious in onset, continuous, of progressively increasing intensity and with a postural variation. she was unable to lie supine due to severe intercostal pain and had to sleep in a sitting posture causing severe disability. there were associated non-dermatomal paresthesias in both lower limbs. she had been bedridden for the past 4 weeks before the presentation due to severe gait instability, resulting in an inability to walk. there were no bowel or bladder symptoms. there was no history of associated fever, significant trauma, constitutional symptoms or history suggestive of an inflammatory etiology. she had a past history suggestive of compressive cervical myelopathy two years ago when she was presented to us with difficulty in walking and weakness in both upper limbs. her neurologic status at that time of presentation was attached in fig. 1a according to the asia/ iscos-isncsci (american spinal injury association/ international spinal cord society-international standards for neurological classification of spinal cord injury). posterior stabilization from c1 to t1 and decompression by cervical laminectomy c1 to c7 and foramen magnum decompression was done at our center. she had a good outcome with an improvement of symptoms and regained the ability to walk without support (fig. 1b) . on examination, there was tenderness in the mid-back over t11-t12 region. movements of the spine could not be tested due to severe pain. higher mental functions, cranial nerve functions and neurological status in the upper limbs were within normal limits. in both lower limbs, there was increased tone and weakness. the neurologic status was as attached in fig. 1c . deep tendon reflexes in knee and ankle were exaggerated and plantar reflexes were extensor bilaterally. on the basis of clinical findings, a provisional diagnosis of thoracic myelopathy was made. radiological examination revealed multiple syndesmophytes with suspected instability between t11 and t12 vertebrae on standing anteroposterior and lateral radiographs with features suggestive of diffuse idiopathic skeletal hyperostosis (dish). the patient could not lie supine in mri due to severe back as well as girdle pain and hence, an mri was done under sedation. it revealed a three-column anderson-like lesion at t11-t12 level with cord edema behind t11 vertebra suggestive of dynamic cord compression (fig. 2) . based on these clinical and radiological findings, the patient was advised stabilization and decompression under general anesthesia to reduce pain and prevent further deterioration in neurological status. after a thorough preoperative workup, preanesthetic checkup and written there was an incidental durotomy, which was covered with fat graft and fibrin sealant. there was no loss in the motor evoked potentials intraoperatively. there was no deterioration of neurological status on immediate postoperative assessment. postoperative antibiotics and analgesics were given according to the institute's protocol. rehabilitation was initiated. on the first postoperative day, there was a significant reduction in back pain but she still complained of severe intercostal pain around t10 to t12 region predominantly on the left side which temporarily responded to intercostal blocks, tens (transcutaneous electrical nerve stimulation) and pregabalin. the intercostal blocks had to be repeated several times postoperatively. she had hyperesthesia in both lower limbs since day two for which the dose of pregabalin was increased gradually. postoperative mri revealed an adequately decompressed cord (fig. 3a, b) . radiographs and ct scan demonstrated a stable fixation (fig. 3c, d) . the screws were well positioned. she had one spike of fever (101 degrees fahrenheit) on day five of surgery for which no infective cause could be identified. the fever subsided with supportive treatment and antipyretic medication. at seven days post surgery, she started developing weakness and loss of sensations in both the lower limbs. repeat mri revealed hyper-intense signal changes extending five levels above the index level (up to t7 vertebra) but no static compression or instability at the index level (fig. 4) . she was provisionally diagnosed as a case of subacute ascending myelopathy, a type of noncompressive myelopathy. the prognosis was discussed with the patient and attendants in detail. she was put on a high dose of intravenous methylprednisolone (1000 mg) for 3 days followed by a course of oral steroids (tapering dose from 16 to 4 mg). there was a temporary halt in the progression of weakness. csf tap suggested no signs of infection, virological and serological workup was negative, and mri of the brain was normal. the wound was dry. there were no other signs of infection. her total and differential white blood cell counts were normal and creactive protein was normal. the weakness gradually progressed from ninth postoperative day resulting in complete paraplegia (neurological level t8) with completely absent perianal sensation and voluntary anal contraction by fourteenth postoperative day (fig. 1d) . mri was repeated at 6 weeks and 3 months post surgery, which suggested persistent edema till t7 vertebral level (fig. 5 ). she underwent a comprehensive rehabilitation program and was independent in the activities of daily living at the time of discharge on the 90th postoperative day. there was no further recovery in her neurological status even after two years of follow up. spam has been described in the literature as an unusual cause of delayed neurological deterioration after traumatic spinal cord injury in cases where the deterioration could not be explained by mechanical instability, syrinx formation or therapeutic mis-intervention. it was originally described by frankel in 1969 [3] . very few such cases have been reported in the literature suggesting that it is a rare entity and the condition is poorly understood [4] [5] [6] [7] [8] [9] . this entity has been described only in post-traumatic cases. common reported features of spam include neurological deterioration after few days to weeks of surgical spinal stabilization, an often preceding episode of pyrexia and an area of hyperintense signal extending at least four levels above the initial injury level on t2 mri imaging [10] . proposed hypotheses include impairment of spinal venous drainage, arterial thrombosis, inflammatory processes or secondary injury processes. inadvertent cord handling rarely causes extension of edema more than two levels above the injured segment and should be evident in the immediate postoperative period [3] . after an exhaustive literature search, we could not identify any case with such findings reported after atraumatic thoracic myelopathy. the case described here had clinical and radiological features closely resembling spam. the fact that there was no significant trauma and no extension of edema from the index level even 6 weeks after onset of symptoms suggests that secondary injury processes are unlikely to be the cause for the condition. the gradual onset of symptoms, no sparing of the posterior column and no evidence of abnormal vascular markings on early and late mri suggest that arterial cause is less likely [7] . venous congestion may involve the central gray matter more than the peripheral white matter, an axial mri finding seen in our case. however, the mri images did not demonstrate venous stasis or engorgement of surface venous structures, findings that are frequently seen in this condition when caused by a dural arteriovenous malformation [7] . the inflammatory pathology of the disco-vertebral anderson-like lesion, radiological findings of enthesitis, the temporal progression of myelopathy and mild pyrexia suggest that inflammatory pathology may be a likely contributing factor for ascending myelopathy [7] . cordectomy has been described as an effective treatment by meagher et al. in his case [4] . laminectomy and pial incision as a treatment option has been proposed by okada [9] . various other treatments proposed are anticoagulation, steroids, and mannitol. none of the treatment options proposed have been established as a standard treatment till date and the prognosis of the condition remains poor. this case report provides us with an insight into a potential cause akin to spam, which needs to be considered in a patient with progressive neurological deterioration after surgical decompression and stabilization for myelopathy. to the authors' knowledge, this is the first case report of such a condition after surgical decompression and stabilization of thoracic myelopathy. in conclusion, ascending myelopathy is a potential cause of delayed deterioration in neurological status after surgical intervention. an mri finding of cord edema extending more than four levels above the involved segments is a characteristic finding of the condition. ascending myelopathy may lead to complete paraplegia or even tetraplegia. the precise cause of the condition remains unknown and prognosis remains poor. staged spinal cord decompression through posterior approach for thoracic myelopathy caused by ossification of posterior longitudinal ligament the incidence and risk factors of postoperative neurological deterioration after posterior decompression with or without instrumented fusion for thoracic myelopathy ascending cord lesion in the early stages following spinal injury resolution of spam following cordectomy: implications for understanding pathophysiology subacute delayed ascending myelopathy after low spine injury: case report and evidence of a vascular mechanism pathological features including apoptosis in subacute posttraumatic ascending myelopathy subacute posttraumatic ascending myelopathy after spinal cord injury ascending myelopathy in the early stage of spinal cord injury sequential changes of ascending myelopathy after spinal cord injury on magnetic resonance imaging: a case report of neurologic deterioration from paraplegia to tetraplegia acute ascending myelopathy of the spine acknowledgements the authors would like to thank the concerned patient for allowing the details to be shared. conflict of interest the authors declare that they have no conflict of interest.publisher's note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. key: cord-308270-343r91km authors: sawlani, v.; scotton, s.; jacob, s.; nader, k.; jen, j. p.; patel, m.; gokani, k.; denno, p.; thaller, m.; englezou, c.; janjua, u.; bowen, m.; hoskote, c.; veenith, t.; hassan-smith, g. title: covid-19-related intracranial imaging findings: a large single-centre experience date: 2020-09-15 journal: clin radiol doi: 10.1016/j.crad.2020.09.002 sha: doc_id: 308270 cord_uid: 343r91km aim to describe the neuroradiological changes in patients with coronavirus disease 2019 (covid-19). materials and methods a retrospective review was undertaken of 3,403 patients who were confirmed positive for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, and admitted to our institution between 1 march 2020 and 31 may 2020, and who underwent neuroimaging. abnormal brain imaging was evaluated in detail and various imaging patterns on magnetic resonance imaging mri were identified. results of the 3,403 patients with covid-19, 167 (4.9%) had neurological signs or symptoms warranting neuroimaging. the most common indications were delirium (44/167, 26%), focal neurology (37/167, 22%), and altered consciousness (34/167, 20%). neuroimaging showed abnormalities in 23% of patients, with mri being abnormal in 20 patients and computed tomography (ct) in 18 patients. the most consistent neuroradiological finding was microhaemorrhage with a predilection for the splenium of the corpus callosum (12/20, 60%) followed by acute or subacute infarct (5/20, 25%), watershed white matter hyperintensities (4/20, 20%), and susceptibility changes on susceptibility-weighted imaging (swi) in the superficial veins (3/20, 15%), acute haemorrhagic necrotising encephalopathy (2/20, 10%), large parenchymal haemorrhage (2/20, 10%), subarachnoid haemorrhage (1/20, 5%), hypoxic–ischaemic changes (1/20, 5%), and acute disseminated encephalomyelitis (adem)-like changes (1/20, 5%). conclusion various imaging patterns on mri were observed including acute haemorrhagic necrotising encephalopathy, white matter hyperintensities, hypoxic-ischaemic changes, adem-like changes, and stroke. microhaemorrhages were the most common findings. prolonged hypoxaemia, consumption coagulopathy, and endothelial disruption are the likely pathological drivers and reflect disease severity in this patient cohort. ☒ performed the analysis ☒ wrote the paper infection with the novel pathogen, severe acute respiratory syndrome coronavirus 2 (sars-cov-2) has resulted in a global pandemic, which has claimed the lives of over 630,000 globally (as of 23 july 2020). severe infection culminating in acute respiratory distress syndrome (ards) along with relatively high transmission rates, has led to the greatest global public health crisis in 100 years. there is predominant respiratory involvement; however, multi-organ complications have been reported. cerebrovascular events and altered mental status have been described as the most common neurological presentations in covid-19 [1] . recent studies have described abnormal brain imaging findings of microhaemorrhages, multifocal white matter hyperintense lesions with variable enhancement, infarcts, haemorrhagic lesions, acute haemorrhagic necrotising encephalopathy, inflammatory cns syndromes including acute disseminated encephalomyelitis (adem), and medial temporal lobe abnormalities [2] [3] [4] . as one of the largest uk centres, the present study describes the intracranial imaging findings and likely pathogenesis of patients with covid-19. this retrospective observational study was approved by the institution's review board and the need for ethical approval was waived. consecutive patients with covid-19 and neurological manifestations who underwent brain imaging between 1 march 2020 to 31 may 2020 were assessed for inclusion. all patients had a confirmed diagnosis of covid-19 based on detection of sars-cov-2 by reverse transcription polymerase chain reaction (rt-pcr) from sputum or nasopharyngeal swabs. they required hospitalisation with neurological signs or symptoms during inpatient admission, warranting brain imaging. patients with abnormal brain imaging studies j o u r n a l p r e -p r o o f were included (fig. 1) . informed consent was obtained from patients or where appropriate, consent was provided by the next of kin. clinical, laboratory, and imaging data ct brain imaging was performed using a 64-section multidetector ct system (siemens, erlangen, germany). mri was performed using a 1.5 t system (siemens, erlangen, germany) with a 32-channel phased-array head coil. the following sequences of the whole-brain were obtained: t1-weighted sagittal, axial t2(table 1 ). the most common indications were delirium (n=44), focal neurology (n=37), and altered consciousness (n=34). brain mri was abnormal in 20 patients and ct was abnormal in 18 patients. results of abnormal ct studies are summarised in table 2 . findings included subacute infarct, acute infarct, basal ganglia haemorrhage, and subarachnoid haemorrhage, with most patients presenting with focal neurology. the majority of patients presenting with altered consciousness and delirium were investigated by brain mri. for patients who had an abnormal mri brain study, the mean age was 59.7 (range 32-91) years, and the male-to-female ratio was approximately 2:1. sixty percent were of white ethnicity and 25% were from an asian background. eighteen outcome was variable with seven patients discharged home, six undergoing rehabilitation, four patients died, and the remaining three patients continued to remain as inpatients for at least 1 month. patient demographic and clinical information is summarised in table 3 . a number of neuroradiological findings were identified in patients with abnormal mri brain studies (n=20). mri patterns and likely pathogenesis are described in detail in electronic supplementary material table s1 . findings included microhaemorrhages j o u r n a l p r e -p r o o f (n=12), watershed white matter hyperintensities (n=4), susceptibility changes on swi in superficial veins (n=3), acute infarct (n=3), subacute infarct (n=2), acute haemorrhagic necrotising encephalopathy (n=2), large parenchymal haemorrhage (n=2), subarachnoid haemorrhage (n=1), hypoxic-ischaemic changes (n=1), and adem-like changes (n=1). results for mri findings are summarised in table 4 (fig. 2) . similar lesions were also seen in the corpus callosum and cerebellar white matter. in addition, microhaemorrhages were noticed in the splenium of the corpus callosum and brainstem. the other watershed pattern was of scattered dwi high signal lesions in centrum semiovale with micro-and macro-haemorrhages (fig. 3) . susceptibility changes on swi were seen in superficial veins in 15% of patients, in conjunction with microhaemorrhages, likely representing microthrombi (fig. 4f) . all of these patients had diabetes and two of these three patients also had hypertension as a predisposing risk factor. haemorrhage. there is emerging evidence that the underlying pathogenesis for these presentations is closely linked to a combination of prolonged hypoxaemia, consumption coagulopathy, and endothelial dysfunction [5, 6] . the spike protein of sars-cov-2 has a strong affinity for angiotensin-converting enzyme 2 (ace2) receptor, which allows it to enter host cells. this protein is expressed on alveolar epithelial cells, intestinal enterocytes, and arterial and venous endothelial cells [7] . using electron microscopy, sars-cov-2 viral elements have been demonstrated within endothelial cells themselves, associated with profound inflammation and tissue oedema in covid-19 patients at autopsy [6] . a recent j o u r n a l p r e -p r o o f neuropathological series of 18 patients has shown that although the virus was detected at low levels in five patients, there was no evidence of encephalitis and the explanation for this could have been due to in situ virions or viral rna from blood [8] . all the patients in this neuropathological series demonstrated acute hypoxicischaemic damage. hypoxic-ischaemic damage has been shown to cause leukoencephalopathy and white matter cytotoxic oedema in critically ill patients. leukoencephalopathic changes with or without cytotoxic oedema are seen in many other condition including posterior reversible encephalopathy syndrome (pres), sepsis, adem, hypotension, hypoxia, prolonged ventilator support, drug therapy, and toxic metabolic diseases [9, 10] . sars-cov-2 infection initiates a pro-inflammatory cytokine storm led by tumour necrosis factor α (tnf-α), interleukin 6 (il-6), and interleukin 1β (il-1β) [11] . this results in a downstream increase in vascular permeability, blood-brain and blood-csf barrier dysfunction, neuroinflammation and subsequent leukoencephalopathy, thought to be due to oligodendroglial cell death and consequent demyelination predominantly in the deep watershed regions [12] . one patient, who had sustained a cardiac arrest, showed restricted diffusion in the basal ganglia bilaterally, in keeping with hypoxic-ischaemic changes. in this patient, the imaging appearances were likely secondary to hypoxia from cardiac arrest, which could have been a complication of covid-19 infection involving the myocardium. a neuropathological study has also demonstrated similar appearances in the brain after cardiac arrest in one covid-19 patient, thought to be secondary to hypoxia [13] . microvascular disruption of the endothelium in brain tissue may be responsible for extravasation of red blood cells and extensive microhaemorrhages [6, 14] . microhaemorrhages have been reported previously in a number of locations j o u r n a l p r e -p r o o f including lobar, subcortical, deep, corpus callosum, pontine, and cerebellar [2, 3] . a few studies have reported the splenium of corpus callosum as a predominant location for microhaemorrhages, with or without oedema [4, 15] . microhaemorrhages in the splenium of the corpus callosum have been reported previously in severe ards and high-altitude cerebral oedema, thought to be due to hypoxaemia [16] . it is increasingly recognised that respiratory failure may be due to micro-emboli, and these may also affect the cerebral microcirculation resulting in microthrombosis and microvascular ischaemia. linear structures resembling vessels were observed with susceptibility artefacts on swi, which are probably microthrombi. this increases the risk of stroke or ischaemia amplifying the cytokine-induced injury to the brain [17] . ischaemic stroke was a common pattern seen on both mri and ct. fifteen patients presented with large vessel stroke on ct and five patients on mri; most were severe, including bilateral mca infarct, as noted previously [2] . acute stroke seems to be the most common neuroradiological presentation in a large cohort of covid-19 patients [18] . similar findings with ischaemic changes and microhaemorrhages have also been published in isolated case reports [19] . elevated d-dimer levels were observed in most of the present patients, probably due to a hypercoagulable environment. four patients presented with intracerebral bleeds on ct and mri; causes could be due to predisposing vascular risk factors (in 76% of the patient cohort) such as hypertension, anticoagulation treatment as prophylaxis from thromboembolism, and ecmo. adem-like presentation was seen in one patient, with evidence of haemorrhage, also reported in a previous study [2] . although scattered white matter demyelinating lesions and perivenular tracking raises the possibility of a parainfectious adem-like process, the authors' impression of the overall phenotype suggested a primarily vascular insult, with secondary white matter injury. a detailed neuropathological examination of one patient has been reported recently [14] , which concluded that vascular insult was the primary driver of the neurological sequelae. at the peak of the pandemic, although delirium and neuro-cognitive symptoms were neurological and neuropsychiatric complications of covid-19 in 153 patients: a uk-wide surveillance study the emerging spectrum of covid-19 neurology: clinical, radiological and laboratory findings brain mri findings in severe covid-19: a retrospective observational study covid-19-associated diffuse leukoencephalopathy and microhemorrhages covid-19 related coagulopathy: a distinct entity? endothelial cell infection and endotheliitis in covid-19 tissue distribution of ace2 protein, the functional receptor for sars coronavirus. a first step in understanding sars pathogenesis neuropathological features of covid-19 differences of clinical manifestations according to the patterns of brain lesions in acute encephalopathy with reduced diffusion in the bilateral hemispheres pattern of brain injury in the acute setting of human septic shock covid-19: consider cytokine storm syndromes and immunosuppression hypoxic-ischemic leukoencephalopathy in man microvascular injury and j o u r n a l p r e -p r o o f hypoxic damage: emerging neuropathological signatures in covid-19 neuropathology of covid-19: a spectrum of vascular and acute disseminated encephalomyelitis (adem)-like pathology unusual microbleeds in brain mri of covid-19 patients the pattern of brain microhemorrhages after severe lung failure resembles the one seen in high-altitude cerebral edema covid-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome evolving neuroimaging findings during covid-19 covid-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features transient cortical blindness in covid-19 pneumonia; a pres-like syndrome: case report key: cord-265293-l9omunq4 authors: schönegger, carmen maria; gietl, sarah; heinzle, bernhard; freudenschuss, kurt; walder, gernot title: smell and taste disorders in covid-19 patients: objective testing and magnetic resonance imaging in five cases date: 2020-10-24 journal: sn compr clin med doi: 10.1007/s42399-020-00606-4 sha: doc_id: 265293 cord_uid: l9omunq4 smell and taste disorders are acknowledged as characteristic symptoms for sars-cov-2 infection by now. these symptoms have been linked to a neuroinvasive course of disease. in this study, we investigated five consecutive covid-19 patients with a prolonged course of dysosmia and dysgeusia. those with objectifiable alteration in taste or smell were subjected to mri with contrast agent to investigate possible involvement of the central nervous system. we found dysosmia and dysgeusia to be mostly objectifiable, but no evidence for neuroinvasiveness could be detected by mri in the late stage of the disease. alterations in taste and smell could be objectified in most patients. nevertheless, no evidence for a neuroinvasive potential could be identified by mri, at least in the late stage of disease. we encourage medical professionals to conduct specialized examinations and mris in the acute stage of disease, which guarantees an optimum patient care. although a lot of effort has been made in order to investigate this novel coronavirus, our knowledge about many pathogenic aspects of covid-19 is still limited. clinical and experimental studies proved that several coronaviruses have neuroinvasive capacities, since they show the ability to spread from the respiratory tract to the central nervous system [1] . hypothesis of neurotropism of sars-cov-2 is based on covid-19 patients with neurological manifestations. furthermore, neurological complications up to actual damage hint neurovirulence [2] . actual case reports substantiate this assumption. covid-19 can cause meningitis with a fatal outcome, which was evidenced by the case of a 24-year-old man in japan, who succumbed to the disease [3] . brain mri demonstrated hemorrhagic lesions that were consistent with acute necrotizing hemorrhagic encephalopathy [4] . another manifestation of nervous system involvement is the appearance of alterations of taste and smell [5] . anosmia and dysgeusia are by now acknowledged as significant symptoms in association with covid-19 by the american academy of otolaryngology-head and neck surgery (aao-hns) and other researches [6, 7] . case series show a high frequency of chemosensitive disorders in patients, ranging between 19.4 and 88% [8, 9] . according to vaira et al., the presence of olfactory and gustatory dysfunction may predict a milder course of disease. on the other hand, the neglect of such symptoms suggests a more severe course of disease [10] . some patients reported isolated olfactory or taste disorders, but more complained about a combined dysfunction. even though a complete recovery could be noted in regard to most patients, evidence has been found about persisting alterations in chemosensory function for a prolonged period [11] . at the shahid beheshti university of medical sciences in tehran/iran, possible olfactory bulb alterations were investigated by olfactory bulb magnetic resonance imaging. in spite of isolated sudden onset anosmia and positive sars-cov-2polymerase chain reaction during the acute phase of the carmen maria schönegger and sarah gietl contributed equally to this work. this article is part of the topical collection on covid-19 disease, the mri demonstrated normal volume and signal intensity of olfactory bulb with no sign of nasal congestion [12] . the study was conducted on five patients reporting impairment of taste and smell with confirmed sars-cov-2 infection in east tyrol. written informed consent was obtained from all participants. age ranged between 41 and 57 years, and all the participants were female. clinical data and history of symptoms were assessed anamnestically. olfactory and gustatory testing was conducted between 11 and 30 days after disease onset, which was defined as the commencement of symptoms. in case objective testing revealed alterations in taste or smell, patients were subjected to mri in a timely manner. a follow-up examination was conducted in three of the patients whose mri raised suspicion of alterations in the first run. olfactory and gustatory function assessment was carried out by means of burghart screening 12 test with taste strips in accordance with the manufacturer's instructions [13, 14] . in order to evaluate olfactory function, an identification test, called sniffin' sticks, was performed [13] . twelve common odorants were consecutively presented to the patient close to both nostrils. out of four options the participant was requested to identify the presented smell. results were interpreted according to a scoring system considering patients age. a score above ten was determined as normal, between six and ten a hyposmia was diagnosed and a score below six was reported as anosmia. gustatory testing was performed by taste strips covering the four basic gustatory qualities sweet, salty, sour, and bitter [14] . taste strips were applied on patient's tongue. for each stripe, the test person had to choose the corresponding odor from four answers. according to the count of correct answers, four categories of classification were established: normal (score 4), mild hypogeusia (score 3), moderate hypogeusia (score 2), severe hypogeusia (score 1), and ageusia (score 0). a standard brain mri protocol was used involving axial t2 tse, axial flair, axial dwi (b0 and b1000), dadc, axial t2w ffe, and isotropic t1w 3d ir tfe with a 1-mm slice thickness without contrast media and cet1w 2d mprage, on a 1.5t prodiva philips mri machine. the 3d t1 sequences with and without contrast were reconstructed in coronal, axial, and sagittal projection for the radiologic evaluation. a short-term follow-up examination 10 days later was performed with the same axial flair and dwi/dadc. sequences were used as well as isotropic 3d t2 and 3d flair sequences (appendix). olfactory and gustatory testing was conducted between 11 and 30 days after onset of disease, which was defined as the commencement of symptoms. out of the five patients three showed a manifest anosmia, one result was rated as a hyposmia and one as normosmia. gustatory testing revealed two normal scores (4/4), one moderate hypogeusia (2/4), one severe hypogeusia (1/4), and one ageusia (0/4). detailed results are summarized in table 1 . three weeks after the first olfactory and gustatory examination, a follow-up testing was conducted with the three patients who also had a second mri. this investigation revealed one persistent anosmia (5/12), one persistent hyposmia (7/12), and one patient's condition improved from anosmia to hyposmia (10/12). gustatory testing showed an enhancement in two patients (3/4; 4/4); one patient had the same score (4/4). detailed results are summarized in table 2 . none of the patients showed any changes in the paranasal sinuses, not even small fluid collections or mucosal swelling. the cribriform plate was normal in all cases, and the olfactory nerve was normal in size and signal, without any side differences and there was no neuronal or perineural enhancement. the meninges showed no enhancement or thickening. the gyrus rectus was normal in size and signal intensity in all patients and showed no swelling. no signal changes in the medial temporal lobes or the thalami could be found and no hemorrhagic microbleeding in t2* sequences were observed. even though ischemic events and leptomeningeal enhancement have already been reported, there were no signs for an acute or chronic ischemic event [15] . in the first examination, one patient showed a symmetric, slightly hyperintense signal in the head of the caudate nucleus, parahippocampal gyrus, and the uncus, predominantly on the left side. in t2, the area appeared thicker and swollen with a higher si, but all the other sequences including dwi were normal. also, si measurements were slightly elevated with values of 1021 compared to 865 on average in primarily healthy individuals. in the follow-up examination, there was a slight drop to 970, but the additional high-resolution 3d flair and t2 images showed no anomalies, so probably this finding lies within the normal range. all the other patients had a normal brain mri (images 1, 2, and 3). in contrast to galougahi et al., we evaluated symptom status in the late stage of covid-19 [11] . the smell and taste disorders could mostly be objectified, although not in regard to all patients, which underlines the necessity of objective testing. compared to dell'era et al., who reported a median recovery time of 10 days, our findings show that olfactory impairment is a long-lasting sequela of covid-19 [16] . even after 30 to 50 days, patients still suffered from objectifiable smell and taste disorders. in order to rule out permanent damage, further surveillance is necessary. however, it should be notified that a loss of smell and taste is not pathognomonic for covid-19, as it appears as well in the course of other respiratory infections. nevertheless, controlled studies indicate that anosmia is more common in covid-19 patients than in patients suffering from other viral infections or controls [17] . in contrast to other infectious smell impairments, a loss of smell and taste in covid-19 seems to be rarely accompanied by a severely blocked nose [18] . the first mri images showed slight alterations in one patient, which could be associated with a sars-cov-2 infection. however, the follow-up examination contradicted this assumption. image 2 mri cor t1 the mri investigation in our patients taught us two things: first, at least in chronic stages of the illness, we did not gain any evidence of prolonged neuroinvasive association. up to now, mri investigations have focused on the acute stage of illness and are very rare. in our case, the organization was hindered by the concern that such investigations might be an incalculable risk for the staff involved. according to politi et al., conducting an mri examination in a patient suffering from persistent severe anosmia and dysgeusia, cortical hyperintensity in the right gyrus rectus could be detected 4 days after symptom onset. consistent with our results, a complete resolution of the previously seen signal alterations could be observed in a follow-up imaging 28 days after symptom onset [19] . contrary to assumptions of other researchers, no evidence of a general neuroinvasiveness could be given, at least in the chronic stage of disease [20] . more extensive studies in the acute stage of illness followed by long-term follow-ups are desirable. contrary to other evaluations, our study population is rather small which is a limiting factor to the informative value. as hygiene measures proved to be sufficient avoiding contagion, we encourage medical professionals to conduct specialized examinations and mris in the acute stage of disease, which guarantees an optimum patient care. authorship contribution sg and cms wrote the manuscript and were responsible for the organization. bh was responsible for magnetic resonance imaging, kf for the objective olfactory and gustatory testing. gw supervised and reviewed the manuscript. conflict of interest the authors declare that they have no conflict of interest. consent for publication written informed consent was obtained from all participants. ethics approval ethical approval was not necessary as the evaluation was performed in the course of patient care and clinical monitoring. human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? viruses neurological complications of coronavirus and covid-19 a first case of meningitis/ encephalitis associated with sars-coronavirus-2 covid-19-associated acute hemorrhagic necrotizing encephalopathy: ct and mri features evidence of the covid-19 virus targeting the cns: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms covid-19 anosmia reporting tool, american academy of otolaryngology-head and neck surgery self-reported loss of smell and taste in sars-cov-2 patients: primary care data to guide future early detection strategies isolated sudden onset anosmia in covid-19 infection. a novel syndrome? olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (covid-19): a multicenter european study olfactory and gustatory function impairment in covid-19 patients: italian objective multicenter-study objective evaluation of anosmia and ageusia in covid-19 patients: single-center experience on 72 cases olfactory bulb magnetic resonance imaging in sarscov-2-induced anosmia: the first report normative data for the "sniffin' sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects taste strips" -a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers neurologic features in severe sars-cov-2 infection smell and taste disorders during covid-19 outbreak: cross-sectional study on 355 patients the role of self-reported smell and taste disorders in suspected covid-19 predictive value of sudden olfactory loss in the diagnosis of covid-19 magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (covid-19) and anosmia sars-cov-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations key: cord-003095-m9hmv8c8 authors: zhang, ya-zhou; cao, xu-yang; li, xi-cheng; chen, jia; zhao, yue-yuan; tian, zhi; zheng, wang title: accuracy of mri diagnosis of early osteonecrosis of the femoral head: a meta-analysis and systematic review date: 2018-07-04 journal: j orthop surg res doi: 10.1186/s13018-018-0836-8 sha: doc_id: 3095 cord_uid: m9hmv8c8 objective: to evaluate the overall diagnostic value related to magnetic resonance imaging (mri) in patients with early osteonecrosis of the femoral head. methods: by searching multiple databases and sources, including pubmed, cochrane, and embase database, by the index words updated in december 2017, qualified studies were identified and relevant literature sources were also searched. the qualified studies included prospective cohort studies and cross-sectional studies. heterogeneity of the included studies were reviewed to select proper effect model for pooled weighted sensitivity, specificity, and diagnostic odds ratio (dor). summary receiver operating characteristic (sroc) analyses were performed for meniscal tears. results: forty-three studies related to diagnostic accuracy of mri to detect early osteonecrosis of the femoral head were involved in the meta-analysis. the global sensitivity and specificity of mri in early osteonecrosis of the femoral head were 93.0% (95% ci 92.0–94.0%) and 91.0% (95% ci 89.0%–93.0%), respectively. the global positive likelihood ratio and global negative likelihood ratio of mri in early osteonecrosis of the femoral head were 2.74 (95% ci 1.98–3.79) and 0.18 (95% ci 0.14–0.23), respectively. the global dor was 27.27 (95% ci 17.02–43.67), and the area under the sroc was 93.38% (95% ci 90.87%–95.89%). conclusions: this review provides a systematic review and meta-analysis to evaluate the diagnostic accuracy of mri in early osteonecrosis of the femoral head. moderate to strong evidence indicated that mri appears to be significantly associated with higher diagnostic accuracy for early osteonecrosis of the femoral head. avascular necrosis of femur head (anfh), or osteonecrosis of the femoral head, is a pathologic process, which was first seen in the weight-bearing area of the femur. the stress can lead to bone trabecular structure injury (microfracture) and influence the repair process of the femur, and if not managed timely, it leads to the collapse and deformation of the femur. with many etiological factors, anfh results from interruption of blood supply to the bone and then leads to ischemic necrosis. anfh can be divided in traumatic anfh and non-traumatic anfh with the non-traumatic anfh further dividing into steroid-induced and alcoholic non-traumatic anfh and so on. the timely treatment of early anfh could promote the recovery the disease. however, in the late stage, it results in femur collapse, loss of hip function, and a very poor outcome that affects the quality of life. therefore, the early diagnosis of anfh is of great significance [1] [2] [3] . several methods for early diagnosis of anfh have been proposed, including mri, spect, ct, x-ray, dsa, and laser doppler with different characteristics. mri has been characterized as being non-invasive, rapid and high sensitive, and commonly used by many clinicians [4] [5] [6] . furthermore, mri has been used in many studies in the diagnosis of early anfh. therefore, in this paper, a systematic review and meta-analysis of all qualified studies were performed to explore the diagnosis accuracy of mri in early anfh. the following electronic databases were searched from their inception to december 2017: the cochrane, pubmed, embase database, for all the qualified trails that analyze the diagnostic accuracy of mri of early osteonecrosis of the femoral head. other related articles and reference materials were also identified for additional available studies. the literatures were searched independently by two investigators, and a third investigator was involved to reach an agreement. the studies that met the following criteria were included in our review: (1) prospective cohort study or cross-sectional study; (2) the research objects are patients suspected with early osteonecrosis of the femoral head without other serious diseases; (3) the studies provided the data of true positive (tp), false positive (fp), false negative (fn), and true negative (tn); and (4) the publications were only available in english and chinese. the studies that met the following criteria were excluded in our review: (1) repeat publications, or shared content and results; (2) case report, theoretical research, conference report, systematic review, meta-analysis, expert comment, and economic analysis; (3) the outcomes were not relevant; and (4) two or more results of the tp, fp, fn, and tn were zero. two independent investigators extracted the following data based on predefined criteria. differences were settled by discussion with a third reviewer. the analyses data were extracted from all the included studies and consisted of two parts: basic information and main outcomes. the first part was about the basic information: the author name, the sample size, the percentage of male, and the age. the second part was the clinical outcomes. a 2 × 2 contingency table was constructed for each selected study; the results corresponding to the gold standard and mri were selected as positive or negative. the data included true positive (tp), false positive (fp), false negative (fn), and true negative (tn). in studies in which one single cell in the 2 × 2 contingency table had a value of 0, 0.5 were added to all of the cells for calculation. sensitivity, specificity, and likelihood ratio were calculated respectively, and the diagnostic odds ratio (dor) was used as the measure of diagnostic accuracy. a dor value of 1 indicates a test without discriminatory power, and the higher the dor value is, the greater the degree of relevance of the assessed diagnostic test. the studies were performed by two reviewers independently. any arising difference was resolved by discussion. all statistical analyses were performed in the stata 10.0 (tx, usa). chi-squared and i 2 tests were used to assess the heterogeneity of clinical trial results and determine the analysis model (fixed-effects model or random-effects model). when the chi-squared test p value was ≤ 0.05 and i 2 test value was > 50%, it was defined as high heterogeneity and assessed by random-effects model. when the chi-squared test p value was > 0.05 and i 2 tests value was ≤ 50%, it was defined as acceptable heterogeneity data and assessed by fixed-effects model. for further assessment of heterogeneity, diagnostic threshold analysis was performed based on the correlation (spearman's) between the logit of sensitivity and the logit of [1-specificity] . when a threshold effect occurs, the sensitivity and specificity of the investigated study exhibits negative correlation (or a positive correlation between sensitivity and [1-specificity]). therefore, a strong positive correlation between sensitivity and [1-specificity] suggests the presence of a threshold effect. when heterogeneity caused by threshold effect was observed, a summary receiver operating characteristic (sroc) curve was plotted. this method was appropriate given that the global sensitivity and specificity values were overestimated. in such cases, analysis of the roc panel points, as well as analysis of the sroc curve, was recommended. deeks' funnel asymmetry plot was used to identify the publication bias. a total of 2092 articles were searched by the indexes. after screening the titles and abstracts, 1986 articles were excluded, leaving 106 articles for further selection. during full-text screening, 63 articles were excluded due to the following criteria: unqualified outcomes [7] , theoretical research or review [8] , and has non clinical outcome [9] . at last, 43 studies with 3133 hips were involved in the final meta-analysis. the selection process was presented in fig. 1 . the main characteristics of the included studies were summarized in table 1 . the basic information included number of hips, age, and gender. all the included studies reported the results of the accuracy of mri of early osteonecrosis of the femoral head. based on the correlation (spearman's r = − 0.209, p = 0.589) between the logit of sensitivity and the logit of [1-specificity], there was no threshold effect. based on the chi-squared test (q = 166.45, p = 0.000) and i 2 tests (i 2 = 74.6%), heterogeneity was high, so we chose the random-effects model to analyze the sensitivity. the global sensitivity was 93.0% (95% ci 92.0-94.0%, fig. 2 ). based on the chi-squared test (q = 144.43, p = 0.000) and i 2 tests (i 2 = 70.9%), heterogeneity was high. therefore, we chose the random-effects model to analyze the specificity, and the global specificity was 91.0% (95%ci 89.0-93.0%, fig. 3) . based on the chi-squared test (q = 125.33, p = 0.000) and i 2 tests (i 2 = 66.5%), heterogeneity was high, so we chose random-effects model to analyze the positive likelihood ratio, and the global positive likelihood ratio was 2.74 (95% ci 1.98-3.79, fig. 4 ). therefore, a positive mri result was increased by 2.74-fold in the odds of an accurate diagnosis of patients who actually had early osteonecrosis of the femoral head. based on the chi-squared test (q = 69.58, p = 0.005) and i 2 tests (i 2 = 39.6%), with low heterogeneity, we chose the fixed-effects model to analyze the negative likelihood ration. the global negative likelihood ratio was 0.18 (95% ci 0.14-0.23, fig. 5 ), indicating the use of mri, which was close to zero. specifically, the odds of a false-positive result were increased by only a factor of 0.18. based on the chi-squared test (q = 59.71, p = 0.037) and i 2 tests (i 2 = 29.7%), heterogeneity was low, so we chose the fixed-effects model to analyze the dor, with the global dor being 27.27 (95% ci 17.02-43.67, fig. 6 ). and the odds of a positive mri result were 27.27-fold higher among individuals with early osteonecrosis of the femoral head compared to those without the disease. the area under the sroc was 93.38% (auc = 93.38%; 95% ci 90.87%-95.89%, fig. 7) , indicating high accuracy. several systematic reviews and meta-analysis have been published concerning the diagnostic accuracy of mri of early osteonecrosis of the femoral head. li et al. [51] found that the sensitivity and specificity of mri were 95%(95% ci 94-96%) and 77%(95% ci 70-83%), respectively. moreover, the dor was 31.89%(95% ci 17.32-58.70%), and the auc under the sroc was 0.9166. mri was associated with high diagnostic accuracy in the patients with suspected early anfh. song et al. [52] , who included 21 articles, reported that mri was more effective than ct in diagnosing anfh. significant statistical difference was identified between them (or, 0.13; 95% ci 0.03-0.51). su et al. [53] , who included 8 studies of 515 patients, found the anfh positive rate between ct and mri was statistically significant (or, 0.12; 95% ci 0.04-0.33), so as the early stage positive rate (or, 0.45; 95% ci 0.26-0.78). therefore, mri appears to be a promising diagnostic tool for avascular necrosis of the femoral head. however, there were several limitations in this analysis: (1) differences in the inclusion and exclusion criteria for fig. 6 forest plot showing the diagnostic odds ratio of mri of early osteonecrosis of the femoral head patients, (2) different patients with previous disease and treatments were unavailable, (3) all the included studies were from english and chinese articles, which may be the source of bias, (4) the fluency of technicians between different studies varied, and (5) pooled data were used for analysis, and individual patients' data were unavailable, which limited a more comprehensive analysis. in summary, in this systematic review and meta-analysis, mri as a diagnostic method is associated with higher accuracy for detecting anfh. more studies and randomized controlled trails with high-quality and large samples are warranted for further evaluation. ethics approval and consent to participate not applicable. nontraumatic necrosis of bone (osteonecrosis) core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis early magnetic resonance imaging and histologic findings in a model of femoral head necrosis idiopathic bone necrosis of the femoral head. early diagnosis and treatment in brief: ficat classification: avascular necrosis of the femoral head comparative analysis of ct and mri in diagnosis of femoral head necrosis comparative study of ct and mri in diagnosis of 100 cases of femoral head necrosis the value of contrast mri and ct in the early diagnosis of femoral head necrosis the application value of ct and mri in early diagnosis of osteonecrosis of the femoral head the application value of ct and mri in early diagnosis of osteonecrosis of the femoral head the value of ct and mri in the diagnosis of early femoral head necrosis the value of ct and mri in the diagnosis of femoral head necrosis application value of ct and mri in the diagnosis of early femoral head necrosis ct and magnetic resonance imaging (mri) in the diagnosis of femoral head necrosis in comparison mri and ct diagnosis of avascular necrosis of the femoral head comparative analysis of ct and mri in the diagnosis of early necrosis of femoral head comparative analysis of ct and mri in the diagnosis of early necrosis of femoral head summary roc plots for diagnostic accuracy of mri of early osteonecrosis of the femoral head clinical value of mri in the diagnosis of early necrosis of femoral head comparative analysis of diagnostic value of x -ray, ct and mri in early diagnosis of avascular necrosis of femoral head analysis on diagnosis value of mri in early femoral head necrosis comparison of x-ray, ct and mri in the diagnosis of early avascular necrosis of femoral head application of spiral ct and high field mri in the early diagnosis of adult femoral head necrosis clinical value of ct and mri in diagnosis of early osteonecrosis of femoral head in adults clinical value of ct and mri in diagnosis of early osteonecrosis of femoral head in adults clinical value of ct and mri in diagnosis of early osteonecrosis of femoral head in adults patients with avascular necrosis of the femoral head using mri, spiral ct examination contrast. china reflexolocy comparison of multislice spiral ct and mri in the clinical diagnosis of femoral head necrosis comparative study of ct and mri in patients with femoral head necrosis femoral head necrosis in patients with a comparative study of ct and mri diagnosis comparative analysis of ct and mri radiological diagnosis of femoral head necrosis comparative analysis of ct and mri in diagnosis of avascular necrosis of femoral head comparison of ct and magnetic resonance imaging in diagnosis and treatment of femoral head necrosis effect of ct and mri in diagnosing femoral head necrosis diagnostic value of two methods of mri and ct in avascular necrosis of femoral head mri combined with ct in the diagnosis of avascular necrosis of the femoral head observation on the mri diagnosis on ischemic bone necrosis and surgical treatment the value of ct and mri examination in the early diagnosis of adult femoral head necrosis low field strength mri diagnosis of avascular necrosis of femoral head diagnostic value of multislice spiral ct and mill on femoral head necrosis evaluation of the value of multislice spiral ct and mri in the diagnosis of femoral head necrosis early diagnosis of avascular necrosis of femoral head in adults early osteonecrosis of the femoral head: detection in high-risk patients with mr imaging evaluation of magnetic resonance imaging in the diagnosis of osteonecrosis of the femoral head. accuracy compared with radiographs, core biopsy, and intraosseous pressure measurements the diagnostic value of magnetic resonance imaging in non-traumatic osteonecrosis of the femoral head the value of magnetic resonance imaging in the early diagnosis of noninvasive avascular necrosis of femoral head bone spect is more sensitive than mri in the detection of early osteonecrosis of the femoral head after renal transplantation comparative study of radionuclide scanning and mri in diagnosis of avascular necrosis of femoral head in early adults avascular necrosis in severe acute respiratory syndrome: mr imaging with radionuclide correlation diagnostic value of ct and mri in the early stage of adult femoral head necrosis meta-analysis of mri diagnosis of early avascular necrosis of femoral head meta-analysis of ct and mri diagnosis of avascular necrosis of femoral head meta-analysis of ct and mri diagnosis of avascular necrosis of femoral head the authors declare that they have no competing interests. key: cord-306611-8s4scr7r authors: fattore, julia; goh, daniel soon lee; al-hindawi, ahmad; andresen, david title: revisiting the important role of magnetic resonance imaging (mri) in long bone acute osteomyelitis: a case report of methicillin resistant staphylococcus aureus acute tibial osteomyelitis with conventional radiography, computed tomography, and mri date: 2020-08-22 journal: radiol case rep doi: 10.1016/j.radcr.2020.07.079 sha: doc_id: 306611 cord_uid: 8s4scr7r the tibia is an atypical site of osteomyelitis (om) in adults, and patients with this infection experience a significant degree of morbidity as well as the need for prolonged aggressive antibiotic therapy. the early diagnosis of om remains challenging, and often relies on imaging modalities which are of variable sensitivity. we present a case of a 49-year-old male with a methicillin resistant staphylococcus aureus (mrsa) left tibial om, contiguous left knee septic arthritis, and concurrent bacteraemia. eight days after the onset of pain in the left knee and lower limb, conventional radiography and computed tomography (ct) imaging had only subtleties of a soft tissue collection and a knee effusion. a mri demonstrated significant involvement of his tibial bone with a collection, from which surgical specimens confirmed mrsa. this case demonstrates the difficulty of diagnosing early acute om with conventional radiography and ct imaging, even after a week of symptoms in the affected limb. given the poor sensitivity of conventional radiography and ct in the diagnosis of early acute om, this case report illustrates how mri is the imaging modality of choice in this setting. mrsa. this case demonstrates the difficulty of diagnosing early acute om with conventional radiography and ct imaging, even after a week of symptoms in the affected limb. given the ✩ informed consent was gained from the patient for the manuscript. ✩✩ acute osteomyelitis (om), a bacterial infection of the bone, is a serious condition which has the potential to result in significant morbidity and high economic impacts on both the individual and the health care systems. it can develop as a complication of contiguous spread from an overlying soft tissue or joint infection, direct inoculation via an open fracture, following surgical or other procedures, or via haematogenous seeding [1] . om has a bimodal age distribution, with acute and subacute haematogenous om more common in children and the metaphysis of long bones being the primary site of pediatric infection [2] . in adults, direct inoculation of bone is the more common mechanism of bone infection, typically associated with open trauma in young adults, with contiguous soft tissue infection in diabetics, and with implant surgery such as hip and knee replacements in older adults. typical sites of nonimplant-associated adult om are the tarsal, metatarsal, toe and vertebral bones. adults at increased risk for hematogenous om include intravenous drug users, patients with indwelling catheters, the immunosuppressed, and those with compromised vascular supply [3 ,4] . the majority of acute om cases are monomicrobial and usually caused by staphylococcus aureus, both methicillin sensitive and methicillin resistant. polymicrobial infections are more likely to be seen on om complicating a contiguous focus of sepsis or open trauma. in this setting, common microorganisms including coagulase negative staphylococci, streptococci, enterococci, pseudomonas aeruginosa, the enterobacterales (enteric gram-negative rods), anaerobes, and in some epidemiological contexts mycobacterium tuberculosis [1 ,5-7] . goals of om therapy includes eradication of infection, minimization of complications, and the restoration of functionality. for this to occur, many patients require a combination of both medical treatment and surgical intervention to ensure adequate drainage of all infected tissue and removal of any hardware present. however, the diagnosis of acute om remains a challenge in clinical practice. along with the assessment of history, clinical examination, microbiological and biochemical laboratory results, the use of imaging is central to the diagnosis of om. plain x-rays are the initial imaging modality of choice and are useful in detecting noninfectious bony disease and more advanced sequelae of om, such as destructive changes of the bone. however, plain films are of variable sensitivity and early infection may not be evident on the initial images [8] . computed tomography (ct) also has utility in the setting of om, where it is particularly useful in detection of sequestrum in the setting of chronic om [9] . as with plain x-rays, though, ct is limited in its ability to demonstrate bone marrow oedema which is a key feature of acute om [10] . hence ct scans are often not diagnostically useful in the acute setting. magnetic resonance imaging (mri) on the other hand, appears to be the most sensitive imaging modality in acute om and can demonstrate early features of infection such as bone marrow oedema just days after infection onset [11 ,12] . in a meta-analysis of the accuracy of diagnostic tests for om in diabetic patients with foot ulcers, dinh et al. showed that plain radiography had a sensitivity of 0.54 and a specificity of 0.68 whereas mri had a sensitivity of 0.90 and a specificity of 0.79 [8] . furthermore mri has the ability to detect associated soft tissue changes and micro-abscesses whether intraosseous or extraosseous which can assist in surgical drainage targets and source control [13] . in this case report, we describe a patient with acute tibial om secondary to haematogenous dissemination who did not have diagnostic features of om on conventional radiographs or ct. he had vivid features of om on mri, supporting the notion that acute om may often require mri for diagnosis when initial conventional imaging is unremarkable. a 49-year-old caucasian male who presented with a 7-day history of fevers, progressive knee pain, and limited range of motion in his left lower limb. presentation for medical review was delayed due to concerns regarding coronavirus disease 2019 infection (covid-19). he had a background history of intravenous injecting drug use 10 years prior, current oral opioid maintenance, and a recent prolonged hospital admission for a left sacroiliac om and a right wrist septic arthritis caused by bacteroides fragilis and streptococcus agalactiae . this had required removal of metal hardware and multiple washouts. the patient further reported a right dorsal foot injury 3 months prior to admission where he sustained a cut from an oyster which had developed into a chronic wound which was described to have had purulent discharge in the weeks prior to admission. other relevant history included a long history of motocross sporting injuries with multiple long bone fractures in his upper limbs and previous skin grafts to these sites. the patient's vital signs were all within normal limits and he was afebrile. physical examination revealed warmth over the left lower limb at the tibial plateau and the left knee. the knee had no clinically evident effusion and preserved passive range of motion. the patient had mild peripheral oedema of the left leg in comparison to the right. there was no erythema, overlying skin lesion or indication of recent trauma in the left leg. he had an ulcerated ovoid wound (8 × 5 cm) over his right foot (see fig. 1 ) with minor purulent discharge. there was no erythema, pain, warmth or tenderness over his left sacroiliac area or right wrist, the sites of his previous infection. his cardiorespiratory and gastrointestinal tract examination were unremarkable. admission investigations revealed that he had a raised white cell count of 16 × 10 9 /l with a neutrophilia of 13.8 × 10 9 /l. his hemoglobin was 105 with a microcytosis, his platelet count was 413 and his c-reactive protein was 212. he had normal renal function and only trivial derangement of liver function tests. blood cultures taken on admission grew a nonmultiresistant methicillin resistant s. aureus with a vancomycin minimal inhibitory concentration of 1 μg/ml. a swab of the right foot wound grew mrsa sensitive to rifampicin, fusidic acid, trimethoprim/sulfamethoxazole, doxycycline and clindamycin. surgical specimens from the left knee and tibial washout grew an identical mrsa. x-ray imaging of the patient's left knee demonstrated a small joint effusion (see fig. 2 ). there were no erosive or destructive changes. x-ray of the right foot was noncontributory. on ct of the left leg there was no bony erosion, periostitis, acute fracture, or left knee effusion identified (see fig. 3 ). there was a small volume of complex fluid between the medial head of the gastrocnemius and soleus muscles, which was suggested to be an acute rupture of the plantaris tendon, although clinically this was unlikely in the absence of acute onset pain. with the patient's ongoing pain, raised inflammatory markers and the identification of mrsa bacteraemia, there was a suspicion of tibial om. mri performed on day 12 after symptom onset demonstrated heterogeneous marrow signal with areas of t2 weighted hyperintense confluent change and patchy enhancement following gadolinium administration in the proximal tibia, as well as a multilobulated collection extending along the posterior cortex (see fig. 4 ). there was a small infected suprapatellar joint effusion and increased oedema in hoffa's fat pad. on subsequent mri imaging a week later, a focal defect in the posterior cortex of the tibia at the proximal metaphysis was visualized, highlighting the anatomical path of contiguous spread from the tibia into the left knee joint. following diagnostic confirmation of the patient's acute om by the mri scan, he underwent an operative washout of the areas of bony infection. intravenous vancomycin and oral clindamycin 450mg 4 times daily were administered. the infected right foot wound, which presumably represented the original portal of entry of his bloodstream infection, was treated with bedside debridement, microdacyn spray and compression bandaging. following these interventions, the patient improved significantly, and further blood cultures were negative for mrsa. a minimum of 6 weeks aggressive antimicrobial therapy was planned. this case illustrates the diagnostic challenges often encountered in a patient clinically suspected to have acute haematogenous om. despite clinical features, microbiological and other laboratory findings that supported a diagnosis of fig. 4 -selected sagittal and axial slices, t1 spectral presaturation with inversion recovery following the administration of gadolinium (a and b), and t2 fat saturation (c and d) sequences demonstrate marked marrow oedema in the proximal tibia with patchy gadolinium enhancement. there is a focal area (x) of cortical thinning with possible breach. no intraosseous abscess is visible. there is an adjacent fluid collection (short arrows) with peripheral enhancement consistent with abscess formation (arrowheads). oedema and enhancement extend to the soft tissues, involving hoffa's fatpad, the adjacent musculature, and subcutaneous tissues. there is also a small enhancing suprapatellar effusion (long arrow) suggesting articular involvement. om, the patient's initial tibial imaging results by conventional radiography and ct were unconvincing. further assessment by mri was required before a definitive diagnosis could be made and hence appropriate medical and surgical treatment initiated. this underscores the importance of pursuing bone imaging in the form of mri in the setting of suspected early acute om, particularly when the clinical concern for bone infection presentation is unsupported by the conventional radiography and ct findings. despite its demonstrable utility, the limited availability of mri and contraindications to using this modality make the appropriate imaging pathway for acute om an ongoing challenge. while mri confers several advantages in the diagnosis of om, there are several instances and settings where mri may not be practicable or possible, placing significant limitations on its utility [10] . some contraindications include devices, such as permanent pacemakers not compatible with mris, or metallic foreign objects in certain locations, such as in the eye, and even aneurysm coils that have been inserted previously. in addition, imaging artifacts from metallic hardware or prostheses may obscure findings despite the use of modern artifact suppression techniques. similarly, hardware artifacts may also complicate ct interpretation in suspected prosthesis-associated infections. mri is still not widely available in certain practice settings, particularly in remote and rural healthcare environments. in certain patient populations assessment with mri may also be difficult, such as patients with claustrophobia or those who may require general anesthesia, such as those with movement disorders or young children. alternative imaging methods for acute om may also be considered in settings where mri may not be practicable, such as the use of nuclear imaging modalities and dual energy-ct. several nuclear imaging techniques may be considered, including positron emission tomography (pet) scans, 3-phase bone scans, and tagged white blood cell scans. in these scans, areas of increased uptake of injected radionuclide can be detected by a gamma camera, and correspond with areas of abnormal bone metabolism suggesting the presence of om [9] . a recent meta-analysis by treglia et al. suggested that fluorine-18-labeled fluorodeoxyglucose pet imaging and pet/ct imaging were useful in the suspected om related to diabetic foot with high specificity [14] . however, several other pathological processes can also result in abnormal bone metabolism, such as degenerative bone disease or tumors. there may also be poor anatomical localization of disease, even when ct co-registered images are produced, usually inferior to that achieved with mri [15] . there has also been interest in the applications of dual energy-ct (dect), where it has several uses, such as in the detection of monosodium urate deposition in gout, and in the detection of bone marrow oedema, particularly in the setting of fractures [16] . a systematic review by suh et al., which included 12 studies, that assessed the sensitivity and specificity of dect in detecting bone marrow oedema found that dect had excellent sensitivity and specificity for bone marrow oedema detection, with a pooled specificity of 0.97 and a pooled sensitivity of 0.85 [17] . more recently, muller et al. investigated the utility of dect, in comparison to mri, in assessing bone marrow oedema and fracture in those with wrist trauma and suspected wrist fracture who had negative radiographs, and found that in terms of detection of bone marrow oedema, dect had a high specificity and moderate sensitivity [18] . however, despite increasing evidence in the use dect in bone marrow oedema detection, whether this translates to better diagnostic utility in acute om compared to other more established imaging modalities remains uncertain and hence should be the subject of further future research directions. acute haematogenous long bone om with contiguous spread into an adjacent joint is a rare occurrence in adults in modern times, although it was well described in the preantibiotic era. at the onset of om, imaging studies including conventional radiography and ct may appear unremarkable, lacking features suggestive of acute active infection. this case report highlights the significant disease severity that can be demonstrated on a mri in the setting of a normal conventional radiography and computed tomography imaging. whilst there are several practical limitations to the use of mri that may preclude its universal use, this case underscores its potential utility in the early diagnosis of acute om in order that timely and appropriate management and treatment can be initiated in such patients. the host and the skeletal infection: classification and pathogenesis of acute bacterial bone and joint sepsis mandell, douglas, and bennett's principles and practice of infectious diseases osteomyelitis-a historical and basic sciences review bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes microbiology and management of joint and bone infections due to anaerobic bacteria trends in the epidemiology of osteomyelitis: a population-based study diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy. seminars in plastic surgery. © thieme medical publishers the imaging of osteomyelitis radiologic approach to musculoskeletal infections infection: musculoskeletal soft-tissue infections and their imaging mimics: from cellulitis to necrotizing fasciitis diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis current concepts in posttraumatic osteomyelitis: a diagnostic challenge with new imaging options dual-energy ct: a promising new technique for assessment of the musculoskeletal system diagnostic performance of dual-energy ct for the detection of bone marrow oedema: a systematic review and meta-analysis dual-energy ct for suspected radiographically negative wrist fractures: a prospective diagnostic test accuracy study key: cord-272623-j5gpww9q authors: sun, wei; shi, zhencai; gao, fuqiang; wang, bailiang; li, zirong title: the pathogenesis of multifocal osteonecrosis date: 2016-07-11 journal: sci rep doi: 10.1038/srep29576 sha: doc_id: 272623 cord_uid: j5gpww9q our objective was to study the incidence, etiology, and diagnosis of multifocal osteonecrosis (mfon) and its treatment options to facilitate an earlier diagnosis and to optimize treatment. a radiological investigation was performed in osteonecrosis patients with a high risk of mfon for a more accurate diagnosis between january 2010 and june 2015. for patients with osteonecrosis of both the hip and knee joints or for patients with a history of corticosteroid use or alcohol abuse who had osteonecrosis of one or more joints in the shoulder, ankle, wrist or elbow, magnetic resonance imaging (mri) was also performed on other joints, regardless of whether these joints were symptomatic. furthermore, we performed a radiological screening of 102 patients who had a negative diagnosis of mfon but were at a high risk; among them, another 31 mfon cases were successfully identified (30.4%). thus, the incidence of mfon during the study period increased from 3.1% to 5.2%. patients diagnosed with osteonecrosis and who are at a high risk of mfon should have their other joints radiologically examined when necessary. this will reduce missed diagnosis of mfon and facilitate an earlier diagnosis and treatment to achieve an optimal outcome. between january 2010 and june 2015, only 48 of the 1507 osteonecrosis patients under our care were diagnosed with mfon (3.1%) upon admission. after the comprehensive evaluation of the joints of 102 patients who had a negative diagnosis of mfon but who were at a high risk, another 31 cases of mfon were successfully identified (30.4%). consequently, the incidence of mfon during the study period increased to 5.2%. the mfon patients admitted to our center had a mean number of 5.7 osteonecrotic lesions, similar to the mean number of lesions (5.8) found in post-sars mfon patients. the associated factors, diseases, and comorbidities are listed in table 1 . of the 48 patients diagnosed with mfon on admission between 2010 and 2015, 31 were male and 17 were female. forty-seven of the 48 mfon patients had a history of corticosteroid use, and the remaining one patient had a history of alcohol use. of the patients with a history of corticosteroid use, 18 had sle, nine had chronic nephropathy, five had hematological diseases (four had acute lymphoblastic leukemia and one had non-hodgkin's lymphoma), five had an organ transplantation (four had a renal transplantation and one had a cardiac transplantation), three had sjogren's syndrome, two had dermatomyositis, two had multiple sclerosis and three received steroid therapy for trauma emergency. of the 31 newly diagnosed mfon patients, 19 were male and 12 were female. all of them had a history of corticosteroid use. fifteen patients had sle, eight had acute lymphoblastic leukemia, five had chronic nephropathy, and three had an organ transplantation (two had a renal transplantation and one had a hepatic transplantation). the mfon patients most commonly had osteonecrosis of the femoral head, followed by the knee, shoulder and ankle bones. the majority of patients had bilateral lesions (hips, knees and shoulders) (fig. 1, table 2 ). there was a significant difference in the number of mfon patients identified after the radiological screening based on risk factors compared with that before the screening (p < 0.05). incidence of mfon. there have not been any journal articles in china concerning mfon, and such reports were also limited in other countries. mont et al. 1 studied 101 mfon cases diagnosed between 1980 and 1996 from 21 centers in the united states. according to the available data from 12 centers concerning their total number of patients with osteonecrosis, 81 patients had mfon of the 2484 patients (3.3%) diagnosed with osteonecrosis. in 2003, we screened post-sars medical workers with corticosteroid use and found 37 patients had mfon of the 176 patients (21%) with a diagnosis of osteonecrosis. by contrast, between 2005 and 2009, we found only 17 patients with mfon of the 657 patients (2.6%) diagnosed with osteonecrosis who were admitted to our center. the incidence of mfon in post-sars osteonecrosis patients was obviously higher than that in daily clinical practice. this is because the lesions found in joints, such as the knees, shoulders and ankles, in the early stages of mfon cases may not have any signs or symptoms. in our screening of post-sars patients, all of them had a comprehensive mri evaluation of their bilateral hips, knees, shoulders and wrists or ankles, which revealed the asymptomatic osteonecrosis. however, in daily clinical practice, we often focus on the osteonecrosis diagnosis of the femoral head without performing an mri on the other joints. this implies that there are possible missed diagnoses of asymptomatic mfon patients. a recent study also showed a higher incidence of mfon than that typically reported in literature 4 . dose of corticosteroids is the main risk factor for mfon. in france, hernigou 4 reported on 140 mfon cases diagnosed between 1985 and 1995, all of which were associated with corticosteroid use. in the cases reported by mont et al. 1 , 91% had a history of corticosteroid use, and the rest had a coagulation disorder. our study showed that 94 of the 96 (98%) mfon patients admitted to our center had a treatment history of high-dose corticosteroids, and the two remaining patients had a history of alcohol use. moreover, the dosage and route of administration of the corticosteroids were obviously related to the incidence of mfon. a study by hernigou 4 demonstrated that the total dose and the daily dose of venous injection were closely related to the occurrence of mfon. this was also found in our study of post-sars osteonecrosis patients caused by the use of corticosteroids 3 . there have been a limited number of mfon case reports and a high occurrence of mfon in asymptomatic patients. therefore, the exact incidence of mfon in patients with various diseases remains unclear. the incidence of mfon in 200 patients with sickle cell disease was reported to be 44% (87 of 200) 4 as a complication in the maintenance treatment of acute lymphocytic leukemia and non-hodgkin's disease, and its incidence in these diseases is also higher than that reported in the literature. solarino et al. 9 performed mri screening in patients with acute lymphoblastic leukemia after chemotherapy and found that 82% of them had mfon 9 . in the mfon cases presented in this study, most were sle, followed by hematological diseases, nephropathy, organ transplantation, dermatomyositis and multiple sclerosis. mfon was especially prevalent in leukemia patients; 17 of the 20 osteonecrosis patients with leukemia under our care were found to have mfon. three of the four patients who received pulse steroid therapy for trauma emergency had a spinal cord injury, for which steroid therapy was considered appropriate. however, one patient received pulse steroid therapy for only an eye injury and was found to have osteonecrosis in eight joints, including the hips, knees, shoulders and ankles. caution should be taken for such cases in the future. mfon patients most commonly had osteonecrosis of the femoral head, followed by the knee, shoulder and ankle bones. osteonecrosis of the shoulder, ankle and wrist never occurred aloneand was always accompanied by osteonecrosis of the hip and knee. among the three populations of mfon patients presented in this study, 98-100% had femoral head involvement, 78-88% had knee involvement, and 29-67% had humeral head involvement. the average number of osteonecrotic lesions was 5.7 per patient. to date, mri is the most sensitive and specific tool to diagnose mfon. initial studies found that low field mri was as sensitive as a radionuclide scan in diagnosing osteonecrosis. nevertheless, recent studies have demonstrated that high field (1.5-3 t) mri has a higher sensitivity, specificity and accuracy in diagnosing osteonecrosis. mont et al. 17 compared the sensitivity of radionuclide scans with mri, and found that mri has a sensitivity of 100%. by contrast, the sensitivity of radionuclide scans is only 45%. radionuclide scans have a higher sensitivity in detecting advanced stage osteonecrosis of the hip and knee than of the shoulder and ankle. although the diagnosis of osteonecrosis by mri has its advantages, the screening for mfon with mri is faced with a long scanning time and high cost. there have been debates regarding the optimal method to screen symptomatic and asymptomatic mfon 18, 19 . plain film x-ray is not sensitive enough to diagnose asymptomatic mfon, but there is still an advantage to carrying out an x-ray examination. even if the x-ray result of a joint with pain is negative for osteonecrosis, it provides a preliminary examination of the local bone structure, which serves as a reference for further investigation by mri. other methods include a short time inversion recovery (stir) mri test followed by mri or a radionuclide scan of specific joints. nevertheless, further studies are required to determine the optimal method for early detection of osteonecrosis. moreover, as the majority (70-100%) of osteonecrosis cases reported in the literature are bilateral, patients diagnosed with osteonecrosis of a joint on one side should be radiologically examined on the other side. missed diagnoses of mfon have frequently occurred in clinical practice. to reduce this, we recommend the following measures. 1) patients with associated diseases and long-term use of high-dose corticosteroids should have their hips and knees evaluated by mri within six to twelve months after the medication. 2) patients diagnosed with osteonecrosis of the hip and knee should have their bilateral shoulders evaluated by mri. 3) patients with corticosteroid use or alcohol abuse and who are diagnosed with osteonecrosis of one or more joints in the shoulder, ankle, wrist and elbow should have their hips and knees evaluated by mri. mfon patients usually start with silent lesions. as the disorder gradually progresses, patients will experience joint pain. at first, the pain is mild and patients may only experience increased pain during movement or weight bearing on the affected bone or joint. as significant damage develops in the joints, patients will experience severe pain. the period of time between the first symptoms and the loss of joint function varies for each patient and ranges from several months to several years. in the late stages of mfon, patients often have symptoms at rest and reduced joint activity, resulting in severe joint dysfunction. the treatment of mfon remains controversial. the general principle is to estimate the prognosis of each lesion. in addition, predicting the presence of collapse of the joint surfaces is the basis for determining the order of treatment. the progress of osteonecrosis is often different for each joint. osteonecrosis of the femoral head progresses the fastest and attention should be paid to the early appearance of symptoms. this is followed by the progression of osteonecrosis to the knees and shoulders. patients who have osteonecrosis of multiple weight-bearing joints and a large necrotic lesion area may develop joint destruction, and early intervention should be used. the progression of osteonecrosis to the elbow and wrist is relatively slow; however, we still lack experience regarding the appropriate treatment method for this area. bone infarction often leads to calcification and self-repair. hence, osteonecrotic elbows and wrists should mainly be managed by monitoring, and over treatment should be avoided if there are no clinical symptoms. in addition, an appropriate treatment strategy should be selected according to the stage of osteonecrosis in each joint involved 20 . for symptomatic patients at an early stage (i.e., arco stages i, ii or china stages i-iii), joint-preservation treatment options are commonly used, such as extracorporeal shock wave, core decompression, and vascularized and nonvascularized bone grafting. when > 2 mm of the articular surface has collapsed or the necrotic lesion area is > 50%, joint-preservation treatments may not provide good efficacy. in the advanced stages of the disease (i.e., arco stages iiic and iv, or china stages v-vi), arthroplasty is required when joint preservation is not possible. there are some limitations of this study. this study is limited by virtue of the retrospective analysis at only one center. and there was no randomized and blinded control group with conservative treatment in this study. the incidence of mfon was high when clinical risk factors were present, such has high-dose steroid use, alcohol abuse, sle, chronic nephropathy and leukemia. for a highly suspected case of mfon, a radiological screening of multiple joints is necessary, and mri is still the gold standard for diagnosing mfon. such screening can help to effectively reduce missed diagnoses. the goals of the treatment should be to take measures to delay the progress of the disease, to preserve the joint function and to avoid joint surface collapse and destruction by diagnosing the disease early. in addition, an appropriate treatment strategy should be selected according to the stage of mfon. conservative treatment and joint-preservation treatment options should be adopted during the early stages, while arthroplasty should be performed during the advanced stages. this study was performed in accordance with the principles expressed in the declaration of helsinki and approved by the ethics committee of the china-japan friendship hospital. informed consent was obtained from all patients. a standardized mri was taken of patients, including their bilateral joints. the apparatus was a ge sigma profile/gold, and t1 weighted, coronal stir, and transverse t1wi sequences were used. the parameters of the scan included a layer thickness of 5 mm and a distance between layers of 5 mm. the t1wi were obtained with a tr from 416~440 ms and a te of 15 ms, and the stir images were obtained with a tr of 1512 ms and a te of 80 ms. if an abnormal signal was found, then a t2 weighted scan was added, and for some of the patients, we also performed fat suppression and water-fat separation sequences. we only used t1 and t2 sequences for the other joints of the patients. osteonecrosis was defined as either a subchondral or an intramedullary area demarcated by a distinct marginal rim with low signal intensity that encompassed the medullary fat on the mri images. in addition to the mri, all patients were subjected to an x-ray that included the affected joints. our general survey on the bones and joints of post-sars medical workers who used corticosteroids revealed that the corticosteroid dose was approximately 2000 mg in unifocal osteonecrosis patients. by contrast, the dose was > 5000 mg in all mfon patients except for one patient who received 2000 mg, with the highest dose at 31,000 mg. the mfon patients also had prolonged corticosteroid treatment (≥ 30 days) 3 . of the 17 mfon patients diagnosed between january 2005 and december 2009, one had a 30-year history of alcohol abuse (average daily alcohol consumption of 500 g). the remaining 16 patients had a history of intensive steroid use for the following diseases: sle (7 patients), acute lymphoblastic leukemia (4 patients), chronic nephropathy (3 patients), anaphylactoid purpura (1 patient) and pulse steroid therapy for traumatic shock (1 patient). therefore, we summarized the high risk factors for mfon to include: a medical history of sle, chronic nephropathy, hematological diseases or coagulation abnormalities (especially leukemia); total corticosteroid (methylprednisolone) dose > 5000 mg, especially for patients with a history of intravenous pulse therapy; and a total corticosteroid administration time of > 30 days. between january 2010 and june 2015, a total of 1507 osteonecrosis patients were admitted to our center, and only 48 of them were diagnosed with mfon (3.1%) upon admission. a radiological investigation was performed in patients with a negative diagnosis of mfon but who had a high risk of mfon and complaints of pain in other joints. for patients found to have osteonecrosis of both the hip and knee, mri was performed on their bilateral shoulders and ankles, and also their bilateral wrists and elbows when necessary, regardless of whether other joints were symptomatic. for patients with a history of corticosteroid use or alcohol abuse and who were found to have osteonecrosis of one or more joints in the shoulder, ankle, wrist and elbow, mri was performed on their hips and knees and their other joints when necessary. the results were analyzed by a chi-square test the using spss 17 software. a p value < 0.05 was considered statistically significant. symptomatic multifocal osteonecrosis. a multicenter study. collaborative osteonecrosis group clinical research of correlation between osteonecrosis and steroid multifocal joint osteonecrosis in sickle cell disease thrombophilia, hypofibrinolysis, the enos t-786 c polymorphism,and multifocalosteonecrosis multifocal osteonecrosis in systemic lupus erythematosus: case report and review of the literature multiple site osteonecrosis in hiv infection osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the children's cancer group on a case of multifocal osteonecrosis in a patient suffering from acute lymphoblastic leukemia multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome multifocal osteonecrosis associated with human immunodefi ciency virus infection symptomatic steroid-induced multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis widespread osteonecrosis in children with leukemia revealed by whole-body mri vibration-induced multifocal carpal osteonecrosis in a 31-year-old man a rare cause of peripheral arthralgia in inflammatory bowel disease: multifocal osteonecrosis non-traumatic osteonecrosis of the femoral head: ten years later bone scanning of limited value for diagnosis of symptomatic oligofocal and multifocal osteonecrosis detection of multifocal osteonecrosis in an adolescent with dermatomyositis using whole-body mri fast sequences mr imaging at the investigation of painful skeletal sites in patients with hip osteonecrosis chinese specialist consensus on diagnosis and treatment of osteonecrosis of the femoral head this study was supported by the national natural science foundation of china (81372013) and the china-japan friendship hospital youth science and technology excellence project (2014-qnyc-a-06). the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the paper. w.s., z.c.s. and z.r.l. conceived the experiments. w.s., z.c.s., f.q.g. and w.b.l. performed the experiments. w.s., z.c.s., f.q.g. and w.b.l. analyzed the data. w.s., z.c.s. and z.r.l. wrote the manuscript. all authors reviewed the manuscript. competing financial interests: the authors declare no competing financial interests. this work is licensed under a creative commons attribution 4.0 international license. the images or other third party material in this article are included in the article's creative commons license, unless indicated otherwise in the credit line; if the material is not included under the creative commons license, users will need to obtain permission from the license holder to reproduce the material. to view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ key: cord-025535-dmcfy7ht authors: chelghoum, rayene; ikhlef, ameur; hameurlaine, amina; jacquir, sabir title: transfer learning using convolutional neural network architectures for brain tumor classification from mri images date: 2020-05-06 journal: artificial intelligence applications and innovations doi: 10.1007/978-3-030-49161-1_17 sha: doc_id: 25535 cord_uid: dmcfy7ht brain tumor classification is very important in medical applications to develop an effective treatment. in this paper, we use brain contrast-enhanced magnetic resonance images (ce-mri) benchmark dataset to classify three types of brain tumor (glioma, meningioma and pituitary). due to the small number of training dataset, our classification systems evaluate deep transfer learning for feature extraction using nine deep pre-trained convolutional neural networks (cnns) architectures. the objective of this study is to increase the classification accuracy, speed the training time and avoid the overfitting. in this work, we trained our architectures involved minimal pre-processing for three different epoch number in order to study its impact on classification performance and consuming time. in addition, the paper benefits acceptable results with small number of epoch in limited time. our interpretations confirm that transfer learning provides reliable results in the case of small dataset. the proposed system outperforms the state-of-the-art methods and achieve 98.71% classification accuracy. brain tumor diagnosis is very important in order to develop an effective plan of treatment. there are more than 120 types of brain and central nervous system (cns) tumors. neurologists classify manually the brain mr images using the world health organization (who) classification [1] . the automation of the classification procedure, in particular brain mr images classification help radiologist in their diagnosis and reduce enormously their interventions. the first automatic classification methods are the machine learning ones. these methods take a long time because they need pre-processing and handcrafted features by experts. the classification accuracy depends on the extracted features which depend on the expert competences. despite the limitation of machine learning methods, some works [2] achieved between 79% and 85% classification accuracy with their proposed method used tumor extracted features such as shape, rotation invariant texture, intensity characteristics and mr images for brain tumor classification. to avoid handcrafted features extraction, deep learning (dl) methods involving deep neural networks to classify images in self-learning without the need of handcrafted features extraction are used by benjio [3] and litjens et al. [4] . among several dl methods, cnns are one of the most useful that have been used to solve complex problems in various applications such as detection [5] , localization [6] , segmentation [7] and classification [8] . they have also yielded good results in medical image application [9] [10] [11] . the first real-word application of cnns was realized by yann lecun in 1998 to recognize hand written digits [12] . since 2010, imagenet launched an important visual database project called imagenet large scale visual recognition challenge (ilsvrc) [13] . this challenge runs an annual software contest where research teams evaluate their algorithms on the given dataset and achieved higher accuracy. moreover, cnns become more useful when krizhevsky et al. (2012) proposed their cnn architecture called alexnet [14] . the later competition allowed creating and improving real deep cnns architectures that have achieved higher accuracy on several visual recognition tasks. in recent years, cnns have achieved good results in medical image applications due to the growth of available labelled training data, the increase of powerful graphics processing gpu, the rise of accuracy to solve complicated applications over time and the appearance of numerous techniques to learn features. according to the statistics that we made from google scholar, the number of publications using cnns in the field of medical image applications in general and brain tumor in particular is increase since 2014. this trend can be observed in fig. 1 . and fig. 2 . today, several public brain mr images datasets for classification are available for researchers. this help medical scientists to develop more automated classification methods [15] . however, the cnns training become more complicated and can lead to overfitting because of the samples size of medical datasets. also, applying deep pre-trained cnns based on transfer learning in medical imaging needs to adjust the hyper-parameters and learning parameters of the models in order to achieve a good result. training the networks with transfer learning is usually much faster and easier than training the networks with randomly initialized weights [16] [17] [18] . in [19] , authors used a small cnn architecture and achieved 84.19% classification accuracy. a block-wise fine-tuning has been proposed, this one, based on transfer learning, reached a classification accuracy of 94.82% [20] . other approach proposed by [21] used pre-trained googlenet and transfer learning to classify brain mr images and achieved 97.1% of classification accuracy. in this paper, we present an automatic classification system designed for three types of brain tumor. we use the brain ce-mri dataset from figshare [22] which consists of three kind of brain tumors (glioma, meningioma and pituitary tumor) in order to classify only abnormal brain mr images. based on this dataset, we adopted deep transfer learning for feature extraction from from brain mr images using nine deep cnns architectures: alexnet [14] , googlenet [23] , vgg16 [24] , vgg19 [24] , residual networks (resnet18, resnet50, resnet101) [25] , residual networks and inception-v2 (resnet-inception-v2) [26] , squeeze and excitation network (senet) [27] . this system makes easier the interventions of radiologist, helps them to solve brain tumor classification problem and develop an effective treatment. we report the overall classification accuracy of the nine pre-trained architectures based on training time and epoch number. we explore the impact of epochs number to minimize the consuming time. we classify the extracted features for three different epochs. we achieve good results compared to related works. also, with smaller number of epochs, we achieve acceptable results in short time. the paper is structured as follows. the proposed method and different pre-trained cnns architectures are given in sect. 2. the experimental setting, the networks preparation and dataset are shown in sect. 3. the experimental results with a brief discussion are provided in sect. 3, the conclusion and an outlook for future work are given in sect. 4. in this work, we applied nine pre-trained deep networks including alexnet, googlenet, vgg16, vgg19, resnet18, resnet50, resnet101, resnet-inception-v2 and senet for brain tumor classification problem using transfer learning. cnns architectures have been designed to learn spatial hierarchies of features by building multiple blocks: convolution layers with a set of filters, pooling layers, and fully connected layers (fcls). the real deep architectures created until 2012 through ilsvrc challenge. the classification error of ilsvrc challenge winners is decreased from 15.3% in alexnet (2012) [14] to 2.251% in senet (2017) [27] . also, the number of layers is increased from 8 layers to 152 layers. table 1 summarizes the differences between those architectures regarding the classification error, the number of layers, the tasks, the execution environment and the training datasets. alexnet. alexnet [14] architecture is deeper and much greater than lenet architecture [28] . it consists of eight layers, five convolutional layers most of them are followed by max pooling and three fully connected layers. the output is the 1000-way softmax that represents the classes. it is trained on two parallel gtx 580 gpu 3 gb which communicate only in certain layers. this scheme reduces the top-5 error rates. alexnet is improved with zfnet architecture [29] which visualizes the alexnet activities within the layers to debug problems and obtain better results. it allows observing the evolution googlenet. googlenet architecture codenamed inception-v1 is the improved utilization of computing resources inside the network [23] . the network with the inception architecture is faster than the network with non-inception architecture. the googlenet architecture including the inception module uses rectified linear activation function, average pooling layer and not fully connected layer and dropout after removing fully connected layer. inception-v1 is improved to inception-v2 by ioffe and szegedy [30] who tried to solve the internal covariate shift. they achieved a top-5 error rate of 4.82%. this result is outperformed to 3.5% by szegedy et al. [31] with their new inception architecture called inception-v3. table 2 shows a comparison between the three inceptions. vggnet. karen simonyan and andrew zisserman [24] investigated the effect of the neural convolutional network depth on its accuracy in image recognition. they pushing depth to 11-19 weight layers of the developed vggnet using very small (3 × 3) convolution filters. the configurations that use 16 and 19 weight layers, called vgg16 and vgg19 perform the best. the classification error decreases with the increased depth and saturated when the depth reached 19 layers. authors confirm the importance of depth in visual representations. resnet/ inception-v4. resnet [25] used residual learning to ease the training of the deeper networks and reduce the errors from increasing depth. this architecture proposed many structures including: 18-layers, 34-layers, 50-layers, 101-layers and 152layers structure, where the 152-layers structure is better than the other ones. it is less complex and deeper than vgg, and has similar performances to the inception-v3 network, this is why szegedy et al. [26] combined the inception architecture with residual connections. they evaluated the three resnet-inception and the inception-v4 architectures: the inception-resnet-v1 has similar performances to inception-v3 while the resnet-inception-v2 performs more than resnet-inception-v1. the inception-v4 is simpler and has more inception modules than inception-v3 but has similar performances to resnet-inception-v2. senet. senet [27] used squeeze and excitation (se) block which improved the representational power of a network by enabling it to perform dynamic channel-wise feature recalibration. it was applied directly in the residual network architecture such as se-inception-resnet-v2, se-resnet-101, se-resnet-50, se-resnet-152 and can be applied to the other existing architectures. it has been performed on imagenet, coco, cifar-10 and cifar-100 datasets across multiple tasks. transfer learning use the gained knowledge that solve one problem and applied them to solve different related problems by using trained model to learn different set of data. the setting for transfer learning used in this work is explained in the following statements. the pre-trained cnns architectures: alexnet, googlenet, vgg16, vgg19, resnet-18, resnet-50, resnet-101, resnet-inception-v2 and senet consist of 1000 classes, 1.28 million training images, tested on 100 k test images and evaluated on 50 k validation images. they are challenging the accuracy of human with the best given results. the networks take an image as an input and produce the object label in the image as an output as well as the probabilities of the object categories. in this research, we focus on slice by slice classification of brain tumor using ce-mri dataset into three types of tumors. first, we modified the last three layers of pre-trained networks in order to adapt them to our classification task. next, we replaced the fully connected layer in the original pre-trained networks by another fully connected layers, in which the output size represents the three kind of tumor. the transfer learning setting and modification are shown in fig. 3 . finally, we used transfer learned and fine-tuned deep pre-trained cnns for experiments using mri data. the proposed classification model is implemented in matlab 2019b on a computer with the specifications of 16 gb ram and intel i9 4.50 ghz cpu. in this section, we describe the dataset used in the experiments, the training parameters and classification accuracy prediction. figure 4 represents the pre-processing of training dataset and the use of transfer learning networks for brain tumor classification. dataset and pre-processing. the public database used to train and test the networks is available in [22] . it has already used in previous works like in [32, 33] . the dataset is collected from nanfang hospital, guangzhou and general hospital, tianjin medical university, in china during 2005-2010. it contains 3064 abnormal brain ce-mri from 233 patients with three kinds of brain tumor: meningioma (708 slices), glioma (1426 slices), and pituitary tumor (930 slices). it is based on two dimensional gray images (2d slices). those data are organized in matlab data format (. mat file). the size of images is 512 × 512 pixels and the pixel size is 49 mm x 49 mm. in our work, we normalize the gray mri images in the dataset in intensity values and we convert them into rgb images by corresponding color map to rgb format using matlab function. we specify the slices as an array of data type where the value 1 corresponds to the first color in the color map. rgb images are returned as an m × n × 3 numeric array with values in the range of [0, 1]. the value 3 corresponds to red, green and blue colors. then, we resize them according to the used network: (227 × 227) in alexnet and senet, (224 × 224) in googlenet, vggnet and resnet, (299 × 299) in resnet-inception-v2 rgb images. the dataset pre-processing is shown on fig. 4 . we divide the data into training and test datasets, where 60% (1836 slices) of the images are used for training and 40% (1228 slices) used for test. the splitting of data into train and test set is performed on a slice basis. training parameters. for transfer learning, we train the networks by stochastic gradient descent (sgd) with 0.9 momentum. we use a minibatch size of 128 images and a learning rate of 10 −4 . to speed up the learning in the new layers, we rise the weight learn rate factor and the bias learn rate factor to 10. even though, the transferred layers are still slower than the new layers. in order to perform the transfer learning, we train for 25, 50 and 90 epochs where an epoch is a full pass during the dataset training. the networks are validated every 50 iterations during training. in this part we use the trained networks to classify the test images and calculate the overall classification accuracy. the classification accuracy is the ability to predict correctly and guess the value of predicted attribute for new data. it is defined as the ratio of sum of true positives (tp) and true negatives (tn) to the total number of trials: where tp and tn are outcomes produced when the model correctly classifies the positive class and the negative class, respectively. while fp and fn are outcomes produced when the model incorrectly classifies the positive class and the negative class, respectively. we evaluate the classification performance using the nine pre-trained architectures and summarize our results in the form of tables. in fact, the purpose of this study is to increase the classification accuracy, speed the training time and avoid the overfitting. this can be assessed through the classification accuracy and the training time of our pre-trained networks. the classification accuracy and the training time using different transfer learning architectures trained for different epochs are respectively shown in table 3 and table 4 . all our pre-trained networks excepting senet are reached up to 90% classification accuracy for three different epochs. despite the use of transfer learning, senet has an overfitting with epoch equal to 25 and 50, but achieves an acceptable result with epoch equal to 90. another characteristic observed during experiments is the impact of epoch number on the classification accuracy. this effect can be seen in table 3 and table 4 . the training time is increasing gradually with incremental epochs number, which means that we can consume less time using less epoch. however, the classification accuracy is neither influenced by the epochs number, nor the deep architectures. as shown in table 3 the table 5 shows a classification of three sample instances. we find that all of the prerained architectures pertain to the class glioma and meningioma. all of them, excepting resnet-inception-v2 pertain to the class pituitary. this confirms that the deeper architectures do not result good with small datasets. table 6 provides a broad comparison based on classification accuracy with the existing methods on the same ce-mri dataset. abiwinanda et al. [19] achieved 84.19% accuracy with their proposed cnn. swati et al. [20] propose a block-wise fine-tuning method based on transfer learning and achieved 94.82% accuracy. deepak and ameer [21] used a pre-trained googlenet to extract features from brain mri images and achieved 97.1% classification accuracy. our proposed method using the pre-trained vgg16 achieved 98.71% classification accuracy. this paper presents a fully automatic system for three kind of brain tumor classification using ce-mri dataset from figshare. the proposed system applied the concept of deep transfer learning using nine pre-trained architectures for brain mri images classification trained for three epochs. our system outperforms the classification accuracy compared to related works. it shows a good performance with a small number of training samples and small epochs number, which allows to reduce consuming time. the architectures which have fewer layers perform more than the deeper architectures. in the future work, we will apply our system to classify medical images from different modalities such as x-rays, positron emission tomography (pet) and computed tomography (ct) for other body organ. also, we will address the effect of epochs number to the classification performances. optimal symmetric multimodal templates and concatenated random forests for supervised brain tumor segmentation (simplified) with antsr classification of brain tumor type and grade using mri texture and shape in a machine learning scheme learning deep architectures for ai. found a survey on deep learning in medical image analysis autonomous concrete crack detection using deep fully convolutional neural network a coarse-to-fine deep convolutional neural network framework for frame duplication detection and localization in forged videos testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants image-based text classification using 2d convolutional neural networks automatic detection of cerebral microbleeds from mr images via 3d convolutional neural networks state-space model with deep learning for functional dynamics estimation in resting-state fmri deep convolutional neural networks for multi-modality isointense infant brain image segmentation gradient-based learning applied to document recognition imagenet large scale visual recognition challenge imagenet classification with deep convolutional neural networks brain mri tumor segmentation with 3d intracranial structure deformation features brainmrnet: brain tumor detection using magnetic resonance images with a novel convolutional neural network model active deep neural network features selection for segmentation and recognition of brain tumors using mri images deep convolutional neural networks for brain image analysis on magnetic resonance imaging: a review brain tumor classification using convolutional neural network brain tumor classification for mr images using transfer learning and fine-tuning brain tumor classification using deep cnn features via transfer learning going deeper with convolutions very deep convolutional networks for large-scale image recognition deep residual learning for image recognition inception-v4, inception-resnet and the impact of residual connections on learning squeeze-and-excitation networks handwritten digit recognition with a back-propagation network | advances in neural information processing systems 2 visualizing and understanding convolutional networks batch normalization: accelerating deep network training by reducing internal covariate shift rethinking the inception architecture for computer vision enhanced performance of brain tumor classification via tumor region augmentation and partition retrieval of brain tumors by adaptive spatial pooling and fisher vector representation key: cord-323470-lpeeugdf authors: ates, omer faruk; taydas, onur; dheir, hamad title: thorax magnetic resonance imaging findings in patients with coronavirus disease (covid-19) date: 2020-08-15 journal: acad radiol doi: 10.1016/j.acra.2020.08.009 sha: doc_id: 323470 cord_uid: lpeeugdf rationale and objectives: the aim of this study was to compare the findings found in thorax computed tomography (ct), which is increasingly used in the diagnosis of the important public health problem of coronavirus disease (covid-19), and the findings of magnetic resonance imaging (mri) as an important diagnostic alternative. materials and methods: thirty-two patients diagnosed with covid-19 who underwent thorax ct for covid pneumonia and mri for any reason within 24 hours after ct were included in the study. the number of lobes affected, number of lobes containing ground-glass opacities and consolidation, number of nodules, distribution of lesions (central, peripheral or diffuse), lobes with centrilobular nodular pattern, and the presence of pleural effusion were recorded separately for both imaging methods. results: seventeen of the patients were female (53%) and 15 were male (47%). the mean age of the patients was 60.5 (range, 20-85) years. a total of 31 patients (96%) had signs of pneumonia on ct. the most common finding in ct was ground-glass opacities in 29 patients (90.6%), followed by consolidation in 14 patients (43.75%). both consolidation and ground-glass opacities were also observed in mri in all of these patients. on ct, nodules were detected in 12 patients (37.5%) on ct and 11 patients (34.4%) on mri. the sensitivity and specificity of mri in nodule detection were calculated as 91.67% and 100%, respectively. conclusion: although thorax ct is widely used in the imaging of covid-19 infection, due to its advantages, mri can also be used as an alternative diagnostic tool. in 2019, a new corona virus disease caused by the severe acute respiratory syndrome coronavirus (sars-cov-2) was reported in the wuhan province of china (1) . the disease spread first in china and then over all the world and was declared as a pandemic by the world health organization (who) (2) . the sars-cov-2 virus has been shown to enter the cell through angiotensin converting enzyme 2 (ace-2) receptors in humans. therefore, the virus first causes interstitial damage in the lungs followed by parenchymal damage (3) . although the most important clinical symptoms are fever and cough, other indications, such as fatigue, headache and shortness of breath can also be seen. however, diagnostic tests are needed because these symptoms are not disease-specific, and the disease can progress rapidly to severe pneumonia (4) . although the real-time reverse transcription polymerase chain reaction (rt-pcr) test for viral nucleic acids in the diagnosis of covid-19 is the gold standard, computed tomography (ct) has become increasingly more important in the diagnosis (5) . however, considering that it contains ionizing radiation, ct should be used as a problem-solving method rather than for screening purposes in patients who are found negative for rt-pcr but present with clinical symptoms (6) . also, the recent consensus statement from the fleischner society lists the risk of radiation exposure to the patient as one of the costs that diminish the value of imaging tests (7) . due to concerns about the effects of ionizing radiation, magnetic resonance imaging (mri) is emerging ct as the primary cross-sectional imaging method in evaluating many organs. today, low dose ct scanning protocols are being developed, however, considering covid-19 pneumonia and similar pandemics that affect a large number of human populations, dose-dependent and dose-independent effects of ct that may occur due to radiation exposure, poses a serious risk in terms of malignancy that may develop after years (8) . although the low proton content and movement artifacts of the lung parenchyma make it difficult to evaluate the lung with mri, with recent advances in mri scanner technology such as t2-weighted spin-echo propeller mri sequence (9) , it is now possible to overcome many of these challenges. in addition, the low proton content of the lung is, in fact, an advantage in imaging pneumonia because pulmonary consolidation and ground-glass opacities occurring in pneumonia cause an increase in proton and signal intensity, which becomes more pronounced with the background of the adjacent normal signal (10) . in addition, cranial mri is very useful for the evaluation of anosmia which is frequently seen in these patients (11) . the purpose of this study is to describe the thoracic mri findings of covid-19 pneumonia with those of ct and to suggest mri as an attractive alternative imaging modality is specific cases for this retrospective study, approval was obtained from the ethical committee of our institution. of the 1,311 patients diagnosed with covid-19 pneumonia (rt-pcr at least once + clinically confirmed) in our institution between march 27, 2020 and april 13, 32 who underwent thorax ct for covid pneumonia and mri for any reason within 24 hours after ct were included in the study. since one patient did not complete the mri examination; thus, his images could not be evaluated, but they were added to the image quality evaluation. a total of 32 patients were included in the study, with 17 being female (53%) and 15 being male (47%). the mean age of the patients was 60.5 (range, 20-85) years. all patients had complaints of dry cough and shortness of breath. the patient population has a wide range from patients with mild disease to those in need of intensive care units. however, none of the patients were intubated. both ct and mri scans were for clinical purposes. t2 propeller images were generally obtained during mri scans for the following reasons: pulmonary mra obtained for suspicion of pulmonary thromboembolism in some patients with increased d-dimer without renal failure but with limited renal function and patients with suspected cardiac involvement and therefore imaged with cardiac mri. mri was performed with a 1.5-t system (signa voyager; ge healthcare, milwaukee, wi, usa) using a phased array body coil. t2-weighted fast spin echo propeller axial images were obtained with respiratory triggering (triggered by the expiration phase of the respiratory cycle) at an echo train length of 13, matrix of 224x256, fov of 38 cm, band width of 125 hz, tr of 1000-1500 ms, effective echo time of ∼90 ms, and four excitations. slice thickness was 5 mm, and interslice gap was 1 mm. the imaging time was approximately 3 minutes, but it was extended to 5 minutes in patients with breathing problems. ct images were obtained with a 64-row multidetector ct scanner (5 mm slice thickness, matrix of 512x512, 120 kv automatically modulated ma; aquilion64, toshiba medical systems, japan) for 21 patients and with a 16-row multidetector ct scanner (5 mm slice thickness, matrix of 512x512, 120 kv automatically modulated ma, alexion, toshiba medical systems, japan) for 11 patients. all scans were performed during inspiration and with the patients placed in the supine position. the mri and ct images of all patients were evaluated for opacity and unilateral or bilateral involvement. the number of lobes affected (n = 1-5), number of lobes containing ground-glass and consolidation, number of nodules, distribution of lesions (central, peripheral or diffuse), lobes with centrilobular nodular pattern, and the presence of pleural effusion were also recorded separately for both imaging methods. on ct and mri, a density/intensity increase in which vascular boundaries could be distinguished was accepted as ground-glass, and a density/intensity increase in vascular structures that could not be differentiated was considered as consolidation. the affected lung volume ratio was evaluated observationally. by definition, a lung nodule is a rounded or irregular opacity, which may be well or poorly defined, measuring ≤3 cm in diameter. the ct and mri images were assessed for quality: 5, excellent no artifacts; 4, good (few artifacts); 3, moderate (of diagnostic value but impaired by artifacts); 2, poor (of no diagnostic value); and 1, not tolerated (examination could not be completed). the causes of impaired quality were attributed to ghosting, motion or patient movement artifacts, or a combination thereof. the evaluation of the images was independently undertaken by two radiologists (both are board-certified and have 8 years of experience) with the pre-diagnosis of covid-19-related pneumonia. two weeks were waited for evaluation of mri images after evaluation of ct images to prevent memory bias. if their initial opinions differed, a consensus was reached. medcalc (ver. 12, ostend, belgium) was used for statistical analysis. the descriptive statistics were given as median (minimummaximum) and mean ± standard deviation. categorical variables were stated as frequencies and percentages. the chi-square test was used for the comparison of categorical variables. the independent samples t-test was used for the comparison of continuous variables with normal distribution and the mann-whitney u and kruskal wallis tests for the data that did not conform to normal distribution in the kolmogorov-smirnov test. coherence between two observers with respect to pulmonary findings was assessed by cohen's kappa coefficient. a value of p < 0.05 was accepted as statistically significant. a total of 31 patients (96%) had signs of pneumonia on ct. pneumonia findings were observed in the mri of these patients. the most common involvement pattern was bilateral and peripheral (table 1) (figure 1 ). almost perfect agreement was found between the two observers in terms of pulmonary findings (κ = 0.934). the most common finding in ct was ground-glass opacities in 29 patients (90.6%). ground-glass opacities were also observed in the mri of all of these patients. lesions were observed in one or two lobes most frequently in both ct and mri (37.5%) (figures 2 and 3) . while a total of 90 lesions were detected on ct, 85 were detected on mri, but there was no statistically significant difference (p = 0.710) ( table 2 ). the second most frequently observed finding in ct was consolidation in 14 patients (43.75%), which was also observed in the same patients on mri. lesions were detected in one or two lobes most frequently in both ct and mri (25%) ( table 3 ). nodules were detected in 12 patients (37.5%) by ct and 11 patients (34.4%) by mri. taking ct as reference, the sensitivity of mri in nodule detection was calculated as 91.7%, specificity 100%, positive predictive value 100%, and negative predictive value 95.2%. while 53 nodules were observed in ct, 52 were observed in mri, and no significant difference was found between the two modalities (p = 0.967) (figures 4 and 5 ). in addition, on both ct and mri, three patients (9.4%) had a centrilobular nodular pattern ( figure 6 ) and eight (25%) had pleural effusion. the median image quality score was 5 for the ct images and 4 for the mri images (table 4 ). however, there was no significant difference between the two imaging methods (p = 0.147). the most important result of our study is the nearly complete overlap of ct and mri findings. minor differences between ct and mri may have been influenced by the fact that ct scanning is obtained during the inspiratory phase of respiration and thoracic mri with respiratory navigator during expiratory phase. in this context, mri was shown to be a useful modality in terms of showing both parenchymal and extraparenchymal (pleural effusion and lymphadenopathy) findings. in a recent study involving 23 patients by yang et al., ultrashort echo time mri was evaluated and compared to ct. in this study, similar to our study, a perfect match was found between mri findings and ct findings. however, the most important difference of this study from our study is that no patient with a nodule was included in the study (12) . there are also two case reports in the literature regarding the mri findings of covid-19. the first belonged to a 47-year-old male patient and both parenchymal consolidation and pleural effusion was demonstrated using mri (13). the other case report described a 33-year-old male patient, who was shown to have parenchymal ground-glass densities and consolidations successfully revealed by mri (14) . various findings can be seen in the lung parenchyma in covid-19 infection (15) . the most common of these is the ground-glass appearance, defined as an increase in fogshaped density in which the walls of the vessels and bronchi are not wiped (16, 17) . it develops due to mild interstitial thickening or air loss within the airways (18) . in a meta-analysis performed by salehi et al. involving 919 patients, ground-glass density was determined in 88% of patients and reported as the most common imaging finding (19) . in a study conducted in italy, all patients were found to have ground-glass density (20) . similarly, in our study, all patients had ground-glass opacities. it is also known that ground-glass density is the earliest radiological finding of the disease (21) . this appearance is considered to be due to edema and hyaline membranes in the lung (22) . ground-glass opacities can be seen alone or together with different findings, such as interlobular septal thickening and consolidation (23) . consolidation is defined as the air in the alveoli being completely replaced with pathological fluid, cells or tissues, resulting in an increase in density, and it is usually multifocal, segmental, patchy and subpleural or peribroncovascular in patients with covid-19 infection (24) . in our study, there was consolidation in 43.75% of patients. pathophysiologically, these cases are thought to be associated with fibromixoid exudate in the alveoli (25) . in addition, the presence of consolidation has been associated with the prognosis of the ailment and may be an indicator of a progressive disease (23) . crazy paving, which is defined as thickened interlobular and intralobular septa and the background with ground-glass density, is important because it is a sign of a progressive disease, although it is not as common as consolidation and ground-glass in covid-19 infection (26) . apart from these major findings, a reticular pattern, air bronchogram, and nodules can also be seen (18) . lymphadenopathy and pleural effusion are rarely observed in covid-19 infection and tends to suggest a bacterial infection in rt-pcr positive patients (18) . the use of thorax mri has been increasing in recent years. since there is no radiation risk, mri allows multiple examinations to be performed on the same patient, and it can provide additional information to ct during patient follow-up. in a study by leutner et al., in which 16 immunocompromised patients with pneumonia were included, all ground-glass opacities and consolidations could be diagnosed with mri. moreover, the presence of early-stage necrotic pneumonia, which could not be shown by contrastenhanced ct in 25% of patients, was demonstrated by mri (27) . in subsequent studies with a similar patient group, mri was found to be very useful diagnostic tool, especially in its use during follow-up (28, 29) ; furthermore, mri was reported to be promising in detecting nodules in these patients (30) . in our study, the sensitivity of mri in nodule detection was 91.67%, and its specificity was 100%. in a recent study by syrjala et al. including 77 patients with immunocompetent pneumonia, the effectiveness of mri in diagnosis was investigated, and it was reported that mri was superior to direct radiography in diagnosis and showed almost identical accuracy with ct (31). one of the disadvantages of mri in pneumonia patients is imaging time and artifacts. in addition to longer scan times, mr is less readily available and more expensive than ct. in our routine practice, we use the propeller technique, which has been shown to obtain better quality and less artifact images, while taking the thorax image (9) . the t2 fse propeller sequence used in our study lasted an average of 3 minutes. shortness of breath, which can be seen in patients with covid-19-related pneumonia, can cause an increase in both ct and mri in motion-related artifacts. at the same time, since this sequence is obtained with a respiratory navigator, the scanning time is prolonged in patients with irregular breathing. although it is more sensitive to motion artifacts due to the long scanning time, respiratory navigation may be an advantage, especially in the imaging of some lesions adjacent to the diaphragm. in breath-hold ct, since inferior slices are taken toward the end of the patient's breath, more intense motion artifacts occur, especially in the inferior slices in patients with shortness of breath. in the technique we use, even the lesions adjacent to the diaphragm can be easily viewed in patients who regularly breathe quickly, as it is not necessary for them to hold their breath. although ct was better in terms of overall image quality in our study, there was no significant difference between the ct and mri examinations. in addition, no artifact formation at the level of no diagnosis was observed in the mri of any patient. in addition, no artifact formation at level 2 (poor image quality, of no diagnostic value) was observed in any patient on mri. there were some limitations of our study. the first was the small number of patients included in the study, and second was the retrospective nature of the research. more comprehensive and prospective studies can be planned for this subject. finally, since the mri examinations were performed without contrast, the effect of the contrast agent could not be evaluated. in conclusion, although thorax ct is widely used in the imaging of covid-19 infection, we consider that mri can be used as an alternative due to its various advantages. especially, mri is important to assess lung pathology over time as more is learned about covid and the long-term impact on lung health. t2-weighted spin-echo propeller sequence, variations of which are readily-available sequence on most mri scanners, is a good option for clinical translation to other platforms, sites. a novel coronavirus from patients with pneumonia in china severe outcomes among patients with coronavirus disease 2019 (covid-19)-united states evolution of the novel coronavirus from the ongoing wuhan outbreak and modeling of its spike protein for risk of human transmission radiological approaches to covid-19 pneumonia clinical features of patients infected with 2019 novel coronavirus in wuhan ct of coronavirus disease (covid-19) pneumonia: a reference standard is needed the role of chest imaging in patient management during the covid-19 pandemic: a multinational consensus statement from the fleischner society cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million australians mri of the lung using the propeller technique: artifact reduction, better image quality and improved nodule detection lung magnetic resonance imaging for pneumonia in children olfactory bulb magnetic resonance imaging in sars-cov-2-induced anosmia: the first report clinical potential of ute-mri for assessing covid-19: patient-and lesion-based comparative analysis findings of covid-19 on magnetic resonance imaging coronavirus disease (covid-19): spectrum of ct findings and temporal progression of the disease ct manifestations and clinical characteristics of 1115 patients with coronavirus disease 2019 (covid-19): a systematic review and meta-analysis imaging features of coronavirus disease 2019 (covid-19): evaluation on thin-section ct chest ct manifestations of new coronavirus disease 2019 (covid-19): a pictorial review coronavirus disease 2019 (covid-19): a systematic review of imaging findings in 919 patients ct imaging features of 2019 novel coronavirus (2019-ncov) pathological findings of covid-19 associated with acute respiratory distress syndrome novel coronavirus (2019-ncov) pneumonia chest ct findings in patients with coronavirus disease 2019 and its relationship with clinical features radiological findings from 81 patients with covid-19 pneumonia in wuhan, china: a descriptive study thin-section ct of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease mr imaging of pneumonia in immunocompromised patients: comparison with helical ct mri of pneumonia in immunocompromised patients: comparison with ct diagnostic accuracy of magnetic resonance imaging in the evaluation of pulmonary infections in immunocompromised patients magnetic resonance imaging of pulmonary infection in immunocompromised children: comparison with multidetector computed tomography chest magnetic resonance imaging for pneumonia diagnosis in outpatients with lower respiratory tract infection key: cord-255240-ltatgq3e authors: kesserwani, hassan title: cerebral microbleeds to treat or not to treat, that is the question: a case report with a note on its radiologic deconstruction and therapeutic nuances date: 2020-09-20 journal: cureus doi: 10.7759/cureus.10548 sha: doc_id: 255240 cord_uid: ltatgq3e with the ubiquity of susceptibility weighted imaging (swi), cerebral microbleeds (cmbs) are fast becoming a prevalent phenomenon. they are tightly associated with age, neurodegeneration and diverse vascular etiologies. cmbs have a unique radiological signature. their morphology, number and topology are quite informative. they also pose a therapeutic conundrum, as they are associated with the risk of cerebral hemorrhage. we present the case of an 86-year-old woman who has a vascular dementia, binswanger's syndrome, and coronary artery disease, who presented with more than five cmbs. we present this case in order to highlight the dilemma of anti-platelet therapy in this group of patients and we demonstrate the cardinal radiologic features of cmbs. we then segue into the pathologic correlates of cmbs and associated risk factors. we finally analyze the risk of anti-platelet therapy in the presence of cmbs, and we unfold the latest data on cmb number and anti-platelet therapy. cerebral microbleeds (cmbs) are an increasingly recognized diagnostic entity. they represent microhemorrhages in brain parenchyma. pathologically, these microbleeds are hemosiderin-laden macrophages. deep seated microbleeds, in the corona radiata and basal ganglia, are more commonly seen in hypertension. cortical lesions are commonly seen with amyloid angiography. parasagittal linear streaks are more typical of brain trauma and diffuse axonal injury [1] . in the rotterdam study of close to 4000 patients, cmb prevalence increases with age, from 6.5% in people aged 45 to 50 years to 35.7% in people older than 80 years. 15 .3% of all patients had at least one cmb [2] . systolic blood pressure, hypertension, smoking, lacunar infarcts and white matter lesions were associated with cmbs in a deep or infra-tentorial region, whereas apo-lipoprotein e4 (apo e4) and diastolic blood pressure were related to cmbs in a lobar location [2] . there is an elevated risk of both hemorrhagic, odds ratio 8.52 (4.23-17) , and ischemic strokes, odds ratio of 1.55 (1.12-2.13) , in patients with recent ischemic stroke or transient ischemic attacks (tia) and cmbs [3] . radiologically, cmbs appear magnified on susceptibility weighted images (swi) due to their paramagnetic properties and this is known as a blooming artifact. cmbs appear dark, hypo-intense, on all swi images. however, this finding can be due to either iron or calcium deposits. in order to differentiate, phase mapping is obtained [4] . these are rapid acquisition images at no extra cost. if the magnetic resonance imaging (mri) scanner software is endowed with a left-handed reference frame such as siemens, the cmbs appear hyperintense on the phase map. if the mri scanner software is endowed with a right-handed reference frame, the cmbs will appear hypo-intense on phase maps. to orient oneself, we can look at the superior sagittal sinus or a venous tributary, and establish the "color" of the mri acquisition sequence on the phase map. in the left-handed reference frame, the sinus will appear bright. in the right-handed system such as a general electric scanner, the cmbs appear dark by noting the dark sagittal sinus or a venous tributary. the reverse situation is seen in the left-handed siemens scanner; here the cmbs and sagittal sinus appear bright. swi images and phase mapping are advanced imaging techniques that are sensitive to cerebral microbleeds. they utilize long echo sequences and gradient echo sequences (gre). these image acquisitions rely on the magnetic susceptibility of tissues, whether paramagnetic or diamagnetic. paramagnetism occurs when atoms have an odd number of electrons. hence, they have a net magnetic dipole moment, which aligns and reinforces an applied magnetic field. if the number of electrons is even, that is paired, then there are no dipoles to align. however, the applied magnetic field distorts the motion of electrons via the lorentz force. the induced magnetic dipoles anti-align with the applied magnetic field, and reduce the applied magnetic field. such a material is diamagnetic. the filtered phase images or phase map exploit the magnetic properties of tissues; paramagnetic (such as iron) and diamagnetic (such as calcium), which have opposite 1 signal intensities in phase mapping [5] . we present the case of an 86-year-old woman with binswanger's disease characterized by a vascular dementia, lower half parkinsonism and more than five cmbs. binswanger's disease is a subcortical vascular dementia characterized by loss of executive function: planning, insight and foresight, with relative preservation of memory. it is frequently accompanied by a gait disorder. she has the typical risk factors of binswanger's disease including chronic hypertension, coronary artery disease, hyperlipidemia and is a lifelong smoker. the question at hand states: is anti-platelet therapy safe in this patient with more than five micro-hemorrhages (cmbs) in the brain? the data to answer this question is evolving [6] . in this article, we lay out the pathologic correlates of cmbs, gently outline the radiological nuances involved in analyzing cmbs and finally we display the latest data addressing the role of anti-platelet therapy. as cmbs are incidentally discovered on routine mri studies, whether to continue or discontinue anti-platelet or anticoagulant therapy, is an open question. the clinician has to individualize therapy, weigh the benefits of therapy and consider the pros and cons, until more definitive data becomes available. we report the case of a previously active and independent 86-year-old divorced female patient who over the course of two years, especially last year, has become increasingly forgetful and confused. she left the stove on at least twice and once boiled eggs without water, forgets relevant family conversations and repeats questions frequently. she was no longer able to balance her checkbook and has become increasingly distracted, "spacey" and "not together", as per her daughter's testimony. her daughter also noted that she cannot keep up with conversations when there are more than two people conversing. sometimes she cannot finish a sentence, has become increasingly argumentative and quit driving five years ago due to anxiety from a car accident. her hygiene has declined, sometimes forgets to bathe or fix her hair, forgets to do laundry, but when remembers may wash clean clothes. in the past, she worked at convenience stores and focused on inventory. the patient now presents emotional lability with excessive crying, with abandonment of social activities, such as reading the newspaper and watching sitcoms. her medications include atorvastatin 20 mg, lisinopril 10 mg, escitalopram 10 mg, baby aspirin 81 mg and mirtazapine 30 mg daily. her past medical history is significant for at least a 20-year-history of hypertension, coronary artery disease and hyperlipidemia. there is no family history of dementia. she has smoked cigarettes, at least one pack a day, for 50 years. on examination, her blood pressure (bp) is 145/63 and a pulse of 67 beats per minute. her height is five foot and three inches with a weight of 120 pounds and a body mass index (bmi) of 21.3. precordial examination revealed no murmurs and carotid auscultation revealed no bruits. her gait was stooped and shuffling, with adequate arm swing. no retropulsion was noted. at most, she had a mild symmetric bradykinesia but without a rest, postural or kinetic tremor. no sequence motion of the hands was noted with rapid finger apposition. cognitively she appeared distracted and a little paranoid despite a mini-mental state score (mmse) of 27/30, which usually indicates a mild dementia when the score goes below 27. visuo-motor skills were impaired with pantomime mimic. she has ideomotor apraxia with tool use, using the hand as the tool object. deftness with a coin, limb-kinetic praxis, was preserved. despite the presence of a grasp reflex and a snout reflex, a palmo-mental reflex was absent. but gegenhalten (paratonia) was noted in the arms, with compensatory increasing resistance with increasing velocity of flexion at the elbow. her cranial nerve examination was significant for a lively gag reflex. power was preserved in the arms and legs, with symmetry. her deep tendon reflexes were lively in the arms and legs, with a negative plantar extensor response bilaterally. of note, stereognosis and graphesthesia were preserved in the hands. due to her dementia presentation and clinical findings of lower half parkinsonism, an mri scan of the brain was obtained revealing severe subcortical white matter disease ( figure 1 ). susceptibility weighted images (swi) and phase map images reveal cerebral micro-bleeds (mcbs), more than five lesions; note hypo-intensity of bleeds on both sequences implying a right-handed reference frame ( figure 2 ). cmbs and betraying the right-handed reference frame of the mri system (red arrows). these images look similar but are different acquisition sequences; note difference in peri-ventricular white matter intensity between both sequences (yellow arrow). mri: magnetic resonance imaging; cmb: cerebral micro-bleeds; swi: susceptibility weighted images. a carotid duplex scan and a transcranial doppler ultrasound did not reveal any significant cervical carotid or intra-cranial artery stenosis respectively. she has stable coronary artery disease and more than five cmbs on susceptibility mri of the brain. hence one faces a therapeutic dilemma; with such extensive cerebral white matter disease and stable coronary artery disease, is anti-platelet therapy warranted in the presence of more than five cmbs? our solution was to continue the statin, atorvastatin 20 mg and aspirin 81 mg daily for the following reasons. we considered substituting cilostazol, an anti-platelet phosphodiesterase inhibitor for aspirin, as we do know that when cilostazol is compared with aspirin, the risk of cerebral and gastrointestinal hemorrhage is lower, with a 25.7% relative risk reduction of ischemic strokes, but only in patients with prior ischemic strokes [7] . however, there is no data for the effectiveness of cilostazol in stable coronary artery disease. we decided to continue low dose aspirin therapy in order to protect her coronary arteries. we continued statin therapy, atorvastatin 20 mg daily, as this too has anti-thrombotic effects on both the coronary and cerebral circulation. she was encouraged to quit smoking. for her cognitive impairment, the patient was started on an acetylcholine-esterase inhibitor, donepezil 5 mg daily. the risk of an ischemic or hemorrhagic stroke in patients with less than five or more than five cmbs, treated with antiplatelets, will be outlined in the discussion section. as outlined earlier, cmbs are radiologically small round or ovoid regions of signal loss seen on paramagnetic mri sequences. cmbs are due to hemosiderin-laden macrophages. cmbs are a direct result of extravasation of erythrocytes from diseased arterioles and capillaries damaged by hypertension, such as the small perforating arteries of the deep gray and white matter, in the basal ganglia and the lobar regions. in caucasians with intracerebral hemorrhage, cmbs in a lobar distribution are associated with cerebral amyloid angiopathy (caa). caa leads to progressive deposition of β-amyloid in small cortical and leptomeningeal arterial walls, increasing their fragility [1, 3] . lipohyalinosis, also known as fibrinoid necrosis, occurs in small vessels in hypertensives, affecting deep perforating arteries, which branch off from large arteries in the basal ganglia, white matter, brain stem and cerebellum. the fibrinoid deposition in the tunica media of the blood vessel wall is due to blood-brain barrier disruption leading to destruction of smooth muscles and the extracellular matrix. this leads to the formation of micro-aneurysms and micro-hemorrhages. hyaline arteriolosclerosis is characterized by thickening of the arteriolar wall by collagen deposits around the basement membrane, leading to fragility and cmbs [8, 9] . the pathologic and radiologic findings of cmbs are summarized below ( table 1) . size of lesion < 10 millimeters; round or ovoid microbleed -extravasation of erythrocytes hyperintensity on gre/swi in patients with cerebral amyloid angiopathy (caa), the prevalence of cmbs is 100%. the distribution of cmbs in caa is lobar, mirroring the histopathology of amyloid angiopathy in cortical vessels. this lobar pattern is also seen in alzheimer's disease. involvement of the leptomeningeal vessels explains the occurrence of superficial siderosis that is observed in both caa and alzheimer's disease [10] . cmbs also occur more frequently in patients with vascular dementia displaying a more central distribution pattern, and may involve the thalamus, brainstem and cerebellum [11] . in diffuse axonal injury, cmbs are typically located in the corpus callosum and at the gray-white matter junction, and tend to have a more radial configuration following the perivascular spaces compared with the more spherical cmbs occurring with neurodegeneration or hypertension [12] . radiation vascular injury begins above a dose of 25 grays (gy). it can acutely involve the small vessels, through fibrinoid necrosis and telangiectasis with vessel permeability and vasogenic edema. chronically, the larger vessels are affected with vessel wall thickening, thrombosis and fibrinoid necrosis. cmbs occur in at least 50% of patients who have undergone radiation treatment, in pediatric and adult patients. the rate of cmb formation increases significantly two years after radiation treatment and is associated with cognitive impairment [13] [14] [15] . cavernous angiomas have a popcorn-like high signal intensity on t1-weighted images and a hypo-intense hemosiderin ring on t2-weighted images. small type iv cavernous angiomas may be indistinguishable from cmbs. cavernous angiomas can be classified into four types: type i -extra-lesional blood beyond cavernous angioma; type ii -mixture of subacute and chronic blood; type iii -area of hemosiderin with a small central core; and type iv -area of hemosiderin deposition without a central core. because of a lack of a central core, type iv lesions are only visible on swi images as hypo-intense spots, identical with cmbs [16] , type iv lesions being the most similar to cmbs. swi hypo-intensity and t1 hyper-intensity have been deployed to detect micro-metastases. these signal characteristics are five times more common in melanoma metastases than in lung cancer metastases. three quarters of melanoma metastases have one or the other signal characteristic and a quarter have both findings. this combination of findings was sixteen times more common with melanoma metastases than with lung cancer metastases. melanin leads to t1 shortening and the propensity of melanomas bleeding, with methemoglobin accumulation, can lead to t1 shortening. the susceptibility effects on swi are due to the presence of metal ions: iron, copper, manganese, and zinc. of note, 7% of melanomas had no t1 shortening and were only detected with swi [17] . there are strong associations of cmbs with age and hypertension, more likely deep in the brain. carrying the apo-lipoprotein e4 (apo e4) gene increases the risk of lobar cmbs most frequently in the parietal lobes [2] . cmbs are strongly correlated with volume of white matter disease [18] . the presence and number of cmbs also correlates with the congestive heart failure/left ventricular systolic dysfunction, hypertension, age ≥75 years, diabetes mellitus, stroke or tia or thromboembolism, vascular disease (chads2-vasc) scores, which is used to estimate ischemic stroke risk in patients with atrial fibrillation. in a study of 131 japanese patients with atrial fibrillation and 112 controls without atrial fibrillation, patients with atrial fibrillation had a significantly higher prevalence of cmbs. there is also evidence that lobar cmbs may be more common than deep cmbs in patients with atrial fibrillation [19] . the various causes of cmbs with their topography and mechanisms are listed below ( table 2) . knudsen et al. [ in the study by lau et al., in 1811 patients who were prescribed anti-platelet therapy, the five-year risk of recurrent ischemic stroke and hemorrhagic stroke both increased with the number of cmbs [6] . high cmb burden, greater than or equal to five, was an independent risk factor for recurrent ischemic stroke, hemorrhage stroke, all cause mortality, and nonvascular death. patients with greater than or equal to five cmbs experienced a three-fold higher risk of recurrent ischemic stroke and a 13-fold increased risk of hemorrhagic stroke than those without cmbs. for the patients with less than five cmbs, the five-year absolute risk of ischemic stroke was much higher than the incidence of intracranial hemorrhage. for those with greater than or equal to five cmbs, the risk of fatal and disabling ischemic and hemorrhagic strokes was similar in the first year, but this calculus changed from the second to fifth year, where the risk of a hemorrhagic stroke was much higher, almost 13 times higher [6] . in summary, cmbs are associated with a higher risk of ischemic strokes than hemorrhagic strokes during the first year, regardless of the number of cmbs and treatment with anti-platelets is recommended, if indicated. for more than or equal to five cmbs, this issue is still contentious, as a head to head study is not available. however, withdrawal of anti-platelet therapy may be considered depending on the risk profile. these findings are summarized below ( table 3) . findings suggest that anti-platelet use is safe when cmb number is below five, but questionable when cmb number exceeds five from year two to year five [6] . our case highlights the dilemma the clinician faces in patients who carry more than five cmbs on an mri of the brain and who have co-existent co-morbid diseases, such as coronary artery disease. as we highlight in the discussion section, anti-platelet therapy in patients who harbor more than five cmbs can be associated with as high as a 13-fold increased risk of an intracranial bleed, especially in those patients who are receiving anti-platelet therapy for more than one year. we tackle this therapeutic conundrum by considering an alternative therapy with cilostazol, a phosphodiesterase inhibitor, which is less likely to lead to an intracranial bleed. however, this approach was deemed insoluble, as there is no evidence for the effectiveness of cilostazol for coronary artery disease. the literature of cmbs is extensive. in this article, we streamline a lot of the data and address the key points. in particular, we unravel the radiological signature of cmbs, its pathophysiologic correlates, outline the risk factors and common diseases associated with cmbs and at the end of the discussion we address the risk of ischemic and hemorrhagic strokes in patients with cmbs who are receiving anti-platelet therapy. human subjects: consent was obtained by all participants in this study. conflicts of interest: in compliance with the icmje uniform disclosure form, all authors declare the following: payment/services info: all authors have declared that no financial support was received from any organization for the submitted work. financial relationships: all authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. other relationships: all authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. cerebral microbleeds: histopathological correlation of neuroimaging prevalence and risk factors of cerebral microbleeds: an update of the rotterdam scan study cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts cerebral microbleeds: imaging and clinical significance cerebral microbleeds: a guide to detection and interpretation antiplatelet treatment after transient ischemic attack and ischemic stroke in patients with cerebral microbleeds in 2 large cohorts and an updated systematic review benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2 fibrinoid necrosis of small brain arteries and arterioles and miliary aneurysms as causes of hypertensive hemorrhage: a critical reappraisal stroke patients with cerebral microbleeds on mri scans have arteriolosclerosis as well as systemic atherosclerosis clinical diagnosis of cerebral amyloid angiopathy: validation of the boston criteria use of antithrombotic drugs and the presence of cerebral microbleeds: the rotterdam scan study the difference in location between traumatic cerebral microbleeds and microangiopathic microbleeds associated with stroke 7-tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma radiation-induced microbleeds after cranial irradiation: evaluation by phase-sensitive magnetic resonance imaging with 3.0 tesla presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors the natural history of familial cavernous malformations: results of an ongoing study improved detection of metastatic melanoma by t2*-weighted imaging white matter lesion progression in ladis: frequency, clinical effects, and sample size calculations cerebral microbleeds and asymptomatic cerebral infarctions in patients with atrial fibrillation covid-19 is associated with an unusual pattern of brain microbleeds in critically ill patients (preprint) key: cord-027730-xn12s005 authors: jlassi, amal; elbedoui, khaoula; barhoumi, walid; maktouf, chokri title: unsupervised method based on superpixel segmentation for corpus callosum parcellation in mri scans date: 2020-05-31 journal: the impact of digital technologies on public health in developed and developing countries doi: 10.1007/978-3-030-51517-1_10 sha: doc_id: 27730 cord_uid: xn12s005 in this paper, we introduce an unsupervised method for the parcellation of the corpus callosum (cc) from mri images. since there are no visible landmarks within the structure that explicit its parcels, non-geometric cc parcellation is a challenging task especially that almost of proposed methods are geometric or data-based. in fact, in order to subdivide the cc from brain sagittal mri scans, we adopt the probabilistic neural network as a clustering technique. then, we use a cluster validity measure based on the maximum entropy (vmep) to obtain the optimal number of classes. after that, we obtain the isolated cc that we parcel automatically using slic (simple linear iterative clustering) as superpixel segmentation technique. the obtained results on two challenging public datasets prove the performance of the proposed method against geometric methods from the state of the art. indeed, as best as we know, it is the first work that investigates the validation of a cc parcellation method on ground-truth datasets using many objective metrics. thanks to advances in magnetic resonance imaging, neuroscientists and clinicians can study in depth the corpus callosum (cc) and mainly the correlation between the cc's dimensions and some neurological diseases. the cc, which is the largest white matter structure and the biggest fiber tract connecting corresponding regions of the cerebral cortex in the two cerebral hemispheres, integrates motor, sensory, and cognitive functions of the brain [1] . anatomically, more than half of the axons composing the cc are surrounded by myelin, which gives this structure its remarkable appearance in midsagittal t1-weighted mri images. however, in many sagittal brain mri slices, the fornix appears in the neighborhood of the cc with a similar intensity ( fig. 1 ) [2] . the cc is usually divided into smaller regions such as rostrum, genu, body, and splenium. this subdivision of the cc is called parcellation and it is proving to be very useful for an effective analysis of the cc [2, 3] . in fact, the cc shape may be the cause of many neurodegenerative diseases such as epilepsy, alzheimer, autism, depression and other types of psychosis [4] . the cc analysis is also important for studying aging, gender differences and laterality [5] . hence, various studies have evaluated shape or volume variation of the cc parcels. they revealed a correlation between cc's abnormalities and many diseases. for instance, [6] shows that the rate of change in cc or one of its sub-regions is more closely associated with the progression of alzheimer's disease. moreover, the cc parceling can be an appropriate group biomarker for an objective evaluation of treatments aimed at slowing the progression of alzheimer [7] . furthermore, several works have identified volume alterations of the cc and its sub-regions in subjects with autism spectrum disorders (asd). in this context, a study of the cc volume of 40 pre-schoolers, with different sex and age, suffering from asd was made by applying the "freesurfer" automated parcellation software. this study demonstrated that the total volume of the cc and its sub-regions is correlated with autism severity [8] . another study conducted on 75 participants with parkinson disease (pd) and 24 healthy control (hc) confirms that cc sub-regions abnormalities might be the cause of parkinson disease. indeed, participants with pd showed an increase in the 3 anterior callosal segments compared to hc [9] . generally, the cc parcellation into callosal regions allows for a precise differentiation of motor connectivity and the structural integrity of these tracts in the cc [10] . thus, the cc parcellation should be so helpful to better understand inter-hemispherical callosal connectivity in patients or healthy subjects [11] . in particular, mri takes advantage of the macroscopic geometrical arrangement of white matter bundles that it makes capable of generating good cc visualization from the sagittal plane. in any way, the parcellation of the cc stills an important task for radiologic assessment despite there are no real or visible borders to allow this subdivision. nevertheless, the visual inspection of cc structures in mri scans suffers from both inter-and intra-specialist variability. on the one hand, the manual cc segmentation methods require strongly visual effort, specialized training skill, and are time-consuming processes. on the other hand, several geometrical methods for the cc parcellation have been proposed such as witelson and hofer methods [12] . however, these methods cannot be satisfactorily validated due to the lack of qualitative parameters and reference standards. although all these difficulties, the development of an automatic cc parcellation method is an inescapable need to ensure a reliable diagnosis. such parcellation is so independent from the operator skills and may be extended to other brain structures parcellation. thus, since there are no visible landmarks indicating where the cc should be subdivided, the development of a fully automatic cc parcellation method is highly challenging, even for specialists. to deal with this issue, we propose to automatically parcel the cc within mri images. by validating it, for the first time, on large and public datasets, the proposed method records promising results. in fact, the contribution of this work is twofold: -as best as we know, we adopt for the first time the superpixel segmentation algorithm called simple linear iterative clustering (slic) for the cc parcellation [13] . despite its simplicity, slic has been demonstrated to be effective in various computer vision applications [14] . -the subdivision process of the proposed method is fully automatic and it is the second study that proposed a non-geometric analysis for the cc parcels, to the best of our knowledge [15] . although it is based only on the mri data of each analyzed subject, with no parameter adjusting, the proposed method proved quantitatively its superiority over state-of-the-art methods. the rest of this paper is organized as follows. in sect. 2, we briefly review existing methods for the cc parcellation. section 3 presents the proposed method based on slic. experimental results are discussed in sect. 4. the last section concludes the paper and points some directions for future work. few cc parcellation methods were proposed. however, most of these methods have not surmounted all the challenges encountered. in fact, the cc parcellation is a challenging task given that a normal shape of the cc might not clearly highlight all parcels, what can increase the diagnosis complexity. in addition, many internal abnormalities might include bumps which are hard to detect. existing cc parcellation methods can be divided into two main classes: geometric methods and non-geometric ones. on the one hand, since there are no real or visible boundaries allowing the cc parcellation, several geometrical methods were presented to perform this task. among these methods, two particular ones are widely adopted. the first was proposed by witelson and it is based on postmortem connectivity analysis in primates and humans [16] . this method divides the cc into five regions ranging from anterior dimension to the posterior dimension. the cc subdivision is done into an anterior third, the middle of the anterior and posterior midbody, a posterior third and the posterior one-fifth. the rostrum, genu, and rostral body presenting the regions of the anterior third illustrate the prefrontal, premotor, and supplementary motor cortical areas. however, the posterior midbody is crossed by the somaesthesic and posterior parietal fiber bundles. the sub-regions of the posterior third, containing the isthmus and splenium, are allocated to temporal, parietal, and occipital cortical regions. thus, this parcellation method, and as any geometric methods, neither reflects the real texture nor the internal organization of the cc. in addition, the cc parcellation is strongly dependent on the brain conservation process, since it is based on post-mortem data. differently, hofer proposed the only work based on tractography of dti (diffusion tensor imaging) by subdividing the cc into five regions from an average behavior observed via tractography in a specific population of 8 subjects [1] . as already proposed by witelson, the geometric baseline in the midsagittal section of the cc is defining the anterior and posterior points of the structure. the first region, which represents the first sixth, contains fibers projected in the prefrontal region. the remainder of the anterior half cc illustrates the second region containing the fibers that form the motor and motor areas of the cerebral cortex. in fact, these fibers form together the largest cc region and are placed in the back section of the structure. the third region presents the posterior half minus the posterior third. it contains fibers responsible for the primary motor cortex. however, this part of the parcellation scheme is in conflict with witelson's method. the fourth region forms third minus the posterior quarter, presenting the primary sensory fibers. the last and the fifth region represents the cc posterior quarter crossed by the parietal, temporal and visual fibers. figure 2 shows a comparison between the geometric schemes proposed by witelson and hofer. we notice that geometric methods allow only to divide the cc into the same regions among all subjects without considering the human and individual brain features between different subjects. on the second hand, differently to geometric parcellation methods, rittner proposed a data-driven method based on the watershed technique [15] . this method is composed of four steps. the first step consists in the weighting of the fractional anisotropy. the second step performs the selection of the brain midsagittal plane, followed by the third and the last step which are the cc segmentation using the watershed technique, and its parcellation with fixed markers. nevertheless, this method suffers from sensitivity to parameters selection. in order to overcome its limitations, cover extended the rittner method with some important changes [12] . practically, the author replaced all steps except the first step in order to lead to a more robust data-driven method. indeed, the parcellation is improved by applying the kmeans algorithm after defining the cc centerline. when comparing this method to that of rittner, and although both are based on watershed, it is confirmed that this method had a better generalization ability using no fixed markers to execute the watershed transform. however, due to the lack of quantitative metrics and reference standards, these methods cannot be correctly validated. differently to existing methods, we propose a subdivision scheme that considers only the mri data [14] . using the slic superpixel segmentation technique, the method is composed of two main steps: cc segmentation and cc parcellation. this comes from that the slic presents one of the most popular images over segmentations that is commonly used as supporting regions for primitives to reduce computations in various computer vision tasks. we adopt herein our previous method [17] for the automatic cc segmentation of mri sagittal section. it includes three main steps: image preprocessing using the anisotropic diffusion filtering (adf), classification based on the unsupervised probabilistic neural network (pnn) classifier, and cc isolation using a spatial filtering (fig. 3) . in fact, the first step aims to enhance the signal-to-noise ratio by eliminating unwanted parts in the background and smoothing the internal part of the region while preserving its borders. in fact, adf allows to unblock high-frequency noise while preserving the main edges of structures [18] . then, the classification step permits to define the target classes using k-means, before classifying them by the pnn [17] . thereafter, the vmep index, which is based on the maximum entropy principle as an evaluation method that is called the cluster validity, is applied in order to determine the optimal number of clusters. the optimal number of classes is obtained when the vmep validity index reaches its maximum value. this number is adopted for the pnn classification process to obtain the final cluster map. once the cc class is identified, the cc region will be isolated by a spatial-based filtering. finally, we defined the cc contour by applying a follow-up algorithm on the border pixels of the cc region that are characterized by a maximum of the spatial gradient [19] . we propose a cc parcellation method based on slic, which is non-geometric and fully automatic superpixel segmentation technique. it works with no parameter adjusting and with no instantaneous training, leading to a more robust technique. thus, in order to segment the cc into a set of superpixels, which refer to groups of pixels that represent perceptually significant small defined regions, we adopt the slic technique. it is an arrangement of k-means for superpixel generation in order to be faster than existing methods, more memory efficient while improving significantly the segmentation accuracy. it allows two important directions [14] . firstly, it reduces greatly the number of distance calculations by restricting the search space to a region corresponding to the superpixel size. therefore, a reduction in the complexity of being linear is achieved in the pixels' number n and superpixels' number k that is independent and user-defined. in our case, n and k are equal to 256 and 200, respectively. secondly, a combination of color and spatial proximity is reached by a weighted distance measure that allows both controls over the size and compactness of the superpixels. thus, each slice of the input mri image is partitioned into different size regions. in fact, the initial grid size is defined as s (1). from the geometric center, the center superpixel of each region is computed. this geometrical center of each region is recursively updated in each iteration. in order to regroup the pixel, both spatial and intensity distances are used. the spatial distance between the pixels i and j is defined as follows (2): where the coordinate values of pixel i and j are represented by p and q. the eq. 3 calculates the intensity distance. where n j and n i represent the normalized intensity of pixel j and i, respectively. equation 4 defines the combined distance measure c d of spatial and intensity. where e denotes the compactness coefficient. in fact, larger value of e illustrates more compact segments, whereas lower value of e represents flexible boundaries. the compactness coefficient is fixed in the range of [0, 1]. the superpixel computation of the proposed method is shown in fig. 4 . for the evaluation of the proposed parcellation method, we are the only study that used brain mri scans from two public datasets. on the one hand, we used the open access series of imaging studies (oasis) dataset, which is freely available on www.oasis-brains.org. it is created by washington university alzheimer's disease research centre. this mri dataset included a longitudinal collection of 416 subjects aged between 18 and 96 years, men and women, including 100 individuals with very mild to moderate alzheimer's disease (ad). all images were acquired on the same scanner using the same sequences. each subject was scanned on two or more visits, separated by at least one year for a total of 373 imaging sessions. each mr image within this dataset is composed of 128 slices with a resolution of 256 × 256 (1 × 1mm). in this work, we selected 1806 sagittal images that are qualified by a quality control according to severe artifacts. on the other hand, autism brain imaging data exchange (abide) is also investigated. in order to accelerate understanding of the neural bases of autism, the abide dataset has supplied functional and structural brain imaging data collected from laboratories around the world. this dataset is composed of two large-scale collections called abide-i and abide-ii. each collection was collected independently across more than 24 international brain imaging laboratories. thus, we generate a total of 2200 sagittal images with a resolution of 256 × 256. it is worthy noting that we have a challenging heterogeneous set of images of normal subjects and individuals with autism and alzheimer. for each subject, the proposed parcellation method gives an apparent variation in the positioning of the cc parcels. this is because this method is purely automatic and does not follow any atlas or any prior knowledge (fig. 5) . the geometric methods of hofer and witelson do not present the variation of their proportion of cc parcels and consequently, the same behavior can be observed on the results of all the subjects. figure 5 shows that the proposed cc parcellation method is more similar to the hofer parcellation than the rittne one. this can be explained by the fact that hofer subdivisions are based on the connections of the cortical fibers to find the cc parcels. the largest differences between the proposed parcellation and that of witelson are observed in the parcels 1 and 4. in fact, according to our collaborator clinician expert, the cc shape and parcellation are well defined and the delineated cc area shows closely the five anatomical subdivisions of the cc, especially the critical ones: the rostrum and the splenium. the fornix is correctly removed from the cc area and the obtained cc parcellation shows a precise subdivision of cc into five regions within brain mri scans, without penetrating the irrelevant neighboring structures. note that, within the selected sample of mri brain scans, the cc is extracted and parcelled both on female (column 1 and 3) and male (column 2 and 4) subjects. in fact, we applied the proposed method on subjects from the abide dataset (column 1 and 2) as well as from the oasis dataset (column 3 and 4). in order to evaluate the performance of the proposed method, we used the following commonly used metrics: dice, accuracy, sensitivity, specificity and precision. -the dice coefficient (5) is a statistical measure that is used for comparing the similarity of two sample sets. -the accuracy (6) is defined as the rate of correctly classified items. -the sensitivity (7) is the proportion of positive items correctly classified. -the specificity (8) is the rate of negative items rightly identified. -the precision (9) is the ratio of correctly predicted positive samples to the total predicted positive samples. tp refers to the true positive (region correctly parcelled as the concerned parcel), tn refers to the true negative (region correctly classified as background), fp refers to the false positive (region which is parcelled as the concerned parcel) and fn refers to the false negative (region which is incorrectly classified as background). we notice that we produce five parcels, and for each parcel we measure the five metrics. it is worthy noting that for the first time, a very useful ground-truth for cc segmentation and parcellation within the challenging widely used oasis and abide datasets is used. therefore, we are the only work that is compared to a such ground-truth. however, the rittner method is evaluated only on the agreement between the results achieved by different cc parcellation methods. in fact, a professional neurologist from pasteur institute of tunis and a junior doctor have been charged with manually preparing the cc regions and parcels from all images belonging to the oasis and the abide datasets. besides, we applied post-processing in order to exclusively extract the cc area and parcels. table 1 shows the recorded results comparatively to the ground-truth. it is clear that the proposed method (pm) records the higher dice coefficient score (> 0.84) in the parcels 1, 2, and 5, and a sufficient dice coefficient score (> 0.75) in parcels 3 and 4 comparatively to the ground-truth. evenly, it reaches a higher accuracy, specificity and sensitivity scores with values > 0.90. the decline of the proposed method performance according to the precision metric can be explained by the cause of the ground-truth which is manually drawing and the processing applied to do the evaluation in each parcel. furthermore, for the two datasets and for each cc parcel, the dice coefficient was computed pairwise for the methods of the state of the art ( table 2) as it is used in the rittner work. therefore, the previous analyzes allow only verifying the similarity between the resulting cc parcels, or which present statistical differences between methods of the literature since this is a problem without a gold standard (table 2) . hence, it is now possible to know the correct cc parcellation by producing ground-truth for both witelson and hofer methods. since the hofer and witelson cc parcellation methods are based on geometric cc parcellation, their results did not vary among different subjects throughout the experimented dataset. this explains this overlap measurement obtained which would have maximum value if any of the methods was the same. the most pertinent difference between these cc parcellation methods was related to the automatic and non-geometric behavior defined by our proposed parcellation. table 2 presents different results between methods while recording interesting similarities in some cases. the proposed cc parcellation method demonstrates to be nearby to the hofer method, mainly on parcels 1, 2 and 3, while the witelson method presents significant statistical difference on the parcels 4 and 5. cc is the biggest fiber tract within the human brain that allows the communication between the two cerebral hemispheres. the cc form and sub-regions might cause some diseases. the cc parcellation from mri images can predict future cases of diseases or progress neurological patterns in the development of different diseases. this paper presented a fully automatic non-geometric cc parcellation based on the slic superpixel algorithm, with no parameter adjusting and instantaneous training. since there is no gold standard used to evaluate the existing methods, we produced for the first time a ground-truth led to evaluate quantitatively cc parcellation methods. extensive experiments and quantitative comparisons with relevant cc parcellation methods, proved the accuracy of the proposed method on two challenging standard datasets. indeed, the proposed method achieves higher performance values for each parcel. as future work, we aim to propose a super voxel method based on the slic algorithm, from not only mri scans but also from functional magnetic resonance imaging. topography of the human corpus callosum revisitedcomprehensive fiber tractography using diffusion tensor magnetic resonance imaging anatomical mri study of corpus callosum in unipolar depression the relationship of hand preference to anatomy of the corpus callosum in men accurate automated detection of autism related corpus callosum abnormalities corpus callosum surface area across the human adult life span: effect of age and gender callosal circularity as an early marker for alzheimer's disease corpus callosum shape and size changes in early alzheimer's disease: a longitudinal mri study using the oasis brain database the effect of age, sex and clinical features on the volume of corpus callosum in pre-schoolers with autism spectrum disorder: a case-control study white matter abnormalities in the corpus callosum with cognitive impairment in parkinson disease parcellation of motor cortex-associated regions in the human corpus callosum on the basis of human connectome project data white-matter microstructural properties of the corpus callosum: test-retest and repositioning effects in two parcellation schemes data-driven corpus callosum parcellation method through diffusion tensor imaging computational methods for corpus callosum segmentation on mri: a systematic literature review slic superpixels compared to state-of-the-art superpixel methods automatic dti-based parcellation of the corpus callosum through the watershed transform hand and sex differences in the isthmus and genu of the human corpus callosum: a postmortem morphological study unsupervised method based on probabilistic neural network for the segmentation of corpus callosum in mri scans multimodal registration of pet/mr brain images based on adaptive mutual information boundaries detection based on polygonal approximation by genetic algorithms key: cord-011669-hkkpw2bl authors: rodríguez-sánchez, diego noé; pinto, giovana boff araujo; thomé, edval fernando; machado, vânia maria de vasconcelos; amorim, rogério martins title: lissencephaly in shih tzu dogs date: 2020-06-20 journal: acta vet scand doi: 10.1186/s13028-020-00528-0 sha: doc_id: 11669 cord_uid: hkkpw2bl background: lissencephaly is a brain malformation characterized by smooth and thickened cerebral surface, which may result in structural epilepsy. lissencephaly is not common in veterinary medicine. here, we characterize the first cases of lissencephaly in four shih tzu dogs, including clinical presentations and findings of magnetic resonance imaging of lissencephaly and several concomitant brain malformations. case presentation: early-onset acute signs of forebrain abnormalities were observed in all dogs, which were mainly cluster seizures and behavioral alterations. based on neurological examination, the findings were consistent with symmetrical and bilateral forebrain lesions. metabolic disorders and inflammatory diseases were excluded. magnetic resonance imaging for three dogs showed diffuse neocortical agyria and thickened gray matter while one dog had mixed agyria and pachygyria. other features, such as internal hydrocephalus, supracollicular fluid accumulation, and corpus callosum hypoplasia, were detected concomitantly. antiepileptic drugs effectively controlled cluster seizures, however, sporadic isolated seizures and signs of forebrain abnormalities, such as behavioral alterations, central blindness, and strabismus persisted. conclusions: lissencephaly should be considered an important differential diagnosis in shih tzu dogs presenting with early-onset signs of forebrain abnormalities, including cluster seizures and behavioral alterations. magnetic resonance imaging was appropriate for ante-mortem diagnosis of lissencephaly and associated cerebral anomalies. lissencephaly in mammals occurs due to the failure of neuroblasts to migrate to the cerebral cortex, during development [1, 2] . it is characterized by smooth cortical appearance and by the absence of surface folds (agyria) or abnormally broad folds (pachygyria). histopathology demonstrates thickening of the cerebral cortex, altered gray-to-white matter ratio and replacement of a normal 6-layered cortex with a 4-layered disorganized cortex [2, 3] . two types of lissencephaly can be distinguished in humans: classical lissencephaly (or type i), characterized by thickened brain surface with agyria or pachygyria that results from neuronal migration arrest [4, 5] and cobblestone lissencephaly (or type ii), characterized by thin and nodular brain surface, resulting from glial and neuronal overmigration [4, 5] . muscular dystrophy, ocular alterations, obstructive hydrocephalus, and malformation of the brainstem and cerebellum are often associated with cobblestone lissencephaly [4] [5] [6] . lissencephaly has been described in lhasa apso [7, 8] , pekingese [9] , australian kelpie [10] , wire-haired fox terrier [11] , irish setter [11] , and mixed-breed dogs [12] . in humans, lissencephaly is associated with gene mutations related to brain development or cerebral metabolism [1, 5, 13] . in addition, nongenetic causes, such as intrauterine viral infections, vascular events (hypoxia or hypoperfusion), and maternal metabolic disorders that interrupt cortical formation, have been described [2, 3, 13] . the neurological signs in dogs commonly begin with an early-onset of seizures and behavioral alterations, leading to disability [7, 8, 10] . clinical findings and magnetic resonance imaging (mri) features of lissencephaly in shih tzu dogs have not been reported previously, and reports of concomitant brain malformations are scarce. four apparently unrelated shih tzu dogs were presented with lissencephaly between 2011 and 2018 at the veterinary neurology service of são paulo state university (unesp), brazil. details regarding clinical features, neurolocalization, ancillary diagnostics and antiepileptic treatment are shown in table 1 . mri was performed using a 0.25 tesla scanner (vet-mr grande, esaote, italy) in all dogs to obtain t1-weighted, t2-weighted, fluid-attenuated inversion recovery (flair) and postcontrast t1 sequences. in addition, gradient echo (gre) sequences were obtained in three dogs, and hybrid contrast enhancement (3d hyce) sequences were obtained in two dogs. all mris were evaluated and interpreted by two researchers (ra and vm). a summary of the mri findings, equipment, positioning, sequences, imaging parameters, and the contrast medium are detailed in additional file 1. the first case was an 8-month-old spayed female referred in 2011 due to seizures of suspected idiopathic origin that were poorly controlled with phenobarbital (gardenal ® , 2.5 mg/kg, orally q12h; safoni, brazil). the dog was evaluated by the referring veterinarian 2 months after the onset of tonic-clonic seizures, which had progressed over the last 2 weeks to 2-3 seizures per week. in our service, the owner reported that the dog experienced cluster seizures that occurred over 48 h and were treated with diazepam and thiopental. on presentation, neurological examination was performed 1 week after cluster seizures and was unremarkable. based on a history of seizures, the lesion was localized to the forebrain. physical examination findings, biochemical profile, and complete blood count (cbc) were normal; polymerase chain reaction (pcr) for canine distemper virus in urine and indirect immunofluorescent antibody tests (ifat) for antibodies against toxoplasma gondii and neospora caninum were negative. mri showed mixed parieto-occipital agyria and pachygyria of the frontal and parietal lobes (fig. 1 ). temporal and occipital regions lacked gyri and sulci. mri diagnosis indicated lissencephaly and supracollicular fluid accumulation (sfa) (fig. 1) . treatment with phenobarbital (gardenal ® , 3 mg/kg, orally q12h; safoni, brazil) and levetiracetam as an adjunct (keppra ® , 20 mg/kg, orally q8h; ucb biopharma, brazil) effectively controlled cluster seizures after presentation. levetiracetam was discontinued after 4 weeks. the neurological signs were nonprogressive and this dog experienced only isolated episodes (interictal period of 2-3 months) over a period of 24 months after diagnosis of lissencephaly (> 50% reduction in the frequency of seizures). it was not possible to obtain information regarding survival for this dog. the second case involved a 43-month-old castrated male which was referred in 2014 due to the occurrence of cluster seizures. the dog was diagnosed by the referring veterinarian with presumed idiopathic epilepsy at 24 months of age and treatment with phenobarbital was then initiated (gardenal ® , 2.5 mg/kg, orally q12h; safoni, brazil). during the first 16 months after diagnosis of presumed idiopathic epilepsy and the onset of treatment, the dog experienced both isolated seizures and cluster seizures, with an interictal period less than 30 days. relatively low levels of phenobarbital (< 25 µg/ ml: therapeutic window 25-35 µg/ml) were detected in serum; therefore, the dose of phenobarbital was gradually increased (gardenal ® , 4 mg/kg, orally q12h; safoni, brazil). however, despite the increase in serum phenobarbital concentration (35 µg/ml), the dog continued to have repeated tonic-clonic seizures. therefore, potassium bromide (kbr) (30 mg/kg orally, q24h) was also prescribed 1 month before referral to unesp. on presentation in our service, in addition to cluster seizures the owner reported behavioral changes between seizures, such as difficulties in learning basic commands, changes in sleep cycle and compulsive pacing. aggression was noted in our service during manipulation for physical examination. during anamnesis, the owner reported polyuria, polydipsia and polyphagia. biochemical profile showed increased levels of alkaline phosphatase (216: reference interval 20-156 u/l). these alterations were presumed to be associated with phenobarbital treatment. neurological examination revealed no abnormalities except for the presence of bilateral central blindness and bilateral ventromedial strabismus during cranial nerve examination. physical and ophthalmological examinations were normal. the anatomical neurolocalization was compatible with a forebrain lesion. pcr in urine for canine distemper virus and ifat in the serum for t. gondii and n. caninum were negative. mri showed absence of sulci and gyri with superficial undulations in the frontal and temporal lobes. the main gyri, including the marginal, ectomarginal, suprasylvian, and ectosylvian gyri, were absent. a rudimentary lateral rhinal sulcus was present, while the cingulate gyrus was not apparent. the internal capsule was abnormally small (fig. 1) . a diagnosis of lissencephaly, internal this dog remained stable and neurological signs were nonprogressive for 36 months after diagnosis of lissencephaly (interictal interval of 3-4 months with > 50% reduction in the frequency of seizures) using combined polytherapy involving both phenobarbital (gardenal ® , 4 mg/kg, orally q12h; safoni, brazil) and kbr (30 mg/ kg, orally, q24h). levetiracetam (keppra ® , 20 mg/kg, orally q8h for 4-6 weeks, ucb biopharma, brazil) was initially included as an adjunct treatment modality. no more cluster seizures were reported after presentation. a carbonic anhydrase inhibitor (acetazolamide, diamox ® , 10 mg/kg, orally q8h, genom, brazil) and a proton-pump inhibitor (omeprazole, gaviz ® , 10 mg/dog, orally q24h, agener, brazil) were used for supportive treatment of hydrocephalus. however, the difficulties in learning basic commands, changes in sleep cycle, compulsive pacing, strabismus and aggression were persistent despite treatment. phone conversation with the owner revealed that the dog was alive 6 years after diagnosis. the third case involved an 18-month-old intact male which was referred in 2014 due to the occurrence of cluster seizures starting 12 days prior to referral. the dog was previously treated with phenobarbital (gardenal ® , 6 mg/kg, orally q12h; safoni, brazil); however, due to poor response to treatment, adjunctive therapy with kbr (40 mg/kg, orally, q24h) was initiated. on presentation, anamnesis revealed that 6 months prior to referral, the dog had experienced over 14 isolated seizures within 45 days and subsequent episodes monthly. at evaluation, the dog experienced two tonic-clonic seizures, and emergency treatment was provided using diazepam (1 mg/kg, per rectum and repeated iv bolus 3x). during the 48-h postictal re-evaluation, neurological examination revealed central blindness, and the owner reported that the dog demonstrated abnormal vocalizations. in addition, aggressiveness during the interictal period was noted, mainly during dog handling. anatomical neurolocalization was consistent with a forebrain lesion. physical and ophthalmological examination was unremarkable. laboratory data, including pcr in urine for canine distemper virus and ifat in the serum for t. gondii and n. caninum were negative. mri of the third dog showed presence of some sulci in the temporal lobe, including the caudal sylvian gyri and lateral rhinal sulci. however, the main gyri, including the marginal, ectomarginal, suprasylvian gyri, and suprasylvian sulcus (division between the parietal and temporal lobe), were absent (fig. 2) . the internal capsule was abnormally small. diagnosis was consistent with lissencephaly, asymmetrical internal hydrocephalus, and corpus callosum hypoplasia. this dog showed progressive reduction in isolated seizures throughout the year following diagnosis (> 50% reduction in seizure frequency) with an interictal interval of 2 months, maintaining combined polytherapy involving phenobarbital (gardenal ® , 6 mg/kg, orally q12h; safoni, brazil) and kbr (30 mg/kg, orally, q24h). serum concentration of phenobarbital was not tested due to financial constraints. no more cluster seizures were observed with combined polytherapy. a carbonic anhydrase inhibitor (acetazolamide, diamox ® , 10 mg/kg, orally q8h, genom, brazil) and a proton-pump inhibitor (omeprazole, gaviz ® , 10 mg/dog, orally q24h, agener, brazil) were used for supportive treatment of hydrocephalus. behavioral changes and central blindness persisted despite treatment. overall survival was 6 years after diagnosis, confirmed by the owners after our phone call. the fourth case was an 18-month-old spayed female which was referred with seizures in 2018. the referring veterinarian suspected meningoencephalitis of unknown etiology and reported poor control of seizures with phenobarbital (gardenal ® , 2 mg/kg, orally q12h; safoni, brazil). prednisolone treatment (predsim ® , 0.5 mg/kg, orally q12h; medley, brazil) was added empirically 1 week prior to referral by the referring veterinarian. in our service, the owner reported the first isolated tonic-clonic seizure when the dog was 9 months old. after the interictal period of 9 months, the owner reported that these seizures began again 3 weeks prior to examination. over the 3-week period before examination, during the interictal periods, subtle behavioral changes such as aggressiveness (mainly after handling), compulsive pacing, abnormal vocalizations, and licking at things were observed. the dog presented with cluster seizures in our service and was treated with diazepam. after stabilization, the postictal state in the following 24 h was characterized by ataxia, paresis, and behavioral signs. upon neurological examination after postictal stage, consciousness, posture, gait, and postural reactions were normal. cranial nerve examination showed bilateral central blindness and bilateral ventromedial strabismus. the findings were consistent with a forebrain lesion. physical and ophthalmological examination findings, biochemical serum profile and cbc test results were unremarkable. thorax radiography and abdominal ultrasound did not show alterations. pcr in urine for canine distemper virus and , h) in the third and fourth cases. mri of the third dog showed a few sulci in the temporal lobe, including the caudal sylvian gyri and lateral rhinal sulci (arrow). the main gyri (including the marginal, ectomarginal and suprasylvian) and the suprasylvian sulcus were absent. the internal capsule was abnormally small, and internal hydrocephalus was visualized (a-d). mri of the fourth dog showed generalized agyria with an absence of sulci and thickened gray matter with smooth appearance (arrow) (e, f). rhinal sulci in the temporal lobe were not apparent and cingulate gyrus was absent (arrowhead). internal hydrocephalus and supracollicular fluid accumulation associated with dorsocaudal outpocketing of the third ventricle (type sfa-iii) were observed (g, h) ifat in the serum for t. gondii and n. caninum were negative. mri showed generalized absence of sulci and gyri and thickened gray matter. the main sulci and gyri, including the marginal, ectomarginal, suprasylvian, ectosylvian, and lateral rhinal sulci, were absent. the cingulate gyrus was not recognizable, and the subcortical internal capsule was abnormally small (fig. 2) . the diagnosis was consistent with lissencephaly with sfa, internal hydrocephalus and corpus callosum hypoplasia. prednisolone was then discontinued due to lack of indication. clinical presentation and mri did not support a diagnosis of meningoencephalitis. after dose readjustment with phenobarbital (gardenal ® , 2.7 mg/kg, orally q12h; safoni, brazil) and levetiracetam as an adjunct (keppra ® , 20 mg/ kg, orally q8h for 4 weeks; ucb biopharma, brazil), seizure frequency was reduced for the first 3 months (> 50% frequency reduction of seizures). adjunct treatment with levetiracetam was discontinued after approximately 4 weeks. at the 12-month follow-up examination, seizure reduction with an interictal interval over 2-3 months was noted and no more cluster seizures were observed. however, the behavioral changes, blindness and strabismus observed were persistent despite treatment. a phone conversation with the owners revealed that the dog was alive at the time of writing this report 2 years after diagnosis. malformations of cortical development have rarely been reported in dogs, but epileptic seizures seem to be a frequent clinical sign in affected dogs [7, 9, 10] . lissencephaly represents an uncommon disorder of the cortical gyration in dogs [7, 9, 10] . lissencephaly without concurrent intracranial malformations was described in lhasa apso dogs, in an australian kelpie dog and in a small mixed-breed dog [7, 10, 12] . this report is the first on lissencephaly in shih tzu dogs with other concurrent intracranial malformations and the first report providing a detailed neuroanatomical description of lissencephaly identified on mri. in humans, malformations of cortical development can lead to lissencephaly type i, characterized by pachygyria or agyria with thickened and smooth brain surface [4, 5] . apart from lissencephaly, cortical development disorders that may cause epilepsy as subcortical band heterotopia, polymicrogyria, and cobblestone malformations have been described [1, 2] . such disorders are rarely reported in dogs [14] . four shih tzu dogs without any known close relationship, were referred because of epileptic seizures. the dogs were not selected among breeds. the onset of seizures was at the age of 6, 9, 12 and 24 months. previous studies have reported the onset of seizures in dogs between the age of approximately 12 months and 5 years in two lhasa apso [7, 8] , one pekingese [9] , one australian kelpie [10] , and one mixed-breed dog [12] . in humans with lissencephaly, approximately 83% of patients experience earlyonset seizures earlier than 7-months-old [15] . neuro-ophthalmological abnormalities have been poorly characterized in dogs with lissencephaly. central blindness was previously reported [7, 9] . we detected central blindness in three out of four dogs. bilateral vision deficits were thought to derive from occipital lobe lesions. bilateral ventromedial strabismus (esotropia) was detected in two out of four dogs. only one other report has described ventromedial strabismus in a dog with lissencephaly, which was associated with an orbital anatomical abnormality or short medial rectum muscle [7] . we assumed that maldevelopment of the primary visual cortex and visual motor control mechanism may lead to esotropia [16] . humans with lissencephaly have visual abnormalities, including no ocular fixation or tracking, poor visual tracking, nystagmus, variable esotropia, oculomotor apraxia, optic nerve and macular hypoplasia/ atrophy, delayed visual maturation, and cortical visual impairment [17] . approximately 67% of human patients with lissencephaly type i have neuro-ophthalmological abnormalities [17] . severe mental retardation may be observed in humans with lissencephaly and is associated with neuronal migration defects in spatial learning areas [3, 5, 18] . motor disability as early hypotonia, spastic tetraplegia and opisthotonos is observed in human cases of lissencephaly due to defects in motor areas [3, 5] . humans with lissencephaly often die before adulthood [1, 6, 17] . in our study, early onset of several behavioral changes was detected in three dogs between 6 and 24 months old. alterations in locomotor behavior (pacing and changes in sleep pattern), aggressiveness (irritability to manipulation) and vocalization in addition to seizures were observed. previous studies observed late-onset behavioral changes in dogs with lissencephaly over 12-months-old [7] [8] [9] [10] 12] , aggressiveness being frequently reported [7, 9, 10] . the different clinical pictures between human and canine lissencephaly could be explained by the fact that the cerebral cortex is less essential in dogs than in humans for motor function [11] . in dogs, motor function may be maintained despite frontoparietal lobe (motor area) and pyramidal system lesions. however, cognitive and learning abilities may be affected [11] . magnetic resonance imaging in dogs with lissencephaly showed thickened cortical gray matter with smooth appearance, an abnormally small internal capsule, and absence of the major gyri and sulci when compared with healthy shih tzu dogs (additional file 2). previous studies did not report detailed neuroanatomical examinations of cortical gyri and sulci in dogs with lissencephaly [7, 9, 10] . in addition, mri was informative for correct ante-mortem diagnosis of multiple congenital anomalies, determination of cerebral morphology, and the degree of lissencephaly in shih tzu dogs. lissencephaly is graded in humans using a 6-point grading system based on the severity and anterior-posterior brain gradient of the abnormalities. grade 1 represents severe lissencephaly with complete agyria, while grade 6 represents mild subcortical band heterotopia [3, 5] . grades 1a to 6a are more severe posteriorly and 1b to 6b anteriorly [3, 5] . using these criteria, the second (fig. 1e) , third (fig. 2a) and fourth (fig. 2e) cases presented here were classified as grade 2a with diffuse agyria and few shallow undulations in the frontal and temporal lobes. the first dog was classified as grade 3a due to mixed parieto-occipital agyria and frontal pachygyria (fig. 1a) . previous studies have reported lissencephaly grade 2a [9] and 2b [10] in dogs. in our study, behavioral alterations and central blindness were noted in dogs with more severe lissencephaly grade, indicating a possible correlation between mri severity and clinical signs. the grade of lissencephaly was not related to the severity of the clinical signs in previous studies [9, 10] . two forms of lissencephaly have been described in humans: classic lissencephaly (or type i), characterized by abnormal thick cortical layers (four layered, with a cell-sparse zone), agyria or pachygyria without malformation of the brainstem and cerebellum [2] . mutations in cytoskeletal genes, such as the platelet activating factor acetylhydrolase 1b regulatory subunit 1, doublecortin, and tubulin a1a genes [1, 2, 5] , can lead to lissencephaly in humans and mice [1, 5] . cobblestone lissencephaly (type ii) is characterized by multiple shallow furrows, a thin cerebral mantle and malformation of the brainstem and the cerebellum [2, 5] . in dogs, genetic mutations for lissencephaly have not yet been described [7, 11] . in our study, muscular and ocular disorders were not observed and mri did not showed nodular brain surface and brainstem or cerebellum malformations associated to cobblestone lissencephaly [4] [5] [6] . therefore, our dogs likely have lissencephaly analogous to type i human lissencephaly [2, 5, 19] . lissencephaly is overrepresented in the lhasa apso dogs and was also reported in the genetically related pekingese breed [7, 9] . considering the genetic relation among lhasa apso, pekingese and shih tzu breeds [20] , it is possible that lissencephaly may be a genetic disease in dogs. hydrocephalus and sfa are intracranial malformations most often reported in young and toy breed dogs [21] [22] [23] . enlarged ventricles (a condition known as ventriculomegaly) comprise a common finding in adult brachycephalic dogs [21, 23] . dogs with only ventriculomegaly do not have increased intraventricular pressure and are considered to be asymptomatic [21, 23] in our study, internal hydrocephalus was confirmed based on specific mri features that indicated increased intraventricular pressure in three dogs [21] . hydrocephalus with concomitant lissencephaly has not been reported in dogs. in dogs, lissencephaly has been diagnosed together with ventriculomegaly rather that with hydrocephalus [7, 10, 12] . in a human study, ventriculomegaly has been observed in 73.7% of patients with lissencephaly type i [15] . supracollicular fluid accumulation without concomitant lissencephaly has been reported in male brachycephalic dogs, and the shih tzu dog breed was most often reported [22] . in dogs, most sfas are associated with dorsocaudal outpocketing of the third ventricle (sfa-iii) [24] . an expansion of both the third ventricle and the quadrigeminal cistern is another type of sfa (sfa iii-qc) [24] . a few cases present with enlargement of the sole quadrigeminal cistern (sfa-qc) [24] . previously, it was hypothesized that type sfa-iii in predisposed breeds can be part of hydrocephalus rather than an anomaly itself [24] . in our study, the first dog presented with sfa-qc and type sfa-iii was detected in the second and fourth dogs. although sfa can be related to the presence of neurological signs in dogs with lissencephaly, the clinical significance of sfa is variable and sfa may be incidental in dogs with other intracranial diseases [22] . there is no reported genetic relationship between sfa and lissencephaly in neither dogs nor humans. in humans, supracollicular fluid accumulation is associated with a defect in leptomeninges development [19] . corpus callosum abnormalities have been sporadically reported and are still poorly understood in dogs, typically being an isolated abnormality or associated with holoprosencephaly and inborn errors of metabolism. the most frequent clinical signs described are hypodipsia/ adipsia, tremors, and seizures [25] . we observed concurrent corpus callosum hypoplasia in the second, third, and fourth dogs, which is not commonly reported in dogs with lissencephaly [11] . epileptic seizures may be related to corpus callosum hypoplasia. in humans, corpus callosum abnormalities are associated with classic lissencephaly (type i), cobblestone lissencephaly (type ii) and polymicrogyria [2, 15] . the antiepileptic drugs used resulted in good control of cluster seizures with mild adverse effects in the long-term follow-up (12-36 months). seizures were persistent, although, compared to pretreatment, a reduction in the frequency (> 50% or more) and severity of seizures as well as cessation of cluster seizures was observed. other signs of forebrain abnormalities, such as behavioral alterations, central blindness, and bilateral strabismus were persistent. several medications, including carbonic anhydrase inhibitor acetazolamide and proton-pump inhibitor omeprazole, with the goal of decreasing cerebrospinal fluid production, have been proposed as medical management in dogs with hydrocephalus [23, 26, 27] . experimental studies in healthy dogs and rabbits reported that cerebrospinal fluid production was reduced after acetazolamide and omeprazole treatment, respectively [26, 28] . due to hydrocephalus, the second and third dogs were medically treated with acetazolamide and omeprazole. nevertheless, aggressiveness, changes in sleep cycle, compulsive pacing, central blindness, and strabismus were persistent during the follow-up period despite treatment with acetazolamide and omeprazole. one previous report has described no significant effects on recovery of the neurological signs or ventricular volume reduction after treatment with acetazolamide in dogs with hydrocephalus [29] . furthermore, chronic oral omeprazole therapy in healthy dogs did not affect cerebrospinal fluid production [30] . the major limitation of this study was the lack of histopathological evaluation, which was not possible because dogs were not euthanized during the follow-up period. although transcranial ultrasonography or computed tomography may aid in diagnosis, these methods are not precise [9, 10] . in our study, the use of low-field mri provided a good resolution for ante-mortem diagnosis of lissencephaly in all dogs. variations in signal intensity, identification of abnormal cortical layers and depth of cortical sulci were observed. all anatomical structures of the cerebral cortex were identified (additional file 2). in agreement, previous studies performed diagnosis in dogs using mri fields between 0.4-and 1.5-tesla [7, 9, 10] . mri is the modality of choice for lissencephaly diagnosis and for the differentiation of other neuronal migration disorders, showing a correlation with histopathological features in dogs and humans [1, 2, 7] . lissencephaly should be considered an important differential diagnosis in shih tzu dogs presenting predominantly with early-onset signs of forebrain abnormalities, including tonic-clonic seizures, behavioral alterations, central blindness, and bilateral ventromedial strabismus. low-field mri may be a useful diagnostic tool to detect cases of lissencephaly. hydrocephalus, sfa, and corpus callosum hypoplasia comorbidities could also be associated with lissencephaly in shih tzu dogs. genetic malformations of cortical development a developmental and genetic classification for malformations of cortical development: update 2012 lissencephaly and other malformations of cortical development: 1995 update genetic basis of brain malformations the genetics of lissencephaly neuropathology of lissencephalies. child's nerv syst magnetic resonance imaging features of lissencephaly in 2 lhasa apsos lissencephaly in two lhasa apso dogs lissencephaly in a pekingese lissencephaly in an adult australian kelpie veterinary neuroanatomy and clinical neurology clinical and mri findings of lissencephaly in a mixed breed dog inborn errors of metabolism leading to neuronal migration defects polymicrogyria in standard poodles lis1-related isolated lissencephaly brain abnormalities in infantile esotropia as predictor for consecutive exotropia ocular findings in lissencephaly wynshaw-boris a. impaired learning and motor behavior in heterozygous pafah1b1 (lis1) mutant mice a developmental and genetic classification for midbrain-hindbrain malformations genetic structure of the purebred domestic dog magnetic resonance imaging signs of high intraventricular pressure-comparison of findings in dogs with clinically relevant internal hydrocephalus and asymptomatic dogs with ventriculomegaly clinical and magnetic resonance imaging characteristics of quadrigeminal cysts in dogs congenital hydrocephalus multidetector computed tomographic and low-field magnetic resonance imaging anatomy of the quadrigeminal cistern and characterization of supracollicular fluid accumulations in dogs corpus callosal abnormalities in dogs inhibition of cerebrospinal fluid formation by omeprazole different effects of omeprazole and sch 28080 on canine cerebrospinal fluid production effect of certain drugs on cerebrospinal fluid production in the dog effect of acetazolamide and subsequent ventriculo-peritoneal shunting on clinical signs and ventricular volumes in dogs with internal hydrocephalus evaluation of the effect of oral omeprazole on canine cerebrospinal fluid production: a pilot study publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations the authors are grateful to heraldo andré catalan rosa for technical support with mri. data have not been published previously. supplementary information accompanies this paper at https ://doi. org/10.1186/s1302 8-020-00528 -0.additional file 1: table s1 . doc. summary of magnetic resonance imaging (mri) findings of lissencephaly and concomitant congenital malformations in shih tzu dogs. details regarding malformation type, mri scan, positioning of the patient, sequence types, imaging parameters and contrast medium are described.additional file 2: figure s1 . doc. brain magnetic resonance imaging (mri) in a healthy shih tzu dog. transverse t1-weighted (a and b) and transverse and sagittal t2-weighted (c and d) imaging. the following structures were identified at the level of the interthalamic adhesion: marginal gyri (a); marginal sulci (b); middle ectomarginal gyri (c); ectomarginal sulci (d); middle suprasylvian gyri (e); middle suprasylvian sulci (f ); middle ectosylvian gyri (g); caudal ectosylvian sulci (h); caudal sylvian gyri (i); pseudosylvian fissure (j); lateral rhinal sulci (k); splenial sulci (l); cingulate gyri (m) and corpus callosum (o) (a). the following structures were identified at the level of the mesencephalic aqueduct: marginal gyri (a); marginal sulci (b); middle ectomarginal gyri (c); ectomarginal sulci (d); caudal suprasylvian gyri (e); caudal suprasylvian sulci (f ); ectosylvian gyri (g); lateral rhinal sulci (h); parahippocampal gyri (i) and caudal composite gyri (j) (b). in transverse and sagittal t2-weighted images, all anatomical structures were normal, including the lateral ventricles, quadrigeminal cistern and corpus callosum (c and d). authors' contributions dnrs and rma conceived and designed the study. dnrs, gbap, eft and vmm performed the diagnostic work-up, clinical assessment, and provided professional discussion regarding the cases. rma and vmm evaluated and interpreted magnetic resonance imaging. dnrs and gbap wrote the manuscript. rma critically revised the manuscript. all authors read and approved the final manuscript. not applicable. mri equipment was acquired through funding (procedure number 2009/54028-8) provided by the são paulo research foundation (fapesp). the datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. this study was not submitted for ethics committee review because it is a retrospective analysis of medical records of the veterinary neurology service, school of veterinary medicine and animal science form sao paulo state university-unesp -brazil. not applicable. the authors declare that they have no competing interests. key: cord-302862-znnlyz3y authors: lim, peter a.c. title: transverse myelitis date: 2019-04-17 journal: essentials of physical medicine and rehabilitation doi: 10.1016/b978-0-323-54947-9.00162-0 sha: doc_id: 302862 cord_uid: znnlyz3y transverse myelitis (tm) is an inflammatory condition across the spinal cord, along one or more levels and in the absence of compression. idiopathic acute tm is rare and with improvements in diagnostic tools and longer follow-up, the etiology which may include post-infectious, multiple sclerosis, or neuromyelitis optica often becomes clearer. the patient may present acutely with weakness, sensory impairments, or bowel and bladder changes. a careful history, physical examination, and appropriate diagnostic studies including blood tests and an mri scan may help determine the diagnosis and etiology. following the acute management, which may include use of steroids, immunosuppressive drugs, and plasma exchange, a comprehensive medical rehabilitation program is important to optimize recovery from the resultant impairments and disabilities and manage associated complications. complications such as paralysis, autonomic dysfunction, neuropathic and musculoskeletal pain, spasticity, contractures, neurogenic bladder and bowels, skin breakdown, and psychological issues will benefit from the expertise of the physiatrist. rehabilitation will include functional restoration with therapy as well as compensation of residual impairment with mobility and various other assistive devices. to maximum weakness in idiopathic tm has been reported to range from 10 hours to 28 days, with a mean of 5 days. 13 subacute presentations, progressing over days to weeks and ascending, are associated with a good to fair prognosis. acute and catastrophic presentations with back pain have a poorer outcome. 14 recovery is often related to the clinical presentation and may or may not be complete. in general, one third of patients with acute tm make a good recovery, another third have fair recovery, and the rest either fail to improve or die. 3, 5, 13 in idiopathic tm treated with methylprednisolone using the medical research council (mrc) scale for muscle strength, 37.5% were reported to have complete recovery or minimal residual deficit (mrc 5-4), 43% had partial recovery (mrc 3), and 19.4% had severe disability or absent recovery (mrc 0-2). factors associated with poor outcomes include severe initial symptoms with spinal shock, delayed presentation to the hospital after maximum deficits have already occurred, development of syringomyelia, and extensive mri lesions. 6, 13 if no recovery has occurred by 1 to 3 months, complete recovery is less likely. 4, 14 patients with tm may present in the ambulatory clinic, urgent care center, or hospital setting with complaints of weakness of the limbs, sensory impairments, pain, and difficulties with the bowel and bladder. weakness may affect only the lower limbs or all four limbs with varying severity. it may be complete, incomplete, or may present as one of the spinal cord syndromes. the clinical spinal level usually corresponds to the lesion, but lower limb findings do not preclude a lesion at the cervical level. sensory complaints may include hypersensitivity, numbness, tingling, coldness, burning, or as a circumferential constriction. pain is a common symptom in one third to one half of patients and may be central or localized, aching or radicular in character. bowel frequency or constipation may occur, and bladder symptoms include increased frequency, retention, and incontinence. 2, 3, 13 the history, including past medical, family, and detailed social, may reveal symptoms of recent infection, immunocompromised or autoimmune condition, space-occupying lesion, demyelinating disease, travel, vaccination, trauma, sexual exposure, animal, insect or tick bites. whether vaccination triggers tm has been debated. there were only seven cases of tm and eight of acute disseminated encephalomyelitis (adem) in the primary vaccination exposure window of 5 to 18 days prior to onset, after 64 million doses within a healthcare network. the incidences were both nonstatistically significant except adem with tdap (tetanus, diphtheria, and pertussis) vaccine at p = .04 (translating into 1.16 cases per million doses). 15 a careful review may yield systemic symptoms, including the upper respiratory tract with cough and difficulty in breathing, chest pain, rashes, joint aches, muscle pain, vision changes, nausea, diarrhea, constipation, and problems with urinary function. particular attention should be paid to details pointing toward potentially treatable or reversible conditions responsive to antimicrobials or surgical decompression. there may be a history of invasive spinal intervention for pain management, and tm relating to the infected catheter tip of an intrathecal morphine pump for chronic pain has been reported. 16 the physical examination should be broadly systemic as well as focused on neurological findings such as motor weakness, changes in sensation (pinprick, light touch, vibration, position sense, or temperature), tone, muscle stretch reflexes, coordination, and bowel and bladder functioning. changes affecting the brain, such as cognitive dysfunction and cranial nerve and visual abnormalities, are generally not seen with idiopathic tm. fever, tachycardia, and tachypnea may indicate an infectious etiology. infections, autoimmune, and other conditions that cause acute inflammation of the spinal cord may also manifest in the other body systems. respiratory, cardiovascular, gastrointestinal, and genitourinary tracts as well as the musculoskeletal and integumentary systems should be assessed accordingly. the findings will assist in determining the level of spinal involvement, guide diagnostic testing, and help rule out other diagnoses. the physiatrist is likely to encounter the patient as a consultation for rehabilitation assessment and management, or referral for a specific problem, such as spasticity or pain intervention. the functional limitations in a patient with tm usually depend on the level of spinal cord involvement and corresponding muscles affected. debilitation and deconditioning from associated illnesses and prolonged recumbency will also affect function secondarily. the functional capability review according to spinal level may be influenced by whether the cord injury is unilateral or bilateral and the degree of completeness. high cervical lesions result in tetraplegia with sensory impairment and also affect the phrenic nerve (c3-c5) with diaphragmatic paralysis requiring mechanical ventilation. a patient with c4 innervation preserved may or may not have respiratory difficulties but will be dependent for most self-care activities. using appropriate technology and devices, whether customized or commercially available, the patient may be able to control the home environment, summon assistance, direct their care, and mobilize in an electric wheelchair with a chin control or a sip-and-puff interface. a patient with c5 level may be able to self-feed and perform personal grooming with equipment such as a universal cuff for the hand allowing attachment of tools (e.g., fork, spoon, or comb). the patient can independently use a powered wheelchair and propel a lightweight manual wheelchair with hand rim projections ("quad knobs") for limited distances over level ground. c6 innervation allows independence with upper extremity dressing, bathing with equipment, and functional propulsion of a manual wheelchair indoors. the patient with superior balance and motor control could theoretically perform independent or supervised transfers with a sliding board, and self-catheterize with appropriate assistive devices. driving a specially adapted automatic transmission vehicle with powered steering, hand-controlled accelerator and brake can be achieved with c7-c8 preservation. a c7 level allows independence in all self-care activities with equipment, independent transfers with ability to push off using intact elbow extensor muscles, and the patient may be able to live alone. a patient with c8 and t1 innervation will have improved manual strength and dexterity for self-care, is independent with a manual wheelchair, and should be able to self-catheterize. preservation of upper thoracic innervation allows a greater degree of trunk control, increasing stability during use and propulsion of a manual wheelchair. it also adds to ease and independence with bladder and bowel self-management. with bracing of the hips, knees, and ankles (kafo or knee-ankle-foot orthoses), minimal ambulation can be attempted, although mainly for training and exercise purposes than truly functional. independent ambulation, even with bracing and bilateral axillary or forearm crutches, is usually not realistic unless the patient has preservation of some upper lumbar innervation. further preservation of lumbar and sacral innervation will increase ease of ambulation with better trunk and pelvic control. the patient with incomplete spinal injury is less predictable, and functional abilities will largely depend on the degree and nature of neurologic preservation. with increasingly greater resolutions and techniques such as t2-weighted fast spin-echo and short-tau inversion recovery (stir) to enhance or suppress the appearance of fat and tissues of different densities, the best tool when tm is suspected is mri. mri not only allows visualization of the lesion but also rules out treatable causes, such as tumor, abscess, and other lesions causing compressive myelopathy. contrast material can be given to highlight lesions, 17 and myelography may rarely be considered if mri is not available. mri scans show features that help differentiate tm from disorders such as multiple sclerosis (figs. 162.1 and 162.2). the lesion in tm tends to affect the central region of the cord and involve more than two thirds of the cord diameter, whereas in multiple sclerosis it is usually more peripheral and involves less than half of the cord diameter. 17 tm is more often associated with high signal intensity on t2-weighted images extending longitudinally over more segments. 17, 18 the number of segments involved may be from 1 or 2 up to 11, and the entire cord or sometimes only the medulla may be affected. 17, 18, 20, 21 the lesion in tm at times resembles a spinal cord tumor and biopsy may even be attempted during investigation. 17, 18, 19 mri of the brain with contrast enhancement is often performed to help determine whether the mri findings point toward multiple sclerosis rather than "idiopathic" tm. in idiopathic partial tm, a study that does not show brain lesions translates to the likelihood of evolving multiple sclerosis at 15% to 44%. when brain lesions such as white matter plaques (especially periventricular) are seen, the chance for development of multiple sclerosis increases to 44% to 93%. 22 asymmetric motor or sensory symptoms and absence of peripheral nervous system involvement at presentation suggest acute myelopathic multiple sclerosis, whereas symmetric symptoms and peripheral nervous system involvement suggest acute tm. 23, 24 immunoglobulin g antibodies may be useful for determining neuromyelitis optica (devic's disease) as the etiology in patients with acute complete tm. longitudinally extensive tm spanning three or more vertebral segments is an important feature and detection of anti-aquaporin 4-specific antibodies (anti-aqp4, aq4p-ab, or nmo-igg) is useful to determine both increased risk for recurrence and conversion to neuromyelitis optica. 13, 25 other tests include the usual blood counts and chemistry, tests for autoimmune conditions, such as antinuclear antibodies, anti-double-stranded dna antibodies, anti-sm antibodies, erythrocyte sedimentation rate, ss-a antibody for sjögren disease, immunoglobulin levels, and vdrl. vitamin b 12 enteric cytopathic human orphan virus may be elevated. the polymerase chain reaction (pcr) technique is useful for amplifying minute quantities of dna or rna. it was used in a recent case report on acute myelitis caused by zika virus infection, which responded well to high-dose prednisolone. 26 a lumbar puncture allows assessment of cerebrospinal fluid pressure, and samples for cell count, determination of protein and glucose concentrations, measurement of immunoglobulins, and protein electrophoresis. oligoclonal bands detected in cerebrospinal fluid are useful in making a diagnosis. in one report, they were present in three of five patients with multiple sclerosis-associated tm, but in none of four patients with parainfectious tm. 4 nerve conduction studies (ncs), electromyography (emg), as well as somatosensory and motor evoked potentials may be useful for establishing diagnosis and monitoring progress. 2,27 urinary system evaluation including cystourethrography, cystoscopy, a baseline renal ultrasound, and urodynamic studies with or without video, have been recommended because of the very high rates of persistent long-term bladder dysfunction. 28, 29 bowel evaluation may require radiography, computed tomography (ct), and mri scans with or without contrast, or colonoscopy to rule out obstruction. in 2002, the tm consortium working group proposed the criteria in table 162 .1 for the diagnosis of idiopathic acute tm. 1 a comparison by de seze 8 of the clinical findings, mri results, laboratory profiles, and outcomes of patients with acute myelopathy according to etiology is presented in although the physiatrist may manage stable long-standing tm on an outpatient basis, hospitalization may be necessary during the initial presentation to monitor vital signs, manage respiratory difficulties, bowel or bladder complications, and carry out diagnostic investigations. 13,28 abnormalities of vital signs such as tachypnea or tachycardia may suggest impaired oxygenation or blood flow to be managed urgently. the ability to provide antiviral or antibacterial agents and surgical intervention may also be critical when a specific cause has been identified. several anti-inflammatory drugs have been tried for tm without clear success. although there is insufficient evidence for corticosteroid efficacy, intravenous methylprednisolone is often used to prevent further damage to the spinal cord as a result of swelling. 12, 20, 21 during the acute phase, it may lead to faster recovery and less disability, and is well tolerated. 22 cyclophosphamide exerts an immunosuppressive and immunomodulatory effect through suppression of cell-mediated and humoral immunity (on the t cells and b cells). 22 cyclophosphamide together with methylprednisolone may help in lupus-related tm. 21, 30 however, there appears to be an absence of any beneficial effect of immunosuppressive drugs (cyclophosphamide, azathioprine, intravenous immune globulin) in patients with idiopathic acute tm. 6, 12 plasma exchange to remove autoreactive antibodies and other toxic molecules from plasma may be effective with a good clinical response, especially within 20 days of onset and when nonresponsive to highdose corticosteroids. 12, 21 the monoclonal antibody rituximab can be effective in decreasing relapses in tm due to nmo. 12 the management of any spinal cord injury will include rehabilitation, and the more severely affected cases of tm will require a comprehensive multidisciplinary rehabilitation program led by a physiatrist. physical and occupational therapists on the team can work with strengthening, endurance, balance, coordination, joint range of motion, reconditioning, mobility, and independence with activities of daily living. the goal is one of optimal functioning and independence in the activities of daily living and mobility for the patient. functional independence measure and the modified barthel index are among the more widely used outcome measures during the rehabilitation process. assessment for appropriate equipment, such as a wellfitting wheelchair and other assistive and walking devices, is needed. gait efficiency, stability, and overall mobility can be improved with bracing devices such as an ankle-foot orthosis or kafo. education of the patient and family about the disease, resultant impairments, potential complications, rehabilitation plans and prognosis is important. the psychological state of the patient should not be neglected, and there should be monitoring for depression and medications initiated if necessary. sexual functioning is often affected, and education and counseling, with or without intervention, may be appropriate early. discharge planning needs and issues potentially affecting the patient's community reintegration, including vocational and recreational, should be assessed. recovery to some extent is expected in tm, but it is important to minimize the effects of even temporary impairments and immobility. all muscles and joints should be kept as active as possible, and daily exercises to preserve range of motion of the joints will help prevent contractures and keep joints flexible. progressive resistive exercises and possibly functional electrical stimulation (fes), also known as neuromuscular electrical stimulation, help maintain strength and decrease muscle atrophy. 31 exercises for inspiratory muscles should be included and use of an incentive spirometer as needed. rarely, glossopharyngeal breathing may need to be taught and electrical stimulation of the phrenic nerve diaphragm considered in the high cervical cord patient not showing recovery. 32 spasticity (see chapter 154) is a possible complication and regular stretching with use of antispasticity medications such as baclofen, diazepam, gabapentin, and tizanidine, can minimize and decrease development of joint contractures. if pain is present, appropriate medications, thermal (heat, cold), and electrical modalities including transcutaneous electrical stimulation may be helpful. antiepileptic drugs such as gabapentin, pregabalin, and carbamazepine, may be prescribed as they have good efficacy for neuropathic pain. amitriptyline may also be useful, although caution is advised with its strong anticholinergic effects. thorough checks of the skin on a daily basis can help avoid pressure sores and associated infections. insensate areas, particularly over bony prominences, should be relieved with special cushions and mattresses such as eggcrate foam and alternating pressure overlays, and pressurerelieving ankle-foot orthoses (prafo) may be helpful. the many varieties of hydrophilic and antimicrobial wound dressings currently available promote faster healing of skin breakdown. bladder (see chapter 138) and bowel (see chapter 139) functioning should be assessed, and a bedside ultrasound for post-void residual urine volume is a simple informative procedure, as is a rectal examination. a program may be needed to avert a neglected neurogenic bowel or bladder leading to stool impaction and hydroureter or hydronephrosis. an indwelling catheter can initially be used for bladder drainage but intermittent catheterization, independently or otherwise, should be instituted whenever possible. longterm follow-up of 2 to 10 years in pediatric patients with tm has shown that residual bladder dysfunction is common even with improvement of paraparesis and lack of urologic symptoms. in one study, 86% had persistent bladder dysfunction and 77% had persistent bowel dysfunction. 28, 29 a bowel program includes adequate fluids, proper diet, activity, and scheduled bowel movements. upper motor neuron bowels may need a stool softener (e.g., docusate), osmotic laxative (lactulose), or stimulant laxative (senna or bisacodyl) for evacuation. digital stimulation of the rectum is often effective and needs to be taught. with areflexic lower motor neuron bowels, use of bulk laxatives like psyllium or methylcellulose to produce formed stools may help during digital manual evacuation. bowel evacuation is often done on a daily basis in the hospital, but frequency can be extended to every 2 or 3 days once an individual returns home. the patient requiring a wheelchair, walker, crutches, or cane will need training, including maneuvering over steps and curbs. if transfers and ambulation require assistance, the training should also include family members or assistants. for patients with tm at the cervical level especially, various types of equipment and orthoses can be provided to help with self-care activities. proper bathroom equipment and modifications, such as a tub bench, commode, handheld shower, raised toilet seat, and grab bars, may make the difference between dependence and independence. selection of appropriate assistive devices helps maximize function. some of this equipment can be fairly expensive; hence, timing of purchases must be carefully considered, as they may not be required soon after. despite a reasonable prognosis for eventual recovery, complacency is to be avoided as it may result in unnecessary secondary complications. renal ultrasound and urodynamic evaluations are relatively routine procedures to assess and monitor bladder dysfunction. electrodiagnosis including ncs and emg are useful for diagnosis and for monitoring recovery. intramuscular botulinum toxin injections are very effective in the management of spasticity and commonly performed by the physiatrist, as are the alternatives of alcohol or phenol nerve and motor point blocks for spastic limb muscles. an intrathecal baclofen pump may be effective in intractable cases and allows much smaller doses and concomitantly fewer side effects. many physiatrists are able to manage the settings and refilling of these pumps. intractable neuropathic pain may respond to an intrathecal morphine pump, which will also require management. 33 the field of rehabilitation uses a plethora of devices and technology during the process of restoring or compensating for the impairments and disabilities resulting from conditions such as tm. some individuals receive fes systems to help maintain fitness and muscle bulk or improve and restore function. fes for the forearm and arm muscles is a routinely employed technique with many devices commercially available. exercise bicycles for the lower as well as upper limbs (e.g., ergys3 [therapeutic alliances, inc.], rt300-s [restorative therapies, inc.]) have also long been used, although are not cheap and have a risk for osteoporotic fractures. from simple body weight-support suspension devices, stationary and mobile, allowing for safer ambulation training, to motorized treadmills allowing flexibility in intensity, velocity, and effort, multiple devices from various manufacturers are available. robotic wheelchairs are ubiquitous equipment, available as either manual, powered, or hybrid, with an almost infinite offering of choices for size, weight, purpose, and even color. control of the wheelchair can be achieved by hand, chin, or other head part, and by voice activation. other than locomotion, there are also wheelchairs available for standing purposes, whether for activities at an erect level, or for weight-bearing exercise. braces or orthotics have also undergone much development and come with different materials, rigidity or flexibility, weight, and functional goals including for support, pressure relief, positioning, or protection. powered exoskeleton systems are currently of interest with systems to assist standing and ambulation such as the rewalk 6.0 (rewalk robotics inc.), hybrid assistive limb or hal (cyberdyne inc.), rex (rex bionics), ekso gt (ekso bionics), and indego (parker hannifin corp). at this time, they are mainly for training and exercise, and limited by the individual's abilities, terrain, device battery, and need for safety supervision including skin breakdown, falls, and equipment failure. 36 the next wave for independent mobility in patients with handicaps could well be that of self-driving or autonomous cars undergoing trials by the major automobile companies and various research laboratories. environmental control units or multiple devices within a smart home controlled using simple touch-pad, infrared or motion-sensitive, and voice-activated mechanisms including automatic doors, curtains, and various electronics such as the television and personal computer, are now commercially available, easy to control, and importantly becoming increasingly affordable. apps (applications) that allow easy communication, videophone interactions, and ready access to the internet are already built-in for many smart phones. intelligent voicecontrolled personal assistants include the apple siri, google assistant, amazon alexa, microsoft cortana, and samsung bixby. there is no specific curative surgical procedure for tm. however, lesions such as abscesses, herniated disks, spinal stenosis, and tumors may need surgery as soon as possible to relieve pressure and prevent further damage to the cord. timely management of compressive lesions may reverse or at least halt further neurologic injury to the cord. pressure sores may require sharp débridement on the unit to remove dead or infected tissue and other debris to accelerate healing. tendon transfers may be considered at a later stage to increase an individual's functioning. nerve transfer in patients with permanent upper limb deficits may be considered to restore or to improve ability to voluntarily activate a muscle. in one case report, a child with tm who underwent multiple fascicle transfers from median and ulnar nerves to the musculocutaneous nerve, spinal accessory to suprascapular nerve, and medial cord to axillary nerve, had excellent recovery of elbow flexion. 37 potential complications from the spinal cord dysfunction of tm are numerous and may require medical or surgical intervention. they include orthostatic hypotension, impaired thermoregulation, autonomic dysreflexia, lung and urinary tract infections, ileus and constipation, electrolyte imbalances, skin breakdown, spasticity and contractures, musculoskeletal and neuropathic pain, injury (including fractures) to bones, muscles and joints due to sensory impairments, heterotopic ossification, osteoporosis, kidney stones, depression, and anxiety. there may be respiratory muscle weakness depending on the level of spinal cord involved, and when severe, mechanical ventilation assistance may be required. the risk of bronchopneumonia and sleep apnea is compounded by any sedating medications or respirationdepressing medications. spasticity and joint contractures are common complications with spinal cord injury and management may be straightforward or extremely difficult, requiring several interventions simultaneously. heterotopic ossification (see chapter 131) may develop around a joint, especially the elbow, knee, and hip. gastrointestinal complications include gaseous distension, regurgitation, indigestion, and chronic constipation. urinary tract infections and urosepsis are also common with a neurogenic bladder, as both retained urine and bladder instrumentation increase infection risk. autonomic dysreflexia/hyperreflexia may occur, especially for lesions above t6. pain is a very frequent complaint and may arise from musculoskeletal sources or be neuropathic in nature. pain management may include medications such as analgesics, nonsteroidal anti-inflammatory drugs, short courses of cyclooxygenase-2 inhibitors, various anticonvulsants, and tricyclic antidepressants. overuse syndromes often occur because muscles and joints are overstressed during functional compensation for weakness or even during the process of rehabilitation training. shoulder pain is a common phenomenon with causes including tendinitis, rotator cuff injury, impingement syndromes, contractures, and inflammatory or degenerative arthritis. steroid and local anesthetic injections in the joint may sometimes be needed, but topical anti-inflammatory drugs, heat, cold, and other modalities, with proper transfer techniques or specific adaptive equipment such as sliding board, are often helpful. a common complication is ischemic breakdown of the skin if pressure relief is not regularly performed. awareness and monitoring for deep venous thrombosis and pulmonary embolism should be routine. prolonged pressure on a peripheral nerve can also cause dysesthesias, pain, or weakness. there may be sexuality, reproduction, and fertility concerns, particularly in younger as well as sexually active patients. the concerns and possible solutions should be discussed, addressed, or referred to a specialist as appropriate. depression and anxiety are not uncommon and usually respond to supportive counseling, but may need antidepressants such as the selective serotonin reuptake inhibitor or the serotonin-norepinephrine reuptake inhibitor drugs. treatment complications may occur because of the medications and equipment required to manage the disease and its complications. strictures or tracheal irritation can result from tracheostomy tubes, lung infections are common in this population, and the ventilators may break down, resulting in an emergency situation. high-dose corticosteroids frequently used for treatment of inflammation in the spinal cord may result in peptic ulcer disease or gastrointestinal bleeding. thromboembolism prophylaxis and anticoagulant treatment in the event of this happening may result in serious bleeding complications. skin breakdown may result at contact and pressure areas with devices or dressings used. frequent catheterization results in increased risk for urinary tract infections and accidental creation of false passages in the urethra with development of strictures. if bowel programs are not well managed or carried out gently, there may be discomfort, pain, and anorectal injuries. transverse myelitis consortium working group. proposed diagnostic criteria and nosology of acute transverse myelitis transverse myelitis fact sheet transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events acute transverse myelitis: incidence and etiological considerations idiopathic acute transverse myelitis: application of the recent diagnostic criteria long-term follow-up of acute partial transverse myelitis acute myelopathies: clinical, laboratory and outcome profiles in 79 cases analysis of prognostic factors associated with longitudinally extensive transverse myelitis the clinical course of idiopathic acute transverse myelitis in patients from rio de janeiro a retrospective cohort study of 8 years follow-up evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the therapeutics and technology assessment subcommittee of the american academy of neurology idiopathic transverse myelitis: an experience in a tertiary care setup the prognosis of acute and subacute transverse myelopathy based on early signs and symptoms acute demyelinating events following vaccines: a case-centered analysis transverse myelitis associated with acinetobacter baumanii intrathecal pump catheter-related infection acute transverse myelitis: mr characteristics magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis idiopathic transverse myelitis mimicking an intramedullary spinal cord tumor sjögren's syndrome with acute transverse myelopathy as the initial manifestation transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices transverse myelitis. comparison of spinal cord presentations of multiple sclerosis discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies acute myelitis due to zika virus infection clinical and evoked potential changes in acute transverse myelitis following methyl prednisolone residual bladder dysfunction 2 to 10 years after acute transverse myelitis transverse myelitis in children: long-term urological outcomes involvement of the entire spinal cord and medulla oblongata in acute catastrophic-onset transverse myelitis in sle neuromuscular electrical stimulation for muscle weakness in adults with advanced disease point: should phrenic nerve stimulation be the treatment of choice for spinal cord injury? effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis effects of locomotor training after incomplete spinal cord injury: a systematic review robot-assisted gait training (lokomat) improves walking function and activity in people with spinal cord injury: a systematic review powered exoskeletons for walking assistance in persons with central nervous system injuries: a narrative review nerve transfers for restoration of upper extremity motor function in a child with upper extremity deficits due to transverse myelitis: case report key: cord-267110-2g6owogs authors: sharma, suvasini; dale, russell c. title: acute disseminated encephalomyelitis date: 2017-11-17 journal: acute encephalopathy and encephalitis in infancy and its related disorders doi: 10.1016/b978-0-323-53088-0.00018-x sha: doc_id: 267110 cord_uid: 2g6owogs acute disseminated encephalomyelitis (adem) is an inflammatory demyelinating syndrome with encephalopathy. adem typically affects young children, is often postinfectious, and is typically monophasic. mri neuroimaging, which shows new lesions with poorly demarcated borders, but not old and established lesions, is essential to diagnosis. autoantibodies against myelin oligodendrocyte glycoprotein (mog) are found in ∼40% of adem patients, and these patients have different clinical and neuroimaging features to seronegative patients. treatment in the acute phase is typically with high-dose corticosteroids and intravenous immunoglobulin or plasma exchange for refractory patients. outcome is usually good, but residual cognitive, inattentive, and executive issues are likely underestimated. in patients who have a relapse, biomarkers and imaging should help differentiate multiphasic adem, neuromyelitis optica spectrum disorder, anti-mog antibody–associated relapsing demyelination, and multiple sclerosis. acute disseminated encephalomyelitis (adem) is an acute immune-mediated inflammatory demyelinating condition involving the brain and spinal cord, which presents clinically with new-onset polyfocal neurologic features, which by definition include encephalopathy. 1 the mri shows characteristic multifocal demyelinating abnormalities. there is often a history of infection or immunization, and adem is considered a postinfectious/parainfectious condition. this condition is a common cause of encephalitis in children and must be considered in the differential diagnosis of a child presenting with acute febrile encephalopathy and altered sensorium with or without fever. children with adem respond well to immunosuppressive treatment (steroids) with the majority having a single event, i.e., a monophasic course. a small proportion of children with adem may have relapses, and in this subset, multiple sclerosis (ms) is a diagnostic consideration. in this chapter we discuss the epidemiology, pathophysiology, clinical features, investigations, treatment, and outcome of adem in children. adem is a clinicoradiological diagnosis because there are currently no diagnostic blood or csf abnormalities or biomarkers (apart from anti-myelin oligodendrocyte protein [anti-mog] antibodies, discussed later). therefore in earlier studies there was a marked heterogeneity regarding the criteria for diagnosis. in 2007, the international pediatric multiple sclerosis study group (ipmssg) proposed consensus definitions for pediatric acquired demyelinating disorders of the central nervous system (cns) to improve consistency in terminology. 2 these criteria were revised in 2013. 3 for the diagnosis of adem, all of the following criteria are required 3 : 1. a first polyfocal, clinical cns event with presumed inflammatory demyelinating cause. 2. encephalopathy that cannot be explained by fever. encephalopathy refers to an alteration in consciousness (e.g., stupor, lethargy) or behavioral change unexplained by fever, systemic illness, or postictal symptoms. or more after the onset. this implies that the confirmation of the monophasic course requires followup and can only be done retrospectively. 4. brain mri is abnormal during the acute (3 months) phase. 5. typically on brain mri, there are diffuse poorly demarcated, large (>1-2 cm) lesions involving predominantly the cerebral white matter. t1 hypointense lesions in the white matter are rare. deep gray matter lesions (e.g., thalamus or basal ganglia lesions) can be present. if a child has a first monofocal or polyfocal clinical cns event with presumed inflammatory demyelinating cause in the absence of encephalopathy and the mri criteria for ms are not met, this is known as clinically isolated syndrome (cis). 3 examples of cis include optic neuritis, transverse myelitis, hemiparesis, monoparesis, and brainstem syndromes. cis has a higher likelihood of progression to ms as compared with adem. 4 the clinical symptoms and radiologic findings of adem can fluctuate in severity and evolve in the first 3 months after onset. accordingly, a second event is defined as the development of new symptoms more than 3 months after the start of the incident illness. there is no strong biological rationale of the use of 3 months as a cutoff, although it is hypothesized that monophasic immune dysregulation is usually resolved within a 3-month period. a small proportion of children with adem (10%) will have a relapse of an inflammatory demyelinating event with encephalopathy. 2 in the 2007 criteria, two terms were used for relapses of adem: recurrent and multiphasic adem. recurrent adem was defined as acute disseminated encephalomyelitis suvasini sharma, md, dm • russell c. dale, mbchb, msc, mrcphch, phd a new event of adem with a recurrence of the same symptoms and signs, 3 or more months after the first adem event. 2 multiphasic adem was defined as a new event of adem involving new anatomic areas of the cns and occurring at least 3 months after the onset of the initial adem event and at least 1 month after completing steroid therapy. in the 2013 revision, the term recurrent adem has been dropped. 3 multiphasic adem now encompasses both new as well as reemergence of previous clinical and mri findings. also, the timing criterion in relation to steroids for recurrent/ multiphasic adem has been removed. a third adem-like event is not consistent with a diagnosis of multiphasic adem but indicates a chronic relapsing demyelinating disorder, such as relapsing optic neuritis, neuromyelitis optica spectrum disorder associated with antiaquaporin-4 antibodies, relapsing anti-mog antibody-associated demyelination, or ms depending the clinical phenotype, biomarker, and neuroimaging findings. 1 epidemiology population-based studies have shown varying incidence rates of adem: 0.07 per 100,000 children per year (germany), 5 0.3 per 100,000 children per year (china), 6 0.4 per 100,000 children per year (san diego), 7 and 0.64 per 100,000 person years (japan). 8 the varying incidence may be influenced by factors such as genetic predisposition, latitude, environmental and socioeconomic factors, and study methodology. 9, 10 the median age at presentation of adem is 5-8 years, with male predominance. 1 a recent study from a single center showed that adem was the most common cause of encephalitis (21% of all encephalitis). 11 adem is preceded by infection or vaccination in 50%-85% of cases. 9 common antecedent infections include flu-like illnesses (56%-61%), followed by nonspecific upper respiratory tract infections (12%-17%) and gastroenteritis (7%). 9, 12, 13 in children, exanthematous diseases are also reported as an infectious antecedent. adem has been reported more commonly in winter and spring. this seasonal distribution is likely due to seasonal viral illnesses and epidemics. viruses (coronavirus, coxsackie b, dengue, hepatitis a virus, hepatitis c virus, herpes simplex virus, varicella zoster virus, epstein-barr virus, human herpesvirus-6, human immunodeficiency virus, measles, mumps, rubella, and parainfluenza) are the infectious agents most frequently associated with adem. 9 bacteria (streptococcus, mycoplasma, legionella, chlamydia, borrelia, rickettsia, campylobacter) and parasites (plasmodium vivax, toxoplasma gondii) may be rarely involved. 14 the mean latency between the infectious prodrome and the onset of neurologic symptoms varies, often being between 4 and 12 days (range: 1-42 days). 9 postimmunization adem accounts for only 5% of cases of adem. 14 postvaccination adem has been associated with several vaccines such as rabies, diphtheria-tetanus-polio, smallpox, measles, mumps, rubella, japanese b encephalitis, pertussis, influenza, hepatitis b vaccine, and human papillomavirus vaccine. in a recent retrospective review of vaccine adverse event reporting system (vaers) database and the eudravigilance postauthorisation module (evpm) from 2005 to 2012, a total of 404 cases of postvaccination adem were reported, 15 and half of the patients were less than 18 years of age and with a slight male predominance. the time interval from vaccination to adem onset was 2-30 days in 61% of the cases. vaccine against seasonal flu and human papillomavirus vaccine were those most frequently associated with adem, accounting for almost 30% of the total cases. the risk of developing adem following vaccination is relatively low, compared with the risk of adem following infections against which the vaccines are aimed to protect. 1 the benefits of vaccinations are considered to far surpass the potential risk of postvaccine adem. the exact pathogenesis of adem is unclear. postinfectious immune-mediated mechanisms are implicated. molecular mimicry with t cell-mediated cross-activation and response against myelin proteins, such as myelin basic protein, proteolipid protein, and mog plus b cell activation and autoantibody production, may play a role. 14 this hypothesis is supported by studies showing the presence of anti-mog antibodies in the serum and cerebrospinal fluid (csf) during the acute phase and their progressive decline along with disease resolution. 16 in a single study comparing the profile of myelin peptide autoantibodies in children with adem versus ms, adem was characterized by igg autoantibodies targeting epitopes derived from myelin basic protein, proteolipid protein, myelin-associated oligodendrocyte basic glycoprotein, and α-b-crystallin. 17 in contrast, ms was characterized by igm autoantibodies targeting myelin basic protein, proteolipid protein, myelin-associated oligodendrocyte basic glycoprotein, and oligodendrocyte specific protein. there may also be a nonspecific self-sensitization of reactive t cells (bystander activation) against myelin proteins secondary to infections. 18 in a recent study comparing the csf cytokine profiles in children with adem, enterovirus encephalitis, and anti-nmda receptor encephalitis, patients with adem showed predominant elevation of th1 (ifn-γ, tnf-α, cxcl9, cxcl10), th2 (il-4, eotaxin, ccl17, il-13), th17 (il-23, g-csf, il-6, il-8, and il-17a), b cell (cxcl13, baff, ccl19), and other cytokine (cxcl1, ifn-α 2, il-1ra) molecules, which supports the hypothesis that both cell-mediated and humoral effector mechanisms may play a role. 19 in a recent study comparing the cytokine profile of anti-mog positive versus anti-mog negative demyelinating disorders it was found that the csf in anti-mog antibody positive patients showed predominant elevation of b cell-related cytokines/chemokines (cxcl13, april, baff, and ccl19) as well as some of th17-related cytokines (il-6 and g-csf) compared with anti-mog antibody seronegative patients. 20 these findings suggest that patients with anti-mog antibodies have a more pronounced cns inflammatory response with elevation of predominant humoral-associated cytokines/chemokines, as well as some th 17-and neutrophil-related cytokines/chemokines, suggesting a differential inflammatory pathogenesis associated with mog antibody seropositivity. 20 these findings also suggest that there is a considerable pathophysiologic heterogeneity in patients with adem, suggesting a spectrum of inflammatory demyelination rather than a single disease entity. histopathologically, the hallmarks of adem include perivenular sleeves of demyelination, perivenous inflammation with infiltrates of myelin-laden macrophages, t and b lymphocytes, plasma cells and granulocytes, axonal injury, and edema. 1, 14 the axonal damage is demonstrated by the increased level of a phosphorylated microtubule-associated protein, primarily located in neuronal axons, known as tau protein, in the csf, indicative of the clinical severity of adem. 21 moreover, the csf tau protein concentration in patients with partial lesion resolution in follow-up brain mri has been shown to be significantly higher than in patients with complete lesion resolution. 21 in addition, there are diffuse cortical microglial alterations (multifocal microglial aggregates), which may be partly responsible for the encephalopathy seen in children with adem. 22 adem clinically presents as an acute onset encephalopathy along with polyfocal neurologic deficits. the neurologic symptoms are preceded by prodromal symptoms such a fever, malaise, irritability, somnolence, headache, nausea, and vomiting. 1 encephalopathy presents as a change in behavior and/or consciousness, varying in severity from lethargy to coma. commonly headache/ vomiting (58%-32%), seizures (13%-47%), and meningismus (5%-43%) may be associated. 9 the patient may also have focal or multifocal neurologic deficits such as hemiparesis, ataxia, aphasia, diplopia, and rarely dystonia and choreiform movements. 14 multiple cranial nerve involvement may occur. spinal cord involvement may be present in up to 24% of cases, with clinical features of flaccid paralysis, constipation, or urinary retention. 23, 24 myelitis is significantly more common in anti-mog antibody-associated adem and is associated with longitudinally extensive lesions on the mri. 25 the clinical course of adem is rapidly progressive, with the development of maximal deficits within 2-5 days. 23 rarely, respiratory failure occurs because of brainstem involvement. fever and seizures are described more frequently in adem compared with other acute demyelinating syndromes. 1 combined central and peripheral demyelination has been reported but is very rare in children. clinical manifestations of peripheral neuropathy may occur simultaneously along with the cns manifestations or after them. 9 the diagnosis of adem is clinicoradiological. the characteristic mri lesions are t2-weighted and fluidattenuated inversion recovery hyperintense multifocal, irregular, poorly marginated areas with diameters between 5 mm and 5 cm. 14 adem lesions typically involve the subcortical and central white matter and cortical gray-white matter junction, thalami, basal ganglia, cerebellum, and brainstem (figs. 18.1-18.4) . 1 the reported frequency of gadolinium-enhancing lesions is highly variable between studies (10%-95%), perhaps depending on the timing of obtaining mri in the course of the illness. 9 spinal cord involvement is seen in 10%-28% of patients. 9 five radiologic patterns have been described in adem 26 : (1) adem with small lesions (<5 mm), (2) adem with large confluent white matter asymmetric lesions, (3) adem with symmetric bithalamic involvement, (4) adem with a leukodystrophic pattern with diffuse bilateral and usually nonenhanced white matter-sited lesions, and (5) adem with acute hemorrhagic encephalomyelitis. the latter two phenotypes are uncommon. mri abnormalities may appear later than the clinical symptoms, and progression of mri lesions has been reported during the course of illness despite clinical improvement. 9 mri at presentation can even be normal, 27 and delays of between 5 days and 8 weeks between symptom onset and the appearance of mri alterations have been reported. 28 in a recent study on the evolution of mri during adem episodes, it was noted that new lesions and enlargement of existing mri lesions occurred in the first 3 months in about 50% of the performed mris, despite clinical recovery. 29 however, this was not noted 3 months after first onset of adem. therefore it should be recommended that convalescent mri scans performed during the first 3 months after adem that show new lesions should not necessarily infer the patient has ms. to differentiate from ms, lesions of ms tend be smaller, discrete and ovoid, and periventricular, especially perpendicular to corpus callosum (dawson fingers), in contrast to the fluffy poorly marginated subcortical lesions in adem. 1 the main differentiating features of adem compared with ms are periventricular sparing and the absence of periventricular dawson finger lesions and black holes on t1 sequences, which are typical of ms (fig. 18.5) . follow-up imaging is important to demonstrate resolution of lesions and confirming that no new lesions have developed. in asymptomatic children, repeat imaging is recommended 9-12 months after the episode of adem. 1 an earlier repeat imaging at 3 months would be optimal. 1 in children with new symptoms, imaging should be considered earlier. advanced neuroimaging techniques such as diffusion-weighted imaging (dwi) and magnetic resonance spectroscopy appear useful to exclude other diseases, such as strokes and neoplasms, to discriminate between acute and chronic lesions, and to add information about the extent of the affected areas. 14 in a recent study of dwi in 16 children with adem, vasogenic edema was demonstrated on dwi and corresponding apparent diffusion coefficient (adc) maps in 12 of 16 patients; cytotoxic edema was identified in 2 patients while the other 2 patients displayed no changes on dwi/adc. 30 because the presentation of adem frequently mimics acute encephalitis, csf studies are often done, and although they may confirm an inflammatory process, they are nondiagnostic in adem. csf examination is, however, important, especially to exclude an infectious pathology, which is a common differential diagnosis. csf examination in adem reveals inflammatory findings in most patients, consisting of elevated protein levels, up to 1.1 g/l (seen in 15%-60% of patients) and lymphocytic pleocytosis, which is typically mild (seen in 25%-65% of patients). 1, 9 the csf may be normal in 25%-33% of patients. 9, 13, 31 intrathecal oligoclonal bands are rare, and if present should raise consideration of ms. 1 in three recent series, of 53 patients, oligoclonal bands were reported in only 1 patient (1.9%). [32] [33] [34] recently, it has been shown that serum igg antibodies to mog are present in up to 40% of children with adem. high-titer anti-mog antibodies have also been found in children with bilateral often relapsing optic neuritis and aquaporin-4 seronegative neuromyelitis optica. 35 although some relapsing patients with positive anti-mog antibodies can fulfill 2013 consensus criteria for ms, anti-mog antibodies generally do not associate with ms and, instead, suggest anti-mogassociated autoimmune demyelination. 36, 37 these antibodies are seen almost exclusively in demyelinating illnesses and may help to differentiate from viral encephalitis. 38 in patients with adem, the majority of children with anti-mog antibodies have a monophasic course with a rapid decline of anti-mog antibodies. 16 the presence of anti-mog antibodies is likely to be a negative predictor for a future diagnosis of ms. 36 in a study comparing children with adem with and without positivity for anti-mog antibodies, children with adem who were seropositive for anti-mog antibodies had mri characterized by large, bilateral, and widespread lesions with an increased frequency of longitudinal extensive transverse myelitis and a favorable clinical outcome in contrast to children lacking mog antibodies. 25 corpus callosal lesions have been found to be uncommon in children with anti-mog antibodies. 39 csf pleocytosis is more common in children with anti-mog antibodies, suggesting more inflammatory burden in the acute phase as compared with seronegative patients. some children with adem and seropositivity for anti-mog antibodies may have a relapsing course with future development of optic neuritis or myelitis, 40 or multiphasic adem, 41 but development of ms is rare. 42 the diagnosis of adem is based on the clinical features and suggestive mri findings. the clinical picture mimics acute meningoencephalitis, and excluding infectious causes is the first priority. this is done by csf examination for gram stain, bacterial culture, and viral studies. peripheral smear should be obtained for malarial parasites in endemic areas. the mri obtained should be a gadolinium-enhanced image to look for any leptomeningeal enhancement or any other feature of infection (e.g., basal exudates, brain abscess). in a child with unexplained altered sensorium and neurologic deficits, other possibilities include autoimmune encephalitis (especially anti-nmda receptor encephalitis), viral-associated encephalopathies such as acute necrotizing encephalopathy, hashimoto encephalopathy, cns vasculitis, primary and secondary (systemic lupus erythematosus, anti-phospholipid antibody syndrome), metabolic (both inherited and acquired) disorders, and rarely toxins and nutritional deficiencies. anti-nmda receptor encephalitis must be suspected if the patient has behavior problems, psychosis, sleep disturbances, and movement disorders (especially orofacial dyskinesias) along with encephalopathy. other inflammatory demyelinating conditions must also be considered in the differential diagnosis. if the patient has monofocal or polyfocal symptoms in the absence of encephalopathy, then clinically isolated syndrome is diagnosed. if the predominant presentation is optic neuritis and myelitis, then neuromyelitis optica must be considered, and testing for aquaporin antibodies must be done if possible. neuromyelitis optica with anti-aquaporin-4 antibodies is an uncommon form of cns demyelination in children; therefore autoantibody testing for aquaporin 4 antibodies should probably be done only with optic neuritis, myelitis, and brainstem symptoms with typical aqp4 antibody-associated features. 43 the diagnosis of ms is not made during the first event but may be considered if the mri findings are suggestive, such as the presence of old and new lesions, and fulfillment of mcdonald or other criteria. 44, 45 treatment the treatment of adem is based on observational studies and expert guidelines, because there are no randomized controlled trials. high-dose intravenous corticosteroids are generally considered the first-line treatment. the treatment regimen consists of iv methylprednisolone at a dose of 30 mg/kg/day (maximally 1000 mg/d) for 3-5 days, sometimes followed by an oral taper over 4-6 weeks with a starting dose of prednisone of 1-2 mg/kg/day. 1 the risk of relapse is increased if the steroid tapering period is less than 3 weeks, although not all experts use tapered prednisolone. 24 the aim of steroid treatment is primarily to reduce the cns inflammatory reaction and accelerate clinical recovery. recovery rates with steroid treatment are generally good, with full recovery reported in 60%-85% of the patients. 23, 24 a repeat pulse of intravenous steroids may be considered in the case of unsatisfactory clinical improvement or early relapse. 46 iv immunoglobulin (ivig) treatment has been described in case reports and small case series, mostly in combination with corticosteroids or as a second-line treatment in steroid unresponsive adem. 47 the usual total dose is 2 g/kg, administered over 2-5 days. treatment with ivig has proven effective in about 40%-50% of steroid-resistant patients. 12, 48 ivig presumably acts by binding and neutralizing autoantibodies, inhibiting cytokine release, and modulating lymphocyte activation. 14 plasmapheresis may be considered in therapyrefractory patients with fulminant disease, with an estimated efficacy of 40%. 49 the usual regimen is five to seven exchanges but there are not infrequent complications in the form of anemia, hypotension, hypocalcemia, thrombosis, and line infections. 14 moreover, plasmapheresis is technically difficult to perform in young children. rarely, patients with fulminant adem and cerebral edema have been treated with hypothermia in which the body temperature is reduced to 34°c and intracranial pressure and cerebral perfusion pressure levels are maintained low using mannitol and dopamine. 50, 51 decompressive craniectomy may be considered in cases of refractory intracranial hypertension. 52 in pediatric series, adem has a favorable prognosis, with a good functional recovery reported in 60%-85% of patients. neurologic improvement is usually seen within days following initiation of treatment, and recovery to baseline usually occurs within weeks. 1 mortality has been reported in 1%-3% of affected patients in recent series. 53, 54 residual severe disability is rare, reported in 7% of children in recent studies. 55 about 10%-40% of children are reported to experience residual cognitive impairment or changes in mood and behavior, and the neurocognitive burden of adem is probably underappreciated. 24, 31, 33 few studies have analyzed the neuropsychological profile of monophasic adem patients. although, overall, these patients showed a satisfactory global performance, a number of children demonstrated isolated deficits in one or more cognitive domains, most frequently the attentive and executive domains. 9 greater vulnerability to cognitive dysfunction and behavioral problems has been noted in adem patients diagnosed before the age of 5 years. 56 optic nerve involvement at presentation 23 and antecedent viral infection 24 have also been suggested as indicative of a poor outcome. in a recent study of the long-term neurocognitive outcome of children with adem, the most common residual symptoms were concentration difficulties (30%), behavior problems (28%), and learning difficulties (26%). 55 on the kaufman intelligence test, a full-scale iq of more than 85 was found in only 60% of patients, and 44% of patients fulfilled the criteria for adhd. male gender was a predictor for a worse neurocognitive outcome in this study. 55 the attention and behavioral impairment in adem may be attributed to the cerebral white matter damage that may interfere with information processing and attention skills, which are critical for emotional functioning and behavioral regulation. 56 when persisting symptoms continue after adem, persisting chronic immune activation should be considered, and a retrial of immune therapy can be used to determine if there is a reversible cause for ongoing symptoms. although in most cases adem has a monophasic course, a variable number of patients (10%-30% in previous studies) experience relapses. 9 because of the high interstudy variability and inconsistency of definitions in the past studies, it is difficult to have conclusive findings on relapsing patients from the current literature. latency from first episode to relapse is variable, ranging from 2 months to 8 years, 23 and even after 33 years in one case. 41 relapses have been reported to be more common in the first 6 months after the first episode, mostly occurring in children who underwent oral steroid tapering for 3 weeks or less. 57 most children experience a single relapse, but as many as three relapses are reported in some studies. 23, 57 an increased risk of relapse after adem has been associated with coexistent optic neuritis, familial history of cns inflammatory demyelination, the presence of ms findings criteria on mri, and the absence of sequelae after the first attack in one study. 58 multiphasic adem is uncommon. in literature, multiphasic adem was diagnosed in only 2 of 117 (1.7%) children in one series, 59 and in 5 of 132 (3.8%) children in another series. 58 after the initial episode of adem, a subsequent diagnosis of ms is not common. a long-term follow-up study using the 2007 international pediatrics multiple sclerosis study group criteria evaluated the parameters at initial diagnosis and eventual conversion to ms in a cohort of 123 children with a first episode of acute cns demyelination. 4 of the 47 patients initially diagnosed with adem, only 4 (8.5%) were eventually diagnosed with ms at follow-up versus 38.8% of those initially diagnosed with clinically isolated syndrome had ms. on multivariate analysis, the following predictors for developing ms were identified: female gender, clinical presentation with monofocal brainstem or hemispheric dysfunction, and fulfillment of the mri criteria for ms. in a patient with first episode of adem, criteria for ms are met, if after the initial adem, a second clinical event (1) is non-encephalopathic, (2) occurs 3 or more months after the incident neurologic illness, and (3) is associated with new mri findings consistent with revised radiologic criteria for dissemination in space. 3 patients with anti-mog antibodies who relapse typically have further episodes of adem 60 or optic neuritis, 61 and typically do not have new lesions on mri during asymptomatic periods. adem is a polyfocal immune-mediated inflammatory demyelinating disease of the cns that involves multiple areas of the white matter, which mostly affects children under 10 years of age. common antecedents include a recent viral or bacterial infection or more rarely immunization. the diagnosis is made in the clinical setting of acute onset of encephalopathy with other neurologic deficits and mri findings of multifocal demyelination after excluding cns infections. commonly, adem has a monophasic course in 70%-80% of cases, with most children having a good recovery with high-dose intravenous steroid pulse treatment. ivig and plasmapheresis may be considered as second-and third-line therapies. adem overall has a good prognosis, but 10%-40% of children may have neurocognitive dysfunction on follow-up. relapses may occur in 10%-30% of patients in the form of multiphasic adem, optic neuritis, myelitis, or ms. there is need for further evaluation of biomarkers such as anti-mog antibodies for prediction of relapses and prognosis. acute disseminated encephalomyelitis: updates on an inflammatory cns syndrome consensus definitions proposed for pediatric multiple sclerosis and related disorders international pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions a long-term follow-up study using ipmssg criteria in children with cns demyelination paediatric multiple sclerosis and acute disseminated encephalomyelitis in germany: results of a nationwide survey epidemiological characteristics of acute disseminated encephalomyelitis in nanchang, china: a retrospective study acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in fukuoka prefecture diagnosis and therapy of acute disseminated encephalomyelitis and its variants geoepidemiology of acute disseminated encephalomyelitis infectious and autoantibody-associated encephalitis: clinical features and long-term outcome postinfectious neurologic syndromes: a prospective cohort study descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors a spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (adem) of children acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems antibodies to mog are transient in childhood acute disseminated encephalomyelitis serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis csf cytokine and chemokine profiles in acute disseminated encephalomyelitis utility of csf cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-nmdar and enteroviral encephalitis b cell, th17, and neutrophil related cerebrospinal fluid cytokine/ chemokines are elevated in mog antibody associated demyelination tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein disseminated encephalomyelitis in children severe acute disseminated encephalomyelitis with normal mri at presentation teaching neuroimages: mri time lag with acute disseminated encephalomyelitis evolution of mri abnormalities in paediatric acute disseminated encephalomyelitis vasogenic edema characterizes pediatric acute disseminated encephalomyelitis clinical and neuroradiologic features of acute disseminated encephalomyelitis in children acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis acute disseminated encephalomyelitis in children and adolescents: a single center experience multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features anti-mog antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination anti-mog antibodies plead against ms diagnosis in an acquired demyelinating syndromes cohort myelin oligodendrocyte glycoprotein antibodies are associated with a non-ms course in children highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children clinical and mri phenotype of children with mog antibodies persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis. neuropediatrics an adult case of anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated multiphasic acute disseminated encephalomyelitis at 33-year intervals antibodies to mog have a demyelination phenotype and affect oligodendrocyte cytoskeleton neuromyelitis optica and neuromyelitis optica spectrum disorders mcdonald criteria for diagnosing pediatric multiple sclerosis risk of multiple sclerosis after a first demyelinating syndrome in an australian paediatric cohort: clinical, radiological features and application of the mcdonald 2010 mri criteria a case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin severe steroidresistant post-infectious encephalomyelitis: general features and effects of ivig plasma exchange for severe attacks of cns demyelination: predictors of response fulminant form of acute disseminated encephalomyelitis in a child treated with mild hypothermia therapeutic hypothermia with the use of intracranial pressure monitoring for acute disseminated encephalomyelitis with brainstem lesion: a case report life-saving decompressive craniectomy for acute disseminated encephalomyelitis in a child: a case report severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset acute disseminated encephalomyelitis in children: outcome and prognosis acute disseminated encephalomyelitis cohort study: prognostic factors for relapse prognostic factors after a first attack of inflammatory cns demyelination in children children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (mog): extending the spectrum of mog antibody positive diseases acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients key: cord-011165-slu5531z authors: rabbitt, angela l.; kelly, teresa g.; yan, ke; zhang, jian; bretl, deborah a.; quijano, carla v. title: characteristics associated with spine injury on magnetic resonance imaging in children evaluated for abusive head trauma date: 2020-01-04 journal: pediatr radiol doi: 10.1007/s00247-019-04517-y sha: doc_id: 11165 cord_uid: slu5531z background: spine injuries are increasingly common in the evaluation for abusive head trauma (aht), but additional information is needed to explore the utility of spine mri in aht evaluations and to ensure an accurate understanding of injury mechanism. objective: to assess the incidence of spine injury on mri in children evaluated for aht, and to correlate spine mri findings with clinical characteristics. materials and methods: we identified children younger than 5 years who were evaluated for aht with spine mri. abuse likelihood was determined a priori by expert consensus. we blindly reviewed spine mris and compared spinal injury, abuse likelihood, patient demographics, severity of brain injury, presence of retinal hemorrhages, and pattern of head injury between children with and without spine injury. results: forty-five of 76 (59.2%) children had spine injury. spine injury was associated with more severe injury (longer intensive care stays [p<0.001], lower initial mental status [p=0.01] and longer ventilation times [p=0.001]). overall abuse likelihood and spine injury were not associated. spinal subdural hemorrhage was the only finding associated with a combination of retinal hemorrhages (p=0.01), noncontact head injuries (p=0.008) and a diagnosis of aht (p<0.05). spinal subdural hemorrhage was associated with other spine injury (p=0.004) but not with intracranial hemorrhage (p=0.28). conclusion: spinal injury is seen in most children evaluated for aht and might be clinically and forensically valuable. spinal subdural hemorrhage might support a mechanism of severe acceleration/deceleration head injury and a diagnosis of aht. compared to accidental head injury, brain injuries in abusive head trauma (aht) are more severe, more often diffuse, and commonly involve hypoxic-ischemic injury [1, 2] . retinal hemorrhages and noncontact injury patterns resulting in multifocal subdural hemorrhages located over the cerebral convexities or within the interhemispheric fissure are also highly associated with aht [2, 3] . occult spine injuries are increasingly common in aht, likely related to increased awareness and screening for injury using improved imaging and autopsy techniques [4] . although few spine injuries require surgical intervention [5] , identification of occult injuries can strengthen maltreatment investigations by highlighting the severity of injury and risk of harm, and by clarifying the mechanism of abusive injuries. given the potential for detection of clinically significant injury and improved child safety, the american college of radiology (acr) recommends mri of the cervical spine in the evaluation for aht, and that whole-spine mri be considered [6] . despite acr guidelines, the use of spine mri for aht evaluations varies among institutions [7] , suggesting that additional research on the utility of spine mri in children evaluated for aht is needed to promote its inclusion in institutional protocols. additionally, the mechanism of some spine injuries is unclear [4] . an accurate understanding of injury mechanism is important in the medical assessment of child maltreatment to ensure evidence-based abuse diagnoses. the purpose of this study was to assess the incidence of spine injury on mri in children evaluated for aht, and to correlate these mri findings with the clinical characteristics of this population. we hypothesized that the clinical characteristics of rotational acceleration/deceleration typical in aht (noncontact intracranial injury pattern, retinal hemorrhages, and severe diffuse brain injury) would correlate with spine injury. all procedures performed in this study were in accordance with the ethics standards of the institutional and national research committees and with the 1964 helsinki declaration and its later amendments or comparable ethics standards. our institutional review board granted a waiver of informed consent, and the study complied with the health insurance portability and accountability act of 1996. in this retrospective case series review we identified all children younger than 5 years who received an mri of the brain for an abuse evaluation between january 2010 and december 2013. during this timeframe, the hospital's child protection team (cpt) used standard guidelines for abuse evaluation, including head ct in any child for whom there were concerns for aht, and in infants younger than 6 months for whom there were concerns of physical abuse. if concerns for aht remained based on the head ct or clinical findings, the cpt recommended a noncontrast mri of the brain and spine. if a brain mri was the first-line study rather than the head ct, we included the case for analysis if the mri was part of an aht evaluation. the spine mri non-accidental trauma protocol included t1 sagittal, t2 sagittal and axial, 3-d t1 sagittal with axial and coronal reformations, axial gradient echo/susceptibility-weighted imaging, and sagittal short tau inversion recovery (stir) sequences. the upper thoracic spine was included in cervical spine mr imaging through the 5th thoracic vertebral body. all children who received a brain mri for an abuse evaluation were included in the study, regardless of whether an mri spine was obtained or revealed any evidence of intracranial injury. we excluded children with a medical condition that might impact the appearance of spine injuries (skeletal dysplasia, connective tissue disorder, prior spinal surgery, a history of spine injury, or bleeding disorders). two members of the hospital's cpt abstracted clinical data from the medical record. they reviewed 10% of charts together to establish a uniform and accurate data collection process, and the lead researcher (a.l.r.; 12 years of experience) reviewed another 10% of data collection that occurred separately to ensure ongoing integrity and consistency. two board-certified radiologists (a pediatric neuroradiologist, t.g.k., with 27 years' experience in pediatric radiology, 11 years in pediatric neuroradiology, and subspecialty certification in pediatric radiology and neuroradiology; and a pediatric radiologist, c.v.q., with 10 years' experience in pediatric radiology and subspecialty certification in pediatric radiology and nuclear medicine) reviewed the anonymized spine mris and recorded findings by consensus. variables included patient demographics (age, gender, race, ethnicity, insurance status); likelihood of abuse (accidental, indeterminate, abuse); whether the child received an mri of the spine and whether the imaging was of the whole spine or cervical spine only; injury severity (length of intensive care stay, ventilation time, initial mental status described by providers, initial glasgow coma scale [gcs], neurosurgical intervention, and mortality); criminal convictions; confessions; mechanism of head injury (combined, contact, undetermined, noncontact); the presence of retinal hemorrhages; and presenting symptoms of spine injury. initial mental status was recorded from the first available physical exam pertaining to the abuse concern. a presenting symptom of spine injury was any symptom documented prior to the spine mri that the treating provider or cpt consultant thought raised concern for a spine injury. the mechanism of head injury was determined using a previously described classification system based on the pattern and characteristics of the head injury [8] . this method classified injuries as: (1) contact: injuries from cranial impact without significant cranial acceleration or deceleration (skull fractures, craniofacial soft-tissue injuries, epidural hemorrhages); (2) noncontact: injuries from cranial acceleration or deceleration without evidence of cranial impact (concussion, abnormal subdural collection extending from the interhemispheric region, diffuse axonal injury); (3) combined: both contact and noncontact injuries; or (4) undetermined: injuries from contact or noncontact mechanisms (subarachnoid hemorrhages, brain contusions or lacerations, a subdural hemorrhage not extending from the interhemispheric region). we classified children with hypoxic-ischemic injury but no intracranial hemorrhage as "undetermined" and those without intracranial injury confirmed on mri as "no head injury." abuse likelihood was determined a priori at the time of the initial cpt consultation. as standard practice, the cpt consultant assigns a physical abuse likelihood score to all cases using a previously described 1-7 scale (table 1 ) [9] . a diagnosis of aht is made by consensus after peer review by the cpt when a child presents with diffuse primary brain injury and extraaxial hemorrhage that cannot be reasonably explained by an accidental mechanism or a medical condition. the diagnosis is made after careful consideration of all historical and clinical data in collaboration with a multidisciplinary investigation. although information about confessions and criminal convictions was collected, this information is unreliable for an accurate medical diagnosis and was not required to classify children as abused. children <5 years of age were included to align with the narrow definition of aht developed by the centers for disease control and prevention [10] . for this study, the cases were grouped into accidental (1-2), indeterminate (3) (4) (5) , and abuse (6-7). cases classified as abuse were further divided into "aht" or "abuse, not aht." children with abusive extracranial injuries with no intracranial injuries, or intracranial injuries that were indeterminate for abuse were classified as "abuse, not aht." to assess the effects of selection bias, we compared variables between children evaluated for aht who did and did not receive a spine mri. outcome variables included intramedullary injury (spinal cord hemorrhage or edema); extramedullary hemorrhage (subarachnoid, subdural and extradural); spinal fracture or bone marrow edema (bony injury); ligamentous edema or disruption (ligament injury); posterior paraspinous muscle edema; prevertebral soft-tissue swelling; and vertebral and carotid artery injury. ligamentous injury was defined as ligamentous disruption or the presence of hyperintensity on stir sequences surrounding the ligaments or membranes (figs. 1 and 2). spinal hemorrhages were classified as subdural if there was epidural fatty tissue without dural displacement and epidural if the hemorrhage caused dural displacement toward the spinal cord (fig. 3) . we compared clinical characteristics with the presence of spine injury seen on mri. to explore the mechanism of spinal subdural hemorrhage (sdh), we performed a post hoc analysis to compare the association between spinal sdh and the presence of other spine injuries and the presence of intracranial hemorrhage. we used the chi-square or fisher exact test to compare categorical variables. we used the kruskal-wallis or mann-whitney test to compare continuous variables. p-values <0.05 were considered significant. we used statistical software sas 9.4 (sas institute, cary, nc) for all the analyses. the study population is described in fig. 4 . of the 137 children who received brain mri as part of a physical abuse evaluation, 76 (55%) received spine mri (age range 2.0 to 9.3 months; 44 definitely not inflicted injury accidental 2 no concern for inflicted injury while no evaluation can completely exclude abuse, the evaluation has not raised a reasonable suspicion of abuse. the injuries or findings could be reasonably explained by accidental or benign events. 3 mildly concerning for inflicted injury indeterminate 4 intermediately concerning for inflicted injury the injuries or findings raise suspicion for abuse, but an accidental or benign event or preexisting medical condition cannot be excluded. 5 very concerning for inflicted injury 6 substantial evidence of inflicted injury abuse 7 definite inflicted injury to a reasonable degree of medical certainty, the injuries/findings cannot plausibly be explained by accidental injury, preexisting medical illness, reasonable discipline, or benign events. of the 47 children diagnosed with aht who had a spine mri, 29 (62%) were abnormal. in 29 children who had a spine mri as part of an evaluation for aht, the cpt could not ultimately confirm aht. sixteen (55%) of these children had a spinal injury (table 3) . injuries in these children would have been missed if mri spine had been assessed only in children diagnosed with aht. mri spine findings often provided additional evidence of trauma when intracranial findings were otherwise nonspecific for trauma, evidence of injuries that were inconsistent with the history provided, or clinical information that influenced medical care (figs. 6, 7 and 8). clinical characteristics associated with spine injury among children with spine mri spine injury was suspected prior to mri in 2 (4%) of those with spine injury, but the assessment was limited by altered mental status at initial presentation in 25 (56%). table 4 describes the demographics and clinical characteristics of children with and without spine injury. there was a confession of shaking in 7 (9%) and of impact in 18 (24%). ultimately 31 (41%) perpetrators were convicted criminally. spinal injury was not significantly associated with an initial history of trauma (p=0.09), confession of shaking (p=0.69) or impact (p=0.20), or criminal convictions (p=0.13). when considered individually, many types of spinal injuries were associated with increased measures of injury severity; however, spinal sdh was the only injury also associated with the combination of non-contact head injury mechanism, retinal hemorrhages and an aht diagnosis (table 5) . fifty-nine children (78%) who received an mri spine had an intracranial hemorrhage on mri brain. of these, 11 (19%) had co-occurring spinal sdh. intracranial hemorrhage was not associated with spinal sdh (p=0.28). none of the three children with accidental intracranial subdural hemorrhage had spinal sdh. the presence of other spinal injuries was significantly associated with spinal sdh compared to those without other spinal injuries (30% vs. 5%; p=0.004). all but one child with spinal sdh had co-occurring subdural hemorrhage, with subdural hemorrhage in the posterior fossa. hypoxic-ischemic injury was the only intracranial finding in the one child with spinal sdh without co-occurring intracranial hemorrhage (case 1 in table 3 , fig. 8 ). she did not receive a lumbar puncture for a sepsis evaluation until after completion of the spine mri. fig. 3 abusive head trauma in a 5-month-old boy with multiple bruises, diffuse severe brain injury and subdural intracranial hemorrhage, liver laceration and multiple fractures. a axial t2-w spine mr image shows a small epidural collection posteriorly (arrow) on the left at the base of the odontoid process with displacement of the dura; low gradient recalled echo (gre) signal was seen as well (not shown). b sagittal t2-w spine mr image shows the epidural collection (thin arrow) as well as a subdural t2 hypointensity extending from c6 to t4 (thick arrow). c axial gre mr spine image shows corresponding low signal layering in the subdural space without epidural displacement (arrow) five of six children with epidural spinal hemorrhage were victims of aht (fig. 3) ; none of the five had a lumbar puncture prior to spine mri. the one child with an epidural spinal hemorrhage not classified as having aht was a 2-month-old who presented with sepsis and an incidental skull fracture with a history of a short fall, and this infant did have a lumbar puncture prior to spine mri. epidural hemorrhages were not associated with bony injury. multiple extremity bruises, metaphyseal fractures, diffuse intracranial subdural hemorrhage, and severe retinal hemorrhages were also present. prolonged unilateral extremity weakness was noted after he regained consciousness. father confessed to shaking him and throwing him onto a bed and was convicted of physical abuse we found a high incidence of spinal injury (59%) in children evaluated for aht and in those ultimately diagnosed with aht (62%). the reported incidence of spinal injury in aht varies considerably (13% to 78%) [11, 12] because of variations in the extent of imaging performed and study designs. in publications with methods like ours, which assessed for a wide range of spinal injuries regardless of whether aht was ultimately diagnosed, the incidence of spinal injury ranges from 30% to 69% [5, 13, 14] . among these studies, jacob et al. [14] described a similar rate of spinal subdural hemorrhage (18%) and spinal epidural hemorrhage (10%) compared to our population, but higher rates of ligament and bony injury (67% and 9%, respectively). in contrast, kadom et al. [13] and oh et al. [5] found no bony injury and spinal subdural hemorrhage in only 1% of cases. the addition of sagittal stir sequences improves the detection of soft-tissue injury and is useful to confirm the presence of spinal hemorrhage [12, 14] , and this might have contributed to the higher percentage of injury detected in our subjects. whole-spine imaging can also result in increased injury detection compared to cervical spine imaging alone [12] . if we had excluded thoracic and lumbar spine mri, we would have missed three children with spinal extramedullary hemorrhages and two with thoracic vertebral body fractures. additionally, 3-d t1-w sequences used in our mri protocol might have facilitated detection of spine fractures (fig. 9 ). research by baerg et al. [15] , the only prospective study assessing spine injury in aht, found the lowest rate of injury (15%). the authors used strict inclusion criteria requiring loss of consciousness, and imaging findings of intracranial hemorrhage, diffuse axonal injury, hypoxic injury or cerebral edema. abuse cases without a confession or witnessed abuse were table 3 , a 35-month-old girl presenting with altered mental status, lethargy and vomiting after a reported fall from standing height in a bathtub. a axial gradient recalled-echo spine mr image shows abnormal left vertebral artery flow void compatible with dissection (arrow). b t2-w axial mr image of the brain shows evidence of completed infarcts in the distribution of bilateral medial branches of the posterior inferior cerebellar arteries (arrows) table 3 , an 18-month-old boy found by mother unresponsive and not breathing in the crib. sagittal short tau inversion recovery spine mr image shows prevertebral soft-tissue swelling (long arrow), posterior paraspinous muscle edema (short arrow) and subtle interspinous ligament injury (arrowheads) excluded. mri stir sequences were included, but authors did not describe how ligament injury was defined or whether paraspinous muscle edema or prevertebral soft-tissue injury was recorded as injury. if we had used similar inclusion criteria, our incidence of spine findings would have remained high at 67%. if we had also used a more restrictive definition of injury by excluding paraspinous muscle edema, prevertebral soft-tissue injury, and ligamentous edema without disruption, the incidence of spine injury in our study would have remained comparatively higher (33%) than in baerg et al.'s (15%). useful interpretation of spine pathology in child abuse evaluations depends on clinicians' ability to interpret findings as traumatic injury and to differentiate abusive from accidental mechanisms. mri findings might overestimate the extent of disruptive ligamentous injury, limiting the utility of spine mri when the goal is to detect potentially unstable injuries requiring surgical intervention [16, 17] . however, in child abuse evaluations the goal is to detect both apparent and occult injuries to outline the severity of injury to the child and support opinions regarding injury mechanism. soft-tissue pathology on spine mri does correlate with clinical impairment in adults with whiplash injuries as compared to controls [18] . in children, choudhary et al. [12] compared spine mri findings among aht, accidental trauma and non-traumatic cohorts. after excluding medical causes, the only spinal finding in the non-traumatic cohort was a nuchal ligament injury in a child with sepsis who sustained a 20-min tonic-clonic seizure. the authors concluded that bony or ligamentous spinal abnormalities in the accidental and abusive cohorts were from injury and not normal variants [12] . although spine mri rarely resulted in additional medical treatment, it did often provide clinically and forensically valuable information including additional evidence of trauma when intracranial findings were otherwise nonspecific for trauma, and identification of injuries that were inconsistent with the history provided. consistent with other studies [15, 19] , spine injuries in our subjects were often occult. none of the fractures noted on mri were identified on preceding plain radiographs. symptoms are difficult to assess in very young children and the symptoms can be masked by severe brain injury. evidence of unexplained trauma might prompt additional investigation for maltreatment and in this way affects medical decision-making. interestingly, in several children with altered mental status, respiratory distress and hypoxicischemic injury, the spine findings were the only clear table 3 , a 2month-old girl with diffuse cerebral hypoxic-ischemic injury and no history of trauma and no intracranial hemorrhage. a sagittal t1-w spine mr image shows linear posterior hyperintensity (arrow). b axial gradient recalled-echo spine mr image shows a corresponding hypointensity layering in the subdural space (arrow) representing hemorrhage without a posterior epidural concave displacement of the dura. c axial gradient recalled-echo spine mr image shows distal extension of subdural hemorrhage without dural displacement (arrow). prevertebral swelling, posterior paraspinous muscle edema, nuchal ligament edema, and interspinous edema were also present on short tau inversion recovery sequences (not shown) evidence of trauma (table 3) . these cases suggest a need for research assessing the prevalence of spinal injury in infants who present with severe unexplained respiratory compromise. in contrast to other spinal injuries, posterior paraspinous muscle edema was interpreted with caution by the cpt because it was often thought to be the result of fluid shifts during resuscitation rather than primary injury. mri spine has only poor to moderate specificity for paraspinous muscle injury when intraoperative findings are used as a gold standard [17] . however, in adults with whiplash injuries from motor vehicle collisions, cervical muscle strain (defined as altered structure, size and signal intensity) and muscle tears/ hematomas on cervical spine mri are significantly more common compared to non-injured controls, as are spinal fractures and bony contusions (defined as altered bone marrow signal intensity without fracture line) [20] . similar comparative studies in children and in more severely injured patients are needed to guide the interpretation of spinal findings in children with isolated paraspinous muscle edema. although no children in the accidental trauma group had bony, hemorrhagic or ligamentous injuries, overall spinal injury and aht were not associated. spinal sdh was the only injury associated with a diagnosis of aht. the low number of accidentally injured children who received a spine mri (n=5) aht abusive head trauma, gcs glasgow coma score, icu intensive care unit data presented are median (interquartile range) for continuous variables and count (%) for categorical variables. percentages from some subgroups do not add up to be 1 because of the rounding of numbers. bolded p-values are statistically significant a race information is missing in 6 patients b initial gcs was not assessed in 40 patients table 5 clinical characteristics associated with spine injury type (n=76) .001 compared to those without the specific type of spine injury compared to the abuse (n=55) and indeterminate groups (n=16) might have caused a lack of power to detect differences; higherpowered comparative studies do suggest cohorts with a higher incidence of spinal injury in abused infants [12, 19, 21] . choudhary et al. [12] found a higher rate of both cervical ligamentous injury (78% vs. 46%) and spinal sdh (48% vs. 2%) in children with aht compared to accidental injury. when henry et al. [19] compared spinal injury in children with aht and with accidental injury associated with non-motor vehicle crash, the authors found a higher incidence of spine injury overall in children with aht (31.3% vs. 7.1%), but the rate of ligamentous injury was similar (8.7% for aht and 5.8% for accidental head injury) [19] . in contrast, other studies did not find a higher incidence of spinal injury in abused infants [11, 13] . the lower number of children with spinal extramedullary hemorrhage in these studies might contribute to the lack of significant findings between their abusive and accidental cohorts. additionally, baerg et al. [11] included children with severe accidental rotational acceleration/deceleration head injuries who can have spinal injury similar to that found in aht. although spinal injury and aht were not associated in baerg et al.'s study, spinal injuries were associated with other clinical findings of severe rotational acceleration/deceleration head injury typical of both aht and severe accidental head injury involving similar mechanisms [11] . we found higher severity of brain injury in children with spinal injury and an association between spinal sdh and other injuries typical of aht. although the association between injury severity and spinal injury should be interpreted with caution because of the low number of less severely injured children who received a spine mri, it is consistent with previous literature [11, 19] . like aht, spinal injury is associated with global parenchymal injury [16] , hypoxic-ischemic injury [12] [13] [14] [15] and a rotational acceleration/deceleration mechanism of head injury in both accidental and abusive trauma [15] . using autopsy techniques that preserve the entire spine for microscopic analysis, matshes et al. [22] found that 100% of subjects with injuries involving hyperflexion/extension forces to the head had injury to the spinal nerve roots. in living children, spinal nerve root injuries are infrequently reported but might be below the current level of detection on mri [12, 23] . although we did not analyze the association between hypoxic-ischemic injury and spinal injury, other research suggests that hypoxic-ischemic injury is more common in children with ligamentous spinal injury [12, 13, 15] , and spinal sdh is rarely identified in accidentally head-injured children [12, 21] . our study supports and adds to this literature by highlighting an association between spinal sdh and a combination of higher injury severity, noncontact head injury pattern, retinal hemorrhages, and an aht diagnosis. despite the association between spinal sdh and aht, the source of the bleeding in spinal sdh is debated. spinal sdh is most commonly attributed either to direct injury to spinal vasculature or tracking of intracranial blood [4] . sequential migration of intracranial blood into the spinal subdural space has been reported in adults [24] . case studies of children with aht report spontaneous resolution of subdural hemorrhages at the clivus, which seemed to have migrated into the spinal subdural space [25, 26] . spinal subdural hemorrhage is also reported as a complication of ventriculoperitoneal shunting, where low intracranial pressure from the shunt is suspected to cause dissection between the dura and arachnoid layer of the spine, allowing migration of the intracranial subdural hemorrhage [24] . however, in the only prospective study assessing the incidence of spinal sdh in people with intracranial subdural hemorrhage, only 2 (1.2%) of 168 adults with intracranial hemorrhage had spinal hemorrhage; both of those people had experienced concurrent injury to the head and the back [27] . direct vascular injury to radicular veins traveling through the spinal nerve root is also a known cause of spinal sdh in victims of aht, likely caused by traction on spinal nerve roots during hyperflexion/extension from shaking [28] . if migration of an intracranial hemorrhage were the sole mechanism for spinal sdh, we would expect to see an association between intracranial and spinal hemorrhage, regardless of the presence of other spinal injuries. although all but one child with spinal sdh also had intracranial hemorrhage in our study, intracranial subdural hemorrhage was not predictive of spinal sdh. spinal sdh was associated with other spine injuries. the lack of association between intracranial and spinal sdh suggests that caudal migration of an intracranial hemorrhage is not the sole mechanism for spinal sdh. our findings suggest that either the spinal sdh is caused by direct spinal injury at least in some cases, or that a similar injury mechanism caused the other spinal injuries and the caudal extension of the intracranial hemorrhage into the spine. choudhary et al. [12] also found a higher incidence of spinal sdh in children with aht compared to their accidentally injured cohort and a correlation between ligamentous spinal injury and spinal sdh. the authors proposed that traction on myodural bridges and the intradural nerve roots and dentate ligaments during flexion/extension of the spinal cord in aht could cause disruption of the dura-arachnoid interface, facilitating the migration of blood from the intracranial compartment into the spine [12] . the association among spinal sdh, other injuries typical of rotational acceleration/deceleration of the head, and a diagnosis of aht in our subjects supports this theory. however, it is important to consider that spine mri extended past t5 in a minority of our subjects, so the incidence of spinal sdh might be underrepresented. additional studies using whole-spine mri are needed. there are several limitations to this study. first, there is a risk of circular reasoning if the presence of spinal sdh heightened providers' concern for aht. however, upon review of consultation reports for children with spinal injury, no children were classified as abused because of a spinal injury. to further assess for circular reasoning, aht likelihood was compared to a second classification method developed by duhaime et al. [29] and then modified by kadom et. al [13] that does not use spinal injury as a diagnostic consideration. because this classification system was meant for people with head injuries, people without concern for head injury were excluded. using the weighted kappa statistic, abuse classifications determined by the modified duhaime criteria and lindberg scale were significantly correlated (îº=0.67, 95% confidence interval [ci] 0.57-0.77). second, the potential for sampling bias exists. because the majority (93%) of spine mris included cervical spine only, our study might underestimate the incidence of spinal injury. the number of children with isolated lumbar and lower thoracic injuries is unknown. abused children and children with higher severity of injury were more likely to receive a spine mri, potentially causing under-detection of spinal injury in accidental, lower-severity injuries and resulting in a lack of power to detect differences between abused and non-abused children. if we assume that all children who were not imaged had a normal spine mri, the incidence of spine injury would remain relatively high at 33%. finally, because we did not assess inter-and intraobserver variability in radiologists' readings of the spine mris, our ability to comment on the validity of the interpretations is limited. our rates of spinal hemorrhage and ligamentous and bony spinal injury overall and within our aht population were similar or lower than reported by other studies that used methods and mri sequences comparable to those in our study [12, 14] . this suggests that our interpretation of the spine mri was similar to or more conservative than those of researchers at other institutions. there is a high incidence of spinal injury in children evaluated for aht (59%) and those ultimately diagnosed with aht (62%). higher measures of injury severity were the only variables associated with spinal injury overall. however when considered separately, spinal sdh was associated with aht and with other head injuries typical of a rotational acceleration/deceleration injury mechanism. spinal sdh might support a mechanism of severe acceleration/ deceleration head injury and a diagnosis of aht when interpreted in conjunction with other intracranial and ocular findings. mri of the whole spine should be included in future studies to further examine the predictive value of spinal sdh for an aht diagnosis. while bone, ligamentous and other soft-tissue spine injuries likely result from a wider range of injury mechanisms, detection of occult injury could be clinically and forensically valuable. additional research assessing spine findings in accidentally and less severely injured children and investigating potential nontraumatic causes of posterior paraspinous muscle edema in children could further our ability to interpret spinal pathology on mri. finally, studies assessing the incidence of spinal injury in children presenting with unexplained hypoxic-ischemic injury and respiratory distress would be useful to examine the emerging link between hypoxic-ischemic injury and spinal injury in abuse evaluations. conflicts of interest none prevalence, patterns, and clinical relevance of hypoxic-ischemic injuries in children exposed to abusive head trauma clinical and radiographic characteristics associated with abusive and nonabusive head trauma: a systematic review abusive head trauma: recognition and the essential investigation spinal injuries in abusive head trauma: patterns and recommendations changes in use of cervical spine magnetic resonance imaging for pediatric patients with nonaccidental trauma acr appropriateness criteria: suspected physical abuse -child hospital variation in cervical spine imaging of young children with traumatic brain injury mechanisms, clinical presentations, injuries, and outcomes from inflicted versus noninflicted head trauma during infancy: results of a prospective, multicentered, comparative study variability in expert assessments of child physical abuse likelihood pediatric abusive head trauma: recommended definitions for public health surveillance and research cervical spine injuries in young children: pattern and outcomes in accidental versus inflicted trauma imaging of spinal injury in abusive head trauma: a retrospective study usefulness of mri detection of cervical spine and brain injuries in the evaluation of abusive head trauma mr imaging of the cervical spine in nonaccidental trauma: a tertiary institution experience cervical spine imaging for young children with inflicted trauma: expanding the injury pattern correlation of mr imaging findings with intraoperative findings after cervical spine trauma efficacy of mri for assessment of spinal trauma: correlation with intraoperative findings magnetic resonance imaging assessment of craniovertebral ligaments and membranes after whiplash trauma cervical spine imaging and injuries in young children with non-motor vehicle crashassociated traumatic brain injury are there cervical spine findings at mr imaging that are specific to acute symptomatic whiplash injury? a prospective controlled study with four experienced blinded readers spinal subdural hemorrhage in abusive head trauma: a retrospective study shaken infants die of neck trauma, not of brain trauma spinal cord injury without radiographic abnormality in children, 2 decades later concomitant intracranial chronic subdural hematoma and spinal subdural hematoma: a case report and literature review retroclival collections associated with abusive head trauma in children acute clinical and spinal subdural hematoma with spontaneous resolution: clinical and radiographic correlation in support of a proposed pathophysiological mechanism prospective assessment of concomitant lumbar and chronic subdural hematoma: is migration from the intracranial space involved in their manifestation? thoracolumbar spine subdural hematoma as a result of nonaccidental trauma in a 4-month-old infant head injury in very young children: mechanisms, injury types, and ophthalmologic findings in 100 hospitalized patients younger than 2 years of age publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. key: cord-289605-gvc673ij authors: klaunberg, brenda a.; lizak, martin j. title: considerations for setting up a small-animal imaging facility date: 2004 journal: lab anim (ny) doi: 10.1038/laban0304-28 sha: doc_id: 289605 cord_uid: gvc673ij imaging techniques allow for the conduct of noninvasive, in vivo longitudinal small-animal studies, but also require access to expensive and complex equipment, and personnel who are properly trained in their use. the authors describe their planning and staffing of the nih mouse imaging facility, and highlight important issues to consider when designing a similar facility. state-of-the-art biomedical research often uses rodents and other small animals for disease modeling. a recurring issue for many investigators is the desire to obtain anatomical and physiological information from valuable research animals without sacrificing them. in vivo imaging is a noninvasive way to gain insight into the animal's anatomy and physiology 1 ; however, the unit cost and complexity of many such methods may preclude an investigator's ability to gain access to such devices. location of the imaging equipment in a shared facility can overcome these obstacles. the vision of the nih mouse imaging facility (mif) is to offer various state-of-theart, in vivo small-animal imaging techniques in one facility. the mif is a shared resource for the nih intramural community, and currently has more than 70 active animal protocols. at this time, the mif has three magnetic resonance imaging (mri) scanners, a micro x-ray computed tomography (ct) scanner, two ultrasound scanners, a combined luciferase/gfp imager, and a laser doppler imager. in addition to administrative personnel, the staff consists of a veterinarian, three imaging scientists, an electrical engineer, and three animal technicians. setting up this facility took planning and intellectual contributions from experts in many fields. we provide resources for a wide variety of investigators from many of the various institutes within the nih. this is not a 'how-to' manual, but we will discuss some of the issues that the principal players considered when designing and staffing the mif. a small-animal imaging facility can represent an enormous investment of capital and personnel. to obtain the maximum usefulness and ensure success, a certain amount of planning must take place before an instrument is ordered or facility construction begins. planners should recruit the advice of experts in various imaging fields and involve as many people as necessary to share in the decision-making processes, so that everyone has a voice. knowledge of the needs of the research community is one of the most important priorities in setting up any facility. a consultation with your research community will help to determine which imaging modalities are most needed. it is pointless to include an instrument that no one will use. consultation with experienced operators for each of the imaging modes chosen will elicit useful advice on special needs for each instrument. veterinarians and animal care staff should also have input because they will have a considerable impact on traffic patterns, animal care requirements, and other features. if possible, one should visit other small-animal imaging facilities. what imaging modalities do they have? what problems have they encountered, and how did they solve them? one must consider what types of animals and models could come to the facility for imaging, because these considerations will impact staffing choices, housing availability, and imaging modalities. one should also consider the health status of the animals; a facility that can accommodate immunecompromised animals has more stringent requirements. the biosafety level that the facility will maintain is also a consideration; animals carrying pathogens or treated with radiolabeled agents will require additional restrictions. the mif operates as a clean conventional facility that excludes the following specific pathogens: coronaviruses, pneumovirus of mice (pvm), sendai virus, endoparasites, and ectoparasites. to prevent cross-contamination between rodents, disposable, absorbent material covers all surfaces. all surgical instruments are steam-sterilized for survival procedures, and devices such as nose cones are either placed in cold sterilization or cleaned with a bleach-based disinfectant. planners should decide whether to design and staff the facility so that researchers can be human and animal safety should be the primary consideration when planning an imaging facility design. in addition to excluding specific rodent pathogens, the mif operates at animal biosafety level-1 (absl-1) [author: edit okay?]. some imaging animals may receive agents (chemotherapeutics, infectious organisms) in higher biosafety levels in other facilities. those animals cannot be imaged until they satisfy absl-1 requirements. planners should determine the need for a preparation room. it is possible to perform simple procedures such as anesthesia induction and tail vein catheter placement adjacent to the imaging instrument. more complicated preparations that require sterile or aseptic procedures will require a dedicated room. in the mif, there is a small preparation area adjacent to each instrument. in addition, we have a preparation room set aside for rodent procedures more complex than anesthesia induction and tail vein intravenous catheter placement. each preparation area is set up with anesthesia and physiological monitoring equipment, as well as a surgical microscope for microsurgery. we use inhalant anesthesia (isofluorane) as much as possible, and each imaging device preparation area is set up identically. all preparation areas have central gas supplies for oxygen, medical air, and nitrogen, as well as a vacuum system for scavenging anesthetic gases. anesthesia and monitoring equipment must comply with magnet safety. anything that enters the scanner room must be nonmagnetic, and any equipment within the fringe field must operate correctly. once there is an understanding of the goals of the research community, the needs of the investigators can determine the imaging techniques to be made available. some techniques, such as optical imaging, are relatively inexpensive in terms of equipment, personnel, and space. individual laboratories may have the financial capability to purchase these types of devices, but more elaborate techniques, such as mri or ct scanning, require a more substantial investment of resources. individual laboratories rarely have the funds to purchase such equipment or the means to maintain them; therefore, mri and ct are usually the core of an imaging facility. please refer to table 1 for a summary of imaging modalities, their applications, and their estimated costs. mri is one of the most powerful noninvasive imaging methods currently available to research. this technology uses radio waves and powerful magnets to generate radiograph-like images of tissue. a strong magnetic field partially aligns the hydrogen atoms on water molecules in the tissue. a radio wave then disturbs the built-up magnetization, and radio waves are in turn emitted as the magnetization returns to its starting place. these radio waves can be detected and used to construct an image (fig. 1a) . unlike radiographs, the mri patient is not exposed to x-ray radiation, so repeated imaging is not a risky procedure 2 . mri is excellent for imaging different types of soft tissue with high contrast 3-6 . researchers can use it for anatomical and functional studies. some applications include tumor growth and treatment, brain function and stroke, and cardiovascular disease. contrast agents, which are drugs that function like histological stains, increase the usefulness of this imaging method. for 2 resource volume 33, no. 3 lab trained to run the instruments independently, or whether to offer complete service, in which researchers can deliver animals to the facility and then return for images. this choice will have a profound effect on staffing requirements. the mif is designed to be a resource, not a service, so that investigators are encouraged to participate fully. even if the investigator has no desire to learn to run the equipment, it is our requirement that someone on the protocol be present and responsible for the animal during scanning. an important initial decision is whether or not the animals will be housed in the facility. the number of animals housed and the duration of housing will have an impact on space usage. animal welfare guidelines dictate space requirements that must be carefully considered. moreover, one must also consider space for traffic between housing, preparation rooms, and instruments. at the mif, we provide temporary housing (monday-friday) for mice only. we have one 60-ft 2 animal room with one ventilated rack that can hold 45 shoebox-sized cages. additionally, we have 400 ft 2 of animal husbandry support area for storage and cage washing. animals involved in long-term studies that must come to the mif periodically for imaging are usually returned to a quarantine facility. because of the surrounding magnetic field, an mri system requires a large area (≥700 ft 2 ). the magnet itself requires ∼200 ft 2 of surrounding clear area. the fringe field is the distance that the surrounding magnetic field extends before it drops to the level of 5 gauss. the fringe field can occupy an area up to 250 ft 2 . the mri suite must have a design that prevents casual visitors from entering the fringe field. a magnetic field >15 gauss can adversely affect persons with pacemakers or other metallic implants. the distance to the 15 gauss line varies widely with field strength and magnet type. there are magnets available that have a fringe field limited to a foot or less, but these cost more. mr scanners use extremely heavy magnets; therefore, most facilities locate the mr imager on the ground floor. additionally, because the magnets are cooled by cryogens, good ventilation must be present. rapid boil-off of the cryogens could lead to asphyxiation. the instrument manufacturer can provide a detailed description of space requirements and suggested architectural layouts. a facility will need to plan for additional space for the electronics and console for the scanner as well as a preparation area outside the magnetic field. this can amount to another 250 ft 2 . researchers currently consider a 7-tesla mri system an optimal field for imaging rodents. at the mif we have several bruker avance mri scanners (bruker-biospin, billerica, ma). some other manufacturers of mri consoles are varian (varian medical systems, inc., palo alto, ca), tecmag (tecmag, houston, tx), and mrrs (mr research systems, guildford, uk). a basic setup for the mri includes the superconducting magnet, the imaging console, and several probes for approximately $800,000-$2,000,000, depending on the options. it is ideal to enclose the magnet in a room shielded from radiofrequency, but this construction would generate additional costs. the magnet itself comes with end caps that adequately shield it; however, passing anesthesia and monitoring lines becomes awkward. because of its complexity, the mri requires a scientist with not only the necessary academic qualifications, but also a technical background for operation. there are many mri measurement methods, each with many control variables, designed for specific purposes. the mr operator must be familiar with the basic physics of the mr measurement and the effect of the controls on the image outcome. if new methods are going to be developed or implemented, a postdoctoral-level scientist will be necessary. new methods require sophisticated knowledge of the hardware and computer programming. this individual will be responsible for running the scanner and maintaining the system. mri maintenance requirements include both hardware and software. hardware maintenance includes the associated magnetic field. the magnet requires liquid nitrogen and liquid helium to maintain the superconducting magnetic field. allowing for a safety margin, most magnets need liquid nitrogen once per week and liquid helium approximately twice per year. if the cryogen level is allowed to become too low, the magnetic field can spontaneously quench (i.e., lose its magnetic force). quality assurance includes regular test images of a standard sample. a small loss in performance can result in unusable images. the operating computer and software also require regular maintenance. system software requires periodic updates to install security patches, repair bugs, and add features. these updates are particularly important if the computers are on a network with outside access. despite hardware and software designed to limit external access, new security holes appear on a regular basis. a malicious attack could destroy valuable work and render the instrument useless until the base software can be reinstalled. archiving and removing old data are important parts of computer maintenance. if the number and size of the stored image files grow too large, system performance can slow or even become blocked. a policy for data management can help prevent major problems, but periodic enforcement is still necessary. this policy can range from a simple principle of moving the oldest data first to a more complicated formula based on size and age. at the mif, we encourage everyone to transfer data from the instrument as soon as possible. when data space becomes an issue, the users with the largest amount of data must export or delete files before they can resume scanning. x-ray ct is an imaging method that uses multiple radiographic views of a subject to construct an image (fig. 1b) . in our system, an x-ray source and detector rotate around the subject 360 degrees while generating a number of projections or views. the mif has a microcat ii ct scanner built by imtek, inc. (knoxville, tn). other manufacturers of the manufacturer can provide exact measurements of the machine footprint. there are several micro-ct manufacturers, and the price ranges from $250,000 to $400,000. the instrument will require one technician for operation and maintenance. this individual should have a sophisticated education in biology or a related field and be comfortable with computers. the ct scanner relies on several computers on a small network. the ct operator will be responsible for maintaining the computer system software, managing the accumulated data, and quality assurance. a good knowledge of anatomy is vital for data interpretation, and the person should be able to interpret radiographs. reporter gene technology has revolutionized the ability to track cell populations in vivo 11 . optical imaging devices, which allow the user to monitor gene expression [author: edit okay?], are easy to operate and have no special environmental requirements. there are several different types of optical imaging. bioluminescence is an enzymatic biochemical process that produces light. the luciferase gene is first inserted into the targeted cell population. image acquisition requires live cells to process the substrate and produce light. advantages of bioluminescence include high sensitivity, and virtually no background noise; disadvantages include the need for cofactors (i.e., oxygen, magnesium, and atp) and expensive substrates (luciferin). fluorescence imaging also requires genetic manipulation; however, the technology does not require a living system to produce an image. fluorescence imaging differs from bioluminescence in that light must be applied to the tissue to generate a signal. one advantage of fluorescence imaging is the commercial availability of numerous markers (gfp, dsred, icg, and cy5.5) with no need for substrate or cofactors; a disadvantage is the low signal/noise ratio due to autofluorescence. basic equipment for bioluminescence or fluorescence imaging consists of a light-tight chamber, a sensitive camera (charge-coupled device), and a computer. it is possible for the ambitious investigator to manufacture his or her own imaging device; however, commercial products are available for about $200,000. the mif owns a xenogen ivis 100 (xenogen corp., alameda, ca); other manufacturers include eastman kodak (eastman kodak co., scientific imaging systems, rochester, ny), roper scientific (trenton, nj), and advanced research technologies, inc. (saint-laurent, quebec, canada). our imaging device occupies a space measuring 16 ft 2 ; additional benchtop space is necessary for preparing the animal. image acquisition is simple, and it is not necessary to have a dedicated system operator. investigators can easily learn to perform their own imaging study. our system's operating software first acquires a black-and-white photographic image of the subject, then acquires the luminescent image, and finally overlays the image onto the photograph for anatomical signal mapping (fig. 2) . both bioluminescence and fluorescence imaging are useful to detect tumor cells, monitor tumor growth, or track cell movement (e.g., metastasis). optical imaging can be highly specific, but it has low spatial resolution. optical data are typically two-dimensional (2d), but 3d methods are in development. a high throughput of animals is possible because imaging time is 4 resource volume 33, no. 3 lab micro-ct equipment include ge medical systems (london, ontario, canada), scanco medical (scanco usa, inc., southeastern, pa), and skyscan (aartselaar, belgium). each projection is the equivalent of a radiographic image. a method called 'filtered back projection' permits these projections to be reconstructed into a three-dimensional (3d) data set. a micro-ct scanner for rodents typically uses less x-ray power than a conventional clinical ct scanner, so the effective radiation exposure per scan is reduced. the highest radiation dose we have measured was 35 rad for skin, but typical scans are much less (9 rad). the radiation dose is ultimately dependent on the scan parameters (i.e., number of projections, exposure time, x-ray beam strength). ct is excellent for studying the skeletal system, certain internal organs, and fat distribution [7] [8] [9] [10] . ct can also be used for tumor studies, depending on the location of the tumor. a typical 3d image with 100-µm resolution takes about 10 minutes to acquire; higher resolution images may take up to 25 minutes. image reconstruction can take as little as 5 extra minutes or up to 24 hours depending on hardware and software options. as with mri, a contrast agent can be used to enhance the appearance of some organs. in rodents, the half-life of most clinical ct contrast agents is short, so some experimentation is required to find the optimum dose and administration regimen. a micro-ct scanner requires ∼200 ft 2 of short, usually from 1 second to 10 minutes. laser doppler is another type of optical imaging that uses a laser light source and the doppler effect to measure capillary blood flow (fig. 3) . the equipment consists of a laser source and computer, and costs less than $50,000. the footprint of the laser device is small (4 ft 2 plus computer), but its sensitivity to movement warrants placement on an antivibration table. this machine is simple to use and is highly sensitive, but it is limited to small vessels within a 1-mm depth. the mif owns a laser doppler imager from moor instruments, inc. (wilmington, de). another manufacturer is perimed, inc. (north royalton, oh). ultrasound imaging is a rapid, real-time in vivo technique. an ultrasound transducer broadcasts sound waves beyond the audible range into tissue. as the sound waves encounter the interfaces between various types of tissue, they are reflected. the transducer detects the reflected sound waves and uses them to construct an image (fig. 4) . the depth of penetration depends on the frequency of the sound wave. the image-processing software produces an image in real time, and the various tissues within the image display different 'echogenic' properties. ultrasound machines used for rodent imaging are similar to those used clinically; however, the larger field of view offered by a clinical scanner is not optimal for imaging smaller subjects. resolution increases (and field of view decreases) as the ultrasound frequency increases; therefore, high-frequency ultrasound is ideal for rodents. ultrasound is excellent for cardiac studies and evaluation of embryonic development 12, 13 . it may also be used for various organ evaluations, tumors, and guided injections. advantages of ultrasound include rapid image acquisition and ease of use; however, time is required for the operator to develop proficiency in the acquisition techniques and image interpretation. knowledge of anatomy is useful for positioning the transducers, as well as evaluating the resulting images. a well-trained operator should be able to distinguish normal and abnormal anatomy. scattering of the sound waves in the tissue often cause ultrasound images to appear 'noisy' . also, most ultrasound images are 2d, although some 3d-capable instruments are available. most ultrasound machines are built on portable carts for easy relocation. the image display is most clearly visible in low ambient light, so this should be a consideration when determining the location for ultrasound imaging. the mif owns two ultrasound machines: a siemens acuson sequoia (siemens medical solutions, malvern, pa) and a visualsonics vevo 660 (visualsonics, inc., toronto, ontario, canada). there are many other ultrasound manufacturers, including philips (philips medical systems, andover, ma) and general electric (ge medical systems, london, ontario, canada). a commercial ultrasound imager can cost about $150,000. although one can perform data analysis on the scanner, this does take time away from available scan time. an additional data-processing workstation could cost as much as $60,000. the mif does not have a dedicated ultrasonographer at this time. the investigators that use our acuson ultrasound most frequently have experience in its operation and often collaborate with other investigators in need of their expertise. the mif staff is developing proficiency in ultrasonography. positron emission tomography (pet) is an excellent method to perform functional imaging in vivo [14] [15] [16] . uptake of radioactive compounds can demonstrate the presence of tumor, abnormal cell function, or metabolic changes. this imaging technique can generate 3d data. pet imaging is highly sensitive but suffers from low spatial specificity and needs to be superimposed on an anatomical image for signal location (fig. 5) . the footprint of a micro-pet system may only be 16 ft 2 , but it is ideal to locate the micro-pet adjacent to a micro-ct or mri because an anatomical image will be required for co-registration. this allows convenient transport of an anesthetized animal from one machine to another. micro-pet imaging presents its own set of unique considerations. the use of radioactivity dictates its own specifications. the imaging area should be in a location that allows the environment to be properly controlled and appropriate precautions taken.your institution should be able to provide you with a detailed description of the rules and regulations that govern the use of radionuclides. the imaging animals will remain radioactive for some time after imaging, so housing for these 'hot' animals must be considered. the half-lives of radionuclides in the radioactive compounds are typically short (e.g., 18 hours), so housing vice to new users. at the mif, we train investigators to perform simple data analysis. for more complex data analysis, mif staff collaborates with the investigators. this system works well because, having trained an investigator, the technician is freed up for other duties; the investigator can often then pass that training on to new individuals in his or her group as well as other collaborators. once the user base is established, equipment needs are defined, and the facility floor plan is designed, one must consider the staffing needs. a variety of personnel are needed for a successful imaging facility. diversity of experience will enhance the resources as well as expand the knowledge base of the entire personnel staff. certain base criteria must be met for each unique position, but it is our experience that personnel experienced in imaging laboratory animals are difficult to find. many of the necessary technical procedures may be learned on site. we believe that a strong desire to learn may be more important than experience and formal education. it is important to have at least one person on the staff that is skilled in the routine technical procedures and can provide training for new staff members. as with any animal facility, husbandry staff is necessary. ideally, housing for imaging animals should be on site and accessible. the size of the animal housing facility will determine the number of necessary personnel. routine husbandry duties include daily health checks, cage changing, cage washing, room sanitation, sentinel maintenance, quality control, etc. husbandry staff is the foundation of all successful animal research programs. the qualifications of the animal care staff are dependent on how many people will be required to run the facility and in what capacity the people are expected to function. if you can have dedicated husbandry staff, their qualifications will be less stringent, and a person with aalas alat or lat experience would be sufficient. staff members who will be assisting with imaging experiments are expected to work independently, so it is ideal to have personnel with aalas latg certification or equivalent experience. if the technical staff is required to assist with (or perform) husbandry duties, they should understand that it is part of their job description so that no misunderstandings occur later. laboratory animals must be immobilized for imaging procedures. it is important for the laboratory animal technical staff to maintain a working knowledge of anesthesia and physiological monitoring for a variety of species. additionally, basic procedure skills such as venipuncture are required for the administration of imaging contrast agents and other pharmaceuticals. familiarity with aseptic techniques and rodent colony health management techniques will aid in maintaining the level of health standards for the facility. additional useful procedures include intubation of rodents, placement of rodent femoral, jugular, and carotid catheters. the computers acquiring the images and the networks they are connected to can be complicated. many of the personnel operating the imaging devices have sufficient knowledge of computer operation and software programming to repair problems as they occur; however, given the number of computers needed for imaging and personnel support, it is a good idea to have someone dedicated to their maintenance. it is important that these networks are secure and protected from any outside abuse. the mif has shared information technology personnel that maintain computer software security and upgrades. the imaging instruments require regular hardware maintenance as well as periodic repair. the best solution is to have an engineer on the staff to address these issues. it is possible to maintain a service contract with an outside company, but an internal person can aid in quicker diagnosis and repair. the mif has maintenance contract on all equipment, but the level of each maintenance plan varies from a 'parts only' plan to a full-service plan that includes yearly preventative maintenance. the mif is fortunate to have mri scientists who are knowledgable in mri mainte-6 resource volume 33, no. 3 march 2004 animals can be a temporary situation. the availability of radioactive compounds will have the greatest impact on the success of a micro-pet program. radiolabeled glucose, oxygen, and ammonia are commercially available; however, many studies may need custom-made radioactive compounds. the ideal arrangement is an imaging suite located adjacent to the radiopharmacy that will produce the radionuclides. production of these reagents can represent the largest expense because of the need for highly specific equipment and personnel. manufacturers of micro-pet imagers include general electric and philips medical systems. micro-pet operation will also require a postdoctorate-level scientist to assemble, operate, and maintain the equipment. it is easy to generate an enormous amount of image data in a relatively short amount of time. a single image data set can range from a few kilobytes to over two gigabytes for highresolution three-dimensional data. the amount of image data generated over time can be a problem. mass storage devices must be available for data storage during analysis. if backup and archiving are required, the amount of equipment needed can be considerable. a room will need to be dedicated to computer storage and workstations for post processing images. a minimal room will have space for a rack containing data servers and network equipment. qualified information technology personnel should be able to provide additional advice. in addition to data storage, extra workstations for data processing are almost a necessity. the alternative is allowing data to be analyzed on the acquisition instruments. this reduces the need for extra computers but takes time away from the instruments. the time required for data analysis can be considerable. some consideration must be given to who will analyze data. often, users of the instrument will not have the experience or skill needed to gain the most information from the images. one solution is for image analysis to be part of the imaging service. another approach is to train the investigators to analyze their own data; this reduces the facility burden, but reduces the usefulness of the ser-nance and repair, as well as an electrical engineer who assists with mri and ct maintenance and repair. the imaging facility also needs personnel to attend to nonscientific tasks. administrators must handle daily paperwork such as budget management and supplies, as well as provide other organizational services. these people are critical, because if the facility is successful, none of the scientific personnel will have time to attend to administrative duties. the mif has shared personnel for these tasks. any facility that conducts laboratory animal research should be accessible by authorized personnel only. we cannot overemphasize this because of magnet safety, radiation safety, and animal health. traffic patterns for animals entering the facility may be necessary if the animal health level varies in different areas. the amount of personal protective equipment (ppe) needed will be defined by the types of animals in the facility, as well as the health standard. the minimum ppe for handling animals in the mif includes a disposable lab coat and gloves. because animal studies are ongoing, and we temporarily house mice, personnel must don a lab coat upon entering our facility, regardless of their animal contact. studies with nonhuman primates require a higher level of ppe that includes mucous membrane protection. standard ppe worn around the mri scanners must be nonmagnetic. an institutional animal care and use committee (iacuc) should approve every study conducted within the facility. new investigators may seek the assistance of facility personnel in writing their protocols. this gives the imaging facility personnel a chance to suggest feasible imaging modalities, preparation methods, and anesthesia regimes. the mif has a committee of experienced researchers that review experiments for feasibility, safety, and time requirement. imaging time may be scheduled on a firstcome first-served basis, or otherwise. instruments with short imaging times allow for a larger number of studies in any given period of time. when demands exceed the available scan time, one solution is to assign blocks of time for specific groups. then individuals within the group can work out their own priority for imaging. in our experience, it is easiest to have the equipment operators schedule the investigators. the operators will be most experienced with the requests of the prospective study and can schedule time accordingly. in the mif, magnet scan time during regular working hours is assigned to institutes in blocks; the remaining scan time is assigned on a first-come first-served basis. the other imaging devices require less time per scan, so it has not been necessary to assign blocks of time yet; each investigator is assigned time on a first-come first-served basis. scan time is charged back to the institute by the hour, and the dollar amount is calculated with a budget-driven formula. noninvasive imaging of rodents and other small animals is a powerful tool for biomedical research. setting up an imaging facility is a complex process that involves many decisions affecting everything from available instruments to staff composition. careful planning should help prevent operational snags. the advice of experienced people will be the most valuable asset. it is our opinion that the facility should be designed around a primary mri scanner because mr offers versatility for many applications. acquisition of other devices will be determined by the needs of the research community. growth of the facility is limited only by usage and executive decisions. staff must include a few experienced personnel, but inexperienced eager personnel can be trained to be experts. we have tried to provide an outline of some of the important considerations that went into the creation of the mif. challenges in small animal noninvasive imaging reproductive and teratologic effects of electromagnetic fields mr microscopy and high resolution small animal mri: applications in neuroscience research imaging transgenic animals in vivo imaging of gene and cell therapies electron paramagnetic resonance for small animal imaging applications molecular imaging in small animals-roles for micro-ct the use of microcomputed tomography to study microvasculature in small rodents a review of high-resolution x-ray computed tomography and other imaging modalities for small animal research high resolution x-ray computed tomography: an emerging tool for small animal cancer research advances in in vivo bioluminescence imaging of gene expression advances in ultrasound biomicroscopy noninvasive cardiovascular phenotyping in mice molecular imaging of small animals with dedicated pet tomographs high resolution spect in small animal research radio-imaging in small animals the authors would like to thank stasia anderson of laboratory of diagnostic radiology research, nih, for providing an mr image, dan schimel of the nih mouse imaging facility for providing a ct image, cecilia lo of the laboratory of developmental biology, nhlbi, nih, for providing an ultrasound image, takashimurakami and sam hwang of the dermatology branch, nci, nih, for providing a luciferase image, michael green and the imaging physics laboratory, nih, for providing a pet image, and afonso silva of the laboratory for functional and molecular imaging, ninds, nih, for providing images for this paper. we would also like to thank alan koretsky of the laboratory for functional and molecular imaging for helpful discussions. key: cord-267605-efb10j3u authors: zheng, li-zhen; liu, zhong; lei, ming; peng, jiang; he, yi-xin; xie, xin-hui; man, chi-wai; huang, le; wang, xin-luan; fong, daniel tik-pui; xiao, de-ming; wang, da-ping; chen, yang; feng, jian q.; liu, ying; zhang, ge; qin, ling title: steroid-associated hip joint collapse in bipedal emus date: 2013-10-21 journal: plos one doi: 10.1371/journal.pone.0076797 sha: doc_id: 267605 cord_uid: efb10j3u in this study we established a bipedal animal model of steroid-associated hip joint collapse in emus for testing potential treatment protocols to be developed for prevention of steroid-associated joint collapse in preclinical settings. five adult male emus were treated with a steroid-associated osteonecrosis (saon) induction protocol using combination of pulsed lipopolysaccharide (lps) and methylprednisolone (mps). additional three emus were used as normal control. post-induction, emu gait was observed, magnetic resonance imaging (mri) was performed, and blood was collected for routine examination, including testing blood coagulation and lipid metabolism. emus were sacrificed at week 24 post-induction, bilateral femora were collected for micro-computed tomography (micro-ct) and histological analysis. asymmetric limping gait and abnormal mri signals were found in steroid-treated emus. saon was found in all emus with a joint collapse incidence of 70%. the percentage of neutrophils (neut %) and parameters on lipid metabolism significantly increased after induction. micro-ct revealed structure deterioration of subchondral trabecular bone. histomorphometry showed larger fat cell fraction and size, thinning of subchondral plate and cartilage layer, smaller osteoblast perimeter percentage and less blood vessels distributed at collapsed region in saon group as compared with the normal controls. scanning electron microscope (sem) showed poor mineral matrix and more osteo-lacunae outline in the collapsed region in saon group. the combination of pulsed lps and mps developed in the current study was safe and effective to induce saon and deterioration of subchondral bone in bipedal emus with subsequent femoral head collapse, a typical clinical feature observed in patients under pulsed steroid treatment. in conclusion, bipedal emus could be used as an effective preclinical experimental model to evaluate potential treatment protocols to be developed for prevention of on-induced hip joint collapse in patients. steroid-associated osteonecrosis (saon) is a common orthopaedic problem although steroids are initially prescribed for many non-orthopedic medical conditions, such as systemic lupus erythematosus (sle), organ transplantation, asthma, rheumatologic arthritis (ra), and severe acute respiratory syndrome (sars) [1] [2] [3] [4] [5] . part of saon patients even evolved to hip joint collapse with subsequent total joint replacement [6, 7] , and its long-term durability however still remained a big challenge [8] . how to prevent accumulation of saon lesions is the first-line strategy for avoiding joint collapse. therefore, establishment of appropriated saon animal models that mimic clinical etiology and even evolves to joint collapse is desirable prior to translating prevention and treatment experimental protocols into clinical validation and applications. up to now there is lack of ideal animal models to exam the treatment efficiency or therapeutic strategy for saon-associated joint collapse. the limitation of the existing animal models, such as rabbit [9] [10] [11] [12] [13] , rat [14] [15] [16] [17] , mouse [18, 19] , pig [20, 21] and chicken [22] is that they fail to progress to the end-stage of saon, i.e. structural collapse of the weight-bearing joints. with bipedality, high activity level and large enough bodyweight similar to that of human beings, on model to be developed in emu femoral head could provide a unique opportunity to progress to human-like femoral head collapse [23, 24] . focal cryogenic (liquid nitrogen) insults [23, 25] and alternative cooling and heating insults [26] have also been tested to induce on in emus with femoral head collapse. however, these models are not etiology-and or pathophysiology-orientated for saon research. accordingly, the aim of the current study was to establish a saon model in bipedal emus, with potentials to bone structural deterioration with subsequent femoral head collapse, a condition seen in saon patients attributed to similar biomechanics or loading ratio imposed onto the hip joint [23, 24] . such a model would be essential for testing strategies to be developed for potential clinical applications for prevention and treatment of steroid-associated joint collapse. of all available animal models, rabbits were intensively used for establishing on model where either lipopolysaccharide (lps) [27] or methylprednisolone (mps) [12, 28, 29] or their combination (lps+mps) [11, 13] were tested. all of them showed effectiveness in on induction, yet with varying degrees of on lesions and mortality of animals. based on our established saon rabbit model with a high incidence of on and low or no mortality that was induced by a combination of lps and mps [11, 30] , we hypothesized that such a combination of pulsed lps and mps injections might also be able to induce saon in bipedal emus with subsequent hip joint collapse. the research ethics committee of shenzhen second peoples' hospital reviewed and approved the experimental protocols [licence no. 2009-001] (appendix s1). both the guide for the care and use of laboratory animal (1996) [31] and the arrive (animals in research: reporting in vivo experiments) guidelines [32] were followed. eight 24 months old young adult male emus were used for this study. they were kept in shenzhen emu institute and received food and water ad libitum. five emus assigned to the saon group were treated with a combination of lps and mps. three emus were used as controls without receiving either lps or mps. the emus were euthanized by intravenous injection of overdose of pentobarbital via jugular vein at 24 weeks post injection. the details of this combined protocol were described as follows: each emu was intravenously injected with lipopolysaccharide (escherichia coli o111:b4; sigma-aldrich, st. louis, mo, usa) twice via jugular vein with 8 mg/kg body weight at an interval of 4 days from day 0. thereafter, three injections of methylprednisolone (pharmacia & upjohn, peapack, nj, usa) with 10 mg/kg body weight were given intramuscularly at gluteus muscle at an interval of 2 days. in addition, each emu was intramuscularly injected at gluteus muscle with 40 mg omeprazole sodium and orally with 250 mg amoxicillin dispersible per day for 7 days immediately after induction to prevent potential stomach ulcers and systemic infection ( figure s1 ). mri was performed with a 1.0 t mr unit (magnetom harmony; siemens, erlangen, germany) at baseline, week 2 and then at monthly basis on saon induced emus for in vivo examination on bilateral proximal femora until 12 weeks post induction. for facilitating in vivo bioimaging examination, a specific posture fixture was designed to obtain a highly reproducible image during mri scanning ( figure s2) . a phased-array body coil was used for mri scanning. coronal turbo spin-echo fatsaturated t2-weighted images (4000 ms repetition time, 96 ms echo time) were obtained with a slice thickness of 3 mm and interslice gap of 0.3 mm from a field of view of 300 mm 6 300 mm with a matrix of 3206320 pixels. blood was sampled at baseline, week 2, 4 and 8 post induction for routine blood examination and serum was prepared for examination of both coagulation and lipid metabolism. the serum parameters related to lipid metabolism, including total cholesterol (tc), total glycerin (tg), low-density lipoprotein (ldl) and high-density lipoprotein (hdl), and the serum parameters related to coagulation, including prothrombin time (pt), prothrombin time and international normalized ratio (pt/ inr), fibrinogen (fbg) and thrombin time (tt), were tested using standard clinical laboratory protocols for blood chemistry in shenzhen second peoples' hospital. gait of emus with saon was observed regularly after induction by recording abnormal gait pattern using a video camera. normal gait of the control emus was also recorded for comparison (video s1 and s2). emus walked or ran on a 20-meter walkway, and the sagittal plane motion was videotaped at 300 hz by a highspeed video camera (casio ex-f1, japan). the videos were analyzed by a motion analysis system (kwon3d xp, korea) to obtain the included ankle joint angle during a gait stride cycle with respect to the time presented in term of percentage stride. gait pattern was defined abnormal when there was a deviation of the included ankle joint kinematics (more than 20 degrees at any time) or the proportion of the stance and swing time (more than 10% deviation from control case). bilateral proximal femora from both control group and saon group were sampled and fixed in 10% buffered neutral formalin solution for 10 days, and then soaked in 70% ethyl alcohol for measurement of trabecular morphology within and around on lesions. in brief, the proximal femur was scanned using a highresolution peripheral ct (hr-pqct) (xtreme ct, scanco medical, brüttisellen, switzerland) at a voltage of 70 kv and a current of 114 ua, with entire scan length of 40 mm in a spatial resolution of 40 mm used for animal experimental studies [33, 34] . after the initial scanning, 2-dimentiaonal (2-d) images were realigned in the z-axis along the direction of femoral neck for further evaluation. for separating the signals of the mineralized tissue from the background signal, noise was removed using a lowpass gaussian filter (sigma = 2.5, support = 2) and mineralized tissue was then defined at a threshold of 85. 3-d structures of entire femoral heads were then reconstructed. the collapse was identified when fracture and/or clear deformation appeared in femoral head. a 10 mm 610 mm 68 mm region in the centre of femoral head was defined as the region of interest (roi) for analysis and comparison. roi was defined within subchondral region centered in the collapsed region or the corresponding region of the non-collapsed femoral heads, where the largest thickness of this roi was 1/3 diameter of the femoral head. bone mineral density (bmd), bone tissue volume fraction (bv/tv), trabecular number (tb. n), trabecular thickness (tb. th) and trabecular separation (tb. sp) in the roi were measured separately by the workstation with the built-in hr-pqct software. after micro-ct scanning, femoral heads were sawed in half longitudinally along the coronal plane. halves were decalcified and embedded in paraffin; and halves were embedded in methyl methacrylate (mma) without decalcification. 1. decalcified sections. for paraffin embedded samples, sections were sliced along the coronal plane for hematoxylin-eosin (h&e) and fast green and safranin o staining, respectively. a microscope imaging system (leica q500mc; leica microsystems, wetzlar, germany) was used to digitalize the histological sections for histomorphometric evaluation. 1) examination of on: the entire area of each h&e stained section was examined for the presence of on with the established criteria, i.e. diffuse presence of empty lacunae or pyknotic nuclei of osteocytes in the trabeculae, accompanied by surrounding necrotic bone marrow [13, 28] . the femoral head with at least one on lesion was considered as on+, while that with no on lesion was considered as on[11, 35] . 2) quantification of fat cells in bone marrow: fat cells were quantified for both average of fat cell size and fat cell area fraction. the total bone marrow in subchondral bone was 200 fold magnified and captured. the fat cells were manually traced and then quantified. the fat cell size was interpreted by fetet's diameter, i.e. the longest distance between any two points along a region of interest (roi) boundary [11] . the fat cell area fraction was defined as total marrow fat cell area normalized by total marrow tissue area [35] . 3) histomorphometry of the subchondral plate: the thickness of subchondral bone plate of the femoral head was measured on the 506 images. at least 10 views per section were randomly selected for measuring. the thickness was examined by measuring point-to-point distance from the top of the calcified cartilage to the deep surface of the subchondral bone plate [36] . 4) examination of articular cartilage: the average thickness of cartilage were examined by the total area of cartilage divided by the length of cartilage band measured from the manually traced region on the entire frontal sections for evaluation under 2006 magnification. the thickness of cartilage at the collapsed region or the corresponding region of the non-collapsed femoral head was also examined. the proteoglycans content was quantified by measuring the thickness of safranin o stained articular cartilage. 5) calculation of osteoblasts: the osteoblast perimeter percentage (%ob.pm) was calculated as the ratio of the total perimeter of the trabecular surface covered by osteoblasts to the whole perimeter of the trabecular surface [37] . 6) blood vessel quantification: the number of blood vessels within the collapsed region or the corresponding region of the non-collapsed femoral head was quantified on h&e sections [38] . 2. undecalcified sections. the mma embedded femoral heads were sectioned along the sawed plane using a diamond saw (isomet, buehler). the cut surface was polished on a soft cloth rotating wheel [39] . the surfaces were acid-etched with 37% phosphoric acid for 2-10 seconds, followed by 5% sodium hypochlorite for 20 minutes. the samples were then sputtercoated with gold and palladium, as described previously [40, 41] and examined for bone matrix and features of osteocytes in the scanning electron microscope (sem) (jsm-6300, jeol, japan). statistical power was set .0.8 and the type i error probability was set ,0.05 for calculating sample size (n = 5) using ps (power and sample size calculations version 3.0) for establishing saon model based on our previous rabbit model with a saon incidence of 93% [11] . the incidence of collapse was defined as the number of collapsed hips divided by total number of hips in each group. the incidence of saon was defined as the number of saon emus divided by total number of emus in each group, and analyzed with fisher's exact test. the serum parameters were expressed as mean 6 sd, and analyzed by one way analysis of variance (anova) with a post hoc bonferroni's multiple comparison test to compare the differences between every time point and baseline. micro-ct and histomorphometry data were expressed as mean 6 sd, and analyzed with mann whitney test to compare the differences between the control group and saon group. spss 10.0 was used. the significance for comparison was set at p,0.05. in t2 weighed mri images, intense signals of edema in the proximal femur were found at week 2 post-induction when compared to the baseline. the edema signals in proximal femur decreased in t2 weighed mri image at week 12 post induction ( figure 1 ). no collapse was found from mri images in the first 12 weeks after induction. the results of routine blood examination showed abnormal increase in percentage of neutrophils (neut %) at 2 weeks post induction (figure 2a ). for the time course changes in serum parameters related to lipid metabolism, tc was significantly increased at each time point post-induction, and ratio between ldl and hdl as well as ldl was also significantly increased at each time point post-injection (p,0.05 for all) while tg did not show significant increase post-induction ( figure 2b ). however, as compared with baseline, no significant difference was found for the time course changes in serum parameters related to coagulation post-induction ( figure 2c ). all emus were observed to be less active but with normal gait in the next day after the first lps injection; while an asymmetric limping gait pattern was firstly observed at week 12 post induction during loading and unloading gait cycle ( figure 3 ). in the early post-induction phase the asymmetric limping gait was only observable when the emus were running. with time the asymmetric limping gait was observed when emus were walking; closing to week 24 post induction some of the emus were observed no more active and kept sitting most of the time. no emus died during the experiment period over 24 weeks. all five emus in saon group developed edema, an early stage sign of on at bilateral hip based on mri observations as described above, in part also shown by gross morphology after sample harvesting ( figure 4a and b) , and confirmed histologically as described below. the incidence of hip joint collapse was 70% (7 out of 10 hips from 5 emus) found in the saon group, including 3 emus with bilateral collapse, 1 emu with unilateral collapse, and 1 without hip joint collapse ( figure 4a-f) . there was no collapse of the hip found in control group. micro-ct analysis was performed for the trabecular bone microarchitecture in the subchondral region ( figure 4e and f) and in the center of the femoral head ( figure 4g and h) , respectively. within the subchondral region, the bmd, bv/tv, tb. n and tb. th in the saon group were found significantly lower than those in the control group (p,0.05 for all), while the tb. sp in the saon group was significantly higher than that in the control group (p,0.05) ( table 1) . however, no statistically significant difference was found for all micro-ct indices of trabecular bone in the centre of the femoral head between the control and saon group (table 1) . gross coronal view of h&e stained femoral head in the control group showed well-arranged trabecular bone supporting the subchondral plate and the articular cartilage ( figure 5a1 ); while the collapsed femoral head in saon group was lack of vertical arranged trabecular bone to support the subchondral plate and the articular cartilage, and bone fracture shown at collapsed site ( figure 5a2 ). though 70% of 10 hips from 5 emus in the saon group developed hip collapse, 100% of hips from all emus in the saon group developed on at bilateral hips as confirmed histologically while as expected no on lesion was found in the control emus (p,0.05) ( figure 5b , c, d, e). osteonecrosis was distributed in whole femoral head, including subchondral bone ( figure 5b2, e) , middle of the femoral head ( figure 5c2 ) and femoral neck ( figure 5d ), with numerous empty lacunae in the trabeculae and marrow tissue degenerated. compared with the control group, the marrow fat cell size (fetet's diameter of fat cell) and fat cell area fraction in the saon group were increased significantly with decreased number of mononuclear cells (p,0.05 for both, figure 5b and figure 6a , b). the thickness of subchondral plate of femoral head of saon emus was decreased significantly (p,0.05, figure 6c ). the articular cartilage of saon emus also showed pathological alteration with significantly thinner thickness (p,0.05, figure 5f , g and figure 6d ). the proteoglycans content as interpreted by maximum thickness of safranin o staining was decreased significantly in saon group (p,0.05, figure 6e ), with osteonecrosis located at the collapsed region ( figure 5e ). the osteoblasts perimeter percentage (% ob. pm) of the saon group was significantly lower than those in the control group (p,0.05, figure 6f ). the blood vessels at subchondral region of saon group were surrounded with enlarged and compacted arranged fat cells, with some blood cells effused out of the vessel (figure 5b ). at the collapsed region or the corresponding region of the non-collapsed femoral head, the number of blood vessels of saon group was significantly less than that of the normal group (p,0.05, figure 6g ). sem images showed that in the collapsed region there was no osteo-like structure; instead, there were more osteo-lacunae outline, with more removal of bone mineral or less matrix; and that in the normal control, there was osteon-like structure and there were few osteo-lacunae outline with much solid bone matrix (figure 7 ). using a combined pulsed lps and mps induction protocol previously established for saon quadrupedal rabbits [11, 13] , the present study established a saon model in bipedal emus characterized with subchondral bone deterioration and hip joint collapse, an experimental model mimicking human on often developed at hip joint with femoral head collapse. as bioimaging evidence, we used mri to evaluate in vivo alteration of mri signals in the first 12 weeks post induction as mri could diagnose early-stage on, even presymptomatically [42] . abnormal signals were firstly detected at week 2 postinduction, showing large scales of edema at the proximal femora. this phenomena is similar to clinical on where the bone marrow edema was found from mri earlier than either formation of the necrotic lesion or the collapse of the necrotic fragment [43] . however, mri of emu hips merely shows bone marrow edema without typical band pattern shown in initial mri signaling of on patients [44, 45] . this could be explained by the differences in anatomy and physiology of human (mammals) and emu (aves), such as that the bone marrow of emu hip mainly presented in subchondral bone in a shell-shaped region and there was hollow structure in emu's bone marrow cavity at both femoral neck and head. irrespective such differences, there were common structural features, i.e. on lesion and hip joint collapse found in saon emus and this would provide a platform, i.e. a large bipedal animal model for testing biomaterials developed for bone defect repair, including for that after surgical core-decompression in hip joints, a condition indicated for patients with early stage of on. for functional evidence, asymmetric limping gait was observed at week 12 post-induction, suggesting that emus might suffer from joint pain caused by the on lesion formation and structural damage confirm histologically after harvesting the samples for detailed analysis. this symptom was also common in patients at early stage of on [46] . the asymmetric limping gait shown in bipedal emus was similar to the low limb dysfunction in saon patients with subchondral lesions [47] . for biochemical evidence, the current study suggested hyperlipidemia occurred after saon induction, which was evidenced by a significant increase in tc at all examined time point postinduction. in addition, abnormal higher lipid transportation to the peripheral tissues also occurred after induction, as evidenced by a significant increase in ldl/hdl, which was consistent with the results found in both saon rabbit model [9, 11] and on patients [48] . however, there was no significant difference in coagulationrelated parameters after induction as compared with baseline, while hypercoagulable and hypofibrinolysis state were reported in saon rabbit model [9, 11] and sars on patients [49] . this inconsistency suggested that the pathogenesis of saon in emu might be explained by the dominant disorder in lipid metabolism. histological and histomorphometric analysis was performed in three rois of the femoral head, including the articular cartilage, subchondral bone region and the central part of the femoral head. under higher magnification of the subchondral bone region where edema was shown in mri images, remarkable necrotic changes were observed in emu after induction, including 1) avascular zone at load bearing region, referring to the blood vessels quantification within the collapsed region; 2) extravascular adipogenesis (fat cell enlargement); 3) apoptosis of osteocytes in regions next to the marrow region packed with fat cells; and 4) thinning of subchondral bone, poor quality of bone matrix and more osteolacunae that weakens the mechanical integrity of the femoral head, which could also be weakened by the necrosis and thinning of articular cartilage. these were essential indices of later joint collapse, typically seen in saon patients [50, 51] that were substantiated in our histomorphometric analysis. on the contrary, our micro-ct evaluation for the central region of the femoral head, where no bone structural collapse was demonstrated, implied that the pulsed lps-mps induction protocol did not result in general osteoporosis as no difference in boney structural and bmd was found between saon emus and normal controls in regions away from the subchondral bone. this finding was also similar to a bone densitometry study in sars patients who underwent pulsed steroid treatment in hong kong [52] . no obvious osteoporosis found in saon patients with joint collapse or animals were mainly explained by short-term effects of pulsed corticosteroid administration that resulted in local damage of vasculature in the subchondral bone region and impairment of bone marrow mononuclear cells, which triggered up-regulation of osteoclastic activities and inadequate bone formation known as destructive repair [1, 6, 10, 34, 53, 54 ]. yet, long-term steroid administration was known to be able to induce secondary osteoporosis in patients [55] or animals [14] . in spite of the presence of difference in hip anatomy, the similarity in biomechanics of the hip joint with regard to proportion of joint loading between human and bipedal emu was well characterized by iowa biomechanics research group [56, 57] . the contact stress of femoral head was reported with a maximum hip contact force of approximately 5.5 times of body weight in emus, directed axially along its femoral neck, which was moderately larger than that of humans [56] and the contact stress magnitude and the sites of habitual loading on the femoral head was also comparable between emu hip and the human hip [57] . that the joint biomechanics plays a crucial role for no-induced hip joint collapse was also well supported by findings obtained from bipedal and quadrupedal animals. in fact, the on-induction protocol with a combination of lps and mps successfully induced saon in quadruped animals, yet without resulting in subchondral collapse [11] , although inadequate repair was also demonstrated in quadruped saon animals [35] . besides emu study, another report showed that the chicken was also bipedal animal suitable for building up saon animal model [22] , yet their induction protocol did not result in hip joint collapse. in order to mimic on and hip joint collapse, we tested large bipedal emus not because of its similarity in hip joint biomechanics to that of human but mainly that emu hip was sizeable to perform core decompression and testing porous scaffold biomaterials developed for potential clinical applications [58] [59] [60] . the saon induction protocol tested in the present study successfully induced hip joint collapse in large bipedal emus. the occurrence of hip joint collapse in emus was apparent more (7 out of 10 hips from 5 emus) than clinical data, such as 32.7% saon incidence reported by li zr and co-workers in their welldocumented clinical study in sars patients who were treated with a high dose of corticosteroid for life-saving [61] . as saon incidence is often dose-dependent and the purpose of the current preclinical study is to establish a saon bipedal large animal model with high incidence of on and hip joint collapse, we tested much higher dose of mps as compared with clinical recommended dose for sars patients [61] . differ to human situation where only mps was used, we used both lps and mps pulsed treatment, where lps served the purpose to mimic clinical conditions, i.e. disease-related tissue inflammation [11, 27] , in addition to higher mechanical loading imposed to the hip joint in emus where emu hip joint share 65-70% of the body weight as compared with around 60% of body weight in human [56] . in present emu study, we selected two lps injections with 4 days interval that showed safe and effective to induce saon. neut % increased 2 weeks post induction and decreased gradually to baseline level from 2 weeks to 8 weeks post induction which indicated inflammation reaction induced by lps. no typical clinical shwartzman reaction was observed in emus as we did not systemically study the non-skeletal tissue thrombosis or reticuloendothelial blockage for comparison with that in saon patients. it would be of interest to study in details the differences in physical or immune responses between human and birds in saon in future. in our previous study, we established saon in rabbit with 16lps (10 mg/kg) +36mps (20mg/kg) [11] . as emu was estimated with similar body surface area to that of human, we calculated the current experimental dose based on the conventional human-rabbit dose conversion. however, the dose for the initial experiment for emu was 6.67 mg/kg. as we found that emus could tolerate larger dosage from our pilot study, we increased mps dose to 10 mg/kg for the current study at a time interval of 2 days for avoiding potential side-effect of mps injection. specific design for studying dosing effects (amount and frequency of lps and mps treatment) would also be of interests for further studies. the limitation of the current experimental study is that we are not able to delineate if the cause of joint collapse is attributed to saon and/or cartilage and subchondral bone thinning as we did not observe typical destructive repair by uncoupling of osteoclasts and osteoblasts as well as extensive local fibrosis found within necrotic regions reported in both quadrupedal rabbit model [35] or patients [62, 63] . future studies shall be designed to monitor such pathological changes at various time points after oninduction. larger sample size would also be appreciated although our findings did reach statistical significance where we estimated sample size using ps (power and sample size calculations version 3.0) for establishing our current emu saon model based on our previous rabbit model with a saon incidence of 93% [11] . in conclusion, this was the first experimental study to confirm that a combined injection protocol of pulsed lps and mps was able to induce on and deterioration of subchondral bone microarchitecture in bipedal emus, with subsequent femoral head collapse. the establishment of this bipedal emu model with hip joint collapse provided a platform for evaluation of potential treatment protocols to be developed for prevention of steroidassociated hip joint collapse. pathogenesis and natural history of osteonecrosis steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy the functional capacity of healthcare workers with history of severe acute respiratory distress syndrome (sars) complicated with avascular necrosis-case report osteonecrosis of the hip: management in the 21st century nontraumatic osteonecrosis of the femoral head: ten years later progression and cessation of collapse in osteonecrosis of the femoral head the natural history of the silent hip in bilateral atraumatic osteonecrosis total hip arthroplasty following failure of free vascularized fibular graft a novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dosedependent manner the effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells corticosteroid enhances the experimental induction of osteonecrosis in rabbits with shwartzman reaction protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats femoral artery constriction by norepinephrine is enhanced by methylprednisolone in a rat model femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway a mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice selective reduction of bone blood flow by short-term treatment with high-dose methylprednisolone. an experimental study in pigs femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs the otto aufranc award. lovastatin prevents steroid induced adipogenesis and osteonecrosis a new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure the apparent critical isotherm for cryoinsult-induced osteonecrotic lesions in emu femoral heads focal cryogen insults for inducing segmental osteonecrosis: computational and experimental assessments of thermal fields emu model of full-range femoral head osteonecrosis induced focally by an alternating freezing and heating insult osteonecrosis induced by a single administration of low-dose lipopolysaccharide in rabbits effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits rapid destruction of the femoral head after a single intraarticular injection of corticosteroid into the hip joint functional perfusion mri predicts later occurrence of steroid-associated osteonecrosis: an experimental study in rabbits guide for the care and used of laboratory animals improving bioscience research reporting: the arrive guidelines for reporting animal research impaired bone healing in rabbits with steroid-induced osteonecrosis promotion of bone repair by implantation of cryopreserved bone marrow-derived mononuclear cells in a rabbit model of steroid-associated osteonecrosis constitutional flavonoids derived from epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis not via direct action by themselves on potential cellular targets the effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis bone histomorphometry: standardization of nomenclature, symbols, and units. report of the asbmr histomorphometry nomenclature committee the vascularity and remodelling of subchondrial bone and calcified cartilage in adult human femoral and humeral heads. an age-and stress-related phenomenon changes in dentin appositional rates during pregnancy and lactation in rats a method for the study of internal spaces in hard tissue matrices by sem, with special reference to dentine loss of dmp1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism early detection of avascular necrosis of the femoral head by mri femoral capital osteonecrosis: mr finding of diffuse marrow abnormalities without focal lesions initial mri findings of non-traumatic osteonecrosis of the femoral head in renal allograft recipients initial changes of non-traumatic osteonecrosis of femoral head in fat suppression images: bone marrow edema was not found before the appearance of band patterns bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial mr images avascular osteonecrosis after treatment of sars: a 3-year longitudinal study hypercholesterolemia: an association with osteonecrosis of the femoral head changes in coagulation and fibrinolysis of post-sars osteonecrosis in a chinese population osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids investigation of proximal femoral marrow with magnetic resonance imaging in recovered patients with severe acute respiratory syndrome reduced bone mineral density in male severe acute respiratory syndrome (sars) patients in hong kong relationship between bone marrow edema and development of symptoms in patients with osteonecrosis of the femoral head decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis osteoporosis management in patients with rheumatoid arthritis: evidence for improvement hip joint contact force in the emu (dromaius novaehollandiae) during normal level walking contact stress distributions on the femoral head of the emu (dromaius novaehollandiae) comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair plga/tcp composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits magnetic resonance imaging and histology of repair in femoral head osteonecrosis osteonecrosis of the jaws in patients treated with bisphosphonates -histomorphologic analysis in comparison with infected osteoradionecrosis the authors would like to thank medical staff from shenzhen second people's hospital, including dr. j xia for mri scanning and dr. jy xiong for providing anesthesia materials for animal experiments and dr. xh pan from the first peoples' hospital (shenzhen, china) for providing technical support. key: cord-351440-vtf3o5ml authors: zhang, tianshu; hirsh, ellen; zandieh, shadi; rodricks, michael b. title: covid-19-associated acute multi-infarct encephalopathy in an asymptomatic cadasil patient date: 2020-10-06 journal: neurocrit care doi: 10.1007/s12028-020-01119-7 sha: doc_id: 351440 cord_uid: vtf3o5ml nan and myalgias which were mild, lasted 4 days, and were self-limited. her sister did not seek any medical care. the patient fell ill 4 days after her sister's return with similar symptoms of a headache and myalgias. after developing lethargy, dysphagia, and speech difficulties, she was brought to the emergency department. the physical examination revealed a patient in moderate acute distress. she was febrile with a temperature of 102.2°f. her blood pressure was 140/80 with a heart rate of 106 and a respiratory rate of 27. the room air oxygen saturation was 92%. neurologically, she was awake and alert and followed commands although sluggishly. she had difficulty with her speech with components of both dysarthria and expressive aphasia, difficulty handling her secretions, and dysphagia. there was no meningismus which could be elicited. her pupils were equal round and reactive, but she showed a right gaze preference and a mild left facial droop. she had mildly decreased but equal bilateral strength. the deep tendon reflexes were preserved. the remainder of the examination was only notable for diffuse rhonchi on auscultation of her lungs. initial laboratory studies showed a mild leukocytosis with lymphopenia. the chest x-ray demonstrated patchy consolidation in the right lower lung. a non-contrast computed tomography (ct) of the head showed no evidence of intracranial hemorrhage, but there were multifocal patchy areas of white matter hypoattenuation (fig. 1) . a lumbar puncture was performed to clarify the diagnosis and to exclude central nervous system infection. cerebrospinal fluid (csf) analysis revealed normal cell counts, protein, and glucose. a polymerase chain reaction (pcr) panel for meningitis and encephalitis, including herpes simplex 1 and 2, human herpes 6, cryptococcus, and varicella zoster virus, was entirely negative as were bacterial cultures. a lyme titer was negative. an electroencephalogram (eeg) did not show electrical evidence of seizures. the covid-19 pcr test of a nasal swab became available 2 days after admission and detected the novel coronavirus (sars-cov-2) target nucleic acid. the covid-19 pcr test of csf was negative (cepheid genexpert system). to assess the white matter lesions found on head ct, a magnetic resonance imaging (mri) of the brain with and without contrast was obtained. the mri showed extensive patchy areas of abnormal signal involving bilateral frontoparietal white matter, anterior temporal lobes, basal ganglia, external capsules, and thalami. additionally, some of these foci demonstrated diffusion-weighted imaging (dwi) changes and corresponding apparent diffusion coefficient (adc) changes, with questionable minimal enhancement (fig. 2 ). magnetic resonance angiography (mra) of the brain and neck was essentially normal. the patient was treated with hydroxychloroquine, ceftriaxone, and a 5-day course of intravenous immunoglobulins (ivig). steroids were not used as it was felt to be contraindicated given the acute covid-19 diagnosis and in keeping with the then current guidelines. the patient was also given aspirin for stroke prophylaxis. after 5 days of ivig, the patient showed signs of improvement-she was better able to handle secretions, less dysarthric, afebrile and had no respiratory symptoms. because of her acute covid-19 diagnosis, it was difficult to get her placed in a rehabilitation facility. the patient's speech, strength, and ability to swallow continued to improve, and she was able to be discharged to home by hospital day 23. at an outpatient follow-up 1 week after discharge, the patient was found to be almost at baseline-tolerating a regular diet, normal speech, symmetric face, normal motor and sensory examination, and able to ambulate independently albeit at a slow pace, with some easy fatigability. a follow-up brain mri (fig. 3 ) was performed 7 weeks after the initial mri study. it showed that the initial dwi and adc changes had largely disappeared. there was a hypodense area on t1 flair images without enhancement and with persistent t2 flair changes in a similar distribution as previous mri. the chronological changes from the initial dwi and adc images to the disappearance of these signals in the follow-up mri support that the patient had acute subcortical ischemic changes or necrotic changes. the patient continued to recover from her acute illness, and 8 weeks post-discharge she resumed driving and returned to her previous work. an additional workup became available a month after the second mri including a negative myelin antibody and notch 3 genetic testing. it revealed the presence of a pathogenic variant in the notch3 gene-a heterozygous missense mutation (sequencing test by athena diagnostics) which was consistent with a diagnosis of cadasil. it is important to consider other infectious etiologies with or without a diagnosis of covid-19 in a patient with fever, neurological deficits, and encephalopathy. an electroencephalogram (eeg) is indicated to exclude subclinical seizures and non-convulsive status epilepticus. the ct findings prompted a further workup for cerebral abscesses and septic emboli. it is difficult to perform an mri on a covid-19-positive patient or a person under investigation (pui) due to the concern for contamination of equipment, the requisite patient transportation, and the risk of exposure to healthcare providers. given the clinical picture and the ct findings, it seemed rational to take the necessary steps to obtain such imaging. the brain mri showed multiple dwi lesions and corresponding adc sequence changes which were consistent with multiple acute infarcts possibly related to hypoxic-ischemic injury from systemic perturbations and resultant tissue hypoxia. the predominance of the extensive t2 flair signal changes in the cerebral white matter lesions is more suggestive of a demyelinating process. these lesions are extensive, bilateral, and predominantly subcortical, with additional involvement of the deep nuclei. these features are compatible with an acute inflammatory encephalopathy in the setting of a recent or ongoing systemic viral infection with acute neurological deficits. this case potentially represents atypical acute disseminated encephalomyelitis (adem) as the csf did not show any pleocytosis or increased protein levels [1] , though absence of csf changes could be related to the timing of lumbar puncture. the initial presentation of multiple sclerosis is within the differential diagnosis, but given the lack of any prior neurological symptoms and the clinical picture described as well as the acute diagnosis of covid-19 it seems unlikely. myelin oligodendrocyte glycoprotein (mog) antibody-associated encephalitis is also a consideration; however, the patient had negative myelin antibody. in a patient with multiple infarcts, the differential diagnosis also includes a cardioembolic cause. in this case, it was initially suspected that these multiple infarcts could be from a combination of hypoxia and a hypercoagulable state from the acute covid-19 infection [2] . the subcortical multiple infarcts this patient experienced along with the relatively symmetric white matter lesions seen on brain mri suggest a case of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil). the acute infection combined with a complete lack of family history of stroke, dementia or migraine, and the patient lacking of prior migraine with aura, stroke, cognitive impairment, or psychiatric illness is unusual but does not exclude a diagnosis of cadasil as de novo cases have been described. the clinical course of complete recovery in a few weeks is also atypical for a diagnosis of cadasil. our patient did undergo genetic testing which revealed the presence of a pathogenic variant in the notch3 gene consistent with cadasil. it is still not clear if the multiple subcortical infarctions seen on mris are from cadasil itself, or some combination of direct viral invasion, an immunological reaction, or a cytokine storm syndrome despite the findings of normal csf and a negative covid-19 pcr of the csf. the distribution of the ct and mri changes in our case is similar to a recent case report of acute hemorrhagic necrotizing encephalopathy in a covid-19 patient [3] , which case, to our knowledge, was not tested for a pathological notch3 mutation. we present a unique case of acute multi-infarct encephalopathy in a covid-19 patient. the clinical features and ct and mri changes are consistent with acute subcortical multiple infarctions which could be related to or provoked by a viral infection. further genetic testing revealed this previously asymptomatic patient to have a pathogenic variant of the notch3 gene consistent with cadasil. even though it is known that there are vascular wall smooth muscle abnormalities related to cadasil gene mutations, it is not clear what triggers the multiple infarcts in these patients. the acute infection likely induced a milieu of inflammation, hypoxia, and coagulopathy in this covid-19 patient which triggered multiple infarcts. further investigation as to the precipitants of the hypoxic-ischemic process in cadasil patients is of interest. our described case is an atypical presentation of an acute covid-19 infection in a previously asymptomatic cadasil patient who presented with multiple infarcts and encephalopathy. it is illustrative of the difficulty in searching for a definite diagnosis and the requisite workup to explore the different treatable etiologies of this clinical picture. acute disseminated encephalomyelitis in 228 patients: a retrospective, multicenter us study arterial and venous strokes in the setting of covid-19 covid-19-associated acute hemorrhagic necrotizing encephalopathy: ct and mri features the submission of the manuscript was approved by the rwjuh somerset institutional review board. all authors participated in the clinical work. t. zhang and m.b. rodricks wrote the draft. none. the authors declare that they have no conflict of interest.ethical approval/informed consent irb approval was obtained for this study. springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. key: cord-308869-tuyac4oq authors: kido, hidenori; kano, osamu; hamai, asami; masuda, hiroyuki; fuchinoue, yutaka; nemoto, masaaki; arai, chiaki; takeda, teppei; yamabe, fumihito; tai, toshihiro; kasahara, mizuki; suzuki, kenichi; shiraga, nobuyuki; sadamoto, sota; wakayama, megumi; takahashi, yukitoshi; iwasaki, yasuo; shibuya, kazutoshi; urita, yoshihisa title: kikuchi-fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: a case report date: 2017-02-01 journal: bmc neurol doi: 10.1186/s12883-017-0807-4 sha: doc_id: 308869 cord_uid: tuyac4oq background: kikuchi-fujimoto disease is a self-limited clinicopathologic entity that is increasingly recognized worldwide. kikuchi-fujimoto disease is characterized by cervical lymphadenopathy occurring in young adults. neurologic involvement is rare, and testitis directly caused by kikuchi-fujimoto disease has not yet been reported. case presentation: a 19-year-old man was brought to our clinic with complaints of fever, headache, fatigue, and left lower quadrant pain that had persisted for 3 weeks. on physical examination, painful cervical lymphadenopathies were observed. meningitis was suspected based on a cerebrospinal fluid examination, and left-sided orchitis was diagnosed based on findings from magnetic resonance imaging and ultrasonography. however, neither antibiotics nor antiviral drugs were effective in treating the patient’s symptoms. on the 20(th) day of hospitalization, the patient experienced a loss of consciousness, and brain t2-weighted magnetic resonance imaging showed asymmetrical, high-signal intensities in both basal nuclei and the left temporal lobe. encephalitis was suspected, and the patient was treated with intravenous prednisolone pulse therapy (1 g/day) for 3 days and intravenous immunoglobulin therapy for 5 days. a left cervical lymph node biopsy showed apoptotic necrosis in paracortical and cortical areas with an abundance of macrophages and large lymphoid cells, which had irregular nuclei suggestive of kikuchi-fujimoto disease; the pathological findings from a brain biopsy were the same as those of the cervical lymph node biopsy. the encephalitis and cervical lymphadenopathies followed a benign course, as did the testitis. conclusions: this is the first report of kikuchi-fujimoto disease involving painful testitis and pathologically proven asymmetrical brain regions. kikuchi-fujimoto disease should be included in the differential diagnosis when a patient presents with encephalitis, testitis, and fever of unknown origin. kikuchi-fujimoto disease (kfd), or histiocytic necrotizing lymphadenitis, is known to be a benign disease that usually resolves spontaneously. it is a rare disease and was first reported in japan in 1972 [1, 2] . kfd usually affects female patients under the age of 30 years and is characterized by regional lymphadenopathy with tenderness, predominantly in the cervical region, and is usually accompanied by mild fever and night sweats. it is of clinical importance because it is often misdiagnosed as tuberculosis, lymphoma, or systemic lupus erythematosus (sle); therefore, the diagnosis should be confirmed by biopsy study. diseases that generally accompany kfd are sle, arthritis, mixed connective tissue disease, and similar conditions; however, comorbid testitis has not yet been reported. neurological complications occur in about 11% of cases, as revealed by a review of 244 cases in which a minority of cases evolved to developing encephalitis [3] . brain magnetic resonance imaging (mri) includes symmetrical hyperintense t2-weighted and flair (fluidattenuated inversion recovery) signals in the temporal lobes, pons, and periaqueductal gray matter [4] [5] [6] [7] . this is the first report of kfd occurring with testitis and pathologically proven asymmetrical brain regions. a 19-year-old man presented to our hospital with complaints of fever (39.5°c), headache, fatigue, night sweats, and lower abdominal pain, which had been present for about 1 month. for 20 days, he had used anti-flatulent medications before presenting to our hospital. he had no history of close contact with pets, he did not travel often, and similar complaints were not present in his social circle. according to the patient's physical examination on admission, his general health status was good; body temperature, pulse, and blood pressure were 37.2°c, 102 beats/min, and 106/70 mmhg, respectively. he was alert, oriented, and cooperative. mobile, painful lymphadenopathies were observed on both sides of the cervical region, of which the largest was 2 × 1.6 cm in size. bilateral cervical lymphadenopathy was present and involved a posterior group of cervical lymph nodes. cardiac, respiratory, and neurological examination revealed no abnormality; vegetation was not detected by transthoracic echocardiography. laboratory investigations showed leukopenia (total leucocyte count: 3200 cells/mm 3 ). cerebrospinal fluid (csf) analyses were normal. no positive results that could explain the high body temperature were found during serological testing for epstein barr virus (ebv); cytomegalovirus (cmv); hepatitis a, b, and c; parvovirus; human herpesvirus; chlamydia trachomatis; mumps; human immunodeficiency virus; echo virus; coxsackie virus enterovirus; and measles spp. results of tests for rheumatologic markers (ferritin, anti-nuclear antibody, anti-neutrophil cytoplasmic antibody, anti-cyclic citrullinated peptide antibodies, extractable nuclear antigen antibody panel, anti-double stranded dna, and rheumatoid factor) were also negative. results of tuberculosis polymerase chain reaction (pcr) and herpes simplex pcr were also negative in the csf. blood and csf cultures showed no growth after incubation for 6 to 8 weeks. brain t2-weighted and flair mri sequences showed a slightly hyperintense signal of about 4 mm in the left temporal lobe (fig. 1) , and antibiotics and acyclovir treatment were begun because we could not rule out encephalitis. however, the patient's body temperature could not be reduced by routine anti-inflammatory drugs and intravenous paracetamol. thoracic and abdominal computed tomography (ct) and mri scans revealed a testicular lesion having no contrast effect (fig. 2) ; lymph nodes were predominantly located on the right side of the cervical region, with the largest measuring 2 cm in diameter. thus, one of the lymph nodes located in the right cervical region was removed and sent to pathology for analysis. on the 4th fig. 1 axial t1-weighted mri with gadolinium contrast (a) and flair-weighted mri (b) show mild enhancement and a highintensity area, respectively, in the left temporal lobe at onset (arrow heads). following periods of acute exacerbation on the 20th day, axial t1-weighted mri with gadolinium contrast (c) showed slightly larger enhancement, and flair-weighted mri (d) revealed an asymmetrical hyperintense signal in the left temporal lobe and both basal nuclei. after 2 months of hospitalization, the abnormal lesions became smaller (e, f) day of hospitalization, an excision biopsy of the cervical lymph node was performed. microscopic examination showed that the lymph nodes were expressed in paracortical and cortical areas of conspicuous apoptotic necrosis with an abundance of enlarged lymphocytes, which had prominent nucleoli in the absence of neutrophils and a proliferation of macrophages (fig. 3) . results of tests using in situ hybridization to detect ebv with marked paracortical expansion due to a proliferation of immunoblasts were negative. on the 20th day of hospitalization, the patient's general status suddenly and temporarily worsened. the signal intensity on brain mri had changed and showed an asymmetrical hyperintense signal in the wider larger left temporal lobe and both basal nuclei ( fig. 1) with slight gd-enhancement. csf protein levels and pleocytosis were increased (protein: 50 mg/dl; pleocytosis: 24 cells/μl), but csf cultures were negative, and cytology showed no malignant findings. anti-nmda, co, tr, gad65, zic4, titin, sox1, rec, hu, yo, ri, ma-2/ta, cv2, and amp antibodies associated with auto-immune-mediated encephalomyelitis were all absent. oligoclonal bands were also not detected in the csf sample. since acute disseminated encephalomyelitis (adem) was suspected, the patient was managed with intravenous prednisolone pulse treatment (1 g/day) for 3 days and intravenous immunoglobulin treatment for 5 days, and these therapies were repeated 3 times every 3 weeks. electroencephalography showed no waves characteristic of epilepsy, but levetiracetam 1000 mg/day was begun. on the 34 th day of hospitalization, mri investigation of the brain revealed that the previous abnormalities were present and had not changed. since the cervical lymph node biopsy before steroid therapy did not reveal lymphoma, a brain biopsy of the temporal lobe was performed. steroids can obscure diffuse large b-cell lymphoma or intravascular lymphomatosis; however, no recurrence was experienced. the pathological results revealed many cd68+ macrophages and histiocytes, as in the cervical lymph node, suggestive of kfd (fig. 4) . the cervical lymphadenopathies disappeared after 2 months of hospitalization, and the previous abnormalities on mri became smaller during follow-up. the testicular mass that showed a contrast effect on mri and ct similarly was smaller (fig. 1) ; therefore, we suspected that the testitis had been caused by kfd. his complaints of fever, headache, and fatigue gradually improved; he was discharged on the 90th day of hospitalization. he was followed for more than 3 months in our clinic and did not show any recurrence. kfd was first described in japan in 1972 and has increasingly been recognized worldwide since 1982 fig. 2 a axial t1-weighted magnetic resonance image shows that the lesion has an isointense signal. b after administration of gadolinium contrast, material internal enhancement is not observed. c coronal t2-weighted magnetic resonance image shows that the lesion has low signal intensity (arrow) fig. 3 left cervical lymph node biopsy shows conspicuous apoptotic necrosis in paracortical and cortical areas with an abundance of macrophages and large lymphoid cells, which have irregular nuclei [hematoxylin-eosin staining × 4 (left), ×40 (right)] [8] . according to a review [3] that summarized 244 kfd cases, the mean age was 25 (1-64) years, and 70% were younger than 30 years; 33% were men, and 77% were women. most of the cases were reported from east asia and the far east (50%), and the others were from europe (27%) and america (7%). as in the present case, the most common symptoms were fever (35%), fatigue (7%), and cervical lymphadenomegaly (100%) [3] . our case did not show any evidence of sle, lymphoma, tuberculosis, arthritis, or viral disease based on laboratory findings and cervical lymph node biopsy. testitis has not been reported as a co-morbid disease in kfd. after diagnosing kfd based on results of the cervical lymph node biopsy, we could not explain the central nervous system (cns) involvement in this case. neurological involvement, including aseptic meningitis and encephalitis, is rare, and abnormal mri findings in kfd usually show symmetrical, hyperintense t2 and flair signals in the temporal lobes, pons, and periaqueductal gray matter [4] [5] [6] [7] . therefore, we considered the possibility of co-morbid adem. avkan-oguz et al. [6] reported the co-existence of kfd and adem based on brain mri findings without a brain biopsy. our case did not show symmetrical lesions, which were reported in the previous kfd reports with cns involvement; hence, we evaluated brain pathology, and the results were consistent with those for kfd and showed a benign course. although the etiology of the disease remains unknown, infectious or autoimmune pathogenesis is thought to be responsible. the factors that likely result in the infection include herpes simplex virus, ebv, cmv, human herpes virus 6, varicella zoster virus, hiv, rubella, measles, coronavirus, coxsackie virus, hepatitis a and b, yersinia enterocolitica, toxoplasma, influenza viruses, mumps, streptococci, leptospira, and chlamydia. it has also been reported that the disease may occur after rabies, diphtheria-tetanus, poliomyelitis, hepatitis b, and influenza vaccines are injected [9] . kfd may initially be mistaken for various benign and malignant diseases, such as tuberculosis, lymphoma, sle, limbic encephalitis, and sarcoidosis. on the other hand, with regards to clinical and laboratory presentations, kfd frequently mimics sle, arthritis, mixed connective tissue disease, aseptic meningitis, encephalitis, tuberculous lymphadenitis, malignant lymphoma, and some other benign and/ or malignant diseases [3, 10, 11] . in addition to painful cervical lymphadenopathies and aseptic meningitis, our case showed testitis and encephalitis, which are not typical mri findings compared with those reported in a previous case report. previous papers reported that most cases of kfd had a benign course; therefore, it was difficult to evaluate the effect of our therapies, such as prednisolone and intravenous immunoglobulin treatment. the definitive method for confirming the diagnosis of kfd is with a lymph node biopsy, and therefore, physicians should not hesitate to perform one in order to diagnose the condition. in addition, if progressive cns involvement is observed, either steroid therapy or brain biopsy should be considered. thus, kfd may exist on a wide spectrum of diseases, and we suggest that kfd should be included in the differential diagnosis of lymphadenopathy, encephalitis, testis, and fevers of unknown origin. in conclusion, this is the first report of kfd involving testitis and pathologically proven asymmetrical brain regions. lymphadenitis showing focal reticulum cells hyperplasia with nuclear debris and phagocytosis: a clinicopathological study cervical sub-acute necrotising lymphadenitis. a new clinicopathological entity kikuchi-fujimoto disease: analysis of 244 cases histiocytic necrotizing lymphadenitis (kikuchi-fujimoto disease) with cns involvement in a child brainstem encephalitis with kikuchi-fujimoto disease a case of fever of unknown origin: co-existence of kikuchi-fujimoto disease and acute disseminated encephalomyelitis (adem) encephalitis and csf increased level of interferon-alpha in kikuchi-fujimoto disease histiocytic necrotizing lymphadenitis without granulocytic infiltration post-infectious encephalitis in adults: diagnosis and management histiocytic necrotizing lymphadenitis (kikuchi's disease) with aseptic meningitis encephalitis associated to kikuchi-fujimoto's disease in a young woman: a case report none. not applicable in order to protect patient privacy.authors' contributions study concept and design: hk, ok. acquisition of data: hk, ok, ah. hk, ok, ah, hm, yf, mn, ca, t. takeda, fy, t. tai, mk, k. suzuki, ns, ss, mw, k. shibuya, yi and yu examined and evaluated the patient. yt contributed to the csf analysis. all authors read and approved the final manuscript. the authors declare that they have no competing interests. we obtained written informed consent from the patient for publication of this report and any accompanying images. a copy of the written consent is available for review by the editor-in-chief of this journal. submit your next manuscript to biomed central and we will help you at every step: key: cord-346172-7ah22li0 authors: yang, shuyi; zhang, yunfei; shen, jie; dai, yongming; ling, yun; lu, hongzhou; zhang, rengyin; ding, xueting; qi, huali; shi, yuxin; zhang, zhiyong; shan, fei title: clinical potential of ute‐mri for assessing covid‐19: patient‐ and lesion‐based comparative analysis date: 2020-06-03 journal: j magn reson imaging doi: 10.1002/jmri.27208 sha: doc_id: 346172 cord_uid: 7ah22li0 background: chest computed tomography (ct) has shown tremendous clinical potential for screening, diagnosis, and surveillance of covid‐19. however, safety concerns are warranted due to repeated exposure of x‐rays over a short period of time. recent advances in mri suggested that ultrashort echo time mri (ute‐mri) was valuable for pulmonary applications. purpose: to evaluate the effectiveness of ute‐mri for assessing covid‐19. study type: prospective. population: in all, 23 patients with covid‐19 and with an average interval of 2.81 days between hospital admission and image examination. field strength/sequence: 3t; respiratory‐gated three‐dimensional radial ute pulse sequence. assessment: image quality score. patient‐ and lesion‐based interobserver and intermethod agreement for identifying the representative image findings of covid‐19. statistical tests: wilcoxon‐rank sum test, kendall's coefficient of concordance (kendall's w), intraclass coefficients (iccs), and weighted kappa statistics. results: there was no significant difference between the image quality of ct and ute‐mri (ct vs. ute‐mri: 4.3 ± 0.4 vs. 4.0 ± 0.5, p = 0.09). moreover, both patient‐ and lesion‐based interobserver agreement of ct and ute‐mri for evaluating the image signs of covid‐19 were determined as excellent (icc: 0.939–1.000, p < 0.05; kendall's w: 0.894–1.000, p < 0.05.). in addition, the intermethod agreement of two image modalities for assessing the representative findings of covid‐19 including affected lobes, total severity score, ground glass opacities (ggo), consolidation, ggo with consolidation, the number of crazy paving pattern, and linear opacities, as well as pseudocavity were all determined as substantial or excellent (kappa: 0.649–1.000, p < 0.05; icc: 0.913–1.000, p < 0.05). data conclusion: pulmonary mri with ute is valuable for assessing the representative image findings of covid‐19 with a high concordance to ct. evidence level: 2 technical efficacy stage: 3 demand with limited manufacturing capacity of rt-pcr kits, especially in less-developed countries. 2) false-negative rt-pcr results have been broadly reported. 3, 4 given the aforementioned challenges, chest computed tomography (ct) has been strongly recommended and encouraged for screening for covid-19. 5, 6 ai et al suggested that chest ct has ultra-high sensitivity (97%) for diagnosing covid-19. 3 besides, excellent performance of chest ct has been reported for diagnosing cases with negative rt-pcr results. 7 previous studies have reported the clinical and ct imaging features of covid-19. 8, 9 typical ct findings include ground glass opacities (ggo), ggo with consolidation, crazy paving pattern, or consolidation in a peripheral, posterior, and diffuse or lower lung zone. [10] [11] [12] ct is helpful to guide clinical management and surveil the progression of covid-19. because of the rapid progression of covid-19, the interval between the initial confirmation and the transfer to an intensive care unit (icu) can be as short as a day. 11 patients often receive more than one chest ct during their disease episode. 3, 13 hence, there is a theoretical radiation risk to these often young patients. an image modality without ionizing radiation would be of great clinical significance for evaluating covid-19. 14 as an image modality without ionizing radiation, magnetic resonance imaging (mri) may be a potential alternative to ct for pulmonary application. being less susceptible to fast t 2 * decay as well as respiratory motions, respiratorygated ultrashort echo time mri (ute-mri) has shown utility in pulmonary applications. [15] [16] [17] ohno et al concluded that ute-mri could be applied for visualizing the ggo, consolidation, and so on, in high concordance with ct. 18 we therefore hypothesized that ute-mri may serve as a valuable technique for noninvasively assessing covid-19. based on the aforementioned points, this study aimed to evaluate the clinical potential of ute-mri for assessing covid-19 with ct as the reference according to both a lesion-based and patient-based comparative analysis. this prospective study was approved by the ethical committee of shanghai public health clinical center. written informed consent of each patient was obtained. from february 2020 to april 2020, a total of 36 patients were enrolled in this prospective study. the inclusion and exclusion criteria were as the follows: inclusion criteria: 1. patients confirmed as covid-19 according to the results of rt-pcr. exclusion criteria: 1. the absence of ute-mri examinations. 2. the time interval between ct and mri examinations was greater than 2 days. the average time interval between the hospital admission and ct examination as well as hospital admission and mri examination was 2.74 days (median: 3 days) and 2.87 days (median: 3 days), respectively. ten patients were excluded because the intervals between the ct examination and ute-mri examination were larger than 2 days. three patients were excluded because of the absence of ute-mri examination. ultimately, this prospective study included 23 patients. ct acquisition: ct examinations were performed with a 64-section scanner (scenaria 64 ct; hitachi medical, kashiwa, chiba prefecture, japan). the scanning parameters were listed as: tube voltage, 120 kv; tube current 150-400 ma; pitch: 1.5; slice thickness: the entire thoracic cavity was excited with a nonselective hard pulse, followed by acquisition of a free induction decay (fid) signal instead of an echo (as in the case of most conventional clinical sequences), resulting in a center-out radial encoding trajectory. signal acquisition was initiated during the ramp-up stage of encoding gradient to further reduce the effective echo time as well as potential susceptibility artifact as a result of the air-tissue boundaries in the lung. the direction of the encoding gradient was incremented from one acquisition to another to cover the whole k-space in a "koosh ball" pattern. a total of 40,000 encoding directions was prescribed. in order to alleviate respiratory motion artifacts, the ute sequence was interleaved with a navigator sequence to track the diaphragm displacement in the superior-inferior direction. the acquisition module was enabled only within a certain predetermined displacement range, during which 2000 fids were collected each time. during reconstruction, the radial k-space data were first regridded onto cartesian the coordinate using a kaiser-bessel convolution kernel. all the qualitative and quantitative assessment of ct and ute-mri were carried out by three experienced radiologists (s.y.y., with more than 6 years' experience of chest ct diagnosis and 3 years' experience of pulmonary mri; f.s., with more than 19 years' experience of chest ct diagnosis and 8 years' experience of pulmonary mri; z.y.z., with more than 36 years' experience of chest ct diagnosis and 20 years' experience of pulmonary mri). all the ct and ute-mri images were randomized and independently analyzed by the above three radiologists without any information about the patients' clinical characteristics and results of other image techniques. image quality analysis. all ct and ute-mri images were independently scored by three radiologists with a 5-point scoring system. detailed scoring standards were: 1: unacceptable nondiagnostic image quality, 2: poor image quality, 3: acceptable image quality, 4: good image quality, and 5: excellent image quality. patient-based evaluation. patient-based quantitative imaging indexes including the number of affected lobes, the number of ggos, the number of consolidations, the number of ggos with consolidation, the number of crazy paving patterns, the number of linear opacities, total lung severity score (the sum of the severity score of each lobe; severity score of each lung lobe was based on the involvement) (score 1: none involvement [0%], score 2: minimal involvement [1-25%], score 3: mild involvement [26-50%], score 4: moderate involvement [51-75%], or score 5: severe involvement [76-100%]) were independently evaluated by three radiologists. lesion-based evaluation. three radiologists independently evaluated the presence of representative image signs and the shapiro-wilk test was performed to evaluate the data normality of the image quality score. the image quality of ute-mri and ct was compared with a wilcoxon-rank sum test, because both the image quality score of ct and ute-mri were not in normal distribution (p < 0.05). kendall's coefficient of concordance (kendall's w), intraclass coefficients (icc), and weighted kappa statistics were calculated for determining the interobserver and intermethod agreement. the interobserver and intermethod agreement were determined as excellent for kendall's w = 0. it should be noted that: 1) all the statistical results concerning the interobserver agreement evaluation were calculated by the independent evaluation of three radiologists. 2) intermethod comparison of image quality and patient-and lesion-based evaluation of intermethod agreement were based on the evaluation of the z.y.z., who is a nationwide recognized radiologist (with more than 36 years' experience of chest ct diagnosis and 20 years' experience of pulmonary mri). intermethod statistical analysis was according to the previously reported method. 19 two-sided p values of less than 0.05 were regarded as statistically significant. all the statistical analyses in this study were conducted with spss 26.0 (chicago, il). a total of 23 patients (men: 12, women: 11; median age: 32, age range: 17-62) were finally included in this study for subsequent analysis. table 1 summarizes the clinical characteristics of the included patients. as shown in table 2 , chest ct examination showed that seven (30.4%) patients had one affected lobe, five (21.8%) patients had two affected lobes, four (17.4%) patients had three affected lobes, five (21.7%) patients had four affected lobes, and two (8.7%) patients had five affected lobes. in terms of lesion distribution, bilateral involvement was present in 10 (43.5%) patients and multifocal involvement was presented in 20 (87.0%) patients. ggo with consolidation was identified in 22 (95.7%) patients, pure ggo and pure consolidation were respectively identified in eight (34.5%) and six (26.1%) patients. air bronchograms (14, 60.9%) and crazy paving patterns (two, 8.7%) were also observed within the lesion. other secondary image findings included linear opacities (10, 43.5%), adjacent pleura thickening (12, 52.2%), vessel expansion (16, 69.6%), and pleural effusion (one, 4.3%) also occurred. figures 1-3 demonstrate that representative radiological signs of covid-19 including ggo, consolidation, ggo with consolidation, air bronchogram, and pseudocavity could be visualized with ute-mri. table 3 shows the interobserver iccs of the evaluation of the image quality score of ct and ute-mri, which were 0.924 (p < 0.05) and 0.862 (p < 0.05). as fig. 4 shows, there was no significant difference between the image quality of two image modalities (ct: mean score: 4.3 median score: 4.0; ute-mri: mean score: 4.0 median score: 4.0; z statistics: 1.72, p = 0.09). the results of interobserver agreement evaluation in table 4 suggest that the interobserver iccs of the patientbased evaluation of covid-19 ranged between 0.939-1.000 (p < 0.05). as demonstrated in table 5 , the overall detection rate of affected lobes, ggo, consolidation, ggo with consolidation, crazy pattern, as well as linear opacities were 98.3%, 66.7%, 100%, 89.8%, 100%, and 84.6%, respectively. moreover, intermethod iccs of two image modalities ranged from 0.913-1.000 (p < 0.05). the total severity score quantified by ct and ute-mri were 2.65 and 2.65, respectively (icc = 0.980, p < 0.05). kendall's w statistic was utilized for quantifying the interobserver agreement of the lesion-based evaluation of image signs, which is listed in table 6 . table 6 demonstrates that kendall's w was between 0.894-1.000 (p < 0.05). lesion-based intermethod agreement of ute-mri and ct for assessing representative pulmonary findings of covid-19 are shown in table 7 and fig. 5 . a total of 100 lesions were included for the comparative analysis. the intermethod agreements for assessing the ggo, consolidation, ggo with consolidation, crazy paving pattern, pseudocavity, air bronchogram, axial location, and anteroposterior location were all statistically significant, with kappa values ranging from 0.332-1.000 (p < 0.05). notably, the intermethod agreement for evaluating the ggo, consolidation, ggo with consolidation, axial location, and anteroposterior location was determined as substantial or excellent (kappa: 0.649-1.000, p < 0.05). as shown in fig. 5 , the visual score differences between ute-mri and ct for assessing the different representative signs of covid-19 were small for most lesions. in detail, for assessing ggo, ggo with consolidation, consolidation, pseudocavity, crazy paving pattern, and air bronchogram, the proportion of lesions with a difference in visual score less than 1 were 95.0%, 77.0%, 98.0%, 94.0%, 98.0%, and 58.0%, respectively, which indicated there was a high intermethod concordance. the results of this study suggest that there was not only high concordance between ute-mri and ct in assessing the representative image findings of covid-19 but also similar image quality for two image modalities, which implies that ute-mri could have potential in aiding the diagnosis and surveillance of covid-19. the imaging findings of covid-19 by ct have been reported recently. 7, 8, 20 typical image manifestations have been described as multifocal ggo, patchy consolidation, crazy-paving pattern, air bronchogram, and multiple lesions with bilateral involvement. 21 our study suggests that the ggo with consolidation, ggo, and bilateral and multifocal involvement with periphery distribution were the most frequently occurring ct imaging signs. pathologically, the alveolar damage with alveolar and interstitial edema results in the appearance of ggo and crazy paving pattern. 12 as the alveoli are progressively filled with alveolar fibrinous exudate with hyaline membranes and reactive pneumocytes, ggo evolves into the appearance of consolidation. 12 chung et al indicated that 86% of patients had the image manifestations of ggo or consolidation. 10 similarly, li and xia indicated that the two principal signs of covid-19 were ggo and consolidation. 13 however, similar to some previous studies that reported that 5-8% of confirmed covid-19 patients were with pleural effusion 5, 8, 22 ; pleural effusion was less frequently observed in this study. it is known that the pulmonary application of mri has been severely limited by respiratory motion artifact, low proton density, and fast signal decay caused by short tissue t 2 *. 23 in this study, there was no significant difference in image quality for the two methods. the results presented above indicate that ute-mri was capable of providing image quality similar to ct when it was utilized for evaluating covid-19, which was concordant with several previous studies. 18, 24, 25 a pilot study carried out by delacoste et al showed that ute-mri had image quality similar to ct for quantifying lung nodule volumes. 24 moreover, another study revealed that submillimeter resolution could be achieved with ute-mri for assessing cystic fibrosis, which suggested that ute-mri holds promise in serving as an alternative to unenhanced ct. 25 the excellent performance of ute-mri for providing an image quality similar to ct was due to the following aspects. 1) respiratory-gated mri is effective at greatly reducing respiratory artifacts. 2) with the assistance of ultrashort echo time, ute-mri is capable of compromising the fast t 2 * signal decay, which improved the signal-to-noise ratio of images. 26 both the lesion-and patient-based comparative analysis showed that ute-mri has high concordance with ct for detecting typical pulmonary lesions, including ggo, consolidation, ggo with consolidation, axial location, anteroposterior location, the number of affected lobes, the number of crazy paving pattern, and the number of linear opacities. however, the lesion-based intermethod agreement for evaluating secondary signs such as air bronchogram, pseudocavity, and crazy paving pattern were between fair and moderate. the potential cause for this may be the lower image resolution of ute-mri as compared with ct. the above results are consistent with one previously reported study. 18 ohno et al suggested that the intermethod agreement of ute-mri and ct for assessing the representative pulmonary findings such as ggo, consolidation, nodule, fibrosis, and so on, were all between substantial and excellent (kappa value: 0.67-0.98). ute-mri also displayed an image quality similar to low-dose ct. due to the high concordance with ct for visualizing the representative pulmonary findings and an image quality similar to ct, ute-mri is considered valuable for evaluating the radiological findings of patients with various pulmonary parenchyma diseases. 18 given the short supply of rt-pcr kits, which was caused by the surge in confirmed covid-19 cases, especially in less-developed countries, and the high diagnostic sensitivity of image techniques, chest ct has been strongly encouraged for aiding prevention and control of covid-19. 13 however, biosafety concerns are warranted due to repeated exposure of x-rays over a short period of time in the hospital. one previous cohort study demonstrated that each patient with covid-19 underwent an average of four ct examinations within 16 days. 11 therefore, ute-mri may be a valuable technique for noninvasively evaluating covid-19. first, because of the strict inclusion criteria and the singleinstitution study, the sample size of this study was relatively small, which may have potential risk for leading to bias. second, the ct image acquisition and ute-mri image acquisition were respectively performed at end-inspiration and end-expiration. moreover, there was a time interval between ct and mri (no more than 2 days), which was established due to consideration of the clinical process. the above issues may affect the quantification of the intermethod agreement. with the continuous and rapid global spread of covid-19, imaging examination has been widely accepted as a useful tool for aiding the control of covid-19 patients. this study suggests that ute-mri may act as a potential alternative to ct for noninvasively evaluating covid-19. this study was funded by the novel coronavirus special research foundation of the shanghai municipal science and technology commission (no. 20441900600). coronavirus disease (covid-2019) situation report -104 nowcasting and forecasting the potential domestic and international spread of the 2019-ncov outbreak originating in wuhan, china: a modelling study correlation of chest ct and rt-pcr testing in coronavirus disease 2019 (covid-19) in china: a report of 1014 cases sensitivity of chest ct for covid-19: comparison to rt-pcr clinical features of patients infected with 2019 novel coronavirus in wuhan china epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study chest ct manifestations of new coronavirus disease 2019 (covid-19): a pictorial review radiological findings from 81 patients with covid-19 pneumonia in wuhan, china: a descriptive study performance of radiologists in differentiating covid-19 from viral pneumonia on chest ct ct imaging features of 2019 novel coronavirus (2019-ncov) time course of lung changes on chest ct during recovery from 2019 novel coronavirus (covid-19) pneumonia pathological findings of covid-19 associated with acute respiratory distress syndrome coronavirus disease 2019 (covid-19): role of chest ct in diagnosis and management assessment of the radiation effects of cardiac ct angiography using protein and genetic biomarkers ultrashort echo time imaging of the lungs under high-frequency noninvasive ventilation: a new approach to lung imaging can texture analysis in ultrashort echo-time mri distinguish primary graft dysfunction from acute rejection in lung transplants? a multidimensional assessment in a mouse model iterative motioncompensation reconstruction ultra-short te (imoco ute) for highresolution free-breathing pulmonary mri pulmonary high-resolution ultrashort te mr imaging: comparison with thin-section standard-and low-dose computed tomography for the assessment of pulmonary parenchyma diseases differentiation between malignant and benign solitary pulmonary nodules: use of volume first-pass perfusion and combined with routine computed tomography chest ct findings in patients with corona virus disease 2019 and its relationship with clinical features coronavirus disease 2019 (covid-19): a perspective from china clinical and ct features of early-stage patients with covid-19: a retrospective analysis of imported cases in shanghai high-resolution lung mri with ultrashort-te: 1.5 or 3 tesla? mr volumetry of lung nodules: a pilot study lung morphology assessment of cystic fibrosis using mri with ultra-short echo time at submillimeter spatial resolution k-space water-fat decomposition with t2* estimation and multifrequency fat spectrum modeling for ultrashort echo time imaging key: cord-289861-i6bfuvq1 authors: macdonald-laurs, emma; koirala, archana; britton, philip n.; rawlinson, william; hiew, chee chung; mcrae, jocelynne; dale, russell c.; jones, cheryl; macartney, kristine; mcmullan, brendan; pillai, sekhar title: csf neopterin, a useful biomarker in children presenting with influenza associated encephalopathy? date: 2018-09-28 journal: eur j paediatr neurol doi: 10.1016/j.ejpn.2018.09.009 sha: doc_id: 289861 cord_uid: i6bfuvq1 purpose: neurological complications of influenza cause significant disease in children. central nervous system inflammation, the presumed mechanism of influenza-associated encephalopathy, is difficult to detect. characteristics of children presenting with severe neurological complications of influenza, and potential biomarkers of influenza-associated encephalopathy are described. methods: a multi-center, retrospective case-series of children with influenza and neurological complications during 2017 was performed. enrolled cases met criteria for influenza-associated encephalopathy or had status epilepticus. functional outcome at discharge was compared between groups using the modified rankin scale (mrs). results: there were 22 children with influenza studied of whom 11/22 had encephalopathy and 11/22 had status epilepticus. only one child had a documented influenza immunization. the biomarker csf neopterin was tested in 10/11 children with encephalopathy and was elevated in 8/10. mri was performed in all children with encephalopathy and was abnormal in 8 (73%). treatment of children with encephalopathy was with corticosteroids or intravenous immunoglobulin in 9/11 (82%). in all cases oseltamivir use was low (59%) while admission to the intensive care unit was frequent (14/22, 66%). clinical outcome at discharge was moderate to severe disability (mrs score > 2) in the majority of children with encephalopathy (7/11, 64%), including one child who died. children with status epilepticus recovered to near-baseline function in all cases. conclusion: raised csf neopterin was present in most cases of encephalopathy, and along with diffusion restriction on mri, is a useful diagnostic biomarker. lack of seasonal influenza vaccination represents a missed opportunity to prevent illness in children, including severe neurological disease. severe neurological complications from seasonal influenza, including influenza-associated encephalopathy/encephalitis (iae), cause considerable morbidity and mortality in healthy children, and those with pre-existing neurological disease. 1e3 recent estimates indicate the annual incidence of iae in australia is 2.8 per 1,000,000 in children under 14 years, with around 1% of hospitalized influenza cases associated with iae. 4 other populations show similar or higher incidence, with japan's annual incidence of iae recorded as 6e11/ 1,000,000. 2, 5 neurological complications attributed to influenza range from a mildly altered mental state, vertigo and brief febrile seizures to life threatening complications such as status epilepticus, meningitis, stroke, and demyelinating disease. 1 antiviral agents, predominantly neuraminidase inhibitors, and immunomodulatory treatments (corticosteroids, intravenous immunoglobulin), are used to treat patients with influenza-associated neurological disease but there is limited evidence on their efficacy. 6 while it is thought that more extensive changes on mri correlate with disease severity 7 there are no other available biomarkers that predict outcome. the australian influenza season typically occurs between july and october. the 2017 season saw the highest levels of influenza reported since the 2009 pandemic year. 8 the authors of this report noted an apparent increase in iae and other severe neurological complications during 2017. here, we describe the clinical presentation, laboratory testing, neuroimaging, treatment and short-term outcome of these cases. in addition, we observed elevated cerebrospinal fluid (csf) neopterin e a marker of central nervous system (cns) inflammation e amongst children with iae that has not previously described. we compared the frequency of iae during the 2017 influenza season with previously published incidence estimates. materials and methods we identified children aged 0e14 years, with evidence of influenza and associated severe neurological disease including status epilepticus or moderate to severe encephalopathy, admitted to two paediatric hospitals which comprise the sydney children's hospital network, the largest paediatric network in australia. cases were ascertained between april 1st and october 31st, 2017. at the children's hospital at westmead, cases were identified from those recruited under pre-existing surveillance studies: the australian childhood encephalitis study (ace), and the influenza complications network (flucan) surveillance study. 4, 9 at sydney children's hospital, children were identified from neurology consultation databases. children were included if they required hospital admission and consultation from a paediatric neurologist for a neurological complication or worsening of a pre-existing neurological condition due to proven influenza. all children included either presented with status epilepticus (for 30 min or longer) or reached level 2 diagnostic certainty on the brighton encephalopathy score. 10 children were excluded if: influenza was not confirmed, neurological symptoms were mild, hospital admission was not required, and when an alternative diagnosis could better explain the presentation. data were retrospectively collected from electronic medical records. we collected demographic data, presenting clinical characteristics, intensive care unit (icu) admission, and length of stay, laboratory results including csf testing, and influenza testing. csf analysis included cell count, protein, glucose, microscopy, lactate, oligoclonal bands, neopterin and influenza pcr. an elevated csf neopterin result was defined as >30 nmol/l. 11 electroencephalogram reports and brain magnetic resonance imaging (mri) (t2 weighted, flair and diffusion weighted imaging) were assessed by a neurologist (s.p.) and neuroradiologist (c.c.h.). the neuroradiologist was blinded to diagnosis during review of the mri. influenza was most commonly acutely diagnosed through the detection of influenza rna in respiratory samples. both hospitals used multiplex pcr assays (seegene, south korea) which detected up to 16 respiratory viruses. the assay has targets for both influenza a and b and was performed daily with a turnaround time of 1e2 days. at sydney children's hospital, the assay also had targets for subtypes of influenza a: h3 strains and the pandemic strain h1n1/09. when influenza serology was requested to diagnose a recent influenza illness, this was performed using a complement fixation assay (virion, germany). treatment given including oseltamivir, empiric aciclovir, or 3rd generation cephalosporins, ivig, corticosteroids, and e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 3 ( 2 0 1 9 ) 2 0 4 e2 1 3 plasmapheresis were recorded. time from admission to commencement of oseltamivir was recorded. each case was assigned a modified rankin scale (mrs) based on the examination at presentation and discharge from hospital. 12 the mrs ranges from 0 (no symptoms) to 6 (death). a poor outcome was an mrs score of >2 which indicates at least moderate disability requiring assistance. the relation between categorical variables was investigated using the two tailed fisher exact test. the mannewhitney u test was used to determine the relation between continuous variables. ethics approval was granted by the sydney children's hospitals network ethics committee (lnr/17/schn/497). twenty two children were included in this case series; 59% (13/22) were female. the median age at presentation was five years (range: 1.25e14 years). eight children (36%) had preexisting epilepsy and/or developmental delay. one child had an immunodeficiency (hypogammaglobulinemia) and receives monthly ivig. this child, who presented with status epilepticus, was the only child recorded as having received the seasonal influenza vaccination. eleven children (50%) met level 2 brighton criteria for encephalitis and were designated as influenza associated encephalopathy/encephalitis (iae). 10 two children with iae had previous episodes of acute disseminated encephalomyelitis (adem) with complete clinical and radiological recovery ( table 3 cases 1&2). one child had mosaic tetrasomy x, while another had epilepsy and developmental delay. the remaining 11 children in our series had status epilepticus. in contrast to the children with iae, over half of this group (n ¼ 6) had preexisting neurological disease including two children with refractory genetic epilepsies (dravet syndrome and cdkl5). the majority of children had a fever (82%) and two-thirds had respiratory symptoms. half presented with neurological symptoms within two days of onset of their influenza illness. sixteen children (73%) presented with an altered level of consciousness. seizures occurred in 19 children (86%) at any stage of illness and status epilepticus was frequent (n ¼ 17, 77%). other neurological findings at presentation were weakness (n ¼ 9, 41%), pyramidal signs (n ¼ 8, 36%), movement disorder (n ¼ 7, 32%) and ataxia (n ¼ 6, 27%). hallucinations, meningism, cranial neuropathy and pupillary changes were infrequent (<20%). the majority of children (n ¼ 18, 82%) had influenza a. of those sub-typed (n ¼ 8) half were h1 (2009) and half were h3. four children had other respiratory pathogens co-identified on npa (rhinovirus, coronavirus, mycoplasma pneumoniae). enterovirus was detected in the npa of one child but was absent in csf. one blood culture was positive for staphylococcus epidermidis, and this was assessed to be a contaminant. lumbar puncture was performed in 14 children where it was considered clinically indicated ( table 2) . of those who did not have a lumbar puncture performed most were children who presented with status epilepticus alone, usually with known pre-existing epilepsy. one case, with acute necrotising encephalopathy (ane), who was deemed to be too unwell to undergo a second lumbar puncture for measurement of neopterin. where sampled, csf showed pleocytosis and elevated protein in only a third (each n ¼ 5). influenza pcr on csf was positive in 1 of 5 children tested, in an immunocompetent previously well 10 year old. the csf neopterin was elevated in 9 of 11 children tested; in seven children it was considerably elevated ranging from 74 to 669 nmol/l (normal < 30 nmol/l), one had a borderline result (34 nmol/l). csf neopterin was measured in one child presenting with status epilepticus and was 31.75 nmol/l (borderline result). while most children with iae had a raised csf neopterin (8/10, 80%), only three had csf pleocytosis (10, 18, 19 cells/mm 3 ) and two had an elevated csf protein (0.7 g/l and 7.0 g/l). oligoclonal bands were measured on serum and/or csf in 10/11 children with iae and were not present in any. some children with iae had anti-neuronal antibodies testing performed on serum and/or csf, usually nmda and vgkc (table 3 ). these were negative apart from two cases with mildly elevated anti-thyroid antibodies. other routine laboratory data were normal or only mildly abnormal in most children (table 1) . mri brain was performed in 15 children and showed new abnormalities in eight (53%), all with iae. the common acute mri abnormalities were the presence of t2-flair hyperintensities, diffusion restriction (each, n ¼ 8), and gadolinium enhancement (n ¼ 4). the spectrum of radiological features are shown in fig. 1aei . diverse clinico-radiological syndromes were diagnosed including: ane (n ¼ 1), acute encephalopathy with biphasic seizures (aesd) (n ¼ 2), posterior reversible encephalopathy (pres) (n ¼ 1), hemiconvulsion hemiplegia syndrome (hhs) (n ¼ 1), and cerebellitis. genetic testing of ran-binding protein 2 (ranbp2) was performed in the child with ane (table 3 case 2) and the child who died from an ane-like illness ( table 3 , case 1). both were negative. one child who met criteria for iae was subsequently found to have a mutation in the polymerase gamma (polg) gene (table 3 , case 11). fourteen (66%) children were admitted to the icu and nine (41%) required mechanical ventilation. thirteen (59%) children received oseltamivir. median time to commencement of oseltamivir from presentation was 1 day (mean 5.6 days, iqr 0e9 days), but >3 days in five cases. two icu ventilated children were commenced on oseltamivir nine days after admission. in contrast, nineteen (86%) children were treated with a 3rd generation cephalosporin, while 14 (64%) received aciclovir. nineteen (86%) received anticonvulsants and 16 (73%) continued these on discharge. first-line e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 3 ( 2 0 1 9 ) 2 0 4 e2 1 3 immunomodulatory treatment (corticosteroids and/or ivig, plasmapheresis) was given to nine children with iae (corticosteroids (n ¼ 9), ivig (n ¼ 7) and plasmapheresis (n ¼ 1)) but none of those with status epilepticus alone. the median length of icu and hospital stay was four days (range 1e37) and 8 days (range 2e108 days) respectively. children with iae were more likely to have both longer hospital (mean 33.5 days vs 4.8 days; p ¼ 0.001) and picu admissions (mean 7.7 days vs 2 days; p ¼ 0.03) compared to children with status epilepticus. one child with iae died following an ane-like illness, although mri findings were atypical (table 3 , case 1). her post-mortem was inconclusive: showing generalised cerebral oedema and some features of acute hemorrhagic leucoencephalitis. ten out of 11 children with iae had an mrs score of 0 (normal) at baseline. at discharge from hospital 7/11 (64%) of children with iae had a higher in mrs score (mrs > 2; moderate disability) compared to those with status epilepticus. the change in mean mrs was significant between the two groups: children with iae had a change in mrs of 3.1 points while those in the status epilepticus group had a mean increase of mrs of 0.4 points (p-value: 0.001). nearly all children (7/8, 88%) with mri diffusion restriction had a poor outcome. the child with mri diffusion restriction and a good outcome had posterior reversible encephalopathy syndrome (pres). among the 7 children with iae and a considerably elevated neopterin, four had an mrs > 2 while three had mild deficits (mrs 1, 2 and 2). there was a mean increase in the mrs of 2.8 points the seven children with highly elevated csf neopterin (74e669 nmol/l). in this case series we observed two groups of children who presented with severe influenza related neurological disease. one group of children fulfilled criteria for iae, while the other group, most often with pre-existing neurological disease, presented with status epilepticus but otherwise did not fulfill criteria for iae. amongst cases of iae, elevated csf neopterin appeared to correlate with the presence of diffusion restriction on mri brain and adverse outcome. use of oseltamivir was infrequent among all cases, although use of antibiotics occurred in the majority. only one child had documented influenza vaccine, even amongst those with pre-existing neurological co-morbidity, despite the fact that this is recommended in australia. 13 influenza associated neurological complications are thought to occur due to an inflammatory or immunemediated response to influenza infection rather than direct viral invasion. 14,15 among those with iae we observed, similar to previous authors 2,6,16 that csf pleocytosis and detection of influenza in the csf occurred in a minority (n ¼ 5; 35%, and n ¼ 1/4; 25%). 3, 7, 17, 18 however csf neopterin, a biomarker of inflammation, was elevated in most children with iae (n ¼ 9, 81%). neopterin, a catabolic product of guanosine triphosphate (gtp), is synthesized by human macrophages upon stimulation from interferon gamma and can be measured in urine, serum and csf. 19 while serum neopterin levels are useful in the diagnosis and monitoring of systemic infectious or inflammatory diseases, such as hiv, 20 csf neopterin, reflecting intrathecal production by microglial cells, more accurately detects cns inflammatory diseases (infectious or immune mediated). 11, 19 a recent review assessing biomarkers of csf inflammation found, among clinically available tests, that csf neopterin performed better than the presence of oligoclonal bands or csf pleocytosis in detection of cns inflammation. 21 there is limited data regarding prognostically significant biomarkers in iae. pro-inflammatory cytokines may impair the blood brain barrier and induce apoptosis of neurons. 14 elevated cytokines such as interleukin-6 (il-6) and tumour necrosis factor alpha have been demonstrated in children with iae and correlates with poorer outcome. 14, 22, 23 testing csf il-6 outside the research setting is currently unavailable. clasmatodendrosis, abnormal morphological changes in astrocytes, occurring presumably due to the effect of proinflammatory cytokines, has recently been suggested to be a pathological feature of iae on autopsy. 24 clasmatodendrosis was found in the cerebral white matter, thalamus, corpus callosum, cerebellum, thalamus and hippocampus of children with iae and may correlate mri changes commonly seen. 24 previous authors have associated abnormalities on mri brain with poorer outcome. 7 in our cohort mri brain abnormalities were diverse and common, particularly diffusion restriction in the subcortical white matter. diffusion restriction correlated with a poor outcome, apart from in the child who had pres, and was associated with an elevated csf neopterin in most cases. further studies of iae are required to evaluate whether significant elevations of csf neopterin, particularly in combination with diffusion restriction and other mri changes, could predict short and long-term outcome. oseltamivir, a neuramidase inhibitor which prevents release of influenza virus from infected cells 25 has been shown to reduce influenza symptoms in otherwise healthy children by 29 h (95% ci 12e47 h,p ¼ 0.001). 26 only 59% (13 children) were treated with oseltamivir and there was a significant delay in commencement in 5 cases (>3 days in hospital). in contrast, empirical 3rd generation cephalosporin (86%) and aciclovir use (64%) was more frequent. this may be related to the perception among practitioners that antiinfluenza therapy has little benefit. we suggest in accordance with local guidelines, 8 that children with encephalitis should be empirically treated with oseltamivir during the influenza season (may to october). the evidence for use of immunotherapy (ivig, corticosteroids) in iae, is limited 27, 28 however, in our case series, most children with iae were treated with first-line immunotherapy with uncertain benefit. no serious side effects were reported. in 2017, the burden of influenza in australia (particularly the eastern states) was the highest seen since the 2009 pandemic. 8 based on iae incidence estimates published by britton et al. 2 from the 2013e15 influenza seasons in australia and the population coverage of our hospitals, we calculated that we would expect 5.2 (1.3e14.5) cases of iae in children (<14 years) per year. the iae case frequency observed in our cohort was twice the expected point estimate based on these previous incidence estimates but within the 95% confidence interval, 2 and so contribute to validating the estimates from britton et al. 2 the short-term outcome of our cohort, particularly those with iae, was alarming with 64% having a poor outcome. while there was a significant rate of icu admission among the group of children with status epilepticus (45%) this was not as high as children with iae (82%) and, most often, non-iae children did not experience a significant change in their mrs. this supports previous observations that survivors of iae during the 2009 h1n1 pandemic, and in more recent nonpandemic influenza seasons in australia, experienced significant ongoing disability. 29, 30 we have previously shown in a large retrospective encephalitis cohort study that icu admission, mri diffusion restriction and status epilepticus and were risk factors for a long-term abnormal outcome. 31 these risk factors were common (82%, 73%, 45%) in children with iae from our cohort. the medium and long-term outcome in our cohort should be assessed including formal neuropsychological testing. further research is required to understand and modulate the cns inflammatory cascade present in iae in order to modulate long term neurodisability. the overall influenza immunisation rate during 2017 in australia was low at 33%, 32 however a recently observed rate of vaccine receipt among children was even lower at 17.1%. 33 four age-specific quadrivalent influenza vaccines containing two strains of influenza a (h1n1 [michigan] and h3n2 [hong kong]) and two strains of influenza b (brisbane and phuket) were available in 2017. children older than six months were eligible to be vaccinated and the vaccine was provided free to children with neurological disease. 34 in our cohort just one child had a documented influenza vaccination, although a third of children were eligible for free immunisation and the remainder could have received an immunisation at the cost of around $20e50 aud. we emphasise that the severe syndromes and adverse outcomes observed here should be considered preventable. following high rates of influenza related morbidity in 2017(including these cases), new south wales and other australian states have introduced universal funded seasonal influenza immunisation to all children aged 6 months to 5 years. 35 our series has limitations. we describe children with severe influenza-associated neurological complications but did not include children with mild neurological complications. children with pre-existing epilepsy may not have always been tested for influenza and may be under-represented. the collection of clinical data was retrospective, and some electronic data were incomplete. seasonal influenza immunisation status was not always clearly recorded, although we reviewed the australian immunisation register to verify vaccination status where possible. influenza sub-typing from npa samples and csf influenza pcr testing was not routinely performed. in the se group, csf studies, including csf neopterin were performed infrequently and mri brain infrequently requested. due to this we were unable to use this group as a direct control for the finding of elevated csf neopterin the iae group. serial csf neopterin to assess treatment and clinical progress were not performed. this is the first series to demonstrate that elevation of csf neopterin, a marker of cns inflammation, occurs commonly in children with iae. csf neopterin may be a useful diagnostic marker for iae while its role as a prognostic marker e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 3 ( 2 0 1 9 ) 2 0 4 e2 1 3 requires further evaluation. mri diffusion restriction was associated with a poor outcome in iae. short-term outcomes of children with neurological complications of influenza, especially within the iae group, were alarming, with nearly two-thirds of children having a poor outcome despite receipt of icu support, anticonvulsants, first-line immunotherapy and, in some, anti-viral treatment. given the severity of influenza associated neurological complications, we recommend a "treat and test" approach to the use of oseltamivir in children presenting with acute encephalopathy/encephalitis during the influenza season. finally, seasonal influenza vaccination should be universally provided to children and those at risk of severe influenza, with better education and awareness to increase uptake in the paediatric population. this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. neurological manifestations of influenza infection in children and adults: results of a national british surveillance study the spectrum and burden of influenza-associated neurological disease in children: combined encephalitis and influenza sentinel site surveillance from australia neuroinfluenza: evaluation of seasonal influenza associated severe neurological complications in children (a multicenter study pilot surveillance for childhood encephalitis in australia using the paediatric active enhanced disease surveillance (paeds) network encephalitis and encephalopathy associated with an influenza epidemic in japan national paediatric hnsg. neurologic manifestations and complications of pandemic influenza a h1n1 in malaysian children: what have we learnt from the ordeal? clinical and mri features of neurological complications after influenza a (h1n1) infection in critically ill children influenza season in australia. a summary from the national influenza surveillance committee paediatric active enhanced disease surveillance: a new surveillance system for australia encephalitis, myelitis, and acute disseminated encephalomyelitis (adem): case definitions and guidelines for collection, analysis, and presentation of immunization safety data cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation recovery of motor function after stroke atagi) atagoi. the australian immunisation handbook australian government department of health acute encephalopathy and encephalitis caused by influenza virus infection evidence for influenza virus cns invasion along the olfactory route in an immunocompromised infant neurological and muscular manifestations associated with influenza b infection in children influenza virus and cns manifestations central nervous system manifestations in pediatric patients with influenza a h1n1 infection during the 2009 pandemic neopterin in the diagnosis and monitoring of infectious diseases csf fluid neopterin: an informative biomarker of cns immune activity in hiv-1 infection utility of csf cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-nmdar and enteroviral encephalitis h1n1 encephalitis with malignant edema and review of neurologic complications from influenza influenza-associated neurological complications clasmatodendrosis is associated with dendritic spines and does not represent autophagic astrocyte death in influenzaassociated encephalopathy prevention and treatment of influenza oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments immunomodulatory therapies in neurologic critical care intravenous immunoglobulin for the treatment of childhood encephalitis national survey of pandemic influenza a (h1n1) 2009-associated encephalopathy in japanese children influenza-associated encephalitis/encephalopathy identified by the australian childhood encephalitis study 2013e2015 infectious and autoantibody-associated encephalitis: clinical features and long-term outcome influenza season in australia. a summary from the national influenza surveillance committee influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel australian hospitals in 2017: results from the paeds-flucan collaboration influenza vaccine effectiveness against pediatric deaths seasonal influenza vaccination the authors have stated that they had no interests, which might be perceived as posing a conflict or bias. this manuscript has been contributed to, seen, and approved by all the authors. all the authors fulfill the authorship credit requirements. no honorarium grant or other form of payment was received for the preparation of this manuscript. supplementary data to this article can be found online at https://doi.org/10.1016/j.ejpn.2018.09.009. r e f e r e n c e s key: cord-011990-feqqx32n authors: carminati, marco; fiorini, carlo title: challenges for microelectronics in non-invasive medical diagnostics date: 2020-06-29 journal: sensors (basel) doi: 10.3390/s20133636 sha: doc_id: 11990 cord_uid: feqqx32n microelectronics is emerging, sometimes with changing fortunes, as a key enabling technology in diagnostics. this paper reviews some recent results and technical challenges which still need to be addressed in terms of the design of cmos analog application specific integrated circuits (asics) and their integration in the surrounding systems, in order to consolidate this technological paradigm. open issues are discussed from two, apparently distant but complementary, points of view: micro-analytical devices, combining microfluidics with affinity bio-sensing, and gamma cameras for simultaneous multi-modal imaging, namely scintigraphy and magnetic resonance imaging (mri). the role of integrated circuits is central in both application domains. in portable analytical platforms, asics offer miniaturization and tackle the noise/power dissipation trade-off. the integration of cmos chips with microfluidics poses multiple open technological issues. in multi-modal imaging, now that the compatibility of the acquisition chains (thousands of silicon photo-multipliers channels) of gamma detectors with tesla-level magnetic fields has been demonstrated, other development directions, enabled by microelectronics, can be envisioned in particular for single-photon emission tomography (spect): a faster and simplified operation, for instance, to allow transportable applications (bed-side) and hardware pre-processing that reduces the number of output signals and the image reconstruction time. the impact of application specific integrated circuits (asics), in particular, of cmos analog front-end interfaces for solid-state sensors and detectors, differs significantly among various application areas. for example, the field of high-energy and particle physics has been heavily reliant on integrated circuits for the readout of the detectors and parallel processing of signals for decades [1] . instead, different from experimental physics, whose advancements are often constrained by the performance of electronics and instrumentation, in the field of bio-medicine, the role of microelectronics appears less consolidated nor univocal. in fact, despite a large penetration of micro-fabrication techniques in this field, and a considerable volume of publications, asics are rarely pivotal in the success of micro-analytical devices, especially from a commercial point of view. in this brief tutorial review, we focus on non-invasive medical diagnostics and discuss some challenges for the future development of integrated electronics, with reference to diagnostics in particular. non-invasive medical diagnostics comprise two complementary approaches: (i) imaging internal organs by means of energy penetrating through the skin and tissues, and (ii) taking out of the body a liquid sample for bio-chemical analysis ( figure 1 ). non-invasive imaging can be performed by the main advantage offered by the deployment of cmos asics in micro-analytical devices is miniaturization. massively parallel readout systems (with thousands of channels, such as 1024 [3] or 2048 [4] ) can be squeezed into a chip footprint of a few millimeters inside. the miniaturization of electronics matches the concurrent miniaturization of fluidics (locs handle volumes of samples in the microliter range) and of micro-machined transducers and electrodes. the main challenges which still need to be addressed in this area can be grouped into two classes: (i) at the circuit level (ii) at the level of packaging and interfaces. at the circuit level, one consolidating trend is the reduction in power dissipation, both for thermal issues, critical in high-density chips, as well as the increase in the battery lifetime in the case of portable (and implantable) applications. in order to reduce the power dissipation in analog front-ends, different approaches can be adopted. amplifiers can be shared among different circuit blocks [5] or stacked to re-use the same bias current [6] . individual ac-coupled transistors can be stacked [7] and self-biased [8] . analog processing (signal shaping, feature extraction) can be tailored to the type of signal and the first approach is mostly based on sophisticated and expensive scanners, which require special facilities, the handling of radioactive material and skilled personnel, thus, are almost exclusively located in hospitals. the second approach, instead, is nowadays mostly pursued within the lab-on-a-chip (loc) paradigm, aiming at the realization of portable and automatic micro-analytical platforms. the main advantage offered by the deployment of cmos asics in micro-analytical devices is miniaturization. massively parallel readout systems (with thousands of channels, such as 1024 [3] or 2048 [4] ) can be squeezed into a chip footprint of a few millimeters inside. the miniaturization of electronics matches the concurrent miniaturization of fluidics (locs handle volumes of samples in the microliter range) and of micro-machined transducers and electrodes. the main challenges which still need to be addressed in this area can be grouped into two classes: (i) at the circuit level (ii) at the level of packaging and interfaces. at the circuit level, one consolidating trend is the reduction in power dissipation, both for thermal issues, critical in high-density chips, as well as the increase in the battery lifetime in the case of portable (and implantable) applications. in order to reduce the power dissipation in analog front-ends, different approaches can be adopted. amplifiers can be shared among different circuit sensors 2020, 20, 3636 3 of 14 blocks [5] or stacked to re-use the same bias current [6] . individual ac-coupled transistors can be stacked [7] and self-biased [8] . analog processing (signal shaping, feature extraction) can be tailored to the type of signal and communication channel [9] and it is generally preferred to fpga-based digital elaboration [10] . in order to reduce the energy consumption in data transmission, analog compression [11] and pulse-coded communication can be adopted [12] . a low-power design is typically opposite to a low-noise design, for instance, in terms of the flicker noise of mosfets, but is clearly fundamental in pushing down the limit of detection (lod) of target molecules. in order to analyze the strategies and compromises in noise minimization, we consider the case of current amplifiers. their application in bio-sensing is ubiquitous, spanning from electrochemical detection (where the charge is exchanged between the electrodes and redox molecules in the solution, figure 2a ) to optical detection (where the current is photo-generated in the photo-detector). as shown in figure 2e , the input-referred current noise of a classical transimpedance amplifier (tia) is given by the sum of three contributions: the thermal noise of the feedback resistor (r f ), the input-equivalent current noise of the amplifier (i n ) and its voltage noise (v n ). the latter becomes the dominant term in the total noise spectral density at high frequencies [13] . the voltage noise produces an input noise current proportional to the value of the total capacitance (c tot ) connected at the input. c tot includes the feedback capacitance, the amplifier input capacitance, the sensor capacitance and the parasitic capacitance of the connection between the sensor/detector and the amplifier input. evolutions of the basic tia scheme, such as integrator-differentiator configurations, enable the combination of low-noise with extended detection bandwidth [13] . additionally, for integrators (i.e., charge amplifiers) the minimization of the c tot is crucial. sensors 2020, 20, 3636 3 of 15 communication channel [9] and it is generally preferred to fpga-based digital elaboration [10] . in order to reduce the energy consumption in data transmission, analog compression [11] and pulsecoded communication can be adopted [12] . a low-power design is typically opposite to a low-noise design, for instance, in terms of the flicker noise of mosfets, but is clearly fundamental in pushing down the limit of detection (lod) of target molecules. in order to analyze the strategies and compromises in noise minimization, we consider the case of current amplifiers. their application in bio-sensing is ubiquitous, spanning from electrochemical detection (where the charge is exchanged between the electrodes and redox molecules in the solution, figure 2a ) to optical detection (where the current is photo-generated in the photo-detector). as shown in figure 2e , the input-referred current noise of a classical transimpedance amplifier (tia) is given by the sum of three contributions: the thermal noise of the feedback resistor (rf), the input-equivalent current noise of the amplifier (in) and its voltage noise (vn). the latter becomes the dominant term in the total noise spectral density at high frequencies [13] . the voltage noise produces an input noise current proportional to the value of the total capacitance (ctot) connected at the input. ctot includes the feedback capacitance, the amplifier input capacitance, the sensor capacitance and the parasitic capacitance of the connection between the sensor/detector and the amplifier input. evolutions of the basic tia scheme, such as integrator-differentiator configurations, enable the combination of lownoise with extended detection bandwidth [13] . additionally, for integrators (i.e., charge amplifiers) the minimization of the ctot is crucial. in order to minimize this noise contribution, three strategies can be adopted: (i) canceling the ctot with an inductor, (ii) reducing the sensor capacitance, and (iii) reducing the parasitic capacitance. it has been shown that by placing an inductor parallel to the ctot it is possible to improve the noise performance (of about one order of magnitude) thanks to the resonance [14] . this approach has two main limitations: (i) the enhancements are limited by the quality factor of the inductor, and (ii) the noise reduction takes place only in a narrow bandwidth around the resonance frequency (tens of mhz), thus being suitable only for impedance sensing at a fixed frequency. a very relevant design guideline is the reduction in the capacitance associated with the sensor geometry, typically an electrode collecting the signal charge, whose area should be minimized. of course, very often, the amount of collected charge is also proportional to the sensor areas, thus, in order to maximize the signal-to-noise ratio (snr), noise should be minimized while preserving the signal amplitude. in the case of electrochemical sensors, despite a decrease in the working electrode area, the capture of molecules by means of this electrode should be simultaneously enhanced, with respect to passive diffusion, by means of active solutions, such as magnetic, electrophoretic, dielectrophoretic, thermal and fluid-dynamic ones. this approach proved to be very successful in the in order to minimize this noise contribution, three strategies can be adopted: (i) canceling the c tot with an inductor, (ii) reducing the sensor capacitance, and (iii) reducing the parasitic capacitance. it has been shown that by placing an inductor parallel to the c tot it is possible to improve the noise performance (of about one order of magnitude) thanks to the resonance [14] . this approach has two main limitations: (i) the enhancements are limited by the quality factor of the inductor, and (ii) the noise reduction takes place only in a narrow bandwidth around the resonance frequency (tens of mhz), thus being suitable only for impedance sensing at a fixed frequency. a very relevant design guideline is the reduction in the capacitance associated with the sensor geometry, typically an electrode collecting the signal charge, whose area should be minimized. of course, very often, the amount of collected charge is also proportional to the sensor areas, thus, in order to maximize the signal-to-noise ratio (snr), noise should be minimized while preserving the signal amplitude. in the case of electrochemical sensors, despite a decrease in the working electrode area, the capture of molecules by means of this electrode should be simultaneously enhanced, with respect to passive diffusion, by means of active solutions, such as magnetic, electrophoretic, dielectrophoretic, thermal and fluid-dynamic ones. this approach proved to be very successful in the field of radiation detection, where the silicon drift detector (sdd) outperformed other solid-state detectors in terms of noise thanks to properly-shaped electric fields, which force the collection of the generated charge (across a wide depleted detection area) to drift towards a miniaturized anode [15] . another drawback of shrinking the electrode area is the increase in the access impedance in the case of ac-coupled sensing, both in solid-state [16] and biological applications, such as impedance flow cytometry [17] . another approach to reduce the sensor capacitance is the repartition of a large sensor area into n smaller ones, each one connected to an independent readout chain. in this way, the individual capacitance of each sensor is reduced by a factor of n. if the output signals of all n parallel chains are then summed, the signal will increase by a factor of n (i.e., it will recover a value equivalent to the case of a large area), while the noise (summed in power, since it is uncorrelated among chains) will only increase by √ n, thus leading to an improvement of the snr of √ n. for example, this has been used in the readout of silicon photo-multiplers (sipm) [18] . this interesting solution implies a growth in power and area occupation due to the multiplication of the readout chains. furthermore, it is important to control the layout of connection between the sensor and the front-end: while the sensors capacitance decreases by a factor of n, the parasitic capacitance of the interconnection typically does not scale down and can become the dominant term. finally, in order to fully profit from miniaturization and to preserve the detection performance by minimizing the length (and parasitics) of the interconnection, the transducers and the readout chip should be closely coupled and, when possible, monolithically integrated. from the noise point of view, the micro-sized sensor-on-chip solution is optimal [19] . figure 3 shows a broad range of bio-sensing technologies that have been integrated on cmos platforms: electrical and electrochemical, photonic, magnetic, micromechanical and nano-fabricated. their position along the bottom horizontal axis qualitatively highlights the increasing technological complexity of integration on a cmos substrate. rf electronics and on-chip coils even enable single-chip nmr and electron spin resonance detectors [20] , targeting, in particular, point-of-care diagnostics [21] . several efforts have been undertaken to improve the compatibility of bio-sensing with cmos platforms: one example is the reduction in the temperature of fabrication of silicon nano wires (down to 200 • c), thus making them compatible with the standard cmos process [22] . field of radiation detection, where the silicon drift detector (sdd) outperformed other solid-state detectors in terms of noise thanks to properly-shaped electric fields, which force the collection of the generated charge (across a wide depleted detection area) to drift towards a miniaturized anode [15] . another drawback of shrinking the electrode area is the increase in the access impedance in the case of ac-coupled sensing, both in solid-state [16] and biological applications, such as impedance flow cytometry [17] . another approach to reduce the sensor capacitance is the repartition of a large sensor area into n smaller ones, each one connected to an independent readout chain. in this way, the individual capacitance of each sensor is reduced by a factor of n. if the output signals of all n parallel chains are then summed, the signal will increase by a factor of n (i.e., it will recover a value equivalent to the case of a large area), while the noise (summed in power, since it is uncorrelated among chains) will only increase by √n, thus leading to an improvement of the snr of √n. for example, this has been used in the readout of silicon photo-multiplers (sipm) [18] . this interesting solution implies a growth in power and area occupation due to the multiplication of the readout chains. furthermore, it is important to control the layout of connection between the sensor and the front-end: while the sensors capacitance decreases by a factor of n, the parasitic capacitance of the interconnection typically does not scale down and can become the dominant term. finally, in order to fully profit from miniaturization and to preserve the detection performance by minimizing the length (and parasitics) of the interconnection, the transducers and the readout chip should be closely coupled and, when possible, monolithically integrated. from the noise point of view, the micro-sized sensor-on-chip solution is optimal [19] . figure 3 shows a broad range of biosensing technologies that have been integrated on cmos platforms: electrical and electrochemical, photonic, magnetic, micromechanical and nano-fabricated. their position along the bottom horizontal axis qualitatively highlights the increasing technological complexity of integration on a cmos substrate. rf electronics and on-chip coils even enable single-chip nmr and electron spin resonance detectors [20] , targeting, in particular, point-of-care diagnostics [21] . several efforts have been undertaken to improve the compatibility of bio-sensing with cmos platforms: one example is the reduction in the temperature of fabrication of silicon nano wires (down to 200 °c), thus making them compatible with the standard cmos process [22] . in the case of electrochemical sensing, the "electrode-on-chip" solution is apparently straightforward. the highest metal layer, commonly exposed to realize the bonding pads, can be used for patterning sensing electrodes. while this is simple in dry applications [23] , it is more complicated in the case of bio-chemical sensing in liquid for two reasons: (i) materials and (ii) morphology. in fact, the metals commonly adopted to realize this metallization (aluminum and copper) are not suitable for electrochemical sensing, where noble metals (such as gold, silver and platinum) are preferred in the case of electrochemical sensing, the "electrode-on-chip" solution is apparently straightforward. the highest metal layer, commonly exposed to realize the bonding pads, can be used for patterning sensing electrodes. while this is simple in dry applications [23] , it is more complicated in the case of bio-chemical sensing in liquid for two reasons: (i) materials and (ii) morphology. in fact, the metals commonly adopted to realize this metallization (aluminum and copper) are not suitable for electrochemical sensing, where noble metals (such as gold, silver and platinum) are preferred thanks to a stable (i.e., minimally reactive) behavior. consequently, post-cmos metallization is performed to electrochemically grow the proper metal on top of the working electrode. the morphology of the pad presents two additional issues: the roughness of the inner surface (even when avoiding the diamond of vias, visible in figure 4a , typically realized to strengthen the stack of metal layer for wire bonding) is not negligible (~100 nm) and this inner area is surrounded by a 2 µm-tall shoulder due to the lifting of the top passivation layer (sin) on the metal. both issues can be solved, for instance, by evaporating a sensing area that extends on the side of the pad (on the flat nitride capping) as recently proposed [3] . sensors 2020, 20, 3636 5 of 15 thanks to a stable (i.e., minimally reactive) behavior. consequently, post-cmos metallization is performed to electrochemically grow the proper metal on top of the working electrode. the morphology of the pad presents two additional issues: the roughness of the inner surface (even when avoiding the diamond of vias, visible in figure 4a , typically realized to strengthen the stack of metal layer for wire bonding) is not negligible (~100 nm) and this inner area is surrounded by a 2 µm-tall shoulder due to the lifting of the top passivation layer (sin) on the metal. both issues can be solved, for instance, by evaporating a sensing area that extends on the side of the pad (on the flat nitride capping) as recently proposed [3] . to quantify the improvement in noise performance enabled by on-chip sensing, different figures of merit (fom) can be adopted. for instance, in capacitive resolution, a δc-fom can be defined at the input-referred noise spectral density in zf/√hz, normalized on the amplitude of the forcing ac voltage signal. for dry sensing (detection of micro-particles in the air), the δc-fom improved from 1100 zf·v/√hz of a discrete-component implementation to 34 zf·v/√hz of a monolithic integration [23] . other figures of merit can include the power dissipation (tens to hundreds of mw for this application), area occupation, maximum operating frequency and detection bandwidth [19] . for measurements in liquid, we can consider the current resolution: in nano-pore current sensing, the current resolution (for a 100 khz bandwidth) improves from 21.8 parms of the state-of-the-art discrete amplifier (with a miniaturized and cooled head-stage and integrator front-end with periodic reset) down to 12.9 parms with an integrated amplifier and on-chip electrode [24] . taking as an example cmos capacitive sensors, a steady improvement of the δc-fom down to 1 zf·v/√hz has been observed in the last decade [19, 25] , where the capacitance resolution has moved from the attofarad to the zeptofarad domains, achieved by miniaturization (parasitics reductions) and differential sensing [26] in the mhz range and leveraging resonance in the ghz range [27] . beyond the circuital and morphological challenges illustrated above, a pervasive diffusion of asics for biochemical detection is still hampered by additional technological challenges which include packaging, patternable passivation and the fluidic interface with the off-chip world. different from all other application areas of microelectronics, here packaging has to protect the chip and its electrical interconnection (such as bonding wires) from environmental agents such as dust and humidity, while allowing the liquid sample to contact only specific areas of the chip with a spatial accuracy down to fractions of the pad size, i.e., to tens of micrometers ( figure 5 ). packaging has to be reliable (to avoid leakage and aging during the device lifetime), bio-compatible (to avoid contamination of the biological sample) and cost-effective (since a very sophisticated packaging easily becomes the most expensive step of fabrication, as witnessed, for instance, in mems [28] and silicon photonics [29] ). coupling a cmos asic to a microfluidic device is often complicated by the difference of materials (silicon vs. plastics, different metals) and disparity of sizes (mm-sized cmos to quantify the improvement in noise performance enabled by on-chip sensing, different figures of merit (fom) can be adopted. for instance, in capacitive resolution, a ∆c-fom can be defined at the input-referred noise spectral density in zf/ hz, normalized on the amplitude of the forcing ac voltage signal. for dry sensing (detection of micro-particles in the air), the ∆c-fom improved from 1100 zf·v/ hz of a discrete-component implementation to 34 zf·v/ √ hz of a monolithic integration [23] . other figures of merit can include the power dissipation (tens to hundreds of mw for this application), area occupation, maximum operating frequency and detection bandwidth [19] . for measurements in liquid, we can consider the current resolution: in nano-pore current sensing, the current resolution (for a 100 khz bandwidth) improves from 21.8 pa rms of the state-of-the-art discrete amplifier (with a miniaturized and cooled head-stage and integrator front-end with periodic reset) down to 12.9 pa rms with an integrated amplifier and on-chip electrode [24] . taking as an example cmos capacitive sensors, a steady improvement of the ∆c-fom down to 1 zf·v/ hz has been observed in the last decade [19, 25] , where the capacitance resolution has moved from the attofarad to the zeptofarad domains, achieved by miniaturization (parasitics reductions) and differential sensing [26] in the mhz range and leveraging resonance in the ghz range [27] . beyond the circuital and morphological challenges illustrated above, a pervasive diffusion of asics for biochemical detection is still hampered by additional technological challenges which include packaging, patternable passivation and the fluidic interface with the off-chip world. different from all other application areas of microelectronics, here packaging has to protect the chip and its electrical interconnection (such as bonding wires) from environmental agents such as dust and humidity, while allowing the liquid sample to contact only specific areas of the chip with a spatial accuracy down to fractions of the pad size, i.e., to tens of micrometers ( figure 5 ). packaging has to be reliable (to avoid leakage and aging during the device lifetime), bio-compatible (to avoid contamination of the biological sample) and cost-effective (since a very sophisticated packaging easily becomes the most expensive step of fabrication, as witnessed, for instance, in mems [28] and silicon photonics [29] ). coupling a cmos asic to a microfluidic device is often complicated by the difference of materials (silicon vs. plastics, different metals) and disparity of sizes (mm-sized cmos chips vs. cm-sized fluidics) [30] . a high-density placement of electrical and fluidic interconnect is typically achieved with a photo-patternable material deposited from the liquid phase, conformally covering bonding wires, which is cured and selectively removed to expose only the sensing electrode. the main challenge of this powerful approach lies in the preservation of the electrode surface cleanness (at the atomic level since the electrical double layer interfacial capacitance depends on the first ionic layer) after dry or wet etching of the passivation. a systematic review of the possible coupling strategies is reported here [31] . sophisticated examples include both clean-room based post-cmos approaches, achieving, for instance, planarization, gap filling of the cmos chip embedded in a die carrier and coupled to taper joints [30] , as well as lab-based solutions such as direct writing of a sacrificial channel [25] . sensors 2020, 20, 3636 6 of 15 chips vs. cm-sized fluidics) [30] . a high-density placement of electrical and fluidic interconnect is typically achieved with a photo-patternable material deposited from the liquid phase, conformally covering bonding wires, which is cured and selectively removed to expose only the sensing electrode. the main challenge of this powerful approach lies in the preservation of the electrode surface cleanness (at the atomic level since the electrical double layer interfacial capacitance depends on the first ionic layer) after dry or wet etching of the passivation. a systematic review of the possible coupling strategies is reported here [31] . sophisticated examples include both clean-room based post-cmos approaches, achieving, for instance, planarization, gap filling of the cmos chip embedded in a die carrier and coupled to taper joints [30] , as well as lab-based solutions such as direct writing of a sacrificial channel [25] . in order to achieve cost-effectiveness, all these challenges should be addressed in a way compatible (in terms of production time and scalability) with large-volume industrial manufacturing. for this reason, polydimethylsiloxane (pdms), which is the workhorse elastomer solution for laboratory-grade microfluidics, fabricated by means of replica molding and which offers excellent bio-compatibility, can hardly become a well-established industrial solution due to the cost and delicate steps in the fabrication process such as degassing and peel-off. other polymers offering similar rapid prototyping versatility but a better resistance to chemicals and operation at high pressures have been identified [32] . additive manufacturing (3d printing of plastic filaments or resins) [33] , the micro-milling of rigid plastics (such as polycarbonate and pmma) and laser ablation are all promising techniques for the fabrication of microchannels that, unfortunately, are all characterized by the sequential operation of a single machining head, not easily scalable to mass production. an emerging solution that can better suit the industrial manufacturability of biochips is represented by photo-patternable dry resists, such as sinr [34] . finally, the standardization of the design flow and of fluidic components and interconnects (similar to that of an electronic design) is still a chimera in this field and should be pursued in order to achieve market success in genomics and real-time, as well as point-of-care diagnostics, with the same effort that was devoted to the integration of the sample preparation on-chip. in order to achieve cost-effectiveness, all these challenges should be addressed in a way compatible (in terms of production time and scalability) with large-volume industrial manufacturing. for this reason, polydimethylsiloxane (pdms), which is the workhorse elastomer solution for laboratory-grade microfluidics, fabricated by means of replica molding and which offers excellent bio-compatibility, can hardly become a well-established industrial solution due to the cost and delicate steps in the fabrication process such as degassing and peel-off. other polymers offering similar rapid prototyping versatility but a better resistance to chemicals and operation at high pressures have been identified [32] . additive manufacturing (3d printing of plastic filaments or resins) [33] , the micro-milling of rigid plastics (such as polycarbonate and pmma) and laser ablation are all promising techniques for the fabrication of microchannels that, unfortunately, are all characterized by the sequential operation of a single machining head, not easily scalable to mass production. an emerging solution that can better suit the industrial manufacturability of biochips is represented by photo-patternable dry resists, such as sinr [34] . finally, the standardization of the design flow and of fluidic components and interconnects (similar to that of an electronic design) is still a chimera in this field and should be pursued in order to achieve market success in genomics and real-time, as well as point-of-care diagnostics, with the same effort that was devoted to the integration of the sample preparation on-chip. when the target molecule in the patient is not accessible from a fluid sample, nuclear imaging techniques with molecular selectivity are needed. the combination of different imaging techniques, offering complementary information, is becoming a consolidated trend in radiography. typically, molecule-specific techniques (pet and spect) are combined with those providing anatomic information (such as ct and mri) in order to register (i.e., align/overlay) both images (simultaneously acquired) and correctly locate the pathology in the body, as illustrated in figure 6. when the target molecule in the patient is not accessible from a fluid sample, nuclear imaging techniques with molecular selectivity are needed. the combination of different imaging techniques, offering complementary information, is becoming a consolidated trend in radiography. typically, molecule-specific techniques (pet and spect) are combined with those providing anatomic information (such as ct and mri) in order to register (i.e., align/overlay) both images (simultaneously acquired) and correctly locate the pathology in the body, as illustrated in figure 6 . the main challenge posed by simultaneous imaging is clearly the mutual compatibility between the two scanning systems. secondary challenges are the complexity and cost, to be compared with the clinical advantages (i.e., benefits for patients and clinicians, especially in terms of improved diagnostics and insight). today, the adoption of integrated circuits is limited to the front-end of the acquisition chain in the gamma cameras pixels. we foresee that future breakthroughs in this field can be enabled by augmenting the range of functions implemented in silicon. pet is a nuclear imaging technique that relies on the emission of a pair of counter-propagating gamma photons (at an energy of 511 kev), generated by the annihilation of a positron with an electron [35] . the positron is produced by the decay of a radiotracer and this recombination takes places in the body within a short distance (~1 mm) from the radioligand. the major trade-off governing the performance of pet is between measurement time, sensitivity and injected activity [36] . there are two main development avenues. one is the extension of the axial field of view in order to improve the solid angle capturing gamma photons. recently, the first results of a total-body pet have been reported [37] . the explorer systems feature an axial field of view of 194 cm, extending along the whole body, and it is fully covered by 53,760 detection channels producing ~1 tb of data per scan. thanks to a 40-fold increase in the signal with respect to traditional clinical scanners (capturing only a few percent of the emitted photons), the same snr can be achieved by reducing the activity injected into the patient or by reducing the measurement time down to seconds. the latter result would lead to an unprecedented capability of tracking fast dynamics. clearly, asics are pivotal in handling tens of thousands of channels and reducing the burden of data processing by implementing data preprocessing on-chip. the main challenge posed by simultaneous imaging is clearly the mutual compatibility between the two scanning systems. secondary challenges are the complexity and cost, to be compared with the clinical advantages (i.e., benefits for patients and clinicians, especially in terms of improved diagnostics and insight). today, the adoption of integrated circuits is limited to the front-end of the acquisition chain in the gamma cameras pixels. we foresee that future breakthroughs in this field can be enabled by augmenting the range of functions implemented in silicon. pet is a nuclear imaging technique that relies on the emission of a pair of counter-propagating gamma photons (at an energy of 511 kev), generated by the annihilation of a positron with an electron [35] . the positron is produced by the decay of a radiotracer and this recombination takes places in the body within a short distance (~1 mm) from the radioligand. the major trade-off governing the performance of pet is between measurement time, sensitivity and injected activity [36] . there are two main development avenues. one is the extension of the axial field of view in order to improve the solid angle capturing gamma photons. recently, the first results of a total-body pet have been reported [37] . the explorer systems feature an axial field of view of 194 cm, extending along the whole body, and it is fully covered by 53,760 detection channels producing~1 tb of data per scan. thanks to a 40-fold increase in the signal with respect to traditional clinical scanners (capturing only a few percent of the emitted photons), the same snr can be achieved by reducing the activity injected into the patient or by reducing the measurement time down to seconds. the latter result would lead to an unprecedented capability of tracking fast dynamics. clearly, asics are pivotal in handling tens of thousands of channels and reducing the burden of data processing by implementing data pre-processing on-chip. the second development direction is the use of the time-of-flight (tof) information to improve the spatial resolution, sustained by the push to improve the timing resolution of photodetectors and readout electronics. a "10ps challenge" has been launched [38] in order to stimulate step-changes in scintillator materials and detection approaches (looking, for instance, to prompt emissions), as well as in electronics [39] . both perspectives clearly impact on the design of asics for pet: the first in terms of the number of channels and scalability and the second in terms of the intrinsic timing performance (currently in the~100 ps range). if we take the coincidence time resolution (ctr fwhm ) of a full detection system as a figure of merit to compare asics in terms of the timing performance (to be compared with similar scintillator and photodetector conditions), we can observe a continuous improvement trend. considering lyso crystals and 3 × 3 mm 2 pixels, the triroc asic (2016 [40] ) achieved 423 ps, tofpet (2016) 294 ps and stic (2018 [41] ) 214 ps. for smaller pixels (2 × 2 mm 2 ) flextot v2 reached 123 ps and nino (2017) 93 ps [42] . spect differs from pet in that it does not rely on proton annihilation: the radiotracer decays, directly emitting gamma-rays. in this case, a collimator is needed to select the trajectories of the photons impinging of the gamma camera. tomographic images are then reconstructed from the planar projections imaged by the gamma cameras surrounding the patient. different radiotracers can be employed, even simultaneously to map different molecules, if the energy resolution of the detector allows the discrimination of the photopeaks. the most commonly adopted is a metastable isotope of technetium ( 99m tc) which has a line at 140 kev. photons at such an energy are not absorbed within the thin silicon wafers and, thus, direct detection cannot take place. instead, an indirect detection approach is adopted. figure 7 illustrates the typical architecture of a solid-state gamma camera. in particular, this scheme refers to the insert system which will be considered as a reference design. each individual gamma photon is absorbed in the scintillator (here a csi:tl crystal of 8 mm thickness) producing a handful of visible photons, collected by the photodetectors placed at the bottom of the crystal. given the limited number of photons, photodetectors with internal multiplication are commonly used. previously, photo-multiplier tubes (pmt) were employed, but they are being systematically replaced by their solid-state equivalent: silicon photo-multiplers (sipm). they offer a much higher compactness and, of utmost importance for mri compatibility, much better compliance with magnetic fields. sipms are typically organized into tiles (here 6 × 6 pixels of 4 mm side in rgb-hd technology by fondazione bruno kessler, italy). the second development direction is the use of the time-of-flight (tof) information to improve the spatial resolution, sustained by the push to improve the timing resolution of photodetectors and readout electronics. a "10ps challenge" has been launched [38] in order to stimulate step-changes in scintillator materials and detection approaches (looking, for instance, to prompt emissions), as well as in electronics [39] . both perspectives clearly impact on the design of asics for pet: the first in terms of the number of channels and scalability and the second in terms of the intrinsic timing performance (currently in the ~100 ps range). if we take the coincidence time resolution (ctrfwhm) of a full detection system as a figure of merit to compare asics in terms of the timing performance (to be compared with similar scintillator and photodetector conditions), we can observe a continuous improvement trend. considering lyso crystals and 3 × 3 mm 2 pixels, the triroc asic (2016 [40] ) achieved 423 ps, tofpet (2016) 294 ps and stic (2018 [41] ) 214 ps. for smaller pixels (2 × 2 mm 2 ) flextot v2 reached 123 ps and nino (2017) 93 ps [42] . spect differs from pet in that it does not rely on proton annihilation: the radiotracer decays, directly emitting gamma-rays. in this case, a collimator is needed to select the trajectories of the photons impinging of the gamma camera. tomographic images are then reconstructed from the planar projections imaged by the gamma cameras surrounding the patient. different radiotracers can be employed, even simultaneously to map different molecules, if the energy resolution of the detector allows the discrimination of the photopeaks. the most commonly adopted is a metastable isotope of technetium ( 99m tc) which has a line at 140 kev. photons at such an energy are not absorbed within the thin silicon wafers and, thus, direct detection cannot take place. instead, an indirect detection approach is adopted. figure 7 illustrates the typical architecture of a solid-state gamma camera. in particular, this scheme refers to the insert system which will be considered as a reference design. each individual gamma photon is absorbed in the scintillator (here a csi:tl crystal of 8 mm thickness) producing a handful of visible photons, collected by the photodetectors placed at the bottom of the crystal. given the limited number of photons, photodetectors with internal multiplication are commonly used. previously, photo-multiplier tubes (pmt) were employed, but they are being systematically replaced by their solid-state equivalent: silicon photo-multiplers (sipm). they offer a much higher compactness and, of utmost importance for mri compatibility, much better compliance with magnetic fields. sipms are typically organized into tiles (here 6 × 6 pixels of 4 mm side in rgb-hd technology by fondazione bruno kessler, italy). figure 7 . architecture of the gamma camera of the insert spect system: the current signals of 72 silicon photo-multiplier (sipm) pixels are read by two asics [43] , featuring a low-impedance input stage, programmable shaper, peak stretcher and fast comparator to trigger the acquisition of events by the fpga-based daq unit [44] . the current signal produced from a single sipm can span from the µa to the ma range, with a typical duration in the tens of ns range. given the large capacitance of the photodetector (~1 nf), differing from biosensors (typically in the pf range) and sdds (in the sub-pf range), the additional [43] , featuring a low-impedance input stage, programmable shaper, peak stretcher and fast comparator to trigger the acquisition of events by the fpga-based daq unit [44] . the current signal produced from a single sipm can span from the µa to the ma range, with a typical duration in the tens of ns range. given the large capacitance of the photodetector (~1 nf), differing from biosensors (typically in the pf range) and sdds (in the sub-pf range), the additional parasitic capacitance of the interconnection (in the pf range) is not too critical, and the readout asic can be placed at a reasonable distance on the pcb. in order to grant a low input impedance, bandwidth and stability in these conditions, different topologies can be adopted. in the angus asic [43] , the weak positive feedback of a themes current conveyor is successfully implemented. sipms are biased at 35 v. the possibility to individually adjust the input potential with a dac allows for the correction of gain mismatch across the channels (typically~15%) and, more importantly, to selectively kill hot pixels affected by fault or large noise (dark counts). the tiles of sipms are typically cooled (here between 0 • c and −10 • c by refrigerant fluid) to reduce such a noise. the attenuated current pulses are then shaped by a programmable rc filter (~µs time constant), setting also the baseline. a fast discriminator triggers the acquisition of all channels and a peak stretcher allows the external 14-bit adc to sequentially sample all outputs through a multiplexer. an fpga acquires all the signals (at a rate of~11 k frames per second) and transmits them to a laptop through an optical digital bus [44] . the operation of the insert system is shown in figure 8a . the spect scanner is placed inside a standard mri scanner, connected to a custom-designed and shielded transceiver coil placed inside the bore of the spect static ring, which contains gamma cameras and the collimator. figure 8b shows the preclinical version of the scanner [45] , while figure 8c shows the clinical prototype [46] , the only existing mri-compatible sipm-based spect insert for human brain imaging. the main features of the two instruments are summarized in table 1 . sensors 2020, 20, 3636 9 of 15 parasitic capacitance of the interconnection (in the pf range) is not too critical, and the readout asic can be placed at a reasonable distance on the pcb. in order to grant a low input impedance, bandwidth and stability in these conditions, different topologies can be adopted. in the angus asic [43] , the weak positive feedback of a themes current conveyor is successfully implemented. sipms are biased at ~35 v. the possibility to individually adjust the input potential with a dac allows for the correction of gain mismatch across the channels (typically ~15%) and, more importantly, to selectively kill hot pixels affected by fault or large noise (dark counts). the tiles of sipms are typically cooled (here between 0 °c and −10 °c by refrigerant fluid) to reduce such a noise. the attenuated current pulses are then shaped by a programmable rc filter (~µs time constant), setting also the baseline. a fast discriminator triggers the acquisition of all channels and a peak stretcher allows the external 14-bit adc to sequentially sample all outputs through a multiplexer. an fpga acquires all the signals (at a rate of ~11 k frames per second) and transmits them to a laptop through an optical digital bus [44] . the operation of the insert system is shown in figure 8a . the spect scanner is placed inside a standard mri scanner, connected to a custom-designed and shielded transceiver coil placed inside the bore of the spect static ring, which contains gamma cameras and the collimator. figure 8b shows the preclinical version of the scanner [45] , while figure 8c shows the clinical prototype [46] , the only existing mri-compatible sipm-based spect insert for human brain imaging. the main features of the two instruments are summarized in table 1 . mutual compatibility between spect and mri electronics entails several critical aspects. in order to reduce the distortion of the magnetic field due to the spect insert, electronic components (free of ferromagnetic metals such as nickel, present in connectors, plating pins and iron cores of inductors) and materials should be carefully selected. in particular, the introduction of metals in the mr bore should be minimized. for instance, collimators are fabricated by laminated layers or powder-epoxy mixtures to avoid solid regions and, thus, reduce the paths for eddy currents. at an electronic level, it is crucial to reduce the irradiation of disturbances from the spect in the regions of the rf spectrum (~130 mhz). to minimize the impact of mri on spect electronics, it is important to design special circuit geometries and layouts (avoiding loops and solid ground planes), add filtering on tracks that could pick-up rf interference and apply mri-compatible shielding. the fundamental design guidelines and the results of compatibility tests are reported here [47] . another direction of development at the system-level is to lighten and simplify the instrument and make it movable, in particular to make it a bed-side scanner. this would avoid the need to bring the patient to the room and might be relevant either during surgery (where intra-operative gamma probes are already used) or to promptly study sudden events such as epileptic seizures and strokes. since the first movable mri has been recently cleared by the fda in the usa (model lucy by hyperfine, targeting stroke), a transportable spect/mri system for the bed-side is foreseeable. the key to make a movable mri system is in the use of low-field (and thus lighter) magnets [48] . the key to realizing a movable clinical spect is the reduction in the weight/size of the collimator, the detector refrigeration system (in the case of multiplication devices) and the electronics (again an opportunity for microelectronics to reduce the bulkiness and power dissipation in data processing). additionally, the increase in speed by reducing the image-reconstruction time (currently in the hour time-frame, compared to acquisition times of about 15 min) is clearly related to new paradigms in the operation of spect, aiming to achieve quasi "real-time" imaging. one of the major challenges hindering the scaling up of static preclinical spect systems to larger ones (i.e., with a larger field of view) is related to the growth in complexity in terms of the number of channels and signals travelling in the system (especially from a reliability point of view), and in terms of the processing time. one promising way to address both aspects is to shift the processing from the digital domain back to the analog domain, i.e., closer to the front-end. the reduction in the number of output channels can be achieved by using smart algorithms for machine learning (particularly for the estimation of the spatial coordinates of absorption of each gamma-ray photon) based on a partial readout of the crystal and by, for instance, principal component analysis and multiplexing strategies [49] . so far, they have been demonstrated in software post-processing and in discrete-hardware implementations (such as the decision-tree classification of gamma events embedded in a microcontroller [50] ), but it is evident that an integrated implementation of such strategies in asics would offer significant benefits in terms of: (i) compactness, (ii) the robustness of signals and reliability, and (iii) processing time, as demonstrated by several emerging examples of hardware acceleration in image processing and machine learning based on neural networks on-chip [51] [52] [53] . in order to increase the robustness of the signals through the long connection from the scanner to the base station placed in the control room, outside of the mri room, and decouple them from electrical interferences, optical fibers are typically employed. in the case of the insert system, a 15 m digital optical daisy chain composed of two rings with 10 nodes each has been implemented. since the operation of powerful digital processing platforms, such as fpgas, inside the bore there can be severe issues of heat dissipation and mutual compatibility, it is possible to envision a tighter combination of readout asics with silicon-photonics transceivers, potentially on the same monolithic silicon platform as the robust analog transmission and direct modulation of thousands of optical signals injected in optical fibers, as recently proposed for high-energy physics [54] . we have summarized some recent results, development strategies and directions for integrated circuits and electronics for biomedical applications. two apparently distant, but complementary, application areas in non-invasive diagnostics can both significantly profit from the advancements of cmos technology. targeted, yet cross-disciplinary, development of microelectronic designs and integration solutions can consolidate the pivotal role of integrated circuits in bio-sensing. clearly, each application domain poses specific challenges and offers a very different performance of molecular detection: for example, the dynamic range of a micro-impedance sensing chip is 100-120 db, while mri can reach 150 db at the expense of size, cost and measurement times that are several orders of magnitude larger. some of the most relevant challenges have been discussed: packaging and the noise/power compromise in micro-analytical devices; scaling to a large number of channels; migration of processing from digital to analog, at least for the reconstruction of the position of the scintillation event; and transition towards transportable systems for medical imaging scanners. the impact of the fabrication cost significantly changes between the two application domains: when considering disposable diagnostic kits (with a production cost in the order of~1$), the fabrication of silicon chips in cmos foundries is economically sustainable only for mass production. instead, when considering medical imaging scanners (with prices in the~m$ range), small-volume and, thus more expensive, asic productions are still acceptable. in conclusion, the current covid-19 pandemic has raised urgent concerns about diagnostic tools. the possible combination of ct scans of the chest with antibody-based assays for early, accessible and systematic diagnostics of the sars-cov-2 [55] is a vivid example of a possible effective combination of complementary diagnostic tools. integrated circuits for particle physics experiments liquid biopsy: a perspective for probing blood for cancer single-cell recording of vesicle release from human neuroblastoma cells using 1024-ch monolithic cmos bioelectronics impedance spectroscopy and electrophysiological imaging of cells with a high-density cmos microelectrode array system low-power and low-noise capacitive sensing ic using opamp sharing technique a low-power current-reuse analog front-end for high-density neural recording implants a 13.9-na ecg amplifier achieving 0.86/0.99 nef/pef using ac-coupled ota-stacking comparative analysis of information rates of simple amplifier topologies an aquatic wireless biosensor for electric organ discharge with an integrated analog front end assessment of analog pulse processor performance for ultra high-rate x-ray spectroscopy toward wireless health monitoring via an analog signal compression-based biosensing platform a low-power high-speed ultra-wideband pulse radio transmission system noise limits of cmos current interfaces for biosensors: a review resonant noise-canceling current front-end for high-resolution impedance sensing design and test at room temperature of the first silicon drift detector with on-chip electronics design guidelines for contactless integrated photonic probes in dense photonic circuits miniaturized impedance flow cytometer: design rules and integrated readout music: an 8 channel readout asic for sipm arrays advances in high-resolution microscale impedance sensors towards low-cost, high-sensitivity point-of-care diagnostics using vco-based esr-on-a-chip detectors integrated circuit technology for next generation point-of-care spectroscopy applications biocompatibility of silicon nanowires: a step towards ic detectors multichannel 65 zf rms resolution cmos monolithic capacitive sensor for counting single micrometer-sized airborne particles on chip integrated nanopore sensing platform with sub-microsecond temporal resolution cmos based capacitive sensors for life science applications: a review note: differential configurations for the mitigation of slow fluctuations limiting the resolution of digital lock-in amplifiers oscillator-based reactance sensors with injection locking for high-throughput flow cytometry using microwave dielectric spectroscopy wafer-level fan-out for high-performance, low-cost packaging of monolithic rf mems/cmos roadmap on silicon photonics lab-on-cmos integration of microfluidics and electrochemical sensors system-on-chip considerations for heterogeneous integration of cmos and fluidic bio-interfaces rapid prototyping polymers for microfluidic devices and high pressure injections 3d printed microfluidic devices: enablers and barriers microfluidic structures for large-scale manufacture combining photo-patternable materials sensors for positron emission tomography applications total-body pet: maximizing sensitivity to create new opportunities for clinical research and patient care first human imaging studies with the explorer total-body pet scanner* the 10-ps challenge high-frequency sipm readout advances measured coincidence time resolution limits in tof-pet triroc, a versatile 64-channel sipm readout asic for time-of-flight pet a silicon photomultiplier readout asic for time-of-flight applications using a new time-of-recovery method a comparative study of the time performance between nino and flextot asics characterization of the detection module of the insert spect/mri clinical system validation and performance assessment of a preclinical sipm-based spect/mri insert clinical sipm-based mri-compatible spect: preliminary characterization spect/mri insert compatibility: assessment, solutions, and design guidelines low-field mri: an mr physics perspective characterization of highly multiplexed monolithic pet / gamma camera detector modules a sipm-based directional gamma-ray spectrometer with embedded machine learning machine learning on-a-chip: a high-performance low-power reusable neuron architecture for artificial neural networks in ecg classifications on-chip sparse learning acceleration with cmos and resistive synaptic devices adaptive neuromorphic systems: recent progress and future directions use of silicon photonics wavelength multiplexing techniques for fast parallel readout in high energy physics covid-19 diagnostics, tools, and prevention. diagnostics 2020 acknowledgments: all the students and technical partners of the insert project (mediso, fondazione bruno kessler, nuclear fields, san raffaele hospital and university college london in particular) are warmly acknowledged for contributing to this 6-year-long effort. the authors declare no conflict of interest. key: cord-319930-ymqnb54a authors: kremer, stéphane; lersy, françois; de sèze, jérome; ferré, jean-christophe; maamar, adel; carsin-nicol, béatrice; collange, olivier; bonneville, fabrice; adam, gilles; martin-blondel, guillaume; rafiq, marie; geeraerts, thomas; delamarre, louis; grand, sylvie; krainik, alexandre; caillard, sophie; marc constans, jean; metanbou, serge; heintz, adrien; helms, julie; schenck, maleka; lefèbvre, nicolas; boutet, claire; fabre, xavier; forestier, géraud; de beaurepaire, isaure; bornet, grégoire; lacalm, audrey; oesterlé, hélène; bolognini, federico; messie, julien; hmeydia, ghazi; benzakoun, joseph; oppenheim, catherine; bapst, blanche; megdiche, imen; henri-feugeas, marie-cécile; khalil, antoine; gaudemer, augustin; jager, lavinia; nesser, patrick; talla mba, yannick; hemmert, céline; feuerstein, philippe; sebag, nathan; carré, sophie; alleg, manel; lecocq, claire; schmitt, emmanuelle; anxionnat, rené; zhu, françois; comby, pierre-olivier; ricolfi, frédéric; thouant, pierre; desal, hubert; boulouis, grégoire; berge, jérome; kazémi, apolline; pyatigorskaya, nadya; lecler, augustin; saleme, suzana; edjlali-goujon, myriam; kerleroux, basile; zorn, pierre-emmanuel; mathieu, muriel; baloglu, seyyid; ardellier, françois-daniel; willaume, thibault; brisset, jean christophe; boulay, clotilde; mutschler, véronique; hansmann, yves; mertes, paul-michel; schneider, francis; fafi-kremer, samira; ohana, mickael; meziani, ferhat; david, jean-stéphane; meyer, nicolas; anheim, mathieu; cotton, pr françois title: brain mri findings in severe covid-19: a retrospective observational study date: 2020-06-16 journal: radiology doi: 10.1148/radiol.2020202222 sha: doc_id: 319930 cord_uid: ymqnb54a background: brain mri parenchymal signal abnormalities have been in association with sars-cov-2. purpose: describe the neuroimaging findings (excluding ischemic infarcts) in patients with severe covid-19 infection. methods: this was a retrospective study of patients evaluated from march 23th, 2020 to april 27th, 2020 at 16 hospitals. inclusion criteria were: (i) positive nasopharyngeal or lower respiratory tract reverse transcriptase-polymerase chain reaction assays; (ii) severe covid infection defined as requirement for hospitalization and oxygen therapy; (iii) neurologic manifestations; (iv) abnormal brain mri. exclusion criteria were patients with missing or non-contributory data regarding brain mri or a brain mri showing ischemic infarcts, cerebral venous thrombosis, or chronic lesions unrelated to the current event. categorical data were compared using fisher exact test. quantitative data were compared using student’s t-test or wilcoxon test. a p-value lower than 0.05 was considered significant. results: thirty men (81%) and 7 women (19%) met inclusion criteria, with a mean age of 61+/12 years (range: 8-78). the most common neurologic manifestations were alteration of consciousness (27/37, 73%), pathological wakefulness when the sedation was stopped (15/37, 41%), confusion (12/37, 32%), and agitation (7/37, 19%). the most frequent mri findings were: signal abnormalities located in the medial temporal lobe in 16/37 (43%, 95% ci 27-59%) patients, non-confluent multifocal white matter hyperintense lesions on flair and diffusion sequences, with variable enhancement, with associated hemorrhagic lesions in 11/37 patients (30%, 95% ci 15-45%), and extensive and isolated white matter microhemorrhages in 9/37 patients (24%, 95% ci 10-38%). a majority of patients (20/37, 54%) had intracerebral hemorrhagic lesions with a more severe clinical presentation: higher admission rate in intensive care units, 20/20 patients, 100% versus 12/17 patients, 71%, p=0.01; development of the acute respiratory distress syndrome in 20/20 patients, 100% versus 11/17 patients, 65%, p=0.005. only one patient was positive for sars-cov-2 rna in the cerebrospinal fluid. conclusion: patients with severe covid-19 and without ischemic infarcts had a wide range of neurologic manifestations that were be associated with abnormal brain mris. eight distinctive neuroradiological patterns were described. eight distinctive neuroradiologic patterns (excluding ischemic infarcts) were identified in patients with severe covid-19 infection with abnormal brain mris. in patients with covid-19, the most frequent neuroimaging features were: involvement of the medial temporal lobe, non-confluent multifocal white matter hyperintense lesions on flair with variable enhancement and hemorrhagic lesions, and extensive and isolated white matter microhemorrhages. a majority of our patients presented intracerebral hemorrhagic lesions, which were associated with worse clinical status. 3. of 37 patients, only one was positive for sars-cov-2 rna in the cerebrospinal fluid. describe the neuroimaging findings (excluding ischemic infarcts) in patients with severe covid-19 infection. this was a retrospective study of patients evaluated from march 23 th , 2020 to april 27 th , 2020 at 16 hospitals. inclusion criteria were: (i) positive nasopharyngeal or lower respiratory tract reverse transcriptase-polymerase chain reaction assays; (ii) severe covid infection defined as requirement for hospitalization and oxygen therapy; (iii) neurologic manifestations; (iv) abnormal brain mri. exclusion criteria were patients with missing or non-contributory data regarding brain mri or a brain mri showing ischemic infarcts, cerebral venous thrombosis, or chronic lesions unrelated to the current event. categorical data were compared using fisher exact test. quantitative data were compared using student's t-test or wilcoxon test. a p-value lower than 0.05 was considered significant. thirty men (81%) and 7 women (19%) met inclusion criteria, with a mean age of 61+/-12 years (range: 8-78). the most common neurologic manifestations were alteration of consciousness (27/37, 73%), pathological wakefulness when the sedation was stopped (15/37, 41%), confusion (12/37, 32%), and agitation (7/ patients with severe covid-19 and without ischemic infarcts had a wide range of neurologic manifestations that were be associated with abnormal brain mris. eight distinctive neuroradiological patterns were described. i n p r e s s sars-cov-2 is the seventh member of the family of coronaviruses (covs) that infect humans (1) and induces covid-19 disease. human covs (hcovs) have neuroinvasive capacities and may be neurovirulent by two main mechanisms (2) (3) (4) : viral replication into glial or neuronal cells of the brain, or autoimmune reaction with a misdirected host immune response (5) . thus, a few cases of acute encephalitis-like syndromes with hcovs were reported in the past two decades (5) (6) (7) (8) . concerning covid-19, current data on central nervous system (cns) involvement is uncommon but growing (9) (10) (11) (12) (13) (14) (15) (16) (17) , demonstrating the high frequency of neurological symptoms. however, the delineation of a large cohort of confirmed brain mri parenchymal signal abnormalities (excluding ischemic infarcts) related to covid-19 has never been performed, and the underlying pathophysiological mechanisms remain unknown. the purpose of this current study was to describe the neuroimaging findings (excluding ischemic infarcts) in patients with severe covid-19 and report the clinico-biological profile of these patients. this retrospective observational national multicenter study was initiated by the french society of neuroradiology (sfnr) in collaboration with neurologists, intensivists, and infectious disease specialists, and brought together 16 hospitals. the study was approved by the ethical committee of strasbourg university hospital (ce-2020-37) and was in accordance with the 1964 helsinki declaration and its later amendments. due to the emergency in the context of covid-19 pandemic responsible for acute respiratory and neurological manifestations pandemic, the requirement for patients' written informed consent was waived. consecutive patients with covid-19 infection and neurologic manifestations who underwent brain mri were included from march 23 th, 2020, to april 27 th, 2020, in 16 french centers, including 11 university hospitals and 5 general hospitals. inclusion criteria were: (i) diagnosis of covid-19 based on possible exposure history or symptoms clinically compatible, validated with a detection of sars-cov-2 by reverse transcriptase-polymerase chain reaction (rt-pcr) assays on the nasopharyngeal, throat or lower respiratory tract swabs; (ii) severe covid-19 infection defined as requirement for hospitalization and oxygen therapy; (iii) neurologic manifestations; (iv) abnormal brain mri with acute/subacute abnormalities. exclusion criteria were: (i) patients with missing or non-contributory data (lack of sequences, numerous artifacts) regarding brain mri; (ii) a brain mri showing ischemic infarcts, cerebral venous thrombosis, or chronic lesions unrelated to the current event. clinical and laboratory data were extracted from the patients' electronic medical records in the hospital information system. only laboratory analysis within three days before the brain mri were considered. in the case of redundancy of the tests, the worst value has been kept. clinical and biological data were reviewed by two neurologists (j.d.s., and m.a. with 25 and 15 years of clinical expertise on neurology, respectively), and by one virologist (s.f-k). they participated to the elaboration of the study design, the interpretation of the data, and to manuscript editing. when available, all electroencephalogram (eeg) were reviewed by one expert neurologist (c.b.) and classified into five groups (normal, under sedation, nonspecific, encephalopathy or seizures). quantitative real-time rt-pcr tests for sars-cov-2 nucleic acid were performed on nasopharyngeal or lower respiratory tract swabs, and cerebrospinal fluid (csf). primer and probe sequences target two regions on the rdrp gene and are specific to sars-cov-2. assay sensitivity is around 10 copies/reaction (in house-method, institut pasteur, paris, france) (18). imaging studies were conducted either on 1.5-or 3-tesla mri. the multicenter nature of the study and the various clinical setups did not allow standardization of sequences. the most frequently sequences performed were 3d t1weighted spin-echo mri with and without contrast enhancement, diffusion-weighted imaging (dwi), gradient-echo t2 or susceptibility-weighted imaging, and 2d or 3d flair after administration of gadolinium-based contrast agent. after anonymization, images were presented to readers with our ge picture archiving and communication system (general electric, milwaukee, wi, usa). after review of mri studies by three neuroradiologists (s.k., f.c., and f.l. with 20, 25, and 9 years of experience in neuroradiology, respectively) who were blinded to all patient data, brain mri findings were divided by consensus into eight groups: (a) unilateral flair and/or diffusion hyperintensities located in medial temporal lobe; (b) flair and diffusion ovoid hyperintense lesion located in the central part of the splenium of the corpus callosum; (c) non-confluent multifocal white matter (wm) hyperintense lesions on flair and diffusion, with variable enhancement; (d) non-confluent multifocal wm hyperintense lesions on flair and diffusion, with variable enhancement, associated with hemorrhagic lesions; (e) acute necrotizing encephalopathy (ane) (9) when symmetric thalamic lesions (edema, petechial hemorrhage, and necrosis), with variable involvement of the brainstem, internal capsule, putamen, cerebral and cerebellar wm; (f) extensive and isolated wm microhemorrhages; (g) extensive and confluent supratentorial wm flair hyperintensities; (h) flair hyperintense lesions involving both middle cerebellar peduncles. patients could have had more than one pattern. data were described using frequency and proportion (n, %) for categorical variables, using mean, median, interquartile range, and range for quantitative data. in a second step, patients with hemorrhagic lesions were gathered into a single group called « patients with hemorrhagic complications », to look for clinico-biological differences between the two populations. categorical data were compared using fisher exact test. quantitative data were compared using student's t-test or wilcoxon test. a p-value lower than 0.05 was considered significant. between march 23 th, 2020, and april 27 th, 2020, 190 consecutive patients with covid-19 infection and neurologic manifestations, performed a brain mri in 16 hospitals. among them, were excluded all patients with normal brain mri, ischemic infarcts, cerebral venous thrombosis or chronic lesions unrelated to the current event. a total of 37 patients with covid-19 infection were finally included in this study (figure 1). the average age of the patients was 61 +/-12 years with 30 men and 7 women included (table 1). the majority of our patients (32/37, 87%) were admitted to intensive care units (icus) because of acute respiratory failure. the most frequent neurologic manifestations were alteration of consciousness (27/37, 73%), pathological wakefulness after sedation (15/37, 41%), confusion (12/37, 32%), and agitation (7/37, 19%). among the 26 eeg performed, 2 (8%) were considered as normal, 6 (23%) were realized under sedation, 10 (39%) showed nonspecific findings, 7 (27%) were classified as encephalopathy, and 1 (4%) case of seizures was also described. at the end of the study, the mortality rate was 14%. the blood counts of patients showed leukocytosis, lymphopenia, and anemia. patients had elevated serum levels of c-reactive protein, ferritin, alanine aminotransferase, aspartate aminotransferase, urea, creatinine, fibrinogen, and d-dimers (table 2) . fifteen out of the 19 patients (79%) studied for the presence of a lupus anticoagulant were positive. thirty-one patients underwent a lumbar puncture, and among them, 21/31(68%) had increased markers of inflammation (high white blood cell count, and/or high proteinorachia, and/or elevated immunoglobulin g). one patient demonstrated the presence of sars-cov-2 on rt-pcr. high levels of interleukin-6 were found in 2 out of 6 patients (table 3) . the results of mri findings are summarized in figure 1 . among the 37 patients included, 28/37 (76%) were associated with one neuroimaging pattern, 7/37 (19%) with two patterns, and 2/37 (5%) showed three patterns (figures 1-6). the most frequent neuroimaging findings were: signal abnormalities located in the medial temporal lobe in 16/37 (43%, 95%ic 27-59%) patients (figure 2), non-confluent multifocal wm hyperintense lesions on flair and diffusion, with variable enhancement, associated with hemorrhagic lesions in 11/37 (30%, 95%ic 15-45%) patients (figure 3), and in 9/37 (24%, 95%ic 10-38%) patients extensive and isolated wm microhemorrhages were detected (figure 4). the comparison between patients with and without intracerebral hemorrhagic lesions shows that the hemorrhagic complications were more frequently associated with icu admission (20/20, 100% versus 12/17, 71%, p=0.01), with acute respiratory distress syndrome (ards) (20/20, 100% versus 11/17, 65%, p=0.005) and with pathological wakefulness when sedative therapies were stopped (13/20, 65% versus 2/17, 12%, p=0.002). the time between the onset of symptoms (most often respiratory) to brain mri was longer for patients with intracerebral hemorrhagic lesions (mean duration of 33 days versus 19 days, p<0.001). leukocytosis (median of 13.4 x 10 9 /l versus 10.4 x 10 9 /l, p=0.03), anemia (median of 87 g/l versus 110 g/l, p<0.001), and renal dysfunction (urea's median of 18mmol/l versus 7mmol/l, p=0.026) were more pronounced in the case of hemorrhagic lesions. among the eight groups of brain mri features classification, three main neuroradiological patterns appeared more frequently in patient with severe covid-19: signal abnormalities located in the medial temporal lobe, non-confluent multifocal wm hyperintense lesions on flair and diffusion with variable enhancement, associated with hemorrhagic lesions, and extensive and isolated wm microhemorrhages. the presence of hemorrhage was frequent, and the detection is of clinical importance as it was associated with worse respiratory, neurological, and biological status. nevertheless, the underlying mechanism of brain abnormalities remains unsolved, and the direct implication of sars-cov-2 is not clear as only one patient was positive for sars-cov-2 rna in the csf. unilateral flair and/or diffusion hyperintensities located in medial temporal lobe were frequent and have been previously reported in one patient with covid-19 (10) . the latter is frequently observed in case of infectious encephalitis (especially with some viruses like herpes simplex virus, human herpesvirus 6, or epstein-barr virus) or in association with autoimmune limbic encephalitis (19) . non-confluent multifocal wm hyperintense lesions on flair and diffusion, with variable enhancement, which could be associated with hemorrhagic lesions, have rarely been reported in patients with covid-19 (20) . the latter presentation is close to what can be observed on brain mris in case of an inflammatory demyelinating disease such as acute disseminated encephalomyelitis (adem) or acute hemorrhagic leukoencephalitis. however, these two latter diagnoses cannot only be retained on the radiological presentation without the typical csf analysis or clinical presentation (21, 22) . several putative mechanisms underlying neurological consequences of covid-19 are evoked and among them immunological parainfectious processes (23) . the immunologic assumption is also reinforced by a recent neuropathological study which described adem-like lesions in the subcortical wm in a patient with severe covid-19 (24) . extensive and isolated wm microhemorrhages pattern was recently described in 7 critically ill patients with covid-19 (12) and in the neuropathology study above mentioned (24) . a similar pattern was recently described in one case (25) with disseminated intravascular coagulation. however, according to the criteria endorsed by the international society on thrombosis and haemostasis (27) , when they were available, no case of disseminated intravascular coagulation was present in our cohort. its precise pathophysiology remains uncertain and will require further studies. radmanesh et al. (12) evoking the assumptions of hypoxia or small vessel vasculitis. a small number of patients presented extensive and confluent supratentorial wm flair hyperintensities (figure 2), as previously described by kandemirli et al. (11) and radmanesh et al. (12) . its precise pathophysiology remains unclear: viral encephalitis (not supported by csf analysis) or post-infectious demyelinating diseases, as previously mentioned, may be evoked. since most of our patients were admitted to icus for an ards, more general assumptions may be considered, such as delayed post-hypoxic leukoencephalopathy (27) , metabolic or toxic encephalopathy, and posterior reversible encephalopathy syndrome (pres). this last hypothesis is in accordance with recently published nonhemorrhagic and hemorrhagic pres in patients with covid-19 (28) . even if this national neuroimaging cohort remains unique, our study has several limitations, mainly due to his retrospective design. the main limitation is that certain laboratory data were missing for some patients, notably the immunological tests. moreover, patients' outcomes were not always known at the time of this communication. thus, the mortality rate is probably underestimated in our cohort. in conclusion, in this multi-institutional study, we report 37 patients with covid-19 and abnormal brain mris (excluding ischemic infarcts). three main neuroradiological patterns could be distinguished, and the presence of hemorrhage was associated with worse clinical status. sars-cov-2 rna was detected in the csf only in one patient, and the underlying mechanisms of brain involvement remain unclear. imaging and neurological follow up has to be undertaken in order to evaluate the prognosis of these patients. n is the total number of patients with available data, and n the number of positive patients. i n p r e s s a novel coronavirus from patients with pneumonia in china neurologic alterations due to respiratory virus infections human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? viruses coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children severe neurologic syndrome associated with middle east respiratory syndrome corona virus (mers-cov) neurological complications during treatment of middle east respiratory syndrome detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis covid-19-associated acute hemorrhagic necrotizing encephalopathy: ct and mri features a first case of meningitis/encephalitis associated with sars-coronavirus-2 brain mri findings in patients in the intensive care unit with covid-19 infection covid-19 -associated diffuse leukoencephalopathy and microhemorrhages hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of covid-19 infection neurologic manifestations of hospitalized patients with coronavirus disease imaging in neurological disease of hospitalized covid-19 patients: an italian multicenter retrospective observational study neurologic features in severe sars-cov-2 infection neurologic manifestations in hospitalized patients with covid-19: the albacovid registry protocol: real-time rt-pcr assays for the detection of sars-cov-2 institut pasteur diagnosing autoimmune limbic encephalitis covid-19-associated acute disseminated encephalomyelitis (adem) acute disseminated encephalomyelitis: updates on an inflammatory cns syndrome weston-hurst syndrome: a rare fulminant form of acute disseminated encephalomyelitis (adem) neurological implications of covid-19 infections neuropathology of covid-19: a spectrum of vascular and acute disseminated encephalomyelitis (adem)-like pathology severe cerebral involvement in adultonset hemophagocytic lymphohistiocytosis towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation posterior reversible encephalopathy syndrome (pres) as a neurological association in severe covid-19 i n p r e s s key: cord-329750-purunxce authors: waldman, amy; o'connor, erin; tennekoon, gihan title: childhood multiple sclerosis: a review date: 2006-06-28 journal: ment retard dev disabil res rev doi: 10.1002/mrdd.20105 sha: doc_id: 329750 cord_uid: purunxce multiple sclerosis (ms) is an autoimmune demyelinating disorder of the central nervous system (cns) that is increasingly recognized as a disease that affects children. similar to adult‐onset ms, children present with visual and sensory complaints, as well as weakness, spasticity, and ataxia. a lumbar puncture can be helpful in diagnosing ms when csf immunoglobulins and oligoclonal bands are present. white matter demyelinating lesions on mri are required for the diagnosis; however, children typically have fewer lesions than adults. many criteria have been proposed to diagnose ms that have been applied to children, mostly above 10 years of age. the recent revisions to the mcdonald criteria allow for earlier diagnosis, such as after a clinically isolated event. however, children are more likely than adults to have monosymptomatic illnesses. none of the approved disease‐modifying therapies used in adult‐onset ms have been approved for pediatrics; however, a few studies have verified their safety and tolerability in children. although children and adults with ms have similar neurological symptoms, laboratory (cerebrospinal fluid) data, and neuroimaging findings, the clinical course, pathogenesis, and treatment of childhood onset ms require further investigation. mrdd research reviews 2006;12:147–156. © 2006 wiley‐liss, inc. m ultiple sclerosis (ms) was first described more than 170 years ago in adults. although rare, ms was recognized in children as early as 1922 [wechsler, 1922] . nevertheless, ms is still thought to be a disease of young adulthood, typically presenting between the ages of 20 and 40 years, and the diagnosis is rarely considered in children. physicians have questioned whether or not childhood ms is the same entity as seen in adults. in 1958, gall et al. published one of the earliest retrospective studies on pediatric-onset ms [gall et al., 1958] . between 1920 and 1952 , 40 children met inclusion criteria for the study. the patients demonstrated neurological signs and symptoms due to scattered lesions within the cns separated by time and space and supported by objective evidence. the study concluded that children and adults with ms have similar clinical profiles, including mode of onset, symptoms, and physical and laboratory (cerebral spinal fluid [csf]) findings. nevertheless, diagnosing ms in children is often difficult and controversial. the estimated prevalence of ms worldwide is 50 per 100,000 with 2.7-5.6% of patients presenting before the age of 15-16 years [ sindern et al., 1992; gadoth, 2003 ]. the calculated frequency of childhood-onset ms is 1.35-2.5 per 100,000 [gadoth, 2003] . ms has been diagnosed during infancy and early childhood (younger than 10 years of age) accounting for 0.2-0.7% of all cases [ruggieri et al., 1999] . there are reports of children presenting before the age of 2 years, even as early as 13 months [cole et al., 1995] . as seen in the adult population, there is a female predominance in childhood ms ranging from 2.1-3:1 [gall et al., 1958; duquette et al., 1987] . the presenting symptoms of ms in children are similar to those reported by adults. in 1987, duquette et al. reviewed 125 pediatric patients with ms who presented most commonly with either pure sensory symptoms or optic neuritis [duquette et al., 1987] . diplopia, pure motor symptoms, abnormal gait including ataxia (cerebellar or vestibular), mixed sensory and motor symptoms, and sphincter disturbances were also reported. in 1992, sindern et al. identified 31 patients with ms using poser's criteria (see diagnosis section) who presented before the age of 16 years and compared them to 72 sex-matched control patients diagnosed with ms between the ages of 20 and 40 years [sindern et al., 1992] . the most common finding at the onset of disease for both children and adults was optic neuritis, accounting for 52% and 40%, respectively. the second most common presenting symptom in children was sensory disturbance, seen in 16% of children and 15% of adults. transverse myelitis was more common in children, whereas motor symptoms were more common in adults (18%) than in children (6%). furthermore, in 71% of children, the initial presentation was rapid, resulting in admission to the hospital within a few hours to days. a longitudinal study by boiko et al. confirmed duquette's and sindern' s findings that sensory symptoms and optic neuritis were the most common initial manifestations in patients with the clinical onset of ms before the age of 16 years [boiko et al., 2002] . in 1995, poser et al. characterized the presentation of ms in adults (table 1) [poser, 1995] , and the diagnosis of ms should be considered in children presenting with similar symptoms. the clinical course of ms is divided into four subtypes: relapsing-remitting (rrms), primary progressive (ppms), secondary progressive (spms), and progressive-relapsing (prms). rrms is the most common subtype in both adults and children. there are no diagnostic tests for ms. however, a lumbar puncture is routinely performed to obtain supportive evidence of cns inflammation. in approximately 60% of patients with childhoodonset ms, the routine analysis (cell count, protein, and glucose) of csf is normal [duquette et al., 1987; dale et al., 2000] . the remainder of patients has a lymphocytic pleocytosis (typically ͻ50 cells/mm 3 ) and/or elevated protein (typically ͻ75 mg/dl) [dale et al., 2000] . intrathecal synthesis of immunoglobulin (ig), predominantly igg, is also seen in patients with ms. approximately 80% of children with ms have increased csf igg synthesis [jones, 2003] . furthermore, oligoclonal bands (ocb), markers of antibody synthesis in the cns, are present in about 85-95% of adult patients with ms [olek and dawson, 2004] . in children, ocb were present in 40 -87% of patients and may appear later during disease convalescence or relapse [sindern et al., 1992; selcen et al., 1996; dale et al., 2000; jones, 2003 ]. ocb are not specific to ms [poser, 1983; olek and dawson, 2004] . they can be found in chronic cns infections, such as subacute sclerosing panencephalitis, viral infections of the cns, autoimmune neuropathies, cervical myelopathies, and cns tumors [ cohen et al., 2000] . magnetic resonance imaging (mri) reveals asymmetric, multifocal white matter lesions on t2-weighted sequences and fluid-attenuated inversion recovery (flair) images [miller et al., 1990] . the lesions are most commonly located in the periventricular and subcortical white matter where they appear ovoid with extensions called dawson fingers [barkhof et al., 1997] . additional lesions can be seen in the cerebellum, spinal cord, basal ganglia, and thalami [dale et al., 2000] . new lesions may enhance with gadolinium administration. there are no longitudinal mri studies in childhood ms to establish whether there is progressive atrophy of the brain or the appearance of "black holes" (chronic inactive lesions). furthermore, unlike in adults, diffusion tensor imaging (dti) and magnetization transfer ratios (mtr) have not been systematically performed. finally, magnetic resonance spectroscopy (mrs) shows similar changes to those reported in adult ms patients with decreases in nacetyl aspartate (naa) reflecting neuronal loss, increases in choline reflecting remyelination, and increases in myoinositol reflecting gliosis [wolinsky and narayana, 2002] . ms remains a clinical diagnosis. in 1983, poser et al. published guidelines incorporating laboratory, neuroimaging, and neurophysiologic data into the diagnostic criteria with four proposed subtypes: clinically definite ms, laboratory-supported definite ms, clinically probable ms, and laboratory-supported probable ms (see table 2 ) . in 2001, the mcdonald criteria were introduced to facilitate and simplify the diagnosis of ms for patients between 10 and 59 years [mcdonald et al., 2001] . the authors further defined mri criteria and included both monosymptomatic disease and ppms in the clinical presentations. caution was suggested in applying these guidelines to children younger than 10 years. in fact, the sensitivity in diagnosing pediatric cases was questioned by a second panel that revised the mc-donald criteria in 2005 (see table 3 ) [polman et al., 2005] . furthermore, hahn et al. reported that many pediatric patients did not meet the mcdonald mri criteria for dissemination in space (see table 4 ) [hahn et al., 2004] . demonstrating dissemination in time (see table 4 ) is also challenging in pediatrics due to the possibility of relapses in a monophasic disease (see differential diagnosis section). nevertheless, a repeat mri performed three months after the initial study is recommended to show dissemination in time. acute disseminated encephalomyelitis (adem), multiphasic disseminated encephalomyelitis (mdem), and ms share similar clinical presentations, laboratory data, and neuroimaging abnormalities. subtle differences between the [dale et al., 2000; hynson et al., 2001; stonehouse et al., 2003 ]. in addition, hepatitis b; measles, mumps, rubella (mmr); bacille calmette-guérin (bcg); meningitis a and c; rabies; influenza; smallpox; and japanese b encephalitis vaccines, given within the six weeks prior to the onset of adem, have been suspected in triggering an autoimmune response [dale et al., 2000] . clinically, adem is more likely to present with ataxia, encephalopathy, bilateral optic neuritis, and seizures [hynson et al., 2001] . children typically have a polysymptomatic presentation with sensory, pyramidal, cerebellar, and bulbar symptoms [dale et al., 2000] . headache, fever, meningismus, and vomiting are more often associated with adem [brass et al., 2003] . unilateral optic neuritis and internuclear ophthalmoplegia are more common in ms [dale et al., 2000] . in adem and ms, the csf can be normal, although many patients have a lymphocytic pleocytosis or elevated protein. in adem, the csf white blood cell (wbc) count can be as high as 270 cells/mm 3 , with a mean around 51 cells/ mm 3 . in ms, the cell count is lower (range, 0 -130 cells/mm 3 ; mean, 18 cells/ mm 3 ) [dale et al., 2000] . the csf protein varies from 0.1 to 3.3 g/dl (mean, 0.69 g/dl) and 0.2 to 0.99 g/dl (mean, 0.38 g/dl) in adem and ms, respectively [dale et al., 2000] . ocb are seen in the csf in more than half of patients with childhood ms but can be seen in adem [dale et al., 2000; brass et al., 2003] . with considerable overlap between clinical and laboratory findings, mri is an important tool in determining the difference between adem and ms. both can affect the periventricular, sub-cortical, and deep white matter; deep gray matter; brainstem; cerebellum; and spinal cord. cortical white matter lesions are typically bilateral but asymmetric. in adem, lesions are less likely to be periventricular. also, adem more com1 yr of disease progression (retrospectively or prospectively determined) and two of the following: a) positive brain mri (9 t2 lesions or 4 or more t2 lesions with positive vep) f b) positive spinal cord mri (two focal t2 lesions) c) positive csf d note: if criteria indicated are fulfilled and there is no better explanation for the clinical presentation, the diagnosis is ms; if suspicious, but the criteria are not completely met, the diagnosis is "possible ms," if another diagnosis arises during the evaluation that better explains the entire clinical presentation, then the diagnosis is "not ms." a an attack is defined as an episode of neurological disturbance for which causative lesions are likely to be inflammatory and demyelinating in nature. there should be subjective report (backed up by objective findings) or objective observation that the event lasts for at least 24 hr. b no additional tests are required; however, if tests (mri, csf) are undertaken and are negative, extreme caution needs to be taken before making a diagnosis of ms. alternative diagnoses must be considered. there must be no better explanation for the clinical picture and some objective evidence to support a diagnosis of ms. c mri demonstration of space dissemination must fulfill the criteria derived from barkhof et al. [1997] and tintoré et al. [2000] as presented in table 4 . d positive csf determined using ocb detected using established methods (isoelectric focusing) different from any such bands in serum, or using an increased igg index. e mri demonstration of time dissemination must fulfill the criteria in table 4 . f abnormal vep of the type seen in ms. abbreviation: vep, visual-evoked potential. three of the following are required for demonstrating dissemination in space 1. at least one gadolinium-enhancing lesion or nine t2 hyperintense lesions if there is no gadolinium-enhancing lesion 2. at least one infratentorial lesion 3. at least one juxtacortical lesion 4. at least three periventricular lesions there are two ways to show dissemination in time: 1. detection of gadolinium enhancement at least three months after the onset of the initial clinical event, if not at the site corresponding to the initial event 2. detection of a new t2 lesion if it appears at any time compared with a reference scan done at least 30 days after the onset of the initial clinical event note: a spinal cord lesion can be considered equivalent to a brain infratentorial lesion, an enhancing spinal cord lesion is considered to be equivalent to an enhancing brain lesion, and individual spinal cord lesions can contribute together with individual brain lesions to reach the required number of t2 lesions. based on data from barkhof et al. [1997] and tintoré et al. [2000] . monly affects the thalami and basal ganglia, with a greater tendency for symmetry in the latter [dale et al., 2000] . in adem, a repeat mri scan performed more than two months after the onset of symptoms often shows partial or complete resolution of lesions with no new lesions. enhancement after the administration of gadolinium can be seen on the initial scan; however, no lesions enhance on the follow-up mri in adem. in ms, both new and enhancing lesions may be present when the scan is repeated, although the time to develop new lesions is unpredictable. in the absence of clinical symptoms, new findings on mri are useful in differentiating ms from adem. mdem presents a challenging dilemma in diagnosing childhood-onset ms. the clinical presentation, laboratory data, and neuroimaging features of mdem resemble adem, both of which are monophasic illnesses. however, patients with mdem have a clinical relapse after their initial illness or develop new lesions on mri, suggestive of a chronic demyelinating disease or ms. despite the presence of new lesions on mri, suggesting dissemination in time, some investigators believe that mdem and ms are separate entities. a diagnosis of mdem should be reserved for patients whose relapses are caused by the same trigger responsible for the inciting event and occur shortly after presentation or within two months of discontinuing steroids [dale et al., 2000] . ms is a neurodegenerative disease that affects young adults and children, often women. linkage and twin studies demonstrate that individuals carry a genetic susceptibility to this disease [rice, 2004] . a susceptibility locus for ms has been identified on chromosome 6, specifically the major histocompatability complex (mhc) class ii alleles human leukocyte antigens (hla) dr15 and dq6. this association is seen in all populations. in sardinians, there is an additional association with dr4, and, in turks, there is an association with dr2 and dr4. in finns, there is an association of ms with myelin basic protein (chromosome 18); however, neither this association nor an association with any other myelin genes has been noted in non-finnish populations [kenealy et al., 2003] . aside from the mhc locus, other regions of interest identified from the united kingdom study for ms susceptibility are located on chromosomes 1, 5, 6p, 7p, 14q, 17q, 19q, and xp [chataway et al., 1998] . some of the genes in these regions include tumor necrosis factor [tnf]␣, interleukin [il]-1ra, il-4, and cytotoxic t-lymphocyte-associated protein 4 (ctla-4). aside from the genetic predisposition for ms, epidemiological data indicates that an environmental factor also plays a role [compston, 2003] . for some time, an infectious agent has been suspected in triggering an autoimmune response. this theory was supported by apparent epidemics that occurred in the faroe islands and iceland following world war ii [rice, 2004] . additional support for an infectious etiology was provided by further studies that showed elevated antiviral titers (measles, rubella, mumps, varicella/zoster, ebv, influenza/parainfluenza,coronavirus, htlv-1, borna, etc) in the csf of ms patients during an acute exacerbation [ sibley et al., 1985; panitch, 1994] . presumably, the elevated titers represent nonspecific activation of b cells in the nervous system. in addition, the ms literature is replete with the isolation of viruses from the brains of patients with ms including measles, coronavirus, retroviruses, htlv-1, hhv-6, and scrapie agent. current focus on infectious agents includes ebv, hhv-6, endogenous retroviruses such as herv-w, and chlamydia pneumoniae [johnson and major, 2003] . oldstone postulated that an environmental trigger activates the immune system by "molecular mimicry" in which an infectious agent has sequence homology to a myelin protein. following the infection, tolerance is broken and an immune response ensues with the appearance of autoreactive t cells (cd4 and cd8) [oldstone, 1998] . alternatively, the pathogen activates toll receptors that then initiate the cellular immune response with the production of il-12 and il-23 [vasselon and detmers, 2002; frohman et al., 2006] . the earliest pathological change seen in an ms lesion is oligodendrocyte apoptosis with microglial activation but lacking infiltrating lymphocytes [barnett and prineas, 2004; matute and pérez-cerdá, 2005] . older lesions have perivascular infiltration by lymphocytes, plasma cells, and macrophages; loss of myelin and oligodendrocytes; axonal damage; and reactive astrocytes. chronic lesions are sharply demarcated with a hypocellular center and axonal loss, perivascular infiltration by lymphocytes, and increased number of oligodendrocytes. in chronic silent lesions, there is a loss of axons and oligodendrocytes. lucchinetti et al. have grouped the neuropathological lesions into four types, each containing t cells [lucchinetti et al., 1996 [lucchinetti et al., , 1999 [lucchinetti et al., , 2000 . type 1 is characterized by a predominance of macrophages, type ii by the deposition of immune complexes, type iii by oligodendrocyte malfunction, and type iv by oligodendrocyte death. there is insufficient data to describe the pathology of ms in children. ms is an organ-specific autoimmune disease mediated by type 1 helper t cells (t h 1) that recognize components of myelin and induce an inflammatory process by recruiting other inflammatory cells such as macrophages. in patients with ms, myelin-reactive t cells found in the blood stream produce a cytokine profile consistent with t h 1 cells. in demyelinating lesions, t h 1 cytokines, such as interferon ␥, tnf-␣, and il-2, are expressed by these leukocytes. the chemokine profile also suggests a t h 1-mediated inflammatory process. nevertheless, ms is likely to be more than a purely t h 1-mediated disease because it is likely that cd4 cells, macrophages, b cells, and a paucity of regulatory t cells also play a role [merrill, 1992; sorensen et al., 1999; frohman et al., 2006] . therapy in ms targets four different aspects of a child's illness. first, disease-modifying drugs, or immunomodulators (id), are used to alter the biological activity of the disease, thereby preventing neurological disability. second, additional medications help alleviate symptoms such as fatigue, spasticity, bladder dysfunction, and depression. third, neuroprotective agents are being studied to prevent and repair nerve injury. finally, rehabilitation is needed to overcome physical handicaps. disease modifying, symptomatic, and neuroprotective therapies will be described in this review. in evaluating effectiveness of therapies that modify the biological activity of the disease in children, a major challenge is the inability to predict the outcome of the disease and the lack of good outcome measures. the goal of any disease-altering therapy is to prevent longterm disability which evolves over many years [goodin et al., 2002] . the efficacy of the newer therapies has predominantly been studied over a short time period. moreover, the expanded disability status scale (edss) that is used as an outcome measure in adult studies has not been validated for use in children. children with ms may have cognitive dysfunction, which has not been evaluated as an outcome measure, although the ms functional composite (msfc) places some weight on mental functioning. once again, the utility of this scale has not been established in children. currently, most studies use the short-term attack rate as an outcome measure as well as mri data to assess t2 disease burden, cerebral atrophy, and the appearance of t1 black holes. although there are very few trials that have included children, in this article we review therapies that are recommended for adults and, where data is available, highlight the pediatric studies. glucocorticoids, such as intravenous (iv) methylprednisolone, are the mainstay of treatment for acute attacks or relapses in ms [goodin et al., 2002] . they suppress the immune system in many ways, such as altering cytokine profiles, inhibiting the synthesis of matrix metalloproteinases, and reducing csf antibodies to mbp and ocb [kupersmith et al., 1994] . in 1970, a multicenter trial compared adrenocorticotropic hormone (acth) (80 u/day given intramuscularly [im] for four days with a 7-day taper) against placebo in 197 patients with acute ms [rose et al., 1970] . after four weeks, the authors found that acth accelerated clinical improvement, although there was no significant difference in the outcome. in another study, acth (80 u/day for one week followed by a taper) was compared with 1 g of iv methylprednisolone for three days. in this study, there was no significant difference between the two treatment arms [thompson et al., 1989] . subsequently, a number of studies have been published using glucocorticoids for optic neuritis, most notably the optic neuritis treatment trial. this multicenter study compared iv methylprednisolone for three days followed by oral prednisone for 11 days against a 14-day course of oral prednisone and a placebo group. for both primary (visual fields and contrast sensitivity) and secondary (visual acuity and color vision) endpoints, the group that received iv methylprednisolone had an accelerated recovery of visual function compared to the placebo group. the rate of recovery for the group receiving oral prednisone was in between the iv and placebo groups. at six months, there was no difference between the treated and the placebo groups [beck, 1988] . furthermore, the group receiving oral steroids had an increased number of recurrences of optic neuritis. in addition to their use in optic neuritis, high-dose ste-roids are also known to enhance the resolution of gadolinium-positive mri lesions [barkhof et al., 1991; burnham et al., 1991] . finally, abrupt discontinuation of steroids can lead to severe clinical, radiographic, and histopathologic relapses; therefore, an oral taper is recommended. although these studies were performed in young adults with rrms and cis, iv steroids (15-30 mg/kg/day given daily for 3-5 days followed by an oral taper over 14 days) are used in children with acute attacks that impair function. interferons (ifn␤-1a and ifn␤-1b) are recombinant proteins, which inhibit the adhesion and the migration of wbc across the blood-brain barrier, thereby blocking antigen presentation and the synthesis and transport of matrix metalloproteinases [harris and halper, 2004] . in addition, they may cause a shift from a t h 1 to a t h 2 response. in adultonset ms, ifn-␤ has a beneficial effect on the clinical and radiological outcome measures. because the drug is not marketed for the pediatric population, there are no recommendations available for dosing children. for older children and adolescents, adult doses are most often used. interferon ␤-1a (inf␤-1a) is available in a weekly im injection (avonex, 30 g) or a subcutaneous (sc) injection given three times a week (rebif, 22 g or 44 g). interferon ␤-1b (inf␤-1b, betaseron, 8 million international units (miu) or 250 g) is given sc every other day. for smaller teens or children younger than 10 years, the doses are often adjusted to minimize adverse events and increase tolerability, such as starting with a half-dose of avonex or betaseron or using the lower dose for rebif. in 2006, banwell et al. retrospectively studied dosing, safety, and tolerability of ifn␤-1b in 43 children diagnosed with ms who had been treated for an average of 29.2 months [banwell et al., 2006] . treatment was initiated at full dose (8 miu or 250 g) in 15 children, all of whom were older than 10 years of age. younger children were started at 25-50% of the full dose and slowly increased; two children, both under the age of 10 years, were unable to tolerate the dose escalation. none of the children had any serious adverse events. therapy was discontinued in 25 of 43 patients after being treated for a mean duration of 111 weeks for various reasons, such as perceived lack of efficacy, cost of medication, lack of adherence, injection pain, and change in diagnosis. nevertheless, of the 38 patients with confirmed ms, the annualized relapse rate was reduced by a mean of 50%. the side effects of inf␤ in children are similar to those reported by adults. fever is the most common side effect, reported in 50% of the patients [ghezzi et al., 2005] . additional side effects include headache, myalgia, flu-like symptoms, injection site reactions, fatigue, nausea, and asthenia [waubant et al., 2001; banwell et al., 2006] . the majority of these symptoms are transient. to alleviate side effects, children may be pretreated with acetaminophen, ibuprofen, or naproxen. laboratory abnormalities, such as elevations of liver function tests, can also occur. when present, a temporary discontinuation of the medication is recommended. often, the inf␤ can be restarted without a recurrence of the elevated transaminases [banwell et al., 2006] . ga is a random polypeptide composed of four amino acids (l-glutamic acid, l-lysine, l-alanine, and l-tyrosine) resembling myelin basic protein (mbp). this drug has a number of effects on the immune system including inhibition of antigen presentation, competition and displacement of bound mbp, conversion of cd4 t cells from t h 1 to t h 2 type cells, and induction of brain-derived neurotrophic factor (bdnf) expression [teitelbaum et al., 1992; neuhaus et al., 2001; aharoni et al., 2003; azoulay et al., 2005] . it also induces antigen-specific suppressor t cells which release anti-inflammatory cytokines thereby generating tolerance to self-antigens [harris and halper, 2004] . there are no trials similar to those conducted in adults that have primarily focused on the efficacy of this drug in children with ms. there are, however, reports of using this drug in children who were given 20 mg sc daily, the standard dose for an adult. in one child treated with ga, chest pain was reported; however, no other clinical or laboratory abnormalities were identified [ghezzi et al., 2005] . although inf␤ and ga have been used in practice, the long-term tolerability, side effects, and overall efficacy in the pediatric population is not yet known. in a multicenter italian study published in 2005, ghezzi et al. focused on effectiveness and tolerability of interferons and glatiramer acetate in patients treated before the age of 16 [ghezzi et al., 2005] . sixty-five cases were reviewed. the majority was treated with avonex (38), followed by rebif (18), betaseron (16), and copaxone (9). relapses were defined as the occurrence of new symptoms lasting more than 24 hr with objective findings of cns involvement in a previously unaffected patient or the acute worsening of preexisting symptoms lasting more than 24 hr and causing an increase of at least 1 on the edss. all four of the drugs substantially reduced the relapse rate with combined data showing a decrease from 2.8 to 0.5 relapses per year and similar results for the individual medications. the change in edss was not significantly different when comparing the first and last visit in the inf␤ subgroups; however, a statistically significant difference was seen in the ga subgroup (baseline: 1.1 ϯ 0.5, posttreatment: 0.6 ϯ 0.5, p ϭ 0.007). it should be noted that the patients on ga had overall lower disease duration when compared to the other groups and edss at entry was lower than that in the avonex and rebif/betaseron groups. natalizumab is a recombinant monoclonal antibody directed against ␣4-integrin. in experimental autoimmune encephalitis (eae), the animal model for ms, the expression of t-cell surface receptors (integrins) promotes adhesion and transport of these cells through capillary endothelial cells. this antibody against ␣4-integrin blocks the adhesion of activated t lymphocytes to endothelial cells thereby preventing these cells from entering the nervous system. this is the only selective immunomodulating drug for the treatment of ms. the results from the natalizumab safety and efficacy in relapsing remitting multiple sclerosis (affirm) and safety and efficacy of natalizumab in combination with interferon ␤-1a in patients with relapsing remitting multiple sclerosis (sentinel) studies in adult patients indicate that the annualized rate of clinical relapses was reduced by 68%, the number of new and enhancing mri lesions was reduced by 83%, and a decrease occurred in progression and prolongation of the interval before neurological deterioration, demonstrating the usefulness of the drug [polman et al., 2006; rudicket al., 2006] . although natalizumab had significant short-term beneficial effects, unfortunately, three patients who received this drug developed progressive multifocal leukoencephalopathy (pml). the relative risk of developing pml in ms patients on natalizumab is 1 in 1,000 [ropper, 2006 ]. moreover, the use of this drug may have other long-term effects, such as unmasking latent viral infections as well as other diseases that are dampened by immune surveillance. in children who have a malignant course of ms, the use of this drug on a short-term basis may be warranted. campath-1h binds cd52 antigen, which is present on the surface of all b and t lymphocytes, as well as some monocytes. it is a lympholytic antibody that has been shown to prevent relapses and the formation of new mri lesions in ms; however, it does not seem to have any effect on disease progression [paolillo et al., 1999] . furthermore, when campath-1h was initially used in patients with ms, a transient worsening of symptoms occurred due to the release of cytokines and nitric oxide (no) [moreau et al., 1996] . in vitro studies demonstrated that no can cause conduction blocks that could account for the transient worsening of symptoms with treatment initiation. pretreating with steroids can avert the cytokine release. rituximab is a humanized monoclonal antibody directed against cd20 and antigens found on b lymphocytes [valentine et al., 1989 ]. b-cell proliferation, as well as an increase in the mutations of their receptors, has been shown in the csf of ms patients. the b-cell response reflects the presence of a specific antigen in the cns. thus, the b cells have become another therapeutic target in ms. rituximab, a drug that depletes b cells, is currently being investigated in the treatment of ms [reff et al., 1994; frohman et al., 2006] . mitoxanthrone is an anticancer drug that acts by intercalating into dna thereby producing dna strand breaks and interstrand crosslinking. in the immune system, it causes the elimination of lymphocytes and reduction of t h 1 cytokines. the major side effects include cardiac toxicity, presenting as a cardiomyopathy with irreversible congestive heart failure, and increased risk of developing malignant tumors. nevertheless, this drug reduced the attack rate of patients with rrms by 66%, reduced the number of gadolinium-enhancing and new lesions on the mri, and reduced the clinical rate of progression of the disease [millefiorini et al., 1997] . given the toxicity profile, this is not a first-line drug for the treatment of ms in children. cyclophosphamide is a powerful immunosuppressive agent that has been used to treat relapsing-remitting and progressive forms of ms. side effects include alopecia, nausea and vomiting, hemorrhagic cystitis, sterility, and long-term risk of malignancy. the use of iv cytoxan (400 -500 mg/day with wbc counts about 4,000 per microliter) did not show any benefit for patients with progressive ms at 1-and 2-year follow-up after the initiation of therapy [hauser et al., 1983; likosky et al., 1991] . in a canadian study using 1,000 mg of cytoxan with a 3-year follow-up of patients with progressive ms, there was no significant benefit from use of this drug [canadian cooperative ms study group, 1991] . nevertheless, in a study of 256 patients with progressive ms, younger patients derived some benefit from the use of cytoxan [weiner et al., 1993] . methotrexate acts as a folate antagonist, thereby affecting dna synthesis in immune cells. it decreases proinflammatory cytokines and enhances suppressor t-cell function. the major side effects are nausea, headache, diarrhea, liver damage, and the risk of developing non-hodgkin's lymphoma. a small, doubleblinded study of low-dose methotrexate revealed a benefit for patients with rrms but not for patients with the progressive forms of the disease [currier et al., 1993] . however, in another study of 60 patients with chronic progressive ms, low-dose methotrexate was found to be beneficial and showed a reduction in the t2 diseased burden [goodkin et al., 1995] . azathioprine is an analog of 6-mercaptopurine that inhibits purine synthesis, thereby impairing dna and rna synthesis in b cells, t cells, and macrophages. its side effects are anemia, lymphopenia, alopecia, liver dysfunction, pancreatitis, reactivation of latent infections, and the risk of developing malignancies. in a retrospective analysis of seven studies that had enrolled 793 patients, use of imuran reduced the number of relapses; however, the drug did not seem to affect the course of patients with progressive ms or their disability [yudkin et al., 1991] . cyclosporine is a potent immunosuppressive agent that selectively inhibits helper t cells. side effects include hirsutism, headaches, nausea, hypertension, edema, paresthesias, nephrotoxicity, and abdominal pain and discomfort. studies conducted in london and amsterdam showed no benefit on the relapse rate but did show some effect on slowing the progression of the disease [rudge et al., 1989] . given the side effects of this drug, its use in ms is very limited [goodin et al., 2002] . cladribine, an adenosine deaminase-resistant purine nucleoside, is a potent immunosuppressive drug that is selective for lymphocytes. side effects include nausea, diarrhea, fever, fatigue, and leukopenia. although cladribine does not have a significant effect in reducing the relapse rate, it may slow the degree of disability. in addition, it reduces the appearance of gadolinium-enhancing lesions on mri [beutler et al., 1996; rice et al., 2000] . 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) reductase inhibitors, also called statins, have been recently studied in a variety of cns disorders, including ms. statins disrupt the activation of proinflammatory t-cells by inhibiting signals from mhc class ii molecules [neuhaus et al., 2002] . they also decrease migration of leukocytes into the cns, expression of inflammatory mediators by t-lymphocytes and in the cns [stüve et al., 2003] . statins, such as simvastatin (zocor) and atorvastatin (lipitor) have been shown to inhibit and reverse chronic and relapsing eae [stüve et al., 2003] . atorvastatin induces stat6 phosphorylation and enhances the secretion of t h 2 cytokines (il-4, -5, and -10 and transforming growth factor [tgf] ␤) while inhibiting stat4 phosphorylation and secretion of t h 1 cytokines (il-2, -12, ifn-␥, and tnf␣) [youssef et al., 2002] . in small, shortterm studies, zocor decreased the number and size of gadolinium-positive lesions on mri scans without effect on progression and disability [vollmer et al., 2004] . the immunomodulatory effects of the statins offer promise in the treatment of ms, and their usefulness is being further investigated [neuhaus et al., 2004] . vaccination therapies are currently being developed that would alter the treatment of ms. vaccinations that promote the development of tolerance have been effective in eae [robinson et al., 2003 ]. in addition, t cell and t cell receptor peptide vaccinations have been studied in humans with ms [correale et al., 2000; bourdette et al., 2005] . none of the vaccines have been studied in children. iv immune globulin (ivig) blocks fc receptors on macrophages, alters the cytokine profile, and has antiidiotypic effects. ivig is typically used as an adjunct for acute relapses; however, its recurrent use has been studied in rrms. in a multicenter, double-blind, placebo-controlled study of 148 rrms patients given ivig (0.125-0.2 g/kg) monthly for two years, a reduction in the clinical attack rate (ϫ49%) with a possible reduction in the degree of disability (not significant) was observed [fazekas et al., 1997] . in a separate study, the number of total and enhancing lesions seen on mri was decreased by more than 60% in patients treated with ivig compared with placebo [sorenson et al., 1998 ]. thus, it appears that ivig may reduce the attack rate in rrms but probably has little effect in slowing the progression of the disease. although it does not alter the long-term course in ms, plasma exchange has been used to treat acute relapses, presumably by removing harmful antibodies. several groups have investigated this particular therapeutic modality for treatment of patients with progressive ms [hauser et al., 1983] . for some patients who had not responded to iv steroids, plasma exchange performed every other day for a total of 14 days provided a greater degree of improvement when compared with a sham-treated group [weinshenker et al., 1999] . some patients receiving plasma exchange improve very rapidly, which is unlikely due to the repair of the injured tissue. instead, the rate of recovery may be due to the rapid shifts in electrolytes that result in improved axonal conduction or the possible removal of an antibody that affects transmission of electrical impulses. although fatigue is a common and debilitating symptom is adults, children rarely complain of this symptom. the mechanism for fatigue is multifactorial and includes depression, excessive effort due to muscle weakness or spasticity, re-lease of cytokines, and sleep disturbance. therapies for fatigue in ms include the use of amantadine, modafanil, and pemoline. all have been shown to have modest beneficial effect in adults. when patients have involvement of the corticospinal tracts, whether it be due to lesions in the spinal cord or higher, treatment should include physical therapy, splints to prevent contractures, and stretching exercises combined with pharmacological treatments, such as diazepam (valium), tizanidine (zanaflex), baclofen (lioreseal), and dantroline (dantrium). less well established is the use of tetrahydocannabinol. for contractures that do not respond to stretching, alternatives include serial casting, botox injections, and tenotomy. in more severe cases, a baclofen pump, or rhizotomy or myelotomy, may be considered. hemiplegia in children is disabling, particularly because of the loss of dexterity. sensory impairment further aggravates movements of the hand. such children do not use the affected hand, which results in learned nonuse of that hand. recent studies indicate that such children benefit from intensive practice and forced use; restraint of the noninvolved arm appears to improve function of the affected hand, probably due to functional reorganization of the nervous system. patients with ms have a variety of paroxysmal symptoms that last seconds to minutes and are not associated with alterations in consciousness or any electroencephalogram correlate for seizure. paroxysmal sensory symptoms and motor symptoms, such as ataxia and lhermitte's sign, respond to low doses of carbamezapine, phenytoin, and acetazolamide. heat-sensitive symptoms can respond to potassium channel blockers with the caveat that these drugs can induce seizures. this is not an uncommon symptom in some children. nonsteroidal antiinflammatory agents are recommended. if they are not sufficient, gabapentin (neurontin), carbamezapine (tegretol), or amitriptyline (elavil) can be beneficial. in ms, axonal injury occurs early in the course of the disease with eventual transection of axons. factors that have been associated with axonal injury are cytokines, no, superoxide radicals, proteases, cd8 t cells, cholesterol breakdown products, abnormal expression of sodium channels and function of the sodium-calcium exchanger, and glutamine excitotoxicity [waxman et al., 2004] . when an axon is demyelinated, there is abnormal expression of voltagegated sodium channels with increased influx of sodium in an attempt to restore conduction. to compensate for this, there is a reversal of the sodium/calcium exchanger with efflux of sodium and an influx of calcium. this could result in calcium-mediated neuronal degeneration. this hypothesis has received some support from work on eae models where sodium channel blockers, such as flecainide and phenytoin, help preserve axons [lo et al., 2003; bechtold et al., 2004] . in patients with ms, mrs has demonstrated increased glutamate concentration, providing the underpinning for considering glutamate excitotoxicity. the increased glutamate could result from a decrease in glutamate transporters in glial cells and elevation of glutaminase, a glutamate-synthesizing enzyme, in microglia [werner et al., 2001] . however, increased glutamate acting through the ␣-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (ampa) and/or nmethyl-d-aspartate (nmda) receptors, which are present on neurons and oligodendrocytes, can result in calcium-mediated cell death. riluzole, a glutamate antagonist that has been used in infants with spinal muscular atrophy, blocks nmda and sodium channels and reduces the number of t1-weighted hypointense lesions on the mri scans of patients with ms [frohman et al., 2006] . because axonal damage is a feature of ms, promoting neurite outgrowth could be beneficial. however, axonal sprouting is inhibited by activation of the nogo receptor by agonists such as nogo, oligodendrocyte-myelin glycoprotein (omgp), and myelin-associated glycoprotein (mag). thus, blocking the nogo receptor could represent a therapy that would be of value in promoting axonal sprouting [wang et al., 2002] . in acute ms plaques, there is clearcut evidence for remyelination; however, this is minimal in chronic lesions. the recruitment of oligodendrocyte precursor cells to areas of demyelination is mediated via chemokine and cytokine receptors, a pathway that appears to be intact. once attracted to areas of damage, these precursor cells recapitulate the differentiation process; however, full differentiation of these cells may be dampened by macromolecules that are negative regulators of this process, such as activation of the notch pathway due to reexpression of the ligand jagged or the nogo receptor interacting protein. in the future, both of these targets may be sites for therapeutic intervention that will aid the process of remyelination. in addition, transplantation of stem cells or oligodendroglial progenitor cells may be a consideration [john et al., 2002; mi et al., 2005; frohman et al., 2006 ]. ms is best recognized for its relapsing and remitting clinical course. in fact, in both children and adults, rrms is the most common form, followed by the secondary and primary progressive forms. however, the prognosis for pediatric ms remains controversial. the edss has been used to quantify the disability associated with ms by assigning a functional score for multiple systems (pyramidal, cerebellar, brainstem, sensory, bowel and bladder, visual, and cerebral) [kurtzke, 1983] . patients with a score of 0 have a normal neurological exam. scores between 1.0 and 3.5 are fully ambulatory, whereas 4.0 -5.5 are ambulatory for short distances without aid or rest. patients with scores greater than 6 require assistance with ambulation as well as other activities of daily living. in 2002, boiko et al. compared the time to edss of 3.0 (mild disability in at least three domains or moderate disability in one area) and 6.0 (requiring intermittent or constant unilateral assistance to walk 100 meters with or without resting) in adult-and pediatric-onset ms [boiko et al., 2002] . on average, adults had a 50% risk of reaching edss scores of 3.0 and 6.0 in 10 and 18 years, respectively, after onset whereas disability in children was much slower, taking 23 and 28 years, respectively. in addition, 53.1% of children with rrms progressed to spms after an average of 17.7 years (sd 1.17 years). the 50% risk for conversion from rrms to spms was 23 years in children, whereas it was 10 years in adults. although this data suggests a slower disease course in children, the overall morbidity is typically greater when children reach adulthood. children have higher edss scores when compared to adults with ms of the same age [ghezzi et al., 2005] . ms is under-recognized in the pediatric population and presents new challenges in diagnosis and treatment. despite significant advances in neuroimaging, ms remains a clinical diagnosis. new guidelines allow earlier diagnosis, but they have not been reliably established in children, especially those younger than 10 years of age. in addition, these guidelines may not be sufficient to prevent the inclusion of monosymptomatic demyelinating disorders, which do not require long-term treatment. early diagnosis and treatment with immunomodulatory agents are critical to reducing the morbidity and mortality associated with this disease. although these drugs have been used in practice, more data is needed on long-term tolerability, side effects, and overall efficacy in the pediatric population. f glatiramer acetate-specific t cells in the brain express t helper 2/3 cytokines and brainderived neurotrophic factor in situ lower brain-derived neurotrophic factor in serum of relapsing remitting ms: reversal by glatiramer acetate safety and tolerability of interferon ␤-1b in pediatric multiple sclerosis comparison of mri criteria at first presentation to predict conversion to clinically definite multiple sclerosis quantitative mri changes in gadolinium-dtpa enhancement after high-dose intravenous methylprednisolone in multiple sclerosis relapsing and remitting multiple sclerosis: pathology of the newly forming lesion axonal protection using flecainide in experimental autoimmune encephalomyelitis the optic neuritis treatment trial the treatment of chronic progressive multiple sclerosis with cladribine early onset multiple sclerosis: a longitudinal study a highly immunogenic trivalent t cell receptor peptide vaccine for ms multiple sclerosis and acute disseminated encephalomyelitis in childhood the effect of high-dose steroids on mri gadolinium enhancement in acute demyelinating lesions the canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis the genetics of multiple sclerosis: principles, background and updated results of the united kingdom systematic genome screen cerebrospinal fluid oligoclonal igg bands in patients with spinal arteriovenous malformation and structural cns lesions very early onset multiple sclerosis genetic susceptibility and epidemiology t cell vaccination in secondary progressive multiple sclerosis low dose oral methotrexate treatment of multiple sclerosis: a pilot study acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children multiple sclerosis in childhood: clinical profile in 125 patients randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis multiple sclerosis-the plaque and its pathogenesis multiple sclerosis in children multiple sclerosis in children: a clinical study of 40 cases with onset in childhood disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an italian co-operative study disease modifying therapies in multiple sclerosis: report of the therapeutics and technology assessment subcommittee of the american academy of neurology and the ms council for clinical practice guidelines low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis mri criteria for multiple sclerosis: evaluation in a pediatric cohort multiple sclerosis: best practices in nursing care. disease management intensive immunosuppression in progressive multiple sclerosis. a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and acth clinical and neuroradiologic features of acute disseminated encephalomyelitis in children multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation infectious demyelinating diseases childhood autoimmune neurologic diseases of the cns the genetic epidemiology in ms megadose corticosteroids in multiple sclerosis rating neurological impairment in multiple sclerosis: an expanded disability status scale (edss) intense immunosuppression in chronic progressive multiple sclerosis phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo a quantitative analysis of oligodendrocytes in multiple sclerosis lesions. a study of 113 cases heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis multiple sclerosis: novel perspectives on newly forming lesions recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis proinflammatory and antiinflammatory cytokines in multiple sclerosis and cns acquired immunodeficiency syndrome lingo-1 negatively regulates myelination by oligodendrocytes randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and mri outcome magnetic resonance imaging of inflammatory and demyelinating white-matter diseases of childhood transient increase in symptoms associated with cytokine release in patients with multiple sclerosis mechanisms of action of glatiramer acetate in multiple sclerosis statins as immunomodulators: comparison with interferon-␤1b in ms are statins a treatment option for multiple sclerosis? molecular mimicry and immune-mediated diseases multiple sclerosis and other inflammatory demyelinating diseases of the cns influence of infection on exacerbations of multiple sclerosis quantitative mri in patients with secondary progressive multiple sclerosis treated with monoclonal antibody campath 1h a randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis diagnostic criteria for multiple sclerosis: 2005 revisions to the "mcdonald criteria multiple sclerosis: a guide for patients and their families onset symptoms in multiple sclerosis new diagnostic criteria for multiple sclerosis: guidelines for research protocols depletion of b cells in vivo by a chimeric mouse human monoclonal antibody to cd20 the genetic epidemiology of multiple sclerosis cladribine and progressive ms: clinical and mri outcomes of a multicenter controlled trial protein microarrays guide tolerizing dna vaccine treatment of autoimmune encephalomyelitis selective treatment of multiple sclerosis cooperative study in the evaluation of therapy in multiple sclerosis. acth vs. placebo-final report randomised double blind controlled trial of cyclosporin in multiple sclerosis natalizumab plus interferon ␤-1a for relapsing multiple sclerosis multiple sclerosis in children under 6 years of age multiple sclerosis in childhood: report of 16 cases clinical viral infection and multiple sclerosis early onset ms under the age of 16: clinical and paraclinical features intravenous immunoglobulin g reduces mri activity in relapsing multiple sclerosis expression of specific chemokines and chemokine receptors in the cns of multiple sclerosis patients acute disseminated encephalomyelitis: recognition in the hands of general paediatricians statins as potential therapeutic agents in neuroinflammatory disorders synthetic copolymer 1 inhibits human t-cell lines specific for myelin basic protein relative efficacy of intravenous methylprednisolone and acth in the treatment of acute relapse in ms isolated demyelinating syndromes: comparison of different mr criteria to predict conversion to clinically-definite multiple sclerosis phosphorylation of the cd20 phosphoprotein in resting b lymphocytes. regulation by protein kinase c toll receptors: a central element in innate immune responses oral simvastatin treatment in relapsing-remitting multiple sclerosis p75 interacts with the nogo receptor as a co-receptor for nogo, mag and omgp interferon ␤-1a in children with multiple sclerosis is well tolerated na ϩ channel expression along axons in multiple sclerosis and its models statistics of multiple sclerosis including a study of the infantile, congenital, familial and hereditary forms and the mental and psychic symptoms intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the northeast cooperative multiple sclerosis treatment group a randomized trial of plasma exchange in acute cns inflammatory demyelinating disease multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain the hmg-coa reductase inhibitor, atorvastatin, promotes a th2 bias and reverses paralysis in cns autoimmune disease overview of azathioprine treatment in multiple sclerosis key: cord-282342-5158g9kb authors: takao, masaki; abe, hirohito; sakai, takashi; hamada, hidetoshi; takahara, shiro; sugano, nobuhiko title: transitional changes in the incidence of hip osteonecrosis among renal transplant recipients date: 2019-07-04 journal: j orthop sci doi: 10.1016/j.jos.2019.06.009 sha: doc_id: 282342 cord_uid: 5158g9kb abstract background immunosuppressive therapy for renal allograft recipients has changed substantially since the introduction of the anti-cd25 monoclonal antibody, basiliximab. we hypothesized that recent improvements in immunosuppressive treatment may reduce the incidence of osteonecrosis of the femoral head (onfh). this study aimed to investigate transitional changes in the incidence of ofnh among renal transplant recipients by mri. methods participants comprised 110 patients who had undergone renal transplantation from 2003 to 2012, during which time basiliximab was in regular use at our institute (recent group), and 232 patients who had undergone rt between 1986 and 2003 (past group). we compared onfh incidence between the two groups and evaluated risk factors for onfh, including immunosuppressants (calcineurin inhibitors, basiliximab, and/or steroids) and postoperative renal function. results incidence of onfh was lower in the recent group (0%) than in the past group (3.4%; p = 0.043). in the recent group, age was greater, abo/human leukocyte antigen incompatibility was worse, while steroid dose was decreased and post-transplant renal function was improved. cumulative methylprednisolone dose at postoperative week 2 and delayed graft function were identified as risk factors for onfh. conclusion risk of onfh after renal transplantation has fallen with the advent of regular use of basiliximab, although this agent does not appear to be a factor directly associated with the incidence of onfh. study design clinical prognostic study (level iii case control study). osteonecrosis of the femoral head (onfh) is well recognized as a musculoskeletal complication after renal transplantation (rt). with advances in immunosuppressive therapy, improved posttransplant renal function and reduced corticosteroid dose are reported to have led to a decrease in the incidence of onfh [1e4]. however, according to recent screening studies using magnetic resonance imaging (mri), this incidence ranged from 3.8% to 25.5% [3,5e11] , inferring that onfh remains a significant complication among renal allograft recipients. immunosuppressive therapy for renal allograft recipients has changed substantially since the introduction of the anti-cd25 monoclonal antibody, basiliximab (simulect; novartis, east hanover, nj). when administered as induction therapy during the early postoperative period, improvements in postoperative renal function have been reported [12e15] . decreases in the doses of steroids and calcineurin inhibitors have also been reported [15] and indications for rt have therefore been expanded to include higherrisk patients with older age and increased human leukocyte antigen (hla) mismatch. however, the impact of basiliximab administration on the incidence of post-transplant onfh has not yet been determined, and few mri screening studies have been conducted since its introduction [3] . we hypothesized that recent improvements in immunosuppressive treatment may reduce the incidence of onfh even with wider indications for rt. the purpose of the present study was twofold: 1) to investigate transitional changes in the incidence of ofnh among renal transplant recipients by mri; and 2) to investigate factors related to onfh for the entire cohort. the ethical review board of our institution approved the design of this study (registration number: 13271). the recent group included 110 patients (61 men, 49 women; mean (±standard deviation) age, 43 ± 13 years, range, 16e70 years); mean body mass index (bmi), (21.9 ± 3.3 kg/m 2 ) who underwent mri of both hips after rt between april 2003 and june 2012 (i.e., during the period in which basiliximab was regularly used). during the period, 155 patients underwent rt. the past group included 232 patients (143 men, 89 women; mean age, 34 ± 13 years; mean bmi, 21.9 ± 3.4 kg/ m 2 ) who had undergone rt between january 1986 and march 2003 (i.e., prior to the regular use of basiliximab). during the period, 332 patients underwent rt. there was no significant difference in the rates of mri screening between the groups. (69.8% (232/332) vs 70.9% (110/155), p ¼ 0.80, chi-square test). all patients were notified about the reported incidences of onfh after rt, benefits and risks of mri, and possible treatment options, and given the opportunity to object. mri was performed 3 months after rt using either a 1.0-t superconducting magnet system (signa horizon lx 1.0t; general electric medical systems, milwaukee, wi), or one of two 1.5-t superconducting magnet systems (smt150x; shimadzu, kyoto, japan or achieva 1.5t a-series; philips healthcare, amsterdam, the netherlands). osteonecrosis was defined as an area of normal intensity demarcated by a low-intensity band on t1-weighted imaging [16] . t1-weighted spin-echo images were obtained using a 1.5-t system in the coronal and sagittal planes, with the following settings: repetition time (tr), 500e800 ms; echo time (te), 12e43 ms; and slice thickness, 2e10 mm. spoiled gradient-recalled echo pulse sequences were obtained using the 1.0-t system in the coronal plane with the following settings: tr, 4.5e14 ms; te, 1.84e3.08 ms; flip angle, 30 ; and slice thickness, 1.0e1.5 mm with no interslice gap. the following items were evaluated: onfh incidence; patient demographic and background factors, including gender, age, bmi, and abo and hla incompatibility; duration of preoperative dialysis; type of renal graft (living/cadaveric donor); preoperative immunosuppressant use, including calcium inhibitors (cyclosporine a/tacrolimus) administered initially or at the time of hospital discharge; concomitant basiliximab administration; steroid administration at 2, 4, 6, and 8 weeks after rt, as prednisolone (psl), methylprednisolone (mpsl), and total steroid doses (converted to psl-equivalent doses); postoperative renal function, including delayed graft function (dgf), blood urea nitrogen (bun) and creatinine (cr) levels at 8 weeks after rt, and acute transplant rejection; and duration of hospitalization. psl-equivalent doses were calculated by adjusting the mpsl dose on the basis of antiinflammatory potency, using a conversion factor of 1.25. acute transplant rejection was diagnosed as follows: a 40% increase in bun or a 20% increase in cr level compared with those at a previous sampling, daily urinary output 750 ml, and diagnosis by biopsy. dgf was defined as a patient requiring hemodialysis in the first week after rt. we compared these items between the recent and past groups using the mannewhitney u-test, chi-square test, and fisher's exact probability test for statistical analyses. in addition, we investigated factors influencing the incidence of onfh for the entire cohort. uniand multivariate logistic regression models were used to identify significant risk factors for onfh for the entire cohort. the adjusted odds ratio (or) for predicting onfh was determined for each factor identified by univariate logistic regression analysis. spss for windows version 20.0j statistical software (spss, chicago, il) was used for all statistical analyses. a 5% significance level was applied to all tests. no cases of onfh were recorded in the recent group (0%; 95% confidence interval (ci), 0%e3.3%), although eight cases of onfh were recorded in the past group (3.4%; 95% ci, 1.5e6.7%; one-sided fisher's exact probability test, p ¼ 0.043). intergroup comparisons of background and demographic factors revealed significant increases in age, bmi, number of patients with abo and hla incompatibilities, and living kidney donors in the recent group ( table 1) . comparison of postoperative immunosuppressant use showed increased frequency of tacrolimus use, increased number of patients with concomitant use of basiliximab, and decreases in mpsl, psl, and total steroid dose at postoperative weeks 2, 4, 6, and 8 in the recent group ( table 1) . regardless of the increase in risk factors for rt such as older age and increased number of abo/hlaincompatible transplants among patients, decreases in steroid administration and improvements in postoperative renal function have been observed in the recent group. in addition, significant decreases were seen in the number of cases with dgf, concentrations of bun and cr at 8 weeks after transplantation, incidence of acute transplant rejection, and duration of hospitalization over time ( table 1) . the overall results were surveyed for risk factors for onfh. according to the analysis of individual factors, total mpsl dose at postoperative weeks 2, 4, 6, and 8, total steroid dose at postoperative weeks 2, 4, 6, and 8 and dgf were identified as significant risk factors (table 2) . psl administration at postoperative weeks 2, 4, 6, and 8 was not a risk factor. we performed multivariate analysis (logistic regression analysis) for age, gender, and total mpsl dose at postoperative week 2, and dgf. significant risk factors for onfh were total mpsl dose at postoperative week 2 (or, 2.90; 95% ci, 1.04e8.07; p ¼ 0.04) and dgf (or, 5.97; 95% ci, 1.36e26.26; p ¼ 0.02) ( table 3) . when the mpsl doses at postoperative weeks 4, 6, and 8 were selected as a risk factor rather than that at week 2, the following were the adjusted values: for week 4, or was 2.29 (95% ci, 1.03e5.13; p ¼ 0.04); for week 6, or was 1.83 (95% ci, 1.02e3.28; p ¼ 0.04); and for week 8, or was 1.71 (95% ci, 1.03e2.83; p ¼ 0.04). mpsl administration at week 2 showed the highest adjusted or. the types of onfh according to japanese investigation committee classification, their natural course and surgical treatment were summarized in table 4 . improvements in post-transplant renal function and reductions in corticosteroid dose may have led to a decrease in the incidence of onfh [1e4]. renal graft function after rt has been improving with advances in immunosuppressive agents such as cyclosporine a [2, 17] and tacrolimus [12e14] . several other immunosuppressive agents including sirolimus, everolimus, mycophenolate mofetil, and basiliximab have been introduced in combination with cyclosporine a or tacrolimus and have also improved postoperative renal function [18] . in contrast, few reports have been published about the influence of these new immunosuppressive agents on the incidence of onfh after rt. basiliximab, an anti-cd25 monoclonal antibody, is a very strong immunosuppressive agent that exerts its effects through competitive interleukin-2 antagonism [19] . when administered as an induction therapy during the early postoperative period, in conjunction with one or more conventional immunosuppressive drugs, decreases in the incidences of acute transplant rejection and dgf and improvements in survival of the transplanted kidney have been reported [12e15] . decreases in steroid and calcineurin inhibitor doses have also been reported [15, 20, 21] . these marked changes in immunosuppressive treatments and postoperative renal function may have reduced the incidence of onfh. the proportion of onfh patients receiving steroid treatment for renal transplantation has reportedly decreased recently according to the multicenter hospital-based sentinel monitoring system for onfh in japan [22] , although the reasons for these decreases in the proportion of onfh patients receiving renal transplantation remain unclear. in addition, only a small number of reports since 2001 have described mri screening for onfh after rt, and the impact of the introduction of basiliximab on the post-transplant incidence of onfh has yet to be determined. we therefore investigated the incidence of onfh since the advent of regular basiliximab use and found that postoperative renal graft function had improved, and the mpsl dose and incidence of dgf as risk factors for onfh had decreased. in addition, the incidence of onfh had decreased. basiliximab seems likely to indirectly reduce the incidence of onfh by reducing the incidence of dgf and allowing reductions in mpsl administration. three main limitations need to be considered when interpreting the results from the present study. first, the number of renal transplant recipients with use of basiliximab might be too small to evaluate its effect on the incidence of onfh. the number of patients included in previous mri screening studies ranged from 26 to 150 [3,5e10] , so the number of patients in the present study is comparable with the numbers in those studies. second, mri screening was not performed before rt, so we could not be sure that onfh had not been present prior to transplantation. nevertheless, because the incidence of onfh in our study was lower than that in any previous study evaluated using mri, the incidence was presumed to have also been low even before transplantation. third, the timing of mri screening was earlier compared to other mri screening studies. this might be one reason the incidence of onfh at our institute was lower than described in other reports performed during a similar period. we did not encounter any symptomatic cases with onfh in which mri had been negative at 3 months after rt, so we considered that the incidence of onfh occurring after 3 months after rt was unlikely to have been particularly high. onfh did not occur in any of the 110 patients who underwent rt between april 2003 and june 2012 at our institution, despite the wider indications for rt in high-risk patients, such as older age and more severe abo and hla incompatibilities. in previous mri screening studies of onfh after rt performed between 1986 and 2001 without the use of basiliximab, incidences of onfh after rt were within the range of 3.4e25.4% [3,5e10] . although a downward trend was observed in those studies, no mri screening studies for onfh have been reported since 2002, and the present study showed the lowest incidence of onfh after rt among all relevant studies (table 5) . to elucidate the risk factors for onfh, all rt recipients who underwent mri screening at our institute were analyzed. the results showed that dgf and cumulative mpsl administration up to 2 weeks after rt were significant risk factors. other risk factors for onfh reported after rt include daily oral steroid dose, bun level 2 months after rt, accumulated steroid dose at 2 months, accumulated steroid dose at 2 weeks, ethnicity (african-american), history of peritoneal dialysis, rejection, delayed graft function, and cyclosporine a administration [1,10,11,23e25] . to date, cumulative steroid dose as of 2 weeks postoperatively has been reported as the shortest-term risk factor for onfh [24] . the risk factors for onfh after rt in the present study were in accordance with past findings. this result suggests that onfh occurs mostly within the first 2 weeks after rt, suggesting the importance of controlling postoperative graft function and reducing cumulative mpsl administration in the first 2 weeks after rt using immunosuppressive agents that are appropriate for the prevention of onfh. a recent meta-analysis of onfh occurrences among patients taking corticosteroids reported positive associations between mean daily corticosteroid doses and onfh across all diagnoses, including severe acute respiratory syndrome, systemic lupus erythematosus, bone marrow transplantation and renal transplantation, although the correlation between mean daily corticosteroid dose and onfh incidence was not significant among renal transplant recipients [26] . no evidence of a significant correlation between cumulative corticosteroid dose and incidence of onfh has yet been provided [26, 27] . in renal transplant recipients, daily steroid dose is gradually tapered according to the immunosuppressive regimen, so reflecting an overall picture of steroid treatment using a mean value for daily steroid dose is difficult. in addition, duration of steroid treatment and overall cumulative steroid dose vary widely among renal recipients, and steroid administration after onset of onfh might be included in the regression analysis. we therefore focused on the correlation between steroid administration including oral steroid administration and pulsed steroid therapy in the 8 weeks after renal transplantation and onset of onfh at 3 months. the risk of onfh after rt has fallen since the advent of regular basiliximab use, although this agent does not appear to be a factor directly associated with the incidence of onfh. factors related to onfh incidence were found to be renal graft function and mpsl administration for up to 2 weeks. since the introduction of basiliximab, immunosuppressive therapy has changed markedly and renal graft control has also been enhanced, which may have led to decreases in the incidence of onfh. this research is supported by the practical research project for rare/intractable diseases from japan agency for medical research and development, amed. in accordance with icmje criteria, ns and st designed the study and mt wrote the initial draft of the manuscript. ha contributed to the collection and interpretation of data and the assistance of the preparation of the manuscript. the literature data were searched and analyzed by mt and ha. all other authors contributed to the data collection and interpretation. all authors approved the final version to be submitted for publication and agree to be accountable for all aspects of the work. none. all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 declaration of helsinki and its later amendments or comparable ethical standards." informed consent was obtained in the form of opt-out on the web-site. those who rejected were excluded. maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the united states cyclosporin a and osteonecrosis of the femoral head incidence of hip osteonecrosis among renal transplantation recipients: a prospective study tacrolimus may be associated with lower osteonecrosis rates after renal transplantation early detection of avascular necrosis of the femoral head following renal transplantation initial changes of non-traumatic osteonecrosis of femoral head in fat suppression images: bone marrow edema was not found before the appearance of band patterns apparent avascular necrosis of the hip: appearance and spontaneous resolution of mr findings in renal allograft recipients initial mri findings of non-traumatic osteonecrosis of the femoral head in renal allograft recipients osteonecrosis of the femoral head after solid organ transplantation: a prospective study degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head incidence and predictors of osteonecrosis among cyclosporin-or tacrolimus-treated renal allograft recipients renal function as a predictor of long-term graft survival in renal transplant patients tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation efficacy and safety of tacrolimus compared with cyclosporin a microemulsion in renal transplantation: 2 year follow-up results induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-il2 receptor and antithymocyte globulin the 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head necrosis of the femoral head after renal transplantation rabbit-atg or basiliximab induction for rapid steroid withdrawal after renal transplantation (harmony): an open-label, multicentre, randomised controlled trial prolonged action of a chimeric interleukin-2 receptor (cd25) monoclonal antibody used in cadaveric renal transplantation monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression a randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients temporal trends in characteristics of newly diagnosed nontraumatic osteonecrosis of the femoral head from 1997 to 2011: a hospital-based sentinel monitoring system in japan hospitalized avascular necrosis after renal transplantation in the united states corticosteroid administration within 2 weeks after renal transplantation affects the incidence of femoral head osteonecrosis cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study high-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review etiologic classification criteria of arco on femoral head osteonecrosis part 1: glucocorticoidassociated osteonecrosis authors thank dr. hideki yoshikawa, dr. koji yazawa, and dr. naotsugu ichimaru for helpful advice. key: cord-257075-9x0530cb authors: claudi, carolin; ganser, joachim; andreisek, gustav; vrugt, bart title: a juxta-articular myxoma of the thumb a case report date: 2020-04-20 journal: j hand surg glob online doi: 10.1016/j.jhsg.2020.04.002 sha: doc_id: 257075 cord_uid: 9x0530cb abstract juxta-articular myxomata are benign tumors which are mostly encountered in the vicinity of larger joints. few cases in the hand have been reported. we present a case of a juxta-articular myxoma at the metacarpophalangeal joint of the thumb in a 40 year-old man. the preoperative diagnostic work-up included 4d mr-angiography and ultrasound. the histochemical examination of the resected tumor established the diagnosis definitively. a follow-up mri, scheduled without any clinical suspicion of tumor-recurrence, 9 months postoperatively, did not reveal any obvious recurrence. at 14 months, the patient has full motion without pain and declined any further imaging. juxta-articular myxomata (jam) are benign soft tissue neoplasms of mesenchymal origin. 18 these cystic tumors resemble a ganglion, and tend to recur after resection 1 thumb. initially, this tumor was hardly noticeable, but it grew slowly over the past year. as it 27 was situated in the commissure between thumb and index finger, the pressure when 28 grasping larger objects provoked mild pain. 29 the clinical examination revealed a solid, circumscribed round mass of 25 mm which was 30 adherent to the ulnar-palmar aspect of the metacarpal joint of the thumb. it was scarcely 31 visible as the texture and color of the skin were normal. the tumor did not adhere to the 32 skin or tendons (figure 1). the stability and mobility of the thumb joints were not 33 compromised. 34 the clinical impression of close contact to the joint was verified by ultrasound. it was by mri 35 (figure 2-4) and 4d mr-angiography that the final diagnosis of a jam was suspected. as a 36 well circumscribed, septated, scarcely vascularized (supported by duplex sonography) mass 37 without any pathological tumor-feeding vessels, it could be distinguished from a 38 myosarcoma. we forewent plain films as they seemed sufficiently replaced by mri and 39 would only be useful to rule out any arthritic changes and bone infiltration. 40 without suspicion of malignancy, we elected to proceed with marginal resection rather than 41 a biopsy to avoid a second operative procedure in a delicate region. 42 at surgery, the tumor could be completely resected without destruction of the joint 43 ligaments, tendons, vessels or nerves (figures 5, 6). 44 the histological examination revealed non-malignant spindle cells, embedded in a myxoid 45 matrix (figure 7). the diagnosis was confirmed immuno-histochemically with the affirmation 46 of cd34 and the exclusion of s100 and actin. 47 the postoperative healing process was uneventful. the thumb regained full motion and 48 became completely pain free. 49 the regular follow-ups including ultrasound and mri examination were initially scheduled on 50 a yearly basis. a first control-mri, conducted without any clinical suspicion of tumor-51 recurrence postoperatively 9 months postoperatively, did not reveal any obvious recurrence. 52 at 14 months postoperatively, the patient is still pain and symptom free. compared with the 53 contralateral side, he has full range of motion, equal power and normal sensibility in the 54 thumb. the patient elected to defer additional imaging during the covid-19 pandemic. 55 compliance with ethical standards 57 58 conflict of interest: the authors declare that they have no conflict of interest. although classified as benign lesions, myxomata can be locally destructive and thus cause 99 symptoms like pain or nerve palsy 15,17 . in the setting of local tissue destruction, one must 100 consider malignancy in the differential diagnosis 2 . 101 macroscopically myxomata present as cystic formations 5 of soft or friable consistency, white 102 to yellow color, ranging from 2 to 6 cm in size 2 . microscopically these tumors can appear 103 like fetal wharton's jelly 18 . few spindle-shaped fibroblast-type or stellate and fusiform cells 104 are found within reticulin fibers and a myxoid matrix. the mucin consists of hyaluronic acid 105 and mucopolysaccharides. vasculature is usually poorly developed 1,3,19 . one report of an 106 unusually large myxoma in the hand even showed hormone receptors 20 . 107 a few differential diagnoses should be considered when seeing a patient with a swelling on 108 the hand or wrist like in our case. the most probable diagnosis would be a ganglion cyst 109 however these are smaller than jam 5 , show no septation on mri and have a less developed 110 myxoid component 8 . a hibernoma of the hand should also be considered, even as a rare 111 cause for carpal tunnel syndrome. this tumor of brown fat tissue shows spindle cells and 112 myxoid structures like a myxoma but would be positive for ps100 and cd 34 21 . 113 in cases of a rapidly growing mass, a sarcoma must always be considered 12,13 . unfortunately 114 the diagnosis is often only confirmed by histologic examination after excision, so reoperation 115 may be needed 7 . careful preoperative planning including mri and even core biopsy should 116 be considered in these cases. nodular fasciitis (nf) is a benign reactive myofibroblastic lesion 117 that may occur after trauma. it also presents as a rapidly growing subcutaneous mass and is 118 sometimes said to be a benign version of a sarcoma. microscopically spindle-shaped cells in 119 myxoid matrix with collagen are found. nf is positive for alpha-smooth muscle actin, and 120 negative for many other markers (beta-catenin, s-100, cd 34, hmga2, cytokeratin, ema, 121 caldesmon, desmin) 22 . lastly, an intramuscular myxoma should be considered in differential 122 diagnosis. it is more common in women around 50 and often affects large muscles in the 123 thigh or shoulder. in contrast to jam it shows only minimal cystic changes and has a low 124 recurrence rate even with incomplete resection 1,2,8 . on ct, mri and ultrasound, they 125 present with an intrinsic high water content and a surrounding rim of fat 8 . activating 126 missense mutations at the arg201 codon of the gs alpha gene leading to increased levels of 127 cyclic adenosine monophosphate are detected in intramuscular myxomata (and also found 128 in mccune-albright syndrome and sporadic fibrous dysplasia of bone), but not in jam 16 . 129 in our case, the diagnosis of a jam was confirmed after immuno-histochemical staining that 130 was positive for cd34 but negative for s100 and actin. juxta-articular myxoma of the wrist: a 136 case report juxta-articular myxoma of the 138 palm recurrent myxoma of the hand myxoma and myxosarcoma of the soft 142 tissues of the extremities juxta-articular myxoma: a clinical and pathologic study of 65 144 cases musculoskeletal sarcomas in the forearm and hand: standard treatment and microsurgical 147 reconstruction for limb salvage soft tissue sarcoma of the hand and wrist: 149 epidemiology and management challenges imaging of soft-tissue myxoma with emphasis on ct and mr and comparison of 152 radiologic and pathologic findings myxoma of the palm an intramuscular myxoma of the hand periosteal myxoma of the femur. a case report juxta-articular myxoma of the shoulder 160 presenting as a cyst of the acromioclavicular joint: a case report juxta-articular myxoma of the 163 tolhurst de. myxoma of the palm myxoma causing paralysis of the posterior 166 interosseous nerve activating gs alpha 169 mutation at arg 201 codon does not occur in juxta-articular myxoma posterior interosseous nerve palsy caused by a 172 myxoma. the british society for surgery of the hand editorial: myxoma of soft tissues myxoma of the dorsal 176 hand carpal tunnel syndrome due to hibernoma of the 178 wrist: case report intra-articular nodular fasciitis of the proximal 180 interphalangeal joint of a finger: a case report the authors do not have any conflicting interests concerning this article. key: cord-330284-r3l6hdrk authors: gao, min; huang, siying; pan, xuequn; liao, xuan; yang, ru; liu, jun title: machine learning-based radiomics predicting tumor grades and expression of multiple pathologic biomarkers in gliomas date: 2020-09-11 journal: front oncol doi: 10.3389/fonc.2020.01676 sha: doc_id: 330284 cord_uid: r3l6hdrk background: the grading and pathologic biomarkers of glioma has important guiding significance for the individual treatment. in clinical, it is often necessary to obtain tumor samples through invasive operation for pathological diagnosis. the present study aimed to use conventional machine learning algorithms to predict the tumor grades and pathologic biomarkers on magnetic resonance imaging (mri) data. methods: the present study retrospectively collected a dataset of 367 glioma patients, who had pathological reports and underwent mri scans between october 2013 and march 2019. the radiomic features were extracted from enhanced mri images, and three frequently-used machine-learning models of lc, support vector machine (svm), and random forests (rf) were built for four predictive tasks: (1) glioma grades, (2) ki67 expression level, (3) gfap expression level, and (4) s100 expression level in gliomas. each sub dataset was split into training and testing sets at a ratio of 4:1. the training sets were used for training and tuning models. the testing sets were used for evaluating models. according to the area under curve (auc) and accuracy, the best classifier was chosen for each task. results: the rf algorithm was found to be stable and consistently performed better than logistic regression and svm for all the tasks. the rf classifier on glioma grades achieved a predictive performance (auc: 0.79, accuracy: 0.81). the rf classifier also achieved a predictive performance on the ki67 expression (auc: 0.85, accuracy: 0.80). the auc and accuracy score for the gfap classifier were 0.72 and 0.81. the auc and accuracy score for s100 expression levels are 0.60 and 0.91. conclusion: the machine-learning based radiomics approach can provide a non-invasive method for the prediction of glioma grades and expression levels of multiple pathologic biomarkers, preoperatively, with favorable predictive accuracy and stability. gliomas are the most common brain tumors and are often classified as world health organization (who) grades i-iv, depending on the different tumor cells, and the degree of abnormality (1, 2) . as a tumor's grade increases, gliomas process more aggressively (3) . treatment options and responses differ from glioma grades (4) . pathological findings are the premise of rational treatment. usually, glioma grades are confirmed by pathological examination during surgery or biopsy (5) . then, a following immunohistochemistry (ihc) test determines the molecular biomarkers of tumor tissues at the microscopic level. these pathologic biomarkers, typical proteins, are useful indicators for diagnosis, prognosis, or treatment response (6) . however, obtaining such information for gliomas requires invasive approaches. the surgical decision making could be difficult and time-consuming for many patients. those patients who are not eligible for a surgery or seek nonsurgical treatment may have limited treatment options without pathological guidance. therefore, presurgical glioma grades and the expression of biomarkers are valued and preferred with non-invasive approaches. at present, the medical imaging can differentiate the tumor phenotype and intra-tumor heterogeneity (7) . conventional magnetic resonance imaging (mri) is routinely used in the diagnosis and management of glioma patients. t1-weighted contrast-enhanced mri (t1c) is the current standard for initial brain tumor imaging (8) . radiomics can generate image features with high dimensional data from the intensity histogram, geometry and texture analyses on the entire tumor volume (9) . with the emergence of artificial intelligence (ai) technologies, advanced informatics tools have become accessible to facilitate machine learning (ml) based radiomics applications using image features as the data source (10) . radiomics is gaining ground in oncology and have the potential to accurately classify or predict tumor characteristics. radiomics approaches have been applied for the predictions of glioma grades or differential diagnoses (11, 12) . several studies have reached a prediction accuracy of above 80% using popular ml models. the commonly and frequently used ml algorithms in radiomics include logistic regression (lr), random forests (rf), support vector machine (svm), and etc. each ml method has their own advantages in the classification. for example, lr fits the variables coefficients and predicts a logit transformation of the probability of being one class or the other. svm separates the classes by finding an optimal hyperplane. rf uses bootstrap aggregating to decision trees and improves classification performance. when compared to tumor grading, to make predictions at a molecular level is more challenging. kickingereder et al. reported the association between established mri features and cancer gene variations (egfr amplification and cdkn2a loss), but failed to build a sufficient ml model to predict the molecular characteristics (13) . in clinic, pathologic biomarkers are more frequently tested for than genetic testing. idh1 is one important glioma biomarker and idh1 mutation along with 1p/19q is a part of the molecular diagnosis in the updated 2016 who classification (14) . ki67, s100, and gfap are also the common protein targets for gliomas. idh1, ki67, and gfap were once considered as the golden triad of glioma ihc (15) ki67 is highly correlated to proliferation that may indicate the tumor grades and prognosis (16) (17) (18) . s100 has been implicated in the regulation of cellular activities, such as metabolism, motility, and proliferation. under the pathological conditions of tumor and inflammation, the concentration of the s100 protein increases to the micromole level, which stimulates microglia and astrocytes, and increases the expression of pro-inflammatory cytokines (19) (20) (21) (22) (23) . gfap is the most widely used markers of astrocytes (24) . under the condition of injury (trauma or disease), the expression of gfap in astrocytes rapidly increases (25) . gfap is often used to reveal the astrocytic lineage of glial cells and glial tumor cells, and plays a more significant role in tumor pathology, when compared to the differential diagnosis of astrocytoma. ki67, s100, or gfap may not be a reliable diagnostic biomarker for gliomas, because their roles in gliomas are still under investigations, while controversies have been observed in experiments (26) . however, there is no doubt that these proteins can provide some insights into the tumor intramicroenvironment. so far, it is not surprising to know that most radiomics studies favor the prediction of the idh expression for molecular diagnosis (11, 27) , with a few reports on ki67 (28) . in order to expand predictive effects of radiomics, the investigators aimed to assess the prediction feasibility of glioma grades and the pathologic biomarkers of ki67, s100, and gfap in gliomas. the investigators believed that the combination of multiple biomarkers can increase the predictive power, and the information obtained can help in understanding the underlying pathologic process in gliomas. the investigators designed the present retrospective study and extracted hundreds of radiomic features from the t1c images of 367 glioma patients. three machine-learning-based models (lr, svm, and rf) were built to perform the tasks: (1) classify the glioma grades, and (2) predict the expression levels of ki67, s100, and gfap. this study demonstrated that multiple pathologic biomarkers in gliomas can be estimated to the certainty levels of clinical using common ml models on conventional mri data and pathological records. the investigators retrospectively collected a data set of 420 glioma patients, who had pathological reports and mri scans performed between october 2013 and march 2019, from the second xiangya hospital of central south university. the patients who met the following criteria were included: (i) a histopathological diagnosis of primary glioma based on the who classification, (ii) the availability of ihc profiles of biomarkers (s100, gfap, and ki67), (iii) preoperative mri data of post-contrast axial t1-weighted (t1c), and (iv) age > 18 years old. patients were excluded due to the following: (i) secondary gliomas or postoperative recurrence of gliomas, (ii) obvious artifacts in mri. ethics approval was obtained for the present study from the ethics committee of the second xiangya hospital, central south university. patient demographics (age and gender), and histopathologic diagnosis and ihc results were obtained from a surgical pathology report. on these reports, the diagnosis included a specific glioma type by cells (e.g., astrocytoma and oligodendrogliomas) and a given who grade (i-iv). the ihc results were presented in the list of glioma biomarkers (e.g., s100, gfap, or ki67) and their own expression profile in tumor cells. it is noteworthy that the list was not standard and varied upon the request or availability of the biomarkers at that time. for example, few patients received an idh1 test before 2017, but after 2016, the who classification standard was published, and idh1 tests became common. so, a patient might have a different set of tested biomarkers, and the number of cases can differ for each biomarker. their ihc results depended on the scoring system used. the expression levels were usually evaluated by the staining intensity of positive cells, and points were assigned to describe these positive cells by count (e.g., 0 points as negative (−), 1 point as positive (+), 2 points as medium positive, and 3 points as high positive), percentage (e.g., 0 points as none, 1 point less than 5%, 2 points approximately 5-25%, and 3 points above 25%), or the appearance of a clear brown color (e.g., 1 point for light yellow). in the study, the glioma grades were classified as low-grade (who i-ii, benign) and high-grade (who iii-iv, malignant), and expression levels of biomarkers were divided into two categories: a low expression scored less than 2 points and a high expression scored 2 points or above. magnetic resonance imaging scans were acquired from different scanners over time. the picture archiving and communication system (pacs) exported the selected dicom images to a local computer using the radiant dicom viewer (medixant, pl). in order to reduce the influence of different scanning parameters, post-processing and image registration were applied using the advanced normalization tools (ants 2.1, pa). then, the dicom images were loaded into itk-snap for segmentation and standardization (29) . two neuroradiologists (5 years of experience) drew the region of interest (roi) around the tumor boundary on the t1c images. the neuroradiologists were blinded to the patient identification and diagnosis. after a joint effort, disagreements with the boundary were solved. the roi segmentations were resampled to match the dimensions of the original images, and both images were saved in.narrd as the input for feature extraction. the pyradiomics extractor was customized to calculate and extract the features (10). all built-in filters [wavelet, laplacian of gaussian (log), square, square root, logarithm, and exponential] were enabled on five image feature classes [first order statistics, shape descriptors, and texture features on the gray-level co-occurrence matrix (glcm), gray-level run length matrix (glrlm), and gray-level size zone matrix (glszm)]. feature definitions and calculation algorithms were available in the pyradiomics documentation 1 . the feature importance and the following predictive ml methods were implemented using python (version 3.7.0) with machinelearning library scikit-learn (version 23.0) (30) . all features were standardized through min-max scaling. features with all zero scores were removed. clinical data (age and gender) were added in constructing the final prediction models. the feature importance helped in understanding the importance of the features, since a large number radiomics features with high-dimensional data are difficult to interpret. three technique approaches were used to identify the important features. first, chi-squared (chi 2 ) tests were applied in the scikit-learn selectkbest class to obtain a list of the top 15 best features. second, the heatmap of correlated features was plotted to identify features highly correlated to predicting targets (glioma grade and biomarker expression) using the seaborn library. third, a rf classifier was initiated and the in-build feature importance was used to extract the top features. three frequently-used machine-learning based models of lr, svm, and rf were built for four predictive tasks: (1) glioma grades, (2) ki67 expression level, (3) gfap expression level, and (4) s100 expression level in gliomas. each sub dataset was divided into training and testing sets at a ratio of 4:1 (train_size = 0.8, test_size = 0.2). principal component analysis (pca) was applied for high-dimension reduction that maps n-dimensional features to k-dimensional features (n > k), resulting in brand new orthogonal features. for the unbalanced data in different classes, the synthetic minority over-sampling technique (smote) algorithm was used to oversample the minority class (31) . on training set, the grid search with crossvalidation was applied for hyper parameters tuning (rf and svm), and k fold validation was used for lr. the accuracy score was compared with the result from their base models (default settings in scikit-learn) for model selection. the testing set was used for final model evaluation. the performance of the models was evaluated according to accuracy, the area under curve (auc) of the receiver operating characteristic (roc), sensitivity, specificity, the positive prediction value (ppv), and the negative predictive value (npv). according to the auc and accuracy, the best classifier was chosen for each task. one way-anova or simple t-test was applied to test the differences among gender, age, glioma grade, and the expression levels of the biomarkers. descriptive statistics was used to summarize the important features through filters and feature classes. all significant levels were tested at 0.05. a data set of preoperative mri and surgical pathologic reports of 420 glioma patients were collected. a total of 51 patients were excluded for not meeting the inclusion criteria. among these patients, 40 patients were under 18 years old, seven patients had quality issues on their mri data, and four patients did not have an assigned who classification level in their records. the age of the enrolled 369 patients ranged within 18-75 years old (mean age: 45.63 ± 13.22 years old), and consisted of 210 males (age: 46.99 ± 13.24 years old), and 159 females (age: 43.84 ± 13.03 years old). the clinical characteristics of patients and the distribution of the selected biomarkers across glioma grades are presented in table 1 . the expression of gfap, ki67, and s100 was reported as follows: 367 patients had gfap results with four negatives (0 point), 323 positives (1 point), and 35 medium (2 points), or 5 high positives (3 points); 348 patients underwent ki67 tests, including 96 negatives or low positives (≤5% in tumor cells), and 252 strong positives (>5%); 338 patients underwent s100 tests, which included eight negatives (0 points), 315 positives (1 point), and 15 medium positives (2 points). there was a significant age difference among male and female patients, as determined by one-way anova [f (1, 367) = 5.17, p < 0.05]. furthermore, there were significant differences in age, gender and tumor volume among glioma grades (who i-iv). moreover, there were significant differences in glioma grade, tumor size, age and gender for the ki67 expression. however, there were no significant differences in age, gender and glioma grade for s100 and gfap expression. the t-test and one-way anova results are shown in table 2 . the investigators obtained the list of the top 15 important features based on the scores obtained from the chi-squared stats between each non-negative feature and the glioma grade, and s100, gfap, and ki 67 expression levels. the features and their scores are shown in table 3 . the scores ranged within 3.67-44.04. the mean score of the top important features was 9.30, with a standard deviation of 5.83. the frequent top features within the image type were exponential (23), wavelet (22) , square (6), square root (3), original (3), gradian (2), and ihp-2d (1). for the feature classes, the frequent top features were divided as follows: glszm (27) , glcm (9), glrlm (8), gldm (7), first order (7), and ngtdm (2) . the heatmaps of the correlated features for glioma grade and the biomarkers of ki67, gfap, and s100 are presented in figure 1 . the rf model built-in feature importance is presented in figure 2 . the performance of the 12 predictive models is presented in table 4 . the rf models performed slightly better, when compared to the other models. the comparisons with accuracy and the results are presented below. figure 3 shows the auc_roc for the rf classifier in sub test sets. the sub data set was randomly split into the training set of 276 cases and the test set of 93 cases. with a pca retention of 0.95, the pca process reduced the dimensions frontiers in oncology | www.frontiersin.org a total of 338 patients had s100 test results, which included 323 low expression levels (<2 points) and 15 high expression levels (≥2 points). the class distribution was 323:15. the training set and test set were split into 270 and 68, respectively. after the smote oversampling, the resampled number increased to 518. with a pca retention of 0.95, the pca process reduced the dimensions to 38 components, and these were used for the final prediction model for the s100 expression. after grid search with cross validation (cv = 5) or k fold validation (n_splits = 5), the selected classifier included: (1) lr (penalty = "l2, " c = 1.0), (2) svm (c = 1, kernel = "rbf, " and gamma = "auto"), and (3) rf (min_samples_leaf = 1,min_samples_split = 2, and n_estimators = 100). among these classifiers, the rf classifier achieved the best prediction performance on the s100 expression, based on the measurements (auc: 0.60, accuracy: 0.91, averageweighted sensitivity: 0.88 specificity: 0.91, and f1 score: 0.90). it is noteworthy that the average-weight computes f1 for each class, and returns the average while considering the proportion for each class in the dataset. for s100 low expression levels: accuracy (0.95), sensitivity (0.94), specificity (0.97), and f1 (0.95). for high expression levels: none of the four high expression cases was correctly predicted. a total of 367 patients had a gfap test. among these patients, there were 327 low expression levels and 40 high expression levels. the class distribution ratio was 327:40. the training set and test set were split into 293 and 74, respectively. after the smote oversampling, the number of samples increased to 532. with a pca retention of 0.95, the pca process reduced the dimensions to 38 components, and those that remained were used for the final prediction model for the gfap expression. after grid search with cross validation (cv = 5) or k fold validation (n_splits = 5), the selected classifier included: (1) lr (penalty = "l2, " c = 1.0), (2) svm (c = 1, kernel = "rbf, " and gamma = "auto"), and (3) rf (min_samples_leaf = 1,min_samples_split = 2, and n_estimators = 100). among these three classifiers, the rf classifier achieved the best predictive performance on the gfap expression measured, as follows: auc (0.72), accuracy (0.81), average-weighted sensitivity (0.74), specificity (0.81), and f1 score (0.76). the machine-learning based radiomics approach was applied to predict glioma grades and the expression levels of pathologic biomarkers ki67, gfap, and s100 in low or high. the overall performance of the ml models was satisfactory. the rf algorithm was found to be stable and consistently performed better than lr and svm. feature importance varies on predictive tasks, glioma grade or specific protein expression. the most frequent important feature classes were textual and first order statistics. we selected lr, svm, and rf as classifiers mainly for their popularity. lr, svm, and rf classifiers can work on non-text data set less than 100k. whether the data is linearly divisible or not, the linearly separable models (lr, svm), and the non-linear separable model (rf) are helpful to view the effect and avoid the impact due to poor data. lr shows a higher auc, in gfap's prediction model, but performs worst in s100's prediction. comparing the overall results from three biomarker prediction models, the combination of pca reduction and rf classification consistently performed best. it suggests a common ml pipeline that may be helpful in standardizing the prediction process of multiple protein expressions. also more recently, researchers have demonstrated achievements of deep learning (dl) in the image segmentation and glioma grades prediction (32) (33) (34) (35) (36) (37) . convolutional neural networks (cnns) started outperforming other methods on several high-profile image analysis projects. dl has advantages in computation, as high-performance graphics processing unit (gpu) supports fast computing and less time on modeling. like a kind of end-to-end learning, dl can automatically extract relevant functions from images, and tasks such as raw data processing and classification can be completed automatically. however, dl is complex and requires thousands of images to start with, otherwise due to a relatively small collection of images like ours, overfitting is more likely. the classic ml methods met our needs and suited the data. rf models performed well for predicting glioma grades and pathologic biomarkers s100, ki67, and gfap. as it is known, the roles of these biomarkers can be complicated and controversial in laboratory experiments (26) . in addition to the abilities of predicting tumor phenotypes, radiomics might offer a new approach to evaluate biomarkers, since their differentiation can be identified through the analysis of imaging features. the expression level of ki67 was significantly correlated with the tumor grade and tumor volume, as well as the patient age and gender. a study once reported that the high level of ki-67 expression was correlated to poor overall survival (os) and progression free survival (pfs) (16) . the accurate prediction of high level ki67 is more meaningful than its low level expression to indicate poor prognosis for glioma patients. the gfap has been widely expressed in gliomas. merely four patients presented as gfap negative. the majority of the patients (323 of 367, 88%) had gfap positive (+), and 327 patients with low expression gfap (90%), combined with four that scored (−), were distributed all over the gliomas grades, including low grade (132, 40%), and high grade (195, 60%). the minority of the patients (40 of 367, 12%) had gfap medium positive (++) or high positive (+++) distributed in low grade (15, 37 .5%) and high grade (25, 62 .5%). in the literature, a high gfap expression is likely to be found in low grade gliomas. the present result was confusing, that is, the high and low expression levels of gfap were more correlated to high grade gliomas. this result may echo that gfap is not a direct predictor of low grade gliomas (15, 26) . on the classification report of the rf_gfap model, the accuracy score of predicting a gfap low expression was up to, while that of predicting high expression levels of gfap was much lower. the overall prediction performance might not be meaningful, since gfap was lowly expressed in 90% of patients, and the model could always answer 90% correctly. the same problem was found in the predictive model of s100. it required the rethinking of these two models. there was a need to determine which expression class is more valued. and then, as one solution, the roc thresholds can tuned, increasing the sensitivity of the favored class. the interpretation of the predicted results is complex, but may be helpful to understand the molecular mechanisms it underlies. in addition, the investigators selected ce mri from several typical cases for demonstration, in which the different expression levels of biomarkers exhibited different imaging characteristics (figure 4) . for the high expression of s100 case (figure 4a) , the tumor exhibited an obvious rosette enhancement, no enhancement of internal necrotic components, and a few edema zones around it, and was diagnosed as glioblastoma (who iv grade). in the image of the tumor with a low expression of s100 (figure 4b) , the tumor mass effect was obvious, but there was no obvious enhancement, and the surrounding edema was not obvious, which was diagnosed as astrocytoma (who ii grade). in this case, the positive correlation appeared as both the s100 and glioma grade moved in the same direction that was contrary to many observations. the study conducted by wang et al. has proven that s100 is expressed in most gliomas, and that this is an important inducer of ccl2 (19) . ccl2 participates in the transport of tumor-associated macrophages (tam) in gliomas, which affects angiogenesis, invasion, local tumor recurrence and immunosuppression. this may explain the relationship between the degree of tumor enhancement and the expression of s100 in the present cases. there are some limitations in our study. first, we only used conventional mri sequences with a default set of tumor features extracted by pyradiomics. advanced mri sequences (e.g., dwi, dki, mrs, asl, et al.) can reflect the microstructure and metabolic information of tumors. in future study, we will further investigate the molecular phenotype of gliomas using a multimode magnetic resonance scheme. second, we only selected 3 common pathologic biomarkers for gliomas from a wide range of biomarkers either current available or under investigation. we have to develop an evaluation plan for other glioma biomarkers and find candidates that can be benefit from radiomics applications. third, imbalance classes did not reflect the incidences of glioma in real world, where glioblastoma is the most common subtype, and grade i glioma is relatively rare in adults. we used the smote algorithm to balance data, oversampling the minority class, but the differences in data distribution cannot be ignored. in our experiments, before and after the use of smote, auc was only changed slightly. a larger dataset from multiple sites is expected to complement predictive effects, and the resulting classifiers can be more accurate and stable. fourth, after pca reducing feature dimensions, a new set of features was less remained but difficult to interpret. a combination of hierarchical clustering on pca may help us to select feature more efficiently. at the current stage, a real-world application is out of our scope, but further prospective assessment is warranted. based on the results we obtained as a reference, we will extend the study to identify the best classifier algorithm and the best set of features to simplify the classification tasks. the standardized computation methods would greatly enhance the reproducibility of radiomics studies, and it may also lead to standardized software solutions available in clinical practice. in conclusion, the machine-learning based radiomics application provided a non-invasive approach for the prediction of glioma grades and expression levels of multiple pathologic biomarkers, with favorable predictive accuracy and stability. the study also demonstrated the potential of radiomics for pathological assessment and individualized cancer treatment. the raw data supporting the conclusions of this article will be made available by the authors, without undue reservation. the studies involving human participants were reviewed and approved by ethics committee of the second xiangya hospital of central south university. written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements. the 2007 who classification of tumours of the central nervous system glioblastoma and other malignant gliomas: a clinical review cbtrus statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2006-2010 malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods limitations of stereotactic biopsy in the initial management of gliomas molecular pathology of tumors of the central nervous system how clinical imaging can assess cancer biology current clinical brain tumor imaging radiomics in glioblastoma: current status and challenges facing clinical implementation computational radiomics system to decode the radiographic phenotype multimodal mri features predict isocitrate dehydrogenase genotype in highgrade gliomas machine learningbased radiomics for molecular subtyping of gliomas radiogenomics of glioblastoma: machine learning-based classification of molecular characteristics by using multiparametric and multiregional mr imaging features the 2016 world health organization classification of tumors of the central nervous system: a summary ki67 and idh1: perhaps the golden triad of glioma immunohistochemistry ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis the use of the monoclonal antibody ki-67 in the identification of proliferating cells: application to surgical neuropathology diagnostic and prognostic role of ki67 immunostaining in human astrocytomas using four different antibodies s100b promotes glioma growth through chemoattraction of myeloid-derived macrophages the heterodimeric complex of mrp-8 (s100a8) and mrp-14 (s100a9) biochemical characterization and subcellular localization in different cell lines anti-infective protective properties of s100 calgranulins biology of the s100 proteins-introduction glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of alexander disease importance of gfap isoform−specific analyses in astrocytoma a radiomics nomogram may improve the prediction of idh genotype for astrocytoma before surgery radiomic features predict ki-67 expression level and survival in lower grade gliomas userguided 3d active contour segmentation of anatomical structures: significantly improved efficiency and reliability scikit-learn: machine learning in python smote for high-dimensional class-imbalanced data deep multi-scale 3d convolutional neural network (cnn) for mri gliomas brain tumor classification automated glioma grading on conventional mri images using deep convolutional neural networks prediction of lower-grade glioma molecular subtypes using deep learning deep transfer learning and radiomics feature prediction of survival of patients with highgrade gliomas a novel fully automated mri-based deep-learning method for classification of idh mutation status in brain gliomas idhresidual convolutional neural network for the determination of status in low-and high-grade gliomas from mr imaging jl, mg, and sh: conception and design, and provision of study materials or patients. jl and ry: administrative support. mg, sh, xp, xl, and jl: collection and assembly of data. mg, sh, xp, and jl: data analysis and interpretation. all authors: writing and final approval of the manuscript. the authors express their appreciation to ying zeng for the acquisition, analysis, and interpretation of data for the work. key: cord-327543-kibjwfad authors: ong, s. j.; renfrew, i.; gopinathan, a.; tan, a. p.; sia, s. y.; low, c. k.; hoon, h. x.; ang, b.w.l.; quek, s. t. title: sir helmet (safety in radiology healthcare localised metrological enviroment): a low-cost negative-pressure isolation barrier for shielding mri frontline workers from covid-19 exposure date: 2020-07-01 journal: clin radiol doi: 10.1016/j.crad.2020.06.015 sha: doc_id: 327543 cord_uid: kibjwfad • low cost reusable acrylic and silicone rubber barrier shield design. • localised negative pressure environment simulating isolation rooms. • does not affect mri image quality even on the most sensitive sequences. • additional personal protective equipment for frontline healthcare professionals. covid-19 is a highly infective infectious disease caused by a novel coronavirus first identified in wuhan, china, in december 2019. it has now evolved into a pandemic affecting at least 216 countries. the precise incidence of stroke in covid-19 patients is unknown but is thought to affect up to 5.7% of severely affected individuals [1] . it is also being recognised as the first clinical presentation of covid-19, especially in young patients [2, 3] . although computed tomography (ct) is the first-line technique to assess patients presenting with acute stroke symptoms, many centres prefer to evaluate further with magnetic resonance imaging (mri) [4] . hence, more patients with covid-19 are attending for mri examinations. in well-resourced hospitals, infective covid-19 patients are nursed within negativepressure rooms. even within these negative-pressure rooms, research has shown extensive environmental contamination when occupied by infected patients [5] . although patients can be provided with filtering face piece (ffp) masks to reduce their infectivity, studies have demonstrated high rates (up to 87%) of poor fit of the face masks among untrained non-healthcare professionals [6]. most mri rooms are not built with negative-pressure ventilation systems. in addition, there are limitations to the use of personal protective equipment (ppe) by both patients and staff within the magnetic field of the mri room. therefore, each time a patient with covid-19 undergoes mri, there is a real risk of mri room contamination and exposure of both staff and subsequent patients to the virus. to address the above problem, a low-cost physical barrier was designed and developed for use within the mri machine that could produce a localised negativepressure containment area around the patient's head. the barrier has been named "sir helmet" from safety in radiology healthcare localised metrological enviroment. the "helmet" can potentially reduce the spread of pathogens via the patient's breath. in addition to assessing its functionality, the present study also evaluates the impact of the shield on mri image quality. the sir helmet is a dome shaped, re-useable barrier that fits into mri machines with a bore size of ≥65 mm. it is made of 3 mm clear acrylic with chloroform used as the primary adhesive. the access port on the front of the "helmet" is covered with a 1.5 mm silicone rubber membrane with slits for access and clamped to the main structure with another layer of 3 mm acrylic, held together by plastic screws (fig. 1) . the calculated raw volume of the helmet is 139 l with an effective net gas volume of approximately 130 l or less depending on patient position within the barrier shield. negative pressure within the "helmet" is generated by connecting a standard medical gas wall vacuum using extension tubing via a port in the barrier shield. continuous for this study, two healthy volunteers were scanned in a 3 t magnetom skyra mri unit (siemens, munich, germany) and a 1.5 t optima mri unit (ge healthcare, chicago, il, usa) using standard head and neck sequences (eight sets of examinations in total; four of the head and four of the cervical spine). each participant was scanned using each machine by the same senior mri radiographer with and without the "helmet". images were loaded onto a standalone staging picture archiving and retrieval system, centricity universal viewer (ge healthcare). the eight anonymised sets of images were reviewed on diagnostic-quality monitors by two consultant musculoskeletal radiologists, two consultant neuroradiologists, and two consultant clinical diagnostic radiologists, blinded to the acquisition history of the images. overall, eight examination sets were read independently by six different readers to provide 48 total sets for scoring. images were scored on a scale of 1 to 4 regarding diagnostic quality, structural delineation, and severity of artefacts for each set of images as per ryu et al. [7] with area for free-text comment. negative pressure airflow rates of >20 l/min was obtained with the underwater seal filter system and at 40 l/min without. this allowed at least 9.2 full gas exchanges per hour for the underwater seal filtered system and at least 18.5 for the other one. there was consensus regarding scoring of all eight sets of images among all the readers with full points for diagnostic quality, delineation of structural margins, and complete lack of mri-related artefacts (fig. 2) . post-scoring, the readers were informed that half of the image sets were performed with the "helmet", but they were not able to identify these sets from those scanned without the helmet. although transmission of covid-19 is predominantly via direct contact or aerosol inhalation, it may also occur via indirect delayed contact, for example, through the use of the same physical seat [8] . droplet transmission enhanced by air-conditioning airflow creating super spreaders is also documented [9] . hence, isolation of the most infective patients is essential [10] . nevertheless, when an infected patient is brought outside their isolation ward to other clinical areas, such as radiology departments, this "isolation" is interrupted, creating potential opportunities for virus dissemination. as the covid-19 pandemic continues, there is high likelihood that more coronavirus-infected patients would present with stroke or stroke-like symptoms, thereby increasing the need to perform mri examinations in these patients. as a limited resource, it may not possible to reserve an mri machine exclusively to image covid-19 patients. hence, it is essential to explore alternative ways to control the spread of infection from transit of an infected patient through an mri room. the effort of thoroughly cleaning the shield between patients is much less than that of cleaning the bore of the mri machine. using the ubiquitous medical gas wall vacuum apparatus, the "helmet" can provide at least 9.2 full gas exchange per hour with the afore-described filtration system or 18.5 full gas exchanges per hour without filtration. this gas exchange rate is similar to or above that of the requirements of a negative-pressure isolation facility, which is usually 10 to 15 exchanges per hour. hence, use of this helmet would effectively provide frontline healthcare staff and patients with an added layer of protection against airborne pathogens. this can also avoid the cost and time required in installing negative-pressure ventilation systems within an mri room. use of the helmet without suction is not recommended due to concerns regarding carbon dioxide retention during long examinations. in an unvented system, there are also concerns of a high concentration of aerosolised pathogen that the mri technician would be exposed to, while removing the "helmet" from the patient. the decision to vent the suction via an underwater seal sterilisation scrub or directly to the wall vacuum port would depend on the local hospital infection-control policy and the underlying infrastructure of the vacuum system. to improve patient comfort and to reduce claustrophobia, the helmet was intentionally fabricated using flame-polished translucent acrylic, using the biggest arc possible to maximise the sense of space. given the multitude of different scanner and coil configurations, the length of the "helmet" was increased intentionally to fit across all the mri machines within our institution. if required, it is possible to customise this shield for individual scanners with shorter lengths to increase the air exchange rates. acrylic is cheap and can be fabricated quickly, and in addition, is suitable for cleaning with most of the usual disinfectants. the image quality of mri examinations was not affected by scanning with the helmet on. the adoption of this or similar barriers would provide frontline healthcare staff and patients with an additional level of protection without prohibitive financial costs to the institution. highlights: 1 • low cost reusable acrylic and silicone rubber barrier shield design 2 • localised negative pressure environment simulating isolation rooms 3 • does not affect mri image quality even on the most sensitive sequences 4 • additional personal protective equipment for frontline healthcare professionals covid-19-related stroke large-vessel stroke as a presenting feature of covid-19 in the young covid-19 presenting as stroke imaging of acute stroke prior to treatment: current clinical feasibility of 1-min ultrafast brain mri compared with routine brain mri using synthetic mri: a single center pilot study investigation of three clusters of covid-19 in singapore: implications for surveillance and response measures covid-19 outbreak associated with air conditioning in restaurant rapid expansion of temporary, reliable airborne-infection isolation rooms with negative air machines for critical covid-19 patients key: cord-338751-2eo7ityc authors: anzalone, nicoletta; castellano, antonella; scotti, roberta; scandroglio, anna mara; filippi, massimo; ciceri, fabio; tresoldi, moreno; falini, andrea title: multifocal laminar cortical brain lesions: a consistent mri finding in neuro-covid-19 patients date: 2020-06-06 journal: j neurol doi: 10.1007/s00415-020-09966-2 sha: doc_id: 338751 cord_uid: 2eo7ityc nan neurologic manifestations of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) have been recently reported [1, 2] , with relevance to vascular aetiology [2, 3] . the neuroinvasive potential of sars-cov-2 has also been advocated, by infecting the cns through hematogenous or neuronal retrograde route [4] . here we report four cases of subacute encephalopathy occurring in patients with sars-cov-2 infection. they are part of a series of 21 patients presenting with neurological symptoms studied with brain mri with otherwise no significant imaging findings. a multifocal involvement of the cortex was evident in all cases (figs. 1, 2) . the multiple areas, from punctiform to some millimeters in extension, appeared hyperintense on t2-weighted and flair images and were located in the parietal, occipital and frontal regions. on diffusion mri, all but two of the lesions were characterized by the absence of apparent diffusion coefficient (adc) changes (figs. 1c, 2c). a minimum involvement of the adjacent subcortical white matter was evident in only a few lesions. susceptibility-weighted imaging (swi) sequences were acquired in all patients and did not show any alteration. very subtle contrast enhancement was detected only in a cortical lesion. in one patient a follow-up mri scan was obtained after one month, demonstrating a complete resolution of all the lesions (fig. 2f-l) . all patients (2 men, 2 women; age range 46-63 years) have been intubated in the first week from onset of ards and presented neurological signs of agitation and spatial disorientation after weaning from mechanical ventilation. one patient had a generalized seizure. the time interval from onset of neurological symptoms to mri was 2-6 days. diagnosis of covid-19 was made by detection of sars-cov-2 viral nucleic acid in a nasopharyngeal swab specimen. all patients received the same treatment for sars-cov-2 infection. none of the patients had a relevant clinical history or previous treatment or hypertension. laboratory findings revealed in all cases a second smaller c-reactive protein peak from the initial one and raise of serum level of aspartate and alanine transaminase before the onset of neurological symptoms. d-dimer elevation was present and stable during the disease course. mri lesions' characteristics are unusual but demonstrate a highly consistent pattern through all the four patients with similar neurological symptoms. they do not fulfill any typical criteria for a definite neuroradiological entity. we speculate that this pattern may be related to a possible transient dysregulation of vasomotor reactivity. in particular, the cortical involvement may suggest a possible vascular mechanism more shifted toward transient vasoconstriction. although the predominantly parieto-occipital distribution of the lesions recalls posterior reversible encephalopathy syndrome (pres) [5] , the prevalent cortical involvement and diffusion mri pattern are not typical of pres. at the same time, an alternative hypothesis of embolic cortical infarctions is unlikely due to the absence of diffusion restriction. it is currently known that sars-cov-2 might dysregulate the renin-angiotensin system (ras) system by acting on ace2 receptors, causing microcirculation impairment possibly impacting on blood flow regulation. more recently, evidence of direct viral infection of the endothelial cell and diffuse endothelial inflammation has been reported, resulting fig. 1 forty-seven-year-old man diagnosed with covid-19 and presenting neurological signs of agitation and spatial disorientation after weaning from mechanical ventilation. before the onset of neurological symptoms, laboratory findings revealed a c-reactive protein peak (262.5 mg/l, normal range 0-6 mg/l). a axial flair, b diffusion-weighted image (dwi), c apparent diffusion coefficient (adc) map and (d, e) sagittal flair mr images. multiple, cortical areas of punctiform and gyriform flair and dwi hyperintensity (arrows) in both parietal lobes, with no adc changes fig. 2 fifty-four-year-old woman diagnosed with covid-19 and presenting neurological signs of agitation and spatial disorientation after weaning from mechanical ventilation. before the onset of neurological symptoms, laboratory findings revealed a small c-reactive protein peak (27.5 mg/l, normal range 0-6 mg/l) and raise of total white blood cell count (12.9 × 10 9 /l, normal range 4.0-10.0 × 10 9 /l). cerebrospinal fluid (csf) analysis performed on the same day was negative for the presence of sars-cov-2 viral nucleic acid. a-e initial mri scan. f-l follow-up mri after one month. a, d, f, i axial flair, b, g diffusionweighted image (dwi), c, h apparent diffusion coefficient (adc) map and e, l sagittal flair mr images. multifocal linear and punctiform cortical flair and dwi hyperintensities in the left parietal lobe, bilateral precentral gyri and left middle frontal gyrus (a-c), with no adc changes. bilateral occipital involvement is shown in d, e, with a cortical/subcortical flair hyperintense lesion at the level of the left occipital pole. f-l follow-up mri demonstrates a complete resolution of all the lesions in endothelial dysfunction and impaired microcirculatory function [6] . along with inflammation, there is a tendency to thrombosis in more severe cases [7] . nonetheless, other vasculo-mediated mechanisms including altered vasomotor reactivity may play a role and cause neurological symptoms in covid-19 patients [6] . in this regard, normalization of mri findings in one patient (fig. 2f-l) may corroborate the hypothesis of a transient functional nature of the impaired cerebral microcirculatory function. we believe that, due to the peculiarity and subtle appearance of the mri findings, our report may alert neurologists and radiologists to the existence of this subacute neuroimaging picture in sars-cov-2 patients, clearly different from cortical ischemia, and also to inform clinicians about the possible spontaneous reversibility of the picture. neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, china neurologic features in severe sars-cov-2 infection large-vessel stroke as a presenting feature of covid-19 in the young neuroradiologists, be mindful of the neuroinvasive potential of covid-19 posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions endothelial cell infection and endotheliitis in covid-19 microvascular covid-19 lung vessels obstructive thromboinflammatory syndrome (microclots): an atypical acute respiratory distress syndrome working hypothesis informed consent all patients provided signed informed consent prior to mr imaging. informed consent was collected from the patients for the inclusion of deidentified clinical data in a scientific publication, in accordance with the declaration of helsinki. key: cord-339759-us1spoxu authors: cornelis, i.; volk, h. a.; van ham, l.; de decker, s. title: clinical presentation, diagnostic findings and outcome in dogs diagnosed withpresumptive spinal‐only meningoen‐cephalomyelitis of unknown origin date: 2017-03-07 journal: j small anim pract doi: 10.1111/jsap.12622 sha: doc_id: 339759 cord_uid: us1spoxu objectives: to summarise clinical presentation, diagnostic findings and long‐term outcome for dogs clinically diagnosed with meningoencephalomyelitis of unknown origin affecting the spinal cord alone. methods: medical records were reviewed for dogs diagnosed with presumptive spinal‐only meningoencephalomyelitis of unknown origin between 2006 and 2015. results: 21 dogs were included; the majority presented with an acute (43%) or chronic (52%) onset of neurological signs. ambulatory paresis was the most common neurological presentation (67%). neurological examination most commonly revealed a t3‐l3 myelopathy, and spinal hyperaesthesia was a common finding (71%). a spinal cord lesion was visible in 90% of cases on magnetic resonance imaging. eighteen lesions (86%) showed parenchymal contrast enhancement and 17 lesions (81%) showed contrast enhancement of overlying meninges. all dogs were treated with immunosuppressive doses of glucocorticosteroids, sometimes combined with cytosine arabinoside. at time of data capture, 10/21 dogs (48%) had died or been euthanased because of the condition. overall median survival time was 669 days. clinical significance: meningoencephalomyelitis of unknown origin should be considered in the differential diagnosis of dogs presenting with a progressive myelopathy. magnetic resonance imaging features can possibly help to distinguish presumptive meningoencephalomyelitis of unknown origin from other more common spinal diseases. overall, long‐term survival is guarded, approximately 50% of dogs will die or be euthanased despite appropriate therapy. pure myelitis (inflammation of spinal cord parenchyma) or meningomyelitis (inflammation of spinal cord parenchyma and surrounding meninges) are rare diseases in small animals but occur most often in combination with inflammatory brain disease (tipold & stein 2010 ) . viruses [canine distemper virus (cdv), feline coronavirus], bacteria ( staphylococcus species, et al . 2009 , csebi et al . 2010 , dewey et al . 2016 . apart from infectious causes, non-infectious meningoencephalomyelitis including granulomatous meningoencephalomyelitis, pyogranulomatous meningoencephalomyelitis and steroid-responsive meningitis-arteritis (srma) are described (meric 1988 , griffin et al . 2008 , parry et al . 2009 , dewey et al . 2016 . current terminology implies that dogs clinically diagnosed with non-infectious inflammatory myelitis without positive infectious disease testing, not classified as srma or eosinophilic meningomyelitis, and not histopathologically confirmed with alternative diagnoses are categorised as having meningoencephalomyelitis of unknown origin (muo), equivalent to dogs diagnosed with meningoencephalitis of unknown origin. a clinical diagnosis of muo is typically made by a combination of clinical presentation, mr imaging of involved part of the central nervous system (brain/spinal cord), and results of cerebrospinal fluid (csf) analysis (griffin et al . 2008 ) . currently, only one study has focused specifically on the clinical presentation, diagnostic findings and outcome in dogs with meningomyelitis caused by a variety of underlying aetiologies (griffin et al . 2008 ). of 28 cases included, 15 dogs were diagnosed with muo. clinical signs were reflected by the affected spinal cord segments, and younger dogs, toy breeds, and hound breeds were suggested to be predisposed for meningomyelitis. although results of myelography, ct, and ct-myelography have been reported, little is reported about magnetic resonance imaging (mri) findings in dogs with muo of the spinal cord. the aims of this study were therefore to describe the signalment, clinical presentation, diagnostic findings, including results of mri and long-term survival in dogs diagnosed with presumptive muo of the spinal cord without concurrent clinical signs of intracranial involvement. the electronic medical database was searched between march 2006 and february 2015 for dogs diagnosed with "mua," "muo," "gme," "myelitis," "inflammatory spinal cord disease." dogs were included based on the criteria used by granger et al . ( 2010 ) , if they had (1) complete medical records available, (2) a complete neurological examination performed leading to a spinal cord localisation, (3) inflammatory csf analysis, (4) mri of the spinal cord and if (5) long-term follow-up information were available through revision of medical records or through contacting the referring veterinarian by telephone. dogs were excluded if (1) the clinical records or imaging studies were incomplete or not available for review, (2) dogs showed clinical or neurological signs of intracranial involvement at time of presentation, (3) they had a peracute onset of clinical signs that were not progressive after 12 to 24 hours, (4) they had signs of extradural or extradural/intramedullary spinal cord compression on mri and if (5) they had positive infectious disease titres or if clinical presentation, csf analysis or necropsy findings were suggestive of srma or eosinophilic meningoencephalomyelitis (>10% eosinophils in csf) (dewey et al . 2016 ) . typical clinical presentation for srma was considered to be a dog less than 2 years of age of a typical breed (boxer, beagle, bernese mountain dog, nova scotia duck tolling retriever, golden retriever, german shorthaired pointer) presenting with pyrexia and cervical hyperesthesia. csf analysis in srma typically reveals a predominantly neutrophilic pleocytosis (dewey et al . 2016 ) . dogs with histopathological confirmation of the disease [granulomatous meningo(encephalo)myelitis (gme) or necrotising meningo(encephalo)myelitis (nme) only needed to fulfil inclusion criteria (1) and (5). information retrieved from the medical records included breed, gender, age at diagnosis, body weight, results of neurological examination including neuroanatomical localisation, duration of clinical signs prior to diagnosis, results of complete blood count (cbc) and biochemistry profile, results of csf analysis including total nucleated cell count (tncc), white blood cell differentiation and total protein (tp) concentration, treatment received and outcome. duration of clinical signs prior to diagnosis (days) was classified as peracute (<2 days), acute (2 to 7 days) or chronic (>7 days). for dogs that had csf analysis performed, site of collection (cisternal or lumbar), tncc, tp and cytological differentiation were recorded. tncc was considered normal if there were <5 cells/mm 3 . protein concentration was considered normal for a cisternal collection if <0·25 g/l and for a lumbar collection if <0·4 g/l. the neurological status was classified from 0 to 5 according to the clinical examination (adapted from scott 1997 ): grade 0=neurologically normal; grade 1=spinal hyperaesthesia without neurological deficits; grade 2=ataxia, ambulatory para-or tetraparesis; grade 3=non-ambulatory para-or tetraparesis; grade 4=para-or tetraplegia with or with-out bladder control, and intact deep pain sensation; grade 5=para-or tetraplegia, urine retention or overflow, and deep pain sensation loss. possible neuroanatomical localisations included c1 to c5, c6 to t2, t3 to l3 or l4 to s3 spinal cord segments. dogs were diagnosed with a focal lesion if only one spinal cord segment was affected, and with a multifocal lesion if more than one spinal cord segment appeared to be affected on the neurological examination. magnetic resonance imaging mri was performed under general anaesthesia with a permanent 1.5-t magnet (intera, philips medical systems, eindhoven, the netherlands) and all images were reviewed by the corresponding author using osirix dicom viewer (osirix foundation, v.5.5.2 geneva, switzerland). sequences varied, but included a minimum of t2-weighted (t2w) [repetition time (ms) (tr)/ echo time (ms) (te), 3000/120] and t1-weighted (t1w) (tr/ te, 400/8) images of the affected spinal cord region in a sagittal and transverse plane. the t1w images were acquired before and after intravenous (iv) administration of paramagnetic contrast medium with a dose of 0·1 mg/kg gadoterate meglumine (dotarem, guerbet). if mr images of the brain were available, they were reviewed concurrently. variables recorded were lesion intensity on t2w and t1w images, lesion localisation and distribution, lesion length and parenchymal and/or meningeal contrast enhancement. lesion length was measured using osirix dicom viewer, and performed on sagittal t2w images for dogs that had focal lesions. lesion length was measured twice, and the mean value reported. to compensate for differences in body size, values were corrected with respect to the length of vertebral body of c6 (for cervical lesions) or l2 (for thoracolumbar lesions). vertebral body length was measured on t1w sagittal images. for all dogs, the specific treatment protocol was recorded. during hospitalisation, all dogs underwent daily at least one general physical and complete neurological examination by a board-certified neurologist or neurology resident. the results of the neurological examination as well as response to treatment (improvement, deterioration or static) were systematically recorded on the kennel sheets. follow-up information during hospitalisation was collected from the medical records, and later through medical records of re-examination visits or telephone contact with the referring veterinarian. a successful outcome was defined as the dog being ambulatory, with faecal and urinary continence and, according to the owners, without overt spinal hyperaesthesia. an unsuccessful outcome was defined as (1) deterioration in neurological status by one or more grades after diagnosis and treatment or (2) if the dog was not independently ambulatory, possibly with previously non-existing or worsening faecal and/or urinary incontinence, or was experiencing spinal hyperaesthesia as defined by the owner. data analysis was performed with the aid of a standard statistical software package (prism, graphpad software inc). numeric variables were expressed as median and interquartile ranges (iqr). values of p<0·05 were considered significant. survival analysis was performed using both a log-rank (mantel-cox) and gehan-breslow-wilcoxin test, resulting in median survival time (mst) calculation and a kaplan-meier survival curve. survival was defined as time from diagnosis to death or euthanasia, including whether this happened because of disease progression or due to unrelated causes, or time from diagnosis to last follow-up for dogs that were alive at time of data capture. dogs that died because of unrelated causes and dogs that were still alive at time of data capture were censored for survival analysis. twenty-one dogs were included in the study. represented breeds included french bulldog (n=2), jack russell terrier (n=2), lhasa apso (n=2) and one each of akita, bearded collie, boxer, bull mastiff, chihuahua, cross breed, english springer spaniel, giant schnauzer, labrador retriever, maltese terrier, rhodesian ridgeback, rottweiler, shih-tzu, west highland white terrier and yorkshire terrier. overall, median age at presentation was 56 months (10 to 128 months). thirteen dogs (62%) were male and eight (38%) were female. compared to the general hospital population between march 2006 and february 2015, there was no difference in sex distribution in the group of dogs with muo (fisher ' s exact test; p=0·075). median duration of clinical signs prior to diagnosis was eight days (ranging from 1 to 90 days). one dog (5%) presented with peracute, nine dogs (43%) with acute and eleven dogs (52%) with a chronic onset of neurological signs. thirteen (62%) and eight (38%) dogs were diagnosed with a focal and multifocal spinal lesion on neurological examination, respectively. for dogs with focal spinal lesions (n=13), three were diagnosed with a lesion affecting the c1 to c5 spinal cord segments, two with a lesion affecting the c6 to t2 spinal cord segments, six with a lesion affecting the t3 to l3 spinal cord segments and two with a lesion affecting the l4 to s3 spinal cord segments. at time of diagnosis, no dogs presented as grade 0; 2 dogs (10%) were grade 1; 14 (67%) grade 2 and 5 (24%) grade 3. no dogs were paraplegic or tetraplegic at presentation. pain on direct spinal palpation was present in 15 (71%) dogs. urinary retention was observed in two dogs (10%), and a combination of urinary and faecal incontinence was noticed in two dogs (10%). one dog (5%) developed seizures 669 days after diagnosis of muo. clinical findings of the 21 included dogs are summarised in table 1 . as required by the inclusion criteria, csf collection revealed pleocytosis in all cases. overall, median tncc was 209 cells/ mm 3 (ranging from 6 to 6000). tp measurement was performed in all but three csf samples, and was above reference values in 17/18 dogs (94%). the median tp concentration was 1·67 g/l (ranging from 0·21 to 16·3 g/l). cbc and serum biochemistry results were available in 16 dogs (76%). leucocytosis was only present in two dogs (10%) and lymphopenia was present in six dogs (29%). infectious disease testing based on serology and/or polymerase chain reaction on csf for cdv, t . gondii , and n . caninum was not performed in two (10%) dogs and was negative in the remaining 19 (90%) dogs. in the two dogs lacking infectious disease testing, full necropsy was performed, revealing gme. magnetic resonance imaging mri of the spinal cord was available in all cases, revealing a focal lesion in 15 dogs (71%), a multifocal lesion in four (19%) and no lesion was visible on sagittal t2w or t1w images in two (10%). lesion length was measured in the focal cases only. median lesion/vertebral body ratio was 4·8 (ranging from 0·6 to 10·9). all visible lesions were ill-defined, intramedullary, hyperintense on t2w images and isointense on t1w images (figs 1 and 2 ). lesions showed parenchymal contrast enhancement in 18 dogs (86%), and contrast enhancement of overlying meninges in 17 (81%). in the two cases in which no lesion was visible on sagittal t2w and t1w images, there was also no observable parenchymal contrast, but one dog only showed meningeal contrast enhancement. in two dogs (10%) intracranial images were contained within the field of view of the cervical spinal cord images (t2w transverse and sagittal images), revealing multiple t2w hyperintensities in the forebrain and/or brainstem. neither of those dogs had clinical or neurological signs of intracranial involvement at time of diagnosis. the first dog, a 56-month-old jack russell terrier, did not recover from general anaesthesia after diagnostic procedures, and full necropsy revealed gme. the second dog, a 123-month-old rhodesian ridgeback, developed seizures 669 days after diagnosis and was euthanased without further investigations. as required by the inclusion criteria, outcome was available in all dogs. as described above, one dog did not recover from general anaesthesia for mri of the spinal cord, and was censored for survival analysis. mean duration of hospitalisation was five days (ranging from 1 to 19 days), with 17 dogs (81%) showing improvement in neurological status within that period. one dog (5%) remained neurologically stable (no improvement nor deterioration), and three dogs (14%) showed deterioration of their neurological status. all dogs were treated with immunosuppressive doses of glucocorticosteroids immediately after diagnosis. this consisted doses of 0·3 to 0·5 mg/kg/day dexamethasone in nine dogs (43%) iv and 2 to 4 mg/kg/day oral prednisolone in 12 dogs (57%). fourteen dogs (67%) received additional treatment with cytosine arabinoside as a constant rate infusion (cri) of 200 mg/m 2 over eight hours in one dog (7%) and as four subcutaneous (sc) injections of 50 mg/m 2 every 12 hours for two consecutive days in 13 dogs (93%). twenty dogs (95%) survived to discharge. of these dogs, nine dogs (45%) were still alive at time of data capture. of these nine dogs, eight were neurologically normal according to the followup information and one dog still showed ataxia and ambulatory paraparesis. of the eight normal dogs, two were still receiving a dose of 5 mg/kg cyclosporine every 24 hours, one was receiving a dose of 50 mg/m 2 cytosine arabinoside every 12 hours for two consecutive days every nine weeks, one was receiving a dose of 0·2 mg/kg prednisolone every 24 hours, one was receiving doses of 1 mg/kg prednisolone every 24 hours and 50 mg/m 2 cytosine arabinoside every 12 hours for two consecutive days every four weeks, and three dogs were not receiving any treatment at time of data capture. the dog that was still showing neurological abnormalities was receiving doses of 0·5 mg/kg prednisolone every other day and 50 mg/m 2 cytosine arabinoside every 12 hours for two consecutive days every 5 weeks. for the 11/20 dogs (55%) that were dead at the time of data capture, three had died or were euthanased because of disease progression, six were euthanased because of acute neurological deterioration after initial neurological improvement and two were euthanased because of unrelated causes (complications after stifle surgery and development of aggression). dogs that showed acute neurological deterioration after initial improvement did so within a median of 171 days after diagnosis (ranging from 30 to 669 days). of those six dogs, one showed acute deterioration after discontinuation of prednisolone treatment and five were still receiving treatment doses of 1 mg/kg prednisolone every 24 hours, 0·5 mg/kg prednisolone every 24 hours, 2 mg/kg prednisolone every 24 hours and 2 mg/kg azathioprine every 24 hours or 50 mg/m 2 cytosine arabinoside every 12 hours for two consecutive days every seven weeks. overall, we can conclude that 10/21 dogs (48%) died or were euthanased because of muo. overall, the mst was 669 days (ranging from 1 to 2250 days) (fig 3 ) . confirmation from post-mortem examination was available in three dogs, revealing gme in two and necrotising meningomyelitis in one dog. all clinical data are shown in tables 1 and 2 . this study evaluated the clinical presentation, diagnostic findings and long-term survival in 21 dogs diagnosed with presumptive spinal muo. dogs had a median age of five years at time of pain on direct spinal palpation was present in 71% of dogs. spinal pain may reflect the involvement of the meninges, and/ or vertebrae (vertebral periosteum), and/or nerve roots or spinal nerves (da costa 2012 ). in the present study, the lesions showed meningeal contrast enhancement in 18/21 dogs, but there was no apparent association between spinal hyperaesthesia and meningeal enhancement on mri. mri of the spinal cord revealed no lesion on sagittal t2w and t1w images in 10% of dogs (n=2), which appears similar to the 7% described for the brain in dogs with muo (granger et al . 2010 ). in the retrospective study of griffin et al . ( 2008 ) , only one dog with meningomyelitis had mri performed, revealing no abnormalities. based on these findings, muo cannot be ruled out based on unremarkable mri findings. the first dog was a 42-month-old bullmastiff with a 1-month history of slowly progressive t3 to l3 spinal cord lesion. after diagnostic procedures, the dog was treated with oral prednisolone but continued to deteriorate and was euthanased after 6 days. no post-mortem examination was performed. the second dog was a 136-monthold bearded collie with a 1-week history of a progressive multifocal spinal cord neuroanatomical localisation (t3 to s3 spinal cord lesion). the dog showed improvement on treatment with prednisolone and cytosine arabinoside (see table 1 ) after diagnostic investigations, and was still alive without current treatment 1100 days after diagnosis. both dogs had inflammatory csf analysis (increased tncc and tp concentration). for both dogs, vascular, degenerative or neoplastic spinal cord lesions cannot be excluded. as both dogs had a progressive disease course, a vascular (ischaemic) lesion seemed less likely. a neoplastic lesion cannot be excluded, although this seems rather unlikely in the bullmastiff considering his very young age. the second dog had a lymphocytic pleocytosis on cfs analysis, but no signs of lymphoma on microscopical examination, although no specific test for clonality was performed. all mri-observed lesions were extensive, ill-defined, intramedullary, hyperintense on t2w images and isointense on t1w images. other spinal conditions, including acute non-compressive nucleus pulposus extrusions (annpe) and ischaemic myelopathy (im), are also associated with intraparenchymal hyperintensities on mri. however, these conditions are associated with other clinical and additional mri characteristics, which could potentially aid in differentiating between these conditions (cardy et al . 2015 , fenn et al . 2016 ). according to cardy et al . ( 2015 ) , in dogs presenting with spinal cord dysfunction, im [most commonly fibrocartilagenous embolic myelopathy (fcem)] and annpe are typically characterised by a peracute onset of non-progressive clinical signs and affected dogs do not commonly demonstrate overt spinal hyperaesthesia at time of admission. this is in contrast with the clinical presentation of dogs with spinal muo, which was characterised by an acute onset of progressive and mainly symmetrical neurological deficits, with pain on spinal palpation or manipulation in 86% of dogs (cardy et al . 2015 ) , which is comparable with the 71% of dogs presenting with spinal hyperaesthesia in the current study. although csf analysis in dogs with im is most often within normal limits, affected dogs can demonstrate an increased tp concentration and mild neutrophilic or mixed cell pleocytosis with a median tncc of 12 cells/ µ l (de risio et al . 2007 ) . a marked pleocytosis with a median tncc of 209 cells/mm 3 was seen in the current study, although this conclusion should be treated with caution because csf pleocytosis was one of the inclusion criteria. to conclude, the presentation of a dog with an acute or chronic onset of a progressive and painful t3 to l3 myelopathy in combination with an extensive, ill-defined, intramedullary lesion plus parenchymal and/or meningeal contrast enhancement on mri, and marked pleocytosis on csf analysis, can be presumptively diagnosed with spinal muo. the importance of differentiating between these conditions is highlighted by the differences in treatment and prognosis between dogs with presumptive muo and dogs with annpe or im. a previous study demonstrated that short tau inversion recovery (stir) hyperintensities in the cervical epaxial musculature of dogs with meningoencephalomyelitis had a sensitivity of 78% and a specificity of 92% in predicting inflammatory csf results (eminaga et al . 2013 ). in the current study, stir images were unfortunately only available in 3/21 cases. adding this sequence to the protocol in dogs with presence of a focal or multifocal, illdefined t2w intramedullary hyperintensity might be considered in the future. several studies have evaluated survival times of dogs diagnosed with muo (granger et al . 2010 , coates & jeffery 2014 . overall, dogs with muo appear to have a guarded prognosis. a large meta-analysis of dogs with muo revealed an overall reported mst of 240 to 590 days in 96 dogs treated with corticosteroids plus any other immunosuppressive protocol, compared to a mst of 28 to 357 days for 43 dogs receiving corticosteroids alone (granger et al . 2010 ). in the current study, dogs with presumptive spinal muo had a mst of 669 days (2 years), but ultimately, 48% of dogs died or were euthanased because of the disease, indicating a more guarded long-term prognosis. limitations of this study are the small sample size and retrospective character, which limited standardisation of patient assessment and treatment. although all dogs were treated with glucocorticosteroids, it cannot be excluded that specific differences in treatment may have influenced outcomes. despite including cases over a relative large period and from a busy referral hospital, only 21 dogs were found through our record search. this could indicate that spinal muo should be considered a rare disorder, which is in agreement with previous reports (cardy et al . 2015 ) , suggesting that muo represents approximately 6% of all spinal disorders in dogs. presumptive spinal muo can be diagnosed in any type of dog of any age that is presented with signs of acute or chronic, possibly painful, myelopathy. although clinical signs can vary, affected animals most typically present with ambulatory paraparesis and ataxia, localising to t3 to l3 spinal cord segments. mri typically reveals an extensive, ill-defined and intramedullary lesion that appears hyperintense on t2w images and isointense on t1w images. most lesions showed parenchymal contrast enhancement and/or enhancement of the overlying meninges on post-contrast t1w images which can possibly differentiate dogs with muo from other more common spinal diseases. in 10% of cases, no lesion was visible on sagittal t2w and t1w images. almost 50% of dogs died or were euthanased because of muo, with a mst of 669 days. none of the authors of this article has a financial or personal relationship with other people or organisations that could inappropriately influence or bias the content of this paper. clinical reasoning in canine spinal disease: what combination of clinical information is useful? perspectives on meningoencephalomyelitis of unknown origin vertebral osteomyelitis and meningomyelitis caused by pasteurella canis in a dog -clinicopathological case report spinal pain magnetic resonance imaging findings and clinical associations in 52 dogs with suspected ischemic myelopathy neurodiagnostics . in: practical guide to canine and feline neurology stir muscle hyperintensity in the cervical muscles associated with inflammatory spinal cord disease of unknown origin inter -and intraobserver agreement for diagnosing presumptive ischemic myelopathy and acute noncompressive nucleus pulposus extrusion in dogs using magnetic resonance imaging . veterinary clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from meningomyelitis in dogs: a retrospective review of 28 cases canine meningitis -a changing emphasis imaging diagnosis -necrotizing meningomyelitis and polyarthritis hemilaminectomy for the treatment of thoracolumbar disc disease in the dog: a follow-up study of 40 cases inflammatory diseases of the spine in small animals key: cord-102474-fmq98aa8 authors: gooding, k. m.; lienczewski, c.; papale, m.; koivuviita, n.; maziarz, m.; dutius andersson, a.-m.; sharma, k.; pontrelli, p.; garcia hernandez, a.; bailey, j.; tobin, k.; saunavaara, v.; zetterqvist, a.; shelley, d.; teh, i.; ball, c.; puppala, s.; ibberson, m.; karihaloo, a.; metsaì�rinne, k.; banks, r.; gilmour, p. s.; mansfield, m.; gilchrist, m.; de zeeuw, d.; heerspink, h. j.; nuutila, p.; kretzler, m.; wellberry-smith, m.; gesualdo, l.; andress, d.; grenier, n.; shore, a. c.; gomez, m. f.; sourbron, s.; investigators, ibeat title: prognostic imaging biomarkers for diabetic kidney disease (ibeat): study protocol date: 2020-01-16 journal: nan doi: 10.1101/2020.01.13.20017228 sha: doc_id: 102474 cord_uid: fmq98aa8 diabetic kidney disease (dkd) is traditionally classified based on albuminuria and reduced kidney function (estimated glomerular filtration rate (egfr)), but these have limitations as prognostic biomarkers due to the heterogeneity of dkd. novel prognostic markers are needed to improve stratification of patients based on risk of disease progression. the ibeat study, part of the beat-dkd consortium, aims to determine whether renal imaging biomarkers (magnetic resonance imaging (mri) and ultrasound (us)) provide insight into the pathogenesis and heterogeneity of dkd (primary aim), and whether they have potential as prognostic biomarkers in dkd progression (secondary aim). ibeat is a prospective multi-centre observational cohort study recruiting 500 patients with type 2 diabetes (t2d) and egfr > 30ml/min/1.73m2. at baseline each participant will undergo quantitative renal mri and us imaging with central processing for mri images. blood sampling, urine collection and clinical examinations will be performed and medical history obtained at baseline, and these assessments will be repeated annually for 3 years. biological samples will be stored in a central laboratory for later biomarker and validation studies. all data will be stored in a central data depository. data analysis will explore the potential associations between imaging biomarkers and renal function, and whether the imaging biomarkers may improve the prediction of dkd progression rates. embedded within ibeat are ancillary substudies that will (1) validate imaging biomarkers against renal histopathology; (2) validate mri based renal blood flow against water-labelled positron-emission tomography (pet); (3) develop machine-learning methods for automated processing of renal mri images; (4) examine longitudinal changes in imaging biomarkers; (5) examine whether the glycocalyx, microvascular function and structure are associated with imaging biomarkers and egfr decline; (6) a pilot study to examine whether the findings in t2d can be extrapolated to type 1 diabetes. the ibeat study, the largest dkd imaging study to date, will provide invaluable insights into the progression and heterogeneity of dkd, and aims to contribute to a more personalized approach to the management of dkd in patients with type 2 diabetes. diabetic kidney disease (dkd) is the leading cause of end stage renal disease (1, 2) . it is currently estimated that approximately 20-40% of people with diabetes will develop dkd (3) , and this is expected to rise in the future. with the global increase in the prevalence of diabetes (4), particularly type 2 diabetes, dkd is reaching epidemic proportions, with health and quality of life implications (e.g. increased risk of cardiovascular mortality) for the individual (5) . even with current approaches to management of diabetes and renin-angiotensin-aldosterone system blockade, there is still large residual risk in dkd (6) . dkd is routinely classified clinically based on albuminuria and reduced kidney function (estimated glomerular filtration rate (egfr)). albuminuria is traditionally viewed as a hallmark of diabetes related kidney damage. however, there are limitations of using albuminuria to classify dkd, which include the need for multiple measurements to mitigate spurious results due to factors such as infection and physical activity. additionally, the heterogeneity of dkd is increasingly recognised, as reflected, for example, by the disparity in dkd progression (fast versus slow dkd progression) and by patients with declining kidney function but normoalbuminuria. for example, 51% of participants in the uk prospective diabetes study whose egfr declined below 60 ml/min/1.73 m 2 had normoalbuminuria (7) . this heterogeneity in dkd highlights the need for novel biomarkers and a more personalized medicine-based approach to managing dkd. the fundamental aim of the biomarker enterprise to attack dkd (beat-dkd) consortium is to increase our understanding of the pathogenesis and heterogeneity of dkd, enabling the identification of novel biomarkers and treatment targets, to facilitate a more personalized medicinebased approach to managing dkd and increase the efficiency of clinical trials (8) . cross-sectional imaging, in particular mri and us, is increasingly proposed as an alternative source of biomarkers to inform chronic kidney disease (ckd) management (9, 10) . an important example is the qualification by the food and drug administration (fda) and the european medicines agency (ema) of total kidney volume (tkv) as a prognostic enrichment biomarker for autosomal dominant polycystic kidney disease (adpkd) -one of only a handful of clinical biomarkers approved by the fda so far (11, 12) . in recent years the interest is increasingly moving towards advanced mri and us techniques that are sensitive to structural and functional tissue characteristics such as perfusion, oxygenation, blood flow, glomerular filtration, tubular flow, fibrosis, inflammation, metabolism and tissue composition. additional utility derives from the fact that these characteristics can be measured separately for left and right kidney, for cortex and medulla, or to map functional and structural heterogeneity within those areas. a number of preclinical and single-centre clinical studies have indicated a potential utility of mri and us biomarkers in dkd specifically. for instance, us-based measurements of kidney volume have suggested that kidney enlargement is associated with poorer outcomes in early and advanced dkd, despite the often better gfr of larger kidneys (13) (14) (15) . a possible explanation is that hypertrophy indicates a sustained state of primary or secondary hyperfiltration and associated damage due to intraglomerular pressures. a mechanistic study suggested that the mri method bold (blood oxygenation level dependent mri) can highlight areas at risk of ischemic damage due to oxygen depletion after sustained hyperfiltration (16) , and a recent clinical study has confirmed that the bold signal is predictive of ckd progression (17) . some mri biomarkers derived from diffusionweighted mri are sensitive to renal fibrosis (18, 19) and can identify microstructural changes after sustained hyperfiltration (20) , though the clinical potential of mri measures of fibrosis and microstructure remains to be confirmed (21) . kidney perfusion and glomerular filtration can be measured with mri. renal blood flow has been shown to correlate with egfr in dkd (22) . other non-renal imaging biomarkers characterising general risk factors for diabetes and its associated complications may be relevant in this context as well and can easily be measured in the same mri scan session, such as liver and pancreatic fat fraction (23) . the aim of ibeat is to evaluate the evidence for the utility of imaging biomarkers in dkd in a large cohort of heterogeneous type 2 diabetes patients, in the early stages of dkd where there is high potential for effective interventions to slow the rate of dkd progression. the key hypotheses are that (1) imaging-based biomarkers of dkd provide additional information on the pathogenesis and histological and clinical heterogeneity of dkd compared to biomarkers sourced from samples or physical exams, and (2) that changes in imaging biomarkers precede increases in albuminuria and decline in kidney function as measured by egfr. as a result, we expect imaging biomarkers to improve the identification of dkd patients at risk of rapid decline in kidney function, either when used alone or combined with clinical data / biological fluid biomarkers. an additional aim of the ibeat study is to establish a biobank of biological samples (blood-and urine-based) from well-characterised patients for use within the beat-dkd programme and future dkd studies. this will facilitate biomarker discovery studies using novel blood-and urine-based biomarkers and may serve as the foundation for a comprehensive multi-scale phenotyping strategy linking data from blood, urine, tissue, microvascular assessments, imaging, physical measurements and medical histories. the specific study objectives are:  primary objective: to examine whether renal imaging biomarkers are associated with severity of dkd as defined using classical biomarkers of dkd, albuminuria and egfr, in individuals with type 2 diabetes and egfr > 30 ml/min/1.73m 2 .  secondary objective: to examine whether renal imaging biomarkers are associated with changes in renal function over time as measured by egfr over a 3-year period. ibeat (registered at clinicaltrials.gov under nct03716401) is a prospective observational study that will enrol 500 participants, stratified into six subgroups based on three albumin-to-creatinine ratio (acr) and two egfr categories, with type 2 diabetes (t2d) and egfr greater than 30 ml/min/1.73m 2 across five european centers. a schematic overview of the study assessments is presented in table 1 . at baseline, each participant will undergo comprehensive renal imaging (mri and us), biological sample collection (blood and urine), physical measurements and their medical history will be collected. they will then be invited back annually for 3 years, where all measurements except the imaging will be repeated. participants can then be followed remotely, through medical notes and/or questionnaires, for a further 15 years. the organisation of ibeat is shown in figure 1 . the study is led by the coordinating centre in leeds with a co-lead in exeter and a study manager in michigan, currently there are 5 recruiting centers (university of leeds, university of exeter medical school, university of bari, university of bordeaux and university of turku), a central laboratory (lund university) and a central data repository (swiss institute of bioinformatics (sib)). all ethical and relevant local approvals are in place at each recruiting site. as a beat-dkd work package the study is supported by the beat-dkd consortium steering committee and an external scientific advisor. . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. (which was not peer-reviewed) the copyright holder for this preprint . https://doi.org/10.1101/2020.01.13.20017228 doi: medrxiv preprint . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. the copyright holder for this preprint . https://doi.org/10.1101/2020.01.13.20017228 doi: medrxiv preprint the ibeat study will recruit participants with a diagnosis of type 2 diabetes, egfr greater than 30 ml/min/1.73m 2 , aged between 18-80 years, who are able to give informed consent, and do not satisfy any of the exclusion criteria. the exclusion criteria are listed in table 2 (see also supplement 3.0). ibeat will recruit across six strata defined by the a1-a3 albuminuria range (normo-, micro-and macroalbuminuria) and the (g1+g2)-g3 egfr range. in line with the national kidney foundation guidelines (24), albuminuria will be classified using two (or three) independent values of acrs measured within a 3-month period: one at the screening visit, one at the baseline study visit, and a third if the classification differs between the first two samples. we define normo-, micro-and macro-albuminuria as an acr of <2.5, 2.5-25, >25 mg/mmol for men, respectively, and as acr <3.5, 3.5-35, >35 mg/mmol for women, respectively. following the provision of written informed consent at the start of the screening visit, potential participants undergo a number of health assessments including, for example, medical history, random spot urine collection for assessment of acr and a blood sample for the assessment of egfr (unless these have been performed in the last 3 months) to assess eligibility for the study. . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. the copyright holder for this preprint . https://doi.org/10.1101/2020.01. 13.20017228 doi: medrxiv preprint baseline study assessments participant preparation: fasting blood samples are taken in the morning following an overnight fast. medications may be withheld or altered on the day of study visit to ensure participant wellbeing (e.g. omitting morning insulin injection to maintain blood glucose levels) and integrity of the study. a point of care glucose measurement will be performed upon participant arrival and the visit will be cancelled if glucose levels are below 3.5mmol/l or if the participant reports a symptomatic hypoglycaemic event on the morning of the visit. all other assessments are performed following a standardised meal. participants are required to be on stable diabetes and hypertension related treatment (though dose changes to current medications are allowed) for the 3 months prior to study assessments. the study visit will include a checklist to record the adherence to instructions (supplement 3.1). mri biomarkers: 59 primary mri biomarkers will be recorded (see supplement 1.0 for a full list), characterising general body composition (e.g. visceral fat volume, pancreatic and liver fat fraction), renal morphology (e.g. parenchymal volume, cortical thickness), renal tissue structure (e.g. mr relaxation times, apparent water diffusion coefficient), renal hemodynamics (e.g. cortical perfusion, renal artery blood flow), filtration (e.g. single-kidney gfr, filtration fraction). all mr scanning is performed at 3t on siemens, philips and general electric scanners. mri data are uploaded on a central xnat database hosted by sib and quality controlled within 48hrs by the central processing site in leeds. the mri protocol takes approximately 1hr and 10mins and involves the injection of a quarter dose of clinical macrocyclic mri contrast agent. the protocol was first developed on the reference siemens scanner in leeds using an iterative optimisation guided by the nist (national institute of standards and technology) phantom and healthy volunteers. the resulting final protocol was then characterised on each mri vendor using a repeatability study in healthy volunteers to determine within-site variability (5 volunteers with 4 scans each). the nist phantom is scanned at regular intervals in all sites to check for between-site calibration. full details of the mri acquisition protocol on the 3t siemens reference scanner in leeds can be found in supplement 1.1. renal ultrasound: kidney size will be non-invasively determined from longitudinal and transversal images of each kidney. resistive index (ri), indicator of the resistance to flow within the kidney, will be determined from three measurements in each kidney (upper, mid and lower poles). the mean of the three measurements will represent ri for each respective kidney. a list of us biomarkers are provided in the supplement 3.7 and the standard operating procedures (sops) for us scanning are in supplement 1.2. blood and urine sampling: fasting blood samples (~70mls designated for ibeat central requirement) will be collected from each participant for participant characterisation and biomarker analysis. glycated haemoglobin (hba1c), full blood count and fasting glucose assessments will be performed locally (supplement 3.4). the remaining plasma and serum samples will be processed and stored following a standardised protocol (see supplemental 2.1-2.3). a first morning urine void and one additional morning void (same day) are collected by all participants. a small proportion of the first morning void is sent to the local laboratories for acr assessment. the remainder of the first morning and second void are then processed and stored following a standardised protocol (see supplemental 2.1-2.3). the standardised sample collection and processing protocol, informed by provalid and neptune trials (25, 26) , was developed to maximise the utility of stored samples for future biomarker analysis (e.g. lipidomics, rna analysis, urinary vesicles and urinary sediment) within beat-dkd and to form a biobank for future dkd related studies. a separate check is performed to confirm that all samples are collected and processed according to protocol (supplement 3.8). . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. the copyright holder for this preprint . https://doi.org/10.1101/2020.01. 13.20017228 doi: medrxiv preprint the central biochemical laboratory is located at the clinical research centre (crc) facility in malmö (university of lund). the central lab will prepare and distribute kits with sample collection and processing materials for each patient labelled and barcoded with the study id. each kit comprises of 66 storage tubes per patient. the samples will be temporarily stored at each recruiting site, with regular shipments returning them to the biobank in malmö. samples will be stored under secure conditions and monitored with a dedicated electronic sample tracking system (laboratory information management systems). a small volume of blood and urine will be analysed in malmö for known clinical biomarkers (e.g. renal function (serum creatinine, cystatin c, potassium and albumin), lipid profile (total cholesterol and sub-fractions, triglycerides) and c-reactive protein) at the central laboratory, according to standardised methods, and the remainder will be stored for future analyses by beat-dkd investigators. the samples will also remain available for secondary research provided approval is granted by the ibeat steering committee. physical examination: the core physical examination assessments include blood pressures (sitting and standing blood pressures) and anthropometrics (height, weight, waist and hip circumference) assessments. see supplement 3.2 for details. medical history. a detailed medical history (including, for example, current medications, smoking history and presence of co-morbidities) is also collected. see supplements 3.3 and 3.6 for data fields that are captured. routine lab data: routine local laboratory data will be captured to aid in the interpretation of the results by tracking temporal changes at a finer time scale than the yearly follow-ups. only laboratory values available for clinical indication will be captured at this time. supplement 3.4 lists the data fields to be captured but missing data from the local chart is not deemed a protocol violation. the biological sampling protocol, medical history and physical examination will be repeated at 1, 2 and 3 years (± 3months) following study enrolment. for participants who are unable to attend the local research centre for an annual follow-up visit but are still willing to participate in the study an update on their medical history will be collected via direct communication with the participant and / or by accessing their available medical records. clinical images, associated data and metadata will be stored using the xnat platform (www.xnat.org) hosted on the dedicated beat-dkd server at sib. clinical study data will be managed using redcap (www.project-redcap.org), also installed on the dedicated beat-dkd server. all variables will be recorded on ibeat central clinical record folders (crf's -see supplements 3.0-3.8) and uploaded onto the central redcap instance. it is envisaged that the ibeat clinical study will be set up as a federated node enabling remote analysis of the data generated in the future, and integration of the ibeat data with other datasets collected in beat-dkd. sample size: the sample size calculation for a study such as this one would be complex and unlikely to be accurate. thus, we opted for a more pragmatic approach, and arrived at the sample size by considering the scientific and feasibility aspects of the study. specifically, in considering the sampling design, we were mainly concerned with whether it would allow us to answer the scientific questions we have and whether it would be feasible to carry out. we opted for a stratified sampling design, as we were interested in evaluating the association between imaging renal biomarkers and dkd in type 2 diabetes patients in various stages of dkd, as measured by acr and egfr, widely used biomarkers of dkd. this ensures that we will have a reasonable sample size for all combinations of acr (a1, a2, a3) and egfr (g1+g2, g3), even those that are typically rare, specifically a1 and g3, as well as a3 and g1+g2. in terms of feasibility, we considered the number of imaging facilities available to us and the estimated rate of recruitment in each for each strata of our sample. based on these considerations we arrived at a stratified sample of 500 patients, 4 groups of 92 and two groups of 66. see table 2 in supplement 5.0 for details. we will begin by describing our data, comparing the descriptive statistics of all covariates across the study centers, assessing the bivariate relationships between sets of related covariates. we will then perform a cross-sectional analysis using data collected at baseline, as well as a longitudinal analysis using the imaging data collected at baseline and blood and urine markers collected over the three years. given the large number of covariates in our study, we will use variable selection and regularization methods such as lasso (27) and the elastic net regularization (28) . the modelling will be done appropriately for a given setting, with linear models for the crosssectional analyses, and linear mixed effects models for the longitudinal analysis. the analyses will be performed separately in each strata and, whenever possible, accounting for the stratification in the modelling, as we expect there to be effect modification in the potential associations we will be estimating across the strata. we will adjust for multiple comparisons as needed. if we identify any renal imaging biomarkers as having promise as early markers of dkd progression, we will use them in risk prediction and evaluate their predictive accuracy, as measured by prediction error, receiver operating characteristics curve (roc) and the area under the roc (area under the curve, auc), using cross-validation. we plan to take a conservative approach in all of our analyses, meaning that we will be careful with the number of models we fit and statistical tests we perform, and will treat our analyses as exploratory and hypotheses generating, rather than hypothesis testing. building on the strengths and interests across the ibeat participating centres, six ancillary studies have been incorporated within the central ibeat study. participants taking part in the ancillary studies will be recruited from the central ibeat study at the relevant sites. ancillary study 1: to examine whether mri and us based imaging biomarkers correlate with histopathological markers of dkd and discriminate different renal lesions in this t2d cohort. for this ancillary study, led by bari university, ibeat participants will undergo a renal tissue core biopsy (n=100). all biopsies will be digitalized and characterized by light microscopy (hematoxylin-eosin, periodic acid-schiff, silver methenamine, and masson's trichrome), immunofluorescence microscopy (with the use of antisera against igg, igm, iga, c3, c4, c1q and fibrinogen) and electron microscopy. glomerular and vascular lesions, interstitial cell infiltrate, fibrosis and tubular atrophy will be quantified (29) . samples will also be processed and stored for later biomarker discovery. the procedures for processing, storing and capturing meta-data regarding the renal biopsy tissue are described in more detail in supplement 4.0. ancillary study 2: to examine whether mri-based measurements of renal blood flow correlate with h2o-positron emission tomography (pet) renal perfusion measurements, validating the mri based measurements against the standard pet perfusion measurements. for this ancillary study, led by turku university, a direct comparison of mri and pet-based measurements of renal blood flow will be performed in a cohort of ibeat participants. renal perfusion will be assessed during hyperaemia with both systems. ancillary study 3: to develop machine-learning methods for automated or semi-automated processing of multiparametric renal mri. in its current form the generation of biomarkers from complex functional mri scans involves significant manual intervention as well as automated but slow iterative optimisation methods. in this study, led by leeds university, a subset of the ibeat data will be used as training data to develop an ideally automated approach for image processing, which will then be validated on the remaining test data against the manual results. . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. the copyright holder for this preprint . https://doi.org/10.1101/2020.01. 13.20017228 doi: medrxiv preprint ancillary study 4: to investigate the longitudinal changes in mri and us based biomarkers, compare them against changes in egfr and other known markers, and determine whether changes in imaging biomarkers precede dkd progression as assessed by egfr decline. for this study a cohort of 100 patients will receive repeat mri and us after 2 years, and changes in imaging biomarkers over that period will be correlated against changes in egfr and other assessments. ancillary study 5: to examine whether the glycocalyx, microvascular function and structure (retinal and skin) are (1) altered in microalbuminuria; (2) associated with dkd progression as assessed by egfr decline and (3) are associated with novel mri and us imaging dkd biomarkers. for this study, led by university of exeter, ibeat participants will also undergo comprehensive microvascular assessments (including non-invasive estimation of sublingual endothelial glycocalyx integrity, retinal vascular oxygenation and skin maximum hyperaemia) at baseline and at 2 years follow-up. ancillary study 6: a pilot study to examine whether the findings in t2d can be extrapolated to type 1 diabetes. in this ancillary study a cohort of 50 patients with type 1 diabetes will be assessed using the same procedures as the type 2 cohort and observed findings / trends will be compared across the two populations. patient and public involvement and engagement is a significant component of the ibeat study. potential participants have played an important role in ibeat, reviewing the protocol to ensure the feasibility of the study design (core and ancillary studies) as well as contributing to the development of patient facing documents (e.g. patient information sheets), ensuring that they are clear and informative. participants within the ibeat study will play an integral role in the dissemination of the study results to the wider, non-expert population. within the beat-dkd consortium discussions with patient representatives, ranging from experienced patient advocates to ibeat participants, will help inform how research from the beat-dkd consortium is taken forward to implement a more precision medicine based approach in dkd into clinical practice; for example, validation and qualification of new biomarkers by regulatory agencies, optimising clinical study design and integration in the regulatory process of drug registration. indeed, this has already commenced with an ibeat participant, along with other patient representatives, attending the 2nd beat-dkd stakeholders' symposiums in april 2019 (30) . quantitative and functional imaging of the kidney has been an active topic of research in the mri physics and radiology community for over two decades (31) , but the last few years have seen an explosive growth in clinical interest. the first international meeting on functional renal mri was held in 2015 and attendance has been increasing steadily ever since (32) (33) (34) . in 2017, a pan-european network of researchers in renal mri (www.renalmri.org) was funded for 4 years by the european cooperation in science and technology (www.cost.eu). in 2018, nephrology dialysis transplantation published a special issue on renal mri with a clinical position statement supported by over 30 authors including leading european nephrologists (9) . in the same year, in the us, the national institute of diabetes and digestive and kidney diseases (niddk) at the national institutes of health (nih) conducted a workshop on renal imaging to review the state-of-the-art and plan potential future endeavours [7] . also in 2018, the uk renal imaging network (ukrin) received a 3-year partnership grant to create a national infrastructure for quantitative renal mri, and has advanced plans for a 10 year cohort study in 450 ckd patients (afirm study; principal investigator: nick selby, university of nottingham). ibeat builds on these developments and is the first study to respond to the clinical need for systematically collected evidence at a larger scale and across institutions, with well-validated methods linking up the imaging findings with other sources of data so the added value can be identified. in that sense, ibeat is inspired by the landmark study crisp (consortium for radiologic imaging studies of polycystic kidney disease) (35) -the first multi-centre cohort study exploring a quantitative mri biomarker (tkv) in ckd and a foundation for the aforementioned fda qualification of tkv. like crisp, ibeat has built in a technical validation phase of the imaging biomarkers by including a repeatability study on all scanner types deployed in ibeat, and by calibrating betweenscanner differences through a travelling test object developed for this purpose by the national institute of standards and technology (36) . also following the example of crisp, ibeat is committed to sharing the technical details of its imaging protocols and expertise in image processing and quality assurance -not only to facilitate the cost and setup of future studies but also to maximise alignment and future opportunities for pooling the data. an example is an ongoing collaboration with the dynamo consortium (https://www.duke-nus.edu.sg/about/achievements/awards/collaborativegrants) in setting up an imaging biomarker study aligned with ibeat. collectively, the integration of the ancillary studies into ibeat will provide valuable information on the pathogenesis of dkd and the clinical utility of these imaging biomarkers. crucially, they will explore the association of renal based imaging biomarkers against histopathological markers and different histological lesions of dkd, validating the imaging biomarkers and substantiating their clinical utility. mri renal based perfusion measurements will also be validated against h2o-pet renal perfusion measurements. the potential automation of the mri image processing will streamline a labour intensive process, thereby increasing the clinical applicability of the assessments. the microvascular assessments, including the examination of glycocalyx integrity and endothelial function, will provide invaluable information on the pathogenesis and heterogeneity of dkd, and may well aid the identification of individuals with fast progressing dkd, for example, we hypothesise that individuals with type 2 diabetes with early signs of perturbations to the glycocalyx will be at an increased risk of dkd progression. ibeat has greatly benefitted in its setup from study documents and standard operating procedures (sops) provided by other investigators, in particular the provalid (26) and neptune (25) studies. in turn, ibeat is committed to a "pay-it-forward" philosophy and will aim to share its study documentation and procedures widely for use by other investigators. ibeat collaborators are also committed to maximise the opportunities for data sharing in order to increase the lifetime value of their research data as assets for human health and to do so timely, responsibly, with as few restrictions as possible, in a way consistent with the law, regulation and recognised good practice. beyond data, ibeat will aim to form a powerful resource for future biomarker discovery sources by . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. (which was not peer-reviewed) the copyright holder for this preprint . https://doi.org/10.1101/2020.01.13.20017228 doi: medrxiv preprint collecting a rich collection of blood and urine samples in its central biobank. these will be made available for external investigators subject to formal application and approval by the ibeat steering committee. after a 2-year setup period the first study participant was recruited into ibeat in october 2018. first results on technical validation of mri methods on the reference scanner are expected at the end of 2019. the projected deadline for recruitment is 1 september 2020 and first results on the primary objective (cross-sectional analysis of baseline data) are expected to be made public in 2021. completion of follow-up data is expected in 1 sept 2023 with results on the longitudinal analysis expected to be submitted for publication in 2024. this project has received funding from the innovative medicines initiative 2 joint undertaking under grant agreement no 115974. this joint undertaking receives support from the european union's horizon 2020 research and innovation programme and efpia with jdrf. . cc-by 4.0 international license it is made available under a is the author/funder, who has granted medrxiv a license to display the preprint in perpetuity. (which was not peer-reviewed) the copyright holder for this preprint . https://doi.org/10.1101/2020.01. 13.20017228 doi: medrxiv preprint chronic kidney disease: global dimension and perspectives. the lancet diabetes and ckd in the united states population diabetic kidney disease: challenges, progress, and possibilities global prevalence of diabetes: estimates for the year 2000 and projections for 2030 albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the swedish national diabetes register the effect of raas blockade on the progression of diabetic nephropathy microvascular disease: what does the ukpds tell us about diabetic nephropathy biomarker enterprise to attack diabetic kidney disease magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the european cooperation in science and technology action parenchima functional magnetic resonance imaging of the kidneys: where do we stand? the perspective of the european cost action parenchima clinical review of pkd outcomes consortium biomarker qualification submissionle renal duplex sonographic evaluation of type 2 diabetic patients persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease renal diffusion and bold mri in experimental diabetic nephropathy reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease new magnetic resonance imaging index for renal fibrosis assessment: a comparison between diffusion-weighted imaging and t1 mapping with histological validation magnetic resonance diffusion tensor imaging for evaluation of histopathological changes in a rat model of diabetic nephropathy use of diffusion tensor mri to identify early changes in diabetic nephropathy could mri be used to image kidney fibrosis? a review of recent advances and remaining barriers arterial spin labeling mri is able to detect early hemodynamic changes in diabetic nephropathy remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery national kidney foundation. k/doqi clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification design of the nephrotic syndrome study network (neptune) to evaluate primary glomerular nephropathy by a multidisciplinary approach a prospective cohort study in patients with type 2 diabetes mellitus for validation of biomarkers (provalid) -study design and baseline characteristics regression shrinkage and selection via the lasso regularization and variable selection via the elastic net pathologic classification of diabetic nephropathy highlights from the beat-dkd symposium on precision medicine in diabetic kidney disease radiologic imaging of the renal parenchyma structure and function 1st international meeting on renal mri 3d international meeting on renal mri volume progression in polycystic kidney disease quantitative magnetic resonance imaging phantoms: a review and the need for a system phantom key: cord-008085-3ihuqvei authors: thomas, william b. title: nonneoplastic disorders of the brain date: 2005-07-06 journal: clin tech small anim pract doi: 10.1016/s1096-2867(99)80030-9 sha: doc_id: 8085 cord_uid: 3ihuqvei computed tomography (ct) and magnetic resonance imaging (mri) are helpful in the diagnosis of many nonneoplastic brain disorders in the dog and cat. the ability of ct and mri to depict normal and abnormal anatomy facilitates the identification of developmental anomalies, including hydrocephalus, chiari malformations, arachnoid cysts, and cerebellar hypoplasia. these imaging modalities also allow the detection of hemorrhage and infarction and are therefore useful in the evaluation of spontaneous cerebrovascular disorders and head trauma. finally, many inflammatory diseases, such as encephalitis, brain abscess, and parasite migration, cause abnormalities detectable by ct and mri. although more research on the imaging features of specific nonneoplastic brain disorders is needed, current information indicates that ct and mri are useful in the management of these disorders. imaging strategies for ct and mri are similar to those described for intracranial neoplasia. (refer to the article entitled "intracranial neoplasia" by kraft and gavin in the may 1999 issue.) throughout this chapter, the mri features of the various disorders are those depicted with spin echo imaging. readers should refer to the article entitled "advanced imaging concepts: a pictorial glossary of ct and mri technology" by tidwell and jones in the may 1999 issue for a description of other pertinent mri techniques such as gradient echo and inversion recovery pulse sequences, magnetic resonance angiography, and diffusion/perfusion imaging. disorders of brain development ecent advances in imaging techniques have greatly improved the ability to detect pathologic processes in the brain, localize lesions precisely, and predict the type of disease more accurately than ever before. 1 although most reports of computed tomography (ct) and magnetic resonance imaging (mri) of brain disease in veterinary medicine have focused on the diagnosis of brain tumors, these imaging methods are also valuable in the evaluation of various nonneoplastic brain diseases. the purpose of this article is to provide an overview for imaging some of the more frequently encountered nonneoplastic diseases of the brain. clinical features of each disease are included because imaging can supplement but never replace a careful history and thorough physical and neurological examination. typical pathological changes are also mentioned, because ct and mri reflect gross and microscopic pathology and an understanding of the expected pathological changes can be very helpful in predicting imaging findings. ideally, a review article such as this would be based on systematic research and clinical data. unfortunately, the current literature on imaging of nonneoplastic brain disease in veterinary patients is fairly sparse. therefore, the information presented in this article is based on the limited data regarding veterinary patients supplemented by the much more complete information on comparable diseases in human patients, as well as my own experience. as more information becomes available, the conclusions in this article may have to be modified. hydrocephalus is a pathological condition in which there is accumulation of cerebrospinal fluid (csf) within the cranium. 23 this usually occurs within the ventricular system (internal hydrocephalus) but can involve the subarachnoid space (external hydrocephalus)) hydrocephalus is not a specific disease, but rather a multifactorial disorder with a variety of pathophysiological mechanisms. csf is produced at a constant rate by the choroid plexuses of the lateral, third, and fourth ventricles; the ependymal lining of the ventricular system; and blood vessels in the subarachnoid space. the csf circulates through the ventricular system into the subarachnoid space, where it is absorbed by arachnoid villi. 3 hydrocephalus can be caused by a blockage of the flow of cse called obstructive hydrocephalus, or secondary to decreased volume of brain parenchyma, termed hydrocephalus ex vacuo. (increased formation of csf is virtually never a cause of hydrocephalus.) a number of conditions, such as infarction and necrosis, can result in decreased volume of brain parenchyma and hydrocephalus ex vacuo. obstruction to csf flow can occur anywhere along the pathway from its formation to the site of absorption in the cranial and spinal arachnoid villi. obstruction within the ventricular system or at its outflow through the lateral apertures is called noncommunicating hydrocephalus because the ventricular system does not communicate with the subarachnoid space. obstruction within the subarachnoid space or at the level of absorption in the arachnoid villi is called communicating hydrocephalus. ~ hydrocephalus can be classified further as congenital or acquired. congenital hydrocephalus is most common in toybreed dogs. the causes are diverse and include genetic factors, developmental anomalies, and intrauterine or perinatal infection or bleeding in the brain. congenital hydrocephalus may be associated with a wide range of other nervous system anomalies, including meningomyelocele, chiari malformation, dandy-walker syndrome, and cerebellar hypoplasia. clinical signs of congenital hydrocephalus include an enlarged, domeshaped head with persistent fontanelles and open cranial sutures. neurological deficits include abnormal behavior, disturbed consciousness, ataxia, circhng, blindness, seizures, and vestibular dysfunction. in mature dogs, diseases such as tumors and inflammatory diseases can cause acquired hydrocephalus. neurological deficits are similar to those m puppms, but if hydrocephalus develops after the cranial sutures have closed, malformation of the skull does not develop. 2, 3 ct and mri allow accurate assessment of ventricular size, extent of cortical atrophy, and the presence of any focal lesions that may account for the hydrocephalus. imaging is also useful in monitoring patients after surgical placement of ventriculoperitoneal shunts used for treatment. changes in ventricular size can be monitored, and the presence of complications such as subdural hematoma or hygroma can be evaluated. 4 ventricular size is usually assessed subjectively, noting the progressively greater proportion of the intracranial volume occupied by the lateral, third, and/or fourth ventricles 4,5 ( fig 1) . several investigators have provided quantitative measurements. when measured at the level of or caudal to the lnterthalamlc adhesion, hudson et al 6 state that lateral ventricles are considered enlarged ff lateral ventncular height exceeds 0.35 cm or the ratio between the height of the lateral ventricle and the width of the cerebral hemisphere (ventriclehemisphere ratio) exceeds 0.19. spaulding and sharp 7 consider the lateral ventricles enlarged if the ratio between lateral ventricular height and the dorsoventral height of the cerebral hemisphere exceeds 0.14. however, there is a poor correlation between clinical signs and ventricular size, and symmetric or asymmetric enlargement of the lateral ventricles is relatively common in normal adult dogs and puppies. 6q° therefore, diagnosis of hydrocephalus must be based on clinical features, not just ventricular size. hydrocephalus ex vacuo can be distinguished from obstructive hydrocephalus based on enlarged cortical sulci and subarachnoid space secondary to atrophy of brain parenchyma (fig 2) . in obstructive hydrocephalus, the site of obstruction may be identified by dilatation of csf spaces proximal to the obstruction, and normal or collapsed spaces distally. for example, obstruction at the level of the third venmcle would be expected to result in enlarged lateral ventricles but no enlargement of the mesencephalic aqueduct and fourth ventricle (fig 3) . dilatation of all the ventricles and the subarachnmd space implies an obstruction at or near the arachnoid vilh. unfortunately, this simplisuc approach has limited accuracy. for example, 25% to 35% of human patients with communicating hydrocephalus have little or no &latation of the fourth ventricle. 4 obstructing masses, such as tumors, granulomas, and cysts, may be identified, especially on postcontrast images (fig 3) . mri is more sensitive than ct in showing small focal lesions, especially those in the caudal fossa) periventricular edema may be identified in some patients with hydrocephalus. experimentally, acute obstructive hydrocephalus in dogs causes edema starting at the dorsolateral angles of the lateral ventricles and spreading into the adjacent white matter, n on ct, this is evident as blurring or loss of the normally sharp ventricular margins. 4 the edema is best appreciated on t2-welghted mri as increased intensity compared with normal white matter. 1~ periventrlcular edema is most frequently associated with acute hydrocephalus and increased intraventricular pressure, rather than chronic, relatively compensated hydrocephalus with normal intraventricular pressure. 4 imaging techniques make it possible to readily identify ventriculomegaly but may give little clue as to its clinical significance. it is therefore necessary to interpret the finding of ventriculomegaly in context with clinical features. chiarl described four unrelated types of malformations of the brainstem and cerebellum in human patients. the most common is chiari i malformation, which consists of caudal displacement of a portion of the cerebellum through the foramen magnum into the cervical portion of the vertebral canal. the cause is an underdeveloped occipital bone that induces overcrowding of the caudal fossa, which is accommodated by caudal displacement of the cerebellum. 12 many human patients with this malformation develop hydromyelia (a dilatation of the central canal of the spinal cord that is lined by ependyma) and/or syringomyelia (an accumulation of fluid within the spinal cord that is not lined by ependyma). the term syringohydromyefia is often used because it can be &fficult or impossible to tell whether the cavity is lined with ependyma except at necropsy. syringohydromyelia in chiarl i malformation is caused by obstruction of csf flow at the foramen magnum. the brain expands as it fills with blood during systole, inducing a pressure wave in the csf that is accommodated in normal subjects by rapid movement of csf from within the skull to the vertebral canal. with obstruction to rapid movement of csf through the foramen magnum, the caudal portion of the cerebellum moves downward with each systolic pulse, acting as a piston on the surface of the spinal cord. this relentless compression of the spinal cord propels csf into and within the syrinx. 13 some pauents also have hydrocephalus attributed to obstruction of csf flow in the crowded caudal fossa. clinical signs of chiari i malformation in human beings can develop in childhood or adulthood and include head and neck pain, myelopathy, or encephalopathy. 12, 13 a similar malformation has been reported m adult dogs with neck pain and tetraparesls. 1~a5 diagnosis is best made on sagittal mri of the craniocervmal junction (fig 4) . the caudal portion of the cerebellum is displaced into the vertebral canal to a variable degree3 4, 16 the cerebellomedullary cistern is small or absent and the caudal fossa may appear subjectively overcrowded. hydrocephalus and syringohydromyelia may be evident. 14-16 syringohydromyelia often involves the caudal cervical or cranial thoracic segments, so this entire region should be imaged. all patients with syrmgohydromyelia should have imaging of the craniocervical region to rule out a chiari i malformation or other obstruction of csf flow. 16 chiarl ii malformation, also known as arnold-chiari or cleland-chari malformation, involves caudal displacement of the brainstem and cerebellum through an enlarged foramen magnum. the fourth ventricle is elongated and extends caudal to the foramen magnum, and the brainstem may be kinked. 16 chiari iii malformation is displacement of the cerebellum through a cervical spina bifida resulting m a cervmal encephalocele. chiari ii and iii malformations are not well described in small animals. chiari iv malformation is severe cerebellar hypoplasia and is discussed separately.17 in human patients, the dandy-walker complex is a group of malformations consisting of an enlarged caudal fossa, hypoplasia of the cerebellar vermis, and cystic dilatation of the fourth ventricle that nearly fills the caudal fossa. the cerebellar hemispheres are usually hypoplastic as well. other anomalies are also common, including hydrocephalus, hypoplasia of the corpus callosum, and syringohydromyelia. dandy-walker malformation is caused by outflow obstruction of the fourth ventricle in the developing embryo. this causes dilatation of the fourth ventricle, which enlarges upward between the developing cerebellar hemispheres, preventing their fusion. when the cerebellar hemispheres do not fuse, the vermis does not form. 16 analogous malformations have been described in the dog and cat. ~<18-21 in contrast to human patients, most dogs and cats with this syndrome do not have obvious enlargement of the caudal fossa, ls-21 neurological deficits typically occur at a young age and primarily reflect cerebellar dysfunction, including ataxia, hypermetria, intention tremor, and vestibular dysfunction, ls-21 on ct and mri, dandy-walker malformation is characterized by an enlarged caudal fossa filled by an enormous fourth ventricle and a small cerebellum. 14,16,2°,21 the cerebellar vermis may be absent, producing a cleft in the middle of the cerebellum. hydrocephalus may also be evident.20.21 a variety of in utero msults and heritable defects may cause failure of normal development of the cerebellum, resulting in a hypoplastic or absent cerebellum. the most common cause in cats is in utero or permatal infection with the feline panleukopenia virus. cerebellar hypoplasia has also been reported in dogs, in which a heritable basis has been suspected in some cases, but in utero infections cannot be excludedy ,23 single or multiple animals within a litter may be affected. there is nonprogressive ataxia, hypermetria, and intention tremor, first apparent at about the time the animal begins to walk. ct or mri shows a small or absent cerebellum. the remainder of the caudal fossa is filled with cse other anomahes, such as hydrocephalus, may also be apparent. = arachnoid cysts (also called intra-arachnold cysts) are accumulations of fluid surrounded by a membrane resembhng the arachnmd mater. they carl develop in the subarachnold space anywhere along the neuraxis. congenital arachnoid cysts are developmental anomalies originating from a splitting or duplication of the arachnoid mater. the cyst wall is formed by several layers of arachnoid cells. acquired arachnoid cysts may result from postinflammatory loculauon of csf caused by trauma, infection, or hemorrhage. 24 in human beings, congenital intracranial arachnoid cysts may be asymptomatic or cause neurological deficits as the cyst progressively enlarges and compresses adjacent neural structures or interferes with csf circulation. enlargement of arachnoid cysts occurs because of fired production by the cyst wall or an anatomical communication functioning as a oneway valve between the cyst and the subarachnoid space. 2~ intracranial arachnoid cysts have been reported in the dog and cat. z5, 26 the most common locatmn is the subarachnoid space between the cerebellum and the tentorium cerebelli. clinical signs may occur in immature or mature animals and include smzures, paresis, abnormal behavior, and cranial nerve deficits. in some patients, the cyst is an incidental finding on imaging. 26 on ct, the cyst has well-defined margins and contains fired that is isodense wath csf (fig 5) . there is mal, or intraventricular. epidural, subdural, and subarachnoid hemorrhages are often associated with trauma and are discussed later. intraparenchymal hemorrhage can be primary or secondary and can extend into the ventricular system. the cause of primary intraparenchymal hemorrhage is incompletely understood. people with this disorder often have systemic hypertension and fibrinoid degeneration of arteries in the b r a i n y although intracranial hemorrhage caused by hypertension is poorly documented in dogs and cats, primary hypertension and hypertension secondary to other disorders, such as renal disease, hyperadrenocorticism, and hyperthyroidism, are well recognized. 28 these animals may be predisposed to cerebrovascular disease and intracranial hemorrhage. 28 secondary causes of intracranial hemorrhage include trauma, infarction, congenital vascular malformations, intracranial tumor, vasculitis, and coagulopathies. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] the clinical signs of intraparenchymal hemorrhage consist of a sudden onset of neurological deficits referable to a focal brain lesion. signs may progressively worsen as the hematoma expands, compressing adjacent neural structures and increasing intracranial pressure. 30-33 36-39 computed tomography ct is exqmsitely sensitive to acute hemorrhage. because the attenuation of x-rays is primarily attributable to the globin portion of blood, there is a linear relationship between ct attenuation and hematocrit. 4° the attenuation of whole blood with a hematocrit of 46% is approximately 56 hounsfield units (hu). in comparison, normal gray matter has an attenuation of 37 to 41 hu, and normal white matter, 20 to 34 hu. 4° acute hemorrhage in a patient with a normal hematocrit is therefore immediately evident as increased attenuation on ct ( fig 6) .31,36 hemorrhage in patients with severe anemia may be less obvious. an acute hematoma may he surrounded by a hypodense region corresponding to edema, and there is often an associated m a s s effect. 31'36 41 the attenuation of extravasated blood increases for the first 72 hours with clot formation and extrusion of low-density serum and subsequent increase in hemoglobin concentration. 4° after that, the attenuation gradually decreases as the result of lysis and phagocytosls of erythrocytes, which starts at the periphery and progresses centrally. 4°~1 the hematoma eventually becomes isodense at about 1 month after onset. 4°-41 use of contrast agent is unnecessary in most acute hematomas and may obscure the inherent hyperdensity, confusing the diagnosis. however, use of contrast agent may be helpful if there is a small hemorrhage with mass effect out of proportion to the size of the hematoma. in this instance, the differential diagnosis includes bleeding into a tumor, and contrast may be necessary to visualize the tumor. 4° in hematomas not associated with underlying neoplasia, enhancement first appears at the periphery of the hematoma at approximately 4 to 6 days because of neovascularization.36.40-42 a ring pattern of enhancement may persist for 2 to 6 weeks. 4° although variations can occur, the mri features of most intracranial hematomas follow a predictable course over time. factors intrinsic to the lesion that affect images include the age of the hemorrhage, whether the bleeding is arterial or venous, the location of the bleeding, and the presence of any underlying lesions. operator-dependent factors that affect the images include the mare magnetic field strength, the exact pulse sequence parameters used, and the method of echo formation. 43 hemorrhage can be thought of as an iron salvage pathway, in which iron from the extravasated erythrocytes is mobilized from hemoglobin and converted to short-term iron-containing proteins for transfer to the reticuloendothelial system, or to long-term storage proteins for local deposition. 44 during this process, oxyhemoglobin is converted in a stepwise fashion to deoxyhemoglobin, methemoglobin, and finally ferritin and hemosiderin. these various forms of hemoglobin affect the appearance of hemorrhage in three ways: (1) protein effects that are present with all forms of hemoglobin; (2) paramagnetm relaxation caused by paramagnetic molecules, which is significant only with methemoglobin; and (3) inhomogeneous susceptibility effects induced by paramagnetlc forms of hemoglobin (deoxyhemoglobin and methemoglobm) within erythrocytes. 45, 46 protein effects. relaxation times are shortened in the presence of proteins in water solutions. 45 this is caused by the changing magnetic fields of nearby nuclei as the molecules undergo brownian motion. 45 protein effects are generally proportional to protein concentrations and result in shortening of t1 and t2; that is, increased intensity on tl-weighted images and decreased intensity on t2-weighted images, compared with pure water. 45 paramagnetic effects. biological substances containing unpaired electrons have magnetic properties dominated by the magnetic effects of these unpaired electrons. the magnetic fields of the unpaired electrons are normally oriented randomly such that there is no net magnetization. however, when an external magnetic field is applied, the unpaired electrons tend to align parallel to that field, resulting in enhancement (increased magmtude) of that applied field. substances that have no intrinsic magnetic field m the absence of an applied magnetic field, but align with and thus enhance that applied field, are termed paramagnetic. 46 some forms of hemoglobin contain iron with paramagnetic properties, which greatly affects the mri appearance. if water molecules approach a paramagnetic center, there is an interaction between the nuclear magnetic dipoles of the water (protons) and the magnetic dipoles of the paramagnetic center (unpaired electrons). this proton-electron dipoledipole interaction shortens relaxation ume of the water protons. for proton relaxation enhancement to occur, however, the water proton must come within about 0.3 nm of the paramagnetic ions' unpaired electrons, because the magnitude of this interaction is inversely proportional to the sixth power of the distance between the dipoles. 46 these paramagnetic effects are more prominent on tl-weighted images than on t2-weighted images. 43 they will therefore result in an increased signal on tl-weighted images, similar to the effects of gadolinium-based contrast agents. (paramagnetism of mri contrast medium is also discussed in the tidwell & jones article in the may 1999 issue.) inhomogeneous susceptibility effects. when paramagnetlsm is confined to a small region (such as within erythrocytes), there is an inhomogeneous distribution of paramagnetic susceptibility that creates microscopic field gradients. 45 water molecules diffusing across the erythrocyte membrane experience a fluctuating magnetic field that results in dephasing and shortened t2 relaxation, a process called inhomogeneous susceptiblhty effect. in spin-echo sequences, inhomogeneous susceptibihty effects result in signal loss because of shortened t2 relaxation. this leads to decreased intensity on t2-weighted images. 46 hematoma evolution. these three relaxation mechanisms along with proton density contribute to image contrast during the various stages of hematoma formation (table 1) . because numerous factors can effect the appearance of intracranial hemorrhage on mri, the following summary is necessarily oversimplified but generally applicable to spin-echo sequences at 0.5 to 2.0 t. (refer to the tidwell &jones article in the may 1999 issue for a discussion on gradient echo imaging of hemorrhage.) furthermore, the timing of various stages may vary significantly, and different stages often overlap. 43, 45 the precise dating of specific hematomas is notoriously inaccurate, so the nomenclature of the temporal stages of hematomas is somewhat arbitrary. 43 oxyhemoglobm. freshly extravasated blood from arterial bleeding is composed of intact erythrocytes containing primarily oxyhemoglobin. 43 the iron in oxyhemoglobin is in the ferrous form (fe+2). because there are no unpaired electrons in the iron (or other atoms), oxygenated blood is not paramagnetic. 43 in the absence of paramagnetism, peracute hematomas appear as a high-proton-density region, with slightly shortened relaxation times, compared with water, mainly because of the protein content of blood. 43 this peracute stage of a hematoma usually persists for fewer than 24 hours. because of their transient nature, peracute hematomas are rarely seen in clinical practice. they are isointense to slightly hypointense on t1weighted images and hyperintense on t2-weighted images, and therefore appear similar to many other brain lesions. 43,.7 thus, ct is the preferred imaging modality if peracute hemorrhage is suspected. deoxyhemoglobin. after a few hours, the oxygen tension within the hematoma is reduced, resulting in the formation of deoxyhemoglobin (acute hematoma). deoxygenation is usually complete by 24 hours. 45 removal of molecular oxygen changes the distribution of electrons in the ferrous ion, leaving four unpaired electrons in the outer shell. these unpaired electrons confer deoxyhemoglobin with paramagnetic properties. the paramagnetic iron of deoxyhemoglobm is contained within a hydrophobic crevice in the hemoglobin mdlecule. this prevents water from coming close enough to the paramagnetic ion to induce paramagnetic (dipole-dipole) interaction, thus, the hematoma is still isointense to slightly hypointense on t 1-weighted images. 43 as long as the erythrocyte membrane is intact, the paramagneuc deoxyhemoglobln is localized within the cell. this results in inhomogeneous suscepub]lity effects# 3 acute hematomas that contain intracellular deoxyhemoglobin consequently appear very hypointense on t2-we]ghted images. 43 at this stage, any surrounding edema appears as a hyperintense perimeter on t2-weighted images) 3 intracellular methemoglobin. as oxygen tension within the hematoma falls further, deoxyhemoglobin is oxidized to methemoglobin (subacute hematoma). in whole blood, methemoglobin begins to accumulate at the rate of about 10% per day, after the first 2 days. 4s conversion to methemoglobin is maximal when the p02 is approximately 20 mm hg. if the oxygen tension is higher or lower, conversion to methemoglobin is slowed, affecting mri contrast. 46 the iron in methemoglobin is in the ferric (fe +3) state, which has five unpaired electrons in its outer shell and is highly paramagnetic. also, one of the coordination sites of the methemoglobln molecule is occupied by a water molecule that is rapidly exchanged with other water molecules in solution. as a result, water is positioned within 0.3 nm of the paramagnetic iron. this allows paramagnetic (dipole-dipole) interaction to shorten t1 relaxation, causing methemoglobin to be hyperintense on tl-weighted images. this hyperintensity begins at the periphery of an intraparenchyreal hematoma and progresses inward, probably because the outer rim of the hematoma has the optimal oxygen tension for the oxidation of hemoglobin. 43,45 at this stage the hematoma is still hypointense on t2-welghted images23 other causes of t1 hyperintensity or t2 hypointenslty include fat, calcification, mucinous material, intratumoral melanin, flow effects, and enhancement with paramagnetic contrast agents23 extracellular methemoglobin. soon after methemoglobin formation begins, glucose reserves in the erythrocytes are depleted and hemolysis ensues. this eliminates the inhomogeneous susceptibility effect as the methemoglobin becomes uniformly distributed. this prolongs t2, and the hematoma is once again hyperintense on t2-weighted images (rebound hyperintensity). 45 on the other hand, tl-weighted images are not affected and therefore continue to show hyperintensity. 45 this paradoxical state of t1 and t2 hyperintensity may persist for 1 month or more (fig 7) . 45 ferritin and hemosiderin. after 2 to 6 weeks, modified macrophages (gitter cells) infiltrate from surrounding brain and remove iron from the hematoma (chronic hematoma). this eventually eliminates the remaining protein and inhomogeneous susceptibility effects. the center of the hematoma eventually either collapses or is replaced by cse 45 the iron is deposited at the periphery of the hematoma as hemosiderin and ferritin, which behave paramagnetically. 43 the iron in these storage forms is not accessible to water, so paramagnetic (dipole-dipole) interaction does not occur, but the inhomogeneous susceptibility effect shortens t2. a chronic hematoma has a rim that is hypointense on tl-weighted images and very hypointense on t2-weighted images. the rim becomes thicker as the hematoma resolves. 45 whenever intracramal hemorrhage is identified, it is important to determine if it is associated with an underlying tumor or is caused by a nonneoplastic lesion. the use of a contrast agent often allows identification of an underlying tumor. 4° an important finding in a hemorrhagic tumor is persistent surrounding edema (decreased attenuanon on ct, hyperintensity on t2-weighted images), whereas edema has usually resolved by the chronic stage of a nonneoplastic hematoma. 43 in neoplastic hemorrhage, mri signal intensity patterns are more heterogeneous and the temporal evolution of intensity patterns is often delayed compared with nonneoplastic hematomas, probably because hypoxia within the tumor delays methemoglobin formation. 4°,43 neoplastic hemorrhage often lacks the well-defined hypointense rim characteristic of nonneoplastic hematomas in their subacute and chronic stage. 4°,~3 this is because the persistently altered blood-brain barrier of tumors may allow more efficient removal of ferritm and hemosiderin. 43 in situations in which the diagnosis is still uncertain, repeat scanning is often useful because this allows evaluation of the expected temporal changes. 4° the most common is the arteriovenous malformation (avm). clinical signs are caused by spontaneous hemorrhage and are usually suggestive of a focal cerebral lesion. the onset of signs is usually acute and occurs in middle-aged to older animals. 3>33 the relatively late onset of signs associated with a congenital lesion can be explained by contmued hemodynamic stress and consequent attenuation of the abnormal vessels, which eventually leads to hemorrhage, z° when a cerebrovascular malformation has bled, early ct or mri usually shows intraparenchymal hemorrhage (fig 6) . 30 ct of capillary malformations is often normal, but may show an isodense to slightly hyperdense mass. contrast enhancement is usually minimal. 51 mri is more sensitive, and shows a lace-like region of stippled contrast enhancement with no or subtle abnormality on unenhanced images. 5a a cavernous malformation appears on ct as a focal hyperdense region with variable calcification with mild contrast enhancement. 5152 on mri, a cavernous malformation is seen as a central region of mixed intensity, corresponding to methemoglobin, surrounded by circumferential rings of hypomtense hemosiderin and ferritin)2 53 whenever a spontaneous intraparenchymal hematoma is identified, it is important to look for any associated large vessels to suggest a vascular malformation. however, the failure to identify large vessels does not entirely exclude a vascular malformation, because compression or obliteration of vessels by adjacent hematoma, extremely slow flow, and thrombosis may obscure the abnormal vessels. 51,52 although ct and mri are useful in detecting hemorrhage associated with vascular malformations and depicting the vascular anatomy of some of these lesions, catheter angiography or magnetic resonance angiography (mra) is often necessary for complete assessment of cerebrovascular malformations m human patients. 51,52,~4 (refer to the tidwell & jones article in the may 1999 issue for a discussion of mra.) obstruction of flow in the vessels of the brain can result in a sudden onset of neurological signs caused by infarction. arterial obstruction can be caused by thrombosis or embolism. a thrombus is a blood clot developing within a vessel that causes obstruction at the site of formation. embolism is occlusion of a vessel by a fragment of blood clot or other substance that has flowed to the site of obstruction from a distant location. because of abundant venous anastomoses, venous infarction is less common than arterial thromboembolism. 55 in human patients, cerebrovascular thrombosis or embolism is often secondary to atherosclerosis. 56 atherosclerosis also occurs in dogs, especially older dogs, dogs with hypothyroidism, and miniature schnauzers with idiopathic hyperlipoproteinemia. 29,57,5s atherosclerosis associated with these conditions can lead to cerebral thromboembohsm and neurological dysfunction. 33 57-59 other diseases associated with cerebral thromboembolism in dogs include sepsis, coagulopathy, neoplasia, and heartworm infection. 3>6° the hallmark of brain infarction is an acute onset of focal bram dysfunction. neurological deficits depend on the site of the lesion and are typically asymmetric. involvement of the forebrain, such as with thromboembolism of the middle cerebral artery, usually results in contralateral hemiparesis with decreased postural reactions. seizures are very common in dogs and cats with infarction affecting the forebrain. there may be contralateral bhndness with normal pupillary light reflexes, and the patient may circle or turn toward the side of the lesion. lesions in the cerebellum may cause ataxia, hypermetria, vestibular dysfunction, or opisthotonos. brainstem involvement is characterized by gait deficits ranging from ipsilateral hemlparesis to tetraplegia, cranial nerve deficits, and abnormal levels of consciousness, including coma. 30, 31, 33, 36, 38, 55, 61 nonhemorrhagic infarction computed tomography. changes may be detected on ct as early as 3 to 6 hours after onset of signs and consist of a slight decrease in attenuation and subtle mass effect. 62 63 these changes are related to edema and reach a maximum at 3 to 5 days (fig 8) and resolve by 2 to 3 weeks after infarction. 62 the location and shape of the lesion correspond with the distribunon of the involved vessel(s), most commonly the middle cerebral artery. 62 abnormal contrast enhancement may be seen as early as 24 hours but often does not become evident until about 1 week after infarction. 62,63 enhancement is most apparent at the periphery of the lesion and reflects growth of new capillaries without a normal blood-brain barrier. 62 enhancement of hypodense infarcts can result in isodense lesions, thereby masking their presence. 62 for this reason, unenhanced as well as enhanced ct should be performed. in the chronic phase (3 to 4 weeks), the hypodense region becomes more sharply marginated as necrotic tissue is resorbed. 62 ultimately there is a loss of parenchymal volume with attendant dilatation of adjacent sulci and ventricles. 62 contrast enhancement does not usually occur in the chronic stage because the integrity of the blood-brain barrier is restored. 62 magnetic resonance imaging. early changes on mri consist of a subtle increase in intensity on t2-weighted and proton density-weighted images. these changes reflect edema and can be detected as early as 1 hour after vascular occlusion. 64 mri is thus more sensitive than ct in early infarction. also, mri is more sensitive in detecting small infarcts and those involving the brainstem. 65 in acute infarction, tl-weighted mri is less sensitive than t2-weighed and proton density-weighted images and may be normal. ~6 parenchymal enhancement with gadolinium is uncommon within the first 24 hours. 66,67 the use of functional mri techniques such as diffusion and perfusion studies for the detection of acute infarction is currently being investigated and is discussed in the arucle by tidwell &jones in the may 1999 issue. after the first 24 hours, the hyperintensity on t2-welghted and proton density-weighted images becomes more obvious (fig 9) .64'66'68 during this time, tl-weighted images may show decreased signal. 64,66 68 gyral swelling and mass effect are more prominent, becoming maximal 2 to 4 days after onset of occlusion. 6466 parenchymal enhancement becomes evident within 4 to 7 days and may persist for 3 to 4 weeks. 66 after several weeks, the signal changes seen on earlier scans become smaller and better defined. there is focal atrophy with dilatanon of nearby sulci and ventricles. there may be a collection of fluid with the s~gnal characteristics of cerebrospinal fluid. 69 contrast enhancement does not usually occur. 66 the above description applies to nonhemorrhagic or "bland" infarcts. however, many infarcts will have attendant bleeding caused by reperfusion of damaged blood vessels. 66 this results in a hemorrhagic infarct. petechial hemorrhage into an infarct may result in an isodense lesion on unenhanced ct because of the combined effects of the brain edema, which decreases attenuation, and acute hemorrhage, which increases attenuation. mass effect caused by the edema usually provides a clue to the presence of a lesion. if hemorrhage is a large component of an acute infarct, unenhanced ct shows a hyperdense hematoma surrounded by hypodense edema. these changes are often confined to a vascular territory, a feature that is helpful in differentiating hemorrhagic infarctions from other causes of hemorrhage. 4° in the subacute phase, the region around the infarct may enhance, increasing the possibility of hemorrhage within a tumor. mass effect from a hemorrhagic infarct is usually minimal or decreasing at the time of maximal contrast enhancement (2 to 4 weeks), which is useful in differentiating between hemorrhagic infarct and tumor. 5~ the mri features of hemorrhagic infarction are similar to those of lntraparenchymal hemorrhage. 4° compared with other causes of lntraparenchymal hemorrhage, hemorrhagic infarcts tend to have a higher p02 because of earlier revascularization and collateral perfusion. the higher p02 decreases the amount of deoxyhemoglobin, and therefore minimizes the acute t2 relaxation effect. 51 uncontrolled seizures or status epileptmus may result in neuronal degeneration progressing to necrosis. the distribution of lesions varies somewhat among individual patients, but the hippocampus, basal nuclei, and frontal and pyriform lobes of the cerebrum are most severely affected. f° lesions are usually bilateral, but may affect one side more severely. f° these changes are thought to be the consequence of ischemia secondary to accumulation of cytotoxic agents and a mismatch between brain metabolism and blood flow during prolonged seizures. 71 persistent or reversible mr lesions have been described in human patients after seizures, and similar abnormalities have there is also a smaller wedge-shaped region of hyperintensity in the vascular territory of the right middle cerebral artery. se, 1500/105, 0.064 t. been described in dogs, [72] [73] [74] the most consistent finding is unilateral or bilateral lesions of the hippocampus, pyriform lobe, and frontal lobe. the lesions are hypointense on t1weighted images and hyperintense on proton densityweighted and t2-weighted images. there is minimal mass effect and no or moderate contrast enhancement tm (fig 10) . these lesions may persist or disappear on subsequent scans. head trauma results from a variety of causes, including motor vehicle accidents, bites, kicks, and gunshot wounds. previously, imaging of head trauma was limited to skull radiography for the detection of fractures. plain radiography, however, cannot identify many traumatic brain lesions, such as hemorrhage, and therefore provides only limited diagnostic information. the development of ct provided a sensitive means for detecting and localizing intracranial hemorrhage, permitting expeditious surgical treatment, and improving outcome. 75 mri has been shown to be similar in sensitivity for detection of hemorrhagic lesions, but is much more sensitive than ct for detecting nonhemorrhagic lesions, such as shearing injuries of white matter. 75 neuroimaging should be considered early in the management of animals with head injury and marked impairment of consciousness or neurological deficits that progressively worsen despite initial medmal therapy. the most critical issue is to detect potential hematomas that may be treatable with sur-gery. 76 in general, ct is the diagnostic study of choice for initial evaluation, because it can be completed quickly and is sensitive to acute hemorrhage, r6 ct also provides fine anatomic detail of bone when viewed at a wide window width allowing accurate characterization of any skull fractures 77 (fig 1 1) . although mri is slightly more sensitive than ct for detection of hematomas, those that are not seen on ct are usually small and typically managed conservatively. 75 a disadvantage of mri is the longer examination ume and the difficulty in monitoring unstable patients in the mri environment. therefore, if ct is available, mr examination is usually delayed until the patient is stabilized. in patients with severe head trauma, mri should be considered in the first 2 weeks after injury, because most parenchymal lesions are more easily detectable during this period. 75 epidural hematomas accumulate in the potential space between the inner surface of the skull and the dura mater. they are usually found in the temporoparleteal region, and have been caused by laceration or tearing of the middle meningeal artery by skull fracture. the arterial force of the bleeding dissects the dura away from the bone, often resulting in a rapidly expanding mass. clinical signs may consist of rapidly progressing focal neurological deficits and deterioration in consciousness. however, patients with associated parenchymal brain injury may have severely impaired consciousness at the time of trauma. 75 on ct, an acute epidural hematoma is typically a well-defined, biconvex lesion between the inner table of the skull and the underlying depressed dura and brain. tm the attenuation of the hematoma is initially greater than brain parenchyma and increases further during the first few hours with coagulation and clot retraction. with time, the attenuation decreases with clot retraction, erythrocyte lysis, and hemoglobin degradation. the hematoma becomes smaller and fades to isodense and then hypodense within 1 or 2 weeks. the inner surface of an epidural hematoma is dura mater, which normally enhances with intravenous contrast material, but this enhancing margin becomes even more prominent as a neovascular membrane develops over time. 78 on mri, the intensity varies depending on the age of the hematoma, as described in the section on intracranlal hemorrhage and summarized in table 1 . occasionally, an epidural hematoma may not have the classic lenticular shape or associated skull fracture, making it difficult to differentiate it from a subdural hematoma. mri can be helpful in this regard, because the medially &splaced dura mater is usually directly visualized as a thin line of low signal separating the hematoma from the underlying compressed brain parenchyma. 75 mri is also superior in the detection of subacute and chronic hematomas, which may be isodense on ct77 78 subdural hematomas accumulate within the potential space between the pia-arachnmd and dura mater. they are usually caused by tearing of veins that traverse the subdural space. subdural hematomas appear to be less common m dogs and cats with head injury, compared with human patients. clinical signs may consist of progressive asymmetrical neurological deficits and decreased levels of consciousness. an acute subdural hematoma appears on ct as a hyperdense, crescentshaped collection conforming to the inner surface of the skull. tm mass effect is evident and may be compounded by contusion and edema of the underlying brain parenchyma. acute hyperdense hematomas may not be vislble on a narrow window width (soft tissue window), appearing only as an apparent thickening of the skull, since the bone and hematoma may have the same pixel brightness, r5 78 mass effect is usually present, however, providing a clue in their detectlon. widening the window width may be necessary to distinguish an acute subdural hematoma from the dense skull, rs as with other intracranial hematomas, the density of a subdural hematoma decreases over time, becoming isodense to gray matter by 1 to 2 weeks. accordingly, subacute subdural hematomas may be difficult to detect on ct but are readily detectable on mri. 75 a chronic subdural hematoma (2 to 3 weeks old or older) is hypodense compared with normal brain on ct and is surrounded by a well-defined capsule (fig 12) . this results in a more focal collection of blood with a straighter medial edge compared with crescent-shaped acute subdural hematomas. 78 the capsule of a chronic subdural hematoma enhances with intravenous contrast material and may calcify. tm subarachnoid hemorrhage is bleeding into the csf-filled subarachnoid space. posttraumatic subarachnoid hemorrhage is relatively common and often associated with cortical contusions. acute subarachnoid hemorrhage is evident on ct as increased attenuation of the sulcl, fissures, or basal cisterns, with the degree of increased attenuation being related to the amount of blood in the subarachnoid space. 78 with time the attenuation decreases and subarachnoid hemorrhage may not be detectable after the first week, unless rebleeding has occurred. 51 acute subarachnoid hemorrhage is usually not detectable on mri, probably because the po2 of the subarachnoid csf is too high for the conversion of oxyhemoglobin to deoxyhemoglobin and methemoglobin. 51 however, mri is excellent at detecting subarachnoid hemorrhage in the subacute or chronic stage. 5i brain contusions are common after head trauma and consist of heterogeneous regions of hemorrhage, edema, and necrosis, often located in the superficial gray matter. in human patients contusions tend to be multiple and bilateral and are much less likely to be associated with severe initial impairment of consciousness compared with diffuse axonal injur~ 75 initial ct findings are often limited to faint, ill-defined hypodense areas mixed with tiny regions of hyperdense hemorrhage. 75 contusions in which edema and necrosis predominate may not be visible imtially on ct but often become apparent several days later as regions of decreased attenuation and mass effect caused by edema. 7s mri, because of its greater sensitivity in detecting edema, is better at detecting early contusions, which appear hypointense on tl-weighted images and hyperintense on t2-weighted images. 75 head trauma that involves rapid angular acceleration may result in diffuse axonal injury. these shearing injuries result from differences in elastic and inertial properties between different but adjacent brain tissues/s,79 in human patients, these injuries are characterized pathologically by disruption of axons, especially at the junction of gray and white matter of the cerebrum, and at the corpus callosum, basal nuclei, and cranial aspect of the brainstem. there is subsequent axonal swelling and infiltration with macrophages. these patients present with severe impairment of consciousness starting from the moment of injury. 76"77,s0 mri is much more sensitive than ct in detecting diffuse axonal injury in human patients, although even mri findings usually underestimate the true extent of these injuries. 75 ct is often normal, but may show scattered hemorrhages. the mri appearance reflects the prolonged t1 and t2 values of increased tissue fluid (edema). there are multiple, small elliptical lesions in the white matter. these lesions are hypomtense on tl-weighted images and hyperintense on t2-welghted images. 75, 78 infectious and inflammatory diseases inflammatory diseases are important diagnostic considerations for patients with brain disease. infectious agents, such as viruses, protozoa, and fungi, cause many inflammatory diseases, but for others the etiology is unknown. despite the numerous causes of mflammatory brain disease, the affected tissue can respond only in a limited number of ways. thus, many of these diseases appear similar on imaging studies and differentiating the potential etiologies based on imaging features alone may be impossible. furthermore, it may be difficult to &scriminate between inflammatory diseases and other categories of disease, such as neoplasia and vascular disorders. accordingly, results of imaging studies must be interpreted in context with clinical features and results of other laboratory tests, especially analysis of cse 8i all inflammatory brain diseases share a common pathological feature--an influx of leukocytes into the brain (cerebritis or encephalitis) or meninges (meningitis). because of the close anatomical association of these structures, more than one area of the nervous system can be involved in the inflammatory process. for example, inflammation of the meninges and brain is called meningoencephalitis, s2 the most common cause of meningitis in dogs is steroidresponsive meningitis-arteritis, a nonseptic suppurative meningitis of unknown etiology that responds to immunosuppressive dosages of corticosteroids, s3 infectious causes of memngitis are less common in small animals and include bacteria, viruses, fungi, and protozoa s4 pathologically. acute leptomeningitls results in congestion and hyperemia of the pia-arachnoid and distension of the subarachnoid space by an exudate containing leukocytes. clinically, affected patients show fever, spinal pain, cervmal rigidity, and stiff gait. several complications can occur m the ensuing days to weeks. there may be extension of the infection to the neural parenchyma, resulting in focal or diffuse encephalitis, myelitis, or abscess. inflammatory exudate may obstruct csf pathways, producing hydrocephalus. endogenous host inflammatory mediators can result in disruption of the blood-brain barrier, cerebral edema, and increased intracranial pressure. 85 definitive &agnosis of meningitis is based on analysis of cse neuroimaging is useful in detectmg some of the complications associated with meningitis and when the differential diagnosis includes other diseases. neuroimaging features of experimental bacterial menmgitls in dogs is comparable with naturally occurring bacterial meningitis in human patients. 868r in human patients with uncomplicated early bacterial or viral meningitis, unenhanced ct and mri are often unremarkable or show mild dilatation of the ventricles or subarachnoid space (fig 13) . 88 with more severe involvement, there may be diffuse or patchy brain edema. 88 postcontrast ct or mri may show abnormal enhancement of the leptomeninges. 89 in experimental studies in dogs, tl-weighted mr images with gadolinium showed abnormal leptomeningeal enhancement better than ct. 8r mri also identifies complications such as encephahtis more effectively than ct. 87 encephalitis generally refers to nonpurulent inflammation of the brain and is distinguished pathologically from suppurauve inflammation of the brain (cerebritis) assooated with bacterial infection. 88 viral encephalitides of small animals include canine distemper and feline infectious peritonitis. other causes of encephalitis include rocky mountain fever, canine ehrlichiosis, toxoplasmosis, and neosporosls. finally, there are encephahtides of unknown etiology, such as pug dog encephalitis and granulomatous meningoencephalitis. distemper encephalitis. the two most common clinical forms of distemper encephalitis are acute encephalitis in young dogs and chronic encephalitis in mature dogs. immature dogs with distemper encephalitis typmafly suffer a rapid onset of systemic illness characterized by conjunctivitis, nasal discharge, cough, vomiting, and diarrhea. neurological dysfunction can occur during or after the systemic illness and includes seizures, abnormal behavior, blindness, and paresis. mature dogs are more likely to develop chromc, multifocal encephalitis with a predilection for the white matter of the brainstem. many of these dogs have an adequate vaccination history, and signs of systemm illness are often absent or transient. 9°-92 these patients often have slowly progressive gait deficits or vestibular dysfunction. 9°, 91 ct of dogs with chromc distemper encephalitis may be normal or show focal or multifocal hypoattenuating lesions with a predilection for the white matter. 93 these lesions may have uniform or ring-like enhancement 93 (fig 14) . some lesions may be associated wlth hypoattenuating edema and mass effect. 93 lesions are typically hypointense or poorly defined on tl-weighted mri, hyperintense on t2-weighted images, and enhance with contrast agent. 94 feline infectious peritonitis. feline infectious peritonitis (fip) is a systemic disease of cats caused by an immune response to a corona virus. neurological signs are generally associated with the parenchymatous (dry) form of fie neurological deficits referable to brainstem involvement predominate and include ataxia, paresis, and vestibular dysfunction. [95] [96] [97] imaging features of fip reflect the pathological changes, which consist of pyogranulomatous inflammation of the leptomeninges, choroid plexus, ependyma, and brain parenchyma. hydrocephalus is common and is probably secondary to obstruction by ependymltis. 95-98 the brainstem and fourth ventricle are consistently involved, but other regions of the central nervous system can be affected. 95 96 the inflammatory process primarily affects the inner and outer surfaces of the brain with only secondary extension into the parenchyma. recognition of this surface-related pattern can be helpful in differentiating fip from other bram diseases in the cat. 98 ct may be normal or show hydrocephalus. 95 mri may show ependymitis, choroiditis, and memngitis. this is evident as hyperintensity of the ventricular lining, choroid plexus, and meninges, respectively, on t2-weighted mri and abnormal enhancement with gadolinium-based contrast agent 97,99 (fig 15) . fungal infections. many fungal agents can sporadically infect the nervous system, causing meningitis or granulomas. cryptococcus neoformans is the most common fungal infectmn to involve the nervous system of dogs and cats. in cats, this organism generally induces a mild, nonsuppurative meningitis or encephalitis, whereas affected dogs typically develop a granulomatous reaction in the brain and meninges. 98 neurological deficits can be acute or chronic and include seizures, lethargy, ataxia, and vestibular dysfunction. 1°° 101 on ct, mass lesions (cryptococcomas) appear as single or multiple isodense or hypodense masses with ring or solid enhancement and surrounding edema. 81,89,93i°2 leptomeningeal enhancement may also be apparent if the meninges are involved. 81,i°2 hydrocephalus may occur secondary to meningitis or obstruction of csf pathways by the mass. 81,89 in human patients, mri is more sensitive than ct and may show clustered foci of signal abnormahties that are lsointense to csf on all sequences. these lesions represent small granulomas or dilated virchow-robin spaces filled with fungal organisms and mucoid. these are often bilaterally symmetrical, and are located in the basal nuclei and midbraln. these lesions do not enhance with gadolinium and are not associated with mass effect or edema. 89 similar changes have been reported on mri of canine cryptococcosis.i°3 cryptococcomas appear as masses that are hypointense on tl-weighted images, hyperintense on t2-welghted images, and enhance with gadolinium. 8<1°3 other fungal organisms sporadically infect the central nervous system, including blastomyces dermatldis, histoplasmosis capsulatum, aspergfllus spp, coccidiodes immitis, and phaeohyphomycosis (fig 16) . l°4qn necrotizing encephalitis (pug dog encephalitis). a necrotizing form of encephalitis has been recognized in pug dogs, maltese terriers, and yorkshire terriers between 6 months and 10 years of age. n2-n6 signs include progressive seizures, abnormal behavior, blindness, ataxia, and walking in circles. pathological changes consist of multifocal necrosis and nonsuppuratlve inflammation, with a striking predilection for the white matter of the cerebrum. lesions are often bilateral but asymmetrical, n2-114,n6 enlargement of the lateral ventricles secondary to shrinkage and cavitation of the cerebral hemispheres (hydrocephalus ex vacuo) is common n2,i14 n6 (fig 2) . in yorkshire terriers, the brainstem may be preferentially revolved. 113 the etiology is unknown. in acute forms of the disease, ct may show one or more focal hypodense lesions, most commonly affecting the cerebral hemisphere. the lesions may or may not enhance with contrast agent. mri shows the early edematous changes as increased signal intensity on proton density-weighted and t2-weighted images and decreased signal intensity on tl-weighted images. in acute cases, there is often substantial mass effect and minimal if any abnormal enhancement with contrast medium (fig 17) . differentials include neoplasia, other inflammatory lesions, and acute infarction. in more chronic cases, necrosis and cystic changes usually predominate. the centers of the lesions appears similar to csf; that is, hypodense on ct, very hypointense on tl-weighted images, and very hyperintense on proton density-weighted and t2-weighted images 114-116 (fig 18) . lesions are usually located in the white matter of the cerebral hemisphere, often in the area lateral to the ventricles. ii3 typically there is no mass effect or even a reverse mass effect (shift of surrounding tissue toward the lesion). lesions usually do not enhance, but may have a ring pattern of enhancement. 93 114, 115 asymmetric enlargement of the lateral ventricles is common. 93 the primary differential is chronic infarction. however, in necrotizing encephalitis the lesions are not confined to a specific vascular territory as is typical of infarction caused by thromboembolism. the onset of signs (sudden in infarction versus slow onset in chronic necrotizing encephalitis) ts also helpful. granulomatous meningoencephalomyelitis. granulomatous meningoencephalomyelitis (gme) is an inflammatory disease of the canine central nervous system characterized pathologically by an accumulation of mononuclear cells in the parenchyma and meninges of the brain and spinal cord. 117 lesions may be disseminated or focal. in the disseminated form, lesions are distributed throughout the central nervous system, with a predilection for the white matter of the cerebrum, cerebellum, caudal aspect of the brainstem, and cervical spinal segments. the focal form is manifested as a single granulomatous mass, most commonly located in the cerebrum, with smaller disseminated lesions, ns-ln the cause is not known. adult dogs of any breed can be affected, although females and toy and terrier breeds are at increased risk. 118122 dogs with disseminated gme usually have rapidly progressive signs including neck pain, vestibular dysfunction, paralysis, and seizures. the focal form is manifested as chronic, gradually progressive signs, with seizures being the most common. iis-123 the clinical presentation of focal gme often mimics that of a tumor. on ct, disseminated gme is seen as multiple foci of ill-defined contrast enhancement involving the parenchyma and meninges. some lesions may be associated with hypoattenuating edema and mass effect. 124 other inflammatory diseases are the primary differentials. focal gme appears on noncontrast ct as an isodense or hyperdense mass, most commonly located within the cerebrum or at the cerebellomedullary junction (fig 19) . 93 '125 on mri, focal gme is usually isointense or slightly hypointense on tl-weighted images and hyperintense on proton density-weighted and t2-weighted images (fig 20) . 126 enhancement is variable, including no enhancement, ring-pattern enhancement, or moderate homogenous enhancement. 93,t24,i25 there may be edema in the white matter surrounding the mass. 93, 125, 126 asymmetric enlargement of the lateral ventricles has also been reported. 93 the primary differentials are neoplasia and other inflammatory lesions. biopsy is often necessary for definitive diagnosis. 125 focal infection of the brain with pyogenic organisms is uncommon in small animals. bacteria may gain access to the brain through penetrating wounds; secondary to direct extension from infections in the eye, ear, nasal passages, or meninges; or via hematogenous spread from extracranial sources, i27128 with hematogenous spread, lesions often arise at the graywhite matter junction of the cerebrum, s8 clinical signs reflect a progressively worsening focal brain lesion. 127 i28 several reports detail the pathological and ct features of experimental cerebritis/abscess in dogs. 129,13° these imaging features are similar to those reported in human patients with spontaneous brain abscess. tm pathologically, serial changes occur over 2 to 3 weeks, starting as cerebritis and culminating in abscess. focal but poorly localized areas of scattered necrosis, edema, vascular congestion, and perivascular inflammatory infiltrates characterize cerebritis. at this stage, unenhanced ct shows only an irregular, poorly circumscribed region of low attenuation, t29-132 scans obtained immediately after contrast administration show ring-like enhancement. on delayed scans, contrast diffuses into the center of the lesion, starting peripherally, until the center of the lesion may be completely filled with contrast by 30 minutes after admmistra-tlonj 29-13t the inherent sensitivity of proton density-weighted and t2-welghted mri to aheradons in tissue water enables earlier detection of cerebritis compared with ct. 89,132 these images show increased signal intensity indistinguishable from or slightly hypointense to surrounding edema, sg,j32 on t1weighted images, cerebritis is isointense to slightly hypomtense to adjacent brain parenchyma, with associated mass effect.89,132 over a period of 1 to 2 weeks, untreated cerebritis may progress to abscess formation when the central zone of necrosis becomes liquefied, better defined, and encircled by a collagen capsule, which is formed by fibroblast migration from the surrounding vessels. because of relatively poor vascularization of white matter, the medial aspect of the capsule may be somewhat thinner. this predisposes to expansion of the abscess into white matter, the formation of daughter abscesses medially, or rupture into the lateral ventricles, lz9,13°,132 the capsule is visible on unenhanced ct as an isodense rim that is visible because it is bordered medially by a hypodense liquid center and surrounded by hypodense edema (fig 21) . 131 the edema may be greater in volume than the abscess itself, causing much of the mass effect. 131 on contrast-enhanced ct, the rim is usually smooth and brightly enhancing. there is no diffusion of contrast into the necrotic center on delayed scans as there is with cerebritis, n9-131 on tl-weighted mri there is mild peripheral hypointensity representing edema and a more markedly hypointense liquid center. the capsule is a discrete rim that is isointense to slightly hyperintense. on t2-weighted images the abscess center is isointense to mildly hyperintense to gray matter. the capsule is seen as a dramatic hypointense rim, possibly caused by paramagnetic free radicals within phagocytic macrophages. 89 the ring pattern of enhancement parallels the enhancement seen on contrast-enhanced ct. the differential diagnosis for a ring-enhancing lesion includes primary brain tumor, metastasis, infarction, granuloma, and resolving hematoma. 42.89 helpful clues that may identify abscesses include the time course, location, temporal pattern of enhancement, and predisposition for the abscess rim to be thinner medially, s9 cuterebra. dogs and more commonly cats can suffer brain disease caused by aberrant migration of cuterebra larvae. [133] [134] [135] fly larvae attach to the host and burrow into the subcutaneous tissue. the developing larva (1 to 10 mm long) may migrate under the skin and enter the brain, most likely through the nasal passages and cribiform plate. 134,135 pathological changes in the brain consist of multifocal meningoencephalitis with malacia and hemorrhage •133-135 affected animals typically have access to outdoors and develop signs from june to october, coinciding with the larval migration portion of the cuterebra life cycle. a recent history of upper respiratory disease is common, likely reflecting migration of the larvae through nasal passages. 135 there is an acute onset of neurological dysfunction, most commonly referable to a focal forebrain lesion. seizures, abnormal mentation, circhng, hemlparesis, and unilateral blindness are common. 134,135 clinical and pathological features in cats are similar to what has been previously reported as feline ischemic encephalopathy.i35 a mottled appearance to the brain has been reported on ct of an affected cat} 35 based on my observations, ct may show focal or muhifocal regions of decreased attenuation with minimal mass effect. the may be one or more tract-like regions of contrast enhancement (fig 22) . lesions may be hypointense on tl-weighted mri and hypermtense on t2-weighted mri. edema is fairly minimal, and there may be small regions of hemorrhage. contrast enhancement is s~milar to that described for ct. an enhancing tract (arrows) extends from the cribiform plate through the right cerebral hemisphere. this cat, which lived outside, presented in october, 5 days after suffering a sudden onset of sneezing followed by seizures, left hemiparesis, depression, and circling to the right. clinical signs gradually resolved over the next 2 weeks, so the diagnosis was not confirmed by necropsy, but the clinical features are consistent with intracranial migration of a cuterebra larva. and does not enhance. i36 the intraparenchymal location is helpful in differentiating these lesions from arachnoid cysts, which are associated with the subarachnoid space. 25,~-6 ct and mri are helpful in identifying and characterizing many nonneoplastic brain disorders in dogs and cats. the imaging features of some of these disorders are unique, permitting definitive diagnosis based on imaging results and clinical features. however, the imaging findings for other brain disorders are nonspecific. in these instances, ct and mri often allow detection and localization of abnormalities, but definitive diagnosis may require other laboratory tests or surgical biopsy. as the use of ct and mr] becomes more widespread in veterinary medicine, further research in the imaging findings associated with various nonneoplastic disorders will improve our ability to diagnose and manage these conditions. imaging the brain (first of two parts) canine hydrocephalus. comp contln ed pract vet computed tomography in evaluation of hydrocephalus diagnosis and management of an atypical case of hydrocephalus, using computed tomography, ventrlculoperitoneal shunting, and nuclear sclntigraphy ultrasonographic diagnosis of canine hydrocephalus. vet radio131 ultrasonographlc imaging of the lateral cerebral ventricles in the dog diagnosis of cerebral ventrlculomegaly in normal adult beagles using quantitative mri normal variation in size of the lateral ventricles of the labrador retriever dog as assessed by magnetic resonance imaging developmental change of lateral ventricle volume and ratio in beagle-type dogs up to 7 months of age magnetic resonance imaging of silastlc-lnduced canine hydrocephalus pathogenesis of chlari malformation: a morphometric study of the posterior cranial fossa pathophysiology of synngomyelia associated with chiarl i malformation of the cerebellar tonsils hydromyelia in the dog occipital dysplasia and associated cranial spinal cord abnormalitles in two dogs magnetic resonance imaging of the brain and spine common congenital brain abnormalities cerebellar malformation in two dogs and a sheep cerebellar vermian hypoplasia in dogs dandy-walker--like syndrome in four dogs: cisternography as a diagnostic aid dandy-walker syndrome in a kitten ataxla of the head and hmbs: cerebeliar disease in dogs and cats comparative cerebellar disease in domestic animals arachnoid cysts arachnold cyst in the cerebellar pontlne area of a cat--diagnosis by magnetic resonance imaging magnetic resonance imaging and computed tomography characteristics of intracranial intraarachnoid cysts in 6 dogs spontaneous intracerebral and infratentorial hemorrhage hypertension: a review of the mechanisms, manifestations, and management cerebrovascular disease in various animal species chnlcal characteristics of cerebrovascular disease in small animals surgical excision of a cerebral arteriovenous malformation in a dog cerebral artenovenous malformation in a dog canine cerebrovascular disease: climcal and pathological findings in 17 cases cerebellar infarction caused by artenal thrombosis in a dog cerebral infarction ~n a dog. prog vet neurol computed tomography of an acute hemorrhagic cerebral infarct ~n a dog vet rad~ol ultrasound 35 magnetic resonance ~maging appearance of intracranfal hemorrhage secondary to cerebral vascular malformation ~n a dog magnetjc resonance imaging of brain infarction in seven dogs cerebral hemorrhage in an old dog intracranlal hemorrhage natural history of experimental intracerebral hemorrhage, sonography, computed tomography and neuropathology intracranlal ring enhancing lesions jn dogs: a correlatwe ct scanning and neuropathologlc study vet radlol ultrasound 36 magnetic resonance imaging of the brain and spree biochemical bas~s of the mr appearance of cerebral hemorrhage mr imaging of cerebral hematomas at different field strengths: theory and applications magnetic resonance imaging of intracranial hemorrhage deo-narjne '4. et al. mr imaging of acute intracran~al hemorrhage: findings on sequential spin-echo and gradient-echo images in a dog model pathology of vascular malformations of the brain embryological bas~s of some aspects of cerebral vascular fistulas and malformations artenovenous malformations of the brain nontraumatic intracran~al hemorrhage intracranial vascular malformations and aneurysms, in atlas sw the mri appearance of cavernous malformations (angiomas) intracranial vascular malformations: mr and ct imaging cerebral infarction with associated venous thrombosis ~n a dog vet patho125 pathophysiology and chnical evaluation of ~schem~c vascular d~sease chnical and pathologic findings in dogs with atherosolerosis 21 cases (1970-1983) hypothyroidism and atherosclerosls rn dogs. comp contm educ pract vet neurologlc manifestations of cerebrovascular atherosclerosis associated with primary hypothyroid-~sm in a dog jam cerebral infarction associated with thromboemboli cerebral infarction caused by heartworms (dirofilaria immitls) in a dog latchaw re cerebral ischemia and infarction sequential computed tomography scans in acute cerebral infarction mr imaging of acute expenmental ischemta in cats the impact of magnetic resonance imaging on the management of acute ischemlc stroke cerebral ischemla and infarction, in atlas sw magnetic resonance imaging of human cerebral infarction: enhancement with gd-dtpa gd-dtpa-enhanced magnetic resonance imaging for study of blood-braln-barner permeabdity in naturally occurnng and experimentally reduced brain infarction magnetic resonance imaging brain damage in the epileptic beagle dog vet patho120 the biochemical basis and pathophysiology of status eplleptlcus magnetic resonance imaging evidence of hlppocampal ~njury after prolonged focal febnle convulsions reversible mri lesions after seizures reversible magnetic resonance imaging abnormalities in dogs following seizures imaging of closed head injury magnetic resonance imaging of the brain and spine blinded companson of cranial ct and mr ~n closed head injury evaluation head trauma mechanisms of brain injury prevalence of mr evidence of diffuse axonal injury jn patients with mild head injury and normal head ct findings fntracranial infectious and rnflammatory diseases, in latchaw re inflammatory diseases of the central nervous system in dogs steroid responswe mening~tis-arteritis m dogs: long term study of 32 cases meric sm canine meningitis: a changing emphasis bacterial meningitis" pathogenesls, pathophysiology, and progress apreliminary study of magnetic resonance imaging (mri) in experimental canine meningitis gd-dtpa-enhanced mr imaging of experimental bacterial meningitis; evaluation and comparison with ct burrows pe imaging of pediatric central nervous system infections magnetic resonance imaging of the brain and spine a retrospective evaluation of 38 cases of canine distemper encephalomyelitis neurological manifestations of canine distemper infection diagnosis of inflammatory and jnfectlous diseases of the central nervous system in dogs: a retrospective study computed tomography of primary inflammatory brain disorders in dogs and cats magnetic resonance imaging--a general overview of principles and examples in veterinary neurodiagnosls feline infectious peritonitis with neurologlc involvement: clinical and pathological findings in 24 cats a review of the clinical diagnosis of feline infectious peritonitis viral meningoencephalomyehtls diagnostic features of clinical neurologic feline infectious peritonitis inflammatory diseases of the central nervous system, in veterinary neuropathology what is your diagnosls'~ (feline infectious virus encephahtis) cryptococcosls of the nervous system in dogs, part 1: epidemlologlc, clinical, and neuropathologic features feline cryptococcosis: a retrospective evaluation acryptococcal granuloma jn the brain of a cat causing focal signs prog vet neurol 7 a case of canine central nervous system cryptococcosis: management with fluconazole blastomycosls in dogs 115 cases (1980-1995) blastomycosis in cats: five cases (1979-1986) central nervous system d~sease due to histoplasmos~s ~n a dog: a case report systemic aspergillosls in a cat vet radio131 coccidioides immitls encephalitis in two dogs granulomatous meningitis caused by coccidioides immitts m a dog bayles wb cerebral phaeohyphomycosis phaeohyphomycotic encephalitis in two dogs a necrotlzlng menlngoencephahtis of pug dogs. vet necrotlzlng encephalitis in yorkshire terriers necrotizing meningoencephalitis of maltese dogs necrotizing encephalitis in a yorkshire terrier clinical and pathological findings of a yorkshire terrier affected with necrotizing encephalitis granulomatous menlngoencephalomyelitls in six dogs clinical and histopathologlcal features of granulomatous meningoencephalomyehtis in dogs cordy dr canine granulomatous meningoencephalomyehtis granulomatous men~ngoen-cephalomyehtls of dogs in new zealand granulomatous meningoencephalomyehtis in 21 dogs differential diagnosis of granulomatous menlngoencephalitls, dlstemper~ and suppurative meningoencephalitis in the dog prognostic factors for dogs with granutomatous meningoencephalomyelitls: 42 cases (1982-1996) imaging dlagnosls--granulomatous meningoencephalitis in a dog computed tomography in the diagnosis of focal granulomatous menlngoencephalitls: retrospective evaluation of three cases magnetic resonance imaging in the dlagnos]s of focal granulomatous meningoencephalitls in two dogs brain abscess associated with a penetrating foreign body brain abscess in a dog neuropathological and computerized tomographic findings in experimental brain abscess experimental brain abscess; computed tomographic and neuropathologic correlation staging of human brain abscess by computed tomography the magnetic resonance imaging of infections and inflammatory diseases cerebral cuterebrosis in a dog aberrant intracranlal myiasis caused by larval cuterebra infection clinical and clinicopathologic features in 11 cats with cuterebra larvae myiasis of the central nervous system cerebral coenurosls in a cat labuc ret al: cerebral coenunasis in a domestic cat magnetic resonance imaging cerebrovascular disease key: cord-346815-4t4gr0jz authors: moshayedi, pouria; ryan, timothy e.; mejia, lucido luciano ponce; nour, may; liebeskind, david s. title: triage of acute ischemic stroke in confirmed covid-19: large vessel occlusion associated with coronavirus infection date: 2020-04-21 journal: front neurol doi: 10.3389/fneur.2020.00353 sha: doc_id: 346815 cord_uid: 4t4gr0jz the outbreak of covid-19 has posed a significant challenge to global healthcare. acute stroke care requires rapid bedside attendance, imaging, and intervention. however, for acute stroke patients who have a diagnosis of or are under investigation for covid-19, the concern for nosocomial transmission moderates operational procedures for acute stroke care. we present our experience with an in-hospital stroke code called on a covid-19-positive patient with a left middle cerebral artery syndrome and the challenges faced for timely examination, imaging, and decision to intervene. the outlook for the ongoing covid-19 pandemic necessitates the development of protocols to sustain timely and effective acute stroke care while mitigating healthcare-associated transmission. rapid attendance at the patient bedside, clinical exam, and timely imaging studies have been emphasized in the care of acute ischemic stroke patients, but the global pandemic outbreak of covid-19 (1) has created novel and significant challenges to acute stroke care. protocols to sustain acute stroke care for covid-19 patients while mitigating nosocomial transmission are needed. in this report, we share unique challenges in treating a covid-19-positive patient with acute ischemic stroke due to occlusion of the left middle cerebral artery. we also discuss the current evidence and recommendations to decrease healthcare-associated transmission in acute clinical examination, imaging, and interventional procedures in acute stroke patients with a diagnosis of covid-19. a patient in his 8th decade of life was admitted to our facility with acute chest pain, diaphoresis, and hypotension with st-elevation myocardial infarction (stemi). he underwent coronary angioplasty followed by stent deployment and was admitted to the coronary care unit (ccu). transthoracic echocardiogram revealed left ventricle (lv) ejection fraction of 10-15% and lv thrombosis measuring 2.8 cm × 1.1 cm, prompting initiation of iv heparin. he also had bilateral lower limb paresthesia and loss of temperature and arterial pulses, raising concern of ischemic limbs, with lower extremity arterial doppler confirming occlusion in multiple arterial segments. due to his presentation with shortness of breath, he was designated as a patient under investigation (pui) for covid-19, and, the day following admission, his pcr testing of respiratory secretions showed evidence of 2019-ncov rna. he was intubated due to hypoxemic respiratory failure. standard facility protocols for droplet isolation in a negative pressure room were implemented. the patient was extubated on day 4. on day 5, an in-hospital stroke code was called after the bedside nurse found him to have an inability to speak, rightsided weakness, and right-sided facial droop, with last known well time the night before. the stroke team arrived, and one team member wore personal protection equipment including an n95 respirator mask, goggle, gown, and gloves and entered the patient's room to perform an examination, which revealed an inability to speak or comprehend, a conjugate gaze preference toward the left side, no blink to threat on the right side, and no movement in the right arm and leg. since the patient presented with a large vessel occlusion stroke syndrome within an extended time window, advanced multimodal imaging was indicated to measure infarct volume as well as salvageable tissue. according to the institutional policy for acute stroke codes, as well as the patient's renal failure prohibiting the use of iodine contrast for ct perfusion studies, he was transported to mri. the institutional protocol for transferring patients in aerosol isolation was applied by having the patient wear a surgical face mask. laboratory results were notable for renal failure, normal platelet count, and activated partial thromboplastin time (ptt) >85.5 while on heparin. brain mri, obtained without contrast administration (due to severe renal failure) and reviewed during image acquisition, revealed a 60-cc acute infarct in the left insular, temporal, parietal, and frontal lobes, as well as smaller acute infarcts in the right caudate and left cerebellar hemisphere. mri also showed evidence of hemorrhagic conversion in the left fronto-temporal territory. mr angiogram showed occlusion of the left middle cerebral artery proximal m1 segment. the patient was not a candidate for thrombolysis as he had elevated activated ptt on heparin, in addition to an unknown time of stroke onset and evidence of large and established infarction with a small region of hemorrhagic transformation. endovascular thrombectomy was considered but not pursued given the large infarct size and evidence of hemorrhagic transformation since reperfusion could have led to a much larger intracranial hemorrhage with no meaningful clinical benefit. following this ischemic stroke, and given other comorbidities including heart failure, cardiovascular shock, and ischemic bilateral lower limbs, discussions on goals of care were held with the family, and his care was focused on comfort according to the patient's wishes. following the completion of his mri, the mri suite was out of commission for about 3 h to complete disinfection. early reports from the covid-19 pandemic have noted a 41% nosocomial infection rate (2) , which highlights the importance of developing protocols for transfer, imaging, intubation, and surgical or endovascular procedures on covid-19 patients presenting with acute stroke. the novelty of the covid-19 pandemic outbreak means that there are few evidence-based and informed protocols. the current recommendations have centered on the airborne and direct contact methods of transmission (3) . to perform mri or other imaging modalities, it is recommended to switch a patient's bed and accessories to mri-compatible equipment in the patient room with enhanced airborne precautions rather than in the mri suite. designation of a single entry point to imaging facilities and limiting other traffic through the healthcare facility is preferred (4). installment of physical barriers and the donning of n95 masks, face protection, and gloves for physicians or ancillary staff en-route are recommended. discussions on safe pre-operative procedures are underway (5) . studies published before the covid-19 outbreak noted that a high-flow nasal cannula, non-invasive ventilation by masks with optimized vent holes, or a helmet connected to a doublelimb circuit may lower airborne transmission (6), but closedcircuit ventilation with use of filters is regarded as a safer option. given the relatively low risk of operative site infection, endovascular suites capable of conversion to negative pressure facilities appear to be ideal solutions. the covid-19 pandemic outbreak has exhausted and overburdened healthcare systems. in a situation of extreme facility shortages, triaging covid-19-positive patients with acute stroke based on severity and extent of their premorbidities is a grim but unavoidable necessity. in acute stroke patients presenting with symptoms of large vessel occlusion in an extended time window, and therefore requiring advanced imaging, ct perfusion has been shown to be equally capable of selecting patients for endovascular thrombectomy when compared with mri (7). the time required for disinfection protocols to be conducted may require judicious use of mri for acute stroke patients. in the face of the current pandemic, our institutional policy for acute stroke care has changed and now prioritizes ct perfusion over mri. all datasets presented in this study are included in the article/supplementary material. the studies involving human participants were reviewed and approved by ucla irb. written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements. and dl: conception and design and administrative/technical/material support. pm: acquisition of data and drafting the article. all authors: analysis and interpretation of data, critically revising the article, and reviewed submitted version of manuscript. dl: approved the final version of the manuscript on behalf of all authors and study supervision. responding to covid-19 -a once-in-a-century pandemic? clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan more awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from china microbiology for radiologists: how to minimize infection transmission in the radiology department intubation and ventilation amid the covid-19 outbreak: wuhan's experience exhaled air dispersion during noninvasive ventilation via helmets and a total facemask thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging dl is consultant to cerenovus, genentech, stryker and medtronic as imaging core lab.the remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.copyright © 2020 moshayedi, ryan, mejia, nour and liebeskind. this is an openaccess article distributed under the terms of the creative commons attribution license (cc by). the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. key: cord-322890-w78tftva authors: suran, jantra ngosuwan; wyre, nicole rene title: imaging findings in 14 domestic ferrets (mustela putorius furo) with lymphoma date: 2013-06-06 journal: vet radiol ultrasound doi: 10.1111/vru.12068 sha: doc_id: 322890 cord_uid: w78tftva lymphoma is the most common malignant neoplasia in domestic ferrets, mustela putorius furo. however, imaging findings in ferrets with lymphoma have primarily been described in single case reports. the purpose of this retrospective study was to describe imaging findings in a group of ferrets with confirmed lymphoma. medical records were searched between 2002 and 2012. a total of 14 ferrets were included. radiographs (n = 12), ultrasound (n = 14), computed tomography (ct; n = 1), and magnetic resonance imaging (mri; n = 1) images were available for review. median age at the time of diagnosis was 5.2 years (range 3.25–7.6 years). clinical signs were predominantly nonspecific (8/14). the time between the first imaging study and lymphoma diagnosis was 1 day or less in most ferrets (12). imaging lesions were predominantly detected in the abdomen, and most frequently included intra‐abdominal lymphadenopathy (12/14), splenomegaly (8/14), and peritoneal effusion (11/14). lymphadenopathy and mass lesions were typically hypoechoic on ultrasound. mild peritoneal effusion was the only detected abnormality in two ferrets. mild pleural effusion was the most common thoracic abnormality (3/12). expansile lytic lesions were present in the vertebrae of two ferrets with t3‐l3 myelopathy and the femur in a ferret with lameness. hyperattenuating, enhancing masses with secondary spinal cord compression were associated with vertebral lysis in ct images of one ferret. the mri study in one ferret with myelopathy was inconclusive. findings indicated that imaging characteristics of lymphoma in ferrets are similar to those previously reported in dogs, cats, and humans. l ymphoma is the most common malignant neoplasia in domestic ferrets, mustela putorius furo. following insulinoma and adrenocortical neoplasia, it is the third most common neoplasia of domestic ferrets overall. [1] [2] [3] [4] in ferrets, lymphoma can be classified based on tissue involvement, including multicentric, mediastinal, gastrointestinal, cutaneous, and extranodal. [1] [2] [3] the presentation and organ distribution of lymphoma has been associated with the age of onset. 5, 6 mediastinal lymphoma is more prevalent in young ferrets, particularly less than 1 year of age. these ferrets tend to have an acute presentation and may present with dyspnea. ferrets with mediastinal lymphoma may also have multicentric involvement. 2, 5, 6 ferrets 3 years of age and greater have a variable presentation with multicentric disease being more prevalent. clinical signs in older ferrets may be chronic and nonspecific depending on organ involvement. some ferrets may have intermittent signs over several months, while others may be asymptomatic with lymphoma being diagnosed incidentally, detected either during routine physical examination or during evaluation of comorbidities. [1] [2] [3] despite lymphoma being common in domestic ferrets and the use of radiography and ultrasonography being touted as part of the minimum database in the diagnosis of lymphoma, 1, 7 imaging findings in ferrets with lymphoma have been limited to a few case reports. 1, 2, 5, 6, [8] [9] [10] [11] the goal of this retrospective study was to describe radiography, ultrasonography, computed tomography (ct), and magnetic resonance imaging (mri) findings in a series of ferrets with a confirmed diagnosis of lymphoma. medical records at the matthew j ryan veterinary hospital of the university of pennsylvania were searched for domestic ferrets with a diagnosis of lymphoma confirmed with cytology or histopathology that had radiography, ultrasonography, ct, or mri performed between january 2002 and april 2012. signalment, clinical signs, laboratory findings, and any prior or concurrent disease processes were recorded. vet radiol ultrasound, vol. 54, no. 5, 2013, pp 522-531. radiographs, ct, mri, static ultrasound images, and when available, ultrasound cine loops were retrospectively evaluated, and abnormal findings were recorded by j.n.s. the imaging reports generated by a board-certified veterinary radiologist at the time the study was performed were also reviewed. ferrets were excluded if the imaging studies were unavailable for review. any imaging studies obtained after the reported start of clinical signs until a diagnosis was achieved were included. in addition to the reported ultrasonographic findings, the maximal splenic and lymph node thicknesses were measured from the available images if they were not reported. as splenomegaly is common in ferrets, most frequently due to extramedullary hematopoiesis, 2 splenomegaly was subjectively graded as within incidental variation ("incidental splenomegaly") and larger than expected for "incidental splenomegaly." those with subjectively normal spleens or "incidental splenomegaly" were referred to as normal for the purposes of this paper, unless otherwise specified. retrieved ct images were reconstructed with a high-frequency high-resolution algorithm (bone algorithm with edge enhancement) in 1.25 mm slice thickness. the maximal lymph node thickness was measured on precontrast images. fourteen ferrets met the inclusion criteria. lymphoma was diagnosed from ultrasound-guided aspirates, surgical biopsies, and/or necropsy; three ferrets had two diagnostic procedures performed. ultrasound-guided aspirate cytology was performed in nine ferrets, surgical biopsy in three, and necropsy in five. both aspirates and biopsy were performed in two ferrets, and both aspirates and necropsy in one ferret. one ferret in this study was previously described. 8 the median age at the time of lymphoma diagnosis was 5.2 years (range 3.25-7.6 years). eight of the ferrets were neutered males, and six were spayed females. prior disease histories included adrenal disease (n = 5), cardiovascular disease (5), cutaneous mast cell tumors (4), diarrhea (3), insulinoma (2), cataracts (2) , and one each of granulomatous lymphadenitis secondary to mycobacteriosis, renal insufficiency, and a chronic pelvic limb abscess. cardiovascular disease included second degree atrioventricular block (3), systemic hypertension (1), hypertrophic obstructive cardiomyopathy (1) , and in one individual both aortic insufficiency and arteriosclerosis. for most ferrets, the time between the first imaging study and a diagnosis of lymphoma was 1 day or less (12/14) . in one ferret each, the time between the initial imaging study and final diagnosis of lymphoma was 7 days and 6.9 months. the duration of clinical signs prior to reaching the diagnosis of lymphoma ranged from less than 1 day to 8 months with a mode of less than 1 day and a median of 6 days. clinical signs include lethargy (n = 9), diarrhea (8) , inappetence (7), weight loss (6), ataxia (4), lameness (1), and vomiting (1) . diarrhea was chronic in three ferrets and consistent with melena in two. two ferrets did not have overt clinical signs. physical exam findings included palpable abdominal masses (8) , generalized splenomegaly (5), palpable splenic nodules or splenic masses (3), dehydration (5), paraparesis and ataxia (4), abdominal pain (4), hypotension (3), lumbar pain (2), abdominal effusion (1), inguinal and popliteal lymphadenopathy (1), pyrexia (1), urinary and fecal incontinence (1), and a right femoral mass (1). paraparesis and ataxia were attributed to t3-l3 myelopathy in three ferrets and hypoglycemia in one. one ferret also presented with ptyalism and tremors, which resolved with dextrose administration. blood analyses, including a complete blood count and chemistry profile, were performed in 12 of the 14 ferrets. blood glucose evaluation alone was performed in one ferret. abnormalities included azotemia (5), elevated liver enzymes (5), nonregenerative anemia (4), hypoglycemia (4), hypoalbuminemia (3), lymphocytosis (2), hyperglobulinemia (2), hypercalcemia (1), and elevated total bilirubin (1). two of the four ferrets with hypoglycemia had a previous diagnosis of insulinoma. radiographs were performed in 12/14 ferrets. each of these 12 studies included the thorax and abdomen-six studies included a right or left lateral projection and a ventrodorsal projection and six included a left lateral, right lateral, and ventrodorsal projections. one ferret's radiographs were in an analog format (screen-film), and the remaining 11 were digital (rapidstudy, eklin medical systems inc., santa clara, ca). ultrasound was performed in 14/14 ferrets using a 13-15 mhz linear transducer (ge medical logiq 9 ultrasound imaging system, general electric medical systems, milwaukee, wi). abdominal ultrasonography was performed in 13/14 ferrets. ultrasonography of a rib mass and a femoral mass was performed in one ferret each. abdominal ultrasonography was performed twice in one ferret after the start of the reported clinical signs, but prior to the diagnosis of lymphoma. ultrasounds were performed by a board-certified radiologist or a radiology resident under direct supervision from a board-certified radiologist. in the one ferret with two ultrasounds performed prior to diagnosis of lymphoma, the later scan was used for measurements. computed tomography of the thorax and abdomen was performed in one ferret. the ferret was scanned under general anesthesia in dorsal recumbency using a 16-slice multidetector ct unit (ge brightspeed, general electric company, milwaukee, wi) in medium-frequency soft tissue algorithms (2.5 mm slice thickness, 1.375 pitch) before and immediately after iv administration of nonionic iodinated contrast (iohexol, 350 mgi/ml, dosage 770 mgi/kg, [omnipaque, ge healthcare, inc., princeton, nj]). contrast was manually injected through an iv catheter preplaced in a cephalic vein. one ferret underwent mri evaluation of the lumbar and sacral spine. magnetic resonance imaging was performed using a 1.5 t mri unit (ge medical system, milwaukee, wi) with the patient in dorsal recumbency under general anesthesia. image sequences included t2 weighted (t2w) image series in a sagittal and transverse plane, t2w fat-saturated images in a sagittal and transverse plane, and a sagittal single-shot fast spine echo. additional sequences including t1 weighted (t1w) images and administration of gadolinium were not performed due to anesthetic concerns for the patient. radiographic and ultrasonographic findings are summarized in table 1 . radiographic abnormalities were predominantly noted in the abdomen. decreased abdominal serosal detail was present in 10 of the 12 ferrets with radiographs. this was interpreted to be potentially due to a poor body condition in two ferrets. abdominal serosal detail was additionally mottled in seven ferrets. sonographically, peritoneal effusion was detected in 11/13 ferrets, and was considered mild in 7, moderate in 4, anechoic in 8, and echogenic in 3. the spleen was considered enlarged in 7 out of 12 ferrets radiographically and in 8 out of 13 ferrets in which abdominal ultrasonography was performed. the remaining five ferrets were considered to have "incidental splenomegaly" on ultrasound and were radiographically considered normal (n = 4) and enlarged (1) . of the eight spleens sonographically considered abnormal, multifocal hypoechoic splenic nodules were present in six ferrets (fig. 1) ; one of these six ferrets was considered to have a radiographically normal spleen. an isoechoic to hypoechoic mass with central hypoechoic nodules was present in one ferret. the spleen had a mottled echotexture in one ferret. three ferrets were sedated with butorphanol (torbugesic, fort dodge animal health, fort dodge, ia) and midazolam (hospira inc., lake forrest, il) prior to abdominal ultrasonography; sedation was not performed in any ferret prior to radiographs. all three sedated ferrets had enlarged spleens with one spleen having a mottled echotexture and the other two spleens having multifocal hypoechoic nodules. splenic cytology or histopathology was not performed in any of the ferrets that received sedation for ultrasound. cytology or histopathology was available in seven ferrets-aspirates were performed in 2/7, necropsy in 4/7, and both aspirates and necropsy in 1/7. lymphoma was confirmed in three out of six ferrets with splenic nodules, the one ferret with a splenic mass, and one out of five ferrets with "incidental splenomegaly." in three of the five ferrets with "incidental splenomegaly," marked splenic extramedullary hematopoiesis with splenic congestion (1) and without concurrent splenic congestion (1) was diagnosed. the other seven ferrets did not have cytologic evaluation of the spleen. splenic thickness in ferrets where the spleen was considered within incidental variation ranged from 8.0 to 16.2 mm (median, 15.0 mm, mean 13.4 mm, standard deviation ±3.5 mm; n = 5), while in ferrets with splenomegaly splenic thickness ranged from 14.2 to 33.1 mm (median 19.9 mm, mean 20.9 mm, standard deviation ±6.4 mm; n = 8). single or multiple, round to oblong, soft-tissue opaque, abdominal masses consistent with enlarged lymph nodes were visible radiographically in 7/12 ferrets (fig. 2) . one of these ferrets had a large cranial abdominal mass, which was subsequently confirmed to be a markedly enlarged pancreatic lymph node. one ferret had splenic lymphadenopathy detected on the radiographs retrospectively after evaluation of the sonographic findings. lymphadenopathy was reported in 11 of the 13 ferrets with abdominal ultrasonography and the one ferret in which whole body ct was performed. sonographically, abnormal lymph nodes were hypoechoic, rounded, variably enlarged, and surrounded by a fig. 3 . ultrasound image of an enlarged hepatic lymph node in the same ferret as fig. 2 . the hepatic lymph node is markedly enlarged and lobular. although the node is predominantly hypoechoic, there are patchy hyperechoic regions and smaller, round, hypoechoic, nodule-like regions within (arrow). the surrounding fat is hyperechoic, producing a halo around the lymph node (arrow heads). scale at the top of the image is 10 mm between the major ticks. hyperechoic rim (fig. 3 ). some lymph nodes had patchy hyperechoic regions within or a reticular, nodular appearance. abdominal lymph nodes involved included the mesenteric (n = 10), hepatic (7), sublumbar (5), splenic (4), gastric (3), gastroduodenal (3), colonic (3), pancreatic (2), ileocolic (1), renal (1), and inguinal (1) lymph nodes. in one ferret other lymph nodes were reported to be involved in addition to the mesenteric and sublumbar nodes, but were not specifically identified. nine of the 11 ferrets with abdominal ultrasound and the one ferret with ct had involvement of 2 or more lymph nodes reported; 2/11 ferrets had only one reportedly abnormal lymph node (1 splenic lymph node, 1 mesenteric lymph node). lymph nodes measured from 4.8 to 29.5 mm thick (median 8.5, mean 11.6 mm, standard deviation ±8.1 mm). the lymph node thickness in ferrets with radiographically evident lymphadenopathy ranged from 6.2 mm to 29.5 mm with a median of 9.7, and mean of 14.5, and standard deviation of ±9.7 mm (n = 7). in ferrets in which lymphadenopathy was detected sonographically but not radiographically, lymph nodes measured 4.8 mm, 5.2 mm, and 11.7 mm thick (n = 3). lymph node cytology or histopathology was available in seven ferrets-aspirates were performed in 3/7 ferrets, both aspirates and surgical biopsy in 1/7, and necropsy in 3/7. it was not clear if lymph nodes were histopathologically assessed in 2/5 ferrets in which a necropsy was performed. lymphoma was confirmed in 6/11 ferrets with sonographically abnormal lymph nodes (range 5.2-29.5 mm thick, median 14.8 mm, mean ± standard deviation 17.2 ± 9.3 mm). in 1/11 ferrets, lymphoid hyperplasia was identified postmortem (6.2 mm thick). cytologic evaluation of lymph nodes was not performed in the remaining ferrets. in ferrets with lymphadenopathy, eight had concurrent splenomegaly with fig. 4 . ultrasound image of the gastric antrum. the wall of the gastric antrum, especially the muscularis layer, is circumferentially thickened (arrows). a small amount of fluid and gas (*) is present in the lumen. splenic nodules (6), a splenic mass (1), or a mottled splenic echotexture (1) . lymphoma was identified in the liver of 2/14 ferrets by surgical biopsy (1) and at necropsy (1) . mild hepatomegaly with a normal echotexture was noted on ultrasound in the ferret with lymphoma diagnosed by biopsy. additional findings in this ferret included mild peritoneal effusion and lymphadenopathy. the ferret with hepatic lymphoma identified at necropsy had no radiographic or reported sonographic liver abnormalities. this ferret also had hepatic lipidosis. imaging findings in this ferret included an aggressive vertebral lesion, splenomegaly with splenic nodules, and lymphadenopathy. lymphoma was confirmed in each of these organs, as well as in the pancreas, which was reportedly normal on ultrasound. in addition to these two ferrets, hepatic histopathology from necropsy was available in four other ferrets. hepatic lipidosis was identified each of these four ferrets; one ferret also had extramedullary hematopoiesis. none of these four ferrets had radiographic or reported sonographic abnormalities. cytology or histopathology was not available in the remaining 8/14 ferrets. of these, 1/8 had no radiographic or sonographic abnormalities noted. mild hepatomegaly was noted radiographically in 5/8 ferrets; however, sonographic hepatic changes were not noted in these ferrets and cytologic evaluation was not performed. on ultrasound, one ferret had moderate hepatomegaly with a hypoechoic, mottled echotexture (radiography was not performed in this ferret). additionally one ferret had two hypoechoic cystic masses, one mass of which had central mineralization, detected with ultrasound (radiography was not performed in this ferret). gastrointestinal lymphoma was confirmed at necropsy in two ferrets. in one ferret, thickening of the gastric antrum up to 4.5 mm and blurring of wall layering was identified sonographically (fig. 4) . (to the authors' knowledge, the normal gross or sonographic wall thickness of the gastrointestinal tract in ferrets has not been previously reported.) fig. 5 . ultrasound image of the right kidney. there is a round, hypoechoic nodule in the parenchyma, which bulges from the renal contour. the calipers (+) denote the renal length (1) and margins of the nodule (2, 3). no abnormalities were noted in the small or large intestines. at necropsy, lymphoma was identified in the stomach and small intestines, in addition to a chronic ulcerative gastroenteritis. in the second ferret, aside from poor abdominal serosal detail attributable to poor body condition and mild anechoic peritoneal effusion, there were no other radiographic or sonographic abnormalities. in this ferret, lymphoma was identified postmortem in the descending colon. the colon was discolored, but there was no reported gross colonic wall thickening. renal masses were present in two ferrets. in each ferret, a single renal mass was detected with ultrasound and was well defined, hypoechoic, centered on the cortex, and protruded from the kidney. the mass was right-sided, rounded, and measured 8.6 mm in diameter in one of these two ferrets. in the second ferret, the mass was left-sided, lobular, and measured up to 17.9 mm in diameter. cytology of the right renal mass in the first ferret was not performed; however, the patient received chemotherapy for the treatment of lymphoma, confirmed from aspiration and biopsy of an enlarged lymph node, and the mass was seen to decrease in size during follow-up studies (fig. 5) . although the masses in both ferrets had similar ultrasound characteristics, the renal mass in the second ferret was diagnosed as a spindle cell sarcoma. additionally that mass had been identified sonographically 1 year prior to the diagnosis of lymphoma, was progressively increasing in size, and did not decrease in size following administration of chemotherapy for the treatment of lymphoma. concurrent sonographic changes in both ferrets included lymphadenopathy and peritoneal effusion. a large lobular retroperitoneal mass was present in one ferret. the mass was on midline, extending into the right and left sides of the retroperitoneal space, laterally displacing the right kidney. the left kidney was not visualized radiographically. in the right cranial retroperitoneal space, cranial to the right kidney, there was a cluster of heterogeneous mineral opacities in an adjacent second, smaller mass. sonographically the large retroperitoneal mass was heterogeneous, hypoechoic with patchy hyperechoic regions, and laterally displaced both kidneys. the smaller mineralized mass was confirmed to be an enlarged right adrenal gland sonographically. at necropsy, the retroperitoneal mass was confirmed to be lymphoma; however, a specific tissue of origin was not determined. as a normal left adrenal gland could not be identified sonographically or at postmortem, an adrenal origin for this mass was considered most likely, although adrenal tissue was not identified histopathologically within the mass. alternatively the mass may have arisen from a retroperitoneal lymph node or retroperitoneal adnexa. concurrent abdominal imaging findings considered incidental to the diagnosed lymphoma included renal cysts (8) , cystic lymph nodes (7), adrenomegaly in ferrets with diagnosed adrenal disease (5), and pancreatic nodules in ferrets diagnosed with insulinoma (2). on thoracic radiographs pleural fissure lines, consistent with a small volume of pleural effusion, were present in 3/12 ferrets. pericardial and pleural effusions were noticed during abdominal ultrasonography in one ferret. possible sternal (2) and tracheobronchial lymphadenopathy (1) were seen radiographically. in one ferret, sternal and cranial mediastinal lymphadenopathy were detected with ct. an interstitial pulmonary pattern was present in two ferrets, but was potentially attributable to the radiographic projections being relatively expiratory. aggressive osseous lesions were detected radiographically in three ferrets. the one ferret with a history of lameness had a soft-tissue mass involving the entire right femur with marked, multifocal areas of geographic to motheaten, expansile lysis throughout. smooth to mildly irregular periosteal reaction was present along the femoral diaphysis and greater trochanter. the adjacent acetabulum and ileum were questionably involved based on the radiographs. sonographically the soft-tissue components of the mass were homogeneously hypoechoic. cortical irregularities and disruption, consistent with lysis, were also present. histopathology of the mass following limb amputation was consistent with plasmablastic lymphoma. this ferret was previously described. 8 vertebral lysis was apparent radiographically in two of the three ferrets with t3-l3 myelopathy. in one of these two ferrets, there was geographic lysis of l1 involving the majority of the vertebral body and a pathologic fracture of the cranial end plate (fig. 6) . other radiographic changes present in this ferret included splenomegaly and decreased abdominal serosal detail likely due to poor body condition. on ultrasound, peritoneal effusion, splenomegaly with splenic nodules, and lymphadenopathy were detected. at necropsy, intramedullary lymphoma was found in the l1 vertebra with epidural extension of the tumor. lymphoma was also found affecting the spleen, liver, pancreas, and fig. 6. right lateral radiograph cropped and centered on l1. at l1 there is geographic lysis, including cortical thinning or loss, of the cranial two-thirds of the vertebral body and the cranial aspect of the pedicles (arrows). the cranial end plate of l1 has a concave indentation, presumptively secondary to a pathologic fracture (arrow head). mesenteric lymph nodes. in the second ferret with vertebral lysis, there was geographic lysis of the cranial two-thirds of the body and pedicles of t14. there was also possible lysis of the cranial body and pedicles of l4. the dorsal half of the left 9th rib was lytic and no longer visible. associated with this rib, there was a large, ill-defined, soft-tissue mass, which extended into the thoracic cavity. the adjacent ribs and vertebra were not appreciably involved. additional radiographic findings in this ferret included splenomegaly, hepatomegaly, and abdominal masses consistent with enlarged lymph nodes. with ct, expansile lysis of the left t14 vertebral body and pedicle was seen associated with a hyperattenuating (to muscle), strongly enhancing mass (fig. 7) . the mass occupied the ventral two-thirds of the spinal canal and resulted in severe spinal cord compression. a possible pathologic fracture was present in the cranial endplate. at l4, there was lysis of the left pedicle and body associated with a mildly compressive, hyperattenuating, contrast-enhancing mass. an additional, similar mass lesion was seen at t4, with lysis of the midvertebral body and mild spinal cord compression. the rib mass was isoattenuating (to muscle), heterogeneous, mildly enhancing, and resulted in severe, expansile lysis. cytology of the rib mass obtained by ultrasound-guided fine-needle aspiration was diagnostic for lymphoma; cytological assessment of the other lesions was not performed in this ferret. one ferret with t3-l2 myelopathy did not have gross skeletal pathology. radiographic changes included splenomegaly and poor, mottled serosal detail. sonographically, a mild peritoneal effusion was present, and the spleen was considered within incidental variation. an mri of the lumbar spine revealed an ill-defined area of suspect intramedullary t2w hyperintensity within the spinal cord at the level of l3. differential diagnoses for this lesion considered at the time included an artifact, prior infarct, gliosis, edema, myelitis, neoplasia, and hydromyelia. at the postmortem examination performed 5 months after the mri, lymphoma was detected in the brain, meninges, choroid plexus, spinal cord, and extracapsular accessory adrenal tissue. additionally there was multifocal spinal cord malacia and hemorrhage. the lesions in the spinal cord were identified in histopathologic samples obtained at intervals from the cervical spine at c1 through to the lumbar spine at l5, including at the level of l3. specific correlation between the suspect mri lesion and histopathologic findings was not performed. splenic changes were consistent with congestion and extramedullary hematopoiesis. multicentric lymphoma was the most common presentation in this study. this is consistent with prior reports in which multicentric lymphoma is the most common presentation in ferrets older than 3 years of age. 1, 5, 6, 12 the most common imaging findings in this study were intraabdominal lymphadenopathy and splenomegaly with mildto-moderate peritoneal effusion. lymphadenopathy consisted of multiple enlarged, predominantly intra-abdominal lymph nodes, particularly including the mesenteric lymph node. only one ferret had peripheral lymphadenopathy, consisting of enlargement of the inguinal and popliteal lymph nodes, in addition to abdominal lymphadenopathy. lymph nodes greater than 6.2 mm thick sonographically were generally appreciable radiographically as round to oblong, soft-tissue nodules or masses in their respective locations. of the three ferrets in which sonographically detected lymphadenopathy was not appreciable radiographically, only one had a lymph node thickness greater than 6.2 mm. that ferret also had a large, retroperitoneal mass that likely accounted for a lack of visualization of the enlarged mesenteric lymph node due to silhouetting and displacement. previous studies in normal ferrets using ultrasound have reported the normal thickness of mesenteric lymph nodes as 5.3 ± 1.39 mm and 7.6 ± 2.0 mm. 13, 14 given that some radiographically visible lymph nodes measured as small as 6.2 mm (which is within the reported normal ranges for mesenteric lymph nodes) it is possible that normal lymph nodes may be radiographically appreciable. in the authors' experiences, however, visualization of normal, small abdominal lymph nodes on radiographs of ferrets is uncommon. normal abdominal lymph nodes are not radiographically distinguishable in dogs and cats. 15, 16 although some lymph nodes in this study that were considered abnormal measured within the reported normal ranges, there were other changes to those nodes to suggest pathology, such as hypoechogenicity. in dogs and cats, sonographic changes that have been associated with malignancy include an increase in maximal short and long axis diameter (enlarged), an increase in short-to-long axis length ratio (more rounded appearance), hypoechogenicity, hyperechoic perinodal fat with an irregular nodal contour, and heterogeneity. [17] [18] [19] similar to previous reports, the spleen was the most common extranodal site of neoplastic infiltration with lymphoma in the current study. 5 in a prior study splenomegaly was attributable to neoplastic infiltration in 67% of ferrets with lymphoma and extramedullary hematopoiesis in 33%. 5 in general, splenomegaly secondary to extramedullary hematopoiesis is common in ferrets. 2 to the authors' knowledge, there is no reference for normal splenic size in ferrets using ultrasound. grossly the normal spleen has been reported to measure 5.1 cm in length, 1.8 cm in width, and 0.8 cm thick. 20 given that these are gross measurements, however, they were likely obtained postmortem. splenic size is variable and decreases postmortem, so these measurements may not be translatable to antemortem studies with sonographic measurements. 21 the smallest splenic thickness in this study was 0.8 cm; using the gross measurement guidelines all spleens in this study would be considered enlarged. the degree of splenomegaly was therefore subjectively characterized as within incidental variation and larger than expected for "incidental splenomegaly" based on the authors' experiences. of the seven ferrets in which splenic cytology was available, lymphoma was confirmed in the four ferrets in which the spleen was considered abnormal and cytology was performed. of the three ferrets spleens in which cytology was performed and the spleen was considered within incidental variation, lymphoma was identified in one, and extramedullary hematopoiesis was confirmed in the other two. potential differential diagnoses for multicentric lymphadenopathy with splenomegaly in ferrets include reactive lymphadenopathy secondary to gastrointestinal disease with splenic extramedullary hematopoiesis, systemic mycobacteriosis, granulomatous inflammatory syndrome, and aleutian disease. 1, [22] [23] [24] [25] with systemic mycobacteriosis, ferrets can have other lymph nodes affected in addition to the abdominal lymph nodes, with the retropharyngeal lymph nodes being affected as commonly as the mesenteric lymph nodes. 25 as with lymphoma, clinical signs of mycobacteriosis in the ferret depend on the organs that are affected and can include lethargy, anorexia, vomiting, and diarrhea; but as with other infectious diseases, changes in white blood cell counts can be seen. mycobacteriosis can be diagnosed on cytology and biopsy of the affected lymph node or organ. 25 granulomatous inflammatory syndrome is a newly recognized systemic disease associated with coronavirus that causes inflammation in the spleen and lymph nodes. 23 this syndrome results in a severe granulomatous disease that can affect the gastrointestinal tract, mesenteric lymph nodes, liver, and spleen. unlike lymphoma, it is usually seen in younger ferrets, but like lymphoma, clinical signs are nonspecific and depend on the organ that is affected. patients with this syndrome usually have polyclonal gammopathy that can also be seen with aleutian's disease virus and lymphoma. definitive diagnosis requires cytology or biopsy of the affected organs. 23 aleutian's disease is a parvovirus that can cause lymphadenopathy and splenomegaly. as with lymphoma and granulomatous inflammatory syndrome, aleutian's disease can cause a polyclonal gammopathy. ferrets with this virus usually present with generalized signs of illness (lethargy, weight loss) as well as neurologic signs such as paresis or tremors. 24 aspirates and biopsy samples of lymph nodes and the spleen can be difficult to interpret as the disease causes lymphoplasmacytic inflammation that can be easily confused with other diseases such as small cell lymphoma and epizootic catarrhal enteritis. 24 in the one ferret with colonic lymphoma, there were minimal imaging findings including poor abdominal serosal detail and mild peritoneal effusion. at postmortem, lymphoma with mucosal erosions was detected in the colon. segmental lymphoplasmatic enteritis was identified in the small intestines. this ferret presented cachexic, hypotensive, anemic, had melena, and died within 24 h of presentation. given that melena is referable to upper gastrointestinal bleeding, the clinical findings in this ferret could have been attributable to both helicobacter mustelidae gastritis and lymphoma. it is also possible that lymphoma was present in other portions of the gastrointestinal tract, but was not detected postmortem. after the spleen, the next most common extranodal sites of neoplastic involvement with lymphoma in ferrets have been reported to be the liver, kidneys, and lungs. 5 in this study, two ferrets had confirmed hepatic infiltration-one of which had mild hepatomegaly on ultrasound (subjectively normal on radiographs) and the other of which had no reported hepatic abnormalities. hepatic lipidosis, identified in four ferrets, was not associated with radiographic or sonographic changes and may have been due to inappetence. 26 given these findings, ultrasound does not appear to be sensitive for the detection of hepatic lymphoma in ferrets. sensitivity of ultrasound for hepatic lymphoma has also been reported to be low in dogs, cats, and humans. 27, 28 one of two ferrets with renal masses had probable renal lymphoma based on the response to treatment. the second renal mass, a confirmed renal sarcoma, was not sonographically differentiable from the presumptive renal lymphoma. pulmonary involvement was not identified in this study. the small number of individuals in this study precludes extensive comparisons of the affected organ distribution to prior studies. the most common thoracic finding in this study was mild pleural effusion, which was present in four ferrets. there were no ferrets with a mediastinal mass in this study. mediastinal involvement, in general, is more prevalent in ferrets less than 3 years of age, and has been reported to be the more common presentation of lymphoma in that age group with or without concurrent multicentric involvement. [1] [2] [3] ferrets with mediastinal lymphoma may present for tachypnea or dyspnea secondary to the space-occupying effect of a large mediastinal mass, as well as concurrent pleural effusion. no ferrets in this study were less than 3 years old, which may have accounted for the lack of mediastinal involvement in this cohort. additionally, although this institution also provides primary care to nontraditional small mammal species, it is also a tertiary care facility and the population of ferret patients may not have been representative of the general domestic ferret population. there may have been a selection bias for ferrets with more insidious signs, which tend to occur in ferrets greater than 3 years of age, as opposed to younger ferrets, which may have a more acute and more rapidly progressive presentation. aggressive osseous lesions were present in three ferrets with skeletal lymphoma involvement. to the authors' knowledge, only three other ferrets with osseous involvement have been described previously. 2, 9 in those ferrets, lytic lesions were present in the tibia, in the lumbar spine, and in the lumbosacral spine. 2, 9 based on those ferrets and the ferrets in this study, it is possible that the lumbar spine is a predilection site for vertebral lymphoma; however, this remains speculative. an alternate possibility is that lysis may be relatively easier to detect in the lumbar spine where there is less superimposition of structures over the vertebrae, compared to the thoracic vertebrae where the ribs proximally are superimposed on the vertebrae. in humans with primary bone lymphoma, three radiographs patterns are described: the lytic-destructive pattern, which is predominantly lytic with or without a lamellated or interrupted periosteal reaction or cortical lysis; the blastic-sclerotic pattern in which there are mixed lytic and sclerotic regions; and "near-normal" findings in which there are only subtle radiographic changes and additional imaging (scintigraphic bone scans or mri) is required. 29 osseous lesions seen in the ferrets of this study and the prior reports are similar to the lytic-destructive pattern, and had cortical disruption. this is also the pattern most typically seen in canines and felines with osseous involvement from lymphoma or other round cell neoplasms. diffuse central nervous system infiltration with lymphoma was present in one ferret. as lymphoma outside of the central nervous system was only detected in accessory adrenal tissues, this ferret presumably had a primary central nervous system lymphoma. primary central nervous system lymphoma in dogs and cats has not been reported to have an extraparenchymal vs. an intraparenchymal predilection. 30 in humans, lesions with primary central nervous system lymphoma are most frequently intraparenchymal, and metastatic central nervous system lymphoma is more frequently extraparenchymal. 30, 31 in this ferret, the meninges and choroid plexus were involved in addition to the brain and spinal cord. protracted clinical signs in that ferret consisted of variable paraparesis and lumbar pain over 8 months from the start of clinical signs to the final diagnosis of lymphoma at necropsy. gradual progression of signs and the protracted clinical signs suggests a relatively slow-growing process. prednisone, administered for palliative treatment, was started approximately 3 months after the initial clinical signs. radiographs and ultrasound, performed prior to starting prednisone, had minimal, nonspecific findings. magnetic resonance imaging, performed 1 month after initiation of the prednisone regimen and 5 months prior to the diagnosis of lymphoma, was inconclusive. administration of prednisone prior to the mri may have resulted in partial regression of lymphoma, therefore making it more difficult to identify; however, the ferret did not demonstrate improvement of the clinical signs so whether prednisone affected detection of neoplastic infiltration or not is speculative. additionally the mri was limited in that only t2w images were obtained. perhaps if additional sequences were performed, particularly t1w postcontrast images, or if a follow-up mri was performed at a later date, meningeal or parenchymal abnormalities may have been detected. also because the necropsy was performed 5 months following mri, it is likely that the extent of the lesions seen postmortem had progressed com-pared to at the time of imaging. magnetic resonance imaging lesions in dogs and cats with primary central nervous system lymphoma (compared to white matter) have been reported to be predominantly t2w hyperintense with indistinct margins, t1w hypointense, contrast enhancing, had perilesional hyperintensity on flair consistent with perilesional edema, and had a mass effect. 30 in humans, lesions have similar signal characteristics (compared to white matter) being t2w hyperintense, t1w iso-to hypointense, and contrast enhancing. 30, 31 these findings are considered nonspecific in dogs, cats, and humans, and lesions may not be detected with mri at the onset of clinical signs. 30, 31 two ferrets had no clinical signs referable to lymphoma. in one ferret, the owner palpated a markedly enlarged abdominal lymph node. radiographic and sonographic findings consisted of multicentric lymphadenopathy, peritoneal effusion, a renal mass, a hyperechoic liver, and "incidental splenomegaly." in the other ferret, progressive lymphocytosis was detected during routine treatment and monitoring of adrenocortical disease. lymphoma was identified in the peritoneal effusion of that ferret. additional sonographic findings included a multicentric lymphadenopathy, splenomegaly with splenic nodules, a cystic hepatic mass, and a renal mass (sarcoma). adrenal disease was a common comorbidity seen with lymphoma, as found in other studies. 32 this is likely because adrenal disease is common in older ferrets in general. 1, 4, 33 other relatively common comorbidities found in this study were cardiovascular disease and cutaneous mast cell tumors, both of which also commonly occur in older ferrets. 1, 33 one ferret had a history of granulomatous lymphadenitis suspected to be secondary to mycobacteriosis. although this study describes the imaging findings in a small number of ferrets with lymphoma, it provides an important source of information for practicing clinicians. the small number of ferrets able to be included during the time frame of the study likely reflects that imaging is not performed in every ferret with suspected or confirmed lymphoma, and that a definitive diagnosis was not always attained prior to treatment in individuals with suggestive clinical and imaging findings. ultrasound-guided aspirates of lymph nodes, spleens, and aggressive osseous lesions performed in ferrets of this study were each diagnostic for or strongly suggestive of lymphoma. although aspirates are often the initial tissue sampling procedure, previous reports have cautioned the use of lymph node aspirates in the diagnosis of lymphoma as inflammatory and reactive changes may be misinterpreted as lymphoma. 1, 3 this is particularly true of the gastric lymph node in ferrets with gastrointestinal signs. a false positive diagnosis of lymphoma is considered not likely to have occurred in the ferrets included for in this study. lack of a definitive diagnosis (i.e., false negative results) from aspirate samples likely resulted in exclusion of some individuals from this study. analysis of the frequency of misdiagnosis and nonconfirmatory aspirate samples in patients with lymphoma was not performed. this study was also limited in that histopathology was not performed on all organs in each individual, and therefore, whether or not the changes seen were each attributable to lymphoma cannot be confirmed. additionally, because ultrasound findings were based on the reports and images obtained; some structures were unable to be reassessed. this is particularly the case in which multiple lymph nodes were affected. images of each lymph node may not have been attained, the imaging report may not have been complete in describing which nodes were affected, and measurement performed retrospectively on the available static images may not have reflected the actual maximal nodal thickness in that individual. in conclusion, findings from the current study indicated that imaging characteristics of lymphoma in ferrets are similar to those previously reported for dogs, cats, and humans. lymphoma may most commonly be multicentric in ferrets. imaging findings frequently included intra-abdominal lymphadenopathy, splenomegaly, and peritoneal effusion. lymphadenopathy and mass lesions were typically hypoechoic on ultrasound. osseous lesions, when present, were predominantly lytic. lack of imaging abnormalities did not preclude the diagnosis of lymphoma. ferrets, rabbits, and rodents. saint louis: w.b. saunders hematopoietic diseases ferret lymphoma: the old and the new neoplastic diseases in ferrets: 574 cases (1968-1997) clinical and pathologic findings in ferrets with lymphoma: 60 cases malignant lymphoma in ferrets: clinical and pathological findings in 19 cases ferrets: examination and standards of care diagnosis and treatment of myelo-osteolytic plasmablastic lymphoma of the femur in a domestic ferret t cell lymphoma in the lumbar spine of a domestic ferret (mustela putorius furo) t-cell lymphoma in a ferret (mustela putorius furo) malignant b-cell lymphoma with mott cell differentiation in a ferret (mustela putorius furo) cytomorphological and immunohistochemical features of lymphoma in ferrets anatomia ultrassonográfica dos linfonodos abdominais de furões europeus hígidos ultrasonography and fine needle aspirate cytology of the mesenteric lymph node in normal domestic ferrets (mustela putorius furo) bsava manual of canine and feline abdominal imaging. gloucester: british small animal veterinary association the peritoneal space characterization of normal and abnormal canine superficial lymph nodes using gray-scale b-mode, color flow mapping, power, and spectral doppler ultrasonography: a multivariate study observations upon the size of the spleen splenomegaly in the ferret. gainesville: eastern states veterinary association ferret coronavirus-associated diseases aleutian disease in the ferret mycobacterial infection in the ferret gastrointestinal diseases diagnostic accuracy of gray-scale ultrasonography for the detection of hepatic and splenic lymphoma in dogs ultrasongraphic findings in hepatic and splenic lymphosarcoma in dogs and cats primary bone lymphoma: radiographic-mr imaging correlation mri features of cns lymphoma in dogs and cats primary cns lymphoma in the spinal cord: clinical manifestations may precede mri delectability bienzle d. laboratory findings, histopathology, and immunophenotype of lymphoma in domestic ferrets the senior ferret (mustela putorius furo) key: cord-345445-9t1vebey authors: radmanesh, alireza; derman, anna; lui, yvonne w.; raz, eytan; loh, john p.; hagiwara, mari; borja, maria j.; zan, elcin; fatterpekar, girish m. title: covid-19–associated diffuse leukoencephalopathy and microhemorrhages date: 2020-05-21 journal: radiology doi: 10.1148/radiol.2020202040 sha: doc_id: 345445 cord_uid: 9t1vebey diffuse leukoencephalopathy and juxtacortical and/or callosal microhemorrhages were brain imaging features in critically ill patients with coronavirus disease 2019. coronavirus disease 2019 (covid-19) has been reported in association with a variety of brain imaging findings such as ischemic infarct, hemorrhage, and acute hemorrhagic necrotizing encephalopathy. herein, the authors report brain imaging features in 11 critically ill patients with covid-19 with persistently diminished mental status who underwent mri between april 5 and april 25, 2020. these imaging features include (a) confluent t2 hyperintensity and mild restricted diffusion in bilateral supratentorial deep and subcortical white matter (in 10 of 11 patients) and (b) multiple punctate microhemorrhages in juxtacortical and callosal white matter (in seven of 11 patients). the authors also discuss potential pathogeneses. © rsna, 2020 online supplemental material is available for this article. this retrospective study was compliant with the health insurance portability and accountability act and approved by the institutional review board. the requirement for informed consent was waived. critically ill patients with confirmed diagnoses of covid-19 by means of reverse-transcriptase polymerase chain reaction assay (cobas 6800; roche diagnostics, rotkreuz, switzerland) of a nasopharyngeal swab specimen, who underwent brain mri between april 5 and april 25, 2020, at new york university langone medical center campuses (manhattan and brooklyn) were included. mri examinations were performed according to a routine brain protocol (detailed protocol is available in appendix e1 [online]). two academic neuroradiologists (a.r. and a.d., with 6 and 9 years of experience, respectively) reviewed brain mri scans independently, with no disagreements. patients with abnormal white matter t2 hyperintensities (more than expected for agerelated microangiopathy on the basis of visual qualitative assessment) and/or microhemorrhages (4 mm in size) were included in the series. microhemorrhages confined to any areas of acute and/or subacute infarcts were excluded. diffusion characteristics of white matter were investigated and qualitatively graded as mild or severe on the basis of apparent diffusion coefficient maps. electronic health records were reviewed for all included patients. twenty-seven critically ill patients with covid-19 underwent brain mri between april 5 and april 25, 2020. of those 27 patients, 11 (mean age, 53 years; age range, 38-64 years; nine men, two women) were included in our series. four patients had only diffuse leukoencephalopathy, one patient had only microhemorrhages, and six patients had a combination of both. among the 16 excluded patients, mri findings were as follows: acute or subacute infarcts in 11 patients (including three with microhemorrhagic transformation), parenchymal hemorrhages larger than 4 mm in four patients (all .1 cm), and thalamic expansile t2 hyperintensity in one patient (presumed acute hemorrhagic necrotizing encephalopathy). all 11 patients in our series were on mechanical ventilation at the time of imaging (mean duration, 26.5 days), and the lowest blood oxygen saturation levels were 60%-85% (mean 6 standard deviation, 73% 6 8). the indication for brain imaging in all patients was persistently diminished mental status. the neurologic examinations showed preserved brainstem reflexes and diminished-toabsent grimace or response to noxious stimuli in extremities. no patient required extracorporeal membrane oxygenation. none of the patients had overt disseminated intravascular coagulation based on the international society on thrombosis and hemostasis diagnostic scoring system (4) . additional individual clinical and laboratory data can be found in appendix e1 (online). cerebrospinal fluid workup was available in only one patient (with both leukoencephalopathy and microhemorrhages) and was negative for infectious or inflammatory meningitis covid-19-associated diffuse leukoencephalopathy and microhemorrhages equally or more conspicuous compared with t2 hyperintensity (fig 2) . abnormalities extended from the precentral gyrus down to the centrum semiovale and corona radiata. at the level of the temporal and occipital horns, the posterior cerebral white matter in all patients was involved more than the anterior (fig 2, g-i) . the deep gray nuclei were spared. the juxtacortical white matter was also relatively spared ( fig 1, a) , with the exception of the precentral gyrus in all 10 patients (fig 2, a-c) and occipital lobes (fig 2, g-i) in seven patients. one patient received intravenous contrast material for mri, and there was no abnormal intracranial enhancement. the infratentorial parenchyma tended to be less affected; only four patients had mild involvement of middle cerebellar peduncles and medial cerebellar hemispheres (fig 3) . microhemorrhages were seen in seven of the 11 patients and varied in number from a few (five or six) to innumerable. microhemorrhages were predominantly punctate, and in all cases smaller than 3 mm. there was no concomitant larger intracranial hemorrhage. punctate microhemorrhages predominantly abbreviations covid-19 = coronavirus disease 2019, dphl = delayed posthypoxic leukoencephalopathy summary diffuse leukoencephalopathy and juxtacortical and/or callosal microhemorrhages were brain imaging features in critically ill patients with coronavirus disease 2019. or encephalitis and negative for coronavirus polymerase chain reaction assay. three patients were diagnosed with bacteremia and treated with antibiotics before mri (appendix e1 [online]). during the 3-5 weeks after brain mri, six of the 11 patients died (three had leukoencephalopathy, one had microhemorrhages, and two had both). the other five patients continue to receive critical care. the 10 patients with leukoencephalopathy had t2 hyperintensities that were symmetric and confluent, demonstrated mild restricted diffusion, and involved bilateral deep and subcortical white matter (fig 1) . the restricted diffusion in all cases was figure 1 : axial brain mri scans in two critically ill patients with coronavirus disease 2019 with persistently diminished mental status. a-c, images in a 56-year-old man. d-f, images in a 64-year-old man. a, d, diffusion-weighted images, b, e, apparent diffusion coefficient maps, and, c, f, fluid-attenuated inversion recovery images at the level of centrum semiovale demonstrate symmetric diffuse t2 hyperintensity (arrowheads) and mild restricted diffusion (thick arrows) involving the deep and subcortical white matter with relative sparing of juxtacortical white matter (thin arrows) in both patients. the restricted diffusion is more conspicuous than the t2 hyperintensity. workup for headache) and revealed that all microhemorrhages present on the current study were new (fig 5) . four of seven patients had undergone brain ct 3-7 days before mri. ct, even upon retrospective review, did not reveal punctate microhemorrhages. all seven patients with microhemorrhages were, at least temporarily, on closely monitored anticoagulation therapy involved the juxtacortical white matter (in five of seven patients) (fig 4, a) and/or corpus callosum, particularly the splenium (in four of seven patients) (fig 4, b) . only one patient with microhemorrhages had previous brain mri scans available for comparison. the scans had been obtained 7 days before the current hospital encounter (during with no supratherapeutic coagulation indexes, and no patient had concomitant intracranial hemorrhage larger than 4 mm or known bleeding in other organs. we report on two neuroimaging features observed in critically ill patients with covid-19: (a) diffuse leukoencephalopathy, with symmetric confluent white matter t2 hyperintensity and restricted diffusion with relative sparing of juxtacortical and infratentorial white matter, and (b) punctate microhemorrhages with predominant involvement of juxtacortical and callosal white matter. in a series of 11 critically ill patients with covid-19 who underwent brain mri for a persistently depressed mental status, four patients had only diffuse leukoencephalopathy, one patient had only punctate microhemorrhages, and six patients had a combination of both. physicians who manage patients with covid-19 should consider these findings during work-up for persistently diminished mental status. although initial reports of brain imaging findings in patients with covid-19 showed ischemic and hemorrhagic complications (2, 5) , there are now increasing reports of other findings such as patchy demyelinating lesions (6) and acute hemorrhagic necrotizing encephalopathy involving the thalami and medial temporal lobes (3). our report comprises 11 patients in a single 3-week period in april 2020, with all patients having been critically ill and on mechanical ventilation for a mean duration of 26.5 days. we believe the diffuse leukoencephalopathy and microhemorrhages described herein are late complications of critically ill patients with covid-19 and likely related to hypoxemia. previously, we reported brain imaging findings in 242 consecutive patients with covid-19 seen at week before the current hospital encounter, during work-up for headaches. b, image obtained after 23 days of mechanical ventilation in the hospital intensive care unit due to coronavirus disease 2019 show multiple juxtacortical punctate microhemorrhages in bilateral temporal and right occipital lobes (arrows) that were not on the previous mri scan. our institution in march 2020 (2) . none of those patients demonstrated these diffuse patterns of white matter involvement that we describe here. this suggests that these findings are not typical of earlier stages of covid-19. the diffuse white matter t2 hyperintensity and restricted diffusion reported herein may relate to delayed posthypoxic leukoencephalopathy (dphl), for which a similar pattern of involvement has been described in patients approximately 10-14 days after a hypoxic insult (7) . dphl was previously described in victims of carbon monoxide poisoning, drug overdose, and cardiopulmonary arrest (8, 9) and is believed to relate to oligodendroglial cell death and subsequent demyelination occurring preferentially in the deep interarterial boundary zones (10) . observed mild restricted diffusion can be related to acute demyelination. the predominant involvement of the deep white matter, sparing of juxtacortical white matter (except in precentral and occipital regions), and sparing of deep gray nuclei are typical of dphl and in contrast to acute hypoxic ischemic injury (11) . the leukoencephalopathy observed in our critically ill patients is, however, nonspecific and the exact cause is not clear. other potential causes of diffuse leukoencephalopathy in critically ill patients include direct cerebral infection (although this was not supported by negative viral cerebrospinal fluid assay in one patient), sepsis-associated encephalopathy (12, 13) , postinfectious demyelinating or hemorrhagic encephalitis, toxic and metabolic causes, and posterior reversible encephalopathy syndrome. white matter microhemorrhages with predominant distribution in juxtacortical white matter and corpus callosum are also nonspecific and similar to dphl, are thought to be related to hypoxia (7) . similar microhemorrhages have been reported in high-altitude exposure, possibly relating to hypoxemia and disruption of the blood-brain barrier (14) . multiple hemorrhages can alternatively be related to a small vessel vasculitis. although the imaging distribution is reminiscent of traumatic axonal injury, none of our patients presented with severe head trauma. of note, none of our patients fulfilled diagnostic criteria for disseminated intravascular coagulation (4) . limitations of the current report include small sample size, retrospective nature, lack of quantification of mri findings, and lack of histopathologic determination of underlying cause. clinical follow-up to determine longer-term outcome in these patients should be further investigated. in conclusion, herein we describe two neuroimaging findings, leukoencephalopathy and microhemorrhages, in critically ill patients with covid-19 that affect white matter diffusely in characteristic patterns. we believe that both findings are related to hypoxia but have different pathogeneses: demyelination versus disruption of blood-brain barrier. it is important to recognize these findings as potential late central nervous system complications of covid-19, particularly in patients with persistently diminished mental status. a.r. activities related to the present article: disclosed no relevant relationships. activities not related to the present article: has stock/stock options managed by a third party and unrelated to the content of this manuscript; received travel/accommodations/meeting expenses unrelated to activities listed from the american society of neuroradiology. other relationships: disclosed no relevant relationships. a.d. disclosed no relevant relationships. y.w.l. activities related to the present article: institution received a grant from the national institutes of health. activities not related to the present article: disclosed no relevant relationships. other relationships: disclosed no relevant relationships. e.r. activities related to the present article: disclosed no relevant relationships. activities not related to the present article: received payment for expert testimony from various law firms; receives royalties from springer; received travel/accommodations/meeting expenses unrelated to activities listed from microvention, stryker, and rapid medical. other relationships: disclosed no relevant relationships. j.p.l. disclosed no relevant relationships. m.h. activities related to the present article: disclosed no relevant relationships. activities not related to the present article: received payment for legal consultation without testimony by uc regents. other relationships: disclosed no relevant relationships. m.j.b. activities related to the present article: disclosed no relevant relationships. activities not related to the present article: is employed by nyu langone; received travel/accommodations/meeting expenses unrelated to activities listed from nyu langone. other relationships: disclosed no relevant relationships. e.z. disclosed no relevant relationships. g.m.f. disclosed no relevant relationships. neurologic manifestations of hospitalized patients with coronavirus disease brain imaging utilization and findings in covid-19: a single academic center experience in the epicenter of disease in the united states covid-19-associated acute hemorrhagic necrotizing encephalopathy: ct and mri features guidelines for the diagnosis and management of disseminated intravascular coagulation. british committee for standards in haematology acute cerebrovascular disease following covid-19: a single center, retrospective, observational study sars-cov-2 can induce brain and spine demyelinating lesions concomitant delayed posthypoxic leukoencephalopathy and critical illness microbleeds delayed posthypoxic leukoencephalopathy: a case series and review of the literature a case of delayed encephalopathy after carbon monoxide poisoning longitudinally monitored by diffusion tensor imaging hypoxic-ischemic leukoencephalopathy in man cellular and molecular pathways of ischemic neuronal death magnetic resonance imaging abnormalities with septic encephalopathy sepsisassociated encephalopathy and its differential diagnosis the pattern of brain microhemorrhages after severe lung failure resembles the one seen in high-altitude cerebral edema key: cord-258556-hglp1vpm authors: peña-solórzano, carlos a.; albrecht, david w.; bassed, richard b.; burke, michael d.; dimmock, matthew r. title: findings from machine learning in clinical medical imaging applications – lessons for translation to the forensic setting date: 2020-10-18 journal: forensic sci int doi: 10.1016/j.forsciint.2020.110538 sha: doc_id: 258556 cord_uid: hglp1vpm machine learning (ml) techniques are increasingly being used in clinical medical imaging to automate distinct processing tasks. in post-mortem forensic radiology, the use of these algorithms presents significant challenges due to variability in organ position, structural changes from decomposition, inconsistent body placement in the scanner, and the presence of foreign bodies. existing ml approaches in clinical imaging can likely be transferred to the forensic setting with careful consideration to account for the increased variability and temporal factors that affect the data used to train these algorithms. additional steps are required to deal with these issues, by incorporating the possible variability into the training data through data augmentation, or by using atlases as a pre-processing step to account for death-related factors. a key application of ml would be then to highlight anatomical and gross pathological features of interest, or present information to help optimally determine the cause of death. in this review, we highlight results and limitations of applications in clinical medical imaging that use ml to determine key implications for their application in the forensic setting. forensic radiology is not clinical radiology applied to a deceased person. in the forensic setting, findings that a clinical radiologist may not typically have encountered are commonplace [1] , e.g. post-mortem gas formation [2] . post-mortem computed tomography (pmct) is widely used in forensic investigations, where acquisition protocols used during clinical ct are not applicable due to rigor mortis and aversion to repositioning the decedent to avoid tampering with evidence. however, ct scans can be acquired with higher doses and there is no patient motion, therefore improving image quality. additionally, recent developments such as pmct angiography (pmcta) with specialized pumps allows the diagnosis of vascular lesions whilst maintaining the integrity of anatomic structures, thus preserving evidence integrity [3, 4] . in order to overcome the limitations of soft tissue contrast and a lack of vascular visualization provided by pmct [5] , postmortem magnetic resonance imaging (pmmri) is increasing in impact, albeit in a small way thus far. whilst pmmri offers improved soft tissue contrast, for vascular diagnoses it presents similar performance to pmcta, with higher associated cost. however, applications to cardiac imaging are an exception, due to improved visualization of the coronary arteries and myocardium [5] . image processing typically involves segmentation, feature extraction, and classification. image segmentation refers to the partitioning of a digital image into multiple segments that are sets of pixels (or voxels) which usually represent discrete structures. approaches to image segmentation prior to ml included probabilistic atlases [12, 13] , statistical shape models (ssms) [14, 15] , graph-cut (gc) algorithms [16, 17] , and multi-atlas segmentation (mas) [18] . feature extraction is a dimensionality reduction technique used to efficiently represent parts of an image as a compact feature vector. feature extraction was traditionally performed through determining properties such as first order textures (e.g. mean or entropy) or correlations [19, 20] . image classification is the process of taking an image or volume and predicting whether it belongs to a list of predefined classes. traditional approaches to classification included linear-and normal-discriminant analysis [21, 22] . a variety of ml alternatives to each of these image processing tasks have now been proposed and pipelines that can automate many diagnostic and prognostic tasks have been introduced to reduce the burden on radiologists [23, 24] . ml techniques can be categorized as supervised learning, unsupervised learning, and reinforcement learning. in supervised environments, data is composed of input-output patterns, and the task is to find a deterministic function that can predict the output from an observed input. unsupervised techniques are a type of self-organized learning that extracts structures from the training samples directly, without pre-existing labels [25] . more recently, self-supervised techniques, a type of unsupervised learning where the training data is automatically labelled by exploiting the relations between different input signals, are being studied for better utilizing unlabeled data [26] . reinforcement learning on the other hand is based on trial-and-error, where the algorithm evaluates a current situation, takes an action, and receives feedback from the environment; this feedback can be positive or negative [27] . the most common ml techniques used in medical applications are summarized below. rfs operate by creating a multitude of decision trees (fig. 1 ) that can be trained for classification and regression tasks [28, 29] , where the output is obtained by majority vote. majority vote is a technique utilized to combine the outputs from multiple classifiers, with the voting rule following one of three forms: (i) unanimous voting, where all the individual votes must agree in one output class, (ii) simple majority, where the class with one more than 50% of votes is selected, and (iii) plurality or majority voting, where the class with the highest number of votes is chosen [30] . in k-nn, the training samples are divided into classes, and the prediction of a new sample or test point is classified by a majority vote of its neighbors (fig. 2) . the algorithm uses a distance measurement function to search the (defined by the user) closest training samples in the feature space, and assigns the case of the class that is the most common in the subset. artificial neural networks (anns) anns are inspired by the biological nervous system. anns contain a large number of highly interconnected nodes (called neurons) separated into layers (fig. 4) , enabling the network to process different pieces of information while considering constraints to coordinate internal processing, and to optimize its final output [25, 33] . cnns were inspired by the connectivity pattern of the animal visual cortex. neurons respond to stimuli only in a restricted region (receptive field) of the previous layer, where receptive fields of different neurons partially overlap until they cover the entire visual field (fig. 5 ). unlike other ml techniques, the network learns the filters that are usually "hand crafted". also, cnns exploit the strong spatially local correlation found on images, allowing the features to be detected regardless of their position. in recent years, deep neural networks (dnns), which differ from anns by their depth (the number of neuron layers), have proven to be successful in solving diverse problems, mainly for their capacity to learn features from large datasets [34] . it should be noted that in the following discussion, algorithmic performance is assessed in terms of dice's coefficient (dc), the modified hausdorff distance (mhd) and the area under the receiver operating characteristic curve (auc or auroc), where possible. the quantification usually starts with calculation of true positives (tps), true negatives (tns), false positives (fps), and false negatives (fns). tp refers to cases correctly classified as pertaining to the class, opposite to fp, when the case is wrongly classified. inversely, tn and fn refer to a case correctly and incorrectly classified as not belonging to the class, respectively. the dc quantifies overlap between the processed image from the technique with a defined ground truth, ranging from zero (no overlap) to unity (identical segmentation). mhd is a measure of similarity between two objects based on their shape attributes. auc combines information of the true positive rate or sensitivity, and false positive rate or fall-out. sensitivity measures the proportion of actual positives that are correctly identified, while fall-out indicates the proportion of cases wrongly classified as positives. inversely, the specificity measures the proportion of negatives that are correctly identified. recall is the ratio of tps to the sum of tps and fns, indicating the proportion of actual positives that are correctly identified. precision is defined as the ratio of tps to the sum of tps and fps, indicating the proportion of identified positives that are correct [35] . in terms of the currently reported use of ml in forensic post-mortem imaging, it is in its infancy. ml has only been trialed in a few specific forensic applications including automatic forensic dental identification [36] ; sex determination [37, 38, 39] ; the automation of bone age assessment [40, 41] ; prediction of bone fractures [42] ; and the automatic detection of hemorrhagic pericardial effusion [43] . as far as we are aware, none of these studies has translated into daily forensic practice, despite the potential to streamline case-work. the legally robust identification of a decedent is the first objective when their body is triaged for a postmortem. dental analysis and comparison of ante-mortem and post-mortem information is one of the recognized tools for determining a decedent's identity. this traditionally requires an odontologist to find the best match to an ante-mortem database, using features such as dental restorations, pathologies, and tooth and bone morphologies. zhang et al. [36] proposed a new descriptor that encodes the local shape of a person's dental features. they subsequently used an rf classifier to match the features of the unknown person to those in the database (n=200). the result yielded 100% accuracy for complete (n=20) and incomplete (n=20) feature datasets. incomplete datasets were derived from cases involving trauma. the method presented was shown to be rotationally and translationally invariant, and was orders of magnitude faster than conventional 2d methods. it is important to note that the database was constructed using a surface laser scanner on plaster samples in contrast to pmct scans. accurate determination of the sex of a decedent also aides in the identification process. several different approaches have been used for sex estimation. arigbabu et al. [37] utilized 100 head pmct scans. they combined and evaluated six local feature representations, two feature learning, and three classification algorithms. this technique of combining multiple features and classifiers is often used in ml pipelines as it has been shown to improve accuracy and reliability. the best prediction rate was 86%, which was within the reported sex prediction range for applications that use cranial features. the small number of cases obtained only from south east asia limited the generalizability of the results. anderson et al. [38] utilized morphological gray matter differences on mris to differentiate between male and female incarcerated offenders, with implications to cognitive neuroscience research. preprocessing steps were described, including realignment and image registration, to obtain the volume and density of the gray matter on each case utilizing statistical parametric mapping software (spm12; http://www.fil.ion.ucl.ac.uk/spm). source-based morphometry (sbm) was utilized to extract features from the gray matter spatial information, with sbm being able to identify distinct regions with common covariation between subjects. a number of ml classification approaches were trialed, however, only an svm and logistic regression were described due to present the highest classification accuracy of 94%. limitations included the use of volumetric brain data only, without accounting for other moderating variables and quantitative methods, such as age, functional activity, and structural and functional connectivity. ortiz et al. [39] compared five different ml techniques in the assessment of panoramic radiographs. the ann outperformed the rest of the models, including k-nns and logistic regression, with an accuracy of 89%. only 100 panoramic radiographs were used, limiting the statistical significance of the results. as with the identification of a decedent's sex, their estimated age is also an important parameter for streamlining the identification process. štern, payer and urschler [40] compared two ml approaches, rfs and dcnns to determine age (through regression) and distinguish minors from adults (classification) using bone ossification from mri scans of the hand/wrist. as a general note, dcnns are often compared with rfs as the dcnn can determine the most important features itself whereas the rf must be supplied with those deemed important by the user. to better study the impact of different input information on the decision process, three strategies were tested: the use of the whole hand, a cropped image with age relevant bones, or the hand-crafted filter-based enhanced epiphyseal gap. the best mean absolute error and standard deviation results with respect to the biological age (as estimated by radiologists) were 0.20±0.42 and 0.23±0.45 years for the dcnn using cropped structures and the rfs using enhanced images, respectively. the results were reported to achieve the new state-of-the-art accuracy compared with previous mri-based methods and their earlier work. furthermore, when the technique was adapted for 2d mri, the method was in line with state-of-the-art methods using x-ray data. limitations of this work included the requirement for age-relevant anatomical information, which implies a labor-intensive pre-processing step, and decreased accuracy for cases with biological ages greater than 18 years. in an alternative approach, li et al. [41] utilized pelvic x-ray images and a dcnn to create a bone age assessment pipeline which yielded a mean error of 0.94 years, 0.36 years better than the existing reference standard. this work used transfer learning from a cnn pre-trained on the imagenet database [44] , achieving an appropriate accuracy for this type of input data. transfer learning is widely used in ml applications and is particularly useful when small or unbalanced datasets are available. limitations acknowledged by the authors included the lack of diversity in ethnicity of patients, and the exclusion of images with artefacts and diseases. many forensic institutions utilize pmct to guide the pathologist in their approach to the autopsy. pmct is particularly useful for identifying fractures due to the high attenuation of bone. heimer et al. [42] used an undisclosed dcnn from a dedicated software (vidi, cognex, natick, ma, usa) to predict the presence of skull fractures using 150 head pmct scans (75 scans for each case: with and without fractures). the skulls were preprocessed through the generation of curved maximum intensity projections, so that the skull's surface could be unfolded onto a single image. deep learning was applied and the best-performing selected network yielded an auroc of 0.965, a sensitivity of 91.4% and a specificity of 87.5%. an auroc of 0.5 defines a model that classifies at random, while 1.0 is a completely accurate model. pmct is also useful for assessing many aspects of cardiac condition prior to autopsy, e.g. the appearance of discontinuities of the aortic wall can be a direct sign of injury in the aorta, whereas the appearance of a blood collection within the chest cavity (hemothorax or hemopericardium) can be an indirect sign [45, 46] . these signs, observed on plain film x-ray or pmct must be interpreted by radiologists and forensic pathologists. ebert et al. [43] used two separated and undisclosed dcnns from a dedicated software (vidi) for the classification of images with or without hemopericardium and also the corresponding segmentation of the blood content in pmct. the average dc, recall, and precision for the classification task were 77%, 77%, and 85% respectively. for segmentation, the values obtained were 78%, 78%, and 79%, respectively. limitations of this study include the small number of training cases (n=14 cases with hemopericardium), while the use of a dedicated software restricted the training data to individual slices, losing sometimes crucial volumetric information. due to the dearth of information relating to the application of ml to forensic imaging, it is important to review the state-of-the-art and establish lessons learned from the significant body of literature describing its application to clinical image analysis. current clinical applications ml techniques have been used in the diagnosis and prognosis of diseases, as well as for segmentation, classification, and measurement of anatomical structures [24, 47] . in this review, the ml applications have been grouped according to the tissue or organ studied, where brain, lungs, and skeleton were chosen to highlight results and limitations. each anatomical section concludes with a summary evaluating the key implications determined from the clinical literature and their application in the forensic setting. traditional atlas-based segmentations require registration to align the atlas images to the unseen image. whereas, ml approaches can learn the variability between patients, making them especially useful in forensics, where variance is greater than for clinical imaging. ml can also be used in combination with atlas-based approaches or in its own right. as an example of the former, srhoj-egekher et al. [48] used atlas-based segmentation for pre-processing t2-weighted mri neonatal brain images to obtain initial probabilities, subsequently refined using a k-nn approach. whilst this approach achieved dcs and mhds ranging from 77% to 93%, and 0.35 to 2.86 respectively, the assignment of a tissue classification to each voxel independently, post atlas registration, meant some voxels were attributed to more than one class, while background voxels were unclassified. conversely, zhang et al. [49] opted for purely ml approaches that analyzed image patches for segmentation into white matter (wm), gray matter (gm), and cerebrospinal fluid (csf) of infant brains (n=10). four network architectures were tested and, in most cases, the cnn method significantly outperformed svms and rfs with overall dc scores and mhds of 85% and 0.32, respectively. the cnn method also outperformed two other common image segmentation methods: coupled level sets (cls) and majority voting (mv). three further publications were found where the authors segmented similar structures within adult brains. van opbroek et al. [50] applied an svm for pixel-wise classification to registered volumes from a variety of mri sequences for patients with diabetes and controls. the resulting segmentation of eight different tissue types demonstrated limited success ( table 1) . the svm showed poor performance in low contrast areas, while atlas misregistration caused voxels to be improperly classified. moeskops et al. [51] used cnns to process t1-weighted scans to segment the same eight tissue types. with cnns, the use of different sized patches during training allowed for a smooth segmentation and analysis of local texture. in general, cnns delivered better segmentation (table 1) , although this was a different patient cohort. a more recent application of 3d dcnns [52] was used to identify 25 brain structures in t1-weighted mri scans (n=30). again, image patches were utilized as input to the network. however, spectral and cartesian coordinate information relating to the patches was added after the convolutional layers (e.g. see arrow in fig. 6 ) in order to introduce spatial information, which substantially increased the segmentation accuracy. ml can also be used for the assisted diagnosis of neurodegenerative diseases. salvatore et al. [53] used a combination of principal component analysis (pca) with an svm to classify morphological mri sequences as patients with parkinson's disease (n=28), progressive supranuclear palsy (psp) (n=28), or controls (n=28). the large cohort sizes, inter-class cohort balance, and separation between psp patients and other parkinsonian variants were identified as particular strengths, compared to other papers. the performance (accuracy, specificity and sensitivity were all > 80%) of the model was shown to be limited by the number of principal components (16 to 26) utilized for classification. this dependence is an important consideration when using dimensionality reduction techniques and was also demonstrated for approaches that classified alzheimer's disease [54] . finally, ml techniques have also been used to segment and classify brain tumors. zacharaki et al. [55] used conventional and perfusion mri from patients with a diagnosis of intra-cranial neoplasm to classify them by type and grade of tumor (n=98). their approach consisted of region of interest (roi) definition, feature extraction, feature selection, and classification by svms. for comparison, linear discrimination analysis (lda) and k-nn were also implemented. the mean classification accuracy was 91% for the svm approach, compared with 81% for lda and 90% for k-nn. some of the limitations were related to the lack of features selected that described deformation of healthy structures due to the tumor, and the utilization of rois which yielded inter-observer variability. once the presence of tumors is verified, one possible subsequent step would be segmentation of the pathology, which is challenging even for experienced neuroradiologists [56] . to address this segmentation problem, a variant of cnns named u-net is often employed [57] . beers et al. [58] utilized two 3d u-nets connected sequentially to perform whole tumor, enhancing tumor, and tumor core segmentation, achieving mean dcs for the test set (n=95) of 84%, 70%, and 71%, respectively. when the methodology was implemented on patients from ongoing clinical trials, the mean dcs decreased to 66%, 54%, and 45%, respectively. the lower performances on the clinical trial patients were attributed to scans being post-operative, highlighting the importance of case selection for training. studies on brain tissues used mostly mri data due to the multi-modality information and a good softtissue contrast. whilst the specific pathologies discussed are not all relevant to the forensic setting, the general conclusions deduced from the segmentation and localization of anatomical abnormalities are. models that utilized dimensionality reduction techniques prior to classification were shown to yield performances dependent on the number of selected components. in addition, the identification of abnormalities in biological tissues required features capable of describing complicated deformations of the healthy structures. for cnns, the performance of the pipeline depended significantly on the training set adequately representing expected cases. in general, cnns outperformed algorithms such as svms, rfs, clss, and mv in segmentation and classification tasks. note that some studies used small datasets, which limited statistical power. in addition, as will be demonstrated throughout this review, a combination of the variability in reporting of metrics, the lack of reporting of a diagnostic odds ratio [59] , the unavailability of datasets and reference implementations, and the effect of imbalanced data in the classification accuracy, common in medical datasets [60, 61] , made it difficult to compare papers quantitatively. in forensics, pmct does not provide good resolution of internal cranial structures or brain metastases, and in general, the resolution is not sufficient to identify neurodegenerative issues, but degeneration can sometimes be observed in defined structures, e.g. in the caudate nucleus in huntington's disease. on the other hand, pmct is adequate in showing evolving brain infarcts and in displaying collections of blood, e.g. subdural hemorrhages (which are reasonably common). pmct can also show intraparenchymal hemorrhages and parenchymal hemorrhagic contusions. intra-parenchymal hemorrhages, e.g. hypertensive hemorrhage, classically involve distinct areas in the brain: basal ganglia, thalamus, pons, and cerebellar hemispheres. parenchymal hemorrhagic contusions are classically seen with contra-coup basal frontal lobe contusions (bleed within brain tissue occurring on the opposite side of the head to the primary injury site) when someone falls onto the back of their head (often associated with a skull fractureoccipital). in ml, feature learning refers to the automatic discovery of meaningful representations from raw data, in contrast to manual feature engineering, where the features have to be chosen by a domain expert. feature learning allows for end-to-end learning, where a complex system can be represented by a single model, bypassing the intermediate layers present in traditional workflow designs. learning a representation of any tissue is a useful process if subsequent classification is required, or if the goal is to find differences between samples in the training data. the representation quality is highly dependent on the learned features. a restricted boltzmann machine (rbm) is a generative neural network that can be used to perform automatic feature learning. li et al. [62] used a gaussian rbm with a training dataset consisting of different sized patches obtained from high-resolution lung ct images (n=92), with the purpose of classifying five tissue types using svms. the best accuracy obtained was 84%, with a high rate of fps caused by the similarity between tissues. van tulder and de bruijne [63] utilized convolutional rbms, adding learning objectives that helped the algorithm to extract features for description and training data classification. the training data consisted of ct scans (n=73) with five types of tissues classified. resulting accuracies were <75% and 85-90% for the classification of lung patches and airway centerlines, respectively. the low accuracies were attributed to small training sets and number of extracted filters due to computational restrictions. netto et al. [64] utilized examinations (n=50) with 198 identified nodules and an svm to classify the structure as nodule or non-nodule. the resulting accuracy was 91%, with a sensitivity of 86%. the largest errors were reported when the feature was very large or very small, where it could be mistaken for other structures or for being the continuation of one. hua et al. [65] used images containing nodules from the lung image database consortium (lidc) ct dataset to train both a cnn and a deep belief network (dbn) constructed by stacking rbms. the performance of the two networks was then compared with two feature-based methods ( table 2 ). the major limitation reported was resizing of the input images, which discarded size cues that were important indicators of malignancy. kumar et al. [66] also classified the lung nodules in the lidc images (table 2) using an autoencoder (ae) and a binary decision tree classifier (bdt). an ae is an unsupervised deep learning technique utilized for feature extraction, while a binary decision tree is a specialized implementation for classification where every node has only two branches. the false positive rate of 39% was attributed to the visual similarity between benign and malignant cases, which can be compared to a 27% rate obtained on the national lung screening trial (nlst) using low-dose ct (ldct) [67] . a more recent study compared massive-training artificial neural networks (mtanns) against cnns [68] using a database of ldct scans (n=38), consisting of 1057 slices. mtanns are an extension of anns, where a large number of overlapping sub-regions are created for each voxel of the original image and used as inputs to the network. the reported auroc was 0.88 for the mtann, and 0.78 for the best of the four cnn architectures. the mtann required a smaller number of training samples than the cnns for a better classification performance. this was attributed to the hierarchies of the learned features, where the mtann learned to detect lesions utilizing low-level features, while the cnns extracted low-, mid-and high-level features, increasing their reliance on irrelevant characteristics. a recent focus of attention was related to the use of ml for early diagnosis, assessment of severity, and differentiation between the novel coronavirus (covid-19) and community acquired pneumonia (cap) from ct scans. barstugan et al. [69] utilized n=150 ct abdominal images from 53 infected patients, five feature extraction methods, and an svm for the final classification, achieving a maximum accuracy of 99.7%. the main limitation of their work was the manual selection of the patches obtained from the original images and used for the training, which restricts the usability and reproducibility of this approach. tang et al. [70] assessed the severity (severe, non-severe) of the disease from chest ct images from 176 patients, utilizing quantitative measures, e.g. the ratio between the volume of the whole lung and the volume of ground-glass opaque regions, with several rf models. the best performing rf yielded results of 93%, 75%, 88%, and 91% for the sensitivity, specificity, accuracy, and auc, respectively. to differentiate between covid-19, cap, or non-pneumonia, li et al. [71] collected 4356 chest ct exams from 3322 patients. a dcnn was utilized, with an architecture denoted covnet, able to classify the volumetric data with a sensitivity, specificity, and auc of 90%, 96%, and 96% for covid-19 cases, 87%, 92%, and 95% for cap cases, and 94%, 96%, and 98% for non-pneumonia cases, respectively. a limitation of this work included the lack of laboratory confirmation for each case, where covid-19 could have similar imaging characteristics as other viral pneumonias. studies on lungs generally used ct scans for the segmentation of tissues and tumors, and classification of nodules for early cancer diagnosis. due to the low contrast between different tissues in the lungs, the approaches reported were reliant on shape, texture, and feature size. the segmentation performance was poor for nodules at the size extremes. major findings included lower performances due to image resizing, and the importance of reporting fp rates, which can yield high values in applications that intend to determine nodule malignancy. potential applications to the forensic setting include detection of emphysema, consolidation of lung parenchyma (pneumonia), and if appropriate windows are used, interstitial changes. of crucial forensic interest is the presence of blood and fluid in the chest. furthermore, establishing the presence of a lung lesion (and especially more than one) independently of the cause of death may indicate the presence of occult malignancy. in such cases, the deceased's next of kin can be alerted, and the family contact nurses can organize appropriate follow up for family members if a cancer is found. it is important to note that the appearance of the lungs in pmcts can be affected by aspiration of gastric content that may occur in the process of dying, e.g. from a 'heart attack'. skeleton skeletal segmentation usually occurs before measurement and/or diagnosis of bone or articular diseases. koch et al. [72] segmented mris (n=110) of the wrist using marginal space learning (msl) and rfs, where msl incrementally learned classifiers in marginal spaces of lower dimensions [73] . the segmented images were used to compute the 3d model of every carpal bone, with aucs of 0.88 for both scan modalities. the approach was an order of magnitude faster than previous work using a semiautomatic method. similar literature did not report segmentation errors and could not be used for comparison. bone age assessment from plain x-rays is used in pediatrics by comparing the results to chronological age for the evaluation of endocrine and metabolic disorders. a fully automated pipeline was presented by lee et al. [74] using a pre-trained cnn (transfer learning). both male and female test x-rays were assigned a bone age within 1 year of the correct value over 90% of the time, and over 98% within 2 years. x-rays have also been widely used for fracture detection, e.g. of the tibia [75] , where texture and shape features were fed into three different ml algorithms: an ann, k-nn, and svm, and the outputs fused using a majority vote scheme. the combination of the classifiers using both types of features presented a significant improvement over using just one classifier, or only one feature type. reported accuracies, precisions, and sensitivities were above 97%. instead of fusing the results from the classifiers, multistage classifiers have also been used. wels et al. [76] reported a fully automatic system using several rf stages, capable of detecting osteolytic spinal bone lesions from ct volumes, with an average sensitivity of 75%. the performance was affected by differences in contrast and noise characteristics in the data used for training and testing, however, values for accuracy were not presented for further interrogation. sharma et al. [77] measured trabecular bone microarchitecture and used the information to discriminate between healthy cases (n=10) and patients with type 1 gaucher disease (n=20). svms were used to classify different genotypes of the disease, achieving an average 70% classification accuracy, 74% sensitivity, and 85% precision. the structure of the trabecular bone obtained from mri have also been used classify knees with osteoarthritis [78] . the characteristics found to relate to the disease were useful in classifying healthy from affected patients (n=159) with an auc of 0.92, as well as predicting the risk of cartilage loss. in a similar study, the fractal analysis of x-ray images with svms enabled the automatic classification of osteoporotic patients (n=39) versus controls (n=38) with accuracies of up to 95% [79] . reported limitations from the papers in this section include the small number of cases and the high percentages of patients at early stages of the disease. orthopedic ml applications include disease diagnosis, age assessment, and risk prediction e.g. osteoporosis, osteoarthritis. plain film x-ray and ct were most common; however, mri studies of joints are being increasingly reported. the performance of ml applications was shown to be affected by the number and selected features, which is significantly influenced by differences in contrast and noise characteristics in the datasets. comparison or ranking of the results was limited by reported performance metrics and the use of databases that were not representative of the disease stages studied. other limitations included small patient cohorts and the processing times. the most common skeletal disorders that could be picked up on pmct scans are osteoporosis and paget's disease, while fracture diagnosis, and then pattern of fracture diagnosis, e.g. a "hangman's fracture", extension/tear-drop fractures of the cervical spine, and spiral fracture of a long bone in an infant are of significant forensic interest. j o u r n a l p r e -p r o o f discussion typical goals of ml techniques in medical imaging include the differentiation of healthy from diseased patients or tissues and the localization of pathologies in anatomic structures. algorithmic performance can be significantly affected when trying to process a new sample that differs significantly from the training dataset. this characteristic is especially important when it comes to applications in forensic medicine, where there is a high variability in the structures and image acquisition protocols, and unclear definition of what normal implies, due to changes occurring because of circumstances of death, tissue decomposition, trauma, or incineration. however, some applications e.g. organ localization, can be immediately translated to the forensic setting by using the appropriate training data, or by using the clinical medical images for the initial training of cnns and then fine-tuning using forensic information. this is usually referred to as transfer learning. on the other hand, due to the size and availability of forensic databases, the opposite is also possible, with applications being trained in forensic data and then fine-tuned to the clinical setting. to improve the capabilities of ml techniques, the training data can be modified, or more informative features can be used as inputs to the algorithms. the selection of features can be optimized using learning objectives [63] or by utilizing an unsupervised technique as a preprocessing step to the classification task [66, 80] . the features selected can also be used to alleviate human labelling, by selecting more representative training data for the medical expert [81, 82] . another approach to the improvement of ml performance is the combination of several techniques using a majority vote scheme [75] , or the use of multi-stage classifiers [58] for segmentation of different spatially related tissues. a wide range of implemented algorithms were found during the review process, where svms outperformed techniques such as lda and k-nn [55] , however the trend in recent works has been the high performance of cnns [49, 51] . the main disadvantage of classic ml approaches compared to cnns is the performance variability due to the quality of the features [53] that must be hand-crafted by an expert according to the goal and dataset. the selected feature pool is commonly processed to lower its dimensionality before training the classifier by using techniques such as pca. it is important to note that the number of principal components or features selected at the end of this step plays a key role in the classification performance [53] . the performance of the algorithms can also be significantly affected if the labelling process (diagnosis) is prone to error [54] . furthermore, for medical and forensic applications, the common practice of resizing input images can yield to a loss of information that could be essential for diagnostic purposes [65] . an additional consideration is that some authors use for example a radiologist to classify cases, then benchmark the performance of the algorithm against radiologists. rajpurkar et al. [83] , for instance, presented a cnn that achieved radiologist-level pneumonia detection on a database [84] for which no gold-standard label existed, and listed as limitation the lack of information in the database that affects the radiologists' accuracy. it is also important to note that the lack of reporting of a diagnostic odds ratio [59] and the variability in reporting of metrics makes it difficult to compare papers. for the task of segmentation, both multi-atlas algorithms and dcnns with multiple patch sizes showed comparable results [48, 49] , demonstrating cnns were most successful. patch-based techniques could be a good approach in forensic cases were organs or structures are not localized in the usual anatomic positions [63] . furthermore, the use of different sized patches in segmentation tasks allows for both a smoother separation and the detailed analysis of local texture [51] . three important results for the use of ml in clinically-related applications were found that can also be applied in the forensic setting: firstly, temporal efficiency through the use of transfer learning; secondly, improved accuracy through the combination of ml classifiers using majority voting techniques or multi-stage approaches; and finally, the addition of an active learning phase, where the human labor can be alleviated during labeling. one of the main issues that affects both the clinical and forensic settings is the lack of interpretability of predictions by black-box approaches such as neural networks. this is active area of current research and a current approach to addressing this concern is the use of visual explanations for the class label under consideration, obtained from the convolutional layer feature maps [85, 86] , and attention mechanisms [87] , able to determine the parts of the input images more relevant for a particular classification. furthermore, depending on the application, it is not required and could be counterproductive to completely automate a task, for which a human-in-the-loop can be beneficial by reducing the complexity through human input and assistance [82] . some applications of ml already found in clinical medicine, that could be repurposed for forensic medicine, include segmentation and classification of organs and structures, including arteries, tiny blood vessels, the liver, spleen, stomach, gallbladder, and pancreas [88, 89] ; computation of organ 3d models [72] for virtual autopsies; detection of lesions and calcification on vascular cross-sections [90]; identification of bone and joint atrophies or disorders [81, 77, 78, 79] ; fluid volume and composition on body cavities (blood, pus, ascites) [91] ; and organ volume estimation, e.g. heart size with respect to body size [92] . tasks in forensic radiology that to our knowledge have not been tackled using ml include: segmentation and classification of foreign bodies, differentiation between ante-mortem and postmortem gases, calculation of body mass index, and determination of skeletal completeness after accidents. for the segmentation and classification of foreign bodies, e.g. bullets, metallic dental fillings, the main challenge becomes finding the object that does not belong inside the body. furthermore, metallic components can create artefacts such as beam-hardening on ct scans or field distortions in mri [93] , which can also be addressed using deep learning [94] . differentiation between ante-mortem and post-mortem gases can be difficult using the voxel values of ct scans or mri, so emphasis should be placed on understanding the expected location and evolution of these gases at different points in time [95] ; also, differentiation between acute and remote infarction on the brain, which on a ct scan can be characterized by voxel values and tissue volume changes, can be tackled utilizing existing tissue classification techniques [50, 51, 54] , with the addition of new classes to differentiate the types of infarction. in forensic anthropology, tasks that could be addressed using ml include: determination of skeletal completeness after accidents [96] , e.g. plane crashes; 3d reconstruction of incomplete bones, that could be extrapolated from the work by hermoza and sipiran [97] on incomplete archaeological objects; and 3d reconstruction of fractured skulls [98, 99, 100] , used to infer a cause of death, or to perform facial reconstruction. in addition to the aforementioned applications traditionally related to medical imaging, there is the potential for the use of ct scans for facial identification [101, 102] . as a final note, the release this year of the new mexico decedent image database (nmdid, https://nmdid.unm.edu/) [103] should be acknowledged as a significant step forward for the development of tools that can be used to enhance the post-mortem workflow. j o u r n a l p r e -p r o o f conclusions ml techniques have been applied to a large number of tasks that can be used in clinical medicine, where the algorithms most widely utilized in applications with medical images include rfs, svms, and cnns. cnns have shown better performance in the literature. techniques to improve the ml performance in radiology include data augmentation, improved feature selection and algorithmic combination, e.g. majority voting. performance was shown to be affected by resizing of the input images and the accuracy of the labels provided with the training data. in addition, benchmarking was found to be difficult due to the lack of gold-standard labels, as well as the variability in reporting of metrics, and lack of reporting of a diagnostic odds ratio. ml applications investigated for clinical medicine could be repurposed to the forensic domain with careful consideration to account for the increased variability and temporal factors, e.g. decomposition, that affect the data used to train the ml techniques. due to the complexity of the autopsy process, a key application of ml to forensic radiology would be to streamline decedent identification and highlight and annotate areas of forensic interest. ml pipelines could be used to present information to optimally determine the cause of death, including differentiation between body cavity fluid accumulations (blood, pus, ascites) and their corresponding volumes, calculation of organ volumes and weights, percentage of coronary artery calcification, identification of subtle fractures especially in critical areas such as the cervical spine, and determination of skeletal completeness and skeletal commingling after mass fatality incidents. the artefacts of death: ct post-mortem findings imaging and virtual autopsy: looking back and forward postmortem ct angiography: capabilities and limitations in traumatic and natural causes of death post-mortem computed tomography angiography: past, present and future future prospects of forensic imaging niftynet: a deep-learning platform for medical imaging advanced machine learning in action: identification of intracranial hemorrhage on computed tomography scans of the head with clinical workflow integration essentials of radiographic physics and imaging computed tomography: physical principles, clinical applications, and quality control the applicability of dual-energy computed tomography (dect) in forensic odontology-a review magnetic resonance imaging: the basics probabilistic liver atlas construction construction of an abdominal probabilistic atlas and its application in segmentation automated segmentation of the liver from 3d ct images using probabilistic atlas and multilevel statistical shape model automatic segmentation of the pelvic bones from ct data based on a statistical shape model interactive graph cuts for optimal boundary & region segmentation of objects in nd images hierarchical scale-based multiobject recognition of 3-d anatomical structures efficient multi-atlas abdominal segmentation on clinically acquired ct with simple context learning handcrafted vs. non-handcrafted features for computer vision classification a comparison of texture features versus deep learning for image classification in interstitial lung disease application of linear discriminant analysis in dimensionality reduction for hand motion classification classification of non-tumorous skin pigmentation disorders using voting based probabilistic linear discriminant analysis workload of radiologists in united states in 2006-2007 and trends since 1991-1992 machine learning and radiology machine learning for audio, image and video analysis self-supervised learning for medical image analysis using image context restoration deep reinforcement learning: a brief survey predicting long-term cognitive outcome following breast cancer with pre-treatment resting state fmri and random forest machine learning enhancing interpretability of automatically extracted machine learning features: application to a rbm-random forest system on brain lesion segmentation improving the prediction accuracy of heart disease with ensemble learning and majority voting rule. in: u-healthcare monitoring systems the nature of statistical learning theory classification of magnetic resonance brain images using wavelets as input to support vector machine and neural network medical image analysis with artificial neural networks automated age estimation from hand mri volumes using deep learning classification assessment methods efficient 3d dental identification via signed feature histogram and learning keypoint detection computer vision methods for cranial sex estimation machine learning of brain gray matter differentiates sex in a large forensic sample sex estimation: anatomical references on panoramic radiographs using machine learning. forensic imaging automated age estimation from mri volumes of the hand forensic age estimation for pelvic x-ray images using deep learning classification based on the presence of skull fractures on curved maximum intensity skull projections by means of deep learning automatic detection of hemorrhagic pericardial effusion on pmct using deep learning-a feasibility study imagenet classification with deep convolutional neural networks guidelines for autopsy investigation of sudden cardiac death: 2017 update from the association for european cardiovascular pathology evaluation of unenhanced post-mortem computed tomography to detect chest injuries in violent death pixel-based machine learning in medical imaging automatic segmentation of neonatal brain mri using atlas based segmentation and machine learning approach. in: miccai grand challenge: neonatal brain segmentation deep convolutional neural networks for multimodality isointense infant brain image segmentation automated brain-tissue segmentation by multi-feature svm classification automatic segmentation of mr brain images with a convolutional neural network deep convolutional neural network for segmenting neuroanatomy machine learning on brain mri data for differential diagnosis of parkinson's disease and progressive supranuclear palsy early diagnosis of alzheimer's disease based on partial least squares, principal component analysis and support vector machine using segmented mri images classification of brain tumor type and grade using mri texture and shape in a machine learning scheme machine learning based brain tumour segmentation on limited data using local texture and abnormality u-net: convolutional networks for biomedical image segmentation sequential neural networks for biologically-informed glioma segmentation the diagnostic odds ratio: a single indicator of test performance a hybrid machine learning approach to cerebral stroke prediction based on imbalanced medical dataset data imbalance in classification: experimental evaluation combining generative and discriminative representation learning for lung ct analysis with convolutional restricted boltzmann machines automatic segmentation of lung nodules with growing neural gas and support vector machine computer-aided classification of lung nodules on computed tomography images via deep learning technique lung nodule classification using deep features in ct images the american college of radiology lung imaging reporting and data system: potential drawbacks and need for revision comparing two classes of end-to-end machine-learning models in lung nodule detection and classification: mtanns vs covid-19) classification using ct images by machine learning methods. arxiv e-prints covid-19) using quantitative features from chest ct images fully automatic segmentation of wrist bones for arthritis patients marginal space learning. in: marginal space learning for medical image analysis: efficient detection and segmentation of anatomical structures fully automated deep learning system for bone age assessment multiple classification system for fracture detection in human bone x-ray images multi-stage osteolytic spinal bone lesion detection from ct data with internal sensitivity control machine learning based analytics of micro-mri trabecular bone microarchitecture and texture in type 1 gaucher disease diagnosis of osteoarthritis and prognosis of tibial cartilage loss by quantification of tibia trabecular bone from mri osteoporosis diagnosis using fractal analysis and support vector machine deep features learning for medical image analysis with convolutional autoencoder neural network active learning based intervertebral disk classification combining shape and texture similarities interactive machine learning for health informatics: when do we need the human-inthe-loop? radiologist-level pneumonia detection on chest x-rays with deep learning chestx-ray8: hospital-scale chest x-ray database and benchmarks on weakly-supervised classification and localization of common thorax diseases grad-cam: generalized gradient-based visual explanations for deep convolutional networks visual interpretability for deep learning: a survey an investigation of interpretable deep learning for adverse drug event prediction hierarchical 3d fully convolutional networks for multi-organ segmentation automatic detection of abnormal vascular cross-sections based on density level detection and support vector machines training and validating a deep convolutional neural network for computer-aided detection and classification of abnormalities on frontal chest radiographs multi-scale deep networks and regression forests for direct bi-ventricular volume estimation 3d surface and body documentation in forensic medicine: 3-d/cad photogrammetry merged with 3d radiological scanning deep learning methods to guide ct image reconstruction and reduce metal artifacts post-mortem ct and mri: appropriate post-mortem imaging appearances and changes related to cardiopulmonary resuscitation the human skeleton in forensic medicine 3d reconstruction of incomplete archaeological objects using a generative adversarial network reverse engineering-rapid prototyping of the skull in forensic trauma analysis fragmented skull modeling using heat kernels virtual reconstruction of paranasal sinuses from ct data: a feasibility study for forensic application case study: 3d application of the anatomical method of forensic facial reconstruction development of three-dimensional facial approximation system using head ct scans of japanese living individuals standardizing data from the dead this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. j o u r n a l p r e -p r o o f key: cord-328513-81yvcgul authors: bellastella, giuseppe; maiorino, maria ida; bizzarro, antonio; giugliano, dario; esposito, katherine; bellastella, antonio; de bellis, annamaria title: revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects date: 2016-08-08 journal: pituitary doi: 10.1007/s11102-016-0736-z sha: doc_id: 328513 cord_uid: 81yvcgul purpose: this publication reviews the accepted knowledges and the findings still discussed on several features of autoimmune hypophysitis, including the most recently described forms, such as igg4 and cancer immunotherapyrelated hypophysitis. methods: the most characteristic findings and the pending controversies were derived from a literature review and previous personal experiences. a single paragraph focused on some atypical examples of the disease presenting under confounding pretences. results: headache, visual field alterations and impaired pituitary secretion are the most frequent clinical findings of the disease. pituitary biopsy, still considered the gold diagnostic standard, does not always receive consent from the patients. the role of magnetic resonance imaging is limited, as this disease may generate images similar to those of other diseases. the role of antipituitary and antihypothalamus antibodies is still discussed owing to methodological difficulties and also because the findings on the true pituitary antigen(s) are still debated. however, the low sensitivity and specificity of immunofluorescence, one of the more widely employed methods to detect these antibodies, may be improved, considering a predetermined cut-off titre and a particular kind of immunostaining. conclusion: autoimmune hypophysitis is a multifaceted disease, which may certainly be diagnosed by pituitary biopsy. however, the possible different clinical, laboratory and imaging features must be considered by the physician to avoid a misdiagnosis when examining a possibly affected patient. therapeutic choice has to be made taking into account the clinical conditions and the degree of hypothalamic-pituitary involvement, but also considering that spontaneous remissions can occur. hypophysitis are inflammatory processes of the pituitary gland often involving contiguous structures that are classified as primary and secondary forms [1] [2] [3] [4] [5] . the primary forms are characterized by an inflammatory process confined to pituitary gland without a well identifiable etiological agent, while the secondary forms are pituitary inflammatory processes triggered by definite etiologic infective or pharmacological agents or by pituitary involvement of more generalized known systemic diseases (table 1) . on the basis of histopathological findings, primary hypophysitis is divided into five types: lymphocytic hypophysitis (lyh), granulomatous hypophysitis, xanthomatous hypophysitis, necrotizing hypophysitis, and igg4 plasmacytic hypophysitis, which are still considered truly distinct entities by some authors or only different expressions of the same disease by others because of the possible occurrence of mixed forms [6] [7] [8] [9] [10] . lyh, which is the most frequent form of primary hypophysitis, is characterized by an extensive infiltration of the pituitary by lymphocytes and plasma cells [11] . because of the involved structures it is classified as lymphocytic adenohypophysitis when the process involves only the anterior pituitary, lymphocytic infundibulo-neurohypophysitis when involves the posterior lobe and the infundibulum and lymphocytic panhypophysitis when it involves globally the anterior and the posterior lobe and the infundibulum [12] . a new form of primary hypophysitis has recently been described: igg4 plasmacytic hypophysitis. this is characterized by the massive infiltration of pituitary gland and/or stalk with numerous igg4-secreting plasma cells [13] . this disease also called igg4-related hypophysitis is included, together with several other diseases, in the spectrum of igg4-related disease [14] (table 1) . autoimmune hypophysitis is still considered rare, but cases with pituitary autoimmunity are increasingly being recognized. an autoimmune pathogenesis for lyh was proposed by goudie and pinkerton in 1962. they described the occurrence of lyh in a young woman showing postpartum amenorrhea and hypothyroidism who died 14 months after delivery for acute hypoadrenalism following surgery for appendicectomy. autoptic findings showed massive lymphoplasmacytic infiltration of both pituitary and thyroid glands and adrenal atrophy [15] . actually, a first description had been made by simmonds [16] in 1917 at pituitary autopsy. subsequently, a case of panhypopituitarism due to pituitary atrophy with diffuse fibrosis and a moderate lymphocytic infiltration with the lymphocytes collected in small foci, was described by rupp and paschkis [17] . however, these authors could not classify this disorder as autoimmune because the concept of endocrine autoimmunity was introduced several years later for hashimoto's thyroiditis [18, 19] . from the first description, the frequency of case reports of lyh in the literature is increasing with time. the 1 per 9 million per year incidence estimate, derived from the data by buxton and robertson [20] may well be an underestimate of the present incidence of the disease. caturegli et al. [3] reviewed 379 cases until 2005 and 750 cases until 2008 [21] , diagnosed on the basis of clinical and histopathological findings, magnetic resonance imaging (mri) and detection of pituitary antibodies but the number of new cases described are increasing considerably from these years onwards. this has been favoured by the growing general awareness in the medical community of the condition. moreover, the recent increase in the use of noninvasive pituitary imaging and of methods to investigate the presence of pituitary antibodies in suspected patients, as well as the pathological findings of pituitary specimens from patients undergoing transsphenoidal surgery, have greatly contributed to the increasing diagnosis of lyh. however, even if several (but not many) cases have appeared in the literature over the years [22] [23] [24] , at present the true prevalence and incidence of lyh are likely to be underestimated. the prevalence of all primary hypophysits is approximately 0.2-0.88 % and the annual incidence is about 1 in 9 million but this is probably underestimated [1] [2] [3] [4] [5] . in fact, in the database of the population only cases of biopsyproven or suspected lyh are included but that the disease is often misdiagnosed has to be considered [3] , especially in patients in the subclinical phase. lyh is the most common form of primary hypophysitis, considering that about 71.8 % of these forms are lyh [2, 3] . lyh is more frequent in women, especially in the last semester of pregnancy and in the post-partum period, with a female/male ratio of about 5:1 [21] . however, cases occurring outside pregnancy have been on the increase in the recent years [3] [4] [5] 21] . the mean age at diagnosis is usually 35 ± 13 years for women and 45 ± 14 years for men [1] [2] [3] , but some cases have been described in children [25] and in the elderly [26] . among the ethnic factors, in the first series of patients the caucasian to japanese ratio was about 3:1 [2] but a recent reevaluation by caturegli et al. [21] lowered this ratio considerably with increased cases of japaneses affected, even if still inferior to caucasians in percentage. the most frequently described hla alleles were in the first series hla-dr4 e dr5 [2, 21] , but recently hla-dq8 and dr53 have been found to be commonly present in patients with lyh [27] . an autoimmune pathogenesis is suggested by several clinical, laboratory and histopathological findings, even if this is still argument of debate [2-5, 21, 28, 29] . other endocrine diseases, such as hashimotos' thyroiditis, addison's disease, type 1 diabetes mellitus and graves' disease fulfil the criteria to be considered autoimmune organ-specific diseases. in particular, their respective target autoantigens are well-known tissue-specific or cell-specific enzymes or hormones or receptors capable of evoking their respective autoimmune response [30] [31] [32] . autoimmune hypophysitis is classified as an organ-specific disease because it is caused by selective destruction of pituitary hormone-secreting cells by immune cells. in fact, even if the true pituitary antigen(s) responsible for the immune reaction is (are) still debated, circulating pituitary autoantibodies can be detected in affected patients. moreover, autoimmune hypophysitis fulfills indirect and circumstantial evidence of autoimmunity according to the established criteria to define a disease as autoimmune, especially regards the histopathological findings [18, 19] . histopathological findings are suggestive of an autoimmune process overlapping those described for other endocrine glands. specimens are usually derived at autopsy, pituitary surgery or pituitary biopsy, which is still considered the gold diagnostic standard. they show massive pituitary infiltration by lymphocytes (t more than b lymphocytes, mainly of the cd4 class), plasma cells and macrophages, grouped in aggregates surrounding atrophic acini of pituitary cells [33] [34] [35] . lymphocytes are sometimes arranged in lymphoid follicles with a germinal center, whereas areas of reactive fibrosis can be shown in the remaining pituitary tissue [11] (fig. 1) . these germinal centres frequently consist of cd20 positive b cells located centrally with peripheral cd3? t cells. it has been recently suggested that two distinct entities of lyh can be distinguished on the basis of the prevalence of t-regulatory cells or th17 cells, which are cd4? t helper cell effectors in many human autoimmune diseases [35] . one of these entities demonstrates an autoimmune process with th17 dominance and lack of t-regulatory cells; another form appears as a process in which t-regulatory cells control the immune response which may not be ''self-targeted'' but rather ''foreign targeted'' (infective agents?). immunochemistry also shows numerous mast cells localized in proximity to capillaries, thus favouring their permeability and angiogenesis, which contribute to perpetuating the inflammatory autoimmune process [36] . other reasons for considering lyh as an autoimmune disease the natural history of lyh is similar to that of other autoimmune diseases, progressing through several stages with cycles of remission and relapse and with good response to immunosuppressive therapy [37, 38] . possible spontaneous remission or the progression to the established chronic stage is most likely related to the severity of damage of hypothalamic-pituitary cells and the relationship between the cytokines produced at the sites of the inflammatory autoimmune process and the hypothalamic-pituitary-adrenal (hpa) axis. in fact, these cytokines usually stimulate the hpa axis leading to its hyperactivation with hyperproduction of crh and avp, both stimulating directly or indirectly adrenal cortisol secretion, which contributes to the limitation or the extinction of the autoimmune process [2] . when the immune aggression causes severe damage to pituitary cells, mostly acthsecreting cells in the early stage of lyh, the consequent impaired secretion of cortisol may not be able to interrupt the immune process. this contributes at perpetuating the aggression to pituitary cells with progression to stable pituitary dysfunction. this condition is even more severe when the autoimmune process involves the hypothalamus, damaging crh-and avp-secreting cells, and thus preventing the stimulatory effect of cytokines on the hpa with perpetuation of the inflammatory process. in contrast, when pituitary cell damage is transient, because mostly related to pituitary edema, hyperactivation by the local cytokines of the hpa axis with the consequent cortisol hyperproduction, may interrupt the immune process with recovery of pituitary function [2] (fig. 2) . patients with lyh often have a family history of autoimmunity and in some of them lyh shows close association with other autoimmune disease or with autoantibodies to other endocrine glands, configuring in some cases an autoimmune polyendocrine syndrome (aps). association has been described with several endocrine or non-endocrine diseases [1] [2] [3] but the most commonly observed association is with autoimmune thyroid diseases [39] among the aps type 3 or with the diseases falling into the aps type 1 (fig. 3) . several autoimmune diseases are correlated with particular human leukocyte antigen (hla) alleles [40] . hla has been typed in a small number of patients with lyh but with results so far inconclusive. in previous studies on 17 patients the predominant allele found was the hla dr4 and less frequently hla dr5 [21] but the pituitary cells of none of these patients showed hla class ii molecules, which are often expressed in tissues attacked by autoimmune processes [41, 42] . however, as previously specified, a recent study by heaney et al. [27] investigated the relationship between specific hla markers and lyh in 15 patients with sporadic lyh and in 4 patients who had developed hypohysitis after treatment with ctla 4 antibodies for melanoma, comparing the results with those obtained in patients with other pituitary mass and in normal controls [27] . in patients with sporadic lyh they found hla-dq8 expressed in 13 (87 %) and dr53 expressed in 12 (80 %) of 15 patients. in contrast none of the four patients with acquired ctl 4 ab hypophysitis exhibited the hla-dq8 and only 1 of 4 (25 %) exhibited the hla-dr53 marker. comparing the results with patients with another pituitary mass, odds ratio of a patient with lyh expressing the hla-dq8 marker was 23.1-fold higher than a patient with another sellar mass. these results, on the hand support the autoimmune pathogenesis of lyh, but on the other suggest that hla-dq8 testing may assist in the diagnosis of patients with atypical lyh [27] . the diagnosis of autoimmune hypophysitis is very problematic, as this autoimmune disease can present not only with many different faces, but also because its natural history is very variable [1] [2] [3] [4] [5] . during the natural history of the disease an endless series of reversible changes in clinical, morphological and functional findings of the disease can be observed. we describe these diseases including the igg4-related hypophysitis, and the ctl4 hypophysitis (a new drug-related secondary form of hypophysitis) as forms of autoimmune hypophysitis, because their characteristics tend to overlap with those of lyh. clinical and hormonal findings lyh may present as an acute, subacute or chronic condition with a correspondence between clinical aspects and pituitary involvement in the autoimmune process. figure 4 summarizes the correlations between the stages of pituitary involvement and clinical and hormonal findings in lyh. in the acute/subacute phase lyh is characterized by pituitary mass-related symptoms and signs frequently accompanied by symptoms of pituitary failure, which are similar to those of a non-functioning pituitary adenoma [34, 43] . in particular, as regards symptoms of mass effect, headache develops frequently and can occur in a dramatic fashion and then other symptoms, such as visual impairment, nausea and vomiting can be also present [2] [3] [4] [5] . usually the symptoms in this phase are evoked by pituitary edema with extrasellar expansion and pituitary infiltration of lymphocytes and plasma cells. even if the pituitary biopsy is still considered the gold diagnostic standard for lyh when symptoms of mass effect are present, this is an invasive procedure not always consented to by the patients. thus, in some patients in the acute/subacute phase, a presumptive diagnosis of lyh could be made on the basis of clinical features and of imaging and laboratory findings [44] . moreover, as regards isolated or multiple pituitary hormone deficiencies, in these stages they can be sometimes misdiagnosed because the patients are clinically asymptomatic. however, in this phase acth is the most frequent and earliest pituitary hormone deficiency, usually associated with hyperprolactinemia. in some rare cases, the rapidity and severity of disease progression may cause a severe secondary adrenal insufficiency with consequent sudden death [1] [2] [3] [4] [5] . a multi-factorial etiology has been suggested for the hyperprolactinemia, which affects approximately one-third of patients, causing amenorrhea/galattorrhea in women and sexual dysfunction in men [2, 3] . in some cases it can be due to a decrease in the dopamine delivery to the anterior pituitary related to stalk compression by a pituitary supra-sellar inflammatory mass or to an alteration of dopamine receptors. hyperprolactinemia can be also present in patients without involvement of extrasellar structures. in these cases, the diffuse lymphocyte infiltration of the pituitary gland could determine an escape of prl into the circulation secondary to the massive cellular destruction. however, prl could be directly released by the immune cells infiltrating the gland, considering the relationship between the immune system and prl [45, 46] . whatever the cause, the high levels of prl could contribute to perpetuate the immune process in lyh, through the well-known proinflammatory immunogenic effect of this hormone [45, 46] . in the established chronic phase, pituitary fibrosis and atrophy are accompanied by mono or pluritropinic deficiencies with secondary impairment of the respective target gland function. acth deficiency may thus be temporally followed by lh, fsh, gh, tsh and more rarely prl deficiency [47] , until a possible panhypopituitarism develops [2] [3] [4] [5] 27] . the symptoms and signs are usually not correlated with the severity of pituitary enlargement, suggesting that pituitary hormone deficiencies could be due to the early direct attack of the autoimmune process on the pituitary-secreting cells rather than to later pituitary histopathological alterations [5, 48] . in patients with infundibulo-neurohypopysitis central diabetes insipidus (cdi) is usually present but in some patients with lyh, cdi can be sometimes present, even in the absence of radiological findings of lymphocytic-infundibulo-neurohypophysitis, [2] [3] [4] 48] . retrospective cross-sectional cohort study on the clinical and endocrinological features of primary hypophysitis in 66 german patients with results partially in contrast with those in the literature [49] . headache (50 %) and weight gain (18 %) were the most frequent nonendocrine symptoms. the association of hypophysitis with pregnancy was observed only in 11 % of the female patients. diabetes insipidus was found in 54 % of the patients at presentation. hypogonadotropic hypogonadism was the most frequent endocrine failure (62 %), whereas gh deficiency was the less frequent (37 %). granulomatous hypophysitis was associated with more severe symptoms than lyh [49] . even if this german study comprises data from several forms of primary hypophysytis and not from only lyh, the discrepancy between the results from a german population and the data in the literature seems to indicate that environmental factors may influence the clinical features of hypophysytis in affected patients. magnetic resonance imaging and its role in differential diagnosis as previously specified, pituitary biopsy is the gold diagnostic standard for lyh. however, this invasive procedure is not always consented to by the patients. magnetic resonance imaging (mri) may help in the diagnosis of lyh and to differentiate this disease from other cases of pituitary mass, in particular pituitary tumor [50, 51] , even if imaging findings sometimes tend to overlap, limiting a correct differential diagnosis. in patients with lyh, mri usually reveals a homogeneous pituitary enlargement, symmetrical supra-sellar extension, compression and displacement of the chiasma, and a thickened, but not deviated, stalk. in german patients thickening of the pituitary stalk is the prevailing neuroradiological sign, being found in 86 % of affected patients [49] . after gadolinium, mri shows a prompt, intense and homogeneous enhancement of the mass with a strip of enhanced tissue along the dura madre, the so-called: dural tail [50] [51] [52] [53] [54] [55] . in patients in whom the process involves the neurohypophysis, the 'bright spot' is usually lost and subclinical or clinical cdi is usually present. in some cases, an empty sella can represent an unusual feature of lyh at mri, particularly during the later stages of the disease [56, 57] . a possible final outcome in empty sella on mri has been described both for lyh and shehan's syndrome (ss) [58] . this syndrome, due to pituitary ischemia after a severe postpartum hemorrage, may be characterized by empty sella on pituitary mri. the finding of prl deficiency with postpartum lactational failure has lead to considering a possible diagnosis of ss. however, it is not always possible to differentiate this disease from lyh, because the pituitary ischemia occurring in ss with the consequent cellular damage may trigger an autoimmune process at the pituitary level, which contributes to perpetuate the hypopituitarism in the affected women [59] . in patients with pituitary adenoma, mri commonly reveals an endosellar mass with unilateral sellar floor depression, asymmetrical supra-sellar extension and controlateral deviation of the stalk. after gadolinium, the enhancement of the pituitary mass is slight, delayed and inhomogeneous. usually, the dural tail is absent and the bright spot is preserved [50] [51] [52] [53] [54] [55] ( table 2) . the above very scholarly criteria do not always provide a correct differential diagnosis. in a further contribution to this argument, gutemberg et al. [54] some years ago proposed a new radiological score to distinguish autoimmune hypophysitis from not-secreting pituitary adenoma before deciding on a more appropriate therapeutic choice. in particular, the authors analyzed, by multiple logistic regression, eight features that contributed significantly to classifying pituitary masses as pituitary adenoma or hypophysitis: relation to age, pregnancy, pituitary mass volume and symmetry, signal intensity, signal intensity homogeneity after gadolinium, posterior pituitary bright spot presence, stalk size and mucosal swelling. the score c1 suggests a diagnosis of adenoma, whereas the score b 0 suggests a diagnosis of autoimmune hypophysitis. use of this score resulted in a significant improvement in the differential diagnosis of adenoma and autoimmune hypophysitis compared with the results obtained from the assessment of the single parameters [54] . however, despite the use of the score suggested by gutenberg et al. [54] the diffferential diagnosis by mri between lyh and other pituitary mass is still problematical. this was also confirmed by an important paper published in 2011, reporting the results of a 10-year experience on a population of 2598 patients who had been submitted to mri because of the presence of sellar and parasellar masses [60] . famini et al. showed that only five patients of 2598 had an lyh, all presenting with panhypopituitarism, but three of these five had been initially diagnosed as having a macroadenoma. these results confirm, on the one hand, the rarity of lyh with respect to the other sellar and parasellar masses of other origin, when investigated by mri, but on the other hand,also the possibility of misdiagnosis also following the criteria suggested by gutemberg et al. [54] . searching for antipituitary antibodies (apa) may help to diagnose or at least suspect an lyh, especially in patients who did not consent a pituitary biopsy and in whom pituitary mri was inconclusive. however, while other organspecific antibodies are considered good markers of their respective autoimmune endocrine diseases [61] [62] [63] , the role of apa in autoimmune hypophysitis is still debated because of several methodological problems and uncertainties in the clinical interpretation [64] [65] [66] [67] . moreover, it has to be considered that the true pituitary antigens reacting with these antibodies are still unknown, even if several antigens have been proposed as responsible for the lyh and as target of apa [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] . but their pathogenic role is still argued. recently, a new target autoantigen, the rabphillin-3a, has been identified as responsible for the autoimmune response in several patients with lymphocytic infundibulo-neurohypophysitis, but also in some patients with lyh [79] . finally, pituitary-specific transcriptor factor 1(pit-1) has been shown as a pituitary target of cytotoxic t lymphocytes in a novel clinical entity, the anti-pit-1 antibody syndrome, that presents an acquired combined pituitary dysfunction characterized by a specific defect in gh, prolactin and tsh. circulating anti-pit-1 antibodies along with other various autoantibodies have been detected in some patients with multiple endocrine organopathy, meeting the definition of autoimmune polyglandular syndrome [80] . the first method used to detect apa was the complement consumption test [81] but after the first report this method was never employed by other laboratories. the most used methods are immunoblotting assay, radioligand binding and indirect immunofluorescence. the immunoblotting method [76] [77] [78] utilizes a homogenate of human autopsy pituitary tissue as a substrate to identify the antigen target of apa. by this method, crock [73] showed that serum antibodies against a 49 kda pituitary cytosolic protein were present in 70 % of patients with biopsy-proven lyh and in 55 % of patients with suspected lyh, including patients with isolated acth deficiency, patients with hypopituitarism associated with other autoimmune diseases or females with sheehan's syndrome [73] . subsequently, crock et al. identified the 49 kda pituitary cytoplasmatic protein as an a-enolase, which is a ubiquitously expressed enzyme and considered the antibodies to this antigen to be a marker of lyh [77, 78] . interestingly, a-enolase is expressed in both the pituitary and the placenta, thus providing a theoretic basis for the strong association between pituitary autoimmunity and pregnancy [78] . subsequent studies have suggested that antibodies to a -enolase cannot be considered specific for lyh because they are frequently present not only in patients with lyh but also in some patients with hypopituitarism secondary to pituitary adenomas or to other pituitary diseases [75] . the technique of radioligand binding assays has led to several studies in organ-specific autoimmune diseases. this method was able to detect autoantibodies against pituitary gland specific factor 1a 306 (pgsf1a) in 33 % patients with biopsy-proven lyh and in 20 % patients with isolated acth deficiency [72] . pgsf2 autoantibodies were detected in 14 % patients with suspected lyh or linh. anti-gh antibodies were present in 25 % patients with lyh and in 6 % patients with other autoimmune diseases. no patients with pituitary adenoma showed reactivity to either pgsf1a or pgsf2, but pgsf1a autoantibodies were found in 77 % patients with rheumatoid arthritis [73, 74] . however, no information is available on pituitary hormone function in these latter patients and it is not possible to know at present whether these results are due to a lack of specificity of this autoantibody marker or to a high diagnostic sensitivity for a subtle pituitary dysfunction. immunofluoresce method is one of the more widely employed methods to detect apa. however, the clinical applicability in the routine diagnosis is still debated for several methodological problems. the main problem of this method is the use of pituitary sections obtained from a variety of species and under a variety of conditions as substrate. in particular, apa were detected in cryostat section of the pituitary gland obtained from humans, primates and rodents and processed with fluorescein isothiocyanate conjugated goat anti-human ig sera. the influence of human or animal pituitary substrate on the sensitivity and specificity of the immunofluorescence method is still discussed. in fact, immunofluorescence has detected apa not only in some patients with suspected or biopsy-proven lyh, but also in patients with non-autoimmune pituitary diseases such as pituitary adenomas or empty sella syndrome [82] [83] [84] [85] [86] [87] . some authors, by comparing the results obtained from the use of either human pituitary gland or animal pituitary substrates affirmed that the results with animal substrates were inconclusive or had a lower sensitivity and specificity than that with human substrates [65, 82, 83, 88] . conversely, other authors obtained the same or quite more reliable results using animal than human section [89] [90] [91] . finally, reliable results were obtained by using adrenal and hypothalamic tissues from animals as substrates to search with immunofluorescence for antibodies against key adrenal enzymes or avp-secreting cells in patients with clinical or subclinical addison's disease or cdi, respectively. thus, these antibodies have been considered good specific, sensible and sometimes predictive markers of addison's disease and cdi, respectively [61] [62] [63] . taking into account the previous arguments and aiming to improve the specificity and the sensitivity of the immunoflurescence method, we have established that some characteristics have to be satisfied when processing the immunofluorescence results. in particular, we consider reliable results from immunofluorescence apa detection, by using as substrate cryostat sections of pituitary from young baboon, only when the titre was higher than a cut-off value and when it was associated with a particular kind of immunostaining pattern. following these criteria, we searched for apa by immunofluorescence in a large cohort of adults and of children with idiopathic ghd and in patients with idiopathic hypogonadotropic hypogonadism [92] [93] [94] [95] . the results of these studies suggested that apa, when present at high titres and with an immunostaining pattern involving selectively some but not all pituitary cells, could be considered good markers of autoimmune isolated hypopitutarism. these antibodies have been further characterized by a four-layer double fluorochrome immunofluorescence test in which, in a second step, the same pituitary section is tested consecutively with the patient's serum, found positive for apa in the first step, and with the animal's pituitary hormone antiserum. the different color of the anti-ig conjugate against the human and the animal serum, respectively green(fitc) and red((rhodamine), allows direct visual assessment of whether the patient'serum and the animal antihormone serum stain the same or different pituitary cells. this allows the identification of the kind of pituitary hormone-secreting cells targeted by apa in patients previously found positive for these antibodies [82, 83] . by this method, we could verify that the pituitary-secreting cells targeted by apa-were somatotrophs in patients with gh deficiency [93, 95] and gonadotrophs in patients with hypogonadotropic hypogonadism [94] . it has been shown that patients with aps or with isolated autoimmune endocrine diseases are at risk of more complex autoimmune diseases, which can be unveiled by searching for the respective autoantibodies [96] [97] [98] [99] . concerning this, in recent studies we have evaluated the predictive value of apa and antihypothalamus antibodies (aha) detected by simple indirect immunofluorescence, for the occurrence of subsequent hypopituitarism. to this purpose we planned to investigate their time-related variations during a longitudinal study in patients with autoimmune polyendocrine syndromes (aps) positive for these antibodies but with normal pituitary function at diagnosis [95] [96] [97] [98] . our results showed that in some cases, the presence of aha but not apa was associated with selective or combined hypopituitarism, suggesting that an autoimmune process involving the hypothalamus but not the pituitary, could be responsible for secondary pituitary dysfunction in these patients [98] . on the other hand, the finding of apa at high titre and with immunostaining involving some but not all pituitary cells, were able to predict the occurrence of subsequent hypopituitarism in a follow-up of 5 years in patients with aps without pituitary dysfunction at the diagnosis (97). moreover, the characterization of pituitary cells targeted by apa in patients with isolated autoimmune diseases, positive for these antibodies at the start but without pituitary dysfunction, may help to foresee the kind of subsequent hypopituitarism [99] . in fact, the detection of apa by double immunofluorescence, selectively directed against gonadotrophs, corticotrophs, thyrotrophs or somatotrophs at the start, was followed during the follow-up by a corresponding pituitary hormone deficiency [99] . recently, to ascertain the responsibility of hypothalamus or pituitary or both on the pituitary hormone deficiencies in patients with autoimmune hypophysitis positive for apa, the italian autoimmune hypophysitis network group performed a study on 95 of these patients, searching for antihypothalamus antibodies [98] . sera positive for aha, detected by immunofluorescence, were retested by double immunofluorescence to identify the hypothalamic cells targeted by these antibodies. the results showed that these antibodies were directed not only towards argininevasopressin-secreting cell (avpc) but also towards releasing hormone-secreting cells. in particular, the detection of aha targeting crh-secreting cells in patients with gh/acth deficiency but with apa specifically directed only to gh-secreting cells, suggested that some pluritropinic deficiencies in some patients with lyh may be due to combined autoimmune aggression both at the pituitary and hypothalamic level [98] . as regards the relationship between pituitary autoimmunity and pregnancy, we recently described a 34 year old woman, who presented with lactational failure after delivery, growth hormone and prolactin deficiencies and subsequently severe primary autoimmune hypothyroidism [100] . immunological study revealed the presence of apa, identified as targeting gh-and prolactin-secreting cells by double immunofluorescence and elevated levels of antithyroglobulin and antiperoxidase antibodies at the subsequent appearance of thyroid dysfunction. this was the first observation of autoimmune hypopituitarism involving growth hormone and prolactin secretions in a patient with lactational failure after delivery, subsequently followed by severe primary autoimmune hypothyroidism, thus falling into an unusual autoimmune polyendocrine syndrome type 3. a second similar case has been recently published by iwama et al. [101] . pregnancy may also favour the transition from a potential/subclinical to a clinical stage of an autoimmune hypothalamic-pituitary disease. recently, we studied two women, positive for avpcabs before pregnancy but without clinical cdi and who became pregnant 5 and 7 months after our first observation. the behavior of post-pituitary function and avpcabs (by immunofluorescence) was evaluated at baseline, during pregnancy and 2 years after delivery [102] . avpcabs, present at low/middle titres at baseline in both patients, showed a titre increase during pregnancy in one patient and after delivery in the other one, with development of clinically overt cdi. therapy with 1-deamino-8-d-avp (ddavp) caused a prompt clinical remission. therapy was definitely stopped at the 6 th and 7th month post partum period, respectively, when avpcabs disappeared, accompanied by stable post-pituitary function recovery, which persisted until the end of the follow-up. these results indicate that the determination of avpcab is advisable in patients with autoimmune diseases planning their pregnancy, because it could be considered a good predictive marker of gestational or post-partum autoimmune cdi. the monitoring of avpcab titres and postpituitary function during pregnancy in these patients may allow an early diagnosis of cdi and an early replacement therapy, which could induce the disappearance of these antibodies with consequent complete remission of autoimmune cdi [102] . an interesting question is whether antipituitary antibodies can change their pituitary target during a life span with consequent change of the kind of pituitary hormone deficiency. concerning this, we conducted a longitudinal study of pituitary function and apa (by immunoflurescence) on 24 children with apparently idiopathic isolated gh deficiency (ghd), treated with replacement rgh therapy from childhood to the transition age [103] . pituitary function and apa detection were investigated before starting rgh therapy and after stopping of therapy at transition age. sera of patients positive for apa were processed by double immunofluorescence to identify their pituitary target. at diagnosis, 16 out of 24 patients were apa positive targeting only somatotrophs (group 1), while eight were apa negative (group 2). when retested off therapy 12 of 16 patients in group 1 persisted being apa positive, while the remaining four became apa negative with recovery of pituitary function. all patients in group 2 persisted apa negative but still showing ghd. of the 12 patients persistently apa positive, eight with confirmed ghd showed apa still targeting somatotrophs, whereas four showed apa targeting gonadotrophs associated with hypogonadotropic hypogonadism (hh). these results suggest that a possible remission of autoimmune ghd, diagnosed in childhood, may occur in patients positive at middle but not at higher titres at diagnosis, after gh replacement therapy. apa may shift their target in transition period, especially from somatotrophs to gonadotrophs. thus, an early characterization of apa by double immunofluorescence is advisable in apa positive ghd patients showing delayed puberty to allow an early diagnosis and an appropriate therapy, thus preventing the progression toward a clinically overt hh [103] . finally, searching for apa in patients with idiopathic hyperprolactinemia may help to disclose the possible occurrence of autoimmune hypophysitis. in these cases, the finding of apa at high titres associated with acth or gh deficiency, suggests the diagnosis of lyh in some of them [104] [105] [106] . in conclusion, in spite of the diffuse use of the immunofluorescence method, the results appeared in the literature so far, are often conflicting, particularly due to the use of different human or animal substrates. however, we think that improvement of specificity and sensitivity of the method may be obtained, excluding the low titres and the confounding immunostaining patterns. this procedure may allow reliable results for diagnosing or at least suspecting pituitary autoimmunity, by also using animal substrates, especially when the results are validated by a second step with the four-layer double immunofluorescence. we think that searching for apa in some particular conditions, may help to avoid an underestimation of autoimmune hypophysitis; thus, we suggest that the possible presence of apa should be investigated [2, 5] : • in patients with apparently idiopathic hypopituitarism especially if associated with other autoimmune diseases • in patients with hyperprolactinemia without pituitary adenoma at mri, without hypothyroidism or associated to iatrogenic causes • in patients with hypoprolactinemia and post-partum lactation failure • in patients with empty sella • in patients with previous traumatic brain injury and in those with infectious meningitis • in patients treated with monoclonal antibodies for several types of tumor • in patients with igg4-related syndrome • when apa are detected at high titre and with a particular immunofluorescence pattern in these patients, a pituitary mri (if not yet performed) and a complete evaluation of pituitary function should be performed to discover those with pituitary impairment even at subclinical stage • in some cases, searching for antihypothalamus antibodies may help to ascertain the occurrence of an autoimmune process involving selectively the hypothalamic cells or associated with pituitary autoimmunity a new form of primary hypophysitis strictly correlated to lyh has been recently described: igg4 plasmacytic hypophysitis. this disease, also called igg4-related hypophysitis, is included, with several other diseases, in the spectrum of igg4-related disease (igg4-rd). this is an increasingly recognized syndrome of unknown etiology, which comprises a collection of disorders that share specific pathologic, serologic, and clinical features [13, 14, 107] . the commonly shared features include tumor-like swelling of the involved organs, a lymphoplasmacytic infiltrate enriched in igg4-positive plasma cells and a variable degree of fibrosis. moreover, elevated serum concentrations of igg4 are usually found. several organs may be affected by this disorder. the most frequent presentations are igg4-related pancreatitis and sclerosing sialoadenitis, but other associated entities have been described, such as sclerosing cholangitis, orbital inflammatory pseudotumor, igg4-related dacryoadenitis, aortitis and periaortitis, igg4-related lung disease and mesenteritis, riedel's thyroiditis, igg4-related kidney disease and igg4related hypophysitis [14, 107, 108] . in particular, igg4related hypophysitis initially was diagnosed in a clinical setting in a 66-year-old woman with inflammatory pseudotumor affecting salivary glands, pancreas and retroperitoneum [13] , and also by pathological examination of a 77-year-old man with a history of sclerosing pancreatitis and cholangitis [109] . subsequently, until 2011 a total of 26 cases of biopsy proven or clinically suspected igg4related hypophysitis has been reported [110] [111] [112] , but further cases have been recently described [113] . this form of hypophysitis is characterized by massive infiltration of the pituitary gland and/or stalk with numerous igg4-secreting plasma cells [13] . this inflammatory pituitary process can be misdiagnosed as it mimics clinical and imaging features of sellar or parasellar tumor. following the criteria proposed by leporati et al. [111] , igg4-related hypophysitis is characterized by the following features: igg4 serum concentration [135 mg/dl; involvement of other organs; infiltration of igg4? plasma cells in the involved tissues, favourable response to glucocorticoid treatment. igg4-related hypophysitis is more commonly present in men of older age. the more frequent findings are: anterior pituitary enlargement with acute acth deficiency when the process involves particularly the pituitary gland; and pituitary stalk thickening with loss of bright spot when the process involves extrasellar structures. in this case cdi may be observed in the majority of the affected patients [18] . a particular case of igg4-related hypophysitis has been recently described by hattori et al. [112] . the affected patient presented with loss of bright spot and pituitary stalk thickening on brain mri but without cdi or anterior pituitary dysfunction. moreover, he showed a high serum igg4 level but without other coexisting igg4-related diseases. an infiltration of lymphocytes and plasma-cells of the posterior lobe, frequently showing igg4 on their surface but no alterations of the anterior lobe observed on biopsy of either anterior or posterior pituitary lobes [112, 114] . the authors suggested that igg4-related hypophysitis can be often unrecognized especially in the asymptomatic phase. with regards to cdi, frequently observed in this form of hypophysytis, we found in previous studies that some patients with lyh associated with cdi, were positive for avpcab without typical signs on mri of infundibulo-neurohypophysitis, suggesting that a direct autoimmune attack to avp-secreting cells could be responsible for their cdi [29, 63] . following these findings and considering that avpcab may belong to igg4, we think that searching for these antibodies in patients with igg4-related hypophysitis, could be advisable to clarify the role of these antibodies in their cdi. a secondary form of autoimmune drug-related hypophysitis has been recently described and related to the treatment with cytotoxic t-lymphocyte-associated antigen-4 (ctla4) blocking antibodies [115] [116] [117] [118] [119] [120] [121] [122] [123] . a recent review by faje summarized the clinical presentation, treatment and biological insight of hypophysitis secondary to immunotherapy [124] . this therapy is frequently employed in the treatment of melanoma and other malignancies. several autoimmune side effects from these agents have been described, termed immune-related adverse events (iraes) and can include multiple endocrinopathies. among these, immune-targeted cancer therapyrelated hypophysitis has been recently recognized as an endocrine irae [124, 125] . in fact, recent reports observed that patients developed lyh and other autoimmune diseases during the treatment with the ctla-4-blocking agent ipulimumab, suggesting a possible correlation between ctla4 and lyh [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] . it has been suggested that these blocking antibodies may act by depleting t-regulatory cells [120] . in another study the antitumor and autoimmune effect of these agents resulted from direct activation of cd4? cd8? effector cells [123] . in this context, future studies should be planned to investigate whether a microsatellite polymorphism on the ctla4 gene, as shown for other autoimmune diseases, could be associated with the development of lyh. clinical features, including pituitary dysfunction, and mri of this form are similar to those of lyh. in some cases an electrolytic alteration with hyponatremia has also been described [121] . usually, following cessation of therapy, a normalization of pituitary morphology at follow-up mri and return to clinical baseline conditions can be observed spontaneously or after early treatment with high-dose of corticosteroids [122] . predictive factors for onset of hypophysitis in patients treated with this immunotherapy remain at present unknown. it often presents insidiously with subtle symptoms and can have life-threatening complications, especially related to possible acute hypocortisolism [121] [122] [123] [124] . thus, it is imperative that this form is distinguished from pituitary metastases of melanoma or other malignancies and that a close clinical observation of patient's progress must be made by physicians. in particular, they have to be cognizant of the overall clinical and radiological picture of this form of hypophysitis, when treating patients receiving ipolimumab or similar drugs with the same effects on the pituitary, to avoid possible severe complications [122, 124] . unusual presentation of lyh or presentation of other diseases mimicking the features of lyh, may delay the diagnosis with possible damage for the affected patients due to untimely or inappropriate therapy. here we report some particular presentations appearing in the literature, that may be considered as examples to help avoiding misdiagnosis. • several years ago lidove et al. described a 36-year-old woman with a prominent lymphoid infiltration of lachrymal and salivary glands, associated with pituitary dysfunction: laboratory and imaging findings allowed the diagnosis of lyh, which showed a dramatic response to steroids with apparent complete recovery. instead, 4 years later, graves' disease developed, which required an appropriate prolonged therapy. in this case the autoimmune process followed a regional tissue distribution, including pituitary, thyroid, lachrymal and salivary glands [126] . • usually the mri in lyh shows pituitary enlargement with symmetrical extrasellar expansion, with homogeneous and hyperintense signals after gadolinium extending sometimes to the basal hypothalamus in a tongue-like fashion, with stalk thickened but not deviated [50] [51] [52] [53] [54] . instead, perez-nunez et al. [127] described in 2005 an interesting case of a patient with lyh presenting with mri of a cystic lesion with ring contrast enhancement. since this appearance in imaging studies is not unusual, it should be considered among the possible features suggesting this disease in an appropriate clinical context. • huang et al. [128] [130] . before this paper only five cases of hypophysitis spreading over the cavernous sinus had been published. cases of lyh presenting as temperature dysregulation have been recently published [131, 132] . • the first case, by jain and dhanwa [131] , presented with documented body temperature oscillations, hoarseness of voice, sexual dysfunction, pan-hypopituitarism, elevated titre of anti-tpo, postural hypotension and typical findings of lyh on mri. prednisone therapy along with hormone replacement therapy induced recovery of a normal rhythm of temperature and of all previous alterations within 30 days. • the second case described a complex association of post-partum hypothermia, hypoglicemia, hypoadrenalism and hypothyroidism, accompanied by characteristic findings on mri. following these results, the authors suggested that practitioners should keep in mind the possibility of lyh in any pregnant women with symptoms of hypoglicemia and hypothermia after delivery [132] . • the rupture of rathke' cleft cyst may cause lymphocytic-infundibulo-neurohypophysitis. two cases were published in 2016 by hayashi et al. [133] presenting with visual disturbances, headaches and endocrine insufficiencies, followed by diabetes insipidus. these are two rare cases of lymphocytic-infundibulo-neurohypophysitis confirmed by post-surgery pathological examination, showing a massive lymphocytic infiltration of the cyst wall and the posterior lobe [133] . • specific characteristics of possible autoimmune hypophysitis may also be observed in patients in late phase of complete or selective hypopituitarism, as in patients with sheehan's syndrome [59, 60, 134] , with hypopituitarism occurring some years after a brain injury [125, 135] or after meningo-encephalitis [136] or in children with celiac disease and short stature, who do not show significant increase in stature on gluten-free diet [96] . in these diseases to search for apa by immunofluorescence may help to disclose a pituitary autoimmunity. the different expressions of this autoimmune disease require different therapeutic strategies, even because a possible spontaneous remission during the natural history of lyh can occur. for this reason, first, a careful follow-up is advisable in patients without symptomatic extrasellar expansion or important hypoadrenalism [2, 3] . then, therapeutic options must be different in the acute and chronic phase [4] . in the acute phase, glucocorticoid replacement with stress doses is mandatory in patients with acute adrenal insufficiency. in this phase a surgical option by trans-sphenoidal surgery may be necessary in patients with symptoms and/or signs of severe compression, even if a possible reduction of pituitary mass volume by high doses of methylprednisolone (1 g/day for 3 days), followed by a tapering dose, may be observed [2] [3] [4] 129] . other immunosuppressive drugs, including azathiopirine, methotrexate, cyclosporine a, have also been used successfully, particularly in corticosteroid-resistant cases, but their long-term efficacy still needs to be confirmed [2] [3] [4] 21] . therapeutic strategy in the chronic phase has to be aimed at restoring adequate hormone levels in affected patients with appropriate replacement therapy, recovering secondary hypoadrenalism, hypogonadism, hypothyroidism and gh deficiency, if present, due to lyh per se or as results of neurosurgical therapy [4] . dopamine agonists (bromocriptine, cabergoline) can lower hyperprolactinemia and improve visual field alterations in some cases but their impact on the course of the disease is still discussed [105] . however, it is well known that high levels of prl can contribute to perpetuation of the immune process in lyh, through the proinflammatory immunogenic effect of this hormone [45, 46] . this has also recently been demonstrated for hyperprolactinemia related to prolacinoma, which may increase the prevalence of autoimmune diseases, mainly thyroid diseases [137] . thus, to normalize prolactin levels by dopamine agonists in hypeprolactinemic patients with lyh it should be advisable to prevent possible autoimmune involvement of thyroid or other endocrine glands. a recent study on the outcome of the main treatment options for lyh has been conducted on 66 german patients, comparing the outcome of the different options. the results showed that glucocorticoid pulse therapy was associated with a high recurrence rate. moreover, evidence suggested that surgery was not able to prevent recurrence. the authors concluded that, considering the favourable results of observation, conservative management is recommended in lyh unless symptoms are severe or progressive [138] . recently, rituximab (rtx), a monoclonal antibody that lyzes b cells expressing cd20, usually employed for treatment of several autoimmune diseases, has been employed to treat single cases of steroid-refractory lyh [139, 140] . it was able to induce a remission both in case of isolated lyh [139] and in case of lyh associated with immune thrombocytemia within a polyendocrine syndrome type 4 [140] . thus, rtx could be considered among the new therapeutic options for the treatment of some type of aps including lyh, provided that these results can be supported by further studies on a large population. recently, a good response to immunotherapy based on the sequential use of infliximab (a monoclonal antibody that antagonizes tumor necrosis factor alpha) and rtx has been obtained in a 52-year-old woman presenting with lyh occurring with the triad of scleritis, uveitis and optic neuritis, opening new therapeutic horizons for lyh [141] . the spectrum and significance of primary hypophysitis lymphocytic hypophysitis: a rare or underestimated disease? autoimmune hypophysitis use of serum pituitary antibodies to improve the diagnosis of hypophysitis giant-cell granulomatous hypophysitis: a distinct clinicopathological entity idiopathic granulomatous hypophysitis: clinical and imaging features xanthomatous hypophysitis: a novel entity of obscure etiology lymphocytic hypophysitis report of 3 new cases and review of the literature a case of granulomatous hypophysitis with hypopituitarism and minimal pituitary enlargement lymphocytic hypophysitis: light and microscopic findings and correlation to clinical appearance necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism multiple pseudotumors in igg4-associated multifocal systemic fibrosis igg4-related disease anterior hypophysitis and hashimoto's disease in a young woman uber das vorkommen von riesenzelle in der hypophyse panhypopituitarism with idiopathic hypoparathyroidism chronic thyroiditis and autoimmunization defining criteria for autoimmune diseases (witebsky's postulates revisited) lymphocytic and granulocytic hypophysitis: a single centre experience pituitary autoimmunity: 30 years later lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy immunological and clinical aspects of lymphocytic hypophysitis diagnosis and classification of autoimmune hypophysitis lymphocytic hypophysitis in the pediatric population lymphocytic hypophysitis in the elderly hla markers dq8 and dr53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis pituitary antibodies and lymphocytic hypophysitis autoimmune central diabetes insipidus insulin antibodies in insulin-dependent diabetics before insulin treatment 21-hydroxylase, a major autoantigen in idiopathic addison's disease determinants of autoimmune thyroid disease lymphocytic hypophysitis. a review of 145 cases autoimmue hypophysitis hypophysitis in surgical and autoptical specimens immunocytochemical localization of mast cells in lymphocytic hypophysitis longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus lymphocytic hypophysitis and autoimmune thyroid disease autoimmune diseases: genes, bugs and failed regulation role of aberrant hla-dr expression and antigen presentation in induction of endocrine autoimmunity on the issue of inappropriate hla class ii expression on endocrine cells: an answer to a sceptic primary (autoimmune) hypophysitis: a single centre experience pituitary volume and headache: size is not everything prolactin and autoimmunity role of prolactin in autoimmune diseases handbook of systemic autoimmune diseases series serum antibodies to human pituitary membrane antigens in patients with autoimmune lymphocytic hypophysitis and infundibuloneurohypophysitis lymphocytic adenohypophysitis and lymphocytic infundibuloneurohypophysitis pituitary working group of the german society of endocrinology. diagnosis of primary hypophysitis in germany lymphocytic adenohypophysitis: contrast-enhanced mr imaging in five cases lymphocytic hypophysitis lymphocytic hypophysitis: its expanding features hypophysitis: endocrinologic and dynamic mr findings a radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively distinct radiological and clinical appearance of lymphocytic hypophysitis a case of postpartum hypopituitarism associated with empty sella: possible relation to postpartum autoimmune hypophysitis unusual presentation of hypophysitis preceding an empty sella in a 75-year-old woman shehan's syndrome: baseline characteristics and the effect of 2 years of growth hormone replacement therapy in 91 patients in kims_pfizer international metabolic database anti-hypothalamus and antipituitary antibodies may contribute to perpetuate the hypopituitarism in patients with sheehan's syndrome pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical immunological and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies bellastella a (1999) a longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus pituitary autoimmunity: a review substrate specificity for the detection of autoantibodies to anterior pituitary cells in human sera antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency antipituitary antibodies in patients with lymphocytic hypophysitis autoimmune hypophysitis of sjl mice: clinical insights from a new animal model novel autoantigens in autoimmune hypophysitis pregnancy and pituitary disorders: challenges in diagnosis and management identification of tpit and other novel autoantigens in lymphocytic hypophysitis: immunoscreening of a pituitary cdna library and development of immunoprecipitation assays detection of autoantibodies against the pituitary-specific protein in patients with lymphocytic hypophysitis cytosolic autoantigens in lymphocytic hypophysitis anti-alpha-enolase antibodies in pituitary disease pituitary autoantibodies in autoimmune polyendocrine syndrome type 1 detection of anti-pituitary autoantibodies by immunoblotting identification of the 49-kda autoantigen associated with lymphocytic hypophysitis as aenolase pituitary autoantibodies in lymphocytic hypophysitis target both gamma-and alpha-enolase-a link with pregnancy? rabphilin-3a as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis anti-pit-1 antibody syndrome; a novel clinical entity leading to hypopituitarism autoantibodies in sheehan's syndrome autoantibodies to prolactin-secreting cells of human pituitary growth hormone cell antibodies and partial growth hormone deficiency in a girl with turner's syndrome lymphoid adenohypophysitis presenting as a pituitary tumor lymphocytic hypophysitis in a patient with amenorrhea and hyperprolactinemia. a case report antipituitary antibodies in patients with the primary empty sella syndrome presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours detection of pituitary antibodies by immunofluorescence. approach and results in patients with pituitary diseases pituitary autoimmunity endocrine and other organ-oriented autoimmune disorders pituitary gonadotropins and autoimmunity antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases antipituitary antibodies recognizing growth hormone (gh)-producing cells in children with idiopathic gh deficiency and in children with idiopathic short stature antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine disease italian autoimmune hypophysitis network study anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. italian autoimmune hypophysitis network group characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarsm late primary autoimmune hypothyroidism in a patient with postdelivery autoimmune hypopituitarism associated with antibodies to growth hormone and prolactin-secreting cells isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with vasopressin cell antibodies: description of two cases italian autoimmune hypophysitis network group. longitudinal behavior of autoimmune gh deficiency: from childhood to transition age antipituitary antibodies in idiopathic hyperprolactinemic patients effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies long-term clinical course of igg4-related systemic disease accompanied by hypophysitis igg4-related disease hypophysitis presented as inflammatory pseudotumor in immunoglobulin g4-related systemic disease igg4 breaking the rules igg4-related hypophysitis: a new addition to the hypophysitis spectrum a case of igg4-related hypophysitis without pituitary insufficiency from japan with love: another tessera in the hypophysitis mosaic endocrine side-effects of anti-cancer drugs: mabs and pituitary dysfunction: clinical evidence and pathogenic hypotheses cytotoxic t-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer enterocolitis in patients with cancer after antibody blockade of cytotoxic t-lymphocyte-associated antigen 4 ipilimumab (anti-ctla4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis effect of cancer treatment on hypothalamic-pituitary function intrapatient dose escalation of anti-ctla-4 antibody in patients with metastatic melanoma ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis ipilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesions anticytotoxic t-lymphocyte antigen-4 induced autoimmune hypophysitis: a case report and literature review immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights pituitary medicine from discovery to patientfocused outcomes lymphocytic hypophysitis with lachrymal, salivary and thyroid gland involvement lymphocytic hypophysitis with cystic mri appearance primary pituitary lymphoma presenting as hypophysitis hypocortisolism in survivors of severe acute respiratory syndrome (sars) autoimmune hypophysitis presenting with intracranial pituitary multi-organ involvement: three case reports and review of the literature a rare case of autoimmune hypophysitis presenting as temperature dysregulation post-partum hypoglycemia and hypothermia as first manifestations of lymphocytic adenohypophysitis: a case report pure lymphocytic infundibuloneurohypophysitis caused by the rupture of rathke's cleft cyst: report of 2 cases and review of the literature pituitary autoimmunity in patients with sheehan's syndrome antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas pituitary working group of the german society of endocrinology. treatment of primary hypophysitis in germany novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab rituximab-induced remission of autoimmune hypophysitis and primary immune thrombocytopenia in a patient with autoimmune polyendocrine syndrome type 4 autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab acknowledgments the authors wish to thank dr trevor g cooper, hong kong sar, pr china, for his precious suggestions and advices in editing the paper. conflict of interest the authors declare that they have no conflict of interest. key: cord-331268-kzy33hdb authors: lynch, sharon g.; rose, john w. title: multiple sclerosis date: 1996-01-31 journal: disease-a-month doi: 10.1016/s0011-5029(96)90012-7 sha: doc_id: 331268 cord_uid: kzy33hdb abstract multiple sclerosis is a chronic disease that begins in late adolescence or adulthood. it is highly variable in its expression and severity. it is believed to be autoimmune in nature. the cause is unknown; both genetic and environmental factors have been implicated in the pathogenesis. ms generally presents with the acute or subacute onset of neurologic abnormalities that may wax and wane over many years. diagnosis is generally made by means of observation of the clinical course in conjunction with a neurologic examination and laboratory tests. these tests may include magnetic resonance imaging of the head and spine, lumbar puncture, and evoked potentials. treatment is based on general supportive care, the use of corticosteroids for relapses, and symptomatic management of ongoing problems. the frequency of relapses can be reduced with interferon-β (betaseron). copolymer 1 and interferon-β la are being evaluated by the u.s. food and drug administration for approval for use for reduction in the frequency of relapses in relapsing-remitting ms. treatment of chronic progression is often attempted with immunosuppressive agents such as corticosteroids, azathioprine, and cyclophosphamide. use of other agents is being investigated. multiple sclerosis (ms) is a chronic disease of the central nervous system that typically begins in late adolescence or early adulthood. the cause is unknown, although the disease is believed to be autoimmune in nature. both genetic and environmental factors have been implicated in the pathogenesis of ms. a viral cause has been postulated, but no single virus has been confirmed to be associated with ms. the pathologic features of ms include the presence of demyelinating areas in the white matter of the brain with perivascular in-flammation and relative sparing of the axons. plaques are commonly found in the periventricular areas of the cerebral hemispheres, in the optic nerves, the brainstem, the cerebellum, and the spinal cord. the presence of inflammation in ms plaques and the presence of oligoclonal immunoglobulin bands suggest an autoimmune basis of the disease. characterization of the inflammatory cells in the plaques and in the cerebrospinal fluid has revealed a predominance of t cells. this finding has focused a great deal of attention on the trimolecular complex, which consists of the major histocompatibility complex, the t-cell receptor, and the antigen. consistent associations with dr2, drbl501, dqb602, and the dw2 haplotypes have been identified in white persons. studies of restricted use of specific t-cell receptor regions in the immune process have not revealed a specific receptor in this disease. the antigen remains unknown, although many investigators are working with myelin basic protein and other proteins associated with myelin. two animal models, experimental allergic encephalomyelitis and theiler murine encephalomyelitis, are valuable in testing experimental immunotherapies and other aspects of autoimmune mediated demyelination. ms generally appears with the acute or subacute onset of neurologic abnormalities that may wax and wane over many years. common early symptoms include numbness, double vision, paraparesis, monoparesis, bladder control problems, optic neuritis, ataxia, or tremor. common ongoing symptoms include those just mentioned, vertigo, increasing spasticity, depression, emotional lability, gait abnormalities, fatigue, dysarthria, quadriparesis, constipation, incoordination, fatigue, and pain. diagnosis is made by means of observation of the clinical course in conjunction with the neurologic examination and laboratory tests. magnetic resonance imaging of the head and spine can be valuable in the evaluation of suspected ms. the presence of an elevated immunoglobulin g (igg) index or oligoclonal bands in the spinal fluid also can be helpful. evoked potentials can help confirm subclinical involvement of the eyes, vestibular function, or sensory tracts. the differential diagnosis of ms includes other demyelinating syndromes, particularly the monophasic syndromes, such as postinfectious encephalomyelitis, postinfectious transverse myelitis, and isolated optic neuritis. some infectious diseases, such as lyme disease, syphilis, and htlv-1 myelopathy, can be confused with ms. other autoimmune conditions, such as systemic lupus erythematosus, behcet's syndrome, sarcoidosis, and sjogren's syndrome, can cause symptoms similar to those of ms. some leukodystrophies and hereditary degenerative syndromes can be confused with ms. ms is often classified by its clinical course. benign ms is charac-dm, january terized by mild intermittent relapses with nearly complete resolution. relapsing-remitting ms is the most common form of the disease. it is characterized by episodes of acute or subacute neurologic dysfunction followed by periods of improvement and stabilization. secondary progressive ms begins with a relapsing-remitting course, but the disease gradually worsens, causing slow accumulation of neurologic signs and symptoms. ms that never has a relapsing-remitting course but begins with a slow progression of signs and symptoms is classified as primary progressive ms. treatment of ms is based on the progression of an individual case. general health measures include exercise, physical and occupational therapy, a balanced diet, and aggressive treatment of fever and overheating. treatment of relapses is recommended for moderate to severe relapses. corticosteroids are choice of treatment of relapses. steroids should be used with caution because of the large number of side effects associated with long-term use. the frequency of relapses can be reduced with interferon-i3lb (betaseron). copolymer 1 and interferon43la are being evaluated by the u.s. food and drug administration for approval for use in reduction of the frequency of relapses in relapsing-remitting ms. these drugs soon may be available for clinical use. treatment of chronic progression is often attempted with immunosuppressive agents such as corticosteroids, azathioprine, methotrexate, and cyclophosphamide (cytoxan). other agents under investigation are cladribine and intravenous immunoglobulin. symptomatic treatment of the chronic symptoms of ms is important. treatment of symptoms can help patients remain functional and comfortable even with relatively severe chronic problems. fatigue can be treated with rest breaks during the day, exercise, and energy-conservation techniques. medications that may help are amantadine hydrochloride and pemoline. spasticity is a severe problem that causes contractures, pain, insomnia, and increased fatigue. it can be treated conservatively with physical therapy, particularly stretching exercises. baclofen and diazepam can also be useful and are often used alone or in combination. in patients with severe spasticity, baclofen can be administered with an intrathecal pump. urinary dysfunction is a common problem. a urologist usually is needed to define the type of dysfunction present. a hypertonic, spastic bladder can be treated with anticholinergic agents. a hypotonic bladder may require intermittent or long-term catheterization. detrusor-sphincter dyssynergia may require a combination of anticholinergic agents and intermittent catheterization. urinary retention, which causes frequent bladder infections, may require acidification of the urine or long-term administration of antibiotics. patients with severe retention may require urinary diversion. sexual dysfunction often requires a multidisciplinary approach, including counseling, modification of sexual techniques, medication, or prosthetic devices for men. tremor can be a severe, intractable problem. medications include clonazepam, propranolol, acetazolamide, or diazepam. emotional problems are common in patients with ms. emotional lability may respond to tricyclic antidepressant medications. depression is treated with antidepressant agents and counseling. pain is a prominent concern in many patients with ms. dysesthetic pain can often be managed with tricyclic antidepressants, carbamazepine, phenytoin (dilantin), or valproic acid. musculoskeletal pain is treated with antiinflammatory medications and physical therapy. cognitive dysfunction can be a disabling and distressing component of ms. documentation with neuropsychiatric testing may be helpful in managing these problems. current investigations of ms center on the concept of autoimmunity, possibly mediated by a viral illness. studies designed to define the role of the immune system in ms may be useful. medications designed to reduce a specific autoimmune response and medications that assist in stimulation of remyelination or improvements in quality of life are being developed. over the past few years, great strides have been made in understanding the role of the immune system, in improving diagnostic capabilities, and in managing the problems associated with ms. as this trend continues, we may have more diverse and effective therapies for the management of ms. table 1 . jean martin charcot's description of the clinical and pathologic features of ms is the foundation of our knowledge of the disease.l the historical aspects of ms are reviewed in previous publications. 2s3 we are now entering a new phase of understanding brought about by careful clinical trials and the capability of monitoring the disorder with longitudinal magnetic resonance imaging (mri). in an individual patient, ms can be described by means of clinical observation. current concepts of the clinical courses, their relative frequencies, and mri characteristics of ms are portrayed in table 2 . investigations with mri have changed the concept of ms by demonstrating more evidence of disease activity than is expected from clinical examination. disease activity, as measured with mri, is particularly high among patients with chronic progressive disease. 4 the acute lesions of ms can now be demonstrated with gadolinium-enhanced mri. the initial event is associated with local disruption of the blood-brain barrier (fig. 1) . as the abnormality evolves, increased signal intensity becomes evident on t2-weighted images (figs. 2 and 3). the lesion may grow larger over a few days and then the areas of high signal intensity may begin to recede. over time, the lesions may completely resolve on tzweighted images. with each relapse, which is defined by new or newly enhancing lesions on mr images, the older areas of involvement may be reactivated. reactivation is associated with the development of permanent lesions on mr images. 5 clinical correlation is frequently observed with areas of contrast enhancement or abnormal signal intensity in the cerebellum, brainstem, or spinal cord. abnormalities in the cerebral hemispheres are frequently periventricular in distribution and only occasionally correlate with specific symptoms or signs.6,7 the accumulation of lesions in the frontal lobes is associated with a decline in memory.8 in addition, a change in the number of lesions on cranial mr images correlates with a change in overall clinical status as measured with standard scales.g observations made with mri are having a marked impact on both our basic knowledge of ms and on therapeutic trialsjo mri studies will provide considerable insight into the natural history of the disease and will be an excellent independent variable in future clinical trials. traditionally ms is thought to have a relatively high incidence in the northernmost latitudes of the northern hemisphere.l* this theory is based on the incidence of the disease in scandinavia and the northern united states. a similar association is documented in the southern hemisphere in australia and new zealand. these observations are supplemented by data from m igration studies, which demonstrate a relation between age at m igration and assumption of disease risk for the location. risk is conferred by exposure to an environcertain populations are susceptible to ms, and certain populations are resistant to ms. for example, lapps in scandinavia have a very low incidence of ms, even though they reside predominantly in the far northern latitudes. in north america the disease is infrequent among hutterites and native americans. ms is uncommon in japan. 13 the incidence of the disease in first-degree relatives of patients with ms is 20 times that of the general population,14 suggesting that genetic factors influence disease expression. the results of populatidn-based studies of twins offer evidence that environmental and genetic factors contribute to the development of ms. these investigations show that the concordance in monozygotic twins is greater than 30%. it is less than 5% in dizygotic twinp suggesting that although genetic factors are important, environmental exposure also is important for disease expression. it is now commonly accepted that multiple genes influence autoimmune diseases in both animals and human beings.16 therefore polygenic inheritance is postulated for ms. like other autoimmune diseases, ms is more frequent in women, with a ratio of 2:l. the pathologic features of multiple sclerosis were first described by charcot,l who recognized plaques in.the white matter (scleroses en plaque) during pathologic examination of brain sections. these plaques were demonstrated to lack myelin and to contain perivascular inflammation. these features were established as the pathologic hallmarks of ms. the following discussion centers on the typical findings in ms. comparisons are made between ms and other forms of inflammatory demyelinating disease. the distribution of plaques within the white matter is restricted to the central nervous system (cns). plaques are found frequently in a periventricular distribution in the cerebral hemispheres. some of these plaques may be associated with the distribution of terminal veins.17j8 plaques may occur anywhere within the white matter. when plaques are near the cortex, sparing of the subcortical myelinated fibers is often observed. plaques adjacent to gray matter may at times spread into the gray matter, including the cortex and deeper nuclei. plaques are frequently found in the white matter of the optic nerves, the brainstem, the cerebellum, and the spinal cord. plaques in these locations more frequently correlate with symptoms. within a plaque, axons are frequently preserved. 18 the evolution of a plaque is not known. mri investigations show that the blood-brain barrier is locally disrupted at the onset of symptoms. pathologists disagree as to whether demyelination precedes inflammation or is secondary to inflammation. at present the latter view predominates. in acute plaques, the inflammatory response of lymphocytes, plasma cells, and macrophages is capable of producing or augmenting demyelination by direct and indirect mechanisms. the inflammatory response is predominantly perivenular, with a lesser response at the edges of or within plaques. the macrophages associated with acute plaques characteristically contain myelin fragments or myelin breakdown products.lg lymphocytes may contribute to the pathologic process by means of direct or indirect pathways. direct mechanisms include antibodyand cell-mediated immunity. t-cell-mediated reactivity is favored because most inflammatory cells are t cells. indirect mechanisms include the secretion of lymphokines and cytokines. the ability of molecules such as tumor necrosis factor to damage myelin or oligodendrocytes is the focus of ongoing research.20 cytokines may influence macrophage activation, stimulating the phagocytosis of myelin. in addition, the release of heat shock proteins may result in stimulation of ty6 cells, resulting in increased cytotoxicity. the cns lesions of ms can be classified as early active, active, inactive, early remyelinating, and late remyelinating, according to histologic criteria. the features of these lesions are detailed in table 3 . studies of oligodendrocytes early in the course of ms have demonstrated relative preservation of these cells in some patients,z1,22 and remyelination is possible in these patients. other patients have a striking loss of oligodendrocytes, making remyelination unlikely. these differences may reflect the severity of the injury at a specific site of demyelination, or they may indicate that the pathogenesis of demyelination varies among patients with ms. this may imply that an autoimmune basis for ms has long been suspected because of the inflammation in the cns and the presence of oligoclonal bands in the cerebrospinal fluid (csf). the inflammatory response is primarily lymphocytic and mononuclear.2~3 the predominance of t cells among the lymphocytes has led investigators to evaluate the role of the t-cell receptor and its recognition of antigen combined with major histocompatibility antigens (mhc). this has been named the trimolecular complex.23 the t-cell receptor recognizes antigen in the context of the mhc molecule. in the case of mhc class ii molecules such as drz, the antigen fragments are bound in a cleft, which is presented to the tcell receptor for recognition. with regard to the components of the 18 in the context of the trimolecular complex, it is important to note that ms has been associated with certain mhc or human leukocyte antigen (hla) markers. a consistent observation is the association of dr2, drbl501, dqb602, and the du2 haplotype with ms.31 different hla associations are reported within ethnic groups. the mhc molecules may contribute to genetic susceptibility to the disorder, but they are only one of a number of factors that confer risk for the disease.32j3 the presence of oligoclonal bands in the csf of patients with ms is frequently observed (fig. 4) . these abnormal immunoglobulins are identified in a high percentage of patients with clinically definite ms, and they are present in approximately 60% of patients at the clinical onset of the disease. 34 the oligoclonal bands in ms are of unknown specificity. small percentages may bind to known viral antigens in some patients. consistent binding of these antibodies to specific viral polypeptides or viral oligopeptides with homology to myelin components has yet to be demonstrated. the oligoclonal bands are not specific to ms and can be observed in patients with cns infections such as syphilis, subacute sclerosing panencephalitis, viral encephalitis, or meningitis. 35, 36 if the infection is self-limited, the oligoclonal bands may be a transitory abnormality. in comparison, chronic infections of the cns are associated with persistence of the oligoclonal bands. in these settings, the antibodies that compose the oligoclonal bands have pathogen specificity. oligoclonal bands can be observed in patients with autoimmune diseases such as systemic lupus erythematosus. the probability that an environmental factor is involved in the pathogenesis of ms has stimulated interest in a viral cause. although viral isolates are reported from the cns of patients with ms,37-3g there are no consistent observations. attempts to detect viral nucleic acids by means of in situ hybridization and polymerase chain reaction (pcr) are in progress. these techniques are extremely sensitive and require rigorous controls. careful confirmation of any future viral isolates or viral nucleic acids by multiple laboratories is required. [40] [41] [42] [43] [44] [45] [46] recent studies of tropical spastic paraparesis demonstrate that the retrovirus human t-cell lymphotropic virus type i (htlv-i) is involved in the pathogenesis of this disorder, which shares some clinical features with ms.3ga it is clear, however, that htlv-i is not a pathogen in ms. 40 there remains the possibility that a retrovirus or endogenous retrovirus could contribute to the pathogenesis of ms. there is considerable interest in the possibility that exposure to a virus may lead to an immunopathologic condition that results in ms. of particular note are investigations that demonstrate the potential of molecular mimicry to produce autoimmunity. the term molecular mimicry arises from the demonstration of shared homology between normal human myelin proteins and viral polypeptides. if an immune response is mounted to such a viral epitope, then it may be perpetuated by exposure of the shared region on the normal human protein. in ms, homology between myelin antigens and viral peptides is established. thus this mechanism could result in cns demyelination after viral infection. autoimmunity could also result from superantigenic stimulation of t cells by viral or bacterial proteins. superantigens are capable of binding to specific t-cell receptor proteins, producing nonspecific stimulation of relatively large numbers of t cells, which might cause clonal expansion of t cells reactive to myelin or oligodendrocyte antigens.47s48 animal mqdels of demyelinating disease cns demyelination associated with inflammation is present in animal models of experimental allergic encephalomyelitis (eae) and theiler murine encephalomyelitis (tme). these models provide an opportunity for the investigation of autoimmune and virus-associated disease, respectively. eae is an autoimmune disease of the cns and a model for immunotherapy. a cd4+ t-cell population specific for a myelin antigen, either mbp or proteolipid protein, is required for initiation eae. eae and ms share characteristics that include cns demyelination, perivascular t cells, association with mhc class ii antigens, and possibly restricted tcr v-gene utilization.4g the murine adoptive transfer model has another important feature of ms: the chronic relapsing clinical course.4g this clinical course is useful for investigations of the immune response and immunotherapy not only during onset of the disease but also during relapse. the pathologic features of this murine transfer model are inflammation and prominent demyelination.4g-51 eae is not associated with an environmental factor. the tme model of immune-mediated demyelination is of particular interest because it has important parallels with postinfectious encephalomyelitis and ms. in this model, antecedent mild or even subclinical viral encephalitis is followed by a period of quiescence and the eventual onset of demyelination. 50 the virus is persistent during the demyelinating phase of the disease. this implies that either low-level expression of viral polypeptides or immunologic cross-reactivity between virus and myelin antigens is crucial for initiating demyelination. the demyelination in the tme virus model is mediated by t lymphocytes. these t cells may have viral specificity but produce demyelination. this mechanism would be relevant to ms if the suspected environmental factor were one or several viruses. as in ms and eae, t cells appear to initiate immunemediated demyelination in tme.!~~z~~ experimental immunotherapies are evaluated in these animal models and provide a basis for clinical trials in human beings. examples of these investigational treatments include cytokine transforming growth factor-i3, (tgf131,53 lymphokine-toxin,54 anti-t-cell receptor vb-specific monoclonal antibody,55,56 t-cell vaccination,57 blocking peptides, anti-adhesion molecule specific monoclonal antibodies,5g and nitric oxide synthetase inhibition. 60 these experimental models provide an invaluable resource for the study of immunotherapy. although these experimental models are not likely to mirror the pathogenesis of ms, they are extremely useful in the study of cns inflammation and demyelination. ms is primarily a disease of young adults. most patients report their first symptoms between the ages of 20 and 45 years. the disorder rarely appears before the age of 15 years or after the age of 50 years, although it has been reported to occur in both children and the elderly. the symptoms of ms in children are essentially the same as those in adults; ataxia, numbness, and visual disturbance are the most common presenting symptoms. in elderly persons, a progressive onset is more common. ms is characterized by episodes of neurologic dysfunction, followed by periods of stabilization or remission. symptoms, once they appear, may partially or completely resolve or may be permanent. these episodes tend to develop over hours or days. sometimes the symptoms occur with almost strokelike suddenness, or they may develop slowly over a few weeks. once the symptoms have developed, resolution generally occurs over weeks or months. certain signs and symptoms are more common in the early stages of ms. these include numbness, double vision, monoparesis, paraparesis, bladder control problems, optic neuritis, ataxia, or tremor (table 1) . 22 dm, january 1996 numbness can be difficult to evaluate. numbness that suggests early ms includes an ascending numbness beginning at the feet. this may be a sign of transverse myelitis. hemiparesthesia, bilateral hand numbness, and dysesthesia in both hands, both feet, or on one side of the body, also are early symptoms of ms. the numbness is usually present for days, weeks, or months. many patients describe numbness or paresthesia with no objective abnormalities. if objective sensory abnormalities occur, they are more commonly reduction of vibration, proprioception, or stereognosis rather than pain or fever. the diplopia that occurs with ms is frequently partial or complete internuclear ophthalmoplegia, which is often bilateral. a small percentage of patients have sixth nerve palsy" or, more rarely, third or fourth nerve palsy. ww sometimes monocular diplopia is a symptom of optic neuritis. optic neuritis is usually characterized by monocular blurred vision, sometimes with scotomata and often with alteration of color vision. retroorbital pain or headache is common in patients with active optic neuritis. 63 the pain may intensify with eye movement. motor weakness is usually accompanied by upper motor neuron signs, such as hyperreflexia or the babinski sign. paraparesis is the most common early symptom, but the weakness also can occur as hemiparesis or monoparesis. spas.ticity can be a later manifestation. signs and symptoms that commonly occur as ms progresses include vertigo, tremor, incoordination, increasing spasticity, depression, mood swings, cognitive abnormalities, impotence or other sexual dysfunction, weakness, lhermitte's sign, gait abnormalities, constipation, urinary incontinence, optic nerve pallor, fatigue, quadriparesis, dysarthria, loss of upper extremity coordination, and dysesthetic pain (table 1) . uncommon but important problems include seizures, atypical facial pain or tic douloureux (trigeminal neuralgia), bowel incontinence, swallowing problems, hearing loss, and dystonia. bell's palsy is sometimes seen in patients with ms (table 1) . the classic course of ms is one of intermittent neurologic signs and symptoms over many years. as time progresses, chronic problems accumulate. the amount of total disability varies from patient to patient. after a number of years, a patient's condition may stabilize permanently, but this does not always occur. d&f, january 1996 23 subtypes of disease ms can be divided into subtypes according to the course of the disease. there is a continuum among the various subtypes, and the disease in some patients does not fit into a pattern. benign ms accounts for 10% to 20% of cases and occurs more often in young women. in this type of ms, symptoms are mild and often sensory. resolution of neurologic problems is nearly complete. over the years, these patients rarely experience considerable disability. relapsing-remitting ms is the most common form of the disease. it is characterized by episodes of neurologic dysfunction [variably called exacerbations, relapses, or attacks) followed by periods of improvement and stabilization (called remissions). during a remission, not all symptoms resolve completely. the patient may be left with permanent disabilities, which may vary in severity. the condition of 30% to 50% of patients with an initial relapsingremitting course begins to worsen gradually over time, and neurologic signs and symptoms accumulate. this form of the disease is classified as secondary chronic progressive ms or relapsing-progressive ms. the latter term is also used to describe disease in patients who have sudden deteriorations in a stepwise manner without clinically significant recovery. primaryprogressive ms occurs in 10% to 20% of patients. disease in these patients begins with a slow progression of neurologic deficits with no history of relapse and may also have periods of stabilization or subacute worsening. common problems that appear and gradually worsen with time include spastic paraparesis, cerebellar ataxia, and urinary incontinence. clinical findings although no neurologic findings are pathognomonic for ms, certain abnormalities found during a physical examination can be helpful in providing a clue to the diagnosis of ms. these include internuclear ophthalmoplegia, which is rarely seen in other diseases and is especially rare in young adults. hyperreflexia and the babinski sign are common in early ms. optic nerve pallor can provide a clue to subclinical or resolved optic neuritis. altered color vision in one eye and a marcus-gunn pupil also are signs of optic neuritis. nystagmus is a common finding in patients with ms. many types of nystagmus are identified, including pendular nystagmus, small-amplitude nystagmus, or gaze-evoke nystagmus.63a65a66 absent abdominal reflexes in a slender patient who has not undergone an abdominal operation may be a helpful sign. a mild intention tremor with or without past-pointing is also an early sign, as is a positive romberg sign or difficulty with balance with 24 divz,january 1996 tandem gait. subtle motor weakness or spasticity may also be found. loss of vibratory or proprioceptive sensation in the lower extremities is common early in the course of the disease. ms should be strongly suspected in young or middle-aged adults who describe symptoms consistent with the lhermitte sign in the absence of obvious cervical cord abnormalities. the lhermitte sign consists of paresthesia or an electric shock-like sensation that radiates up the head or down the spine on neck flexion or extension. other important abnormalities are gait disturbances, persistent binocular double vision when looking in a particular direction, or a history of optic neuritis or transverse myelitis. fatigue and depression are not criteria for the diagnosis of ms. no laboratory test is universally diagnostic for ms. certain studies can be helpful in confirming the presence of separation of lesions in space and time. examination of the csf can be valuable for two reasons. first, the pattern of csf findings can help confirm the presence of demyelinating disease. the protein level is often slightly elevated but is rarely greater than 0.1 g/l unless the patient is experiencing a severe exacerbation, particularly optic neuritis or transverse myelitis. a modest elevation in cell count, generally less than 50/mm3, is seen in some patients. the cell pattern usually consists mostly of mononuclear cells. if more sophisticated testing is conducted, most cells can be identified as t lymphocytes. qualitative analysis of proteins can be helpful in suggesting the diagnosis of ms. at electrophoresis oligoclonal immunoglobulin bands can be identified in the csf but not in the serum of many patients with ms 34,67 (fig. 4) . the igg index, a comparison between igg levels in the csf and igg levels in the serum, is elevated in many patients with ms. 68,6g although these findings suggest ms, they also are found in other diseases, most commonly other inflammatory diseases of the cns. these diseases include lyme disease, systemic lupus erythematosus, progressive multifocal leukoencephalopathy, encephalitis, and subacute sclerosing panencephalitis. 35 the ver is abnormal in approximately 70% of patients with ms, regardless of whether there is a history of optic neuritis.70 a slowed ploo in a patient without a history of optic neuritis can be paraclinical evidence of a second lesion and can be used to confirm a diagnosis of ms (fig. 5) .6g the baer is more difficult to interpret than the ver and is abnormal in approximately 30% of patients with ms. in the baer, five 26 d&z, january 1996 consecutive waves are identified; these are numbered i-v the wave interval i-iii is considered the peripheral system. abnormalities in this wave suggest a lesion in the peripheral auditory nerve. the wave interval iii-v is generated from the central hearing areas in the brainstem. slowing in this area suggests a brainstem lesion. abnormalities in waves iii-v are seen in approximately 30% of patients with ms. 70 the sser is a technically more difficult study than the other responses, but it is useful for identification of slowed central conduction in the sensory pathway in the spinal cord and brain. the sser is abnormal in approximately 80% of patients with definite ms. 70 the sser also is useful in the identification of peripheral lesions, suggesting that peripheral neuropathy rather than a central lesion is the cause of numbness. the development of mri has been extremely important in both making the diagnosis of ms and helping researchers understand the dynamics of ms in patients with the disease. mri findings should be interpreted with caution, however. abnormal mri findings alone are not sufficient to confirm a diagnosis of ms without clinical evidence. 71, 72 in patients with ms, patchy areas of abnormal white matter are seen on t%weighted and spin-echo images. these are most commonly found in the cerebral hemispheres in the periventricular areas. in some patients, however, lesions also are identified in the brainstem and cerebellum. mri also helps identify lesions in the cervical and thoracic spinal cord. gadolinium enhancement can be seen around some lesions, particularly if a patient is having an exacerbation or fairly rapid chronic progression. gadolinium enhancement is considered a sign of an active lesion. (table 4 ).76-7g mr images should be interpreted with caution, particularly in patients with chronic illness of any kind or in patients older than 50 years. fazekas et a1.75 attempted to differentiate the mr images of healthy persons older than 50 years from those of patients with ms. they identified the following three criteria for the diagnosis of ms: lesions abutting the lateral ventricles, lesion diameter greater than 0.6 cm, and lesions present in the posterior fossa. if two of the three criteria were met, the specificity for ms was 88% and the sensitivity was 100%. a follow-up study in which 1500 consecutive mris were examined yielded a sensitivity of 81% and a specificity of 96%" these criteria may be useful in the interpretation of mri findings in some patients, but they should be used with caution for patients with other diseases that can affect mri, such as hypertension and diabetes mellitus. patients with those diseases were excluded from the study by fazekas et al. the size and area of the lesions present on mr images correlate poorly with the patient's disability. 4,81 many patients with large lesions on mr images have minor clinical findings, whereas some patients with small lesions have severe disability. one area in which mri may indicate the severity of the problem is in the cognitive status of the patient. an increase in the area of the lesions in the cerebral hemispheres or thinning of the corpus callosum may correlate with poor cognitive function. the presence of lesions in the spinal cord does not correlate with disease severity. a recent study in which body coil imaging was used showed that 74% of patients with ms had lesions in the spinal cord that were identified by this technique. 82 although the presence of lesions and the area and number of lesions did not correlate with a patient's level of disability, the presence of spinal cord atrophy did correlate with greater disability. 82 patients with partial or complete transverse myelitis who subsequently are found to have ms often have lesions on mr images that correspond to the level indicated by symptoms and the level of neurologic findings (simnad v, rose jw, manuscript in preparation). the use of mri for the follow-up evaluation of ms has become an integral part of research into the course of the disease. however, because mri findings do not correlate with a patient's clinical condition, new abnormalities on mr images in the absence of clinical worsening should not be treated as an exacerbation of the disease. new abnormalities can, however, indicate that the disease remains active. mri should be repeated in patients in whom the diagnosis has not been confirmed or in patients who have new symptoms that suggest a second disease. as the choice of treatments of ms increases, monitoring of disease activity may become useful in determining the course of treatment. optic neuritis is often seen as a first demyelinating episode in patients with ms. the diagnosis of ms should be considered in patients with optic neuritis, and a careful history and examination should be performed to exclude other neurologic abnormalities. however, many patients who have a single episode of optic neuritis never have other demyelinating episodes. one study of 60 patientsgo found that ms developed in 74% of women and 34% of men within 15 years of an attack of optic neuritis. transverse myelitis, inflammation of an area of the spinal cord causing ascending weakness and numbness up to the level of the lesion, can also be seen as the initial demyelinating event in ms. 88 other causes include infectious, postinfectious, and postvaccinal demyelination. 81 sometimes the cause is never determined. when transverse myelitis occurs, an imflammatory lesion can be identified on mri images of the cervical or thoracic spinal cord. estimates of the risk of ms after an isolated episode of transverse myelitis range from 50% to 80%.g1-g3 im'z, january 1996 29 the use of the cranial mr images in patients with optic neuritis or transverse myelitis may be helpful in predicting which patients are more likely to have additional problems. one prospective study identified patients with a single demyelinating episode such as optic neuritis or transverse myelitis. patients with abnormal mri findings at the time of the first episode had a 65% risk of a second episode within 5 years. patients with normal mri findings at the time of the first episode had a 5% risk of development of a second lesion in 5 years.g4 a syndrome in which optic neuritis and transverse myelitis develop with no other demyelinating events is called devic's neuromyelitis optica. in this disorder, cranial mri findings remain normal. this is considered a monophasic illness-both abnormalities occur within a year of each other, and patients may never have another demyelinating event. this is a rare syndrome.g5 the following characteristics are associated with a favorable prognosis: (1) female sex, (2) early age at onset, (3) onset of symptoms referable to a single neurologic system, (4) substantial recovery from relapses, (5) early symptoms of numbness rather than corticospinal or cerebellar symptoms. unfavorable prognosis is associated with chronic progressive disease (either primary or secondary), older age at onset, and male sex.g6-g8 dlagnostic criteria because of the difficulties involved in the diagnosis of ms, several criteria have been published to standardize the terms used to describe the certainty of the diagnosis. the two primary sets of criteria are those of poser et a1.6g and shumacher et a1. 83 the poser criteria are more recent and are summarized in table 5 . it is important to remember that no abnormality should be used as a criterion if it can be explained by another medical problem. other conditions may commonly be confused with ms and should be considered in the differential diagnosis. the differential diagnosis depends in part on the clinical and laboratory findings in an individual patient. postinfectious encephalomyelitis is a subacute syndrome, possibly caused by an autoimmune response to a viral infection. patients with this illness experience the acute or subacute onset of confusion, disorientation, gait abnormalities, loss of bowel or bladder control, weakness, or other symptoms. abnormalities in the white matter can be seen with mri, and evidence of inflammation frequently is seen in the cse the patient's condition may or may not return to normal; recovery may take months or even years. 84 lyme disease is a prominent concern and appears to be a cause of intermittent neurologic events, 85 the most common of which is bell's palsy. encephalomyelitis may develop, with vague symptoms of numbness, fatigue, and memory deficit. abnormalities in the white matter may be seen with mri, and csf findings may resemble those in ms, including mild leukocytosis and oligoclonal bands. patients may have a history of a tick bite, a rash, or recent arthralgia. lyme titers or a lyme pcr in the blood or csf may be helpful to these patients. 85 systemic lupus erythematosus is a well-known syndrome that may cause transverse myelitis, strokes, encephalopathy, and optic abnormalities. clues to the differential diagnosis are systemic abnormalities such as hematuria or leukopenia, arthritis, or an elevated antinuclear antibody titer, erythrocyte sedimentation rate, or other blood measurement. sometimes both systemic lupus erythematosus and ms occur in the same patient. primary cns vasculitis can cause a syndrome similar to ms. differentiating features include prominent headaches, confusion, and sudden strokelike episodes. an elevated erythrocyte sedimentation rate may be present in some patients, as may an elevated csf protein level. patients may have an abnormal cerebral angiogram. bi-opsy of the temporal lobe or meninges may be helpful in the diagnosis of this syndrome. 77 the htlv-i, a retrovirus, causes a syndrome known as tropical spastic paraparesis or htlv-i-associated myelopathy. it may cause progressive spastic paraparesis or generalized white matter disease. htlv-i is relatively rare in the united states but is present in some patients who have resided around the caribbean sea. 86 behqet's syndrome can cause mri findings identical to those in ms. cardinal features of behqet's syndrome include oral ulcers, genital ulcers, and uveitis. variable features include involvement of the skin, eyes, joints, lungs, intestines, and heart and venous thrombosis. neuropsychiatric symptoms, including quadriparesis, pseudobulbar palsy, cranial neuropathy, cerebellar ataxia, peripheral neuropathic lesions, or cerebral venous thrombosis may be present.7g,87 sarcoidosis and sjggren's syndrome are autoimmune diseases that may show lesions on mr images that resemble those of ms. meningeal enhancement is a clue to cns sarcoidosis. a chest radiograph may show granulomatous lesions suggestive of systemic sarcoidosis. although igg levels are raised in the csf of patients with cns sarcoidosis, oligoclonal bands are found in some patients. csf angiotensin-converting enzyme determination may be used to further differentiate cns sarcoidosis from ms.78 vitamin b deficiency and syphilis can cause posterior column abnormali& and dementia. tests for these problems should be performed when a patient with these symptoms is seen. certain leukodystrophies may appear in adulthood. these include adrenal leukodystrophy, krabbe's disease, and metachromatic leukodystrophy. mri findings in these diseases show large areas in which no normal white matter is present. female carriers of the adrenal leukodystrophy gene may have an ms-like syndrome.88~8g hereditary degenerative syndromes, such as familial spastic paraparesis, olivopontocerebellar degeneration, and spinocerebellar degeneration, may be confused with ms, particularly with primary progressive ms. in these diseases, mr images may be normal or may show atrophy of the brainstem, spinal cord, or cerebellum. the csf is normal in these patients. studies support the concept that exercise is beneficial for the patients with ms.ggjoo simple measures such as walking, using an exercise bicycle, and swimming may be of considerable value. exercise should be performed in a cool environment whenever possible to prevent heat-associated transient declines in neurologic function. swimming and water aerobics in pools that are not overly heated are particularly valuable, because the patient is cooled while exercising. physical and occupational therapy are often invaluable for maintenance or improvement of neurologic function. bracing disabled portions of limbs, particularly the ankle, provides considerable benefit. exercise regimens tailored to the patient may help to maintain or improve strength, range of motion, and mobility. devices that provide assistance with walking can be important in reducing the risk of falls, allowing for greater independence and increased activity. other assistive devices can be helpful in reducing fatigue and increasing independent activity. careful consultation with a specialist in rehabilitative medicine can assist the patient with management of work and daily activities.l"o it is advisable for persons with ms to maintain a balanced diet. weight control is a prominent concern. overweight patients with motor, sensory, or coordination deficits that impair ambulation are at particular risk of falls, which may result in serious injuries, including fractures. patients who are overweight and whose strength is decreased lose any reserve strength they may have because of their weight. some patients with ms lose weight and require dietary supplementation. patients with dysphagia may require feeding tubes to help prevent aspiration pneumonia. although various diets have been advocated for ms, there are no substantial data from controlled trials to support the assertions. as a general health measure, it is commonly suggested that patients with ms restrict cholesterol and fat in the diet. diets that meet the requirements of the american heart association are likely to be useful, because most patients with ms live into middle age and beyond. pregnancy is a concern among young women with ms. many studies of the effect of pregnancy on ms have been undertaken. an increased risk of exacerbations in the first 3 months postpartum has been reported.lol-la4 however, the risk of exacerbations during pregnancy appears to be unchanged or slightly reduced.lo5 overall longterm disability does not appear to be altered by pregnancy.lo4j05 the increased relapse rate seen during the postpartum period has been postulated to be caused by an increase in immune tolerance during pregnancy, followed by a return to normal in the postpartum dm, january 1996 33 period. it has also been postulated that the relapses are secondary to the decrease in the level of female hormones after parturition.lo*-lo3 in addition to the physical effects of pregnancy, another major concern is the care of an infant or child by a person with physical problems. persons with ms need to consider carefully whether they can handle the additional work of caring for a child. persons with chronic physical problems may need special provisions, such as extra assistance in the home or special equipment. the physician should discuss pregnancy, delivery, and child care with women of childbearing age. increased core temperature, whether due to heat exposure or to a febrile response, may lead to a transient increase in neurologic symptoms.lo6 if the event is due to heat exposure, the patient simply needs to rest in a cool environment and await recovery. if an infection is responsible, the source of the infection should be determined and treated. an antipyretic medication such as acetaminophen can then be administered. many patients with ms are susceptible to urinary tract infections and may not have clinical manifestations of the infection. in some patients this is due to impaired sensory capabilities, and some patients have chronic urinary symptoms that may not change substantially with an infection. one study of ms exacerbations pointed to an association with antecedent infection.lo7 if a patient has persistent worsening after an infection that has been appropriately treated and resolved, steroid therapy should be considered in the event the infection recurs. a relapse is considered to be the onset of new neurologic symptoms or marked worsening of old symptoms lasting longer than 24 hours. certain conditions may mimic an exacerbation and should be ruled out or treated before steroid therapy is considered. these include fever, infection (commonly urinary tract infection or viral illness), overheating, fatigue, severe emotional stress, or the effects of medications such as baclofen, which can increase weakness. if these problems are appropriately treated, the patient's condition usually improves. mild relapses may be best treated without steroid therapy. the symptoms include a mild numbness, mild changes in bladder function, mild optic neuritis (visual acuity better than 20/40), slight increase in spasticity, or a dysesthetic pain syndrome. any new abnormality that does not change a person's ability to perform his or her usual daily activities may not require steroid therapy. in these patients, rest is sometimes helpful. patients with more severe worsen-ing may benefit from steroid therapy. the symptoms include gait disturbances, severe numbness or paresthesia, moderate to severe paresis, moderate or severe optic neuritis, severe vertigo, or marked impairment of eye movement. it is often appropriate for the physician to observe the patient for a few days before making a decision about the use of steroids. standard therapy for many years, immunosuppression with corticotropin (acth) or steroids has been used in the treatment of the exacerbations of ms. the primary effect of these agents is to shorten the duration of an attack, and no benefit has been proven in the overall outcome from an attack. steroids should not be given until an abnormality resolves because this may never occur. acth was the first immunosuppressant to be widely used in ms.lo8 although it is still given to some patients who respond well to the medication, acth has been largely supplanted by other steroids, most commonly prednisone and methylprednisolone. many different regimens have been used. a typical regimen is 80 units by intravenous or intramuscular injection once a day for 10 days. prednisone is commonly used for mild or moderate exacerbations of ms. although low doses do not appear to have any effect on an exacerbation, larger doses do appear to shorten the duration of an ms attack.log there is no standard treatment regimen; a dose of at least 1 mg/kg per day is commonly recommended and should be continued for 7 to 10 days. our regimen is 80 mg once a day by mouth for 10 days, then tapered by 20 mg every 3 days. other regimens range from 10 days to 6 weeks or longer. methylprednisolone with sodium succinate (solu-medrol) is often used in the treatment of severe relapses, or when the patient's condition continues to worsen after several days of high-dose prednisone.'lo typical dosages range from 500 to 1000 mg/day and last from 3 to 14 days. a typical dose is 250 mg in 250 ml of 5% dextrose in water over 45 minutes every 6 hours to a total of 16 doses. another is 500 mg in 250 ml of 5% dextrose in water over 45 minutes every 12 hours for 10 doses. an oral prednisone taper over about 10 days to 2 weeks may be used afterward. one study of optic neuritis suggested that high-dose methylprednisolone produces more favorable results than oral prednisone for patients with poor visual acuity. this study showed only a faster recovery time; follow-up examinations at 1 year did not show any difference in final outcome."l the study involved patients who did not necessarily have a diagnosis of ms. however, a follow-up evaluation with patients in whom ms subsequently developed did suggest that the methylprednisolone-treated group had a longer time interval to the development of a second demyelinating event than dm,january 1996 3.5 those who received prednisone or placebo.l12 for this reason, some neurologists believe that all attacks of ms should be treated with intravenous methylprednisolone. the side effects of steroids are well known. these include nonspecific immunosuppression leading to opportunistic infections, induction of hyperglycemia, fluid retention, hypertension, emotional abnormalities, hypokalemia, peptic ulcers, occasional aseptic necrosis of the femoral head or other bones, and demineralization of bone. chronic use may lead to cataracts, osteoporosis, muscle wasting, hypertension, diabetes, increased susceptibility to infections, and a cushingoid appearance. steroids should be used with caution. we have found the,following precautions helpful: administration of calcium and possibly vitamin d during the administration of steroids and restriction of foods with a high sugar or sodium content. we encourage our patients to eat foods rich in potassium, such as bananas, orange juice, and tomatoes. patients who experience indigestion may benefit from the use of histamine blockers such as ranitidine. some patients may need sedation with diazepam or other agents because of severe mood swings, anxiety, or sleeplessness. patients who receive high doses of methylprednisolone should be observed for hypertension, electrolyte imbalance, and hyperglycemia. these problems should be treated appropriately. occasional psychiatric symptoms, including depression, psychosis, and severe anxiety, may necessitate cessation of steroid therapy. betaseron, a recombinant interferon-& has been approved by the u.s. food and drug administration (fda) for use in ambulatory patients with relapsing-remitting ms. this approval followed a 2year, controlled, double-blind study that showed in patients treated with 8 million units of betaseron administered subcutaneously every other day the relapse rate was reduced to 0.84 relapse per year compared with 1.27 relapses per year in patients given placebo.l13 an mri study performed with the same population revealed fewer new lesions in the treatment group than in the control group.lo the drug did not improve ongoing symptoms. the study was limited to patients with relapsing-remitting disease, and the findings should not be extrapolated to patients with chronic progressive disease. a study of the use of betaseron by patients with chronic progressive ms is planned. patients whose condition is stable would not benefit from the use of betaseron. there are problems with the use of betaseron. although the drug may be helpful in patients with frequent relapses, it does have seri-ous side effects. almost all patients experience local reactions at the site of injection, and some patients have had tissue necrosis at injection sites. the injection site must be changed regularly to reduce the likelihood of ulceration. many patients have a flulike reaction, which may include fever, chills, malaise, and myalgia. this reaction resolves with time and commonly lasts only a few months; however, it may last as long as a year. these symptoms can be partially controlled with acetaminophen or ibuprofen. liver function studies may show abnormalities, and leukopenia may be present. fatigue and emotional disturbances have been reported. our patients have experienced episodes of acute depression and anxiety, and one patient had an episode of uncontrollable rage. depression may necessitate temporary or permanent cessation of betaseron treatment. however, antidepressants, such as fluoxetine, sertraline, and paroxetine hydrochloride, may help counteract the depression. in a few cases, ms appears to worsen when the patient is taking betaseron. acute weakness develops in some patients with the first few injections. this is not always associated with fever and may resolve with time. menstrual irregularities have been reported, and betaseron cannot be used during pregnancy. some patients tolerate the medication better if the full dose is titrated up over approximately 1 month. periodic blood tests to check for leukopenia and abnormal liver function are suggested. clinical trials of other preparations of interferon-a and interferon-13 are nearing completion. one clinical trial involved administration of a weekly intramuscular injection of interferon4la. the results suggested that this drug reduces the likelihood of progression in patients with early disease. 114 a phase iii clinical trial of another investigational agent, copolymer 1, has been completed. this drug appears promising in reducing relapses and has a good safety profile.115j16 these agents will likely be available in the near future, pending fda approval. although most treatment aimed at chronic progression remains experimental, the use of intermittent intravenous methylprednisolone has become a common practice. most commonly, patients who experience subacute worsening may respond to a course of highdose solu-medrol similar to that given for a severe relapse. the condition of some patients appears to stabilize, at least temporarily, with this course of therapy. some patients with progressive disease may respond to a single dose of 1000 mg of solu-medrol in 250 ml of 5% dextrose in water given over 1 hour once a month for 6 to 12 months. subsequent treatments may be given every 6 to 8 weeks. azathioprine has been used for the treatment of chronic progres-sion with some success. studies have shown a modest benefit of azathioprine, primarily in stabilizing the condition of some patients.l17j18 patients who take this drug should be examined for leukopenia or hepatotoxicity. about 15% of patients are unable to tolerate azathioprine because of fever, rash, or nausea. patients with continued progression during therapy with azathioprine or solu-medrol may benefit from combined therapy. cyclosporine was evaluated in a multicenter clinical trial and was found to have modest clinical benefit.llg the prolonged use of cyclosporine in patients with chronic progressive ms was complicated by side effects, principally nephrotoxicity and hypertension. the use of cyclophosphamide in the treatment of chronic progressive ms is controversia1.120-122 the results of clinical trials of this agent in chronic progressive ms are contradictory. the drug may have use in rapidly progressive ms that does not respond to steroid therapy. further investigation with mri and neuropsychological testing and careful clinical assessment should resolve the controversy. a number of promising phase iii clinical trials of therapeutic agents for relapsing-remitting ms are being conducted. for two of these agents, the 2-year placebo-controlled phase has been completed. these are an interferon-& given once a week by intramuscular injection, and copolymer 1. both drugs reduce the frequency of relapses and favorably influence disability. the interferon-l3 is identical to human interferon-8 and differs from betaseron in that it has the sequence of amino acids and glycosylation of human interferon.l14 the results of a review of the safety profile of this drug compared with that of betaseron will be of considerable interest. copolymer 1 appears to have activity similar to that of betaseron with regard to reduction of relapses in ms.l15,116 the side-effect profile appears to be favorable compared with that of betaseron. laboratory investigations demonstrate additive effects of copolymer 1 and interferon-l3 in vitro. because the drugs theoretically act through different mechanisms, combined therapy might be possible. because of the results of a pilot study, oral myelin is being tested in a phase iii clinical trial. lz3 in the pilot trial, the efficacy of the drug was observed in only a subgroup of patients (dr2-negative men). two pilot studies of the use of methotrexate for ms have been performed.124j25 methotrexate in low doses is used for the treatment of rheumatoid arthritis, psoriasis, and crohn's disease. similar therapy may be of benefit to patients with advanced ms.lz5 a phase iii controlled trial and dose response testing will be of considerable interest. methotrexate should be used in clinical settings that allow careful neurologic and laboratory follow-up evaluation. 38 dm, january 1996 cladribine by intravenous administration appears to alter the progression of ms. lz6 the drug has relatively selective toxicity for lymphocytes; however, the side effects can be substantial. additional studies to evaluate dose and route of administration are being initiated. the clinical effects of repeated dosage with this medication also require study. immunoglobulin therapy may be useful in ms; however, controlled trials of intravenous immunoglobulin (ivig) must be completed.lz7 this therapy may be useful in relapsing disease and can be considered for patients with both ms and diabetes. ivig therapy is not necessarily benign and can be responsible for the transmission of viral hepatitis. several clinical trials of monoclonal antibodies are in progress. a number of monoclonal antibodies with specificities for either lymphocytes or adhesion molecules are being subjected to initial trials in human beings. a monoclonal antibody that appears to lower lymphocytes and have an appreciable effect on the lesions of patients with ms as seen on mr images is being studied.lz8 ,%klptomtic therapy one of the most important aspects of the treatment of ms is helping patients manage their ongoing symptoms. because of the chronic nature of the problems associated with ms, medication and adjustments in lifestyle are used to help patients cope with their disabilities. table 6 gives a summary of possible symptomatic treatments. fatigue can be disabling in patients with ms. it is described in different ways by different patients. the classic description of fatigue is increased weakness with exercise or as the day progresses. the patient may walk fairly well in the morning but need a cane or walker by afternoon. other descriptions include sudden attacks of sleepiness or excessive chronic sleepiness, even though the patient has had enough sleep at night.lzg patients who describe fatigue should be questioned closely about their sleep habits and other symptoms of depression. many patients with fatigue may have poor sleep habits or insomnia, which lead to daytime fatigue. depression is a common problem in patients with ms.130 if the fatigue is a product of depression, treatment of the depression should be helpful. fatigue is sometimes managed without medication. patients may respond to one or two brief (15 to 30 minutes) naps during the day. if this is not helpful or not possible, amantadine may be given to help control the problem. the mechanism of action of amantadine is not known, but it is helpful in approximately 40% of patients.lzg side effects, such as dizziness, headaches, nervousness, or edema, may limit the usefulness of the drug. pemoline is a cns stimulant that may be helpful in some patients.131 it should be used in low doses and should generally be given early in the day because it may cause insomnia. anxiety and anorexia are other problems that may occur with this drug. liver function studies should be performed periodically to monitor for hepatotoxicity. fluoxetine (prozac) may be helpful both to increase energy and to treat depression.*32 40 d&z, january 1996 vertigo vertigo can be an intractable and disabling problem. vertigo can occur in sudden spells that last a few minutes, or it can be chronic and last for hours. some physical therapy techniques involve habituation exercises to help with vertigo. medications that may be helpful include meclizine, promethazine hydrochloride, and low-dose diazepam. oscillopsia may occasionally respond to clonazepam or baclofen. vertigo with nausea and vomiting may respond to metoclopramide. spasticity can appear in many different ways. it may be seen at direct examination as a "catch" in the muscles with passive rapid movement of the limbs, or it may cause severe stiffness or rigidity. some patients may have severe spasms of the affected limb, which may be precipitated by movement or occur at night. these are most common in the lower limbs and may be either flexor or extensor spasms. the spasms can be quite painful. primary treatment of spasticity includes physical therapy with stretching exercises, combined with medication. baclofen is the most commonly used drug for spasticity, although its mechanism of action is not known. the dose of baclofen should be low when treatment begins and should be titrated slowly and carefully. patients who take an overdose of baclofen experience weakness. the dose of baclofen is extremely variable-some patients with only moderate spasticity tolerate high doses, whereas others with severe spasticity tolerate only low doses. other limiting side effects include drowsiness, confusion, and nausea. use of baclofen should not be discontinued abruptly but should be tapered over a few weeks.132 *133 diazepam in combination with baclofen may be helpful for patients with severe spasticity or those who cannot tolerate high doses of baclofen but need to control spasticity. diazepam can be used alone for spasticity, but it is not as effective as baclofen.133 diazepam can be particularly helpful for flexor or extensor spasms at night. dantrolene has limited value because of its hepatotoxicity and the weakness that accompanies the muscle-relaxant effect. it may be helpful in intractable cases of spasticity. the baclofen pump was developed for use in patients with intractable spasticity. 134 this device is an intrathecal pump with a subcutaneous reservoir of baclofen that administers continuous doses of baclofen directly into the spinal canal. this method of administration can be effective. with the lower dose delivered directly to the spinal cord, patients seem to have fewer side effects than with other routes of administration. dose levels can be programmed to change throughout the day, so patients with problems that are worse during the night or another part of the day can take increased doses of the drug during those times. tizanidine is an agent used outside the united states for spasticity. 135 it is being studied in the united states and may become available in the near future. other agents that may be useful in the treatment of spasticity include carbamazepine, phenytoin sodium, methocarbamol, and cyclobenzaprine hydrochloride. clonidine patches may be used for adjunctive therapy in patients with persisting spasms who are taking other drugs. spastic dysarthria is an uncommon symptom in ms. speech is hesitant and stuttering, and breath control is difficult. baclofen sometimes is helpful in this condition. bladder dysfunction is an extremely common problem in ms. examination of postvoid residual urine volume and urodynamic testing are extremely important in delineating the causes of bladder dysfunction. other urologic examinations, such as cystoscopy, may help eliminate mechanical problems as the cause of urinary dysfunction. consultation with a urologist skilled in the evaluation of neurologic dysfunction of the bladder is essential to the best therapeutic outcome. the most common problem is a spastic bladder. this is a small, hyperactive bladder. symptoms of this type of bladder dysfunction are urgency, increased frequency, and incontinence in which the bladder empties completely with brief warning. this condition can be treated with anticholinergic agents such as oxybutynin or propantheline .136j37 sometimes baclofen or amitriptyline can be of use in the control of this problem (table 7) . detrusor-external sphincter dyssynergia is a common problem. in this syndrome, the bladder attempts to empty, but the urethra remains closed. symptoms may be urgency and hesitancy, double voiding, and increased frequency with a feeling of incomplete emptying. anticholinergic or tricyclic agents alone may be of help with this syndrome, but more commonly a combination of anticholinergic drugs and intermittent catheterization is needed to control the problem. 137 the patient performs self-catheterization two to four times a day. a flaccid bladder is less common than the other types of bladder dysfunction. this is an enlarged bladder that empties poorly. symptoms include hesitancy, double voiding, a feeling of incomplete emptying, and dribbling incontinence. untreated urinary retention can result in hydronephrosis. urecholine can be of use in a few patients. frequently, however, a schedule of intermittent selfcatheterization may be needed (table 7) . patients with flaccid bladder or sphincter dyssynergia may have frequent urinary tract infections. acidifying agents such as hippuric acid or vitamin c may be useful in the prevention of infections.136 longterm administration of antibiotics should be avoided to reduce the risk z patients with severe bladder problems that are unresponsive to noninvasive therapy may require a chronic indwelling catheter or urinary diversion. these techniques may be required by patients who cannot perform intermittent self-catheterization. sexual dysfunction is common in both men and women with ms. women often report decreased sensation, lack of vaginal lubrication, difficulty achieving orgasm, or painful muscle spasms in the legs or pelvis during intercourse. men report diminished sensation and difficulty in achieving or maintaining an erection or experiencing orgasm. there is no simple answer to the sexual problems that occur with ms. a multidisciplinary approach is needed in which the physical and psychological aspects of sexual problems are considered. for women, treatment of muscle spasms with medications for spasticity may allow intercourse with less pain. techniques to increase vaginal and clitoral stimulation may help women experience orgasm. other methods of increasing arousal may be helpful. men are interviewed to determine whether there are other causes of erectile dysfunction. medications that may affect erectile function should be eliminated if possible. yohimbine, an a-2-adrenergic receptor antagonist, can sometimes help restore function in a patient with borderline function .138 other methods, including papaverine or phentolamine injections, a vacuum erectile device, or a penile prosthesis, may be considered.137 inappropriate affect can be a problem in patients with ms. many patients have severe mood swings that can affect both their work and their social relationships. low-dose amitriptyline or another tricyclic antidepressant is frequently helpful in controlling mood swings.13g depression is a common problem in ms.130j32,140 the suicide rate among persons with ms is estimated to be 7.5 times that of the healthy population. 130 whether the depression is a primary symptom of ms or a situational problem is not known. physicians should be alert to the possibility of depression in their patients. full-dose antidepressant medications and psychological counseling may be beneficial. tremor can be a limiting factor in many patients with ms. treatment with medications is frequently unsuccessful. agents that may be useful include clonazepam, acetazolamide, propranolol, primidone, and diazepam. 132 isoniazid has been reported to be helpful in some patients. 141 we have found clonazepam to be the most helpful of these agents in our patients, but treatment may be limited by drowsiness. a common misconception is that pain is not a symptom in patients with ms. the truth is that pain is often a problem and may be a prominent concern for patients with ms.142 this can be a primary factor in the disease, or it can be a consequence of disability associated with the disease. much of the pain reported with ms is musculoskeletal and is related to abnormal use of muscles and joints. for example, patients who use a wheelchair may experience wrist, shoulder, or elbow pain from manipulating the wheelchair. patients with paraparesis or ataxia may experience back or leg pain from poor posture and balance when walking. these problems should be treated with antiinflammatory medications and physical therapy. primary ms pain is often dysesthetic.14z the patient describes a burning sensation or perhaps even electric shock-like pain. this pain can be in any location, but it is most commonly in the lower extremities. some patients experience tic douloureux or atypical facial pain. this primary pain may be controlled with tricyclic antidepressants, phenytoin, or carbamazepine.142 in patients with refractory pain, valproic acid can be tried. 13z headaches can become a problem in patients with ms. it is not known whether these headaches are caused by ms or are a separate problem. both tension and migraine headaches are common, and treatment is similar to the treatment of headaches in patients who do not have ms. retro-orbital pain is frequently observed in patients with optic neuritis. these patients may require steroid therapy. spasticity and muscle spasms can cause severe pain. treatment of the spasticity helps the pain. many patients with ms experience cognitive abnormalities. unlike the dementia of alzheimer's disease, the cognitive deficits seem to be more scattered and tend to be retrieval deficits rather than memory loss. 143 patients can have substantial cognitive difficulties but still have normal mini-mental state examination findings. neuropsychological studies have shown that as many as 40% of patients may have some cognitive difficulties.143 these difficulties can be important in terms of disability and ability to cope with illness. only a minority of patients have severe cognitive abnormalities. mr images in patients with cognitive problems tend to show a larger number and size of lesions in the white matter of the cerebral hemispheres. frontal lesions are more common in patients with cognitive difficulties.* the corpus callosum may be thinner than normal, as seen on sagittal images.8 patients with cognitive problems should undergo careful neuropsychiatric testing. sometimes depression or anxiety can be contributing factors in these symptoms. the minnesota multiphasic personality index or the beck depression scale in conjunction with cognitive testing may be helpful in differentiating emotional problems from structural cognitive deficits. proper treatment of the anxiety or depression may lead to improved cognitive function. recognition of the areas and degree of cognitive difficulty in patients with ms may be helpful in the care of the patients. patients may be able to learn ways of working around a problem. problems with a job may be related to cognitive problems, and ways of altering the job may be found. patients may become disabled from working because of these problems. this testing also may help the family understand the need for helping the patient deal with problems that have become too difficult to handle alone. cognitive rehabilitation techniques are being tested for patients with ms in some centers. further investigation is needed to evaluate the efficacy of these techniques. careful assessment of the patient's abilities and disabilities is crucial for proper management. in many patients, chronic symptoms cannot be prevented. symptomatic therapies are often effective for alleviating the afflictions produced by ms and for allowing the patients to live a productive and comfortable life. the cause of ms is unknown. theories revolve around the idea that the disease is either autoimmune or virus-mediated. it is still reasonable to question which pathologic feature is the inciting event. much research is focused on the t cell and potential mechanisms by which these cells could initiate ms. hla associations are found in many populations; however, hla markers are neither necessary nor sufficient to confer disease susceptibility, and other factors that confer disease susceptibility are being sought. at this time there is no confirmed evidence of a viral cause of ms. investigations with in situ hybridization and pcr technology are being conducted in an attempt to identify viral nucleic acids in the cns. perhaps these techniques will assist in unraveling the pathogenesis of ms. an intriguing possibility is that molecular mimicry may be re-sponsible for the initial generation of autoreactive lymphocytes. this mechanism involves exposure to viral or bacterial antigens, which generates an immunologic response that consists of reactive t-cell populations. because t cells cross-react with myelin peptides, a potential for demyelination exists. this theoretic mechanism is known to cause demyelination in rabbits. 144 an interesting investigation of human mbp-reactive t cells demonstrates that mbp-specific t-cell clones can recognize multiple viral polypeptides presented by dr2 or dql mhc antigens. 145 this would imply that ms could be generated by exposure to any one of a number of antigenic stimuli, such as influenza viruses or herpesviruses or even bacterial antigens. selected activated t-cell populations that enter the cns could then recognize a myelin epitope and initiate the autoimmune response, which would persist long after the inciting infection was cleared. recent investigation with mr spectroscopy demonstrates that white matter outside ms plaques may be abnorma1.14" these findings may signify that there is a fundamental abnormality in the white matter. whether these findings are secondary to genetic, biochemical, autoimmune, or viral factors remains to be determined. despite the deficiencies in our understanding of disease pathogenesis, therapy for ms has advanced. phase iii clinical trials with interferon-8 and copolymer 1 have demonstrated modest but definite benefit. the mechanisms by which these drugs favorably influence the clinical course of ms remain to be elucidated. recent studies of chemotherapeutic agents suggest that control of chronic progressive disease may be a real possibility. future clinical trials will attempt to define the efficacy of and parameters for these therapies. another question that remains unanswered is whether the use of multiple-drug therapy might be beneficial in the treatment of ms. for example, combined therapy with interferon-i3lb and copolymer 1 may produce more benefit than either drug alone. in chronic progressive disease, the use of solu-medrol in combination with another immunosuppressant such as azathioprine or methotrexate also should be explored. remyelination is another topic of interest for future research. research is being conducted into the use of ivig as a remyelinating agent. in addition, oligodendrocyte transplant experiments are being conducted in canine modes and may eventually be used for human patients. research involving medications to improve the symptoms that limit the lives of many patients with ms is ongoing and should continue. 4-amino-pyridine and 2,3-diamino-pyridine are being studied as agents that may improve conduction through poorly myelinated areas. these agents may reduce double vision, improve strength, and possibly reduce tremor. more research is needed to evaluate these dm,january 1996 47 and other compounds that may improve the quality of life of many patients with ms. although the cause of ms remains a mystery, important advances have been made in the understanding and treatment of ms in the past few years. as this trend continues, we may have more diverse and effective therapies to offer patients with ms in the years to come. lectures on the diseases of the nervous system multiple sclerosis multiple sclerosis benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features neuroimaging in multiple sclerosis acute vith cranial nerve dysfunction in multiple sclerosis genetic epidemiology of multiple sclerosis: a survey genetics of multiple sclerosis a population-based study of multiple sclerosis in twins: update genetic analysis of autoimmune type i diabetes mellitus in mice demyelinating diseases oligodendrocytes in the early course of multiple sclerosis allen iv pathology of multiple sclerosis tumor necrosis factor identified in multiple sclerosis brain histopathology and the bloodcerebrospinal fluid barrier in multiple sclerosis multiple sclerosis: oligodendroglia survival and proliferation in an active established lesion isolation of myelin basic proteinreactive t-cell lines from normal human blood assessment of antigenic determinants for the human t cell response against myelin basic protein using overlapping synthetic peptides heterogeneity of the t-cell receptor beta gene rearrangements generated in myelin basic proteinspecific t-cell clones isolated from a patient with multiple sclerosis a myelin basic protein peptide is recognized by cytotoxic t cells in the context of four hla-dr types associated with multiple sclerosis t and b cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid multiple sclerosis is associated with genes within or close to the hla-dr-dq subregion on a normal dr15, dq6, du2 haplotype the molecular and genetic basis of neurological disease linkage strategies for genetically complex traits. part 1. multilocus models multiple sclerosis: diagnostic usefulness of cerebrospinal fluid immunoglobulin abnormalities in the guillain-barre syndrome relationship between measles virus-specific antibody activities and oligoclonal igg in the central nervous system of patients with subacute sclerosing panencephalitis and multiple sclerosis multiple sclerosis: relationship to a retrovirus? multiple sclerosis and human tcell lymphotrophic retroviruses amplification and molecular cloning of htlv-i sequences from dna of multiple sclerosis patients htlv1 and tropical spastic paraparesis the g and brahic m analysis of human tlymphotrophic virus sequences in multiple sclerosis tissue serologic studies of ms patients, controls, and patients with other neurologic diseases: antibodies to htlv i human t lymphotrophic virus type i may not be associated with multiple sclerosis in japan detection of human t-cell lymphoma virus type i dna and antigen in spinal fluid and blood of patients with chronic progressive myelopathy detection of coronavirus rna and antigen in multiple sclerosis brain bacterial toxin superantigens activate human t lymphocytes reactive with myelin autoantigens v-beta specific stimulation of human t cells by staphylococcal toxins the t lymphocyte in experimental allergic encephalomyelitis adoptive transfer of myelin basic proteinsensitized t cells produces chronic relapsing demyelination disease in mice adoptive transfer of experimental allergic encephalomyelitis in sjl/j mice after in vitro activation of lymph node cells by myelin basic protein: requirement for lyt-1+2-t lymphocytes pathogenesis of theiler's murine encephalomyelitis virus cellular immunity in chronic theiler's virus central nervous system infection characterization of theiler's murine encephalomyelitis virus (tmev)-specific delayed hypersensitivity response in tmev-induced demyelinating disease, correlation with clinical signs prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1 chimeric cytotoxin il2-pe40 inhibits relapsing experimental allergic encephalomyelitis limited heterogeneity of tcell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention experimental allergic encephalomyelitis by t cell receptor v-beta-specific antibodies immunization with a synthetic t-cell receptor v-region peptide protects against experimental autoimmune encephalomyelitis prevention of experimental encephalomyelitis with peptides that block interaction of t cells with mhc proteins prevention of experimental autoimmune encephalomyelitis by antibodies against alpha, beta, integrin aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in sjl mice isolated pupil-sparing third nerve palsy as the presenting sign of multiple sclerosis the ocular manifestations of multiple sclerosis. part 2. abnormalities of eye movements optic neuritis and ischemic optic neuropathy: overlapping clinical profiles mcalpine's multiple sclerosis nystagmus in multiple sclerosis acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report formulas for the quantitation of intrathecal igg production: their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis new diagnostic criteria for multiple sclerosis: guidelines for research protocols trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of multiple sclerosis contribution of mri to the diagnosis of multiple sclerosis national multiple sclerosis society working group on neuroimaging for the medical advisory board the role of i\tmr imaging in the assessment of ms and isolated neurological lesions fazekas e magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates criteria for an increased specificity of mri interpretation in elderly subjects with suspected multiple sclerosis nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals mri brain scanning in patients with vasculitis: differentiation from multiple sclerosis magnetic resonance imaging in central nervous system sarcoidosis mri findings in neuro-behcet's disease assessment of mri criteria for a diagnosis of ms patterns of disease activity in multiple sclerosis: a clinical and magnetic resonance imaging study spinal cord mri using multi-array coils and fast spin-echo. part 2. findings in multiple sclerosis problems of experimental trials of therapy in multiple sclerosis: report by the panel on evaluation of experimental trials of therapy in multiple sclerosis influenza1 encephalopathy and post-influenza1 encephalitis lyme disease: recommendations for diagnosis and treatment human t-lymphocyte virus type i antibodies in the serum of patients with tropical spastic paraparesis in the seychelles the diagnosis of childhood neurodegenerative disorders presenting as dementia in adults textbook of child neurology risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events long-term follow-up of acute partial transverse myelopathy early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord prognostic significance of brain mri at presentation with a clinically isolated syndrome suggestive of ms: a five-year follow-up study neuromyelitis optica and schilder's myelinoclastic diffuse sclerosis prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up multiple sclerosis: early prognostic guidelines studies on the natural history of multiple sclerosis: eight early prognostic features of the later course of the illness cardiovascular testing and exercise prescription in multiple sclerosis patients multiple sclerosis. part 1. common physical disabilities and rehabilitation multiple sclerosis andgestation pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients pregnancy and multiple sclerosis: a prospective study pregnancy and multiple sclerosis the effect of pregnancy in multiple sclerosis the effects of induced hyperthermia on patients with multiple sclerosis clinical viral infections and multiple sclerosis multiple sclerosis: treatment of acute exacerbations with corticotropin (acth) use of oral corticosteroids in the treatment of multiple sclerosis: a double-blind study a double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: part 1. clinical effects a randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis the effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis ifnb multiple sclerosis study group. interferon beta-lb is effective in relapsing-remitting multiple sclerosis results of a phase iii trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis experimental therapy of relapsing-remitting multiple sclerosis with copolymer-l clinical experience with cop-l in multiple sclerosis clinical experience with azathioprine: the pros azathioprine in multiple sclerosis: the cons efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of highdose intravenous cyclophosphamide, plasma exchange, and acth experience with cyclophosphamide in multiple sclerosis: the cons intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the northeast cooperative multiple sclerosis treatment group double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis meydrech ee low dose oral methotrexate treatment of multiple sclerosis: a pilot study low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis cladribine in treatment of chronic progressive multiple sclerosis open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis amantadine therapy for fatigue in multiple sclerosis depression and multiple sclerosis a double-blind, randomized crossover trial of pemoline in fatigue associated with multiple sclerosis new advances in symptom management in multiple sclerosis antispasticity drugs: mechanisms of action intrathecal baclofen for spasticity of spinal origin: seven years of experience safety and efficacy of tizanidine in therapy of spasticity secondary to multiple sclerosis management of bladder dysfunction in multiple sclerosis urological and sexual problems in multiple sclerosis the role of yohimbine for the treatment of erectile impotence treatment of pathologic laughing and weeping with amitriptyline suicide in the medical patient a controlled trial of isoniazid therapy for action tremor in multiple sclerosis pain syndromes in multiple sclerosis fujinami rs, oldstone mba. amino acid homology between the encephalitogenic site of myelin basic protein and virus: a mechanism for autoimmunity molecular mimicry in t cell-mediated autoimmunity: viral peptides activate human t cell clones specific for myelin basic protein fdg-pet, mri and nmr spectroscopy of normal appearing white matter (nawm) in multiple sclerosis key: cord-022594-fx044gcd authors: pirko, istvan; noseworthy, john h. title: demyelinating disorders of the central nervous system date: 2009-05-18 journal: textbook of clinical neurology doi: 10.1016/b978-141603618-0.10048-7 sha: doc_id: 22594 cord_uid: fx044gcd nan demyelinating disorders of the central nervous system istvan pirko and john h. noseworthy multiple sclerosis (ms) is now known to be a common malady even though it was first recognized as a distinct clinicopathological entity less than 150 years ago. 1 the lack of clear medical reports before the early 1800s is sometimes interpreted as evidence that ms is a relatively new disease. however, it is more likely that the evolution of medicine into science led to more precise observation and description of human diseases, including ms. saint lidwina of schiedam (1380-1433) developed a relapsing neurological disorder at the age of 18 and may be the first case of clinically described ms. 2 ollivier was the first to report a clinical case in the medical literature in 1824. 1 shortly thereafter, carswell illustrated a case of what is now clearly recognizable as ms in his atlas of anatomical pathology. cruveilhier published gross pathological and clinical descriptions of ms. vulpian first suggested the rubric of "sclerose en plaque" in 1866. charcot was primarily responsible for establishing ms as a unique and recognizable syndrome. 3 he also described the clinical spectrum and the histological appearance. pierre marie was the first to suggest an infectious cause of ms in 1884, a hypothesis that is still debated. toxins were also considered to be responsible in the early 1900s. a major advance toward the understanding of demyelinating diseases was the discovery of experimental allergic encephalomyelitis (eae) by rivers in 1935. 4 a variety of different demyelinating diseases have subsequently been described (table 48 -1). myelin provides insulation for axons and is necessary for saltatory conduction. it is composed of tightly wrapped lipid bilayers with specialized protein constituents. peripheral nervous system (pns) myelin is formed by the extension of schwann cells, and central nervous system (cns) myelin is produced by oligodendrocytes. the myelin coating is interrupted at regular intervals (nodes of ranvier) where the axon membrane with its concentration of voltagegated sodium channels is exposed to the extracellular environment ( fig. 48-1) . 5 the presence of myelin is essential to maintain conduction velocity; its loss or damage can lead to significantly slower conduction or conduction block. other factors affect conduction velocity including certain antibodies and chemicals like nitric oxide. in certain cases, blockade may be the initial event in the cascade of events leading to demyelination. cns and pns myelin differ in a number of important ways. schwann cells myelinate only one internodal segment from a single pns axon, whereas oligodendrocytes myelinate multiple cns axons. the proteins also differ. proteolipid protein (plp) accounts for approximately 50% of the cns myelin proteins. mutations in this highly conserved protein cause pelizaeus-merzbacher disease. protein zero is the major pns myelin protein and performs a function similar to plp in compacting the intraperiod line. myelin basic protein (mbp) makes up 30% of cns and 10% of pns myelin proteins. mbp is not an integral protein but binds to the cytoplasmic surface and is responsible for compaction at the major dense line. myelin associate glycoprotein accounts for about 1% of both peripheral and central myelin. myelin oligodendrocyte glycoprotein and cyclic nucleotide phosphodiesterase are minor constituents of cns myelin and are not found in the pns. peripheral myelin protein 22 is a minor component of pns myelin. ms is an inflammatory relapsing or progressive disorder of cns white matter and is a major cause of disability in young adults. pathologically, it is characterized by multifocal areas of demyelination, loss of oligodendrocytes, and astrogliosis but with relative preservation of axons. while demyelination is the classic hallmark of ms, axonal and neuronal injury are important aspects of the disease and are gaining more recognition. although certain clinical features are characteristic of ms, investigative studies are often needed to confirm the clinical suspicion and exclude other possibilities. recently, there have been advances in understanding the etiology, mechanisms of myelin injury, and potential for repair, and several partially effective agents are now approved for use in relapsing-remitting and secondary progressive ms. the pathogenesis and pathophysiology of ms remains incompletely understood. several mechanisms may be important to ms plaque formation: autoimmunity, infection, bystander demyelination, and heredity. although convincing proof is lacking, dietary factors and toxin exposure have been hypothesized to contribute as well. these mechanisms are not mutually exclusive, and the true pathophysiology is likely to depend on more than one of them. autoimmunity. during ontogenesis, autoreactive lymphocytes normally undergo clonal depletion, but some escape and are merely suppressed, becoming tolerant to their antigens. low levels of autoreactive t and b cells persist even in normal individuals. autoimmune disorders occur when the tolerance of these cells toward their antigen is broken. the decreased suppressor activity of circulating lymphocytes from patients with ms and other presumed autoimmune diseases may reflect loss of tolerance. 6 one potential mechanism that may break tolerance is molecular mimicry between self and foreign antigens. autoreactive t4 lymphocytes may become activated on exposure to structurally similar foreign antigens. some evidence suggests that molecular mimicry is relevant in ms. not only do several viral and bacterial peptides share structural similarities with mbp, but it has also been demonstrated that these antigens may activate mbp-specific t-cell clones derived from ms patients. 7 blood-brain barrier leakage alone may break tolerance because it gives cnsreactive lymphocytes easy access to otherwise inaccessible antigens. alternatively, a primary event such as an infection or injury may release cns antigens into the periphery, where they may activate corresponding autoreactive cells. 8 the major support for autoimmunity in the pathogenesis and pathophysiology of ms is by analogy to eae, the major animal model for ms. eae is, however, an artificial situation and there is no spontaneous autoimmune animal model of ms. while eae is the most commonly studied model of ms, several features of human ms can not be adequately captured by this model. 9, 10 over a hundred different effective treatments have been described for eae; however, almost all of them are ineffective and some are harmful in human ms. a recent editorial discusses the merits and important limitations of eae as a model for ms. 10 in eae, just like in classic human autoimmune diseases such as systemic lupus erythematosus (sle) or rheumatoid arthritis, the main target antigens are known. however, despite the discovery of several "weak" antigens in human ms, no dominant antigens have been identified to date. the only human demyelinating disease with an identified specific antigen is devic's disease (neuromyelitis optica), which appears to be a novel autoimmune chanellopathy with an antigen that is neither neuronal nor myelin related (see later discussion of devic's syndrome under neuromyelitis optica). 11 infection. the role of viral infections in the initiation and maintenance of ms has been debated for some time. several viral infections are known to cause demyelination in animals, including visna virus of goats and sheep, canine distemper virus, and theiler's murine encephalomyelitis virus. viral infections in humans can also cause demyelination (progressive multifocal leukoencephalopathy [jc papillomavirus], subacute sclerosing panencephalitis [measles virus], and human t-cell lymphotropic or leukemia virus type 1 [htlv-1]-associated myelopathy). the epidemiology of ms suggests that environmental factors may promote the disease state, possibly due to one or more viruses. a virus may be involved in the pathogenesis of ms in several ways: 1. transient or persistent infection outside the cns may activate autoreactive t cells by means of molecular mimicry or by other nonspecific means (as superantigens do). 2. transient cns infection may initiate a cascade of events that fosters autoimmunity (breach the blood-brain barrier, release cns antigens). 3. recurrent cns infections may precipitate repeated inflammation and demyelination. 4. persistent cns viral infection could either incite inflammatory reactions detrimental to oligodendrocytes or directly injure them. beyond speculation and epidemiological observations, there is insufficient evidence for a viral infection playing a causative role in ms. early serological studies are difficult to interpret because of nonspecific immune activation and resulting elevation of titers to many different viruses. many ms patients have elevated cerebrospinal fluid (csf) titers to measles and herpes simplex (hsv) viruses, but this finding appears nonspecific. virus has rarely been cultured from csf of ms patients, but a new strain of hsv (the ms strain) and a new virus (inoue-melnick virus) were first isolated from the csf of ms patients. 12, 13 newer molecular techniques to search for a viral genome in csf and brain have rejected the claim that htlv-1 is associated with ms. the finding that human herpesvirus 6 (hhv6), although present in 70% of brains from both control subjects and ms patients, is localized to the oligodendrocyte nuclei near plaques of ms patients and to oligodendrocyte cytoplasm in control subjects indicates that persistent cns viral infection is common. 14 this raises the possibility that ms may depend on an aberrant host response to this normal condition or that a defective virus that lacks the ability to evade immune detection may be to blame. more recently, measles and canine distemper virus antibodies were found elevated in blood and csf samples of ms patients, although their relationship is not clear to the disease process. in a study from denmark, patients with serological markers for late-stage epstein-barr virus (ebv) infection had a threefold increase in the likelihood of developing ms. a follow-up study from sweden failed to reach this conclusion. in general, serum samples of ms patients may contain higher titers of antibodies to the following infectious organisms: adenovirus, canine distemper virus, hsv, hhv6, and influenza, measles, mumps, parainfluenza, rubella, vaccinia, and varicella zoster virus (vzv). similarly, csf samples from ms patients may show higher titers of adenovirus; chlamydia pneumoniae; cytomegalovirus (cmv); ebv; hhv6; coronavirus; influenza viruses a and b; measles or mumps virus; mycoplasma pneumoniae; parainfluenza viruses 1, 2, and 3; respiratory syncytial virus; rubella virus; vaccinia; and vzv. there has been an interest recently in a potential link between c. pneumoniae infection and the development of ms. no direct cause-and-effect relationship has been observed between any of these infections and ms. "bystander" demyelination. immune actions may mediate myelin injury in a nonspecific manner. many soluble products of the immune response other than immunoglobulins are known or suspected to be toxic to myelin and oligodendrocytes. activated complement is capable of lysing oligodendrocytes in an antibody-independent fashion. 15 the proinflammatory cytokine tumor necrosis factor-a causes myelin disruption and oligodendrocyte apoptosis in vitro. 16 arachidonic acid metabolites may also participate in myelinolysis, and reactive oxygen species released by macrophages cause lipid peroxidation that can damage myelin. other soluble substances that are potentially toxic to myelin include nitric oxide and vasoactive amines. histological subtypes of ms lesion development. through the groundbreaking work of lucchinetti and associates in the ms lesion project, it is postulated that the formation of ms lesions follows one of four patterns. 17 patterns i and ii are related to immune-mediated damage to myelin sheaths. in pattern i, cellular mechanisms of injury seem to prevail (macrophages and t-lymphocytes) whereas in pattern ii humoral mechanisms of injury predominate (e.g., antibody and complement-mediated mechanisms). patterns iii and iv are related to oligondendrocye pathology: in pattern iii, a distal oligdendrogliopathy and apoptosis have been reported, whereas in pattern iv, primary oligodendrogliopathy and degeneration of oligodendrocytes have been described. currently these subtypes can be diagnosed only by biopsy; serum and magnetic resonance imaging (mri) markers are not yet known, although lesional t2 hypointense rims and response to plasma exchange may correlate well with pattern ii pathology. it is important to note that the patterns do not correlate with clinical subtypes of ms, with the exception of pattern iv, which has been identified only in primary progressive (ppms) patients. evidence to date suggests that the pattern of lesion formation remains the same within an individual patient; patients do not "switch" from one pattern to the other. also, the patterns do not seem to represent different chronological stages of lesion formation. gray matter involvement. it has been known since the late 19th century that ms affects both gray and white matter structures. the importance of gray matter involvement has received little attention until recently, largely due to the development of advanced mri techniques (see later) that indicate neuronal and axonal involvement even in the earliest stages of this disease. a classification system of gray matter plaques was proposed by peterson and associates 18 they described three patterns of cortical demyelination: type i lesions are contiguous with subcortical white matter lesions; type ii lesions are confined to the cortex, and are often perivascular; type iii lesions extend from the pial surface to cortical layer 3 or 4. besides cortical gray matter involvement, there is also evidence for prominent basal ganglia involvement, which can be seen in the early stages of ms, and may correlate better with motor outcome and cognitive measures than measures of white matter involvement. lucchinetti and associates demonstrated that biopsy samples from newly diagnosed demyelinating cases contain numerous infiltrating immune cells, and can be destructive. the pathological classification of cortical lesions as described by petersen can also be found in these early ms biopsy samples. approximately 20% of biopsy cases in which gray matter was also sampled had evidence of clear cortical demyelination. in 2005, an extensive histological study by kutzelnigg and associates investigated the role of cortical demyelination in all clinical subtypes of ms. 19 in this study, 52 brains of ms patients (relapsing-remitting [rr], secondary progressive [sp], and ppms) and 30 control subjects were studied using advanced quantitative morphological techniques. cortical demyelination and diffuse axonal injury in the normal appearing white matter (nawm) were reported as hallmarks of progressive forms of ms. cortical demyelination was mainly seen in the subpial layer of cortex, and was associated with significant inflammatory infiltrates in the surrounding meninges. diffuse inflammation was also found throughout the white matter of the progressive cases, associated with activation of microglia. no significant correlation was shown between focal white matter lesion load and cortical demyelination. this study defines three crucially important pathological hallmarks of ms-focal demyelinated white matter lesions, diffuse injury in the white matter, and cortical plaque formation-and concludes that white matter lesion formation predominates in active forms of ms, while cortical pathology and diffuse white matter injury characterizes the progressive forms. the authors of this landmark paper also established that these three processes are potentially independent of each other. heredity. epidemiological findings support a polygenic hereditary predisposition to ms. a number of candidate genes have been investigated, often with conflicting results. the only definitive genetic association in ms is with the serologically defined human leukocyte antigen (hla) dr15, dq6. this is one of the dr2 haplotypes, also known as dw2 in cellular terminology and drb1*1501, dqa1*0102, dqb1*0602 in molecular nomenclature. though its link to ms is well established, the risk conferred by this haplotype is small (relative risk of 3 to 4), and it is neither necessary nor sufficient for the development of ms. linkage to this locus has not been proved, indicating that it plays only a minor role in familial susceptibility. other susceptibility genes likely contribute, possibly the t-cell receptor variable b region and the igg heavy-chain variable region (especially the vh2-5 gene). but their specific roles have not been established. other genes under study have been the mbp coding gene, the ctla-4 gene on chromosome 2q33, and the interleukin-1ra associated gene, in concurrence with the hla-dr15 haplotype. mitochondrial mutations are also under investigation, and an lhon-associated mtdna mutation may be an important cofactor in developing ms in some patients. the apoe4 gene, as in alzheimer's disease, has been associated with a higher incidence of ms. on the other hand, apoe3 is considered to have neurotropic, immunomodulatory, and antioxidant properties. these findings are yet to be confirmed by larger studies. twenty percent of ms patients have at least one affected relative. only about 4% of first-degree relatives of patients develop ms, but this represents a 20-to 40-fold increase in risk compared with the general population. unaffected family members sometimes have abnormal findings on cranial mri, implying that this risk is even higher. one study of ms rates in adopted relatives of ms patients verified that the familial distribution is due to genetic factors rather than shared environment. 20 twin studies lend support to both genetic and environmental influences on ms development. genetically identical monozygotic twins are more often concordant for ms than dizygotic twins (26% and 2.4%, respectively), indicating a genetic component; 21 however, even after following monozygotic twins past age 50 or using mri data, less than 50% are concordant, suggesting a role for environmental factors. epidemiology and risk factors. ms is not a rare disease. it affects millions worldwide and approximately 400,000 in the united states alone. symptoms usually begin during young adulthood, with the peak onset at age 24. approximately 0.3% of ms cases are diagnosed before age 15. women are affected nearly twice as often as men. ms has a predilection for whites, especially those of northern european heritage. other races and ethnic populations are resistant to a variable extent. ms is virtually unknown among black africans but occurs in african-americans at half the rate of whites, possibly due to racial admixture or environmental factors. ms is rare in tropical areas, and the prevalence increases proportionally to the distance from the equator, excluding polar regions. the prevalence is less than 5 cases per 100,000 in tropical areas; in high prevalence areas it can be higher than 30 per 100,000, 22 reaching up to 100 per 100,000 in selected areas. although usually interpreted as the effect of environmental factors, the prevalence gradient is at least partially due to racial susceptibility. 23 perhaps the most incriminating evidence for the role of environmental factors in the development of ms is the changing risk with migration and the occurrence of ms clusters and epidemics. immigrant populations tend to acquire the ms risk inherent to their new place of residence. migration from high to low prevalence before the age of 15 lowers the ms risk, whereas migration after this age does not affect risk. 18 migration from low to high prevalence areas increases the risk of ms, but the effect of age is less clear. many clusters of ms have been reported. 24, 25 the occurrences of ms epidemics in iceland and the faroe islands have been proposed to be the result of exposure to a pathogen brought by british troops during their occupation in world war ii. other environmental factors associated with the development of ms include cigarette smoking (odds ratio of 1.81, ci: 1.1-2.9), animal fat intake, and deficiency of vitamin d. 26, 27 epidemiological data support the view that ms is caused or triggered by an environmental factor in persons who are genetically susceptible. the familial frequency and distribution implies that several genes contribute to susceptibility, and this is consistent with the low relative risk conferred by the genetic loci studied so far. data from clusters, migration studies, and family studies reveal that there is a latent period of some 20 years between exposure to the environmental factor and the development of clinical symptoms and that the age at exposure is around 15, the putative age at acquisition. the precise environmental events that lead to cns demyelination are uncertain. viral infection is the most plausible, but because of the nonspecific elevation of viral titers and long latent period, there is little direct evidence. minor respiratory infections precede 27% of relapses in patients with established ms. measles infection was found to have occurred at a later age in ms patients than control subjects, although the incidence of ms has not been reduced by immunization against measles. head injury and trauma have received attention as putative triggering events, but cohort studies have not verified any link. pregnancy does not alter the risk of developing ms, but it does seem to influence disease activity. the annualized relapse rate drops from approximately 0.56 to 0.12 by the third trimester, but this is offset by an increase to 1.2 in the first 3 postpartum months. most studies have found no longterm effects of pregnancy on the prognosis for progression or disability, although one did report a favorable effect. 28 a multitude of other environmental factors have been suspected to alter the risk for ms (cold climate, precipitation, amount of peat in the soil, exposure to dogs, and consumption of meat, processed meat, and dairy products), but none has been verified to be an independent risk factor. ms can cause a wide variety of clinical features. many signs and symptoms are characteristic, and a few are virtually pathognomonic for the disorder. conversely, some symptoms are atypical and some are so rare as to suggest a different diagnosis (table 48 -2). the course of the illness is also variable, but it remains a critical consideration in the diagnosis of ms. sensory symptoms are the most common presenting manifestation in ms (21% to 55%) and ultimately develop in nearly all patients. 29 loss of sensation (numbness), paresthesias (tingling), dysesthesias (burning), and hyperesthesias are common. these symptoms may occur in practically any distribution: one or more limbs, part of a limb, trunk, face, or combinations. the more distinctive sensory relapses of ms consist of the sensory cord syndrome and the sensory useless hand syndrome. a common scenario is that of numbness or tingling beginning in one foot, ascending first ipsilaterally and then contralaterally. the sensory symptoms may ascend to the trunk, producing a sensory level, or may involve the upper extremities. associated symptoms commonly include poor balance, weakness, urinary urgency, constipation, and lhermitte's sign (see later). brown-sã©quard syndrome may occur with sensory disassociation and hemiparesis. the sensory cord syndrome reflects an evolving demyelinating lesion that begins in the medial posterior column ipsilateral to the first symptoms. sensory cord syndromes are common in ms and suggest the diagnosis when they occur in young persons and remit spontaneously or in response to corticosteroids. patients with the sensory useless hand may note subjective numbness and lose discriminatory and proprioceptive function, resulting in difficulty writing, typing, buttoning clothes, and holding onto objects, especially when not looking at the hand. this problem can occur bilaterally even without lower extremity symptoms. the responsible lesion is in the lemniscal pathways either in the cervical spinal cord or in the brain stem. this syndrome usually remits over several months. the useless hand syndrome is a very specific symptom and is only rarely caused by other disorders. a large portion of ms patients have persistent sensory loss, usually consisting of diminished vibratory and position sensation in distal extremities (video 5, sensory ataxia). itching may occur in a dermatomal distribution with relapse or in paroxysms. pain is not a major manifestation of ms, but distressing lower extremity dysesthetic pain associated with spinal cord involvement, radicular pain from lesions at the root entry zone, paroxysms, and an uncomfortable sensation of pressure or tightness surrounding a leg or the trunk may be present. pyramidal tract dysfunction is common in ms and causes weakness, spasticity, loss of dexterity, and hyperreflexia (video 80, hyper-reflexia). motor deficits can occur acutely or in a chronic progression with weakness of one or more limbs and facial weakness, leg stiffness that impairs gait and balance, or extensor and flexor spasms (video 3, spastic gait). exercise or heat frequently worsens subtle deficits. muscle atrophy is usually due to disuse, but lesions of lower motor neuron fibers or of the anterior horn itself can cause a pseudoradiculopathy with segmental weakness, atrophy, and diminished reflexes. motor symptoms are presenting manifestations of ms in 32% to 41% of all cases; their prevalence is higher than 60% in long-standing ms. the initial symptom of ms is optic neuritis (on) in 14% to 23% of patients, and more than 50% experience a clinical episode of on during their lifetime. the most common manifestation is visual loss in one eye that evolves over a few days. periocular pain, especially with eye movement, usually accompanies and may precede the visual symptoms. bilateral simultaneous on is uncommon in adults, but formal visual field testing reveals unexpected defects in the clinically normal eye in a substantial number of patients. children and asian patients are more likely to have bilateral simultaneous on; it may also be seen in neuromyelitis optica (nmo) patients. examination shows an afferent pupillary defect, diminished visual acuity, subdued color perception, and often a central scotoma (video 200, afferent pupillary defect). funduscopic examination is usually normal but occasionally will reveal papillitis (more common in children) or venous sheathing. most patients begin to recover within 2 weeks, and significant visual patients with frequent and severe on events in the first 2 years were more likely to convert to nmo; they also had a higher likelihood for significant persistent vision loss. 30 cerebellar pathways are frequently involved during the course of ms, but a predominately cerebellar syndrome is uncommon at onset. the manifestations include dysmetria, dysdiadochokinesia (video 12, dysdiadochokinesis), action tremor with terminal accentuation, dysrhythmia, breakdown of complex motor movements, and loss of balance (video 14, tremor with ataxia). patients with long-standing ms may develop a "jiggling" gait and an ataxic dysarthria with imprecise articulation, scanning speech, or varying inflection, giving it an explosive character. urinary urgency, frequency, and urge incontinence (due to detrusor hyper-reflexia or detrusor-sphincter dyssynergia) result from spinal cord lesions and are frequently encountered in ms patients. the combined incidence of bowel and bladder dysfunction in ms is thought to be higher than 70%. symptoms of bladder dysfunction may be transient and occur with an exacerbation but are commonly persistent. impaired vesicular sensation causes a high capacity bladder and may lead to bladder atonia with thinning and disruption of the detrusor muscle. incontinence results in constant dribbling of urine in this irreversible condition. interruption of brain stem micturition center input sometimes leads to cocontracture of the urinary sphincter and detrusor muscles (detrusor-sphincter dyssynergia). the resulting high pressure may lead to hydronephrosis and chronic renal failure if untreated. constipation is a common problem, occurring in 39% to 53% of ms patients, especially with limited activity and spinal cord involvement. fecal incontinence is a socially devastating symptom that is often associated with perineal sensory loss in ms patients. sexual dysfunction is seldom mentioned, even though it is a frequent problem in ms. nearly two thirds of patients report diminished libido. one third of men have some degree of erectile dysfunction, and a similar percentage of women have deficient vaginal lubrication. besides direct neurological impairment, sensory loss, physical limitations, depression, and fatigue additionally contribute to sexual difficulties in ms patients. in addition, the partner's attitude and psychological factors dealing with self-image, self-esteem, and fear of rejection may also lead to impotence or loss of libido. intense vertigo associated with nausea and emesis is an occasional manifestation of ms relapse. in the absence of a clear diagnosis of ms, these symptoms are often attributed to vestibular neuronitis. patients may also develop a persistent but mild vertigo that is precipitated by movement, or this may be a residual finding after an acute relapse. internuclear ophthalmoplegia, caused by a lesion in the medial longitudinal fasciculus, is the most common cause of diplopia in ms patients (video 200, afferent pupillary defect). when symptomatic, it produces horizontal diplopia on lateral gaze that usually remits. examination discloses incomplete or slow adduction of the eye ipsilateral to the lesion and nystagmus of the contralateral eye during abduction (see chapter 9) . dissociated nystagmus may be the only finding of an old or subtle internuclear ophthalmoplegia (video 19, internuclear ophthalmoplegia). bilateral internuclear ophthalmoplegia is strongly suggestive of ms, although this rarely may occur with tumor, infarct, mitochondrial cytopathy, wernicke's encephalitis, and chiari malformation (video 229, wernicke's encephalopathy). vertical and diagonal diplopia usually results from skew deviation. nystagmus, slow saccadic movements, broken ocular pursuits, and ocular dysmetria are other eye findings produced by lesions of cerebellar and vestibular pathways (see chapters 9 and 12; video 228, saccadic dysmetria). abducens paresis occurs on occasion, but oculomotor and trochlear nerve impairment is rare. corticospinal, spinothalamic, lemniscal, vestibular, and cerebellar pathways can all be affected. cranial nerve impairment may be seen with lesions that affect brain stem nuclei or exiting and entering fibers. usually this occurs in association with other symptoms. because of the long spinal tract and nucleus, the trigeminal nerve is frequently involved (video 106, trigeminal neuralgia). facial nerve paresis does occasionally occur, but ms is an extremely rare cause of bell's palsy in patients without previous symptoms. acute unilateral hearing loss is an uncommon manifestation. dysphagia is often due to impairment of cranial nerves ix, x, and xii and generally appears late in the course of some patients. once thought uncommon, cognitive disorders are now known to be present in 40% to 70% of ms patients. 31 age, duration of ms, and physical disability do not completely predict the presence of cognitive dysfunction, but classic mri measures like the total t2-weighted lesion load does not seem to correlate well with the degree of cognitive decline. measures of cortical atrophy, venticular enlargement, and neuronal integrity seem to correlate better with the cognitive aspects of ms. the problems are often subtle and may not be detected on standard mental status evaluation. the pattern of cognitive decline is typified by decrease of episodic memory, processing speed, verbal fluency, and difficulty with abstract concepts and complex reasoning. to a lesser extent, executive functioning and visual perception, semantic memory, and attention span may also be also decreased. general intelligence is not typically affected. as expected, cortical symptoms such as aphasia, apraxia, and agnosia are unusual. homonymous hemianopia, which can be caused by cortical or subcortical lesions, is also uncommon. despite prominent cerebral white matter involvement, many of the disconnection syndromes such as alexia without agraphia, conduction aphasia, and pure word deafness have not been reported in ms patients. affective disorders are more frequent in ms patients than in the general population. these include both anxiety and depression. in long-term studies, the incidence of depression in ms patients is close to 75%. neither depression nor anxiety is related to physical or cognitive disability or mri lesion load. patients sometimes experience uncontrollable weeping or less commonly laughter incongruent with their mood. interruption of inhibitory corticobulbar fibers is responsible for these symptoms (pseudobulbar affect). fatigue is a pervasive symptom among ms patients that is not related to disability or depression. over 75% of ms patients experience fatigue during their disease course. a diurnal pattern is characteristic and follows the normal circadian pattern of body temperature fluctuations, with the worse symptoms occurring in afternoon hours (peak core body temperature) often giving way to improvement in the late evening. ms symptoms may fluctuate in a predictable fashion. transient worsening of symptoms frequently follows exercise or elevation of body temperature. one example is uhtoff's phenomenon, in which visual blurring occurs during strenuous activity or with passive exposure to heat. these episodes resolve when the body temperature cools to normal or after a period of rest. an intercurrent infection with fever can induce worsening of symptoms and may be confused with a relapse. heat sensitivity is presumably related to conduction block, as demyelinated axons are more prone to failed conduction than normal, myelinated fibers. 32 paroxysmal symptoms are characteristic of ms and are believed to be due to the lateral spread of excitation (ephaptic transmission) between denuded axons in areas of demyelination. symptoms are typically brief (seconds to 2 minutes) and recur frequently, occasionally dozens of times per day. they may be precipitated by hyperventilation, certain sensory input, or particular postures. tonic spasms (paroxysmal dystonia) most often affect the arm and leg on one side, but the face, one limb, or bilateral limbs are sometimes involved (video 20, tonic spasms). these spasms may result from lesions anywhere along the corticospinal tract. they often begin during the recovery phase after an acute relapse and remit after a few months. intense pain and ipsilateral or crossed sensory symptoms may accompany them. paroxysmal weakness occurs, but it is uncommon. a wide variety of paroxysmal sensory symptoms may occur with ms, including tingling, prickling, burning, or itching, and sharp neuralgic pain is common. trigeminal neuralgia may appear in patients with ms (video 106, trigeminal neuralgia). the occurrence of trigeminal neuralgia in a person younger than age 40 is suggestive of ms. lhermitte's sign (transient sensory symptoms usually precipitated by neck flexion) is usually described as an electrical or tingling sensation that travels down the spine or into the extremities. although quite common in ms, lhermitte's sign can also occur with a wide variety of other disorders, such as vitamin b 12 deficiency, spondylosis, chiari malformation, and tumors, and after cisplatin chemotherapy. several other paroxysmal symptoms are occasionally encountered, including paroxysmal dysarthria and ataxia, paroxysmal diplopia, and combinations of these symptoms. facial myokymia and hemifacial spasm are additional transient (lasting months) phenomena sometimes due to brain stem demyelination (video 110, facial myokymia; video 224, hemifacial spasm). trismus, kinesigenic dystonia, paroxysmal kinesigenic choreoathetosis, and segmental myoclonus have also been described in case reports of ms patients as rare and unusual examination findings. seizures occur in a larger proportion of ms cases compared to normal control subjects. a recently published review of 29 case series of ms patients with epileptic seizures yielded a prevalence of 2.3%. 33 this represents an approximately three-to sixfold increase compared to the general adult population. cortical and juxtacortical lesions may be responsible for the increased incidence of seizures in ms patients. however, such plaques are common and seizures in ms are not, which suggests that other factors may also contribute to the relationship between epilepsy and ms. focal motor seizures, possibly with secondary generalization, are the most frequent. the occurrence of seizures usually follows one of two patterns. on occasion, focal onset seizures begin early in the course of ms and later remit. the start of seizures late in the course of ms more often poses a chronic problem and may be difficult to control. the eye is the only organ outside the nervous system that is sometimes involved in ms. uveitis and retinal periphlebitis each occur in at least 10% of ms patients. in a recent study, most patients with ms-associated uveitis were white females between 20 and 50 years of age. 34 the diagnosis of ms preceded the onset of uveitis in 56%, followed it in 25%. in over 90% of the cases, the uveitis was bilateral. pars planitis was found to be the most frequent form of uveitis (over 80%), and concomitant anterior chamber inflammation was also common. usually ms-associated uveitis is benign from the standpoint of visual acuity. uveitis can involve the posterior, intermediate (pars planitis), or rarely anterior portion and resembles that seen in other inflammatory (e.g., sarcoid, reiter's syndrome, behã§et's syndrome, inflammatory bowel disease, systemic lupus erythematosus) and infectious (e.g., syphilis, tuberculosis, lyme disease) conditions. periphlebitis is seen as venous sheathing on funduscopic examination and is histologically identical to the perivascular inflammation present in brain white matter. it is interesting that inflammation commonly occurs in the retina, which has a peripheral type of myelin produced by schwann cells. there are occasional reports of peripheral nerve or nerve root demyelination in ms patients as well as central demyelination in acute inflammatory demyelinating polyradiculoneuropathy and chronic inflammatory demyelinating polyradiculoneuropathy (see chapter 49) . some of these cases may be due to the incidental occurrence of two unrelated disease processes. however, because the pns and cns share many antigens, including mbp, it is possible that an autoimmune reaction or a viral infection could involve both the cns and pns. persons with one autoimmune disorder generally have an increased risk of others. even though there are several reports of systemic and organ-specific autoimmune diseases in ms patients, population-based studies have not confirmed any increase in prevalence of these disorders among ms patients. 35 in fact, there appears to be a negative association between ms and rheumatoid arthritis. multifocal cns involvement and acute relapses, remissions, and slow progression of neurological deficits typify ms. a single episode of neurological dysfunction can be suggestive of ms if it follows the typical time course of a relapse: progression over less than 2 weeks (usually days), with or without a period of stabilization, and improvement or resolution (often over months). insidious progression of deficits localized to a single site in the cns can also be due to ms, but other causes must be excluded. the temporal course of ms can be described by one of four categories: relapsing-remitting (rr), secondary progressive (sp), primary progressive (pp), and progressive relapsing (pr). 32 many physicians use the term relapsing progressive, which encompassed patients with spms, prms, and even those with rrms who have stepwise relapse-related worsening disability. this term has recently been abandoned. other terms that relate to the course of ms but have no consensus regarding their definition are sometimes encountered. benign ms generally refers to patients who have had ms for a long time but have little or no disability. malignant ms is sometimes used to describe patients with frequent relapses and incomplete recovery but is also used in reference to patients with acute fulminant demyelinating syndromes (see later). the term clinically isolated syndrome (cis) refers to patients presenting with their first episode of region-restricted episodes of cns inflammatory demyelination. this may remain an isolated syndrome (no recurrence), it may remain a forme fruste of acute disseminated encephalomyelitis (adem), or it may be the harbinger for one of the relapsing forms of ms. the probability of recurrent demyelinating episodes (e.g., clinically definite ms) has been the subject of several important investigations, and several clinical features and test results are of predictive value. optic nerve, spinal cord, and brain stem are the most common sites of these recurrent monosymptomatic events, and the time profile follows that of ms relapses. the pathogenesis, pathophysiology, epidemiology, clinical features, associated disorders, differential diagnosis, evaluation, and management are the same as in ms. the prognosis for visual recovery after each episode of on is good, and most patients regain normal visual acuity. profound visual loss, recurrent on, and age older than 35 are associated with a higher risk for poor recovery. investigators have concluded that recurrent multifocal demyelinating episodes, fulfilling the diagnostic requirements of clinically definite ms, develop in 50% or more of patients after isolated on when follow-up is extended beyond 20 years. 36 most of this risk is incurred within the first few years, although significant risk may continue into the fourth decade after the event. children much more often develop simultaneous bilateral on and have a lower risk for subsequent ms than adults. factors that are associated with an increased risk of developing ms as a disseminated illness are the presence of venous sheathing, recurrent on, family history of ms, white race, previous vague or nonspecific neurological symptoms, and the presence of oligoclonal bands (ocbs), elevated igg index, or igg synthesis rate in csf. the severity of acute transverse myelitis is inversely related to the risk of acquiring further symptomatic demyelinating lesions. complete transverse myelitis with profound loss of motor, sensory, and sphincter function imparts a relatively low risk of 3 to 14 for the later diagnosis of ms. partial transverse myelitis with preservation of significant motor function at peak is associated with a much higher incidence of ms. although monosymptomatic brain stem demyelination is not as common as either on or acute transverse myelitis, similar conclusions have been reached. in the only study available, two thirds of these patients with cerebral white matter lesions detected on mri developed ms within 5 years, compared with none of 5 patients with normal head mri. 37, 38 a recently published 10-year follow-up of the original queen square series continues to demonstrate the value of the baseline cranial mri study in determining risk of recurrence (ms risk). in this cohort study of 81 cis patients, approximately two thirds had at least one asymptomatic lesion (54 of 81, 67%) at baseline. after 5 years of follow-up, slightly more than half with one to three asymptomatic baseline cerebral lesions had developed ms (13 of 24) compared with the majority of cases presenting with at least four baseline lesions (28 of 33, 85%). after 10 years of follow-up, the majority of patients with any asymptomatic cerebral lesions had developed definite ms (45 of 54, 83%). 39 the recently published 14-year follow-up data on this group of patients reveals that 88% of the initially mri positive patients developed ms versus 19% of the mri negative subgroup. 40 this information is helpful for treating patients in the setting of cis. differential diagnosis. only a few diseases cause neurological deficits that regress spontaneously and relapse in different areas of the cns over the course of many years. however, because of the remarkable heterogeneity of ms, many disorders may resemble ms (table 48-3) , especially in the first years of active disease. other primary idiopathic inflammatory demyelinating cns disorders may be mistaken for ms. adem usually causes monophasic cns demyelination. although it frequently involves multifocal areas of white matter simultaneously, adem cannot be reliably differentiated from the initial clinical episode of ms. fulminant brain demyelination in persons without previous symptoms of ms is more likely due to adem or other conditions (schilder's myelinoclastic diffuse sclerosis, balo's concentric sclerosis, marburg's variant of ms). neuromyelitis optica differs from ms primarily in the topography and intensity of the lesions. several systemic or organ-specific inflammatory conditions can involve the cns white matter. on, myelitis, and other syndromes sometimes occur with systemic lupus erythematosus. whether this autoimmune disease increases the risk of developing ms or causes similar syndromes by a different pathological process is unknown. sarcoidosis can affect the nervous system in several ways, including multifocal, corticosteroid-responsive white matter lesions. sjã¶gren's syndrome sometimes occurs with ms, but this may only represent a chance association. neuro-behã§et's disease has a predilection for the brain stem. occasionally, isolated demyelinating syndromes are associated with inflammatory bowel disease. a wide variety of vasculitic syndromes (e.g., primary angiitis of the cns, periarteritis nodosa, wegener's granulomatous angiitis, vasculitis associated with rheumatoid arthritis, susac's syndrome, eales'disease) may mimic ms. however, these syndromes can usually be distinguished by involvement of the cortex, seizures, early dementia, personality changes, psychosis, infarcts involving large vessel territories on mri, and lack of improvement. findings characteristic to the particular vasculitis (uveitis and vitreal hemorrhage in eales' disease, retinal and cochlear involvement in susac's syndrome, upper and lower respiratory tract involvement in wegener's granulomatosis) also aid in the correct diagnosis. a few infections must also be considered in the differential diagnosis of ms. both lyme disease and syphilis may cause multifocal white matter lesions. htlv-1 causes a chronic progressive myelopathy (htlv-1-associated myelopathy/tropical spastic paraparesis). acute or recurrent myelitis can be caused by vzv. progressive multifocal leukoencephalopathy and toxoplasma abscesses should be considered in immunocompromised patients with progressive neurological decline. bacterial endocarditis with brain abscess formation, subacute sclerosing panencephalitis, or chronic rubella encephalomyelitis may need to be considered in the appropriate circumstances. cerebrovascular disease is only rarely mistaken for ms. occasionally, an ms relapse has an abrupt onset that may mimic an infarct, especially in those not previously diagnosed with ms. the usual circumstance is that of a hemisensory or hemimotor deficit imitating a lacunar infarct. disorders with multiple cerebral infarcts (emboli, hypercoagulable states, sneddon's syndrome, cadasil, vasculitis) may produce an mri appearance and course resembling ms. vascular malformations may also produce symptoms similar to ms. additional neurological illnesses capable of producing multifocal lesions rarely mimic ms. metastatic tumors and multifocal gliomas are often cited examples, but rarely is this distinction difficult for an experienced clinician. lymphoma more commonly masquerades as ms because the lesions may involve the white matter, may be multifocal, and are corticosteroid responsive. in addition, demyelination sometimes presents as one (or a few) mass lesion(s). in this situation, biopsy may be needed for diagnosis. neoplasms can cause paraneoplastic syndromes that may be confused with ms. a high index of suspicion must be kept for older age at presentation, subacute ataxia, early dementia, and personality changes. a few metabolic disorders may resemble ms, such as vitamin b 12 deficiency, vitamin e deficiency (seen in bassen-kornzweig syndrome, hypobetalipoproteinemia, and refsum's disease), and central pontine or extrapontine myelinolysis (video 113, pontine myelinolysis). leukodystrophies are usually not difficult to distinguish from ms. krabbe's disease (galactocerebroside-b-galactosidase deficiency), metachromatic leukodystrophy (mld; arylsulfatase a deficiency), and the usual adult form of adrenoleukodystrophy (ald) and adrenomyeloneuropathy (amn) exhibit both central and peripheral dysmyelination. blood leukocyte or fibroblast culture enzyme activity levels will confirm the diagnosis of krabbe's disease and mld, and elevated levels of very long chain fatty acids occur in ald/amn. mitochondrial disorders should also be given consideration because symptoms and mri appearance may be similar to ms. a relapsing remitting disorder identical to ms is sometimes seen in patients with the mutations responsible for leber's hereditary optic neuritis (lhon). 41 this usually occurs in female patients, and there may not be a family history of visual loss. a number of rare biochemically defined illnesses and other genetic disorders may occasionally merit consideration (including cobalamin and folate dysmetabolism, adult polyglucosan body disease, hereditary spastic paraparesis, spinocerebellar degeneration, and hereditary cerebroretinal vasculopathy). 42 several additional disorders must be excluded before diagnosing primary progressive ms (ppms). spinal cord compression from spondylosis or tumor may produce chronic progressive myelopathy. chiari malformations, syringomyelia, syringobulbia, other foramen magnum lesions, spinal arteriovenous malformations, and dural fistulas may also need consideration. careful imaging readily identifies these structural abnormalities. degenerative diseases such as olivopontocerebellar atrophy may mimic ppms. mri and csf examination will help distinguish between the two. conversion reactions and somatization disorders are commonly encountered in a busy referral practice and must be accurately diagnosed to afford optimal patient management. evaluation. the diagnosis of ms is based on the demonstration of white matter lesions disseminated in time and space in the absence of another identifiable explanation. ms remains a clinical diagnosis, although mri, evoked potentials, and csf examination can help clarify less certain cases. for research purposes, various categories of ms have been defined based on the certainty of the diagnosis. 43 at least two attacks and evidence of two separate cns lesions (clinical or paraclinical) are required for the designation of clinically definite ms (cdms). two attacks and evidence of one cns lesion or one attack and evidence of two cns lesions (clinical or paraclinical) is considered clinically probable ms. cases that fulfill the criteria for clinically probable ms and have supportive csf findings are labeled as laboratory-supported definite ms. patients with a clear history of at least two attacks and supportive csf but a normal neurological examination and no paraclinical evidence of cns lesions are categorized as having laboratory-supported probable ms. suspected cases that do not fit any of these criteria may be regarded as possible ms. paraclinical evidence generally refers to abnormalities on evoked potential studies or imaging procedures. as a result of increasing availability of refined paraclinical diagnostic modalities (especially mri) and an overall better understanding of the disease process, new diagnostic criteria for ms were proposed by an international expert panel in 2001. 44 three out of four of the following findings should be present on mri: (1) one gadolinium enhancing lesion, or nine t2 hyperintense lesions; (2) at least one infratentorial lesion; (3) at least one juxtacortical lesion; and (4) at least three periventricular lesions. according to the clinical diagnostic criteria, if a patient had two or more attacks with objective evidence on examination of two or more anatomical areas involved, no additional data is required to make the definite diagnosis. however, if such diagnostic studies were done and are not supportive of a diagnosis of ms, then the diagnosis should be reconsidered. if a patient presents with a history of two or more attacks, but objective clinical evidence only suggests one lesion, the following additional data is needed to confirm the diagnosis: the disease process has to be disseminated in space as demonstrated by mri; alternatively, two or more mri-detected lesions consistent with ms plus positive csf would suffice to meet the newly defined criteria. the clinician also may elect to await a further attack implicating a different anatomical site. in case a patient had one attack, with objective clinical evidence of two or more lesions, dissemination in time as demonstrated by serial mris separated by at least 3 months or a second clinical attack would clarify the diagnosis. if a patient has a clinically isolated syndrome, or "monosymptomatic" presentation, the following criteria should be met: dissemination in space as demonstrated by mri (again separated by at least 3 months), or two or more mridetected lesions consistent with ms plus positive csf and dissemination in time on serial mri scans, or a second clinical attack. in case the patient presents with a progressive course, the presence of positive csf is required, and dissemination in space should be present, as suggested by nine or more t2-weighted brain lesions, or two or more cord lesions, or four to eight brain lesions plus one cord lesion on mri. alternatively, abnormal visual evoked potentials (veps) with four to eight brain lesions, or fewer than four brain lesions plus one cord lesion, and dissemination in time on serial mri scans, or continued progression for a year would meet the diagnostic criteria. "positive csf" according to this set of criteria is defined by either the presence of oligoclonal bands detected by established methods (preferably isoelectric focusing on agarose gel followed by immunoblotting) different from any such bands in serum, or by a raised igg index. the presence of both enhancing and nonenhancing white matter lesions on a single mr image must not be used as evidence of dissemination in time as well as space, because these can also be seen in adem. oligoclonal bands (ocbs) and an elevated igg index provide supportive csf findings. ancillary tests are frequently required to confirm the diagnosis of ms and to exclude other possibilities in uncertain cases. laboratory tests on peripheral blood can help to exclude many of the infectious and other inflammatory disorders. a chest x-ray is generally needed to assess for sarcoid or paraneoplastic disorders if these are under consideration. an ophthalmological examination may be needed to search for alternative causes of visual loss. imaging studies, csf examination, and evoked potentials are often helpful because characteristic abnormalities are frequently present. mri of the head is the most sensitive imaging study for ms ( fig. 48-3 ). focal areas of increased t2-weighted and decreased t1-weighted signal reflect the increased water content associated with demyelinated plaques. the mri appearance of ms lesions, however, is not specific and similar abnormalities may be seen in normal aging, small penetrating vessel infarcts, lyme disease, tropical spastic paraparesis/htlv-1-associated myelopathy, sarcoid, systemic lupus erythematosus, sjã¶gren's syndrome, mitochondrial cytopathies, vasculitis, and adem. the specificity for ms can be increased by consideration of lesion number, size, location, and shape. 45 this is especially important in persons older than age 50. mri characteristics, other than the ones suggested by the international criteria outlined previously, are size larger than 6 mm, oval shape (often with the long axis directed perpendicular to lateral ventricles), and locations in the periventricular area, corpus callosum, and posterior fossa. longitudinal mri studies have shown the evolution of ms lesions. 46 gadolinium enhancement, indicating blood-brain barrier disruption, sometimes precedes the development of t2-weighted lesions and typically lasts for 4 weeks in the brain (occasionally longer, especially in larger hemispheric lesions), and perhaps somewhat longer in the spinal cord. flair imaging is especially helpful for evaluating periventricular lesions that may go unnoticed on regular t2-weighted scans. the disadvantage of the technique is its relative insensitivity to posterior fossa lesions. proton density weighted images are also part of the usual sets of images used in the mr diagnostics of ms. these images can be evaluated similarly to t2-weighted images. technically, they are usually acquired together with the t2-weighted datasets, as a first echo in conventional fast spin echo sequences, where the subsequent echoes can be used for generating the t2-weighted images. new t2weighted lesions have a fuzzy border and enlarge over a few weeks. after a period of stabilization, the t2-weighted lesion regresses and becomes more sharply delineated from the surrounding white matter as edema resolves. most of the time, a residual abnormality with increased t2 weighting and decreased t1-weighted signal remains, reflecting demyelination and gliosis. the low attenuation t1 signal, or "t1 black hole," is more often seen in secondary progressive ms and is thought to represent actual tissue loss. in several well-documented cases, hypointense lesions on t2-weighted scans were described in subcortical gray matter structures in ms patients. on a molecular level these areas are thought to represent iron deposition; their significance in ms is not fully understood. the mri activity of disease, defined as either the number of new, recurrent, and enlarging lesions or the number of gadolinium-enhancing lesions, is usually higher than the clinical activity. this may be either because of the involvement of asymptomatic areas of the cns or because of a pathophysiological difference between symptomatic and nonsymptomatic lesions based on the presence or absence of axonal dysfunction. there is only poor correlation between disability and lesion load (volume of white matter abnormalities) determined by head mri. sometimes individuals have severe impairment and few mri abnormalities, and the converse may occur. this disparity is partially explained by variable spinal cord involvement, but a pathophysiological difference may account for some of the discrepancy. several mri markers of gray matter involvement correlate better than measures of white matter pathology with clinical functional outcome measures in ms. in a recent study 47 edss showed the strongest correlation with gray matter volume loss and with t1 black hole volume increase (p < 0.01); both are considered to reflect neuronal and axonal pathology. ambulatory function, assessed as the 25-feet timed walk, also correlated well with gray matter volume loss and t1 black hole volume. on normal appearing gray matter magnetization transfer ratio (mtr) histograms, normalized peak heights inversely correlated with edss in 18 rrms patients (r â¼ ã�0.65, p â¼.01). 48 in a study evaluating a number of mri parameters (including brain t1-hypointense and flair-hyperintense lesion volume, third ventricle width, brain parenchymal fraction and t2 hypointensities in the dentate nucleus), the best correlation with edss (and the only correlating parameter with 25-feet timed walk) was t2 hypointensity in the dentate nucleus. 49 in 41 ms patients, an mri study concluded that gray matter atrophy correlated with clinical status (edss, 25-feet timed walking and disease duration). 47 a study of patients with ppms and rrms showed that neocortical volume as determined by mri correlated with edss scores across all the patients, but the strength of the correlation was stronger (p < 0.05) in the ppms (r â¼ ã�0.64, p < 0.0001) than in the rrms group (r â¼ ã�0.27, p â¼ 0.04). 50 mr spectroscopy is increasingly becoming an accepted diagnostic modality, where information can be obtained about the biochemical constituents of selected voxels of interest. with this technique, a cubic volume of interest is defined based on a regular mr image set. simultaneous acquisition of multiple volume units is possible. with long echo time (te) studies, naa (n-acetylaspartate), choline, creatinine, and lactate peaks can be identified on the mr spectrum. with short te studies, myoinositol, lipids, and some neurotransmitters may be identified. the resolution of the mr spectrum (the "number of lines" in the spectrum) is proportionate to the magnetic field strength used. naa is the second most abundant amino acid constituent in the brain after glutamate. it is localized almost exclusively in neurons and axons. creatinine is used as the "constant" peak in a mr spectrum, since it is the least likely to be altered by cns-specific processes. therefore, numeric mrs data are usually presented as ratios related to creatinine. the naa/creatinine ratio is decreased in areas of axonal or neuronal loss. it correlates well with disability. it can be decreased in normal appearing white matter, also in early stages of lesion formation, thus representing a challenge to the usual dogma of axonal loss being secondary to myelin damage. the decrease of the naa/creatinine ratio may return to normal following the resolution of the acute phase. this process may be related either to reversibility of neuronal injury or to disappearance of edema in the involved areas. in general, more reduced naa peaks are seen in progressive forms of ms with more profound tissue loss. if a relatively large hemispheric lesion shows decreased naa content, similar findings may be seen in the other hemisphere in a "mirror" location. the lactate peak can be elevated in a variety of acute processes, and as such, carries relatively low specificity. the short te spectrum is used less frequently; the "mobile lipid" peak (which is thought to represent macromolecular protein fragments) is increased in areas of acute demyelination. another newer mri technique used in ms research is magnetization transfer imaging. the principle behind this imaging modality is relatively simple. in complex macromolecular systems, there is a baseline magnetization exchange in equilibrium between macromolecular protons and mobile protons. if the macromolecular protons are saturated before each excitation (and subsequent data acquisition) with a prolonged off-resonance broadband pulse, then the signal intensity of the image will be reduced owing to magnetization transfer exchange between the saturated ("bound") and free ("mobile") protons. by obtaining duplicate sets of images (with and without magnetization transfer pulse), a magnetization transfer ratio can be calculated. the ratio reflects the integrity of the macromolecular environment. it is reduced by approximately 3% to 5% in areas of edema, but it is more significantly reduced in areas of demyelination or axonal loss. if the ratio "normalizes" in a lesion, no subsequent tissue loss is usually seen on other imaging modalities. despite these advantages, the magnetization transfer imaging is technically difficult because it produces variable findings depending on the technical environment and is not universally available. it has not become an accepted and standard technique for evaluation of ms patients. it may be very useful as a marker for remyelination and tissue repair in future neuroprotective or tissue restorative trials. diffusion-weighted imaging is well known from its widespread use in the diagnosis of ischemic stroke. this technique can show early stages of ms plaque formation. the increase in apparent diffusion coefficient correlates with acute plaques, and seems to best correspond with t1-enhancing lesions; this technique may show the lesions at an even earlier stage. mri has become an important component of clinical trials in ms. because of the high sensitivity of mri for disease activity, it is reasoned that periodic mri may determine treatment efficacy more quickly than monitoring relapse rate or disability level. many studies have used mri as a secondary outcome, but clinical outcomes are still used as the primary outcome for definitive trials. additional mri techniques have also proved useful in the diagnosis of ms. mri of the spinal cord shows discrete lesions in about 80% of cdms patients. several semiautomatic methods exist to determine lesion volume, ventricle volume, or hemispheric volume. these are generally applied for research purposes only, and are not part of the usual workup or diagnostic follow-up of ms. csf evaluation remains a valuable diagnostic tool for ms. a lymphocytic pleocytosis occurs during acute exacerbations in about one third of patients, but this seldom exceeds 50 cells. eighty percent of the lymphocytes are cd3 positive. the ratio of cd4 to cd8 cells is 2:1. less than 20% of the cells are b cells. csf protein is normal in up to 60%; levels above 100 mg/dl are unusual and may suggest a different disorder. the proportion of g globulin is high owing to the synthesis of immunoglobulins within the blood-brain barrier. the majority of csf immunoglobulin is igg, although igm and iga may also be elevated. measures of intrathecal igg production have been devised that are more useful than simple g-globulin levels. the igg index and synthesis rate are elevated in 70% to 90% of cdms patients and occasionally in other disorders. agarose gel electrophoresis, or the more sensitive isoelectric focusing of csf proteins, often reveals discrete bands of immunoglobulin, each a monoclonal antibody. it is pertinent to compare serum and csf banding patterns because peripheral monoclonal gammopathies may produce csf bands. to reduce false-positive results, only unique csf ocbs should be reported. between 85% and 95% of clinically definite ms patients have ocbs; however, early in the course they are not as prevalent. once present, ocbs persist and the pattern does not vary, although new bands occasionally appear. unlike subacute sclerosing panencephalitis, in which the majority of ocbs are antibodies specific for measles virus, the antigenic specificity of ocbs in ms is unknown; they are unlikely to be pathogen specific or autoantigen directed; there is some evidence that they may be genetically determined germline antibodies. five percent to 10% of noninflammatory cns samples and 30% of inflammatory samples are also positive for ocbs. 51 more detailed recommendations about the inclusion of csf parameters to the diagnosis of ms were recently published 52 suggesting that the cell count and differential should be completed within 2 hours. the new and recommended method for the detection of ocbs includes immunoelectophorsesis on agarose gel followed by immunoblotting. the reported sensitivity of this technique is above 95%, with a specificity of 86% to 87%. in other inflammatory or infectious illnesses, ocbs are often transient features. their persistence is more suggestive of ms. the presence of myelin components, antimyelin antibodies, and kappa light chains in csf has also been used in the diagnosis of ms. however, the sensitivity and specificity of these products is less than that of ocbs. in late 2005, a new set of recommendations were published based on the first 5 years of using mcdonald's criteria in diagnosing ms. 53 the original mcdonald criteria have been incorrectly interpreted by some as mainly relying on mri for making a diagnosis of ms. in reality, the mcdonald criteria cannot even be applied without careful clinical evaluation of the patient. neurological deficits must be evident to the examiner, and must be suggestive of ms. scans that "look like" ms (and meet the criteria of barkhof and tintore) but have never been accompanied by an obvious and documented neurological examination finding do not fulfill the mcdonald criteria. there was some sympathy among the international panel members revising the mcdonald criteria to allow selected symptoms that are clearly and specifically enunciated by the patient (e.g., lhermitte's symptom, trigeminal neuralgia, numbness ascending to the waist or higher) coupled with objective paraclinical (such as imaging and csf) findings to be sufficient as an indicator of a prior or current attack needed for an ms diagnosis. however, the panel was reluctant to endorse the diagnosis of ms in the absence of any objective clinical findings, even if objective paraclinical findings are in place, at least until such a scheme is tested in prospective settings. patients with imaging and csf findings suggestive of ms but not showing any objective evidence for neurological deficits commonly seen in ms require careful clinical and radiological monitoring. until objective evidence for neurological deficits are found, ms can not be diagnosed. ms may be the correct diagnosis with less stringent imaging criteria than originally proposed; however, the panel was uncomfortable making changes that would allow mri confirmation of dissemination in space based on lower stringency imaging criteria without appropriate prospective data. most studies performed to date have been inadequately designed to address this issue. advanced imaging technologies are constantly evolving and will likely one day be shown to aid in making the diagnosis of ms. visualization of intracortical lesions, use of higher field strength magnets, and analysis of "normal appearing brain tissue," may be conrnerstones of a future mri criteria for ms. preliminary evidence suggests that "occult" damage in normalappearing white and gray matter seen with magnetization transfer, diffusion tensor imaging, or spectroscopy is an early feature of ms, whereas it likely does not occur in other demyelinating conditions such as acute disseminated encephalomyelitis and nmo. important changes have been made to the original definition of "dissemination in time" by mri. in keeping with the definition that clinical relapses must be separated by at least 1 month, it was agreed that new t2 lesions on mri should occur at least 30 days after disease onset. this means that any new t2 lesion occurring at any time point after a so-called reference scan performed at least 30 days after the onset of the initial clinical event is useful in meeting imaging diagnostic criteria for dissemination in time. it should be noted though that a new t2 lesion must be of sufficient size and location to exclude lesions that could have been missed previously for technical reasons of slice orientation, thickness or spacing, tissue contrast, patient motion, or other artifacts. this requires standardized scanning procedures with emphasis on careful repositioning, as well as input from qualified evaluators experienced in ms imaging. with the new revision, there are two ways to show dissemination in time using imaging: (1) detection of gadolinium enhancement at least 3 months after the onset of initial clinical event, if not at the site corresponding to the initial event; or (2) detection of a new t2 lesion if this appears at any time compared with a reference scan done at least 30 days after onset of the initial clinical event. spinal cord lesions can be important in differentiating ms from other white matter diseases; however, the original mcdonald criteria did not provide sufficient guidelines for the use of cord imaging in ms. spinal cord imaging that detects typical ms cord lesions (minimal or no swelling of the cord; clearly hyperintense on t2-weighted imaging; at least 3 mm in size, but less than two vertebral segments long; and occupying only part of the cord cross section) is particularly helpful if brain imaging does not detect dissemination in space in a patient suspected to have ms. for dissemination in space, a spinal cord lesion is equivalent to, and can substitute for, a brain infratentorial lesion, but not for a periventricular or juxtacortical lesion. an enhancing spinal cord lesion is equivalent to an enhancing brain lesion, and an enhancing spinal cord lesion can "count" doubly in fulfilling the criteria (e.g., a single enhancing spinal cord lesion can "count" for an enhancing lesion and an infratentorial lesion). individual cord lesions can contribute together with individual brain lesions to reach the required nine t2 lesions to satisfy the barkhof-tintore criteria (the mri criteria incorporated in the original mcdonald's criteria). the panel recognized that diffuse cord changes may occur in ms, especially in the progressive forms; however, these changes are not sufficiently reliable to allow for their incorporation into the diagnostic criteria at this time. repeat spinal cord imaging in patients without new symptoms of myelitis has a low yield in efforts to demonstrate dissemination of lesions in time. in other words, while it is common to see asymptomatic new brain lesions on repeated scans, new cord lesions generally do result in new neurological symptoms. therefore, repeat cord imaging is recommended only to support an ms diagnosis when there is a clinical reason to suspect a new cord lesion. important changes have been proposed in diagnosing primary progressive ms. these revised criteria stress clinical and imaging (brain or spinal cord) evidence for diagnosis and place less emphasis on csf findings. the new criteria for ppms is as follows: (1) at least 1 year of disease progression (retrospectively or prospectively determined) (2) plus two of the following: (a) positive brain mri (nine t2 lesions or four or more t2 lesions with positive vep), (b) positive spinal cord mri (two focal t2 lesions), (c) positive csf (isoelectric focusing evidence of oligoclonal igg bands or increased igg index, or both). evoked potentials are summed cortical electrical responses to peripheral sensory stimulation that can be used to localize sites of disease and measure conduction velocity along sensory pathways. vep and somatosensory evoked potentials (sseps) may detect subclinical sites of demyelination, thus providing evidence of multifocality. brain stem auditory evoked potentials (baeps) are occasionally informative. more than 90% of persons with a history of on have an abnormal vep, and 85% of cdms patients have abnormalities on veps even when the history of on is absent. slowed conduction is present on ssep in nearly three fourths of patients with cdms. baes are the least sensitive, with abnormalities in less than 50%. mri has largely supplanted the use of evoked potentials in ms because of the greater sensitivity in the diagnosis and the detailed anatomical information it provides. in 2001, the american academy of neurology released practice parameters regarding the usefulness of evoked potential studies in ms. according to these recommendations, veps are considered probably useful (class ii evidence) to identify patients at increased risk for developing clinically definite ms. sseps are possibly useful, whereas the evidence for baeps supporting the diagnosis of cdms is insufficient. management. there is no available prevention or cure for ms. treatments focus on three areas: treating acute exacerbations and hastening their recovery; altering the natural history of ms; and providing symptomatic relief of current symptoms by enhancing physical abilities and preventing or treating complications. a fourth management topic concerns special treatment issues related to pregnancy. acute exacerbations. corticosteroids are the most commonly used treatment for ms, although there have been few studies to address their efficacy. adrenocorticotropic hormone (acth) was shown to speed recovery from an exacerbation but had no effect on the ultimate degree of recovery. because of the unpredictable cortisone response to acth, oral prednisone and later intravenous methylprednisolone became the preferred treatments. the optic neuritis treatment trial verified that intravenous methylprednisolone but not prednisone increased the recovery rate and unexpectedly increased the time to the next relapse, thus delaying the diagnosis of cdms. 54 moreover, the prednisone-treated group had twice as many recurrences. the finding was not replicated in a second study, but it has affected the practice of treating acute ms exacerbations. the current recommendation is to treat disabling attacks with 500 to 1000 mg of intravenous methylprednisolone per day for 3 to 5 days with or without a short tapering dose of oral corticosteroids. according to the practice parameters for steroid treatment of acute on attacks released by the american academy of neurology in 2001, oral prednisone in doses of 1 mg/kg/day has no proven value. higher dose of oral or parenteral methylprednisolone may result in quicker and more thorough recovery of visual function. there is no evidence of long-term benefit for visual function. a study suggested that intravenous steroids may also have long-term effects on disease progression when given regularly. 55 in this study, rrms patients randomized to receive regularly scheduled pulses of iv methylprednisolone (every 4 months for 3 years, then every 6 months for 2 years) demonstrated stability or improvement in disability measures, fewer "t1 black holes," and less brain atrophy than did control patients randomized to receive steroids only with relapses. these findings suggest a possible long-term benefit of pulsed iv methylprednisolone therapy on brain atrophy and disability. this as yet unconfirmed approach to long-term therapy might be considered a reasonable "control arm" in future phase iii trials of experimental therapies. up to one third of patients do not have an adequate recovery after a relapse despite the use of corticosteroids. plasma exchange (plex) alone was found beneficial in a substantial proportion of patients with severe inflammatory demyelinating episodes who had failed to improve following treatment with high-dose iv methylprednisolone. 56, 57 a randomized, sham-controlled, double-blind trial in 22 patients (seven exchanges over 14 days) without concomitant use of immunosuppressants in acute demyelinating events confirmed these findings. 58 moderate or greater clinical improvement was observed in over 42% of participants. a trial of seven plex treatments (alternate days) is a reasonable option for patients who fail to respond to conventional iv methylprednisolone therapy in acute, severe episodes of demyelinating diseases. the response to plex is stongly associated with the histological ms subtype. 59 antibody and complement plays a crucial role in pattern ii lesion formation. in a study of 19 biopsy-proven ms cases by keegan and associates, 10 pattern ii cases showed good response to plex, whereas 9 cases of pattern i or iii did not respond at all to plex. neuromyelitis optica, which is now considered an antibody-mediated condition with a known serological marker, also shows good response to plex: in a study by the mayo group, 60% of nmo patients showed moderate or marked improvement to plex, and an additional 10% showed mild improvement. 60 alteration of the natural course. the primary goal of drug treatment is to alter the natural course of the disease (e.g., reducing the frequency and severity of relapses, preventing the chronic progressive phase, and slowing the progression of disability). the disease activity seen on mri is often used as a secondary outcome, although mri measures currently correlate imperfectly with clinical outcome. knowledge on altering the course of ms is largely restricted to three patient groups, those with clinically isolated syndromes, those with rrms, and those with secondary progressive ms. before we discuss the known data in each of these demyelinating disease categories, it may be worth while to review the use of the most important evidence-based medicine (ebm) statistics that are applied to measure the magnitude of treatment effect. relative risk reduction (rrr) is the metric most commonly cited in publications and promotional materials about clinical trials. the rrr is the degree that the treatment reduced the frequency of the outcome measure (experimental event rate, e.g., relapse, progression) compared with the control treatment (control event rate). the rrr is a ratio, not an absolute number, and is calculated as follows: rrr â¼ ã°control event rate ã� experimental event rateã�= control event rate if the control event rate is low (making the denominator smaller), it will obviously inflate the rrr. an "impressive" 50% rrr may have a low biological significance if the outcome occurs infrequently. therefore, the absolute risk reduction (arr) should be calculated as this corrects for the frequency of the outcome. for most of the approved ms agents, the calculated arr is considerably less than rrr. this metric is usually not cited in reports of clinical trials of disease-modifying agents. to calculate risk reduction, one must have access to the data citing comparisons of proportions (ratios), and this is not always immediately available in publications. another useful measure of treatment effect is the "number needed to treat" (nnt). it is calculated as the inverse of the arr: overall, the nnts for the disease-modifying agents in ms are in the 7 to 14 range for treatment periods of 2 to 3 years. however, these nnts are for outcomes that have limited predictive value for long-term outcomes (e.g., relapse behavior does not precisely predict long-term disability) and the agents are expensive, inconvenient to use, and not without risk. we must also remember that clinical trials typically enroll patients with very restricted eligibility criteria (often a history of considerable recent disease activity or progression), and considerable efforts are in place in trials to optimize compliance with the treatment plan. as such, the nnt experienced in a practice setting (effectiveness) may considerably exceed what was reported in the trial setting. altering the course of a clinically isolated syndrome. when should treatment be initiated in patients with very early demyelinating disease? two recently published multicenter studies have addressed this issue in persons at high risk of developing ms. in the champs study, 61 383 patients with their first episode of presumed demyelinating disease ("clinically isolated syndrome") in the setting of an abnormal, asymptomatic baseline cranial mri scan, were randomized to receive either weekly interferon-b 1a 30 mg im or placebo after an initial course of steroid therapy. this study was terminated early when the primary outcome measure of conversion to "clinically definite ms" (cdms) status was reached in a greater number of placebo-treated patients. these findings were not unexpected given the known effect of interferons on reducing relapse rate but do provide some support for early treatment. the duration of follow-up in this study (71% 1 year, 34% 2 years, 16% 3 years) is insufficient to determine long-term benefit from early intervention, however. it is also clear that the treatment is only partially effective, as 50% of interferon (ifn)-treated patients in the champs trial had clinical or mri evidence of recurrent disease within 18 months of starting treatment. 62 the analysis of treatment effect related to the champs trial reveal a rrr of 38%, an arr of 14.6%, and an nnt of 7 patients over 2 years to prevent one conversion to "clinically definite ms." in a second placebo-controlled study of 309 patients with either monosymptomatic (61%) or multifocal onset (39%) early demyelinating disease, early treatment with interferon-b 1a in an unusually low dose (22 mg subcutaneously once weekly), reduced conversion to cdms (34% versus 45%) at 2 years. 63 again, there is no data on whether these treatments offer long-term benefit. the ebm calculations regarding this trial show an rrr of 24%, and arr of 11%, and an nnt of 9 patients over 2 years in order to prevent one conversion to "clinically definite ms." these two studies provide support for considering early treatment in patients presenting with first attack, in the presence of multiple asymptomatic mri lesions, but further studies are needed to determine whether this approach will provide a prolonged benefit on disease course. it is important to note that these studies do not provide guidance about clinically isolated syndromes that present with a brain mri that is not suggestive of ms (i.e., only one optic nerve lesion, or one brain stem or cord lesion explaining the cis symptoms). we do not recommend that cis patients with fewer than two asymptomatic mri lesions receive treatment with interferons. please see the discussions under "summary of recommendations for the treatment of rrms patients" for further advice on patient counseling and decision making about the use of the disease-modifying medications. altering the course of relapsing-remitting multiple sclerosis b-interferons. interferons are a class of peptides that have antiviral and immunoregulatory functions. both interferon-a and interferon-b are part of the anti-inflammatory t h 2 response. interferon-b 1b (betaseron) was the first drug approved by the u.s. food and drug administration (fda) specifically for the treatment of ms. a large clinical study in rrms patients demonstrated a reduction in the frequency of relapses by about one third with subcutaneous injection every other day. 64 the severity of relapses was also lessened. interferon-b 1b had a striking effect on mri measures of disease activity. the placebo-control group continued to accumulate white matter lesions, whereas patients in the high-dose arm (8 million iu) had stabilization of their mri lesion load. no difference was found in the disability levels, however. side effects include injection site reactions, flu-like symptoms (low-grade fever, myalgias, headache; these lessen in frequency after treatment for a few months), mild liver enzyme elevation, and lymphopenia. depression and attempted suicide were more common in the treated groups. to illustrate the magnitude of treatment effect of the pivotal interferon-b 1b trial, the rrr was 18%, the arr was 15%, and the nnt analysis showed that 7 patients are needed to be treated over 3 years to increase the number of those who were relapse free by one. one particularly disturbing result was the production of neutralizing autoantibodies (nabs) in 38% of patients after 3 years of treatment. not only do patients with these antibodies thereafter fail to respond to this drug, but there is also a concern that nabs may cross-react with natural interferon-b and interfere with its function. all positive sera for nabs seem to cross-react with both interferon-b 1a and 1b. switching from one preparation to the other does not change the pattern of antibody response. 65 the long-term effects of nabs are unknown. recent studies seem to support that nab formation reduces clinical and mri effects although often nab formation subsides with time. there are no firm guidelines for monitoring nab formation. most physicians do not measure nabs but rather change therapies empirically when patients appear to be failing treatment. low titer nabs may be just transient phenomenon related to ifn treatment; persistent high titer nabs on two consecutive tests at least 6 months apart is likely associated with poor treatment response to inf. interferon-b 1a (avonex) has the same amino acid sequence as natural interferon-b and differs from interferon-b 1b by one amino acid as well as by the presence of carbohydrate moieties. once-weekly intramuscular interferon-b 1a has been found to have effects similar to that of interferon-b 1b in reducing the frequency of ms relapses. in addition, a favorable effect on disability was also demonstrated and side effects were less common. in the original interferon-b 1-a intramuscular trial, the primary outcome measure was time to edss progression. the rrr was 37%, the arr was 13%, and the nnt was 8 for 2 years to prevent one patient from developing edss progression. the calculations for "proportion relapse free" show an rrr of 16%, and arr of 12%, and an nnt of 8 over 2 years (8 patients need to be treated for 2 years to increase the number of patients who were relapse free by one). nabs occurred half as often as with interferon-b 1b. interferon-b 1a has been approved by the fda for treatment of "relapsing ms." 66 the "correct" dose of interferon continues to be debated. in a recent placebo-controlled trial, patients randomized to a high dose of interferon-b 1a (44 mg three times per week) did better than those receiving half this weekly dose. both groups outperformed placebo and the high dose seemed to have more effect on relapse severity, hospitalizations, mri activity, and lesion volume accumulation, and possibly on delaying disability in the most severely disabled patients. at the end of the 2 years of follow-up, placebo-treated patients were randomized to 22 or 44 mg subcutaneously three times weekly; patients on active treatment were continued on their original dose. 67 the authors reported a benefit for the higher dose and for those treated for the full 4 years, again suggesting that early treatment and perhaps higher doses of interferons may be beneficial. the primary outcome, however, was relapse count per patient per 4 years and, as such, patients treated early had a significant advantage using this outcome measure. there were trends favoring the higher dose (relapse rate, mri volumes; not for time to first confirmed progression, however). the authors did not make statistical adjustments for multiple comparisons and there were many dropouts in the high-dose groups, making it difficult to draw firm conclusions. again, the answer to the question about the benefit of early treatment can best come from long-term (perhaps 8 to 10 years) studies using "hard outcomes" (e.g., time to progression, major milestones in disability). the ebm calculations based on the "proportion relapse free" data for the original interferon-b 1a (rebif) study show an rrr of 19%, and arr of 16%, and an nnt of 6 over 2 years to increase the number of relapse free by one. relative treatment advantages of interferon-b 1a and 1b have not been clearly established but are under study. 68, 69 a pilot study in rrms patients suggests that interferon-a may also have a therapeutic effect. 70 a study of interferon responders showed that younger patients with frequent relapses, and higher edss scores upon entry may be associated better response. 71 laboratory monitoring of interferon products. it is important to note that even though the interferon products are generally safe to use, they can be associated with potentially harmful adverse reactions. we recommend that every newly starting patient should have a baseline complete blood count, liver function tests, and thyroid-stimulating hormone (tsh) test. the liver function tests and blood count studies should be repeated in 1 week, 1 month, and every 3 months thereafter; the tsh should be repeated every 6 to 12 months. glatiramer acetate. glatiramer acetate (ga) is a synthetic mixture of polypeptides produced by the random combinations of four amino acids that are frequent in mbp. after a preliminary study suggested efficacy, 72 a phase iii randomized, double-blind, placebo-controlled, multicenter trial showed a 29% reduction in relapse rate. 73 the fda has approved this medication for use in rrms. even though this disease-modifying therapy requires daily subcutaneous administration, the side effects are relatively minor compared to the interferons, and patients do not need regular laboratory monitoring (table 48lesions, lesion volumes, and the percentage of new lesions that will evolve into t1 "black holes," although the mri effect may be less pronounced compared to the interferon products, and is not apparent until the agent has been used for at least 6 months. [74] [75] [76] the ebm calculations for ga using the "proportion relapse free" data show an rrr of 10%, arr of 7%, and an nnt of 14 over 2 years to increase the number of relapse free by one. combined azathioprine and interferon-b 1b. a small trial at nih showed significant reduction in the number of contrast-enhancing lesions when azathioprine in an average maintenance dose of 2 mg/kg/day was added to interferon-b 1b in a study of six rrms patients followed for a median period of 15 months. the addition of azathioprine may be considered in "treatment failure" cases, but this study was hampered by the small number of patients, no control subjects, and no blinding. 77 intravenous immunoglobulin. monthly treatment with low-dose (0.15 to 0.2 g/kg) intravenous immunoglobulin (ivig) in rrms patients resulted in fewer and less severe relapses in addition to slowing the accumulation of disability in a single randomized trial. the outcome was similar to that of injectable interferons. 78 this therapy is less accepted in the united states. more studies with larger number of patients and extended follow-up are needed to confirm these limited observations. recent studies have failed to demonstrate that ivig administration reverses long-standing deficits from ms and on. [79] [80] [81] ivig was also recently studied in acute on and failed to demonstrate benefit on any of the outcome measures. 82 natalizumab. in late 2004, natalizumab was approved for the treatment of rrms. 83 natalizumab is a humanized a-4 integrin antibody that inhibits the migration of all leukocytes (except for neutrophils) to target organs. a phase 2 study established 84 that a 300-mg monthly dose reduced the number of gadolinium-enhancing lesions by 90% and the clinical relapse rate by over 50% compared to placebo. this study was followed by the affirm and sentinel phase iii studies. the affirm study enrolled over 900 patients with rrms; none of them had been on other approved immunomodulators for longer than 6 months. the annualized relapse rate at 1 year was reduced from 0.74 in the placebo group to 0.25 in the treated group (66% relative reduction, p < 0.0001). the proportion of relapse-free patients was 76% in the treated group, 53% in the placebo group. the number of enhancing lesions was reduced by 92%, and the number of new or newly enlarging t2 lesions was reduced by 80%. the proportion of patients without clinical and mri activity was 46% in the natalizumab group, and 14% in the placebo group. in the sentinel trial, the combination of intramuscular interferon-b 1a and natalizumab was studied against im interferon-b 1a and placebo in patients who had demonstrated an incomplete response (relapse suppression) to interferon therapy. the ebm calculations of the affirm data based on proportion with relapses suggests an rrr of 49%, an arr of 23%, and an nnt of 4 over 1 year to increase the proportion of relapse free by one. the senti-nel data shows an rrr of 31%, an arr of 17%, and an nnt of 6 over 1 year to increase the proportion relapse free. the original pilot trial data shows a rrr of 50% and an arr of 19%, with an nnt of 5 over 6 months to increase the proportion relapse free. based on these data, the fda granted expedited approval of natalizumab on november 23, 2004. on february 28, 2005 , the medication was voluntarily withdrawn from the market by the sponsor (biogen-elan) after two cases of progressive multifocal leukoencephalopathy (pml) were reported in the sentinel study cohort. 85 both patients were in the combined interferon and natalizumab arm. a third pml case was later identified from one of the phase iii inflammatory bowel trials of this agent. at the time of writing this manuscript, natalizumab is still off the market. the natalizumab story has received significant media attention. several consequences can be drawn from this failure. first, highly potent immunomodulators like natalizumab are best used by specialists in selected cases. a large number of prescriptions were written for natalizumab during its short 3 months on the market, including prescriptions by general practitioners. widespread use of such medication in relatively stable cases of ms is not indicated. second, the combination of potent immunomodulators may result in unpredictable adverse outcomes. many ms experts anticipate that in the future ms therapies will need to be administered in combination to optimize therapeutic benefit. however, the exact effect of such combinations on the highly complex immune system is difficult if not impossible to predict. furthermore, our inability to treat ms more effectively does not stem from the fact that we can not provide powerful immunosuppression, as evidenced by the autologous bone marrow transplantation studies. ms is a complex disease with a prominent inflammatory component; however, increasing evidence suggests that the neurodegenerative component of this illness may be independent of the inflammatory component, and is just as important, if not more important, from the standpoint of long-term disability. third, in chronic diseases such as ms, a short 1-year trial, no matter how convincing the outcome may be, should not be considered sufficient to approve a medication, which will then be used in tens of thousands of patients on a "lifelong" basis. there clearly is a need for new and more effective medications for treating ms; however, clinical trials in chronic conditions are very difficult to sustain. to overcome this, many ms trials use primary mri outcome measures, since inflammation and new lesion formation-related mri markers respond more immediately to treatment; however, these markers do not correlate well with long term disability, as discussed earlier. summary of recommendations for the treatment of rrms patients. when making decisions about starting an ms patients on immunomodulators, several factors must be considered. one must realize that even though there are medications available for relapsing forms of ms, all the currently available therapies are only partially effective, the most reliable data is about short-term relapse rate reduction, and a relapse rate reduction does not necessarily translate into reduction of future disabilities. natural history data clearly suggest that a subset of ms patients will do very well without treatment (see discussion about the olmsted county cohort later); this information can be very useful when deciding about treatment in patients with a 5-or 10-year disease history and minimal disability (edss 2.0). in this patient group, a careful wait and see approach with appropriate monitoring is acceptable. counseling of newly diagnosed ms patients is of crucial importance, and it should usually include family members. most patients have easy access to an abundance of frequently misleading information on the internet, or from relatives and friends with ms. it is important to realize that every case is different; however, through the rational use of natural history data, clinical and mri features of the specific case, and the clear understanding of the available clinical trial data, the clinician should be able to provide customized and relevant advice to patients and families. considering that the treatments are only partially effective, the wishes of an educated patient constitute an important part in the decision-making process. ultimately, the treatment decisions should remain individualized between the patients and their treating physicians, and the physician's role as an information clearinghouse and educator cannot be overemphasized in this process. the three interferon products and ga represent the most commonly used ms immunomodulators in the united states; therefore, it is important to draw some practical conclusions about these agents. by now, several class i studies demonstrate that these agents are effective in reducing the relapse rate in rrms over a 2-to 3-year period; the reduction is roughly 30% with the high-dose interferons and ga. the above-mentioned nnt data are also very useful for the clinician and the well-informed patient when making treatment decisions. there is evidence for a dose-response relationship among the interferon products, mostly from the evidence and incomin studies. the double dose im interferon-b 1a study did not show a dose-response relationship; this may be related to the fact that the increased dose was given with the same frequency as the standard dose. the injectable immunomodulators have incomplete evidence for efficacy in disability-based outcome measures. many of the long-term extension studies suffer from several drawbacks, including open label unblinded design, significant dropout rate, and lack of control subjects; this is especially true for the ga extension data. the currently available few head-to-head comparison studies are also hampered with methodological issues; new comparative studies are under way. overall, these agents remain partially effective in relapsing forms of ms; their long-term effects on reducing the clinically most important feature of ms-disability-still remains unclear. altering the course of secondary progressive ms. within 15 years of onset, almost 60% of rrms patients will enter the secondary progressive phase of the disease. treatment approaches aimed to affect the natural course of disease are available for these patients. interferons. interferon-b 1b may have a beneficial effect on the overall outcome of spms and may also alter mr lesions, 86, 87 but this question remains incompletely answered. in the placebo-controlled european study 88 of inteferon-b 1b in spms, the time to worsening was extended for treated patients. treated patients were less likely to be wheelchair-bound and had fewer hospitalizations. another analysis 89 of this study confirmed the benefits, though the dropout rate in this study was relatively high. the patients who responded best to interferon therapy were those who experienced relapses during their disease course. mri monitoring suggested that the benefit on t2 lesion activity was seen early and persisted into the second half of the second year of treatment. t2 lesion load increased in placebo-but not interferon-treated patients in the first 2 years of treatment. 90 contrasting with these results, in another trial involving patients with spms, 91 both high dose (44 mg) and lower dose (22 mg) interferon-b 1a failed to change the primary outcome of time to disability worsening. positive effects were seen on relapse rate and reduction of mri activity, but the effect on disability did not replicate the european interferon-b 1b report. a combined analysis of the american and european trials concluded that continued relapse activity and more rapid progression over the preceding year (by >1 on the edss scale) are the best predictors of response. 92 ivig in secondary progressive ms. a recent european trial reported that ivig did not have a significant impact on clinical and disability related outcome measures. ivig did reduce the accumulation of brain atrophy in spms, but did not reduce the incidence of blood-brain barrier abnormalities. there was no statistically significant change on magnetization transfer mri measurements; however, a trend for conservation of normal-appearing brain tissue was found. 93 overall recommendations for spms. in general, as the evidence that interferons alter long-term disability is limited and controversial, we generally do not newly start spms patients on interferon products. in a subset of patients still having disabling relapses, interferon therapy may be offered to specifically reduce relapse rate. the data by confavreux and associates, however, suggest that the edss in populations of spms patients continues to progress independent of relapses 94 once a "fixed" baseline level of moderate disability has been reached. therefore, while interferons may reduce the relapse rate in spms, the rate of progression of disability may not be reduced by these treatments. more usually, spms patients are already on an injectable immunomodulator, and the question of whether it is worth continuing the therapy may come up, especially in patients who have a hard time tolerating these medications and feel that the side effects of the medications have a clear negative impact on their overall health. in these cases, we usually allow the patients to stop their medications. just like in the rrms cases, however, patient education about spms trials and realistic expectations about the treatment is a crucial element in the decision-making process. understanding the patient's needs and fears and clarifying potential misconceptions constitute a very important role of the treating neurologist. in those patients who continue their interferon therapy, we must continue to follow them for toxicity and disease activity. please also see the following discussion under mitoxantrone for recommendations on the potential use of that specific agent in spms. mitoxantrone. mitoxantrone (novantrone) is an anthracenedione chemotherapeutic agent licensed . . .for reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e. patients whose neurologic status is significantly abnormal between relapses). mitoxantrone is not indicated in treatment of patients with primary progressive multiple sclerosis. significant benefits were observed in a group of spms patients as in a european phase iii study of mitoxantrone. 95 it has also been used in combination with methylprednisolone. 96 several clinical and functional outcome measures were reported to stabilize or improve with every 3-month administration of this intravenous medication. secondary mri outcome measures, including enhancing lesion formation and overall t2 lesion load, were also better in the treated patients. the greatest concern regarding this medication is its cardiac toxicity: the cumulative lifetime maximum dose was established at 140 mg/m 2 . mitoxantrone can induce a seemingly dose-dependent cardiomyopathy, leading to potentially fatal congestive heart failure. we generally avoid exceeding a total lifetime dose of 96 mg/m 2 (8 doses of 12 mg/m 2 ). patients receiving mitoxantrone should also be monitored every 3 months with echocardiograms or muga (multiple gated acquisition) scans to determine the ejection fraction. reduction in the ejection fraction should prompt discontinuation of this therapy. besides the cardiac side effects, mitoxantrone may cause menstrual irregularities or overall ablation of the menstrual cycle, which may be permanent. in a review of the literature, ghalie 97 estimated the risk of mitoxantrone therapyrelated acute leukemia in ms patients at 0.05% to 0.1%; in an international registry of ms patients taking mitoxantrone, the risk of leukemia seems somewhat higher. this therapy has been approved by the fda for treatment of spms, but no peer-reviewed full report of the mims study had been published until 4 years after the initial report in an abstracts form. the study 98 showed a treatment effect in rrms and spms patients with "recent rapid worsening." the study had a high dropout rate and a small sample size. most patients (74%) had relapses in the preceding 2 years, suggesting this cohort mostly includes worsening rrms or prms patients, in whom a positive treatment effect is expected; however, it does not mean that for classic spms patients who no longer have relapses the study outcome is applicable, and it is especially not applicable to ppms cases. the primary outcome measure was a composite score comprised of five clinical measures: change in edss at 2 years; change in ambulation index at 2 years; change in the baseline standardized neurological status at 2 years; number of relapses requiring corticosteroid treatment; and time to first relapse. seventy-seven percent completed 24 months of follow-up. at 24 months, benefit was reported in all five components of the composite measure for both active treatment arms, with the overall greatest benefit noted between placebo and the group receiving mitoxantrone at a dose of 12 mg/m 2 . the magnitude of the effect on edss was rather modest (mean edss change for high-dose mitoxantrone, -0.13 [sd 0.90] versus ã¾0.23 [sd 1.01] in the placebo group). the mri results of the mims trial were published in 2005 and are frankly disappointing. 99 in a subset of 110 patients (out of 194 in the trial overall), the 12 mg/m 2 dose failed to reach a significant difference from placebo as measured by the primary mri outcome (total number of scans with gadoliniumenhancing lesions). the 12 mg/m 2 dose reduced the number of t2-weighted lesions at month 24 (p â¼ 0.027) and showed a trend at month 12 (p â¼ 0.069). the number of active mr lesions showed a trend toward reduction in the 12 mg/m 2 group only at month 24 (p â¼ 0.054). overall, the limited evidence to date supports the conclusion that mitoxantrone reduces relapse frequency and mri evidence for blood-brain barrier disruption in patients with very active ms. the benefit for patients with relapse-independent progression is uncertain at best. from the mims results, one would need to treat 11 patients with secondary progressive multiple sclerosis for 2 years to prevent one person from worsening by 1.0 edss point. this modest benefit must be carefully examined in light of the significant risk for toxicity. therapy of ppms. unfortunately, for classical ppms cases that present with insidious progression of usually myelopathy symptoms, none of the currently available treatments offer any clear benefit. the promise trial, in which over 900 ppms patients were treated with ga, was terminated early owing to lack of effectiveness. the results of this trial have not yet been published. a small study with intramuscular interferon-b 1a was also negative. 100 currently a large trial is under way with rituximab in csf ocb-positive ppms patients. until we clearly understand the pathophysiology of slow progression in ms, it is unlikely that we will find a treatment that has an important impact on this form of ms. symptomatic treatment modalities, including physical and occupational therapy, are very important, yet frequently overlooked in this patient population. other immunomodulator therapies. cyclophosphamide is an alkylating agent that has indiscriminate cytotoxic effects on rapidly dividing cells, including lymphocytes, making it a potent immunosuppressant. several studies have claimed a beneficial effect in both relapsing and progressive patients. because one of the major studies included acth, iv methylprednisolone is sometimes given with the cyclophosphamide. other trials have not found a favorable effect. because of the inconsistent results, high potential for serious side effects, and adverse reactions, including hemorrhagic cystitis and malignancy, cyclophosphamide is not widely used. some centers, however, use cyclophosphamide in patients with aggressive disease in whom more conventional treatments have failed. azathioprine, a purine analog antimetabolite, has marginal efficacy in the treatment of ms. a meta-analysis of all blinded, placebo-controlled studies confirmed a slight benefit of slowed progression and less frequent relapses. 101 the toxicity of azathioprine and its slow onset of action have prevented its widespread use. besides the liver toxicity and hematological effects, the induction of malignancies has been a concern. one retrospective study did not find an increased incidence of cancer in ms patients treated with azathioprine, but this remains a potential risk. methotrexate is a folate antagonist that is effective in rheumatoid arthritis. weekly low-dose oral methotrexate was found to delay upper extremity dysfunction in spms patients, although it had no effect on the more traditional measures of disability, including the expanded disability status scale (edss). 102 the use of cyclosporine in the treatment of ms has been evaluated in three clinical trials, none of which have demonstrated a convincing benefit. in addition, side effects such as hypertension and elevation of creatinine were common. numerous additional therapies have been tested, and many others are undergoing evaluation. the antiherpesvirus drug acyclovir has been shown to reduce relapse frequency in a small prospective trial. total lymphoid irradiation was found to slow the chronic progression of ms, but because this approach precludes the later initiation of immunosuppressant drugs and may be associated with a higher mortality rate, it is not widely used. cladribine is a nucleoside derivative that was found to decrease relapse rate and slow the progression in patients with spms in an initial investigation. 103 the drug is better tolerated than other parenteral immunosuppressants, although bone marrow suppression is a risk. in a more extensive clinical trial, 104 cladribine therapy did not change disability scores, but significant reduction in enhancing lesions and overall t2 lesion burden was observed with higher dose treatment. a study of a small number of patients treated with autologous stem cell transplantation 105 suggested possible clinical stabilization or minor improvement over a 15-month period of follow-up in both secondary and primary progressive ms. the induction chemotherapy (beam regimen) resulted in one fatality in this trial; similar incidences are known in patients undergoing this procedure. the small number of patients and the different methods used (some patients received cd34 ã¾ selected graft) makes the interpretation of this data very difficult. trials with higher number of patients under standardized circumstances are needed to verify the validity of these observations. symptomatic treatment of existing disabilities spasticity. spasticity is common even in patients with only minimal weakness (video 3, spastic gait). it is usually prudent to begin treatment of mild spasticity with a stretching program. a randomized controlled crossover trial 106 of physical therapy (8-week blocks of therapy twice a week, for 45 minutes per session) showed significant benefit on several outcome measures related to improved mobility. no apparent differences were observed between home-based or hospital-based therapy. the addition of an evening dose of benzodiazepine may help relieve extensor spasms and clonus that may interfere with sleep. as spasticity worsens, it becomes necessary to use baclofen. doses should be escalated slowly to prevent the occurrence of overt side effects, and up to 120 mg/day may be required. although baclofen is well tolerated in most patients, limiting side effects such as sedation and increased muscle weakness may occur, and rarely a paradoxical increase in spasticity is noted. liver enzyme elevation and nonconvulsive status epilepticus presenting as encephalopathy have also been reported in association with baclofen. abrupt withdrawal of baclofen may result in hallucinations or seizures, making it necessary to taper doses. despite symptomatic improvement, antispasticity measures may not increase function or independence. in paraplegic patients with severe spasticity and intolerance to the required oral dose, intrathecal baclofen delivered by a subcutaneously implanted pump allows a much smaller dose and is often effective in alleviating intractable spasticity and may lessen urinary urgency. tizanidine seems to be as effective as baclofen, although it may be associated with more fatigue. dantrolene has been used for spasticity, although the therapeutic window is small. fatigue. for treating fatigue, medications are only partially effective. amantadine at 100 mg twice a day is the standard initial treatment, although pemoline 37.5 mg daily is also superior to placebo. a recent, small pilot study by the mayo group suggested that high-dose aspirin (1300 mg/day) may sometimes be effective in the treatment of ms-related fatigue. 107 this finding needs to be confirmed by a second, larger trial, however. the stimulating effects of the selective serotonin reuptake inhibitors may also be somewhat effective in combating ms-related fatigue. modafinil, a medication approved for the treatment of narcolepsy, has also been used with good success. often, however, patients need to limit activities and schedule rest periods. paroxysmal symptoms of ms. paroxysmal symptoms are highly responsive to medical treatment. a small dose of carbamazepine is often very effective. if not tolerated, several alternative medications may be tried, including phenytoin, acetazolamide, baclofen, and gabapentin. in addition, misoprostol has been claimed to be effective in ms-related trigeminal neuralgia. after about 1 month of treatment, a periodic attempt at tapering off these medications is a reasonable approach because these symptoms usually remit. seizures in ms are treated no differently than in non-ms conditions. heat sensitivity. heat sensitivity may require avoidance of precipitating activities, but this depends on the nature of symptoms and the situation in which they occur. if the precipitating activity cannot be avoided, a cooling jacket may be an option. a potassium channel blocker, 4-aminopyridine, improves temperature sensitivity in some patients but occasionally causes seizures or disturbing paresthesias. action tremor. action tremor is a common disabling symptom (video 14, tremor with ataxia). unfortunately, it is often only marginally amenable to medical therapy. clonazepam may offer some relief, but tolerance frequently develops, necessitating increasing doses. isoniazid and carbamazepine have also been found marginally beneficial. one clinical trial showed ondansetron to reduce tremor-related disability. anecdotal reports suggest that gabapentin may be partially effective. improvements in stereotactic neurosurgery have made thalamotomy a legitimate option in those whose disability is mainly due to tremor and not ataxia. cognitive and memory problems. cognitive problems can also be seen in ms patients. these symptoms are generally not very severe; however, in some patients these may be one of their subjectively most bothersome complaints. it is important to make sure that such complaints are not depression related, as mood disorders are otherwise rather common in ms, and may explain the subjective cognitive impairment. while it is not fda approved for the treatment of ms related cognitive dysfunction, in a placebo controlled, randomized, 24-week long study of donepezil in 69 patients, significant improvement was found on the selective reminding test (srt). 108 this improvement was independent of ms subtype, gender, age, reading ability, and baseline srt results. the patients did not improve on other cognitive scales, but they were twice as likely to report cognitive improvement. dysesthetic pain. dysesthetic pains are difficult to control but sometimes respond to tricyclic antidepressants, carbamazepine, or baclofen. gabapentin, tramadol, and duloxetine may also be effective. standard analgesics are not often useful in ms-associated pain, and narcotics should be avoided in the treatment of chronic pain. emotional incontinence may be amenable to a low dose of a tricyclic antidepressant (video 10, dysarthria). symptoms of bladder dysfunction. symptoms of a hyper-reflexic bladder (urgency, frequency, and urge incontinence) are often manageable with anticholinergics such as oxybutynin, propantheline, or imipramine. a flaccid bladder can sometimes be aided by bethanechol, although intermittent self-catheterization is more often needed. symptoms that suggest urinary retention (a feeling of incomplete emptying, frequency, hesitancy, or a need to apply pressure to the lower abdomen to urinate) should prompt evaluation with urinalysis and a post-void residual urine measurement. residuals in excess of 15 ml are abnormal; and if they are above 50 ml, consideration should be given to urological consultation for more thorough investigation and to blood chemistries to determine urea and creatinine levels. detrusor-sphincter dyssynergia, diagnosed by cystometrography, is treated with anticholinergics, sometimes with the addition of an a-1 blocking agent (terazosin) or intermittent catheterization. it is important to reassess bladder function periodically, and residual urine volumes should be monitored if there are any persistent changes in function or symptoms. intermittent catheterization should be considered when post-void residuals reach 100 ml. a chronic indwelling urinary catheter should be avoided if reasonably possible. it is usually not necessary to use antibiotics prophylactically in the prevention of urinary tract infections. urinary calculi may be prevented by acidification of the urine with cranberry juice. bowel dysfunction in ms. constipation can usually be managed with bulk laxatives and stool softeners. more severe cases may require osmotic agents, bowel stimulants, anal stimulation, suppositories, or enemas. bedridden patients may develop fecal impaction unresponsive to these measures and require manual disimpaction. fecal incontinence can be minimized by adherence to a schedule for bowel movements. fiber supplementation may be of some benefit even in these cases. sexual dysfunction in ms. the clinician should determine the precise nature of any sexual dysfunction in patients with ms. physical difficulty from spasticity may be alleviated by premedication with baclofen, and a fast-acting anticholinergic such as oxybutynin may calm urinary urgency. sexual dysfunction should not be automatically attributed to ms. it may be necessary to investigate hormonal levels and to obtain urological or gynecological consultation. manual lubrication with gel is a ready solution to vaginal dryness. erectile dysfunction responds very well to sildenafil. less frequently, vacuum devices, intracavernous injections of papaverine (or combinations of papaverine, prostaglandins, and epinephrine; triple agent), or penile implant are also used in the treatment of erectile dysfunction. thalamotomy or thalamic stimulation may provide some short-term clinical benefit to patients disabled by appendicular cerebellar tremor and ataxia. the benefits on disability and quality of life are much less clear, however, and the early benefits may wain within 1 to 3 years. 109, 110 further studies are needed to clarify how best to select patients for these ablative and stimulation treatment interventions. general recommendations for ms patients. it is advisable for ms patients to attain good health habits, including proper diet and fitness. smoking, excess alcohol intake, and obesity should be avoided. exercise can help maximize function by increasing and maintaining joint mobility, strength, and stamina; may promote improved sleep hygiene; and may reduce the severity of fatigue. physical and occupational therapy can play an important role in regaining independence. canes, walkers, and wheelchairs or scooters may be needed to maintain safe mobility. hand controls can be installed in automobiles for patients with lower extremity dysfunction. in debilitated, immobilized patients, periodic shifts in posture to change weight-bearing regions and air or water mattresses prevent bedsores. passive range of motion exercises prevent contractures. when ventilatory dysfunction occurs, it should be evaluated and activity schedules should be appropriately modified. 111 special considerations during pregnancy. before initiation of any drug in a woman of reproductive age, the potential for teratogenicity must be discussed. in general, immunomodulator therapy should be avoided if one is planning a pregnancy. the treatment of acute exacerbations is unchanged during pregnancy, although one might have a higher threshold for treatment. both corticosteroids and plasma exchange are relatively safe during pregnancy. none of the drugs used to alter the disease course, however, should be used during pregnancy. interferon-b drugs should be stopped 2 to 3 months before planning pregnancy. interferons are associated with an approximately 39% likelihood of abortions. this is close to eight times higher than the usually quoted approximately 5% spontaneous abortion rate in women. interferon-b use is also associated with lower birth weight. 112 the cytotoxic immunosuppressants have teratogenic effects. the effects of many of the other drugs are unknown. it is best if these drugs are stopped several months before a planned pregnancy. prognosis and future perspectives. because most information on the prognosis of ms is reported in terms of the edss, it is important to have some understanding of this scale. the edss is a 10-point scale, with each increase representing worsening symptoms of function. the score is derived from severity scores in each of six systems as well as ambulation and work ability. a score of 0 means no signs or symptoms; 1 to 3 represent mild disability with no or minimal impairment of ambulation; 3.5 to 5.5 refer to moderate disability and impairment of gait; the need for a cane to walk one-half block (100 m) receives a score of 6; an edss of 8 refers to the need for a wheelchair and effective upper extremity function; an edss of 10 refers to death related to ms. ms has a highly variable outcome, ranging from asymptomatic to fulminant with death ensuing in a matter of months. autopsy series have estimated that unsuspected ms may occur in as many as 0.2% of the population. even when symptomatic, ms may cause only nuisance symptoms. benign ms, when defined as unrestricted ambulation or edss of 3 or less 10 years after onset, accounts for about one third of cases. however, many of these patients acquire more disability later. when considering all patients with ms, weinshenker found that 15 years after onset, 80% had edss worse than 3, 50% had reached edss of 6 or more, 10% were at edss 8, and 2% had died. the percentage of patients with initially rrms who develop spms increases steadily with disease duration. 113 at 10 years, 40% to 50% have continual deterioration; after 25 years, approximately 80% have slow progression. in the most recent study published about the olmsted county ms prevalence cohort consisting of 161 patients, the mean change in edss over 10 years was 1 point, and only 20% of patients had a change larger than 2.0 points. 114 eighty-three percent of the patients with mild symptoms (edss < 3.0) were still ambulatory without cane 10 years later. among the patients with an edss of 3 to 5, 51% were using a cane; in the 6 to 7 edds range, 51% were wheelchair bound. strong predictors for the outcome were not identified in this study. population-based studies with complete ascertainment can effectively remove the bias of a referral practice, which is inherently biased towards the more active and more serious cases. these studies also provide some much needed balance to the "heavily skewed for recent disease activity" clinical trial experience. from the most recent extensions to the olmsted county ms cohort studies conducted by the mayo group, several conclusions can be drawn. the number of relapses in the first year of the disease do not predict long term outcome. the time to disability is not influenced by ongoing relapses once patients achieve an apparently permanent degree of moderate disability (edss 3.5). overall, 80% patients who are still classified as rrms into their second decade of disease continue to do well for 15 to 20 years with limited permanent disability. patients doing extremely well (edss 2.0) after 10 years of ms generally do well in the next decade. however, very rarely patients doing well even for 2 to 3 decades may develop severe late disability. we advise that neurologists share these findings with patients who are in periods of prolonged remission during the discussions about the merits of beginning disease-modifying agents. natural history studies have identified several prognostic indicators that predict outcome to a limited extent. factors associated with a better prognosis (slower accumulation of disability, longer time before chronic progression) include young age at onset, female gender, rr course (as opposed to ppms), initial symptoms of sensory impairment or on, first manifestations affecting only one cns region, high degree of recovery from initial bout, longer interval between first and second relapses, low number of relapses in the first 2 years, and less disability at 5 years after onset (both edss and number of systems affected-sensory, motor, sphincter, brain stem, vision, cerebral). despite the indolent nature, a pp course is the worst prognostic factor, with the median time to reach edss 6 of only 6 years, compared with approximately 20 years in rr patients. men and patients with an older age at onset are more likely to have ppms. the survival of ms patients is only slightly below expected. seventy-six percent of patients are alive 25 years after onset, which is 85% of that seen in age-and sexmatched control subjects. 35 ms is rarely the direct cause of death. complications of ms such as pneumonia, pulmonary emboli, aspiration, urosepsis, and decubiti are responsible for 50% of deaths. most of the other deaths are from heart disease, cancer, cerebrovascular disease, and trauma. suicide is the only cause of death that is overrepresented among these cases. the suicide rate among ms patients may be as high as two to seven times that of non-ms persons. neuromyelitis optica (nmo) is an uncommon neurological illness characterized by the occurrence of optic neuritis and myelitis. the names devic's syndrome, devic's disease, and nmo are often used interchangeably, although the first name encompasses all patients who fit the preceding definition and the second and third should only be used to refer to those patients presumed to have a distinct disorder. the term opticospinal ms is often used in the far east to denote patients with exclusive or predominant involvement of optic nerves and spinal cord, encompassing most patients with devic's syndrome. devic's disease (nmo) may be a monophasic illness, or may show a relapsingremitting course. 115 it is the first inflammatory demyelinating disease with a known serum marker, the nmo-igg antibody. pathogenesis and pathophysiology. devic's syndrome may occur with adem, autoimmune disorders (e.g., systemic lupus erythematosus), ms, and possibly viral infections. also, patients with devic's disease may have other coexisting autoimmune conditions. classically, acute spinal cord lesions demonstrate diffuse swelling that extend over several levels or involve nearly the entire cross section of the cord. acutely, there is destruction with dense macrophage infiltration involving white and gray matter, loss of myelin and axons, and lymphocytic cuffing of vessels. in chronic lesions, the cord is atrophic and necrotic, occasionally with cystic degeneration and gliosis. in the absence of perivascular cuffing, these extensive lesions resemble infarctions. the prominent spinal cord swelling in the confines of the restrictive pia presumably may raise intramedullary pressure, leading to the collapse of small parenchymal vessels, further propagating tissue injury. proliferation of vessels with thickened and hyalinized walls similar to that seen after infarction or other extensive injury may occur. 116 less fulminant lesions may coexist and are much more typical of inflammatory demyelination. the optic nerve lesions often involve the chiasm. even though nmo is usually restricted to the optic nerves and spinal cord, one may see classic ms like lesions in up to 10% of cases, and hypothalamic lesions have also been described in approximately 10%. the newly discovered serum marker, nmo-igg has a sensitivity of 73% and specificity of 91%. 117 the discovery of this novel immune marker also clarified that most if not all cases of "opticospinal ms" reported in the japanese literature are also cases of nmo. to the surprise of the ms research community, the antigen is neither myelin nor neuron related: it is the aquaporin-4 water channel, a component of the dystroglycan protein complex located in astrocytic foot processes at the bloodbrain barrier. 11 nmo thus may represent the first example of a novel class of autoimmune channelopathies. epidemiology and risk factors. devic's syndrome occurs in patients of varied ages (range, 1 to 73 years). the mean age at onset of monophasic devic's syndrome is 27, whereas relapsing nmo (see later) tends to occur in an older age group (mean age at onset of 43). monophasic devic's syndrome affects males and females equally, whereas relapsing nmo affects females predominantly (f:m, 3.8:1). one third of patients have a preceding infection within a few weeks of neurological symptom onset. most commonly this is a nonspecific upper respiratory tract infection, flu, or gastroenteritis. the most common specific infections preceding the development of devic's syndrome are chickenpox and pulmonary tuberculosis. devic's syndrome has also followed vaccination for swine flu and mumps. only a few instances of a possible familial occurrence of devic's syndrome have been reported, and in one of these families, a unique mitochondrial mutation was found. devic's syndrome is said to be more common in japan and east asia, although even there it is uncommon (less than 5 per 100,000). three cases have been described in the literature with familial occurrence of devic's disease in the far east. in a genetic study, hla-dpb1*0501 was more frequently associated with "opticospinal ms," whereas hla-dpb1*0301 is the most strongly associated allele with conventional ms in the japanese. symptoms of on and myelitis develop over hours to days and are often preceded or accompanied by headache, nausea, somnolence, fever, or myalgias. continued progression of symptoms over weeks or months occasionally occurs. most patients (greater than 80%) develop bilateral optic neuritis. bitemporal or junctional field deficits, indicating chiasm involvement, are sometimes present early in the course of the on. visual loss is often accompanied by periocular pain, and myelitis onset is sometimes heralded by localized back or radicular pain. lhermitte's sign is common. severe degrees of neurological deficits are usual, and the degree of recovery is variable. approximately 35% of nmo patients have a monophasic illness, 55% develop relapses usually limited to the optic nerves and spinal cord (relapsing nmo or opticospinal ms), and rarely patients have a fulminantly progressive course without relapses or a course typical of ms. 115 according to a study conducted at the mayo clinic, 115 patients with a monophasic course usually presented with rapidly sequential events (median, 5 days) with only moderate recovery. patients showing characteristics of the relapsing form of devic's had a median interval of 166 days between index events, followed within 3 years by clusters of severe relapses isolated to the optic nerves and spinal cord. most relapsing patients developed severe disability in a stepwise manner. approximately one third died from respiratory failure. predictors of a relapsing course in nmo 118 include longer inter-attack intervals (relative risk [rr]: 2.16 per month increase), older age at onset (rr â¼ 1.08 per year increase), female sex (rr â¼ 10.0), and less severe motor impairment with sentinel myelitis event (rr â¼ 0.48 per severity scale point increase). autoimmune disease history (rr â¼ 4.15), higher attack frequency in first 2 years (rr â¼ 1.21 per attack), and better recovery following index myelitis (rr â¼ 1.84 per point) are associated with increased mortality rate. features of nmo distinct from "typical" ms included normal initial brain mri, more than 50 cells/ml in csf with polymorphonuclear predominance, and lesions extending over three or more vertebral segments on spinal cord mri. relapsing nmo is often associated with autoimmune disorders, most commonly systemic lupus erythematosus. these patients also frequently have an elevated erythrocyte sedimentation rate and nonspecific elevation of autoantibodies, including antinuclear antibodies, anti-ds-dna, and antiphospholipid antibodies. tonic spasms and neuropathic lower extremity pain are common sequelae to the spinal cord damage. symptoms referable to brain stem lesions (nystagmus, ophthalmoparesis, and vertigo) can occur in these patients as well. differential diagnosis. the differential diagnoses for devic's syndrome includes ms, adem, pulmonary tuberculosis, and viral infection (especially in the immunocompromised patient). in patients with an apparent affected family member, consideration should be given to mitochondrial disease. relapsing nmo should raise the suspicion for associated autoimmune disorders. because devic's syndrome can occur in persons older than age 60, when an unrelated ischemic optic neuropathy could occur, and because isolated or recurrent myelopathy may precede the on, additional consideration must be given to spinal cord compression, spinal cord tumor, and spinal arteriovenous malformation (avm) or dural fistula. evaluation. imaging is needed to exclude structural lesions and provide information on the pathological process. optic nerve or chiasm enlargement, t2-weighted signal changes, and enhancement may be seen on head mri during the acute phase. increased t2-weighted signal in the medulla is not uncommon and usually represents extension of high cervical lesions. spine mri characteristically shows cord swelling, signal changes, and enhancement extending over at least three levels ( fig. 48-4) . this appearance may resemble a spinal cord tumor, prompting consideration for biopsy. on magnetization transfer (mt) mri, no significant difference was found on normal-appearing white matter of devic's patients and control subjects, whereas ms patients had a significantly lower mt ratio peak and histogram average. 119 t1 hypointense lesions in the cord and linear lesions that cross over more than two segments are more suggestive of devic's disease. an occasional patient may need prone and supine myelography to exclude a spinal dural-based avm. laboratory investigations reveal an elevated erythrocyte sedimentation rate in one third, positive antinuclear antibodies in nearly one half, and occasionally other autoantibodies (e.g., thyroperoxidase antibodies). 39 it is reasonable to exclude syphilis, lyme disease, and human immunodeficiency virus by laboratory testing. in a few patients with the far east variety of devic's disease, hyperprolactinemia was described predominantly with optic nerve involvement. a chest x-ray helps to exclude pulmonary tuberculosis and sarcoidosis. csf examination is an essential part of the evaluation for devic's syndrome, and repeated studies are sometimes necessary to ensure that there is no infection in that the csf findings are sometimes atypical for inflammatory demyelination. a marked pleocytosis is often present, sometimes exceeding 100 cells. moreover, neutrophils are commonly seen in csf and may predominate, a situation virtually unknown in ms. 120 the protein concentration is often very high and in 41% exceeds 100 mg/dl. anti-mog antibodies are the predominant autoantibody detected in csf; anti-mbp or anti-s100b antibodies are less frequently seen. despite the intense inflammatory response, ocbs are conspicuously absent in the majority, being present in fewer than 20% of patients. csf serology for the herpesvirus family (hsv types 1 and 2, vzv, ebv, and cmv) is important, and polymerase chain reaction testing should be done in cases suggestive of viral infection (immunocompromised patients). management. patients with acute or subacute devic's syndrome may respond to corticosteroids (e.g., intravenous methylprednisolone). they may respond to plasma exchange even when intravenous methylprednisolone does not produce significant improvement. attempts at preventing relapses and the subsequent disability are often disappointing even with the use of immunosuppressive agents. the classic injectable immunomodulators used in ms are insufficient to reduce the relapse rate in relapsing nmo. most commonly, a combination of azathioprine and prednisone is used for secondary prevention. other agents including mycophenolate mofetil, ivig, and mitoxantrone have been described to be effective in some cases. a small study of rituximab, a humanized anti-cd20 antibody showed a siginifcant reduction in the relapse rate of 8 patients, making 6 of 8 relapse free. 121 a large multicenter study of rituximab in nmo is in the planning stages. supportive care is important in the management of nmo. these patients are prone to many complications and require measures to prevent deep venous thrombosis and pulmonary embolism, urinary tract infection, decubiti, and contractures. mechanical ventilation may be needed either temporarily or permanently. patients with monophasic devic's syndrome generally have simultaneous or rapid onset of the on and myelitis (interval usually less than 1 month). although some have significant residual disability, many recover remarkably and have little or no permanent deficits. a history of previous vague neurological symptoms or definite demyelinating events is predictive of future relapses, either typical of ms or relapsing nmo. those patients destined for recurrent myelitis and on have a longer interval between the onsets of myelitis and on. the vast majority of patients with relapsing nmo have very aggressive disease with frequent and severe exacerbations and a poor prognosis. adem is a monophasic inflammatory demyelinating disorder that characteristically begins within 6 weeks of an antigenic challenge such as infection or immunization. it occurs more often in the young and causes the rapid development of multifocal or focal neurological deficits. perivenous inflammation, edema, and demyelination are the pathological hallmarks of adem, although these lesions commonly enlarge and coalesce, forming lesions pathologically indistinguishable from ms. moreover, perivascular changes typical of adem are common in patients with ms. there is considerable overlap in the epidemiological, clinical, csf, imaging, and pathological features between adem and ms, often making it difficult to distinguish between the two with reasonable confidence when encountering patients with a single demyelinating event. pathogenesis and pathophysiology. adem closely resembles the experimental allergic encephalomyelitis animal model of ms (eae) both clinically and pathologically, and is most likely due to a transient autoimmune response toward myelin. the occurrence of adem after vaccination with the rabbit spinal cord preparation of rabies virus led to the discovery of eae. infections and non-cnscontaining vaccinations may induce adem by molecular mimicry or by activating autoreactive t-cell clones in a nonspecific manner. lymphocyte reactivity toward mbp has been identified in blood and csf from patients with adem, but its absence in others indicates a role for other antigens. increased peripheral blood g interferon-producing t cells have been described in adem. epidemiology and risk factors. adem can occur at any age but perhaps because of the higher frequency of immunization and exposure to new antigens; it is most common during childhood. unlike ms, both sexes are affected with equal frequency. no association has been noted with pregnancy. adem has been reported to follow a number of different immunizations, usually within 6 weeks, including those for pertussis, diphtheria, measles, mumps, rubella, influenza (postvaccination adem), tetanus, and yellow fever. in addition, there are case reports of adem following hepatitis b vaccination. however, the only epidemiologically and pathologically proved association is with rabies vaccination, which also causes demyelinating peripheral neuropathies. the original pasteur rabies vaccine, prepared in rabbit spinal cord, was associated with an incidence of adem of approximately 1 per 3000 to 1 per 35,000 vaccinations and is no longer in use. a later vaccine, made in duck embryo, which contains little neural tissue, carries a risk for adem of 1 per 25,000 vaccines. the use of human diploid cell lines, which contain no nervous system tissue, for the production of rabies vaccine has virtually eliminated the risk of adem. the association of bee stings with adem has also been reported. parainfectious adem usually follows onset of the infectious illness, often during the recovery phase, but because of the latency between pathogen exposure and illness it may precede clinical symptoms of infection or the two may occur simultaneously. the most commonly reported associated illness is a nonspecific upper respiratory tract infection. there have been a vast number of specific infections associated with adem, such as virus infections (including rubella, mumps, vzv, ebv, cmv, influenza, coxsackievirus, and hepatitis c) and infection with mycoplasma, borrelia burgdorferi, and leptospira. measles carries the highest risk for adem of any infection, occurring in 1 per 400 to 1 per 1000 cases. although adem has been reported in association with measles immunization, the risk is far lower than the risk of acquiring measles and its neurological complications. clinical features and associated disor-ders. a prodrome of headache, low-grade fever, myalgias, and malaise often precedes the onset of adem by a few days. in a german study of 40 cases, 122 the most frequent clinical signs were motor deficit (80%), followed by sensory deficits, brain stem signs, and cerebellar signs. csf findings were variable; normal results were present in up to 20% of patients. oligoclonal bands were positive in over 60%. almost all patients improved during the acute phase of the disease. of the 26 patients with the final diagnosis of adem, 21 had minor or no symptoms, 2 died, the rest had moderate symptoms. compared to ms patients, the adem patients were older, and more often had a preceding infection, clinical signs of brain stem involvement, a higher csf albumin fraction, and infratentorial lesions. neurological symptoms develop rapidly in the acute phase and are commonly associated with encephalopathy, stupor, coma, meningismus, and seizures. peak severity occurs within several days, and recovery may begin soon afterward. occasionally, adem may evolve over a few months and there may be a second clinical deterioration or subacute progression for a time. in these unusual cases, the distinction from ms is difficult. three recent large retrospective series and an accompanying editorial have highlighted that there remain no clinical or laboratory features that accurately allow one to predict which adult or pediatric adem patients will develop. [122] [123] [124] [125] differential diagnosis. one of the primary concerns after a single demyelinating episode is whether other bouts can be expected (e.g., ms). several features may tip the balance toward one or the other, but the proper diagnosis becomes apparent only with time. classically, adem is characterized by the multifocal involvement at onset whereas ms often presents with monosymptomatic deficits such as on. however, adem may cause unifocal symptoms and ms may present with multifocal cns involvement, especially in children. the monosymptomatic deficits caused by adem are more commonly severe, such as bilateral on and complete transverse myelitis. although ocbs occur transiently in about one third of adem cases, their persistence implies a diagnosis of ms. the subsequent disappearance of ocbs, when performed by consistent techniques, is evidence against ms. the mri appearance of these two disorders is often identical, 125 but the presence of basal ganglia or cortical lesions, or large globular white matter lesions, is more frequent in adem. the fulminant development of adem is distinctive but not pathognomonic, because a rare form of ms known as marburg's ms is also rapid in onset and often deadly. the appearance of brain stem, periventricular, and multiple, large cerebral white matter lesions and the presence of ocbs may distinguish marburg's variant from adem. on rare occasions, inflammatory demyelinating lesions may reach a large size and resemble tumors (especially lymphoma) on mri, necessitating biopsy for clarification. there is usually one dominant lesion, but smaller separate lesions may be identifiable. these have been referred to as both adem and ms in the literature. the prognosis for recovery is often quite good, although approximately one third suffer subsequent attacks. some develop typical ms, whereas others have recurring tumor-like lesions. the term multiphasic adem has been used when patients have large recurrences in the same location, and relapsing adem refers to recurrences at different sites. the relationship of these entities with ms is unclear. balo's concentric sclerosis refers to the pathological finding of alternating bands of demyelination and remyelination. these patients typically have large lesions and subacute deficits similar to those described earlier. typical demyelinating lesions commonly coexist, and rarely cdms patients are noted to have similar-appearing lesions. the reason for this peculiar alternating pattern is unknown. schilder's myelinoclastic diffuse sclerosis is another rare condition that may be confused with adem or other demyelinating conditions. this progressive demyelinating disorder usually begins in childhood. the features are often atypical and include dementia, aphasia, homonymous hemianopia, seizures, psychosis, elevated intracranial pressure, and the absence of ocbs. the most characteristic finding is the presence of two large, roughly symmetrical lesions on mri, one in each hemisphere. the diagnosis is made by excluding the known inherited leukodystrophies, especially adrenoleukodystrophy. management. treatment with intravenous methylprednisolone seems to halt progression and allow recovery to begin sooner, just as with ms. plasma exchange can be tried in those with severe deficits and little response to corticosteroids. ivig has also been used successfully according to case reports in the literature. one fulminant case responded to hypothermia only. genetics of multiple sclerosis utility of mri in suspected ms the use of mitoxantrone (novantrone) for the treatment of multiple sclerosis disease modifying therapies in multiple sclerosis natural history of multiple sclerosis a randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis cortical lesions and brain atrophy in ms the pathology of multiple sclerosis management of multiple sclerosis: current trials and future options competing interests in multiple sclerosis research diagnostic criteria for multiple sclerosis: 2005 revisions to the "mcdonald criteria immunization and multiple sclerosis: a summary of published evidence and recommendations revised diagnostic criteria for neuromyelitisi optica neuromyelitis optica randomized controlled trials to assess therapies for multiple sclerosis does the history of multiple sclerosis go back as far as the 14th century? the 150-year anniversary of multiple sclerosis: does its early history give an etiological clue? encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys morphological aspects of myelin and myelination t-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function molecular mimicry in t cellmediated autoimmunity: viral peptides activate human t cell clones specific for myelin basic protein t cells responsive to myelin basic protein in patients with multiple sclerosis the cd4-th1 model for multiple sclerosis: a critical experimental allergic encephalomyelitis: a misleading model of multiple sclerosis igg marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel isolation of herpes simplex virus type 1 during first attack of multiple sclerosis isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis plaque-associated expression of human herpesvirus 6 in multiple sclerosis oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors evidence for pathogenic heterogeneity in multiple sclerosis transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions cortical demyelination and diffuse white matter injury in multiple sclerosis a genetic basis for familial aggregation in multiple sclerosis. canadian collaborative study group genetics of multiple sclerosis multiple sclerosis: changing times epidemiology of multiple sclerosis in u.s. veterans: v. ancestry and the risk of multiple sclerosis unusual occurrence on a tropical island of multiple sclerosis when is an apparent excess of neurologic cases epidemiologically significant smoking is a risk factor for multiple sclerosis environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis diagnosis of ms the natural history of recurrent optic neuritis the prevalence of cognitive impairment in a community survey of multiple sclerosis defining the clinical course of multiple sclerosis: results of an international survey. national multiple sclerosis society (usa) advisory committee on clinical trials of new agents in multiple sclerosis epilepsy and multiple sclerosis multiple sclerosis-associated uveitis a reappraisal of the epidemiology of multiple sclerosis in olmsted county optic neuritis: a population-based study in olmsted county the significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. a 5-year follow-up study interscanner variation in brain mri lesion load measurements in ms: implications for clinical trials the prognostic value of brain mri in clinically isolated syndromes of the cns. a 10-year follow-up a longitudinal study of abnormalities on mri and disability from multiple sclerosis occurrence of a multiple sclerosis-like illness in women who have a leber's hereditary optic neuropathy mitochondrial dna mutation genetic disorders that masquerade as multiple sclerosis new diagnostic criteria for multiple sclerosis: guidelines for research protocols recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis assessment of mri criteria for a diagnosis of ms neuroimaging in multiple sclerosis the relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction magnetization transfer ratio histogram analysis of normal-appearing gray matter and normalappearing white matter in multiple sclerosis mri t2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis evidence of early cortical atrophy in ms: relevance to white matter changes and disability csf electrophoresis in one thousand patients early differential diagnosis of multiple sclerosis using a new oligoclonal band test diagnostic criteria for multiple sclerosis: 2005 revisions to the "mcdonald criteria the optic neuritis treatment trial: three-year follow-up results effects of iv methylprednisolone on brain atrophy in relapsing-remitting ms double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis plasmapheresis in acute episodes of fulminant cns inflammatory demyelination a randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange plasma exchange for severe attacks of cns demyelination: predictors of response intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. champs study group interferon beta-1a for early multiple sclerosis: champs trial subgroup analyses effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study interferon beta-1b is effective in relapsing-remitting multiple sclerosis. i. clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. the ifnb multiple sclerosis study group further study on the specificity and incidence of neutralizing antibodies to interferon (ifn) in relapsing remitting multiple sclerosis patients treated with ifn beta-1a or ifn beta-1b intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. the multiple sclerosis collaborative research group (mscrg) the long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the prisms study randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. prisms (prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis) study group magnetic resonance imaging results of the prisms trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. prevention of relapses and disability by interferon-beta1a subcutaneously in multiple sclerosis ingested ifn-alpha: results of a pilot study in relapsing-remitting ms clinical characteristics of responders to interferon therapy for relapsing ms a pilot trial of cop 1 in exacerbating-remitting multiple sclerosis copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase iii multicenter, double-blind placebocontrolled trial. the copolymer 1 multiple sclerosis study group glatiramer acetate reduces the proportion of new ms lesions evolving into "black holes european/canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. european/canadian glatiramer acetate study group united states open-label glatiramer acetate extension trial for relapsing multiple sclerosis: mri and clinical correlates. multiple sclerosis study group and the mri analysis center longitudinal mri study: the effects of azathioprine in ms patients refractory to interferon beta-1b the austrian immunoglobulin in ms (aims) study: final analysis a randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis iv immunoglobulin does not reverse established weakness in ms placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis a double-blind, randomized trial of iv immunoglobulin treatment in acute optic neuritis a controlled trial of natalizumab for relapsing multiple sclerosis progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis t(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. european study group on interferon beta-1b in secondary progressive ms effect of interferon-beta-1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a european multicenter, randomized, double-blind, placebo-controlled trial. european study group on interferon-beta-1b in secondary progressive multiple sclerosis final analysis of the european multicenter trial on ifnbeta-1b in secondary-progressive ms the effect of interferon beta-1b treatment on mri measures of cerebral atrophy in secondary progressive multiple sclerosis. european study group on interferon beta-1b in secondary progressive multiple sclerosis randomized controlled trial of interferonbeta-1a in secondary progressive ms: mri results interferon beta-1b in secondary progressive ms: a combined analysis of the two trials european study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis relapses and progression of disability in multiple sclerosis mitoxantrone in progressive ms: a placebo controlled, randomized, observer blinded phase iii multi-center study: clinical results therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using mri and clinical criteria a study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial effect of mitoxantrone on mri in progressive ms: results of the mims trial interferon beta-1a in primary progressive multiple sclerosis overview of azathioprine treatment in multiple sclerosis lowdose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis cladribine in treatment of chronic progressive multiple sclerosis cladribine and progressive ms: clinical and mri outcomes of a multicenter controlled trial. cladribine mri study group autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis a randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis donepezil improved memory in multiple sclerosis in a randomized clinical trial stereotactic lesional surgery for the treatment of tremor in multiple sclerosis: a prospective case-controlled study a study of tremor in multiple sclerosis ventilatory dysfunction in multiple sclerosis the reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort the natural history of multiple sclerosis: a geographically based study. i. clinical course and disability change in ms-related disability in a population-based cohort: a 10-year follow-up study the clinical course of neuromyelitis optica (devic's syndrome) devic's neuromyelitis optica: a clinicopathological study of 8 patients a serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis neuromyelitis optica: clinical predictors of a relapsing course and survival mri and magnetization transfer imaging changes in the brain and cervical cord of patients with devic's neuromyelitis optica clinical, csf, and mri findings in devic's neuromyelitis optica neuromyelitis optica acute disseminated encephalomyelitis: a follow-up study of 40 adult patients adem: distinct disease or part of the ms spectrum clinical and neuroradiologic features of acute disseminated encephalomyelitis in children acute disseminated encephalomyelitis. mri findings and the distinction from multiple sclerosis interactive study questions and referenced videos for this chapter are available on the dvd-rom key: cord-006828-i88on326 authors: nan title: abstracts dgrh-kongress 2013 date: 2013-09-15 journal: z rheumatol doi: 10.1007/s00393-013-1255-1 sha: doc_id: 6828 cord_uid: i88on326 nan im namen der dgrh, der dgorh und der gkjr begrüßen wir sie ganz herzlich zu unserem diesjährigen kongress visualisierung therapeutischer effekte von vasodilatantien beim sekundären raynaud-syndrom mittels fluoreszenzoptischer bildgebung di.14 stellenwert der gelenksonographie bezüglich diagnose, behandlung und therapiekontrolle der bursitis intermetatarsalis -einer häufig übersehenen differenzialdiagnose. fünf fallbeispiele wegen der deutlich eingeschränkten nierenfunktion konnten therapeutisch keine nsar angewandt werden. wir haben mit 2×0,5 mg colchicin täglich behandelt. die anfänglich schwerkranke bettlägerige patientin konnte innerhalb von 48h mobilisiert werden. um eine abschließende sicherung der diagnose einer uratinduzierten sakroiliitis erreichen zu können ist die patientin mit einem dual-energy-ct (dect) untersucht worden. ergebnisse. mit dieser methode konnten gichttophi in beiden sakroiliakalgelenken dargestellt werden, ebenso an beiden mtp1-gelenken. schlussfolgerung. aktuell liegen bisher noch keine weiteren berichte vor, dass diese methode auch für die diagnostik einer gicht im bereich der sakroiliakalregion zuverlässige ergebnisse liefern kann. zudem zeigt dieser krankheitsverlauf, dass sich die gicht durchaus primär im bereich des achsenskeletts manifestieren kann und nicht in erster linie an den peripheren gelenken zu entsprechenden beschwerden führen muss. a. glimm 1 , s. werner 1 , s. ohrndorf 1 , c. schwenke 2 , g. schmittat 1 , g. burmester 1 einleitung. typische pathologische veränderung bei der rheumatoiden arthritis (ra) ist die synovialitis. auch bei der osteoarthrose (oa) lassen sich entzündliche veränderungen der gelenke finden. diese können mittels fluoreszenzoptischer bildgebung (foi) und dem gelenkultraschall (us) sichtbar gemacht werden. ziel der studie: vergleich der foi mit dem us bei patienten mit ra und oa. methoden. es wurde bei 90 patienten (67 ra, 23 oa) die foi beider hände sowie die us des handgelenks (hg) und der fingergelenke (mcp, pip, dip) der klinisch beschwerdeführenden hand von dorsal und palmar sowohl im b-bild (b-us) als auch mit power-doppler (pd-us) durchgeführt. synovialitis und tenosynovitis im us sowie die intensität des fluoreszenzsignals im bereich der gelenke in der foi wurden qualitativ als auch semiquantitativ nach standardisierten verfahren für den primavistamode (pvm) und drei verschiedene phasen (p1-3; [1] ) bewertet. in der statistischen analyse wurden anschließend sensitivitäten und spezifitäten für die foi bei der ra und oa getrennt für synovialitis und tenosynovitis, dorsal und palmar jeweils für b-us und pd-us als referenzmethode berechnet. ergebnisse. in abhängigkeit von der betrachteten phase zeigen sich für die ra und oa moderate sensitivitäten und spezifitäten. für die ra wurden in der phase 2 des foi die höchsten sensitivitäten mit 68% für b-us und 77% für pd-us berechnet. auch bei der oa ergaben sich die höchsten sensitivitäten in der phase 2 des foi mit 77% für b-us und 89% für pd-us als referenzmethode. die höchsten spezifitäten für beide diagnosen wurden in der foi in phase 3 erreicht. hierbei lag die spezifität bei der ra für b-us bei 96% und für pd-us bei 90%. der höchste spezifitätswert bei der oa sowohl für b-us als pd-us war 88% (. tab. 3 background. pet is a nuclear imaging technique that depicts functional processes within the body with high sensitivity by detecting annihilation radiation from radioactive decay of a positron-emitting radionuclide that was labeled to a biologically active molecule (tracer) and introduced into the body. 18f-fluoride (18f) can be used for pet as a bone-seeking agent reflecting bone perfusion and remodeling. we inaugurated a pilot study with simultaneous pet/mr to examine whether addition of pet provides different and additional information in comparison to mri in axspa patients. methods. eleven axspa patients, median age 39 y, disease duration range 0.5-10 y, mean basdai 5.3, were examined by pet/3-tesla mri 40 minutes after injection of a mean dose of 157 mbq of 18f using a integrated whole-body pet/mr scanner (siemens biograph mmr®). 3t-mris were scored blinded to patient's clinical characteristics by two readers (1 rheumatologist and 1 radiologist/nuclear medicine specialist) using the berlin mri score and also by recording inflammatory lesions on a vertebral edge (ve) level. in a second step pet/mris were read blindly by the same readers also based on the ve involvement of individual vertebral bodies. results. the procedure was successful in all patients. the resulting mean effective radiation dose per patient was 3.76 msv. co-registration of pet/mri fusion images was highly accurate, allowing a precise comparison of mri and pet. in the direct comparison of the mri and pet signal the two readers saw consistent signals in almost 90% of the sites studied. however, there were areas where signals differed, e.g. within existing syndesmophytes where pet signal was increased but conventional mris showed no signal, or the sternum area and lateral or posterior spinal elements such as facets and spinous processes. conclusion. the new technique of integrated pet/mri provides similar imaging signals as conventional mri. however, we observed differences between the two modalities in areas with less inflammatory activity but where bone metabolism seemed to be active or in areas with blurred resolution on conventional mri. the possibility that pet detects osteoblastic activity in areas where no inflammatory signal is detected with mri seems to be of interest. einleitung. sensitiven bildgebenden verfahren wie der hochauflösenden arthrosonographie kommen bei der detektion initial entzündlicher veränderungen im rahmen der frühdiagnostik der psoriasisarthritis (psa) eine große bedeutung zu. die vorliegende prospektive studie untersucht die diagnostische und prognostische wertigkeit der sonographischen befunde im vergleich zur klinischen untersuchung auf ebene einzelner gelenke bei früher psoriasis-arthritis (psa). methoden. rekrutierung von 50 patienten mit therapienaiver früher psa. sonographie von 56 gelenken mit semiquantitativer graduierung (grad 0-3) von b-bild (gsus) und power-doppler-aktivität (pdus; baseline, 12 monate). klinische parameter: anzahl druckschmerzhafter und geschwollener gelenke (tjc68, sjc66), visuelle analogskala, das28-crp, health assessment questionnaire haq. für jede followup-visite erfolgte eine kategorisierung des klinischen ansprechens nach eular-response-kriterien und der für die psa validierten minimal-disease-activity(mda)-kriterien (coates et al.). ergebnisse. baseline 50 patienten, nach 12 monate 19 patienten, erkrankungsdauer (12±17,6 monate). patienten ohne therapie (1), mit nsar (1), steroid i.a. (1) , dmards (10), biologicals (6). bei diagnosestellung zeigte sich eine signifikante korrelation zwischen dem us synovitis score und folgenden klinischen parametern: tjc68 (r=0,52), scj66 (r=0,63), das28-crp (r=0,34). nach 12 monaten zeigte sich eine gute korrelation zwischen der relativen veränderung des us synovitis scores und der relativen veränderung folgender klinischer parameter: tjc68 (r=0,72), haq (r=0,41), pasi (r=0,42), das28-crp (r=0,33). zu baseline waren 407 von 2730 gelenken sonographisch auffällig, davon zeigten 239 kein klinisches korrelat (subklinisch). nach 12 monaten zeigten 29% der initial subklinischen gelenke einen unveränderten befund, 61% waren sonographisch nicht mehr auffällig und 10% wurden klinisch manifest. bei den klinischen respondern war der rückgang deutlicher ausgeprägt. schlussfolgerung. der ultraschall-synovitis-score korreliert mit klinischen aktivitätsparametern sowohl zum zeitpunkt der diagnosestellung als auch im krankheitsverlauf unter immunsuppressiver therapie. die subklinischen veränderungen bilden sich unter immunsuppressiver therapie zu einem großen teil zurück, deutlicher bei klinischen respondern. ein geringer anteil der initial subklinischen gelenke wird im verlauf klinisch manifest, in höherem maße bei klinischen non-respondern. t. diekhoff 1 , k. hermann 1 1 charité -universitätsmedizin berlin, radiologie, berlin einleitung. die gicht ist mit einer prävalenz von 0,4-0,6% insbesondere in den industrieländern eine häufige erkrankungen, die mit gelenkschmerzen einhergeht. bei typischer symptomatik und laborkonstellation ist die diagnose der arthritis urica oft einfach zu stellen, ein atypisches beschwerdebild kann jedoch gelegentlich die abgrenzung zu anderen erkrankungen erschweren. besonders die kalziumpyrophosphat-kristallarthropathie (cppd oder pseudogicht), die selbst mit sehr variabler symptomatik auftreten kann, ist eine relevante differenzialdiagnose, besonders bei älteren patienten. methoden. mit der dual-energy-computertomographie (de-ct) steht ein modernes, innovatives verfahren zur verfügung, das eine detektion von harnsäurehaltigen weichteilverkalkungen ermöglicht und darüber hinaus eine sichere abgrenzung zu kalziumhaltigen verkalkungen gewährleisten kann. das prinzip der de-ct ist relativ simpel und seit längerem bekannt: die messung des untersuchungsvolumens mit zwei unterschiedlichen röhrenspannungen macht es möglich, einen schwächungskoeffizienten zu errechnen, der spezifisch für das untersuchte material ist. allerdings ermöglichten erst moderne cts mit zwei röntgenröhren die klinische anwendung. in jüngster zeit werden jedoch anstrengungen unternommen, die de-ct auch für ein-röhren-systeme verfügbar zu machen. ergebnisse. mit der de-ct können gichttophi sicher vom knochen aber auch von anderen verkalkungen getrennt und zum beispiel farblich kodiert dargestellt werden. im gegensatz zum konventionellen röntgenbild verspricht die de-ct jedoch nicht nur eine höhere sensitivität für tophöse veränderungen, sondern als schnittbildverfahren auch eine bessere abgrenzung und einordnung von anderen morphologischen veränderungen wie zum beispiel von erosionen. schlussfolgerung. dieser vortrag fasst die vor-und nachteile der de-ct in der detektion und abgrenzung von weichteilverkalkungen bei kristallarthropathien zusammen und gibt darüber hinaus einen ausblick auf zukünftige entwicklungen in diesem gebiet. background. anionic glycosaminoglycans interact with a variety of soluble and membrane bound molecules. chondroitin sulfate was shown to have anti-inflammatory properties but its role in arthritis is controversial. methods. we have analyzed the effect of chondroitin sulfate on collagen induced arthritis starting treatment before and after induction of arthritis and in mice with established arthritis. results. in all of these settings chondroitin sulfate significantly reduced the severity of arthritis. it prevented joint destruction, diminished the inflammatory infiltrate and reduced proinflammatory cytokines in joints and plasma. splenocytes restimulated with collagen produced less il-2 and more il-10 and il-13. the beneficial effects of chondroitin sulfate were transient and closely correlated to the suppression of the collagen-specific humoral immune response. chondroitin sulfate, but not other glycosaminoglycans induced a direct btk and syk-dependent proliferation of b cells and markedly expanded the number of plasma cells in the spleen. in immunized mice chondroitin sulfate reduced the number of antigen specific plasma cells in the bone marrow and was able to suppress established humoral immune responses. conclusion. displacement of disease inducing plasma cells from the bone marrow might contribute to the beneficial effects of chondroitin sulfate and could be an attractive strategy to suppress antibody mediated autoimmunity. background. in rheumatoid arthritis a functional deterioration of the hpa-axis in form of inadequately low secretion of glucocorticoids in relation to severity of inflammation can be detected. the reasons for this phenomenon are not known. the purpose of this study was to find possible reasons responsible for adrenal insufficiency during arthritis. methods. da rats were immunized with type ii collagen in incomplete freund adjuvant to induce arthritis. plasma corticosterone was evaluated by ria and plasma acth by elisa. adrenal cholesterol was quan-titatively studied by sudan-iii staining and scavenger receptor class bi (sr-bi, the hdl receptor) by immunohistochemistry. fluorescent nbd-cholesterol uptake kinetics were analysed by flow cytometry. ultrastructural morphology of adrenocortical mitochondria and lipid droplets was studied by electron microscopy. results. initially increased corticosterone and acth levels were reduced to baseline levels in the later phase of the disease. serum levels of corticosterone relative to il-1β were markedly lower in arthritic than control animals (inadequacy). cholesterol storage in adrenocortical cells and expression of sr-bi did not differ between immunized and control rats. however, number of impaired mitochondria largely increased during the course of arthritis (maximum on day 55), and this was paralleled by reduced numbers of activated cholesterol droplets (inhomogenous droplets relevant for generation of glucocorticoids). in addition, number of normal mitochondria positively correlated with serum corticosterone levels. conclusion. this first study on adrenal reasons for inadequate glucocorticoid secretion in arthritis demonstrated impaired mitochondria and altered cholesterol breakdown paralleled by low corticosterone levels in relation to ongoing inflammation. justus-liebig universität gießen, kerckhoff-klinik gmbh, rheumatologie u. klinische immunologie, osteologie, physikalische therapie, bad nauheim, 2 agaplesion markus krankenhaus, akademisches lehrkrankenhaus der johann wolfgang goethe-universität, klinik für orthopädie und unfallchirurgie, frankfurt/main, 3 universitätsklinikum gießen und marburg, orthopädische klinik, labor für experimentelle orthopädie, gießen, 4 universitätsklinikum gießen und marburg, orthopädie und orthopädische chirurgie, gießen, 5 universitätsklinikum erlangen, medizinische klinik 3 , rheumatologie und immunologie, erlangen background. obesity is a risk factor in osteoarthritis (oa), but there is limited information about the interaction between bone formation and adipose tissue-derived factors, the so-called adipokines. adipokines such as adiponectin, resistin or visfatin are associated with the pathogenesis of rheumatoid arthritis (ra) and oa. adipokines are produced also by other cell types than adipocytes in ra and oa joints, for example osteoblasts, osteoclasts or chondrocytes. however, in contrast to their joint-destructive role in ra, their role in oa joint remodeling is unclear. therefore, adipokine expression in osteophyte development and bone forming cells as well as their effect on these cells was analyzed. methods. osteophytes and bone were obtained from oa patients during joint replacement surgery. serial sections of bone tissue were stained (masson trichrome, trap) and scored from grade one (no ossification, mainly connective tissue and cartilage) to five (ossified, mineralized osteophyte, <10% connective tissue, ossified remodeling zones). immunohistochemistry against alkaline phosphatase, collagen-type ii, adiponectin, resistin, and visfatin was performed. oa osteoblasts were stimulated with adiponectin and measurements of il-6, il-8 and mcp-1 were performed in cell culture supernatants. results. adiponectin, resistin and visfatin were detectable in osteoblasts and all osteophyte grades. in non-ossified osteophytes (grade 1), especially adiponectin and to a lower extend resistin and visfatin were localized in connective tissue fibroblasts. in ossified osteophytes (grade 2-5), resistin, visfatin and to a lower extend adiponectin protein expression was co-localized with osteoblasts. resistin and visfatin were expressed by osteoclasts. visfatin was found in chondrocytes of all osteophyte grades (50% of chondrocytes) and adiponectin was detectable in blood vessels. osteoblast stimulation with adiponectin increased the release of the inflammatory mediators il-6 (2.6-fold), il-8 (4.9-fold), and mcp-1 (2.1-fold). zeitschrift für rheumatologie suppl 2 · 2013 | conclusion. the expression of adiponectin and visfatin expression in osteophyte connective tissue and cartilage suggests their involvement in early osteophyte formation. resistin and visfatin expression by osteoblasts and osteoclasts in ossified osteophytes indicates a role in bone remodeling of osteophytes at later stages. osteoblasts respond to adiponectin stimulation with the release of inflammatory mediators. therefore, adipokines are most likely involved in osteophyte formation at different stages affecting different cell types of bone remodeling. free fatty acids contribute to promotion of arthritis k. frommer 1 , a. schäffler 2 , s. rehart 3 , a. sachs 3 , u. müller-ladner 1 , e. neumann 1 1 justus-liebig universität gießen, kerckhoff-klinik gmbh, rheumatologie u. klinische immunologie, osteologie, physikalische therapie, bad nauheim, 2 universitätsklinikum regensburg, klinik und poliklinik für innere medizin i, regensburg, 3 agaplesion markus krankenhaus, akademisches lehrkrankenhaus der johann wolfgang goethe-universität, klinik für orthopädie und unfallchirurgie, frankfurt/main background. obesity is a known risk factor for several arthritic diseases and mechanical stress has been shown not to be the only factor. due to increased levels of free fatty acids (ffa) in obese compared to nonobese individuals and due to the involvement of ffa in inflammatory cardiovascular and metabolic diseases, we hypothesized that ffa play a role in the promotion of arthritic diseases. therefore, we therefore investigated the effect of ffa on various effector cells of arthritis. methods. rheumatoid (ra) synovial fibroblasts (sf), osteoarthritis (oa) sf, psoriatic arthritis (psa) sf, human primary chondrocytes (hch), human osteoblasts (ob), human macrovascular (huvec) and microvascular (hbdmec) endothelial cells were stimulated in vitro with different ffa within their physiological range of concentrations. immunoassays were used to quantify ffa-induced protein secretion. sulfosuccinimidyl oleate sodium (sso) was used to inhibit fatty acid translocase (fat). results. ffa dose-dependently increased the secretion of the proinflammatory factors (il-6, il 8 and mcp-1) as well as matrix-degrading enzymes (mmp-1 and mmp-3) in rasf (e.g. for lauric acid [100 µm] with rasf/il-6: 9.1-fold increase; il 8: 14.9 fold increase; mcp-1: 2.4fold increase; pro-mmp1: 5.1-fold increase; mmp-3: 83.6 fold increase). saturated and unsaturated ffa had similar effects on rasf. however, saturated ffa induced strong secretion of il-6 in chondrocytes, while unsaturated ffa only had a weaker effect on this cell type. at 100 µm, both saturated and unsaturated ffa significantly increased il-6 secretion by osteoblasts to a similar degree as for sf. a high concentration of ffa (100 µm) significantly induced il-6 secretion in huvec and hbdmec, whereas a low concentration of ffa (10 µm) did not have a significant effect (p>0.05) on human endothelial cells. blocking ffa transport into rasf by using sso almost completely abolished the effect of palmitic acid on il-8 secretion. conclusion. ffa are not only metabolic substrates but can also directly contribute to articular inflammation and degradation mediated by various effector cells of arthritis. our data also show that ffa transport into the cell is required for ffa-induced effects in sf. background. chronically inflamed tissues in ra are characterized by local hypoxia and enhanced angiogenesis. the hypoxia inducible factor (hif)-1 and (hif)-2 serve as key regulators of adaptation to hypoxia thereby promoting both angiogenesis and metabolic adaptation of endothelial cells. to investigate the impact of hif-1/hif-2 on the angiogenic and metabolic transcriptome under hypoxia (1% o2) versus normoxia (18% o2) we performed a knockdown of either hif-1α or hif-2α in human microvascular endothelial cells (hmec). methods. specific knockdown of either hif-1α or hif-2α was achieved using shrna-technology. angiogenic and metabolic transcriptome of hmecs was studied by performing an agilent human whole genome microarray under normoxia vs hypoxia. significantly regulated genes were allocated to angiogenic and metabolic processes using panther database. results. in comparison to normoxia the incubation of untransduced hmecs under hypoxia resulted in 73 regulated angiogenesis related genes and 17 regulated cellular metabolism related genes. in both hif-1α and hif-2α knockdown cells, hypoxia was still capable of inducing a differential gene expression pattern, but with a much less pronounced effect compared to control cells. analysis of angiogenesis related processes (vegf-pathway, hif-activation, egfr-pathway) showed that 74% of the differentially expressed genes are controlled by both hif-1 and hif-2. another 14% of the regulated genes are controlled by hif-1. the remaining 12% of regulated genes are under control of hif-2. the differentially regulated genes involved in the cellular metabolism (atpsynthesis, glycolysis, tca-cycle) were found to be to 80% controlled by both hif-1 and hif-2. the remaining 20% are dependent on the presence of hif-1. conclusion. hif-1 and hif-2 are both key regulators of the adaptation of endothelial cells towards hypoxia with overlapping functions. however, they do differ in their capacity to regulate cellular energy metabolism and angiogenesis. this leads us to conclude that hif-1 affects angiogenesis via indirect effects on cellular energy metabolism as indicated by the regulation of metabolic transcriptome to one fifth. hif-2 does more influence angiogenesis directly via regulating the synthesis of proangiogenic factors (as has been previously shown).these findings provide new insights into the divergent regulation of angiogenesis in inflamed (hypoxic) tissues by hif-1 and hif-2 and are, therefore, considered to be of clinical relevance in ra. background. membrane bound glucocorticoid receptors (mgr) play a pivotal role in pathogenesis of chronic inflammatory diseases as indicated by clinical observations. patients with sle show high frequencies of mgr positive monocytes, sometimes even higher than found in patients with active ra. with increasing glucocorticoid dosages expression of mgr on monocytes of sle-patients is downregulated, suggesting a negative feedback loop to control glucocorticoid action. these receptors represent an effective target for diagnosis and monitoring of different inflammatory diseases, but a feasible detection method is still necessary. objectives. we compare two methods of high-sensitive immunofluorescence staining -the well established liposome procedure with the commercialized faser-technique. methods. hek293t cells were cultured for 24 h with/without 5 µg/ml brefeldin a in a humidified incubator at 37°c. human cd4 positive t cells and cd14 positive monocytes were isolated via magnetic-activated cell sorting and subsequently cultured in rpmi 1640. monocytes were incubated for 24 h with/without 2 µg/ml lps. for liposome based highsensitivity immunofluorescence staining cells were incubated with the monoclonal (digoxigenin conjugated) anti-gr antibody, followed by incubation with anti-digoxigenin/anti-biotin matrix. subsequently biotinylated cy5 liposomes were added. faser technique was performed as described by the manufacturer (miltenyi biotec). dead cells were excluded by adding pi before cell acquisition, using a bd facs calibur flow cytometer. the acquired data were analyzed using flowjo 7.6.1 software. results. the human mgr, which cannot be reliably detected with conventional staining methods, is detectable with the liposome procedure as well as with the commercialized faser-apc technique. furthermore, the faser-apc-procedure is more sensitive (94.51% vs 73.2%) and more specific (99.57% vs. 98.93%) compared to the liposome technique. additionally, minor changes of mgr expression can also be demonstrated with the faser technique. the faser procedure shows technical advantages: the commercially available faser-apc-kit is performed according to a standarized protocol and is less time consuming compared to the liposome procedure. conclusion. the human mgr is easily detectable with the commercialized faser kits, which represent an alternative due to a consistent quality and a standardized production. this method facilitates the analysis of the role that mgr play in the pathogenesis of chronic inflammatory diseases and perhaps provoke new insights in glucocorticoid therapy. background. in previous studies we detected th-positive, catecholamine-producing cells in inflamed hypoxic synovial tissue. therefore, the aim of our study was to investigate the influence of hypoxia induced catecholamines on inflammatory responses in arthritis. methods. synovial cells of rheumatoid arthritis (ra) and osteoarthritis (oa) patients were isolated and cultivated under normoxia or hypoxia with/without stimulating enzyme cofactors of th and inhibitors of th. expression of th and release of cytokines and catecholamines was analyzed. the effect of th+ cells was tested by adoptive transfer into dba/1 mice with collagen type ii-induced arthritis (cia). th+ cells were generated from mesenchymal stem cells by defined dopaminergic factors. results. hypoxia increased th protein expression and catecholamine synthesis and decreased release of tnf in oa/ra synovial cells compared to normoxic conditions. this inhibitory effect on tnf was reversed by th inhibition with alpha-methyl-para-tyrosine (αmpt). incubation with specific th cofactors (tetrahydrobiopterin and fe2+) increased hypoxia-induced inhibition of tnf, which was also reversed by αmpt. adoptive transfer of th+ cells reduced cia in mice, and 6 hydroxydopamine, which depletes th+ cells, reversed this effect. conclusion. in summary, this study presents that th-dependent catecholamine synthesis exhibits anti-inflammatory effects in human ra synovial cells in vitro, which can be augmented under hypoxic condi-tions. in addition, the anti-inflammatory effect of th+ cells has been presented the first time in experimental arthritis in mice. background. previously, we demonstrated that long-lived plasma cells contribute to the pathogenesis of antibody-mediated diseases and should therefore be considered as a promising therapeutic target in systemic lupus erythematous (sle). in bone marrow stromal cells expressing the chemokine cxcl12 organize these niches that provide for the plasma cell survival. cxcl12 is the ligand of cxcr4 expressed on plasma cells. in this study we investigated the contribution of cxcl12-cxcr4 interaction to the longevity of plasma cells in the murine model of lupus. methods. plasma cells purified from spleens of nzb/w mice were incubated with the cxcr4 blocker amd3100 and then adoptively transferred to immunodeficient rag1−/− mice. after 14 days we analyzed the number of plasma cells in bone marrow. furthermore, ova immunized nzb/w mice were treated intraperitoneally with amd3100 after boost; anti-ova secreting plasma cells in bone marrow were checked on day 3 and 15 after boost. the effect of plasma cell depletion was investigated in nzb/w mice using amd3100 alone or combined with bortebomib for two weeks. results. two weeks after adoptive transfer the number of plasma cells treated with amd3100 was lowered by 60% in bone. after secondary immunization with ova the amd3100 treatment resulted in a significant reduction of anti-ova secreting plasma cells in bone marrow by 33% on day 3 and by 23% on day 15. after 15 days the number of mhc class ii negative anti-ova secreting plasma cells significantly decreased by 42% in bone marrow of treated mice. amd3100 efficiently depleted plasma cells including long-lived. after two weeks treatment, total plasma cell number was decreased by 69% in spleen and 61% in bone marrow; long-lived plasma cells were reduced by 67% in spleen and 64% in bone marrow. the combination of bortezomib with amd3100 in nzb/w significantly enhanced the depletion of long-lived plasma cells compared to monotherapy. conclusion. cxcr4 blockade with amd3100 can reduce the homing of plasma cells to the bone marrow and the survival of long-lived plasma cells. the combination of bortezomib with amd3100 shows synergistic effects on plasma cell depletion. the findings highlight the importance of the cxcr4-cxcl12 axis for the plasma cell niche. zeitschrift für rheumatologie suppl 2 · 2013 | er.09 tnfr1 expression defines synovial tissue infiltrating cd4+ t cells in patients with rheumatoid arthritis k background. one hallmark of rheumatoid arthritis (ra) is the infiltration of the synovial membrane by cd4+ t cells. it has previously been shown that infiltrating cd4+ t cells differ from non-infiltrating ones in their increased expression of tnfr1. furthermore, tnfr1 is expressed on a fraction of circulating cd4+ t cells from ra patients, but not from healthy controls. aim of the study was the characterization of tnfr1+ cd4+ t cells in patients with rheumatoid arthritis. methods. peripheral tnfr1+ cd4+ t cells from ra patients were analyzed by flow cytometry. the expression of naive and memory t cell markers (cd45ra and cd45ro), markers for t cell activation (cd25, cd71 and cd154) and of icam-1 as well as the frequencies of the positive cells were determined. to identify the t helper cell signature of tnfr1+ cd4+ t cells, intracellular staining of the th1, th2 and th17 master transcription factors t-bet, gata-3 and ror-γt, respectively, was performed. results. peripheral tnfr1+ cd4+ t cells have neither a preferential naive nor a memory phenotype, but showed higher expression of the activation markers cd25, cd71 and cd154 than tnfr1-cd4+ t cells. tnfr1+ cd4+ t cells express higher frequencies of the t-bet and rorγt than tnfr1-cd4+ t cells. there is no difference in gata-3 expression between tnfr1 positive and negative cd4+ t cells. functionally, it has been shown that the cytokine tnf acts as chemokine to attract cd4+ t cells to the rheumatoid joints. beside this direct effect of tnf, there are known indirect effects of tnf including the upregulation of cell adhesion molecules like icam-1. therefore, icam-1 expression of migrating tnfr1+ t cells was investigated. the results show, that migrating tnfr1+ t cells recovered from synovial tissue are more frequently icam-1 positive than non-migrating ones. conclusion. tnfr1+ expression characterizes cd4+ t cells functionally capable of infiltrating the rheumatoid synovium in an icam-1 dependent manner. the results show, that tnfr1 expression defines a pathogenic subset of activated cd4+ t cells with th1 and/or th17 signature in patients with rheumatoid arthritis. hypoxia increased the production of interleukin-1β in lps-primed human monocytes n background. monocytes are major players in the innate immune system and are recruited to sites of inflammation, where the environmental conditions vary extremely compared to the interstitium under physiological conditions. for example, in rheumatoid arthritis the inflamed joints are severely hypoxic. this decreased oxygen level could be a triggering factor for the activation and survival of monocytes. aim of the study was to analyze the influence of hypoxia on lipopolysaccharide (lps)-induced cytokine production in primary human monocytes methods. immunomagnetically separated monocytes from the blood of healthy donors were cultured for 16h under hypoxic conditions (1% oxygen). results. cytokine measurement in the supernatant with elisa showed increased concentrations of interleukin-1β (0.9 ng/ml vs. 4 .35 ng/ ml, p=0.0019) and interleukin-6 (63.8 ng/ml vs. 125.9 ng/ml, p=0.019), but not of tnf, after hypoxia and lps-stimulation. cleavage of the il-1β proform to its active form is dependent on the assembly of the inflammasome and the recruitment of caspase-1 followed by their activation. when inflammasome assembly was blocked with high extracellular k+-buffer or by inhibiting intracellular ca-signalling with the ca-chelator bapta-am, hypoxia induced il-1β release was abrogated. similarly, il-1β release after culture under hypoxia was also abolished in monocytic thp1-cells, which are genetically made deficient for the inflammasome components nlrp3 and asc. one activating signal for the inflammasome was shown to be the release of reactive oxygen species (ros), since mitochondrial ros staining with mitosox revealed an increased mitochondrial ros release under hypoxic conditions. accordingly, the induction of mitochondrial ros through decoupling of the electron transport chain with rotenone also triggered an increase of il-1β release under normoxic conditions. analysis of blood monocyts from ra patients showed no difference in lps and hypoxia induced il-1β release compared to healthy controls (1.84 ng/ml vs. 1.88 ng/ml). conclusion. this study shows, that hypoxia leads to the activation of the inflammasome, the recruitment of caspase-1 and the subsequent cleavage and release of interleukin-1β in human primary monocytes. intracellular calcium mobilization and mitochondrial ros production were shown to be essential mechanisms triggering inflammasome assembly. background. cell-derived membrane-coated microparticles have been identified as important mediators in intercellular communication. during the process of apoptosis, dying cells start to dynamically release microparticles. polymorphonuclear neutrophils are the most abundant type of leukocytes, representing 50-70% of all white blood cells. due to their very short lifespan, they are the source of massive amounts of apoptotic cell-derived microparticles (admps). while the interaction between neutrophils and t lymphocytes has been focus of extensive research, the influence of neutrophil-derived microparticles on t cells has not been analysed yet. in this study, we investigated the effect of membrane-coated microparticles released by apoptotic neutrophils on different t helper cell subsets. methods. different cd4+ t cell subtypes were sorted according to the expression of cd25, cd127, cd45ra and cd45ro and co-cultured with admps or apoptotic cell remnants purified from uv-irradiated neutrophils isolated from the peripheral blood of healthy donors. t cells were stimulated by okt3 and anti-cd28 antibodies and cell proliferation was measured by 3h-thymidine incorporation or pkh26-staining. secretion of cytokines was quantified by elisa. results. admps released by neutrophils selectively suppressed the proliferation of cd4+cd25-cd127+ tc in a dose-dependant manner and prevented the upregulation of cd25 on the t cell surface, while maintaining the expression of cd127. the secretion of tumor necrosis factoralpha (tnfα) by t cells stimulated in the presence of admps was significantly reduced. interestingly, in contrast to admps, the apoptotic cell remnants of neutrophils exerted no effect on t cells. the suppressive effect of admps could be completely abrogated by the addition of interleukin(il)-2 or il-7 or by the presence of cd4+cd25+cd127+ t cells. conclusion. neutrophil admps suppress the proliferation of cd4+cd25-cd127+ t cells under conditions of limiting il-2 and il-7 concentrations. this could represent an important mechanism to prevent inappropriate activation and expansion of resting t helper cells in the absence of sufficient stimulation and cytokine production. t. alexander 1 background. recent reports have shown dysregulated micrornas in murine lupus models, among them increased expression of mirna-182, which has been demonstrated to target the transcription factor foxo1 in activated cd4+ t cells. the loss of foxo1 activity in t cells is associated with spontaneous t cell activation, clonal expansion and autoantibody production, all of which are present in systemic lupus erythematosus (sle). methods. expression levels of microrna-182 and foxo1 were analyzed with rt-pcr in magnetic purified peripheral blood cd4+ t cells from 9 patients with sle and healthy controls (hc). multicolor flow cytometry was performed to analyze cd4+ t cell expression for ccr7, cd45ra, ki-67, foxp3, the interleukin-7 receptor-α and phosphorylated stat-5a (pstat5). analysis of serum il-7 levels was performed with elisa in 27 sle patients and hc (r&d systems). results. mirna-182 was significantly upregulated in cd4+ t cells from sle patients compared to hc (median expression 8.89×10e-7 vs. 3.96×10e-7, p=0.008) while foxo1 mrna levels were decreased, yet without reaching statistical significance. analysis of ki-67 expression revealed an increased percentage of proliferating cd4+ t cells in sle (5.23% vs 2.21%, p=0.006). overall, cd4+ t cellular proliferation in sle was associated with increased frequencies of cd45ra-ccr7-effector memory t cells and enhanced basal pstat5 levels (median mfi 503.5 vs 399.0, p=0.010), suggesting a recent stimulation with common gamma chain(γc)-signaling cytokines. in this regard, tcons from sle samples displayed decreased expression levels for the foxo1 target gene cd127 (mfi 2021 vs. 2553, p=0.049) and serum il-7 levels were significantly higher in sle compared to hc (17.0 pg/ml vs. 10.2 pg/ml, p=0.001). conclusion. mir-182 expression has been shown to be dependent on stat5 activation and to promote clonal expansion of activated cd4+ t cells. our data suggest that enhanced il 7r/stat5 signaling mediates induction of mir 182 expression, which in turn promotes the proliferation of tcons in sle. the relative contribution of il 7r/mir-182/foxo1 axis on the enhanced proliferative capacity of sle tcons remains elusive and merit further investigation. collectively, our data provide new insights in the pathophysiology of t cell hyperactivity in sle and identifies mir-182 as a candidate target for future therapeutic approaches. background. cell activation and apoptotic cell death leads to the formation of membrane-coated vesicles (mcvs). mcvs have previously been identified as mediators of cell-to-cell communication and carriers of microrna. an impaired clearance of apoptotic debris caused by an increased rate of apoptosis or a defect in phagocytic-cell clearance has been observed in sle patients. in this study, we analyzed the microrna content of activated and apoptotic lymphocytes and their corresponding mcvs from both normal healthy donors (nhds) and sle patients. further we investigated the immunomodulatory effect of mcv uptake by monocytes. methods. microrna content of activated and apoptotic lymphocytes and corresponding mcvs of nhds and sle patients were compared in an agilent microrna array and validated by qpcr. apoptosis was induced by uvb-irradiation. mir-155 expression in monocytes after uv-mcvs engulfment was determined by qpcr. expression of mir-155 target protein tab-2 was analyzed by western blot. results. mir-155* levels were decreased after apoptosis induction in lymphocytes and apoptotic mcvs compared to their viable correlates. mir-155, mir-99a and mir-34b were decreased in apoptotic lymphocytes compared to viable ones but increased or not significantly changed in apoptotic mcvs compared to viable mcvs, indicating a directional transport of microrna into mcvs. mir-34a was expressed at higher levels in viable sle lymphocytes and mcvs compared to nhds. mir-34b expression was decreased in uv-lymphocytes and uv-mcvs of sle patients. functional assays confirmed higher mir-155 levels and consecutively decreased target protein levels in monocytes after engulfment of uv-mcvs. conclusion. within this study we could show an unequal distribution of distinct microrna into mcvs released by activated or apoptotic lymphocytes. further the microrna content was regulated in whole apoptotic cells after uvb-irradiation. this suggests a directional transport rather than a random distribution. thus, cells regulate their microrna as well as the microrna content within released mcvs. we could show a microrna and protein expression change in phagocytes after mcv engulfment. hence, our results suggest mcvs could serve as a transport vehicle for microrna to mediate cell-to-cell communication and influence intracellular processes in phagocytes. disturbances of this system might contribute to the pathogenesis of sle. results. we found in the spleens of nzb mice 10-times higher numbers of long-lived plasma cells and megakaryocytes compared to wildtype, in nzw mice equal numbers and in nzb/w mice numbers between those for nzb and nzw or wildtype. moreover, in the spleen a fraction of plasma cells clustered around megakaryocytes. we also detected a missense mutation in the c-mpl gene of nzb mice leading to an amino acid replacement within the essential tpo-binding site. upon tpo stimulation of splenocyte and bone marrow cultures nzb cultures responded significantly stronger resulting in the double amount of megakaryocytes compared to nzw cultures. conclusion. in summary, our data indicate that augmented megakaryopoiesis enables the accumulation of a greater number of autoreactive plasma cells in lupus prone nzb/w mice. thus, we assume that enhanced megakaryopoiesis and higher megakaryocyte numbers are contributing to the development and/or pathogenesis of sle. background. baff is a cytokine important for the stimulation and survival of autoreactive b cells and therefore might play a role in several autoimmune diseases, e.g. autoimmune arthritis. in psoriasis arthritis, baff correlates with disease activity and testosterone, but only in male patients, suggesting a role for sex hormones in the regulation of baff. therefore, we wanted to determine if baff production in rheumatoid arthritis and osteoarthritis fibroblasts was regulated by neuroendocrine mediators. methods. fibroblasts were isolated from synovial tissue of ra (n=10) and oa (n=10) patients and cultured in vitro under different conditions. baff was determined by elisa. results. isolated fibroblasts were cultured in the presence or absence of interferon-gamma (ifn-γ), il-1, lipopolysaccharide (lps), tumor necrosis factor (tnf), cpg, poly i:c, and cortisol in different combinations for 48 and 72 hours to determine the optimal stimulation strategy for induction of baff production (measured by elisa in supernatants) in fibroblasts. ifn-γ best induced baff in ra and oa fibroblasts. ifn-γ-induced baff production in fibroblasts was decreased by dihydrotestosterone in a concentration dependent manner. the effect was specifically inhibited by nilutamid, a testosterone receptor antagonist. furthermore, stimulation of beta-adrenoceptor increased, whereas stimulation of alpha-adrenoceptors did not change inf-γ-induced baff in synovial fibroblasts. in general the effects were more pronounced in ra as compared to oa fibroblasts. conclusion. taken together, inf-γ-induced baff production in synovial fibroblasts is decreased by testosterone and increased by betaadrenergic stimuli. therefore, neuroendocrine regulation of inflammation in the inflamed joint might be in part mediated by regulating baff production in synovial fibroblasts. a. grützkau 1 , c. kyogoku 1 , b. smiljanovic 2 , j. grün 1 , r. biesen 2 , t. alexander 2 , f. hiepe 2 , a. radbruch 1 , t. häupl 2 1 deutsches rheuma-forschungszentrum (drfz), berlin, 2 charité -universitätsmedizin berlin, medizinische klinik mit schwerpunkt rheumatologie und klinische immunologie, berlin background. gene expression profiling experiments using peripheral blood mononuclear cells (pbmcs) revealed a crucial role of type i interferon (ifn) in the pathogenesis of systemic lupus erythematosus (sle). however, it is almost unknown how particular leukocyte subsets contribute to the overall type i ifn signature described for pbmcs. furthermore, a detailed analysis of how ifn signatures differ in autoimmune disease from that observed after viral infection is missing so far. therefore, we compared expression levels of 2442 ifn signature genes in peripheral cd4+ t helper cells and monocyte (mo) subsets isolated from patients with sle, healthy donors (nd) and nd vaccinated against yellow fever by global gene expression profiling. methods. peripheral blood from 8 patients with sle and 4 nd were recruited. same nd were examined before and after immunization by yellow fever vaccine. after sorting cells, isolated rna were applied to affymetrix human genome u133 plus 2.0 array. data analysis was done using bioretis database, genesis software and ingenuity pathway analysis (ipa). results. comparing gene expression profiles of yellow fever immunized individuals and active sle patients it was possible to identify a "common" and an "autoimmune-specific" ifn signature. although major ifn signature genes were commonly expressed in cd4+ t cells and mo of patients with sle and immunized nd, expression magnitudes of them were higher in patients with sle compared to immunized nd. in sle, in addition to the typical "viral-induced" ifn signature, genes that are involved in apoptosis signaling, antiviral pkr signaling, fcγ receptor-mediated phagocytosis and il-10-/il-9-/il-15-mediated jak/ stat signaling pathways were identified by ipa. conclusion. this study demonstrated that ifn signature in autoimmunity and that in viral infection are quite different in the number of ifn-related genes activated and their expression magnitudes. autoimmunity is characterized by a much stronger expression of ifn signature genes and is obviously modulated by a separate set of co-regulated genes defining the "autoimmune-specific" ifn signature. in summary, "common" and "autoimmune-specific" ifn signature genes are of potential interest as clinical biomarkers in sle diagnostics to differentiate between a disease flare and a viral infection. of peripheral blood lymphocytes (pbl). there is currently no data available about nk cells in gpa. the aim of this study was to evaluate the presence of nk cells in gpa granulomas and their proportions in pbl as a basis for a potential role in gpa. methods. paraffin sections of granulomas of 20 gpa, 5 sarcoidosis and 5 tuberculosis patients were stained with a cd56 monoclonal antibody. nk cell (cd3-cd56+) proportions of pbl in 30 gpa patients and 27 healthy controls (hc) were analysed by facs analysis. clinical data was extracted from medical records. results. contrary to granulomas from tuberculosis and sarcoidosis which showed a considerable infiltration by cd56 positive cells, there was not a single cd56 positive cell in granulomas from 20 gpa patients. therefore, the tissue destructive character of gpa granulomas is associated with a lack of nk cells. gpa patients with inactive disease [birmingham vasculitis activity score (bvas) = 0, n=19] possessed a significantly higher nk cell proportion in pbl (mean ± standard deviation: 24.4±13.5%) than both gpa patients with active disease (bvas>0, n=11, mean=10.7±5.6%) (p=0.0026) and hc (n=27, mean=14.4-7.7%, p=0.004). thus, clinical remission is accompanied by an increase in the nk cell proportion in pbl. interestingly, patients with inactive disease that had "normal" nk cell proportions of less than 20% of pbl (n=7) showed a more severe disease course than those with more than 20% of pbl. conclusion. nk cells might, therefore, be helpful to limit granulomatous inflammation. whether nk cell proportion in pbl might be a useful biomarker in gpa, e.g. as predictor for relapses, will be further evaluated in our future studies. v. gerl 1 background. plasmacytoid dendritic cells (pdcs) are considered a crucial element in sle pathogenesis due to their potency to produce high levels of ifn-α. this innate immunological function of pdcs is lost by terminal differentiation into a professional antigen-presenting cell (pdc-derived dc), thereby upregulating costimulatory molecules and downregulating innate characteristics, e.g. bdca-2 and ifn-α expression. pdc-derived dcs have not been described in vivo yet, probably due to the fact that they lose their specific markers during differentiation. furthermore, pdcs can differentiate into myeloid dcs by various stimuli. in sle, where low expression of bdca-2 is commonly seen, this differentiation could be relevant and point to such a lineage switch as well as to an activated state of pdcs. aim. to characterize pdc subsets of differentiation/activation in human peripheral blood and to study their impact on autoimmune inflammation in sle. methods. 8-color-flowcytometric analyses were performed on whole blood of healthy donors and sle patients. pdcs were identified by cd3-/cd19-/cd14-/cd123high//bdca-2+/hla-dr+ expression and characterized for cd11c, bdca-1 and the macrophage-associated siglec-1, expressed on monocytes of active sle patients in an ifn-α dependent manner. cd86 and cd83 expression were measured in parallel. results. we found a small subpopulation of siglec-1 expressing pdcs in human peripheral blood. compared to siglec-1 negative pdcs, siglec-1 positive pdcs express significantly lower bdca-2 and cd123, higher hladr background. agonistic autoantibodies against the angiotensin ii receptor type 1 (at1r) and the endothelin receptor type a (etar) have been identified in patients suffering from systemic sclerosis (ssc). here we examined the expression of at1r and etar in human immune cells and pathological effects mediated through these receptors by corresponding autoantibodies (aabs). methods. at1r and etar protein expression on peripheral blood mononuclear cells (pbmcs) from healthy individuals and ssc patients was analyzed using flow cytometry, mrna expression was examined by real-time pcr in pbmcs from healthy donors. in addition, pbmcs from healthy donors were stimulated in vitro with affinity-purified immunoglobulin g (igg) fractions from ssc patients positive for at1rand etar-aabs, and with igg from healthy donors serving as control. alterations in cell surface marker expression, cytokine secretion and chemotactic motility were analyzed using flow cytometry, elisa, and chemotaxis assays, respectively. results were correlated with characteristics/clinical findings of the igg donors. results. both at1r and etar were expressed on human peripheral lymphocytes and monocytes. protein expression of both receptors was decreased in ssc patients when compared to healthy donors and correlated negatively with disease duration. in addition, igg fractions of ssc patients induced t cell migration in an anti-at1r and anti-etar aab level-dependent manner. moreover, igg of ssc patients was capable of stimulating pbmcs to produce more il-8 and ccl18 than igg of healthy donors. all effects could be significantly abrogated by the application of selective at1r and etar antagonists. statistical analysis revealed a negative correlation between ssc igg-induced il-8 concentrations and disease duration, between ssc igg-induced ccl18 concentrations and time since onset of lung fibrosis as well as an association of ccl18 concentrations with vascular complications of the corresponding ssc igg donors. conclusion. we demonstrated the expression of both, at1r and etar, on human peripheral t cells, b cells and monocytes and found signs for a chronic receptor activation in ssc patients. the inflammatory and profibrotic effects upon aab stimulation in vitro, and their associations with clinical findings suggest a role for autoantibody-mediated activation of immune cells mediated through the at1r and etar in the pathogenesis or even the onset of the disease. the bioenergetic role of hif-1 and hif-2 during angiogenesis of human microvascular endothelial cells background. hypoxia and angiogenesis are features of inflamed and injured tissues. the transcription factors hypoxia inducible factor (hif)-1 and (hif)-2 regulate the cellular and metabolic responses to reduced oxygen tensions thereby promoting angiogenesis with implications on the pathogenesis of ra. we investigated the effects of a knockdown of either hif-1α or hif-2α in human microvascular endothelial cells (hmec) on angiogenesis and bioenergetics under hypoxia (1% o2) versus normoxia (18% o2). methods. specific knockdown of either hif-1α or hif-2α was conducted by shrna-technology. to assess angiogenesis of hmecs both tubuli and node formation under hypoxia versus normoxia were investigated. expression of hypoxia driven genes involved in the metabolic response to hypoxia (gapdh/pgk/glut1/ldha) was quantified by realtime rt-pcr. the bioenergetic status of the cells was quantified via atp/adp measurements. results. knockdown of hif-1α/hif-2α resulted in a loss of hypoxia induced angiogenesis. focusing on bioenergetic aspects, we found hypoxia to significantly induce pgk, ldha and gapdh in control cells. knockdown of hif-1α and hif-2α, respectively, did not affect the hypoxic induction of pgk and ldha. in hif-1α and hif-2α knockdown-cells, hypoxia was still capable of inducing gapdh, with a less pronounced effect in hif-1α knockdown-cells. hypoxia did not significantly up-regulate glut1, neither in control nor in hif-1α or hif-2α knockdown-cells. the knockdown of hif-2α resulted in significantly decreased expression of glut1 under hypoxia. we also found the atp/ adp ratio to be similar in control, hif-1α and hif-2α knockdown-cells under normoxia. under hypoxic conditions hif-1α knockdown-cells showed significantly reduced atp/adp ratios -indicating that less atp is available -compared to hif-2α knockdown-cells. conclusion. hif-1α and hif-2α are both key regulators of angiogenesis. however, they do differ in their potency to regulate cellular energy metabolism. this leads us to conclude that hif-2α does directly influence angiogenesis via regulating the synthesis of proangiogenic factors (as previously shown), whereas hif-1α affects angiogenesis via effects on cellular energy metabolism as indicated by the reduced expression of gapdh and the diminished atp/adp ratio. these findings provide new insights into regulation of angiogenesis in inflamed (hypoxic) tissues and are, therefore, considered to be of clinical relevance in ra. low baseline complement levels, autoantibody persistence and delayed thymic reactivation are risk factors for development of relapses after hematopoietic stem cell transplantation for refractory sle background. our previous research has provided the evidence that an autoreactive immune system can be "reset" into a healthy, tolerant state by immunoablative treatment to eradicate pathogenic effector cells, followed by transplantation of hematopoietic progenitor cells (hsct). nevertheless, disease flares may occur in a subset of these patients posttransplantation. here, we longitudinally analyzed the immune reconstitution of these patients to identify markers for favorable long-term responses. methods. since 1998, 10 patients with refractory sle received a cd34+selected autologous stem cell transplantation after immunoablation with antithymocyte-globulin (atg) and cyclophosphamide as part of a monocentric phase i/ii clinical trial. autoantibody titers were evaluated with elisa, peripheral t-and b lymphocyte subsets immunophenotyped using multicolor flow cytometry. results. clinical remission (sledai ≤3) could be achieved in all patients, despite immunosuppressive drug withdrawal, associated with disappearance of anti-dsdna antibodies and marked reduction of protective antibodies in serum. unfortunately, two patients died due to transplant-related infections. from the remaining eight patients, five patients are in long-term clinical remission for up to 14 years after hsct, while three patients suffered a relapse of sle at 18, 36 and 80 months post-transplantation, respectively. patients with early relapses (≤36 months) had decreased baseline complement levels, showed persistence of antinuclear antibodies (ana), less significant reduction in protective antibody levels and had slower repopulation of cd31+ cd45ra+ thymic-derived cd4+ t cells after hsct (<100/µl at 18 months) when compared to long-term responders. in addition, flow cytometric analyses revealed an expansion of circulating plasmablasts and increased coexpression of siglec-1 on monocytes (as surrogate marker for type-i interferon signature), preceding the clinical flares by ~6 months. conclusion. low baseline complement levels, persistence of ana and delayed thymic reactivity post-transplantation could be identified as risk factors for development of lupus flares after hsct. since atg-mediated cell lysis is complement-dependent, we conclude that low serum complement is directly associated with incomplete depletion of immunologic memory cells in these patients, which provides a rationale for complement substitution before immunoablation. moreover, lupus flares may be predicted individually by flow cytometry with plasmablast expansion and recurrence of type-i interferon signature. background. systemic lupus erythematosus (sle) is a chronic autoimmune disease characterized by the generation of pathogenic antibodies directed against a variety of autoantigens. we have previously shown that long-lived autoreactive plasma cells can contribute to chronicity and refractoriness of sle. our study is aimed to develop new methods for depletion of long-lived plasma cells in nzb/w mice, a model of sle. methods. we studied different treatment protocols on plasma cell survival: irradiation-based and more selective depletive treatments. 10-12 week-old nzb/w f1 mice were exposed to three different irradiation doses (10, 14, and 15 gy in two splitted doses with a 3-h interval). the following protocols were also investigated: 1) two bortezomib (bz) injections (0,75 mg/kg, i.v.) combined with anti-mouse cd20 (10 mg/kg, i.v.), 2) three bortezomib injections combined with anti-mouse cd20, 3) three bortezomib injections combined with anti-lfa-1 and anti-vla-4 antibodies (affecting directly the plasma cell niche; 200 µg, i.p.) in a 2-d interval, plus anti-mouse cd20 and anti-b220 (250 µg, i.v.). the plasma cells were analyzed in spleen and bone marrow by facs and elispot. results. the frequency of remaining plasma cells in bone marrow after 10, 14 and 15 gy irradiation were 52, 14 and 0,7% respectively, and in spleen were almost 50, 10 and 0,2%. short-term treatments with agents that affect plasma cells (bortezomib, anti-lfa1 plus anti-vla4) effectively deplete plasma cells including long-lived plasma cells in spleen and bone marrow of nzb/w mice. because of the b cell hyperactivity in nzb/w mice, we observe a rapid regeneration of autoreactive plasma cells in spleen and bone marrow. therefore, plasma cell depletion protocols were combined with b cell depletion. especially, the combination of plasma cell targeting with bortezomib, anti-lfa1 and anti-vla4 with b cell targeting (anti-cd20 plus anti-b220) interrupted the repopulation of autoreactive plasma cells in spleen and bone marrow. conclusion. very high doses of irradiation result in effective depletion of long-lived plasma cells but lower doses not. depletion of long-lived plasma cells can be achieved by the proteasome inhibitor bortezomib and by targeting both adhesion molecules lfa1 and vla4. the combination with b cell depletion is needed to prevent regeneration of autoreactive plasma cells. varicella-zoster-virus(vzv)-specific lymphocytes and igg antibody avidity in patients with juvenile idiopathic arthritis or rheumatoid arthritis background. varicella zoster virus (vzv) is a herpes virus that establishes a life-long latent infection with risk of reactivation (shingles) particularly in immunosuppressed patients with autoimmune disorders. patients with rheumatoid (ra) or juvenile idiopathic arthritis (jia) have a high risk for disseminating varicella zoster virus (vzv) infection or herpes zoster. this study was aimed to investigate the humoral and cellular immune response to vzv including assessment of igg-anti-vzv avidity and vzv-specific reactivity of lymphocytes in ra (n=56) or jia patients (n=75) on different treatments, including biologic agents, such as anti-tumor-necrosis-factor(tnf)-alpha or anti-interleukin-6 (il-6) receptor inhibition (tocilizumab), compared to 37 healthy adults (ha) and 41 children (hc). methods. igg-anti-vzv concentrations and avidities were quantified by an adapted elisa. vzv-specific interferon-gamma-producing lymphocytes (spot forming units, sfu/1,000,000 cells) were analyzed by elispot. results. no significant differences in the vzv-igg concentrations or avidities were found between the groups. however, lower igg-anti-vzv concentrations were found in tocilizumab-treated ra compared to ha and ra without biologic agents. ra showed lower median sfu (15/1,000,000 cells) than ha (57/1,000,000 cells), with lowest sfu in adalimumab-treated ra (10/1,000,000 cells). sfu were not altered in tocilizumab-treated ra and after incubation with anti-il-6 in vitro. no differences regarding igg-anti-vzv concentrations, rai and cellular reactivity were found between jia and hc. conclusion. our study demonstrated that ra and jia patients are still able to maintain humoral and cellular immune responses to vzv despite immunosuppressive therapy or biologic agents. in ra, the role of lower cellular reactivity for risk of herpes zoster has to be considered for recommendations on vaccination. cmv-specific cd8+ t cells from ra patients contribute to autoimmune disease 41 zeitschrift für rheumatologie suppl 2 · 2013 | 1. increased frequency of lir-1 (also called cd85j or ilt2) on cd8+ t cells has been associated with autoimmune disease. furthermore, it has been shown that latent cytomegalovirus (cmv) infection contributes to the expansion of cd28− t cells. hence we were interested in the influence of cmv infection on the lir1 expression on t cells in ra patients. methods. we were interested in the role of lir1+ t cells in ra patients, which potentially contribute to the autoreactive t cell pool, especially in cmv+ patients. therefore, we investigated the expression and function of lir-1 on cd8+ t cells in peripheral blood mononuclear cells (pbmc) from patients with rheumatoid arthritis by flow cytometry and cytotoxicity assay. results. flow cytometry analysis revealed higher frequencies of lir-1+ cd8+ t cells in cmv seropositive ra (n=49, mean%: 10.4) compared to cmv+ hd (n=51, mean%: 7.5, p=0.043). using hla-a*0201/cmvpp65 dextramers we analyzed cmv-specific cd8+ t cells. patients with ra had higher frequencies of cvm specific cd8+ t cells (n=8; mean%: 3.28) compared to healthy individuals (n=12; mean%: 1.35, p=0.04). phenotypically, cmv-specific cd8+ t cells are mainly cd28 negative and express lir-1. analysis of the cytolytic potential by cd107a expression revealed higher numbers of cd107a+cd8+ t cells in ra patients (n=3, mean%: 0,57) compared to healthy donors (n=3, mean%: 0,17). importantly, we found a significant correlation (p=0.034) of high numbers of cd8+lir-1+ t cells with high disease activity score (das28) in ra patients without immunosuppressive treatment (n=14, r=0,568) . tab.5 . conclusion. this is the first demonstration of significantly increased frequencies of lir-1+cd8+ t cells and of cmv-specific cd8+ t cells in patients with rheumatoid arthritis. these cells are characterized by a terminally differentiated phenotype. the higher cytolytic potential of cmv-specific t cells likely can be attributed to their function in containing latent cmv infection and to prevent cmv disease, but might potentially contribute to disease severity in ra patients. background. systemic lupus erythematosus (sle) is an autoimmune disease characterized by an acquired il-2 deficiency, which leads to a homeostatic imbalance between regulatory t cells (treg) and effector t cells (tcon; humrich et al. 2010). we recently demonstrated that treg homeostasis in lymphoid organs of diseased (nzbxnzw) f1 mice can be restored by treatment with recombinant il-2 (il-2) resulting in an amelioration of kidney disease. the aim of this study was to investigate the impact of il-2 therapy on intrarenal foxp3+ treg and kidney infiltrating conventional cd4+ t cells (tcon) in the (nzbxnzw) f1 mouse model of lupus nephritis. methods. (nzbxnzw) f1 mice with active nephritis were treated with recombinant il-2 either for a short period of 5 days or for a longer period of 30 days in total. absolute numbers, phenotype and proliferation of kidney infiltrating cd4+ t cell subsets were determined by flow cytometry at different time points. results. short-term il-2 treatment resulted in an enhanced proliferation and increased numbers and frequencies of intrarenal cd4+foxp3+ treg compared to untreated control mice. on the other hand, long term il-2 treatment did not result in a persistent expansion of the intrarenal foxp3+ treg population. however, total numbers of kidney infiltrating cd4+ tcon with a memory/effector phenotpye were diminished and cd4+ tcon showed markedly reduced signs of cellular activation. conclusion. our data indicate that short term il-2 treatment is able to expand the size of the intrarenal treg pool. in contrast, long term il-2 treatment decreases the numbers of kidney infiltrating memory/ effector t cells and reduces cellular hyperactivity suggesting that treg suppress the activation and expansion of infiltrating tcon. these results may in part explain the amelioration of disease induced by treatment with il-2 and underline the important role of intrarenal treg for the suppression of kidney disease in lupus mice. these results also provide additional important rationales for an il-2 based immunotherapy of human disease. from transcriptome to protein biomarkers in ra: joint compartment and monocytes outperform serum and whole blood background. a main challenge in disease-management of ra is to establish objective criteria relevant for diagnosis and therapeutic stratification of patients. this study focused on global approaches in dissecting inflammation in ra including transcriptome analyses of synovial tissue and blood monocytes and proteome analyses of synovial fluid and serum. methods. gene-expression profiles from synovial tissues and blood monocytes of ra and osteoarthritis (oa) patients were generated by affymtetrix arrays. elisa and multiplex immunoassays were used for validation of 30 candidate markers at the protein level in synovial fluid (sf) from ra and oa patients and in serum from the same group of patients and healthy donors. results. transcriptome analyses of synovial tissues from ra and oa revealed more than 1000 differentially expressed genes. to avoid difficulties in sampling synovial tissue and to avoid fluctuation in cellular composition of various cell types in blood, the transcriptome analyses from peripheral blood was focused on a specific cell population. monocytes were selected as the favourable cell type involved in the production of cytokines, which are often considered as therapeutic targets in ra. comparisons between ra and oa monocytes disclosed differential expression of more than 100 genes. in total, 30 genes that were up-regulated in synovial tissues and/or monocytes were used for validation at the protein level as potential biomarkers for ra. among these 30 biomarkers, chemokines (cxcl13, ccl18, ip10), adhesion molecules (vcam1, icam1, e-and p-selectins), proteolytic enzymes (mmp1, a1at), and the shedding form of cell surface molecules (cd14, cd163) background. idiopathic membranous nephropathy (imn) is a common cause of nephrotic syndrome in adults and has recently been identified as an autoimmune-mediated disease [1] . autoantibodies directed towards the m-type phospholipase a2 receptor (pla2r) are fairly specific for idiopathic mn and only found to a small percentage in sera from patients with secondary mn [2] . the outcome of patients with imn is quite diverse: about one third of patients have spontaneous remission, another third progress to require dialysis and the last third continue to have proteinuria without progression to renal failure. we performed serological profiles of 162 imn patients in order to compare antibody profiles to antibody frequencies found in the normal healthy population and to hopefully identify factors that help to predict disease course in imn. methods. serum samples of 162 patients with imn were assayed for a variety of autoantibodies by elisa, addressable laser bead immunoassay (albia) and to dsdna by crithidia luciliae assay. results. the prevalence of autoantibodies found in our imn cohort is summarized in tab. 1. anti-pla2r antibodies were found in about 54% of imn patients whereas the frequency of other antibodies was mostly below 2%. the one exception is anti-dfs70 that was found in 16.05% of imn patients. conclusion. the prevalence of anti-pla2r positive patients in our imn cohort matches what has been previously described [3] . the frequency of the other antibodies that we determined is comparable to what has been reported in the normal healthy population. it is important to note that anti-dfs70 antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases (sard; [4] ) whereas anti-ro52 reactivity is often regarded as a marker for sard. the absence of anti-ro52 and the high prevalence of anti-dfs70 confirms that imn is a rather organ specific autoimmune disease. background. activity and the quality of movement belong to the most fundamental diagnostic parameters for neurobehavioural analysis but in the past it has been difficult to include this information into pre-clinical murine disease models. here we tested the applicability of a radiofrequency identification (rfid) based automated tracking system in the experimental murine model of ovalbumin induced arthritis. methods. c57bl/6 mice were immunized twice with cationized ovalbumin in freund's complete adjuvant and onset of arthritis was induced two weeks after the last immunization by direct injection of cationized ovalbumin into the knee joint of the right hind leg. severity of arthritis was assessed through measurement of joint swelling and evaluation of histological changes. additionally mice were implanted with a rfid transponder and throughout the experiment their activity level was monitored by an id-grid sensor plate placed underneath the homecage. results. the joint inflammation in the ovalbumin induced arthritis model showed a quantifiable impact on the activity levels of the mice. our experiments could also show that movement activity correlates with disease severity as evaluated by clinical and immunological parameters. in the past employing behavioral methods was often limiting by group size, observation time and reproducibility and the stress of handling and new surroundings made results difficult to interpret. in our experiments a rfid-based automated tracking system allowed us to monitor individual activity long-term without removal of the mice from their homecage environment. this allowed for the correlation of clinical parameters to behavioral factors and adds another level of analysis to an established murine model. progranulin antibodies in a wide spectrum of autoimmune diseases results. autoantibodies against progranulin, a secreted and direct inhibitor of tnf-α receptors 1&2 were frequently identified in primary vasculitides. in detail, progranulin-antibodies were found during the course of disease in giant cell arteritis/polymyalgia rheumatica (14/65), takayasu's arteritis (4/13), classical panarteritis nodosa (4/10), behcet's disease (2/8), in granulomatosis with polyangiitis (31/81), churg-strauss syndrome (7/31) and in microscopic polyangiitis (6/17). in extended screenings progranulin-antibodies were also frequently detected in autoimmune connective tissue disorders, in rheumatoid and psoriatic arthritis and in inflammatory bowel disorders. in contrast progranulin-antibodies were only detected rarely in healthy controls (1/97), patients with obesity (0/40), residents of nursing homes (1/48), not in patients with cutaneously limited psoriasis (0/100), not in patients undergone sepsis (0/22), and not in patients with melanoma (0/98). a significant association of progranulin-antibodies with active disease states in granulomatosis with polyangiitis suggested a pro-inflammatory activity of progranulin-antibodies. this was supported by an observed neutralizing effect of progranulin-antibodies on the levels of circulating progranulin in elisa and western-blot. moreover, functional assays revealed, that progranulin-antibody containing sera render wehi-s cells far more sensitive to effects of administrated tnf-α, providing evidence for the suspected pro-inflammatory effect of progranulin-antibodies. conclusion. progranulin-antibodies occur in a widespread spectrum of autoimmune diseases and have a pro-inflammatory effect by neutralizing the physiologic tnf-blocker progranulin. background. flow cytometry (fcm) is widely used in research for molecular characterization at single cell level. conventional analysis is a semiautomated process of user defined gating and investigation in 2-d projections. for multiple parameter analysis with hundreds of marker combinations, this manual process is most limiting and impedes high throughput analysis. therefore, we developed a new algorithm for automated and standardized analysis of multiplex fcm data. methods. automation included asinh-transformation of data, cell grouping, population detection and population feature extraction. for grouping of cells, an unbiased unsupervised model based t-mixture approach with expectation maximization (em)-iteration was applied. populations were identified by meta-clustering of several experiments according to position and extension of cell-clusters in multi-dimensional space and by including a general procrustes analysis (gpa) step. for validation, peripheral leukocytes from healthy donors and patients with rheumatoid arthritis (ra) were prepared by hypoosmotic erythrocyte lysis and stained with different sets of lineage-specific antibodies. in parallel, different leukocyte samples were depleted of one of these populations by magnetic beads. qualitative and quantitative characteristics of major populations were compared with conventional manual analysis. results. whole blood leukocytes stained simultaneously with up to 7 markers were correctly distinguished in all major populations including granulocytes, t cells and their subpopulations, monocytes, b cells, and nk-cells. the result was comparable to the "gold standard" of manual evaluation by an expert. the new technology is able to detect subclusters and to characterize so far neglected smaller populations based on the new parameters generated. automated clustering did not require fluorescence compensation of data. cell-grouping is applicable even for large fcm datasets of at least 10 parameters and more than 1 million events. comparing the cell-clusters between ra and healthy controls, differences were detectable in several cell (sub-)populations, stable enough to perform correct classification into controls and disease. conclusion. this new approach reveals promising results for automated and time-saving analysis of large datasets from multiplex fcm. the algorithm avoids operator-induced bias, is able to detect unexpected sub-clusters and to characterize so far neglected populations. this may reveal not only new markers for disease activity but also for therapeutic stratification. background. lasp-1 localizes at focal adhesions, along stress fibres and leading edges of migrating cells regulating metastatic dissemination of different tumors. since rasf have been implicated in the spreading of disease by leaving cartilage destruction sites, migrating via the bloodstream and re-initiating the destructive process at distant articular cartilage surfaces, the underlying mechanisms are of special interest. therefore, we investigated the role of lasp-1 in sf migration and its effects on ra. methods. to identify lasp-1 expression and its sub-cellular distribution in human sf as well as in hind paws of wt and htnftg mice, we performed western blots and immunofluorescence. the migration of sfs derived from wt, lasp-1-/-, htnftg and lasp1-/-/htnftg mice was studied in a modified scratch assay as well as in live cell imaging studies. furthermore, a transmigration assay using sf from all four genotypes and murine endothelioma cells (bend.5) as an endothelial barrier was carried out. sf transmigration under inflammatory conditions was also evaluated by tnf-alpha stimulation of the endothelial cells in vitro. results. lasp-1 expression was up regulated in rasf and in sf from htnftg mice compared to healthy controls and was found at structures of cell adhesion and invasion. the scratch assay as well as the live cell imaging studies showed a significantly reduced migration of lasp(1 ng/ml) was applied. in parallel, il-2 stimulation significantly amplified the expression of anti-apoptotic bcl-2 in sle treg but not tcon. conclusion. in analogy to our previous findings in lupus-prone mice, treg from sle patients show the classical hallmarks of il-2 deficiency with loss of cd25 expression and a homeostatic imbalance between treg and tcon. these findings could be associated with a reduced il-2 expression by cd4+ t cells in sle patients. on the other hand, low-dose il-2 stimulation in vitro could restore these defects, underlying the potential of il-2 as a novel therapeutic option in sle. the glucocorticoid-dependent modulation of immune-mediated inflammatory arthritis by osteoblasts in mice is t cell independent background. at present, the role of adiponectin in rheumatoid arthritis is still controversial. there is some evidence indicating anti-inflammatory effects, for example adiponectin reduces the tnf release by macrophages. in contrast to its anti-inflammatory role, adiponectin also exerts pro-inflammatory effects locally in joints, inducing for example pro-inflammatory factors and matrix-degrading enzymes in ra synovial fibroblasts. moreover, our immunohistochemical analysis of ra bone tissue showed a co-localization of adiponectin with key cells of bone remodelling (osteoblasts, osteoclasts). however, the role of adiponectin in bone remodelling of ra still needs to be defined. in this study, we therefore focussed on adiponectin and its immunomodulatory properties on ra osteoblasts and osteoclasts. methods. human osteoblasts and osteoclasts were isolated from bone tissue and blood samples of ra patients. immunocytochemistry and rt-pcr were used to analyze the expression of adiponectin and its receptors in osteoblasts and osteoclasts. osteoblasts and osteoclasts were treated with adiponectin (10 µg/ml). adiponectin-mediated effects on the cytokine expression in osteoblasts and osteoclasts were analyzed using elisa. results. the expression of adiponectin and its receptors (adipor1, adipor2, and paqr3) by cultured ra osteoblasts and osteoclasts could be confirmed on translational and transcriptional level. stimulation of primary ra osteoblasts and osteoclasts with adiponectin resulted in an alteration of cytokine release. osteoblasts showed a time-and dose-dependent increase in il-6 production. furthermore, adiponectin induced the secretion of il-8 and gro-alpha and significantly increased the il-6 and mcp-1 production (il-6: 5-fold, p=0.004; mcp-1: 6-fold, p=0.004). stimulation with adiponectin resulted in an increase in il-6 production in pre-osteoclasts (5-fold) but not in osteoclasts. the secretion of il-8 was increased in pre-osteoclasts (18-fold) and osteoclasts (2-fold). the results of the present study confirm the pro-inflammatory potential of adiponectin in ra. the cytokines released after adiponectin treatment by osteoblasts and osteoclasts promote osteoclastogenesis or the migratory potential of osteoclasts and monocytes. together with the finding that adiponectin is present in the bone compartment of ra suggest an involvement of adiponectin in articular destruction. acknowledgement: funded by the german research society (spp1468, immu-nobone, ne1174/6-1). novel mechanisms of glucocorticoid therapy in arthritis anti-inflammatory acting glucocorticoids (gcs) are an important component of rheumatoid arthritis (ra) therapy. but their beneficial usefulness, especially in ra therapy, is hampered by severe side effects like glucocorticoid-induced osteoporosis (gio). until now the molecular mechanisms underlying the beneficial and side effects of gc therapy are poorly understood. gcs exert their actions via the glucocorticoid receptor (gr) that alters gene expression by either binding as a dimer to gc response elements in the promoter region of target genes or by interacting with and thus interfering with other transcription factors. for a long time gr dimerization was considered as the molecular base of side effects. interference of pro-inflammatory transcription factors, such as ap-1 and nf-κb by the gr monomer was believed to contribute to the therapeutic effects of gcs. in a model of gio we previously showed that unexpectedly interaction of the gr monomer with ap-1, but not nf-kb in osteoblasts is decisive for bone loss (cell metabolism 2010 11:517). in contrast, in antigen-induced arthritis (aia), we could demonstrate that gcs act in the acute inflammation of ra via the dimerized gr. particularly, gc therapy suppressed th1 and th17 cell derived pro-inflammatory cytokines in a dimerization dependent manner. furthermore th17, rather than th1 cells seem to be the most crucial targets for an efficient gc therapy since il-17-/-mice were resistant to gc therapy whereas ifnγ-/-mice responded as efficient as wild type mice to steroid treatment (pnas 2011 108:19317). in a more chronic arthritis model, the k/bxn serum transfer induced arthritis, we demonstrate now that, unexpectedly, dimerization of the gr in non-hematopoietic cells also contributes to the anti-inflammatory effect of gcs. thus, for immunosuppression of arthritis the gr is required in distinct cell types. taken together, for anti-inflammatory actions the gr dimerization dependent gene regulation is decisive in ra, whereas gio depends on the suppression of ap-1 dependent gene expression. intriguingly for anti-inflammatory activities of gcs immune and non-immune cells are involved. our approaches give new insights into gc action on arthritis and bone that can be translated into new concepts for anti-inflammatory therapies preventing gio. background. new bone formation and ankylosis are a hallmark of ankylosing spondylitis (as). the impact of cytokines and different mechanisms of new bone formation (endochondral vs. membranous) to syndesmophyte formation and joint ankylosis in as are still poorly understood. in order to analyze cartilage hypertrophy -as a potentially important element of endochondral bone formation -and to assess the possible influence of cytokines, we performed an immunohistochemi-cal study of the hyaline articular cartilage of facet joints of as patients in comparison to autopsy controls and patients with osteoarthritis (oa). methods. the cytokines interleukin(il)-6, il-10 and il-22, as well as the marker of cartilage hypertrophy runt-related transcription factor 2 (runx2), matrix metalloproteinase 13 (mmp13) and collagen type 10 (col10) were determined in facet joints from 13 patients with as (undergone correction surgery of rigid hyperkyphosis), 11 oa patients (undergone surgery of the lumbar spine, because of neurological deficits) and 12 controls (autopsies without spinal diseases). immunohistochemistry was performed and the entire cartilage area was analyzed for the frequency of positively stained chondrocytes. background. immunization with glucose-6-phosphate isomerase (g6pi) induces arthritis in susceptible strains of mice. depletion of regulatory t cells (tregs) prior to immunization switches the usually acute, self-limiting course to a non-remitting, destructive arthritis. this provides a possibility to study molecular switches for the transition from acute, self-limiting to chronic, destructive arthritis within one mouse model. to examine the role of fibroblast-like synoviocytes (fls), which are known to modulate immune responses via the production of pro-and anti-inflammatory mediators, the phenotype and function of fls from mice with either acute, self-limiting or non-remitting, destructive arthritis was studied. methods. fls from dba/1 mice that developed either the acute or the chronic form of arthritis were isolated from joints over a time course of 56 days. to investigate the phenotype of fls elisa studies as well as zymography have been performed. for the functional clarification of those cells the matrix-associated transepithelial resistance invasion (matrin) assay and a cartilage attachment assay have been used. furthermore, fls have been transferred in vivo into the knee joints of immunodeficient mice and the joints have been scored histologically. results. fls from treg-depleted mice produced significantly more cytokines (e.g. interleukin 6 (il-6)) upon stimulation with other cytokines, growth factors and tlr ligands. this increased susceptibility to cytokine stimulation in chronic animals compared to acute ones is observable throughout the disease course (56 days). furthermore, the secretion and activity of matrix metalloproteases (mmps) was enhanced in the fls from chronic mice compared to samples from acute ones. additional functional differences include the collagen-destructive potential and the potential to attach and eventually invade wild type cartilage. here, fls from treg-depleted chronic arthritic mice showed a higher invasive and destructive potential. ultimately, fls from treg-depleted mice were able to destroy cartilage in immunodeficient mice. conclusion. our results are compatible with the hypothesis that uninhibited inflammation in the early phase of treg-depleted mice causes the acquisition of an autonomously aggressive phenotype of synoviocytes which contribute to the switch from acute to chronic arthritis even in the absence of late support from t and b lymphocytes. collagen-induced arthritis modulates reactivity to sympathetic neurotransmitter stimuli during osteoclastogenesis of bone marrow-derived macrophages from da rats background. osteoclast(oc)-mediated bone destruction contributes to increased disease burden in rheumatoid arthritis. simultaneously, changes in synovial tissue innervation occur, leading to a reduction in catecholaminergic nerve fibres. studies on sweat gland innervation revealed that catecholaminergic fibres are capable of phenotypic transition to cholinergic nerves. the sympathetic neurotransmitters norepinephrine (ne) and acetylcholine (ach) affect osteoclastogenesis oppositely prompting us to study osteoclastogenesis at different phases of collagen-induced arthritis (cia) in an altered neurotransmitter microenvironment. methods. for induction of experimental arthritis, da rats were immunized with bovine collagen type ii while controls received isotonic nacl solution. to generate oc, bone marrow-derived macrophages (bmm) were isolated and differentiated with recombinant m-csf and rank ligand. the influence of ne and ach stimulation on osteoclast differentiation and activity was compared between arthritic and control animals at the acute (20 days post immunization, pi) and the chronic (40 days pi) disease state. as the nicotinic α7 ach receptor subunit is involved in the cholinergic anti-inflammatory reflex, we also applied a specific agonist, arr-17779. additionally, the gene expression profile for ne and ach neurotransmitter receptors was analyzed. results. ach stimulation generated significantly more osteoclasts in controls (40 days pi). arr-17779 mediated effects were similar to ach. ne decreased osteoclastogenesis via β-adrenoceptors and enhanced via α-adrenoceptor stimulation. cells from arthritic animals were less affected by ne and ach stimulation.oc from arthritic animals showed tendentially decreased activity in an enzymatic cathepsin k activity assay. ach and arr-17779 stimulation decreased cathepsin k activity 20 days pi, but the effect disappeared 40 days pi, representing the chronic arthritis state. ne stimulation significantly inhibited enzyme activity 20 days pi, but has little effect under chronic conditions. the receptor gene expression profile changed in the time course of arthritis. 20 days past immunization muscarinic ach receptors m3 and m5 were significantly upregulated whereas after 40 days adrenoceptors α1d and α2b were significantly downregulated. conclusion. we conclude that cia differentially modulates neurotransmitter influence during oc differentiation and activation but the underlying processes remain still unknown. the observed time pointdependent changes in neurotransmitter receptor gene expression may constitute a regulatory mechanism to counteract alterations in the local neurotransmitter composition. background. the generation of memory t lymphocytes allows effective and fast immune responses during antigen re-challenge and represents a hallmark of adaptive immunity. previous work from our group has demonstrated that murine memory cd4+ t cells reside in specific bone marrow niches and are characterized by the high expression of cd69 and ly-6c. these cells were designated as resting in the context of gene expression and proliferation. here, we aimed to phenotypically and functionally characterize human memory t lymphocytes in peripheral blood and bone marrow of healthy individuals. methods. mononuclear cells were isolated from paired blood and bm samples from individuals undergoing hip replacement surgery. phenotypic analysis and cytokine profile of distinct memory t cell subsets were assessed by flow cytometry. proliferation and cell cycle status were analyzed using ki-67 and propidium iodide (pi) staining, respectively. results. distinct populations of cd69-expressing cd8+cd45ra-and cd4+cd45ra-t cells were detected in bone marrow but not in the periphery. ccr7 and cd62l expression was reduced on bone marrow cd69+cd4+cd45ra-and cd69+cd8+cd45ra-t cells compared to their cd69-counterparts in bone marrow and peripheral blood. cell cycle analysis and ki-67 expression levels demonstrated the nonproliferative state of bone marrow memory t cells. furthermore, bone marrow resident memory t cells showed reactivity against various pathogenic agents, such as tetanus, measles and cmv. conclusion. we have identified a population of cd69-expressing cd8+cd45ra-and cd4+cd45ra-t cells in the bone marrow. despite cd69 expression, which is generally regarded as early activation marker, the cells were resting in terms of proliferation. bone marrow cd69+ memory t cells have downregulated ccr7 and cd62l indicating reduced homing capacity to secondary lymphoid organs. our data underline the role of the bone marrow as a major reservoir for resting memory t lymphocytes. therapeutic methods exerted an influence on satisfaction and future expectations in patients with rheumatoid arthritis (ra). methods. when visiting their rheumatologist, patients with ra were asked to complete a questionnaire at home after the consultation and then return it to an independent opinion research centre, where the data was collected and analysed. the form comprised various areas, namely demography, aspects of the diagnosis, medical care, therapeutic measures, and the illness in a personal context. results. 127 patients (122 females/25 males) from the whole of austria with a particular emphasis on lower austria, upper austria and tyrol completed the questionnaire (of 150 distributed), resulting in a response rate of 85%. 63% of the patients lived in settlements of under 5,000 inhabitants; a further 18% in settlements of under 50,000 inhabitants.. the rheumatologist attended could be reached within one hour for 90% of the patients and within 30 minutes for 41%. in slightly fewer than 30% of the respondents the diagnosis was made within three months, in 44% within six months. in 75%, the diagnosis was made by a rheumatologist. after experiencing the first symptoms, 80% contacted their general practitioner. a high degree of satisfaction appears to originate from the information supplied by the rheumatologist attended. most patients felt they were involved in decisions regarding their therapy. 77% of the respondents were employed prior to their illness; as a consequence of the disease 27% had to leave their jobs. conclusion. the majority of the respondents came from rural areas. the correct diagnosis was made within six months for almost half of the patients questioned. most patients felt well informed by their rheumatologists and involved in therapeutic decision-making. , combinational therapy of synthetic dmards (9.6; 5.1-14.1), and biological-monotherapy (6.07; 0-13). all of these differed significantly on later observation periods. comparing the prescriptions separately by sequential treatments there were no differences in retention rates for the individual dmard classes. regarding retention, in the first treatment synthetic dmards showed the longest retention, but from the second on this was the case for tnfi-combinational treatment and non-tnfi-biologicals (. abb.12) conclusion. traditional dmards are the starting point of therapy and mtx is the anchor drug for the first and all subsequent courses. already at the second sequential course, the combination therapies of mtx+tnfi become numerically more relevant, and their retention is better than mtx. therapie der rheumatoiden arthritis im letzten jahrzehnt -was hat sich verändert? abb.13 | ev.198 anzahl eingeschlossener patienten nach einschlussjahren und therapie sowie zeitlichen entwicklungen im das28 und der eular-response cal features of ra (erosive arthritis with classical radiological features) plus specific laboratory markers (ccp-antibodies). the third patient, a 48-year-old female presented initially with features of ra and sle simultaneously (alopecia, subcutaneous nodules, leucopenia, positive ccp-antibodies, high titres of ana and dna-antibodies). the fourth patient, a 40-year-old patient presented with severe polyarthritis in the upper and lower limbs, subcutaneous nodules, fever and cervical lymphadenopathy, she had high titres of ccp-antibodies (170 u/ml by a normal range of less than 5 iu/ml), ana of 5120 (normal less than 80), and dna of 290 iu/ml (normal less than 100 iu/ml). conclusion. the take home massage of this presentation is to be aware of rhupus if the sle patient develops erosive arthritis or subcutaneous nodules, or if the ra patient develops features of sle like leucopenia, active urine sediment, or clinically significant serositis. rhupus seems to be a distinctive entity and should be kept in mind while dealing with patients having ra or sle as it can affect the treatment and outcome. vorgeschichte. bei der abklärung eines akuten thoraxschmerzes sind auch seltene ursachen, so zum beispiel der einbezug thorakaler organe in eine entzündliche systemerkrankung, zu bedenken. anhand eines besonderen falles möchten wir den weg zur diagnose bei einem schwer kranken notfallpatienten zeigen. leitsymptome bei krankheitsmanifestation. ein 57-jähriger mann wird bereits zum dritten mal mit akuten thoraxschmerzen in die notaufnahme aufgenommen, jeweils war eine kardiale ischämie ausgeschlossen und ambulante diagnostik empfohlen worden. nach der schmerzcharakteristik, der vorgeschichte von rezidivierenden thoraxschmerzen und entsprechenden risikofaktoren wird bei massiver symptomatik jetzt von einem akuten koronarsyndrom ausgegangen und die invasive diagnostik durchgeführt. eine akute koronare ischämie kann jedoch ausgeschlossen werden. fieber, hohe entzündungszeichen, hinfälligkeit und gewichtsverlust von mehr als 10 kg in den letzten wochen lassen dann eine infektbedingte oder tumorbedingte ursache vermuten, abdomensonographie und röntgen-thorax sowie ausführliches labor samt immunologie führen nicht weiter. wegweisende weitere organbefunde finden sich nicht. die behandlung mit antibiotika hat keinerlei effekt auf klinik oder entzündungsparameter. nach 3 tagen wird der krankheitsverlauf kritisch evaluiert, eine nichtinfektiöse ursache der beschwerden wird in betracht gezogen, eine transösophageale echokardiographie wird zum ausschluss einer endokarditis und zur beurteilung der aorta (leitsymptome thoraxschmerzen und fieber!) durchgeführt. dabei zeigen sich die klappen sämtlich unverdächtig, die aorta ascendens weist eine massive echoarme wandverdickung auf. zum sicheren ausschluss eines intramuralen hämatoms wird sofort eine ct der thorakalen aorta durchgeführt, die eine ausgeprägte zirkuläre wandverbreiterung ohne hinweise auf dissektion zeigt. diagnose. riesenzellarteriitis mit aortitis. therapie. steroide, einleitung einer remissionsinduzierenden therapie mit cyclophosphamid boli. weiterer verlauf. innerhalb von 2 tagen ist der patient beschwerdefrei, die entzündungsparameter sind halbiert, der bettlägerige patient lässt sich mobilisieren und verlässt nach 10 tagen die klinik. bei der diffe-renzialdiagnose des akuten thoraxschmerzes sollten eine unklare entzündungsserologie und eine b-symptomatik frühzeitig an eine aortitis denken lassen. in diesem fall fand sich bereits in tee und ct ein ausgeprägter befund, der sich am ehesten durch den langen verlauf vor diagnosestellung erklären lässt. einleitung. die progressive familiär intrahepatische cholestase (pfic) gehört zu einer heterogenen gruppe seltener, autosomal rezessiv vererbter erkrankungen der gallensäurenexkretion mit intrahepatischer cholestase, hohem risiko der leberzirrhose bereits im kindesalter und hepatozellulärem karzinom. das auftreten eines sle bei pfic ist bisher in der literatur nicht beschrieben. methoden. wir berichten über eine jetzt 23-jährige patientin mit genetisch gesicherter pfic-2 (defekt der atp abhängigen gallensalz-exportpumpe bsep), biliostomaanlage im kindesalter, therapie mit udca und kontinuierlicher hepatologischer betreuung. 12/2011 manifestierte sich ein sle mit az-minderung, florider polyarthritis, polyserositis, splenomegalie, anämie und leukozytopenie. die ana waren mit >1:5120 homogen erhöht, die dns-ak im elisa mit 6738 u/ml, ena und antiphospholipid antikörper waren negativ. eine steroidtherapie wurde mit prednisolon 30 mg/tag begonnen. bei guter verträglichkeit und stabilen cholestaseparametern wurde die therapie um chloroquin mit 250 mg an 3 tagen der woche ergänzt. die betreuung wurde interdisziplinär fortgesetzt. ergebnisse. unter der steroidtherapie waren gelenkbeschwerden und serositis gebessert, das crp, die leukozytopenie und anämie normalisiert. die dns-antikörper fielen auf 1977 u/ml, c3 und c4 stiegen um 20%. es persistierten lediglich physiotherapeutisch behandelte muskuläre schmerzen und schonatmung nach pleuritis. bei steroidreduktion unter 10 mg traten die gelenkbeschwerden wieder auf, die dns-antikörper stiegen auf 4549 u/ml und c3/c4 fielen um 10%, das crp blieb normal. die steroiddosis wurde auf 15 mg/tag und die chloroquindosis auf 5×250 mg/woche erhöht. neue organkomplikationen im rahmen des sle sind nicht aufgetreten. die gallensäuren waren mit 47 µmol/l (norm <8) im jahr 2009 (letzte messung vor manifestation des sle) deutlich erhöht, bei manifestation des sle mit 12 µmol/l bereits deutlich gebessert und unter hoch dosierter steroidtherapie mit 4,7 µmol/l nach 1 woche sowie 5,4 µmol/l nach 1 monat normalisiert. unter prednisolon 15 mg/tag stiegen sie bei inaktiviertem sle auf 15 µmol/l nach 4 monaten an, bei steroidreduktion unter 10 mg auf 69 µmol/l. nach erneuter steroiddosiserhöhung auf 15 mg prednisolon/tag fielen sie auf 12 µmol/l ab. schlussfolgerung. die pfic-2 schützt nicht vor der manifestation eines sle. eine behandlung mit steroiden und chloroquin ist auch bei pfic sicher und wirksam. der floride sle und die höher dosierte steroidtherapie senken trotz bestehenden genetischen defekts unabhängig voneinander und synergistisch die gallensäurenspiegel im serum bei genetischer störung der atp-abhängigen sekretionspumpe bsep. augenentzündungen. eine ausgeprägte b-symptomatik mit fieber, nachtschweiß und abgeschlagenheit seit ca. zwei jahren hatte sich jeweils unter der therapie der hörstürze verflüchtigt. die mr-angiographie der aortenwand zeigte den typischen befund eines ausgeprägten wandenhancements der thorakalen aortenwand sowie der supraaortalen gefäße, duplexsonographisch fand sich eine zirkuläre wandverdickung der proximalen und mittleren acc beidseits ohne relevante stenosen. bei fehlendem nachweis zerebraler vaskulitischer oder embolischer veränderungen im kraniellen mrt und bei normalem eeg wurde der cerebrale krampfanfall als gelegenheitsanfall dd im rahmen der hochaktiven grunderkrankung interpretiert. diagnose. takayasu-arteriitis mit assoziiertem cogan-syndrom und rezidivierender polychondritis. therapie. steroidstoß, darunter rasche reduktion der entzündungszeichen und promptes ansprechen der b-symptomatik, beginn einer steroidsparenden therapie mit mtx. bei anhaltender krankheitsaktivität und hohem steroidbedarf wird der patient aktuell mit tocilizumab behandelt. schlussfolgerung. der präsentierte fall zeigt, dass mittels neuer bildgebender verfahren gelegentlich eine großgefäßvaskulitis detektiert werden kann, obwohl das klinische bild (hier: kopfklinik) eine kleingefäßvaskulitis vermuten lässt. das cogan-syndrom ist häufig mit einer großgefäßvaskulitis assoziiert, in diesem fall auch mit einer polychondritis. umgekehrt erweitert sich unser wissen um das befallsmuster der großgefäßvaskulitiden, die zwar überwiegend große, aber auch mittelgroße und kleine gefäße einbeziehen können. in unserem zentrum ist dies der zweite fall einer takayasu-arteriitis mit assoziiertem cogan-syndrom in einem kollektiv von 8 fällen. diagnostik. im rahmen einer vorstellung in unserer rheumatologischen ambulanz zur abklärung eines möglichen sjögren-syndroms, konnte in der lungenfunktionsdiagnostik eine leichte restriktion und überblähung festgestellt werden. in einem auswärtig durchgeführten mrt der halsweichteile zeigten sich die glandula parotis und submandibularis beidseits inhomogen und kräftig kontrastiert, ebenfalls mehrere grenzwertig große lymphknoten. aufgrund der erneut pathologischen lungenfunktion und dem verdacht auf eine lungenbeteiligung bei sjögren-syndrom erfolgte ein ct-thorax. hier zeigte sich eine zysti-sche rarefizierung vor allem der zentralen lungenanteile, differentialdiagnostisch mit einer langerhans-zell-histiozytose vereinbar. auch erschien der diabetes insipidus passend zur histiozytose. die immunologischen untersuchungen waren unauffällig, insbesondere konnten keine ssa-/ssb-antikörper oder eine hypergammaglobulinämie nachgewiesen werden. somit erschien ein sjögren-syndrom unwahrscheinlich. zur weiteren abklärung erfolgte eine bronchoskopie, in den biopsaten konnte immunhistochemisch eine langerhans-zell-histiozytose nachgewiesen werden. in einer pathologischen nachuntersuchung auswärtiger parotis-biopsate bestätigte sich diese, zudem konnte eine mutation des braf-proto-onkogens nachgewiesen werden. im abschließend durchgeführten pet-ct konnte eine vermehrte kontrastmittelaufnahme des hypophysenstiels, eine vermehrte stoffwechselaktivität der parotis beidseits sowie kutan axillär links diagnostiziert werden. abschließend lag somit eine langerhans-zell-histiozytose mit befall von hypophyse, lunge, parotis, haut, lymphknoten sowie einem fraglichen befall des darms vor. therapie. in absprache mit der adulten langerhans-zell-histiozytose studiengruppe erfolgt nun eine therapie mit cytarabin. weiterer verlauf. der weitere verlauf nach geplantem therapiebeginn bleibt abzuwarten. einleitung. die anti-gbm-erkrankung (goodpasture-syndrom) ist eine prototypische autoimmunerkrankung mit ernster prognose, wenn sie als "pulmorenales syndrom" mit der trias rapid-progressive glomerulonephritis, alveoläre hämorrhagie und nachweis von autoantikörpern gegen glomeruläre basalmembranen (anti-gbm-ak) auftritt. über weniger aggressive verläufe ist wenig bekannt. in der literatur wird die bedeutung der frühen diagnosestellung für die prognose der patienten betont. wir berichten über eine 36-jährige patientin, die sich mit abgeschlagenheit, müdigkeit und blutbeimengungen im sputum vorstellt. sie betreibt einen nikotinabusus. methoden. wir sehen eine blasse patientin (hb 4,0 mmol/l, normochrom, normozytär), die keine weiteren auffälligen befunde in der körperlichen untersuchung zeigt. die apparative diagnostik mittels endoskopie und sonographie ergibt keine befunde, die die anämie erklären können; in der bronchoskpie zeigt sich das bild einer alveolären hämorrhagie ohne aktive blutungszeichen. neben der ausgeprägten anämie bestehen eine milde proteinurie mit 300 mg/d sowie eine geringe erythrozyturie. die immunologische diagnostik ergibt gering erhöhte anti-gbm-ak, negative ana und anca. die nierenbiopsie zeigt eine rapid-progressive glomerulonephritis mit halbmondbildung in einem glomerulum, zusätzlich können lineare igg-ablagerungen in der immunfluorenz dargestellt werden. es ist ein glomerulum in der biopsie betroffen, die anderen glomeruli sind unauffällig. es bestehen einzelnen erythrozytenzylinder, diffuse entzündungszeichen lassen sich nicht nachweisen. die nachträglich durchgeführte immunfluoreszenz in der lungenbiopsie bestätigt den befund linearer igg-ablagerungen. ergebnisse. in unserem fall sehen wir eine junge patientin in einem relativ guten allgemeinzustand mit gering erhöhten anti-gbm-antikörpern und einer gering ausgeprägten nierenschädigung mit einem befallenen glomerulum in der biopsie. es wird angesichts des jungen alters der patientin und der geringen ausprägung der erkrankung eine therapie mit cyclophosphamid nach dem "euro-lupus-protokoll" von f. hossiau eingeleitet. im verlauf steigt der hb auf 5,6 mmol/l, die alveoläre hämorrhagie sistiert und die proteinurie ist rückläufig. schlussfolgerung. das goodpasture-syndrom mit einer inzidenz von 0,5-1,0/1 mio. einwohner und jahr ist eine sehr seltene autoimmunerkrankung mit ernster prognose. möglicherweise spielen umweltfaktoren (hier: nikotinabusus) eine rolle für die manifestation der erkrankung. interessant ist, dass die erstbeschreibung im rahmen einer influenza-epidemie -wie auch in diesem jahr bei unserer patientinerfolgte. über die therapie gibt es wenige informationen. die meisten empfehlungen gibt es zum pulmorenalen-syndrom, über weniger aggressiv verlaufende manifestationen gibt es nur wenige informationen. einleitung. wir berichten über einen 46-jährigen raucher mit akut aufgetretener polyarthritis und neu aufgetretenem raynaud-phänomen. auffallend war die diskrepanz zwischen nur geringer systemischer entzündungskonstellation und einer hochaktiven polyarthritis mit schwerem raynaud-phänomen. im verlauf kam es zu einer spontanen thrombophlebitis der v. cephalica. methoden. pathologische werte: crp maximal 1,4 mg/dl (norm <0,6), zellzahl im gelenkpunktat 20.000 leukozyten/µl. im normbereich lagen: bsg 12 mm/1 h, ana, ena, ds-dns-ak, rheumafaktoren, anca, kälteagglutinine, kryoglobuline, tumorsuche initial ohne befund (ct-thorax, bronchoskopie, ct abdomen und becken, coloskopie, gastroskopie, skelettszintigraphie), fdg pet-ct: zwei suspekte lymphknoten rechts cervical sowie suspekte rechte tonsille. ergebnisse. selbst unter 60 mg prednisolon weiterhin hochaktive polyarthritis. nach unauffälliger initialer tumorsuche veranlassten wir ein fdg-pet ct mit nachweis zweier suspekter lymphknoten rechts cervical sowie einer suspekten rechten tonsille. die biopsie der klinisch sich nur in der palpation diskret induriert darstellenden region ergab ein gering differenziertes, gering verhornendes plattenepithel mit 98%iger sequenzhomologie mit hpv typ 16. nach resektion des tumors und radiatio sistierten sowohl die polyarthritis als auch das raynaud-phänomen ohne weiteres rezidiv auch nach absetzen der glukokortikoide. schlussfolgerung. eine akut auftretende hochaktive polyarthritis mit hohem glukokortikoidbedarf in kombination mit einem raynaud-syndrom, auffallend niedriger systemischer entzündungsaktivität und fehlendem autoantikörpernachweis sollte insbesondere bei einem langjährigen raucher anlass zu einer intensiven tumorsuche geben. ein fdg-pet-ct kann bei okkulten tumoren zielführend sein. bemerkenswert ist hier der nachweis von hpv-16 im tumor als weiterer risikofaktor neben dem zigarettenrauch. methoden. bei der klinischen untersuchung fielen ein beidseits positives menell-zeichen und deutlicher klopfschmerz über dem lumbosakralen übergang auf. labordiagnostisch konnte ein erhöhtes c-reaktives protein und ein positiver hla-b27 nachgewiesen werden. der bath ankylosing disease activity (basdai) index betrug 6,875. die beckenübersichtsaufnahme zeigte eine definitive bilaterale sakroiliitis grad 3 gemäß den modifizierten new-york-kriterien. der befund der kontrastmittelunterstützten mrt der iliosakralgelenke bewies das vorliegen einer bilateralen floriden sakroiliitis. bei gesicherter hla-b27 positiver ankylosierender spondylitis wurde die indikation zur einleitung einer biologikatherapie mit einem tnfα-inhibitor gestellt. während der abklärung von kontraindikationen wurde in der konventionellen röntgen-thorax-aufnahme eine rundliche, glatt begrenzte zystische läsion mit flüssigkeitsspiegeln im rechten mittellappen entdeckt. die weitere abklärung mittels nativer thorax-ct, bronchoskopie und biopsieentnahme bestätigte den verdacht auf eine bronchogene zyste. die erregerdiagnostik in der bronchoalveolären lavage zeigte lediglich eine kontamination mit der residenten standortflora. ergebnisse. in anbetracht der geplanten immunsuppressiven therapie, die mit einem erhöhten infektionsrisiko einhergeht, wurde die bronchogene zyste im september 2012 operativ entfernt. zur linderung der beschwerden erhielt die patientin eine schmerztherapie mit nsar. als sich die patientin sechs monate später erneut zur einleitung der biologikatherapie vorstellte, berichtete sie, dass die schmerzen etwa einen monat nach der operativen resektion praktisch verschwunden seien. die klinische untersuchung war unauffällig, der basdai-index lag bei 1,2. auch das zur verlaufskontrolle angefertigte mrt der isg zeigte im vergleich zur voruntersuchung einen deutlichen rückgang der floridität. schlussfolgerung. es handelt sich um den ersten fall einer kompletten klinischen und radiologischen remission einer hla-b27-positiven ankylosierenden spondylitis nach operativer entfernung einer bronchogenen zyste als potenziellen entzündlichen fokus. bei der systemischen verlaufsform der erkrankung treten neben kutanen erscheinungen zusätzlich muskuloskeletale, hämatopoetische (20-60%), renale (ca. 50%), kardiale, cerebrale und pulmonale (4-9%) manifestationen auf. eine polyserositis (11-60%) ist häufig. mit 8-40% werden im sle-schub abdominelle schmerzen beschrieben. nur in seltenen fällen (amerika 0,9%, asien 2,2-9,7% aller sle-patienten) kommt es zum bild einer lupusassoziierten mesenterialen vaskulitis (lmv). die ätiologie der lmv ist weitestgehend unklar, eine genetische präsidsposition sowie auslösende faktoren (bakterielle darminfektionen, medikamente wie nsar, phosphodiesterasehemmer) werden diskutiert. pathogenetisch wird eine mesenteriale ischämie durch eine mikroangiopathie (arteriolen, venolen) bei inflammatorischer immunkomplexpräzipitation sowie thrombembolischen ereignissen angenommen. radiologisch/sonographisch zeigt sich ein segmentales darmwandödem mit darmdilatation. endoskopisch dominieren oberflächliche ulzerationen, perifokale hämorrhagien bis hin zur gangrän. eine erhöhte perforationsneigung wird beschrieben. mikroskopische befunde zeigen eine fibrinoide nekrose subseröser gefäße mit leukozytoklasie der gefäßwand bzw. ein submuköses ödem mit nur diskreter invasion mononukleärer zellen. die prognose der lmv scheint abhängig von genetischer prädisposition, raschem beginn einer immunsuppression sowie restriktivem einsatz operativer interventionen und wird je nach literaturquelle mit einer letalität bis zu 50% angegeben. background. we report a patient with tma in the context of sle treated successfully with the c5 inhibitor eculizumab. the patient had sle with lupus nephritis (ln). before she developed tma with renal failure and neurologic manifestations, she was treated with various immunosuppressive regimens for mucocutaneous and musculoskeletal manifestations and later for ln. the diagnosis of atypical hemolytic uremic syndrome (ahus) was made based on the presence of coombs-negative hemolytic anemia, thrombocytopenia, renal failure, seizures due to cerebral ischemia and signs of tma in the renal biopsy. plasma exchange and hemodialysis were started immediately and could stabilize her condition. six weeks after the beginning of plasmapheresis but still severely compromised renal function and thrombocytopenia, complement inhibition with eculizumab became a therapeutic option. after the first infusions, renal function, anemia and thrombocyte counts markedly improved. dialysis could be stopped. extensive genetic testing of mutations associated with the overactivation of the alternative complement pathway was negative. after 7 months, when the patient was still in remission, eculizumab infusion intervals were widened and it was finally stopped after 12 months of treatment. since then, renal function remained stable with nearly normal glomerular filtration rates. background. il-6 signaling plays an important role in inflammation but is restricted by different regulatory mechanisms. these mechanisms include the decreased availability of gp130, the signal transducing chain of the il 6 receptor, on the cell surface. the aim of this study was to determine whether the inflammatory environment in the arthritic joint has an impact on monocytic gp130 surface expression and the extent to which regulatory processes in the synovial fluid (sf) can be transferred to an in vitro model. flow cytometry and live cell imaging were used to measure the cell surface expression and internalization of gp130. stat3 phosphorylation was monitored by flow cytometry and western blotting. results. the level of cell surface gp130 expression on sf monocytes was reduced compared to peripheral blood (pb) monocytes from patients with juvenile idiopathic arthritis (jia). this reduction could be reproduced by stimulating pb monocytes from healthy donors with sf and was dependent on p38 mapk. the induction of p38 by il-1β in pb monocytes interfered with il-6 signaling due to the reduced cell surface expression of gp130. the results suggest that p38-mediated pro-inflammatory stimuli induce the downregulation of gp130 on monocytes and thus restrict gp130 mediated signal transduction. this regulatory mechanism could be relevant in the inflamed joints of patients with jia. kr.08 sjia patient characteristics of those who successfully discontinued corticosteroids during canakinumab treatment: secondary analysis from a pivotal phase 3 trial background. interleukin-1β (il-1β) is a key driver in the pathogenesis of systemic juvenile idiopathic arthritis (sjia). canakinumab (can), a selective fully human anti-il-1β monoclonal antibody, has been shown to be efficacious in the treatment of sjia [1] . corticosteroids (cs) are a mainstay of therapy for sjia, however due to the well-known long-term side effects, reduction of cs dosage is desirable. objectives. to assess patient features associated with cs discontinuation during can therapy. methods. patients (2-19 years of age) with active sjia received s.c. can (4 mg/kg to 300 mg max) every four weeks during the maximum 20week cs-tapering phase [1] . cs tapering was to be initiated when at least an adapted acr50 was achieved and no fever. a 12-year-old boy presented with nocturnal tingling paresthesia affecting his feet and his calves. no excessive leg movements were noted at night. within a few months, his symptoms worsened. the paresthesia occurred both during the day and at night. moreover, the paresthesia came to be triggered by merely standing up. affecting a sharply demarcated area not corresponding to dermatomes, symptoms resolved promptly with movement. the paresthesia was associated with local skin erubescence in spots that slowly began spreading all over the affected area. symptoms did not occur while the patient was seated. mild painless swelling around both of the ankles was noticed in the evenings. approximately one and a half years after the initial manifestation, painful triphasic color changes of all fingers and toes triggered by cold or stress occurred. the family history was positive only for psoriasis. extensive laboratory studies excluded inflammatory and hematological conditions as well as occlusive arterial diseases known to be associated with secondary raynaud's phenomenon. polyneuropathy and other neurological disorders were excluded as well. inflammatory joint disease suspected from the initial imaging with magnetic resonance of the feet and ankles was not confirmed by repeated investigations and scintigraphy. the only consistent abnormality was a reduced pulse amplitude corresponding to vasospasm, which was revealed by photoplethysmography of toe vessels. additionally, paradoxical amplitude reduction after application of nitroglycerine was seen in finger vessels. placing his hands or feet in cold water did not trigger raynaud's phenomenon. initial treatment with non-steroid anti-inflammatory drugs, topical isosorbiddinitrate and local steroid instillation (suspicion of inflammation of tibialis posterior tendon) was ineffective. systemic therapy with the calcium channel blocker amlodipine was initiated. the initial dosing of 5 mg (0.09 mg/kg/day) was slowly increased to 15 mg (0.27 mg/kg/day) which lead to complete resolution of the patient's ailments. after three years of pharmacotherapy and 1.5 years in remission, a weaning off the treatment is planned. based on the patient's positive response to calcium channel blocker, we conclude that the lower-leg paresthesia was of vascular origin and can be considered an atypical presentation of raynaud's phenomenon. background. the initial treatments of choice for jdm are high-dose corticosteroids and methotrexate. however, no consensus exists about second line therapeutic options in refractory or recurrent cases. results. we present a 9-year-old boy who was diagnosed with jdm due to severe proximal muscle weakness, dysphagia, a heliotrope rash, gottron's sign, nail teleangiectasia and a characteristic muscle biopsy. creatine kinase levels were within normal range and no antinuclear antibodies were present. over a period of seven years, the patient was treated with high-dose corticosteroids, methotrexate, intravenous immunoglobulins, oral steroids, mycophenolate mofetil, rituximab and infliximab. despite all treatment efforts, skin and muscle inflammation persisted and the boy developed severe subcutaneous calcifications, rendering him wheelchair-bound. as il-6 production correlates with disease activity in adult and juvenile dm, treatment with tocilizumab (8 mg/kg every 4 weeks) was initiated, leading to a complete resolution of skin inflammation within 6 months. within 12 months of treatment, the disease activity score (das) decreased from 16 to 9 (out of 20), the childhood myositis assessment scale (cmas) increased from 17 to 27 (out of 52) and the kendall manual muscle test (mmt) increased from 60 to 75 (out of 80). in daily life the wheelchair was no longer necessary. treatment was well tolerated but accompanied by a moderate increase in liver transaminase activities. interestingly, therapy with rituximab was associated with a decline in igm levels only, whereas igg and iga stayed markedly elevated. in contrast, following initiation of tocilizumab treatment, igg levels rapidly declined to normal range, emphasizing the role of the humoral immune system in the pathogenesis of dm. conclusion. taken together, treatment of a severely affected jdm patient with tocilizumab was safe, well tolerated and led to a significant improvement in disease activity. further investigations of il-6-blocking agents as a treatment option in otherwise therapy-resistant jdm patients are warranted. functional capacity of jia patients with an initial adjustment to an anti-tnf-alpha therapy background. thirty three percent of patients with polyarticular jia are treated with biologics [2] . despite substantial improvement achieved by anti-tnf-α treatment according to disease activity [1] patients have joint-specific impairments. this factor should be considered when analyzing the functional effects on joint limitations while performing daily activities. methods. in a prospective study on polyarticular jia patients treated with anti-tnf-α therapies plus functional therapies we study the longitudinal effects on joint function. the measurements include 3-d gait analysis (eight vicon f40 cameras, omg, london, balance control (s3-check, tst, großhoeflein), pedobarography (emed plate (4sensors/ cm², novel, munich), daily activity assessment (step watch, orthocare innovations, ok usa), acr pedi and joint mobility testing. we here present the cross-sectional data of the first 17 patients (15.0±3.1 yrs, 162.7±14.6 cm, 60.0±17.2 kg, pain-level: 4.8±1.7/10 vas, active joints: 6.2±5.9, chaq: 0.4±0.4). results. preliminary results demonstrate that the ability to walk is slightly limited. patients have a reduced push off power generation within the ankle joint (patients: 3.4±1.4 w/kg; healthy controls: 4.5±0.9 w/ kg). further on they show limited sensory motor control and stability in comparison to patients with an inactive disease status while performing balance tests (patients: sensory index: 2.9±1.0, stability-index: 3.7±1.1, patients with inactive status: sensory-index: 2.1±0.8, stability index: 3.0±1.0 (p<0.05). note: lower indices values are better results. conclusion. it is one of the first studies which show functional joint-specific deficits during every day activities in patients who receive an initial anti-tnfα-therapy. the limited stability and motor control might be due to limited joint integrity in the ankle joint. this is supported by the impaired push off function while walking. the next study step will show possible effects of the anti-tnfα-therapy. background. the role of sport as a therapeutic tool in treating patients with jia is becoming more important recently [2] . effects of exercise therapy are reviewed beneath others by takken et al. [3] . they state that short-term effects look promising but the effects of long-term studies remain unknown. methods. the preventive mobility workout (pmw) is a whole body home-exercise-therapy (10 min each day) for patients with an inactive diseases status. it counteracts the deficits which were observed during functional studies in the past [1] . it consists of exercises for muscular strengthening (squads: hamstring to quadriceps ratio), hamstring flexibility (lift and raise), core stability (prone bridge -time-to-failure), shoulder griddle mobility (horizontal extension) and ankle joint integrity (mechanical power while walking . for statistical analysis an anova was calculated and the level of statistical significance was set to p<0.05. results. preliminary results show a group effect of the pmw for the hamstring to quadriceps ratio (h-q-r) for the right side (p<0.05) and a tendency for the left side (p=0.065). the h-q-r for the right side has changed in the tg and cg from 1.6±0.3 to 2.0±0.6 and from 2.1±0.6 to 1.6±0.3, respectively. it has changed for the left side in the tg and the cg from 1.9±0.5 to 1.6±0.3 and from 1.5±0.2 to 1.7±0.3, respectively. all other parameters regarding flexibility or joint integrity show low or no effects. we have re-tested n=18 out of 75 so far and the pmw training show little training-effects. the preliminary results might be a reasonable proof for long-term effects. a possible reason for the little effects might be that patients are supposed to train every day but the training diaries show that they exercise approximately three times a week. the authors would like to thank the "deutsche kinder-rheumastiftung" for supporting the study. conclusion. we will validate these proposed definitions prospectively in a jia associated uveitis cohort. based on the results, we will weight these measures to develop an overall scoring system. background. 6 minute walk is a primary outcome measure in studies in pulmonary hypertension. currently we have a two of sets of data [1, 2] regarding test results in the 6 minute walk test (6mwt) in healthy children with a large span in the norm values in the different age groups. aim of the study was to establish norm values for healthy german children for the 6 minute walk test. methods. the team of an occupational therapist and a study nurse were visiting schools. permission from the parents was give before the test. always just probands from one class were invited to participate. the test were performed according the international guidelines [3] . the demographic data of the probands were collected and the parents filled out a short survey regarding the physical activity and the health condition. children with chronic diseases, which decrease the stamina were excluded. up till now 611probands participated from the age 5 to 14 years. 343 of them were female. the mean 6 minute walk continuously increased with age (. tab background. juvenile idiopathic arthritis (jia) is the most common chronic disease in pediatric rheumatology which often results in foot impairments [1] . patients with jia are reported to have smaller pressure loads underneath the foot while walking [2] . the aim of the study was to analyze the peak plantar pressure distribution of a well described cohort of jia patients with an active symmetrical ankle joint arthritis and no history of foot involvement. [1] ) wurden in bezug auf therapie und outcome anhand der wallace-kriterien beurteilt: "active disease" (ad), "inactive disease" (id), "clinical remission under medication" (crm), "clinical remission off medication" (crom; [2] background. familial mediterranean fever (fmf) is one of the most common autoinflammatory diseases (aid). pathogenomic relevant mutations in the mefv gene show autosomal recessive inheritance, but co-dominant mutations have been described. we aimed to evaluate correlations between ethnic origin, phenotype and genotype for fmf patients in the german aid-net-registry. methods. we used two common scoring systems modified for children (mor et al., pras et al.) to assess disease severity in 243 fmf patients of the aid-net-registry. for the five most frequent mutations, we tested for a correlation of the genotype with the phenotype, mean crp and ethnic origin, respectively. furthermore, we evaluated the applicability of the two severity scores for children. results. among the 243 patients, we detected a total of 433 pyrin mutations and 22 different sequence variants, including one new mutation (p.gly488asp). the five most frequent alterations were p.met694val (55%, n=238), p.met680lle (12%, n=52), p.val726ala (10%, n=44), p.glu148gln (8%, n=34) and p.met694ile (2.3%, n=10). ethnic origin could be determined in 224 cases; the prevailing ancestry was turkish (83%, n=185), 8% (n=18) were lebanese. p.met694val in homozygous form (30%, n=73) was correlated with a more severe disease activity, based on the score by mor, as well as with a higher mean crp (74 mg/l, n=60, 31 mg/l, n=59) compared to patients without this mutation (p=0.01 and p<0.01, respectively). the score suggested by pras did not yield a significant genotype-phenotype correlation; indeed, the two scoring systems were inconsistent with each other (κ<0.07). although a typical distribution of mutations in different ethnic populations was obvious, this trend was not statistically significant, probably due to the divergent number of cases. conclusion. the homozygous p.met694val substitution was associated with a more severe disease activity. there was no origin-genotype correlation in this fmf population. the well-known severity scores for children (mor, pras) are inconsistent. the aid-net is working on a new scoring system. 3. all patients with rp should be investigated by capillaroscopy. capillaroscopy will be classified into "normal", "aspecific changes" or "scleroderma pattern". 4. all patients who have additional symptoms pointing to a definite connective tissue disease should be evaluated according to disease specific guidelines. 5. ana-negative and capillaroscopy-negative patients should be followed-up at least every 6 months. 6. ana positive patients without disease-specific antibodies and with negative capillaroscopy findings should be followed-up at least every 6 months. 7. ana and disease-specific antibody positive patients should have organ specific evaluation according to symptoms, examination and relevant to that particular disease e.g. patients who are ana and scl-70 positive may need organ specific evaluation for jssc as per the juvenile systemic sclerosis inception cohort protocol (www.juvenilescleroderma.com). 8. ana-positive patients, who have no disease specific antibody but have positive capillaroscopy results, should be followed-up at least every 3 months. 9. ana-negative patients with positive capillaroscopy result should be followed-up at least every 6 months. 10. the group could not reach an agreement regarding treatment, due to a lack of data for the paediatric age group. the group agreed that implementation of adult recommendations conclusion. the group made a suggestion for a standard of good clinical practice for rp in children. our aim is that this will facilitate a large multicentre prospective follow-up study of children with rp. background. chronic non-bacterial osteomyelitis (cno) is an inflammatory disorder of the skeletal system of unknown etiology. long-term follow-up and response to treatment data have rarely been reported. the aim of the study was to characterize the clinical, radiological, histological and laboratory data at juvenile cno onset, and to analyze the long term treatment response. methods. the course of disease of 95 juvenile patients with non-bacterial inflammatory bone lesions was evaluated retrospectively. clinical, radiological, histological and laboratory data were assessed at disease onset and for a median time of disease of 40 months. results. the mean age at disease onset was 11.7 years, the mean time between the first symptoms and the diagnosis of cno was 9 months. 84% of the patients had multifocal bone lesions. biopsy was performed in 80 patients. only when bone biopsy was taken within 12 months of symptom onset, cellular infiltrates could be observed. at later time points, fibrosis, hyperostosis and bone edema predominated. the initial treatment consisted of non-steroidal anti-inflammatory drugs (nsaids). 39% of the patients required second line therapy consisting of sulfasalazine and short term oral corticosteroids, 8% of the patients required bisphosphonates or tnf-blocking agents. the number of clinical lesions decreased to 50% within 3.1 months and reached 18.8% after 24 months of treatment. the number of radiological lesions, however, declined to only 66.5% after 24 months of treatment. in detail analysis of the tre-atment response revealed that initiation of sulfasalazine treatment in nsaid non-responders led to a significant and sustained decline of the clinical, as well as the radiological number of lesions. conclusion. the rapid clinical improvement in cno, following initiation of therapy with nsaids, is not accompanied by a likewise decrease of the number of radiological lesions. treatment with sulfasalazine is effective in childhood cno. background. exercise has a wide variety of beneficial health effects. it stimulates bone formation and maintains bone strength as well as decreases the risk of falls. moreover, exercise at regular intervals is also assumed to positively affect immune functions. conversely, in more than 50% of the astronauts during/after space flight and under simulated weightlessness immune functions are suppressed. to assess the effects of simulated weightlessness during the 2nd berlin bedrest study (bbr-2) on immunological parameters. furthermore, to compare the effects of two different exercise performances (resistive vibration exercise and resistance exercise without vibration). methods. 24 physically and mentally healthy male volunteers (20-45 y) experienced 60 days of six degree head down tilt bed rest. they were randomized to 3 groups: resistive vibration exercise (n=7), resistance exercise without vibration (n=8), inactive controls (n=9). blood samples were taken 2 days before bed rest, on day 19 and 60 after beginning of bed rest. composition of immune cells was analyzed by flow cytometry. cytokines and neuroendocrinologic parameters were analyzed by a multiplex suspension array/ elisa in plasma. general changes over time were identified by paired t-test, exercise-dependent effects by 2-group repeated measurements anova. results. for all cases pooled, the number of granulocytes (p<0.05), nkt cells (p<0.01) and hematopoietic stem cells (p<0.01) increased during the study; the concentrations of dhea (p<0.01) and eotaxin (p<0.05) decreased. different impacts of the specific types of exercise on the change over time were shown for lymphocytes, nk cells, nkt cells, tcell subpopulations and the concentrations of ip-10 and rantes. conclusion. we found immobilization/simulated weightlessness to significantly impact immune cell populations, and cytokine and neuroendocrine factor concentrations. exercise was able to specifically influence immunologic parameters. interestingly, these changes resemble those found during the aging process. background. novel therapies have made remission and low disease activity (lda) achievable goals in ra. we assessed the impact of treatment with subcutaneous abatacept or adalimumab on these goals and on functional and radiographic outcomes in ample (abatacept versus adalimumab comparison in biologic-naïve ra subjects with background methotrexate), the first head-to-head trial of biologics in ra patients with inadequate response to mtx (mtx-ir). methods. ample is a 2-year, phase iiib, randomized, investigator-blinded study. biologic-naïve ra patients with mtx-ir were randomized to receive 125 mg abatacept weekly or 40 mg adalimumab biweekly, combined with a stable dose of mtx [1] and radiographic non-progression (defined as change in modified total sharp score ≤2.8) were analysed in patients achieving or not achieving remission or lda at days 85 or 169. results. baseline clinical characteristics of abatacept and adalimumab treatment groups were balanced, as was clinical, functional and radiographic efficacy and safety at day 365 [1] . the proportions of patients meeting each of the remission criteria or lda at day 365 were similar for both groups, but significantly more patients achieved das28 (crp) remission compared to cdai, sdai or rapid3 remission, and the smallest proportion achieved boolean remission. compared to remission, a higher proportion of patients achieved lda. across all definitions of remission or lda, >60% of the patients achieving remission at days 85 and 169 were haq responders at day 365. more than 80% of patients achieving remission or lda at days 85 and 169 were radiographic nonprogressors at day 365. improvement in physical function and radiographic outcomes were consistent between the two treatment groups in both remission and lda populations (. tab.11). conclusion. through 1 year, patients treated with subcutaneous abatacept or adalimumab in ample achieved comparable rates of remission and lda. similar improvements in physical function and radiographic outcomes were observed. these data help to illustrate the relationship between remission, lda and functional and radiographic outcomes independent of treatment with subcutaneous abatacept or adalimumab. background. previous small studies suggest that responses to some immunizations may be attenuated by intravenous abatacept but remain clinically meaningful [1, 2] . we investigated the magnitude of response to pneumococcal and influenza vaccination in a larger number of patients receiving subcutaneous (sc) abatacept therapy. the objective of the study was to evaluate the antibody response to the standard 23-valent pneumococcal polysaccharide vaccine and the 2011-2012 seasonal influenza trivalent vaccine in adult patients with ra on sc abatacept and background dmards. these multicentre, open-label sub-studies of the 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine enrolled patients in the acquire (pneumococcal and influenza) or attune (pneumococcal) studies. patients were enrolled at any point during their sc abatacept treatment cycle after completion of ≥3 months' abatacept treatment. all patients received fixed-dose sc abatacept 125 mg/week with background dmards. a pre-vaccination blood sample was collected and vaccines administered, while continuing background sc abatacept and dmards. after 28±3 days, a post-vaccibackground. in real life, dosage increases are common with biologic agents [1] . intravenous abatacept is administered by patient body weight (10 mg/kg) 2 and 4 weeks after the first infusion and every 4 weeks the-reafter [2] totalling 8 infusions over the first 6 months. no adjustments to this schedule are recommended. abatacept retention rates, efficacy and safety over 12 months in action (abatacept in routine clinical practice) have been reported previously [3, 4] this study was designed to assess adherence to recommended dosing of abatacept over the first 6 months in action. methods. action is an ongoing, 2-year, international, non-interventional, prospective cohort of ra patients treated with intravenous abatacept. all patients on abatacept treatment for ≥6 months, and with infusion data available at initiation and at 6 months, were considered in this analysis. good adherence was defined as correct dose by patient body weight and number of actual-to-recommended infusions within the range 80-120% (i.e. 7-9 infusions). results. in total, 783/1120 (69.9%) patients received abatacept ≥6 months and had the infusion data available. most had established ra and failed ≥1 anti-tnf agent (87.5%). of 774 patients with body weight data available at initiation, 87.6% received the recommended initial dose, 6.5% a lower dose and 5.9% a higher dose than recommended. good adherence to the abatacept treatment schedule was found in 670/783 (85.6%) patients. over 6 months, 34.0% of patients received 7 infusions, 50.1% received 8 infusions and 1.5% had 9 infusions. change in dosage over time was assessed in 680/774 patients with data available at both time points. the majority of patients (86.6%) maintained the recommended dosage. 500/680 (73.5%) patients received abatacept at the recommended dose for body weight and at the recommended treatment schedule over 6 months. conclusion. in the real-world action study, adherence to the recommended abatacept treatment regimen over 6 months was good. few patients received changes in dose and/or frequency of administration over this time period. background. in rheumatoid arthritis (ra), synovial fibroblasts (sf) secrete large amounts of il-6, il-8 and matrix metalloproteinases (mmps) which are crucial for cartilage destruction. rasfs are sensitive to the action of cannabinoids and they express cannabinoid receptors type i and ii (cb1 and cb2), the vanilloid receptor (trpv1) as well as endocannabinoid degrading enzymes. cannabinoids are regarded as antiinflammatory and since anandamide (aea) is found in ra synovial fluid we investigated how this endocannabinoid affects adhesion, proliferation, and production of inflammatory mediators of rasf. methods. adhesion was assessed by the xcelligence system. proliferation was quantified by the amount of incorporated fluorescent dye into cellular dna. mmp-3 and cytokines were detected by elisa. in oasf, aea dose-dependently decreased the il-1β induced production of mmp-3 (by 23%) in a trpv1-mediated manner. il-6 and il-8 levels were only weakly modulated. in rasf however, aea decreased il-1β induced production of il-6 (23%), il-8 (18%) and mmp-3 (20%). the effects of aea were not inhibited by cb1, cb2 or gpr55 antagonists but were blocked by the trpv1 antagonist capsazepine. the inhibitory capacity of aea was enhanced by cyclooxygenase-2 inhibition in rasfs and oasfs, but was unaltered or even slightly reduced by faah inhibition. aea was even more potent in reducing above mentioned mediators when rasfs but not oasfs were incubated under hypoxic conditions and treated with tnf. furthermore aea increased adhesion of oasfs and rasfs to fibronectin. adhesion was modulated by cb1, gpr55, and trpv1 antagonists. combined faah and cyclooxygenase-2 blocked the stimulatory effect of aea on adhesion. proliferation was decreased by aea in rasfs and oasfs via a cyclooxygenase-2 but not via cb1, cb2 or trpv1 dependent mechanism. conclusion. in conclusion, aea promotes an antiinflammatory phenotype of rasfs and oasfs by activating trpv1. cb1, trpv1, and gpr55 act in concert to modulate adhesion of sfs and this is highly dependent on the intracellular concentration of aea. additionally, cyclooxygenase-2 metabolites of aea exert their anti-proliferative effects independent of cb1 and cb2. fc. it has been reported that lower levels of czp, compared to ada or ifx, are transferred from treated mothers to the neonate [1] . this discrepancy may be due to active transport of antibodies across the placenta thought to be mediated by the neonatal fc receptor (fcrn). however, anti-tnf binding to fcrn, and fcrn-mediated transcytosis have not been studied. the objective of this study is to quantify binding of czp, ifx, ada and eta to fcrn and to measure fcrn-mediated transcytosis. a biacore™ assay was used to determine binding of czp, ada and ifx to human fcrn. anti-tnfs were passed over an fcrn-coated chip .mdck-ii cells transfected with human fcrn were used to measure fcrn mediated transcytosis. the anti-tnfs and the control antibody (p146), which possessed a fc modified to prevent binding to fcrn, were biotinylated to allow visualization. the amount of each anti-tnf transcytosed across the cell layer over 4 hours was measured by msd assay. results. ifx (132 nm) and ada (225 nm) had high binding affinity to fcrn while the binding affinity of eta to fcrn was 5-10-fold lower (1500 nm). in contrast, czp did not bind to the fcrn with any measurable affinity. the levels of transcytosis seen with ifx and ada were 249.6 ng/ml and 159.5 ng/ml, respectively (mean of 3 experiments). transcytosis of eta (81.3 ng/ml) was lower than that of ada and ifx. in contrast, the level of czp transcytosis was significantly lower, at 3.2 ng/ml, than that observed with the other anti-tnfs and comparable to the control p146 (5.9 ng/ml). conclusion. czp didn't bind to fcrn and thus no fcrn-mediated czp transcytosis was detected. in contrast, ada and ifx had a relatively high binding affinity to fcrn and were actively transcytosed. eta showed lower binding affinity and transcytosis, but fcrn-mediated transport could still be measured. these results explain the previously observed active transport of anti-tnfs across the placenta seen in patients treated with ifx and ada, whereas only low levels were observed with czp [1]. background. anti-cyclic citrullinated peptide (ccp) status was reported previously as predictive of abatacept response [1] . predictors of retention with abatacept have not been published previously. this study was designed to identify predictors of abatacept retention after failing ≥1 biologic agent. in routine clinical practice) is an ongoing, 2-year, international, non-interventional, prospective cohort including patients with ra treated with intravenous abatacept [2, 3] . patients from canada, germany, greece and italy, where patient numbers were sufficient to explore between-country effects, were included. at data cut-off (february 2012), all patients had 1-year follow-up (interim analysis). abatacept discontinuations were reported by the investigator at any time point during follow-up. socio-demographics, disease characteristics and medical history at abatacept initiation, and previous and concomitant treatments were deemed potential predictive variables. clinically relevant variables and those with p≤0.2 (univariate analysis) were entered into a multivariate cox proportional-hazards regression model, adjusted for clustered data from one investigator. using backwards selection, variables with p≤0.1 were retained in the final model. . there were no interactions or effects of c-reactive protein level, rheumatoid factor status, type of previous anti-tnf failure, infection at initiation and abatacept monotherapy. sensitivity analysis, including all variables significant in univariate analysis, was consistent. conclusion. in this first report of real-world predictors of abatacept patient retention, anti-ccp positivity and failing <2 prior anti-tnf agents were associated with higher retention. differences in retention between some countries may reflect specificities in healthcare systems and populations. abatacept, a biologic agent with no contraindications or special warnings for cardiac comorbidity, seems to be a good option for these patients. weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over 6 months when administered with or without an intravenous abatacept loading dose 109 zeitschrift für rheumatologie suppl 2 · 2013 | methods. patients from the intent-to-treat populations of the acqui-re [2] and ample [3] studies randomized to subcutaneous abatacept plus mtx were included. all patients received fixed-dose subcutaneous abatacept 125 mg/week; in acquire but not ample, patients also received an intravenous loading dose (~10 mg/kg based on weight range) on day 1. for this post-hoc analysis, assessments included acr20 and haq-di response (improvement ≥0.3) over 6 months, with patients who discontinued considered non-responders. mean changes from baseline over 6 months in das28 (crp) were assessed in patients with das28 >5.1 at baseline (last observation carried forward) to account for differences in baseline disease activity between the two studies. results. all patients were biologic naïve at baseline, with mean disease duration of 7.6 and 1.8 years, das28 (crp) 6.2 and 5.5, and haq-di 1.72 and 1.5 in acquire and ample, respectively. efficacy was compared throughout the study. for patients treated with subcutaneous abatacept with and without an intravenous loading dose, acr20 response rates were similar (. tab.18). haq-di response rates were also similar with and without the intravenous loading dose (. tab.18). for the overall populations, mean (standard deviation [sd]) changes from baseline to day 169 in das28 were −2.57 (1.30) and −2.09 (1.38) in acquire and ample, respectively. for patients with baseline das28 >5.1, mean (sd) changes in das28 from baseline to day 169 were −2.65 (1.29) and −2.49 (1.35) in acquire and ample, respectively. conclusion. time to onset and magnitude of acr20 and haq-di responses and das28 improvements were generally similar with subcutaneous abatacept with or without intravenous loading in patients with ra and an inadequate response to mtx. the findings from this posthoc analysis suggest that subcutaneous abatacept can be given effectively without an intravenous abatacept loading dose. background. ra is associated with pain and impairment of physical function, significantly impacting a patient's health-related quality of life (hrqol) and ability to perform daily activities. patient-reported outcomes (pros) related to hrqol and daily activity have become an essential part of assessment in ra. we continue to report here comparative findings from pros assessed with subcutaneous abatacept or adalimumab on background mtx in the first head-to-head study, ample. we compared changes in pros at 1 year in patients with ra treated with abatacept or adalimumab, both on background mtx. methods. ample is a phase iiib, randomized, investigator-blinded study of 24 months' duration. biologic-naïve patients with active ra and inadequate response to mtx were randomized to either 125 mg abatacept weekly or 40 mg adalimumab biweekly in combination with mtx. pros evaluated through day 365 included: hrqol, assessed using short form-36 (sf-36; including physical and mental component summary subscores [pcs and mcs]); activity limitation over the previous 30 days, using the activity limitation questionnaire (alq; [1] ); productivity, using the work productivity and activity impairment questionnaire for ra [2] ; physical and psychosocial independence, captured using items from haq, sf-36 score; and alq [3] . other pros previously reported from ample include: patient pain, patient global assessment, fatigue, and physical function [4] . all efficacy analyses were done using the intent-to-treat population, which included all patients who were randomized and received at least one dose of study drug. baseline characteristics were analysed descriptively and changes in pros from baseline were assessed using ancova. results. baseline demographic and clinical characteristics of the abatacept and adalimumab treatment arms were similar. improvements in all domains of the sf-36, including pcs and mcs observed at day parameter baseline woche16 woche32 itt-gesamt das28, mw ± sd 5,7±1,0 (n=507) 2,6±1,3 (n=423) 2,7±1,4 (n=150) vas da pat., mw ± sd 63,3±20,6 (n=509) 26,3±22,5 (n=429) 28,9±25,3 (n=155) sjc28, mw ± sd 8,3±4,9 (n=509) 3,2±3,6 (n=425) 3,0±3,9 (n=152) vas schmerz, mw ± sd zielsetzung der ole-studie beinhaltete die beurteilung der verträglichkeit und der wirksamkeit von czp. die retentionsraten sowie die wirksamkeit wurden bis woche 280 und die verträglichkeitsdaten bis woche 364 beobachtet. in die verträglichkeitsanalyse wurden alle pat einbezogen, die in die ole-studie eintraten und czp erhielten (n=402; n=276 kombitherapie; n=126 monotherapie), einschließlich der plazebo/czp-patienten, die die ausgangsstudien erfolgreich abgeschlossen/abgebrochen haben. bezüglich der wirksamkeit wurden folgende analysen vorgenommen: 1) czp pat, die die ausgangsstudien erfolgreich beendet haben und zu irgendeinem zeitpunkt während der ausgangsstudien oder ole-studie andere dmards eingenommen haben (n=123; kombitherapie completer); 2) czp pat, die die fast4ward studie erfolgreich beendet haben und zu keinem zeitpunkt andere dmards eingenommen haben (n=48; monotherapie completer). ergebnisse. verteilung und häufigkeit der unerwünschten ereignisse (ue), einschließlich der reaktionen an der injektionsstelle (ereignisse/100 patientenjahre: monotherapie 1,4, kombitherapie 0,9) und der schwerwiegenden unerwünschten ereignisse (sue) waren mit dem vergleichbar, was bisher für czp berichtet wurde (. tab.21) . das auftreten von schwerwiegenden infektionen (si) und malignitätsraten war niedrig. es wurden 11 todesfälle berichtet: 7 kardiovaskuläre ereignis-se, 2 infektionen, 1 unfall und 1 tumorerkrankung. die retentionsraten der pat, die die ausgangsstudien erfolgreich beendet haben, waren zur w280 in der czp monotherapie-(24/48, 50%) und der czp kombitherapie-gruppe (67/123; 55%) vergleichbar. der durchschnittliche das28-3(crp)-wert und dessen abweichung vom baseline-wert der ausgangsstudien zum zeitpunkt des eintrittes in die ole-studie und nach 280 w der monotherapie-completer und der kombitherapie-completer, sowie die zugehörigen haq-werte sind in . tab.22 dargestellt. schlussfolgerung. vorliegende ole-studie konnte das günstige risiko-nutzen-profil der czp-monotherapie bestätigen. die langzeitwirksamkeitsdaten zeigten keine unterschiede zwischen pat, die czp als monotherapie erhielten und pat, die czp in kombination mit anderen dmards erhielten. background. rheumatoid arthritis (ra) is the most common disease of joints that non-or deficiently treated leads to functional loss and premature cardiovascular death within years. but nearly 50% of the ra patients fail to treatment with tnfα-inhibitor (tnfi) indicating a switch to rituximab (rtx). the urgency of personalized promising treatment in time presupposes predictive parameter. rheumatoid factor (rf) and anti-citrullinated protein antibodies (acpas; especially accp) are shown to be better diagnostic than less theranostic biomarkers. in that context we investigated the role of antibody subtypes against mutated citrullinated vimentin (amcv) that determine response outcome in rtx-treatment. methods. a cohort of 50 only amcv igg positive ra patients was tested for amcv subtype igm and iga (additionally for rf igg, igm, iga and accp igg) by elisa at baseline (after failure to first approach with tnfi) and at week 24 (after first rtx cycle). responders were characterized by a difference in their das28 of ≥1.2 (eular good-response) between baseline and week 24. the cohort comprises 37 responders (rr) and 13 non-responders to rtx (nrr). results. amcv igg, igm and iga showed higher treatment related decreases compared to rf and accp ig subtypes and additionally even diverged in both groups depending on response outcome: especially amcv iga exhibited a higher mean titer decline of rr by 67% at lower baseline titers (90.14 to 29.84 u/ml) and a mean titer increase of nrr by nearly 20% at higher baseline titers (182.51 to 218.57 u/ml). at baseline rr displayed relatively more negative iga titers (68%; n=25/37) than nrr, who in return showed more iga positive titers (69%; n=9/13). amcv iga positive patients were more likely to show positively for rf iga (80%) and igm (70%), what could be inversely detected for iga negative patients with seronegativity of rf iga (68%) and igm (60%). conclusion. amcv immunoglobulin subtypes showed treatment dependent changes contrary to already known antibodies (accp). especially amcv iga reflects response outcome: amcv iga negativity at baseline and decreasing titers during treatment are predictive for good eular-response to rtx. einleitung. im rahmen der abklärung eines unter tocilizumab-therapie aufgetretenen arzneimittelexanthems erfolgte die bestimmung von c3c und c4 -beide parameter waren erniedrigt. bei recht geringer und nur kurz andauernder ausprägung des exanthems wurde die therapie komplikationslos fortgeführt. die komplementfaktoren wurden im verlauf bestimmt und blieben erniedrigt. im weiteren verlauf erfolgte die konsekutive messung bei weiteren patienten. methoden. nephelometrische bestimmung von c3c und c4 im serum vor und während der therapie mit tocilizumab (jeweils vor der nach 4 wochen anstehenden infusion) bei patienten mit gesicherter rheumatoider arthritis (rf+, ccp+). ergebnisse. c3c-und c4-komplement wurden bei 13 konsekutiven patienten mit rheumatoider arthritis vor und unter tocilizumab-therapie bestimmt. bei allen patienten fielen sowohl c3c, als auch c4 unter der therapie mit tocilizumab (8 mg/kg kg) ab. 8/13 patienten hatten eine c3c-erniedrigung (bestimmter wert unterhalb des laborinternen normbereichs). 4/13 patienten hatten eine c4-erniedrigung (bestimmter wert unterhalb des laborinternen normbereichs). drei patientinnen entwickelten unter der therapie ein exanthem, davon hatten 2 eine komplementerniedrigung. keine "offensichtlich" erhöhte infektneigung in abhängigkeit von komplementspiegeln. bei verlängerten infusionsintervallen aufgrund von infekten zeigte sich, dass der effekt von tocilizumab auf die komplementspiegel reversibel ist. durch blockade des il-6-rezeptors tocilizumab kann ein erworbener komplementmangel induziert werden. ähnliche daten wurden im rahmen einer pilotstudie an sle-patienten erhoben, die mit tocilizumab behandelt wurden. der effekt ist bei der rheumatoiden arthritis nicht vorbeschrieben. der genaue umfang des komplementmangels ist bisher nicht untersucht (andere bestandteile der kaskade?) wurde in der sle-studie ausführlicher untersucht. da die verschiedenen komplementbestandteile erniedrigt waren wurde auf eine synthesestörung und nicht auf einen gesteigerten verbrauch geschlossen, was auch in dieser kohorte der fall zu sein scheint. der erworbene komplementmangel könnte einen teil der infektiösen komplikationen unter der therapie erklären. eine korrelation ist aber aufgrund der geringen fallzahl nicht möglich. schlussfolgerung. anhand dieser studie konnte eine exzellente korrelation zwischen den parametern der dxr und des bx verifiziert werden. mittels der neu entwickelten voll digitalisierten bx-technik ist somit eine quantifizierung der periartikulären demineralisation möglich und als surrogatparameter der radiologischen progression bei einer ra eingesetzt werden. 3 jahre, die ra bestand im median seit 7,8 jahren. 74,7% der patienten waren mit tnf-alpha-blockern vortherapiert, 23,7% ausschließlich mit dmards. der mittlere das28 lag zur baseline bei 5,3. zur woche 76 zeigten 34,0% der patienten eine das28 remission (<2,6) und 29,1% bzw. 56,9% der patienten ein gutes bzw. moderates ansprechen gemäß eular-kriterien. über den beobachtungszeitraum stieg der anteil der tcz-monotherapiepatienten von 40,1% auf 58,4%. die mtx-komedikation sank im gleichen zeitraum um 13,3%. 21,9% der patienten, die tcz zunächst zusammen mit einem dmard erhalten haben, konnten dieses absetzen. tcz zeigte in der mono-und kombinationstherapie eine vergleichbare wirksamkeit: 18,3% bzw. 20,3% der patienten erreichten eine cdai remission (≤2,8). der anteil von patienten ohne glucocorticoid(gc)-begleittherapie stieg über den beobachtungszeitraum um 8,2% auf 25,6% an, der anteil mit einer tagesdosis ≤5 mg auf 76,2%. bei 49,4% war eine reduktion der gc-dosis möglich, nur bei 10,1% war eine erhöhung notwendig. bei 14,5% der patienten, die zur bl mit gc behandelt wurden, konnten diese komplett abgesetzt werden. die mittlere gc-tagesdosis verringerte sich kontinuierlich von 9,2 (bl) auf 5,9 mg/d (w76). schlussfolgerung. diese interimsanalyse der nichtinterventionellen studie ichiban zeigt bei den ersten 490 patienten mit mittelschwerer bis schwerer ra über die bisherige beobachtungsdauer von 76 wochen deutliche verbesserungen der aktivitätsparameter, sowie eine reduktionen der begleitenden dmard-therapien und des bedarfs von glucocorticoiden unter behandlung mit tcz. vergleichbar mit den kontrollierten studien ist die tcz-monotherapie auch unter praxisbedingungen der kombination mit dmards ebenbürtig. diese anhaltende wirksamkeit wird erstmals in rheumatologischen praxisdaten für den langzeitverlauf von 1,5 jahren gezeigt. zeitschrift für rheumatologie suppl 2 · 2013 | einleitung. die arteriosklerose (as) steht als häufigste todesursache im besonderen fokus der medizinischen forschung. neuere erkenntnisse weisen auf einen starken zusammenhang zwischen parametern der systemischen entzündung und der pathogenese der as hin. patienten mit rheumatoider arthritis (ra) haben daher ein stark erhöhtes kardiovaskuläres risiko. ziel: untersuchung des zusammenhangs zwischen verschiedenen ra-krankheitsspezifischen risikofaktoren und dem auftreten einer arteriosklerose bei ra-patienten. methoden. 139 ra-patienten, davon 77% weiblich, 64±11,6 jahre alt, wurden hinsichtlich der krankheitsaktivität (krankheitsdauer 13,8±0,9; das28 3,5±0,1; serum-crp 8,1±0,9 mg/dl,; anti-ccp-antikörper 80,4±8,8 u/ml, radiologisches stadium 1,8±0,1; davon 50,5% mit erosionen), sowie klassischer kardiovaskulärer risikofaktoren der as erfasst, welche durch den score-wert (systematic coronary risk evaluation) zusammengefasst wurden. zur as darstellung wurde eine carotis-duplexsonographie mittels eines 7 mhz-schallkopfes (ge vivid 7 pro) durchgeführt. die mittlere intima-media-dicke (imd) der a. carotis communis wurde durch ein softwaregestütztes messverfahren ermittelt. ergebnisse. plaques waren bei 54 patienten (39%) nachweisbar. diese korrelierten mit einer erosiven form der ra (p=0,05), einer längeren krankheitsdauer (p=0,03) und höheren anti-ccp-antikörpern (p=0,02). die mittlere imd betrug 0,67±0,11 mm. je ausgeprägter die radiologischen veränderungen sind, umso höher war die wahrscheinlichkeit der plagues (p=0,02). mittels altersadjustierter partieller korrelationsanalyse wurde der das28 als altersunabhängiger einflussfaktor auf die imd ermittelt (p=0,02). mittel-und hochgradige stenosen zeigten sich bei fünf ra-patienten (3,4%), welche ausnahmslos eine erosive verlaufsform aufwiesen. normalbefunde stehen in zusammenhang mit einem crp-wert unter 5 mg/dl (p=0,04). auch die traditionellen kardiovaskulären risikofaktoren haben signifikanten einfluss auf as. der score-wert erwies sich als äußerst verlässlicher prädiktor für plaques (p<0,01), imd-verdickung (p=0,01) und stenosen (p<0,01). durch elimination der traditionellen risikofaktoren mittels partieller score-adjustierter korrelationsanalyse bestätigte sich erneut die assoziation von pathologischen ultraschallbefunden mit dem das28 (p=0,03). schlussfolgerung. die erhebung klassischer risikofaktoren bei ra-patienten ist unerlässlich. die nutzung des score-werts als screening-parameter ist besonders effektiv. zusätzlich sollten parameter der krankheitsaktivität von ra zum management von arteriosklerose herangezogen werden. besonders aussagekräftig hierfür sind der das28, ein erosiver krankheitsverlauf, die crp-werte und die erkrankungsdauer background. apremilast, an oral small molecule specific inhibitor of phosphodiesterase-4, works intracellularly to modulate inflammatory mediators. the palace 1-3 trials compared the efficacy and safety of apremilast vs placebo in patients with active psa despite prior dmards and/or biologics. the overall safety and tolerability of apremilast was assessed in a pooled analysis of the palace 1, 2 and 3 placebo-controlled phases. methods. safety data was pooled from 3 phase 3, randomized, placebo-controlled studies; patients with active psa despite prior dmards and/or biologics were randomized 1:1:1 to placebo, apremilast 20 mg bid (apr20), or apremilast 30 mg bid (apr30) stratified by baseline dmard use. at week 16, patients with <20% reduction in swollen and tender joint counts were required to be re-randomized (early escape) to apr20 or apr30 (placebo group) or remained on initial apremilast dose through week 24. stable concurrent dmard therapy was allowed (mtx, sulfasalazine, leflunomide, or combination). the analysis comprises data from the placebo-controlled periods (weeks 0-24). results. 1493 patients were randomized to placebo (n=495), apr20 (n=501), or apr30 (n=497) and included in the safety population. baseline demographic and disease characteristics and prior/concurrent therapy were comparable across treatment groups; 22.4% had prior biologic exposure. adverse events (aes) occurred in 47.5% (placebo), 61.5% (apr20), and 60.8% (apr30) of patients. aes occurring in ≥5% of any treatment group were diarrhea, nausea, headache, and urti (. tab.27); most occurred within the first 2 weeks of treatment and nearly half resolved within 2 weeks. of patients with these aes, most (93-96%) were mild or moderate. rates of discontinuation due to aes were low: 4.2% (placebo), 5.6% (apr20), and 7.2% (apr30). serious aes occurred in 3.8% (placebo), 3.4% (apr20), and 3.8% (apr30) of patients. one death occurred (apr20) due to multiorgan failure not suspected to be treatment-related. no cases of serious systemic opportunistic infections, lymphoma, vasculitis, or reactivation/de novo tb were reported. there were no clinically meaningful differences between apremilast and placebo in terms of major cardiovascular aes, changes in blood pressure, malignancies, or effects on laboratory measurements. conclusion. apremilast was generally well-tolerated with no new safety concerns identified compared with the known profile. the aim of the current study was to investigate the relationship between worsening of functional status, clinical disease parameters and radiographic spinal progression over two years in patients with early axial spondyloarthritis (axspa). methods. in total, 160 patients with early axspa (91 with as and symptom duration ≤10 years, and 69 with non-radiographic axspa (nr-ax-spa) and symptom duration ≤5 years) from the german spondyloarthritis inception cohort (gespic) were included in the current analysis based on the availability of radiographic data and data on the functional status at baseline and after 2 years of follow-up. spinal radiographs were scored according to the modified stoke ankylosing spondylitis spinal score (msasss). functional status was assessed by the bath ankylosing spondylitis functional index (basfi), and clinical disease activity by the bath ankylosing spondylitis disease activity index (basdai). results. basfi worsening in ≥1 point after 2 years (n=44, 27.5%) was significantly associated only with higher basdai worsening over 2 years in comparison to those without functional worsening: 1.2±1.4 vs -0.6±1.6, p<0.001. basfi worsening by ≥2 points (n=20, 12%) was, however, associated not only with basdai change (1.5±1.6 vs -0.3±1.6, p<0.001), but also with a higher rate of radiographic spinal progression measured by the proportion of patients with msasss worsening by ≥2 units (35.0% vs. 13.6% in patients without basfi worsening, p=0.024), or with new syndesmophyte formation (25.0% vs. 6.4%, p=0.018). importantly, in the multivariate analysis both basdai increase and progression of structural damage in the spine remained statistically significantly associated with basfi worsening. no other disease-related parameters (e.g. sex, hla-b27 positivity, symptom duration etc) were found to be significantly associated with basfi worsening over two years. conclusion. in this prospective study we could demonstrate that only 2 factors were significantly associated with worse functional outcome over two years in patients with early axspa: 1) increase of disease activity and 2) progression of structural damage. elevated serum vascular endothelial growth factor is highly predictive for radiographic spinal progression in patients with axial spondyloarthritis who are at high risk for progression background. vascular endothelial growth factor (vegf) is an essential mediator of the endochondral ossification and, therefore, might play a pathogenetic role in the process of syndesmophyte formation in axial spondyloarthritis (axspa). the aim of the study was to investigate the role of serum vegf as a predictor of radiographic spinal progression in patients with axspa. methods. altogether 172 patients with definite axspa [95 with ankylosing spondylitis (as) and 77 with non-radiographic axspa] from the german spondyloarthritis inception cohort (gespic) were included in the current study. radiographic spinal progression was defined as 1) worsening of the modified stoke ankylosing spondylitis spine score (msasss) by ≥2 units after 2 years, and 2) development of a new syndesmophyte or progression of existing syndesmophytes after 2 years. serum vegf levels were detected at baseline. results. mean baseline vegf values were significantly higher in patients with msasss worsening by ≥2 units after 2 years (n=22) as compared to those without progression (562±357 vs. 402±309 pg/ml, respectively, p=0.027) and in patients with syndesmophyte formation/ progression (n=18) as compared again to those without progression (579±386 vs. 404±307 pg/ml, respectively, p=0.041). area under the curve (auc) was 0.646, p=0.027 for the msasss worsening ≥2 units and 0.648, p=0.041 for syndesmophyte formation/progression. importantly, the performance of vegf as a predictor of radiographic spinal progression was clearly in patients who were already at high risk for such a progression due to the presence of syndesmophytes at baseline (n=48): auc was 0.812, p=0.001, and 0.772, p=0.003, respectively. vegf serum level of >600 pg/ml in high-risk patients had a sensitivity of 53%, a specificity of 97%, and an odds ratio (or)=36.6 (95%ci 3.9-341.5) as a predictor of msasss worsening by ≥2 units over 2 years. the same serum level of results. immediately after the second session of plasmapheresis, therapy with infliximab 5 mg/kg resumed. after 2 weeks of hospitalization with repeated administration of infliximab had good dynamics (bas-dai 5.6, asdas (crp) = 3.8, basfi 7.8), significantly reduced pain in the joints and spine, stiffness, increased mobility in the joints and spine. the treatment continued: holding plasmapheresis followed by infliximab. after 6 infusions patient experienced a good effect -basdai 3.6, asdas (crp)=2.2, basfi 6.2. conclusion. plasmapheresis in some patients could be effective by reducing activity and dealing with secondary tnf inhibitors failure, since this procedure deletes the macromolecular blood proteins, including tnf-, igg antibodies, and circulating immune complexes results. there were still signs of osteitis in sacroiliac joints in 5 patients at week 24, in 1 patient the mri-determined sacroiliitis has resolved completely. the patient has improved clinically and fulfilled asas40 improvement criteria. there was a minor decrease in sparcc sacroiliitis score (from 16 to 10) in 5 patients at week 24, indicating reduction of inflammation in sacroiliac joints. sparcc sacroiliitis score stayed the same in the remained patient. conclusion. rituximab may be of some benefit in decreasing mri-evident sacroiliitis in patients with highly active as, even in patients in whom tnf-α inhibitors have failed. background. despite the differences in the pathogenesis of ra and as, neck pain is a frequent clinical symptom in both diseases. we evaluated the correlation between subjective reports of neck pain and objective signs of inflammation as assessed by f bone marrow edema (bme) on mri in ra and as patients. methods. stir-mri of the cervical spine of 40 patients (34 ra, 6 as) were included. mris were scored by two blinded readers using a recently published mri scoring system, with quantification of the extension of bme in the atlantoaxial region, corpus, facet joints and processus spinosus of all cervical vertebrae, ranging from 0-57 points. the presence or absence of degenerative changes was also recorded. conclusion. the majority of patients with ra and as had objective signs of bme but also degenerative changes on mri at different cervical locations. assessment of bme in the atlantoaxial region is important in clinical practice, in addition to degenerative changes, since its presence seems to influence the intensity of neck pain reported by these patients. x. baraliakos , 13 having mri data at w94. of these 13, ten were treated with secukinumab and 3 with placebo in the core study. mris were rescored for this study. asspimri-a scores and the occurrence of vertebral edges (ve) inflammatory and fatty lesions were evaluated by an independent blinded reader. results. all 13 pts completed this exploratory mri substudy. in pts receiving 2×10 mg/kg secukinumab followed by 14×3 mg/kg (n=10) secukinumab, spinal inflammation was reduced compared to bl at w28 -similar to the results of the core study -and this reduction was sustained up to w94 (abb. 1). also in 3 pts who had initially received placebo switching to secukinumab at w28, mri inflammation at w94 was reduced. of the 920 ves evaluated, the proportion of ves with inflammatory lesions was reduced from 9.9% (n=91) at bl to 3.7% (n=34) at w28 and 3.6% (n=33) at w94. in contrast, the proportion of fatty lesions at bl (13.5%, n=124) remained largely unchanged at w28 (14.3%, n=132) and w94 (13.7%, n=126). secukinumab reduced mri inflammation at w28 and w94. conclusion. mri analysis suggests that the il-17a inhibitor secukinumab can reduce spinal inflammation and this effect may be sustained for up to 2 years. unlike reports with tnf blockers, secukinumab appeared to leave the proportion of fatty lesions unchanged. the potential impact of these preliminary findings on radiographic progression under secukinumab therapy will be studied in larger trials. schlussfolgerung. es zeigen sich keine signifikanten unterschiede in der krankheitsaktivität der beiden gruppen (vor einleitung der ada-therapie nach dmard-und nach anti-tnf-versagen). auch bei der patientengruppe mit mehreren vortherapien mit tnf-inhibitoren können keine signifikanten unterschiede in der ausprägung der erkrankung nachgewiesen werden. im trend wurde ein früheres einsetzen der haut-und gelenkmanifestation sowie eine stärkere systemische entzündungsreaktion in den patienten mit vorheriger tnf-therapie festgestellt werden, während die dauer der erkrankung und der bmi mit den charakteristika der patienten mit ausschließlicher dmard-vortherapie vergleichbar sind. long-term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis (palace 1) background. apremilast, an oral phosphodiesterase 4 inhibitor, works intracellulary to modulate a network of pro-and anti-inflammatory mediators. the palace 1 study assessed the efficacy and safety of apremilast in patients with active psoriatic arthritis (psa) despite prior dmards and/or biologics. methods. patients were randomized 1:1:1 to placebo, apremilast 20 mg bid (apr20), or apremilast 30 mg bid (apr30). at week 16, patients with <20% reduction from baseline in swollen/tender joint counts were required to be re-randomized (early escape) to apr20 or apr30 (placebo group), or remained on their initial apremilast dose. at week 24, all remaining placebo patients were re-randomized to apr20 or apr30 through week 52. results. 504 patients were randomized. at week 16, significantly more apr20 (31.3%; p=0.0140) and apr30 patients (40.0%; p<0.0001) achieved an acr20 vs placebo (19.4%). at week 52, all patients had a minimum 28 weeks of apremilast exposure. response to apremilast was generally maintained over the treatment period. at week 52, acr20 was achieved by 63.0% (apr20) and 54.6% (apr30) of patients (table) . exposure-adjusted incidence rates for adverse events (aes), severe aes, and serious aes were comparable between 0-24 and 0-52 weeks. the proportion of patients remaining on apremilast to week 52 who first reported the most common gi disturbances (e.g., diarrhea, nausea, and vomiting) after week 24 was low (ranging from 0.6-3% for apr20 and 0-1.8% for apr30). there were no clinically meaningful laboratory findings with exposure up to 52 weeks. no deaths beyond the 1 previously reported in the 0-24 week period were observed in the 24-52 week period. no safety signals with respect to major cardiac events, malignancies, and opportunistic infections were observed, consistent with the 0-24 week period. no cases of lymphoma, tuberculosis, or tuberculosis reactivations were reported for the 52-week period (. tab.30). conclusion. apremilast administered to patients with psa beyond 24 weeks continued to demonstrate meaningful clinical response. for patients who completed 52 weeks of the study, acr20 response rates up to 65% were observed. apremilast continued to be well tolerated with an acceptable longer-term safety profile. methods. to identify how conventional cd4+ and cd8+ t cells and regulatory t cells are recruited into the inflamed kidneys in ln, serum and urine samples of 98 sle patients were analyzed for 18 chemokines using multiplex assays. based on the assay's results a group of 8 corresponding chemokine receptors (ccr1-6, cxcr3 and cxcr6) was chosen, whose frequencies on urinary t cells were subsequently determined in 9 patients with acute ln by flowcytometry. results. 12 chemokines (ccl2, ccl3, ccl4, ccl5, ccl7, ccl8, ccl11, ccl20, cxcl9, cxcl10, cxcl16 and cx3cl1) were significantly elevated in the urine of patients with active ln when compared to the control group. the other 6 chemokines (ccl1, ccl17, ccl22, cxcl1, cxcl5) and cxcl11 showed no significant differences between the groups. ccr5 and cxcr3 were the most prominent receptors on both urinary cd4+ and cd8+ t cells, although cd4+ t cells also expressed high amounts of ccr4 and ccr6. however, when compared to t cells in the blood, urinary cd4+ t cells showed significantly higher expression of all examined chemokine receptors but ccr2 while urinary cd8+ t cells only had higher expression of ccr1 and ccr5. the chemokine receptor expression on cd4+foxp3+cd127-regulatory t cells (treg) differed from conventional cd4+ t cells as well. treg expressed significantly more ccr4 and significantly less cxcr6. conclusion. ccr5 and cxcr3 are the primary receptors in the mechanism of recruiting t cells into the inflamed kidney. key chemokines are ccl3, ccl4, ccl5 and ccl8 as well as cxcl9 and cxcl10. however, at least for cd4+ t cells, there are secondary pathways of recruitment involving ccr4/ccl2 and ccr6/ccl20. also, treg recruitment seems to rely more on ccr4 than that of conventional cd4+ t cells. methods. observe is a multicenter, retrospective medical chart review study. rheumatologists from german academic and non academic centers who treat >10 sle patients annually and have >5 years of practice experience were randomly recruited. physicians identified consecutively all their adult sle patients who had received belimumab as part of usual-care. index date was the first belimumab infusion date. the primary outcome was the change in overall sle disease manifestations 6 months after index date based on physician judgment. the overall response rates as well as reasons for early treatment discontinuation within 6 months were assessed. changes in formal disease area indices, e.g. selena-sledai if available and changes in oral steroid dose are also reported. results. previous analyses from us patients treated with belimumab have described significant clinical improvement across relevant organ systems based on clinical judgment and formal disease activity indices and marked reductions in corticosteroid use in patients that received at least 8 infusions of belimumab. the current study is the first description of patient characteristics and outcomes after 6 months of therapy with belimumab outside of the us. it is also the first time overall responder rates and reasons for discontinuation with belimumab have been described in a real world setting. the study provides insights into the effectiveness and safety of belimumab in an ex-us clinical setting. larger, prospective observational studies are needed to confirm the results. commercial support grant disclosure: research funded glaxosmithkline. background. toll-like receptor 9 (tlr-9) signaling is considered to play an important role in b cell hyperreactivity in sle. b cells from slepatients express significantly more tlr-9 than those from healthy donors (hd), especially if patients have positive dsdna-antibodies and high disease activity. tlr-9 stimulation of b cells is tightly linked to their differentiation into plasma blasts and memory cells. the objective of this study was to analyze in a comprehensive manner the effect of tlr-9 signaling on cytokine production by b cells from sle-patients, in comparison to b cells from hd, and in relation with disease activity. methods. b cells from 19 sle-patients and 13 hd were stimulated in vitro using cpg for 48 hours, and culture supernatants were then tested for 28 cytokines and chemokines (bio-plex). the cytokine responses were compared between both groups. in addition, within sle patients, the patterns of cytokines produced by b cells were compared with indices of disease activity. results. cpg-stimulation significantly increased cytokine production (24 out of 28 parameters; p<0.05) compared to baseline. striking increases were found for il-1ra (94±40 pg/ml), il-6 (431±225 pg/ml), il10 (72±37 pg/ml) and ip-10 (361±289 pg/ml; p<0.001). there was no significant difference between both groups. remarkably, production of il-2, il-4, il-7, il-12p70, il13, il-15, il-17a, eotaxin, basic fgf, g-csf, gm-csf, ifn-γ, ip-10, mip-1α, and vegf correlated inversely with the sledai (p<0.05) and even more (additionally il-1β, il-1ra, mip-1β and tnf-α) with anti-dsdna antibody titers. the frequency of cd27+ memory b cells showed a positive correlation between the production of ip-10 and tnf-α in sle, whereas the levels of il-1β, il-7, mip-1α, and mip-1β showed a positive correlation with cd27+ b cells in hd. conclusion. the current data indicate hitherto unknown perturbations of cytokine/chemokine production by b cells in active sle. the inverse correlation of cytokines/chemokines produced by b cells from sle patients with sledai and anti-dsdna titer suggests that the known enhanced b cell proliferation and differentiation upon tlr9-stimulation possibly diminishes cytokine production. background. several cytokines, including ifn-γ, il-18, il-12, and il-23 have been implicated in the pathophysiology of autoimmune disease. il-18, a potent inducer of ifn-γ, enhances th1 responses that are thought to be synergistic and dependent on il-12. we tested the hypothesis that intra-renal il-18 mediates kidney and systemic disease in mrl-faslpr mice. methods. by constructing il-12p40/il-23-/-mrl-faslpr mice and using an ex-vivo gene transfer to deliver il-18 intra-renally, we determined that il-18, independent of il-12 and/or il-23, incites kidney disease in mrl-faslpr mice. moreover, we provide the novel finding that local intra-renal il-18 mediates systemic disease (lung pathology, systemic auto-abs). results. thus, our data indicate that il-18 is a potential therapeutic target for immune mediated kidney and systemic disease in mrl-faslpr mice. using a caspase-1 inhibitor, that inhibits the release of active il-18 and il-1β, we successfully treated kidney (improved renal function, pathology) and systemic disease (skin lesions, lymphadenopathy, and splenomegaly) in mrl-fas lpr mice, while administration of an il-1 receptor antagonist did not influence disease progression. probing further we found that inhibition of il-18 activation results in an amelioration of lupusnephritis by a reduction of intra-renal infiltrating leukocytes (macrophages and t cells) and reduced activation of these leukocyte populations. moreover, caspase-1 inhibition resulted in decreased inf-y and il-17 production, indicating an altered balance of th17 and th1 cell responses in this model. conclusion. taken together, our findings indicate that il-18, independent of il-1β, il-12 and/or il-23, is the major mediator of kidney and systemic disease mrl-faslpr mice. therefore, caspase-1 inhibition is a potential therapeutic target for autoimmune disease in the mrl-faslpr mice. background. in the treatment of giant cell arteritis (gca) glucocorticoid-related adverse effects occur frequently, particularly in patients with relapsing disease. a 50-year-old woman presented with a 2 month history of fever, chills, arthralgias and cephalgias and markedly elevated serum inflammatory markers. whereas further evaluation including ultrasound of the temporal arteries was unremarkable, a positron emission tomography-computed tomography (pet-ct) demonstrated an intense fluorodeoxyglucose uptake of the aorta, the subclavian, carotid and femoral arteries. gca was diagnosed and treatment with high dose prednisone was begun. results. because of disease flares at prednisone dosages below 20 mg/ day and the occurrence of vertebral fractures, cyclophosphamide and methotrexate (mtx) were added as glucocorticoid-sparing agents. as these treatments had to be stopped because of intolerance and mtxpneumonitis, respectively, we started tcz infusions (8 mg/kg body weight). the clinical status rapidly improved. after 2 infusions of tcz follow-up pet scan showed resolution of the previously seen uptake and we were able to taper the daily dose of prednisone to 5 mg. treatment was well tolerated. however, the patient developed mild hyperthyroidism with a rapid rise of the initially normal levels of anti-thyroid peroxidase and anti-thyroid antibodies, anti-tsh receptor antibodies remained normal. thyroid function normalized and the antibody-levels fell without further treatment in the following months. in conclusion, this case demonstrates the successful treatment of a patient with relapsing giant cell arteritis with tcz. for the first time, we report the occurrence of a transient autoimmune thyreoiditis possibly induced by tcz. klinik für pädiatrie mit schwerpunkt pneumologie und immunologie, sektion rheumatologie, berlin, 4 vestische kinder-und jugendklinik der universität witten/herdecke 13 deutsches zentrum für kinder-und jugendrheumatologie organización médica de investigación arthr care res ar&t in press sp division of rheumatology diagnosesicherung: a + b) mr-morphologisch myositistypische veränderungen (os) histologie + c) generalisierte myalgien und laborchemisch dtl. elevierter ck, sowie positivem nachweis von ana und jo-1-ak, pulmonales ct mit diffusen milchglasinfiltraten, in bronchoalveolärer lavage neutrophile alveolitis. ergebnisse. vormedikationen: a) glukocorticoidmonotherapie, mtx-monotherapie, mtx in kombination mit etanercept, cyclophosphamidboli, und zuletzt intravenöse immunglobuline (ivig) in kombination mit mycophenolatmofetil . b) mtx-monotherapie, mtx in kombination mit glukokortikoiden, cyclophosphamidboli, intermittierend intravenöse immunglobuline, cyclophosphamid per os (fau-ci). c) cyclophosphamidboli jeweils gutes ansprechen des ck-wertes auf jeweilige rituximabgaben mit ebenfalls ansprechen des klinischen bildes mit guter regredienz des aus myalgien resultierenden schmerzniveaus. im fall a keine beatmung mehr notwendig. im fall von c) auch gute regredienz subjektiver dyspnoesymptomatik und besserung wichtiger lungenfunktionsparameter, regredienz ctmorphologischer milchglasinfiltrate, im verlauf fehlender nachweis neutrophilie in bal. weitere rituximabgaben bei a, b und c im verlauf zum remissionserhalt nach jeweiligem klinischem befund production of cytokines by b cells in response to tlr9 stimulation inversely correlates with disease activity in sle-patients berlin zeitschrift für rheumatologie suppl 2 · 2013 | das muskuloskeletale system, eines der am häufigsten betroffenen organsysteme bei sle (bei 53-95% der sle-patienten). das ziel dieser analyse war es um diejenigen parameter zu identifizieren, die zu diesem effekt beigetragen hatten, wurde jeder der 9 einzel-parameter zur untersuchung und symptom-erfassung innerhalb des muskuloskeletalen bilag-organsystems analysiert. die post-hoc-analyse umfasste nur patienten, bei denen ein parameter zu studienbeginn als vorhanden gewertet wurde, und jeder parameter erforderte ≥20 patienten-beobachtungen pro kohorte um einen vergleich zu erstellen dadurch wurde die zahl der patienten mit einer initialen beteiligung des muskuloskeletalen systems aufgedeckt, die eine in woche 52 auflösung der manifestation aufwiesen auch im selena-sledai-score war die rate der verbesserung bei dem arthritis-parameter in der belimumab-gruppe mit 1 mg/ kg (58,3%; n=362) und 10 mg/kg (56,6%; n=364) signifikant höher als die daten weisen darauf hin, dass 10 mg/kg belimumab effektiv auf muskuloskeletale organmanifestationen sind akzeptiert als posterbeitrag auf dem eular klinische forschergruppe für rheumatologie (kfr), freiburg i. br., 10 universitätsklinikum ulm, klinik für dermatologie und allergologie die physikalische therapie (pt) ist ein wesentlicher bestandteil der medizinischen versorgung von ssc-patienten patientenregister des dnss erfasst prospektiv, jährlich klinische verlaufsdaten zur organbeteiligung und therapie von patienten mit systemischer sklerodermie. die mittels freitext erfassten angaben zur verordneten pt wurden ausgewertet hivamat n=50 (3,7%) und hylase n=54 (3,9%) anwendung. die anzahl der verfahren, die die patienten zeitgleich erhielten, variierte zwischen mind. 1 und max. 8. über 50% der patienten erhielten 2 anwendungen gleichzeitig. insgesamt wurden 39 therapiearten genannt. 12,5% der patienten mit gelenkkontrakturen zeigten nach einem jahr physikalischer therapie eine signifikante verbesserung der symptomatik (p=0,027) gegenüber den patienten die keine physikalische therapie erhielten. nach drei jahren waren es 15,7% der patienten (p=0,023). bei den patienten mit muskelschwäche zeigten 11% der patienten eine signifikante symptomverbesserung (p=0,048) dieser studie kann erstmals gezeigt werden, dass pt-symptome wie gelenkkontrakturen und muskelschwäche bei ssc-patienten signifikant verbessern kann. dennoch erhält weniger als die hälfte der ssc-patienten eine physikalische therapie punkten zur kontrolle einer mmf-therapie in der klinischen praxis zu untersuchen bei 15 patienten (12-mal sle, je 1-mal systemische sklerose, sharp-syndrom und primäres sjögren-syndrom) die mmf erhielten, wurde 40, 120 und 180 min nach einnahme von mmf die mpa-konzentrationen im serum per hplc bestimmt. die mpa-auc wurde durch die mathematische methode der bayes 20%) und in der standarddosis von 2 g/tag bei 6 von 9 patienten (66%) eine mpa-auc von >35 µg.h/ml. bei zwei patienten wurde nach der messung die dosis adjustiert: eine patientin mit einem sle mit diffus-proliferativer lupusnephritis hatte trotz einer mmf-dosis von 2 g/tag nur eine mpa-auc von 32,9 µg.h/ ml. die dosis wurde daraufhin auf 3 g/tag erhöht. der mpa-auc stieg danach auf max. 54,9 µg.h/ml und die krankheitsaktivität nahm ab (sledai von 8 auf 0, proteinurie von 550 auf 150 mg/24 h und prednisondosis von 6 auf 4 mg/tag) pharmakokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of bayesian estimator using limited sympling strategies mycophenolic acid area under the curve correlates with disease activity in pupus patients treated with mycophenolate mofetil colony stimulating factor-1 (csf-1) -neuer aktivitätsmarker der lupusnephritis? brigham and wome's hospital, boston, renal division the authors would like to thank pfizer for supporting the study. furthermore the authors would like to thank the "deutsche kinder-rheumastiftung". einleitung. bei patienten mit früher axialer spondyloarthritis (spa) mit einer krankheitsdauer von<5 jahren und nachweis von akut-entzündlichen veränderungen in der ganzkörper-magnetresonanztomographie (mrt) in der wirbelsäule und/oder den sakroiliakalgelenken (sig) zu baseline [1] untersuchten wir die langzeit-effektivität über vier jahre. methoden. in der esther-studie wurden patienten mit etanercept (eta, n=40) vs. sulfasalazin (n=36) behandelt [1] . ab dem zweiten studienjahr wurden alle patienten mit eta behandelt (einige patienten unterbrachen zwischenzeitlich die therapie (n=12) zur untersuchung der biologika-freien remission und wurden dann (erneut) mit eta behandelt) [2] . klinische, laborchemische und mrt-daten der patienten, die zu den jeweiligen studienzeitpunkten vorhanden waren, wurden im vierten studienjahr analysiert (as-observed-analyse). ergebnisse. von 76 patienten, die zu baseline eingeschlossen wurden, erreichten 52,6% das ende von jahr 4 (n=40). in der gesamtgruppe zeigte sich ein gutes bis sehr gutes ansprechen, wobei etwa 50% eine asas partielle remission und etwa 60-70% eine asdas inaktive erkrankung erreichten (. tab.29). der anteil der patienten mit normalem crp ("crp-remission") stieg von 43,7% zu screening auf 90,2% zu woche 216, während der anteil der patienten mit negativem mrt ("mrt-remission" definiert als fehlen akut-entzündlicher veränderungen in den sig und der wirbelsäule gemäß beider scorer) auf von 0% auf 18,4% anstieg. 10,5% der patienten zu woche 216 waren sowohl in asas-remission, im status einer asdas inaktiven erkrankung als auch in mrt-remission. das ansprechen nach vier jahren war sehr ähnlich in den gruppen unabhängig davon, ob im ersten jahr sulfasalazin gegen wurde oder die therapie im jahr 2 unterbrochen worden war (ergebnisse werden nicht gezeigt).schlussfolgerung. es zeigte sich ein konstantes und anhaltendes ansprechen bei patienten mit früher axialer spa, die mit etanercept behandelt wurden. das ansprechen scheint besser zu als bei patienten mit etablierter ankylosierender spondylitsi mit einer langen krankheitsdauer (>10 jahren; [3] ). einleitung. in einer 12-wöchigen placebokontrollierten studie mit 40-wöchiger offener verlängerung bei 46 patienten mit aktiver nichtröntgenologischer axialer spondyloarthritis (nr-axspa) wies adalimumab eine gute effektivität auf [1] . bei patienten, bei denen es zum wiederauftreten der krankheitsaktivität nach absetzen des medikaments in woche 52 kam, wurde die therapie wiederbegonnen ziel der studie war es, die langzeiteffektivität nach wiederaufnahme der therapie von adalimumab nach stopp über 5 jahre zu evaluieren. methoden. bei 46 ursprünglich in die studie eingeschlossenen patienten wurde die therapie nach 52 wochen beendet und 23 patienten (52% männlich, mittleres alter 32 jahre, range 24-45, mittlere krankheitsdauer vor therapiebeginn 4 jahre, range 1-10, 74% positiv für hla-b27) hatten, definiert durch erreichen eines 40% ansprechens gemäß der assessments in spondyloarthritis society-kriterien (asas40), gut auf die therapie angesprochen. bei wiederauftreten von krankheitsaktivität (definiert durch nicht mehr erreichen von asas40) wurde adalimumab 40 mg alle 2 wochen über 5 jahre (woche r264) weitergeführt. die asas kriterien und der bath ankylosing spondylitis disease activity index (basdai) wurden in form einer completer-analyse berechnet. ergebnisse. 19 der 23 patienten mussten wiederbehandelt werden: 17/19 (90%) erreichten jahr 3, 16/19 (84%) erreichten jahr 4 und 11/19 (58%) der patienten erreichten jahr 5 der wiederbehandlung. nach 3 jahren wiederbehandlung mit adalimumab erreichten 13/17 (77%) wieder asas 40 und 11/17 (65%) erreichten partielle remission gemäß der asas-kriterien. nach 4 jahren erreichten 11/16 (81%) und nach 5 jahren 9/11 (91%) asas 40. asas partielle remission wurde nach 4 jahren von 9/16 (56%) und nach 5 jahren von 7/11 (64%) patienten erreicht. in der completer analyse fiel der mittlere basdai von 5,1±1,8 zum zeitpunkt der wiederbehandlung auf 1,6±1,6 im jahr 3 (p<0,001), 2,2±2,1 (p=0,001) im jahr 4 und auf 1,5±1,8 (p=0,001) im jahr 5 der wiederbehandlung ab. schlussfolgerung. in dieser gruppe von 19 patienten mit aktiver nr-axspa, die ein gutes therapieansprechen über 52 wochen mit adalimumab erreicht hatten und die bei wiederauftreten von krankheitsaktivität nach stopp der therapie in woche 52 weiterbehandelt werden mussten, sprach die mehrheit der patienten, die in der studie verblieben, gut und anhaltend auf das fortsetzen der therapie an. tab. 29 | sp-17 langzeit-effektivität über 4 jahre etanercept-therapie bei patienten mit früher axialer spondyloarthritis. daten zu baseline (bl), jahr 1 (w48), jahr 2 (w108), jahr 3 (w156) und jahr 4 (w216). daten background. secukinumab (ain457) is a new fully human monoclonal antibody (mab) targeting il-17a for the treatment of inflammatory diseases. administration of mabs can be associated with immunogenicity via the induction of anti-drug antibodies (adas). adas can lead to unwanted clinical consequences, such as loss of exposure, loss of efficacy due to altered pharmacokinetics and/or functional neutralization and, in the worst case, anaphylactic reaction and immune complex diseases. the assessment of ada formation is therefore a critical component in the assessment of biotherapeutic safety. methods. the immunogenicity assessment strategy for secukinumab follows a three-tiered approach. first, samples are analyzed for presence of ada in a screening assay which takes a 5% false-positive rate into account. in a second step, screening assay positive samples are tested in a confirmatory assay that identifies true positive responses. finally, true immunogenicity-positive samples are quasi-quantified via titration. a biacore-based assay was used during the early stages of the secukinumab program, and an msd-based bridging assay was applied during the later stages of the program. in addition, pharmacokinetics and clinical efficacy as well as safety data are also evaluated. samples to assess immunogenicity were obtained from 1582 individual subjects encompassing 18 clinical studies in different indications during treatment and during follow-up. dosing regimens included single doses such as 25 mg subcutaneously in psoriasis patients as well as multiple 7×10 mg/kg doses intravenously in ms patients over a six-month period.results. none of the subjects tested for immunogenicity developed sustained adas. in total, 4 subjects met the definition of treatment-related, transient positive immunogenicity showing low ada titers. none of these subjects had evidence of loss of efficacy, deviating pk behavior or reported anaphylactic reaction or immune complex disease.conclusion. based on the available data, secukinumab appears to carry a low risk of immunogenicity. in the very few transient immunogenicitypositive patients identified so far, there has been no indication of altered pharmacokinetics or loss of efficacy, and no adverse event that could be linked to immunogenicity has been detected. more data from the ongoing phase 3 studies are required to strengthen this encouraging finding in a larger patient population. risikofaktoren für eine aa-amyloidose bei entzündlich-rheumatischen erkrankungen und bei der idiopathischen aa-amyloidose methods. we report a case of an 84-year-old woman suffering from ulceration and signs of infection of the ulnar aspect of the right forearm due to subcutaneous calcification in association with crest syndrome.results. this case presents an unusual case of extensive subcutaneous calcification in crest syndrome requiring surgical excision due to secondary ulceration, inflammation and infection. while a surgical approach has already been described for calcification in different connective tissue diseases, only scant data of massive subcutaneous calcification related to a forearm in crest syndrome followed by surgical excision exist. conclusion. in crest syndrome, extensive subcutaneous calcification related to the forearm can occur. surgical excision followed by primary wound closure can lead to an excellent postoperative result. background. the whole blood interferon signature (wbifns) is measured in several clinical trials studying inhibitors of interferon alpha (ifn-α) in sle, but failed repeatedly -in contrast to the less sensitive ifnα -to reflect longitudinal changes in lupus activity and to guide dosage finding of rontalizumab. therefore, better ifn biomarkers reflecting disease activity over time and individual response to the inhibition of ifnα are needed to optimize the risk-benefit ratio of ifn-inhibitors. here, we show that the highly sensitive monocyte restricted ifnα response protein siglec-1, also known as sialoadhesin or cd169, is a useful biomarker to monitor longitudinal changes in disease activity of sle patients. methods. ifn-α and siglec-1 were measured by delfia and flow cytometry, respectively, in 24 accurately characterized lupus patients over a period of up to 12 months (overall 112 visits). changes of biomarker and changes of disease activity (bilag2004) were correlated using spearman rank test (srt). disease courses of selected sle patients were plotted to demonstrate in detail the relations of ifn-biomarkers with disease activity, sle medication and clinical manifestations. background. a 74-year-old woman was admitted because of sudden attack of convulsion and somnolence situation with positive canca and myeloperoxidase antibodies. cerebral magnetic resonance imaging (mri) showed thickening and marked progression of the dura-meningeal enhancement and edematous changes at pre and post central gyrus left side. based on these findings, it was diagnosed as hypertrophic cranial pachymeningitis related to anca-associated vascultis as unusual presentation. there was only temporarily und partial responce to a 7-month therapy with cyclophosphamide 1000 mg i.v and oral glucocorticosteroids . taking into consideration the severe, life-threatening course of the disease in the case of our patient, the decision was made to use rituximab, a chimeric, monoclonal igg1 antibody directed against cd20, leads to destruction of b cells via complement mediated lysis and antibody dependent cellular cytotoxicity. the first administration of the medication was performed according to the pattern for rheumatoid arthritis patients treated with rituximab, i.e. 2 infusions for 1000 mg in 14-day intervals in combined therapy with glucocorticosteroids. a follow-up mri at 6 months after start with rituximab showed significant regression of the meningeal pathology at temporo-occipatel aspects (pachymeningitis) and completely resolution of edematous changes at pre and post central gyres. the complete clinical remission was achieved by introducing rituximab. conclusion. rituximab seems to be successful therapie for the induction and maintenance of remission in patients with anca-associated vasculitis (aav) with cns involvement (hypertrophic cranial pachymeningitis ) , who had previously failed to respond to standard treatment with cyclophosphamide and steroids and a range of alternative treatments [1, 2] . antikörperdiagnostik. mit prednisolon-therapie (1 mg/kgkg, 40 mg/ tag) und zusätzlich methotrexat 15 mg wöchentlich war keine anhaltende normalisierung der entzündungsserologie zu erzielen. infliximab (5 mg/kg) 6-wöchentlich i.v. erbrachte nur kurzzeitig eine normalisierung der entzündungswerte, dann trotz weiterer infusionen einen erneuten anstieg der bsg bis auf 91 mm, crp 58 mg/l. nach umstieg auf tocilizumab (400 mg /8 mg/kgkg) alle 4 wochen konnte nach 6 wochen eine bislang anhaltende normalisierung der entzündungsserologie erzielt werden (crp 1,1 mg/l, bsg 9 mm 1. std.). der allgemeinzustand der patientin besserte sich deutlich, der hb-wert normalisierte sich auf 7,9 mmol/l. in der kontrastverstärkten sonographie fand sich ein abfall in der kontrastmittelaufnahme der a. carotis communis. die maximale intima-media-dicke reduzierte sich bislang auf 1,7 mm. schlussfolgerung. die bisherige standardtherapie der takayasu-arteriitis mit prednisolon und mtx führte auch im vorliegenden fall nicht zur remission. für infliximab fanden wir ein frühzeitiges therapieversagen des sonst erfolgreich beschriebenen ansatzes einer tnf-α-blockade bei riesenzellarteriitis. dennoch gelang mit tocilizumab eine bislang über 12 monate andauernde klinische, sonomorphologische und serologische remissionsinduktion bei monatlicher fortführung der il-6-blockierenden therapie. 4 background. cd56 is the prototypic nk receptor that is also expressed on a unique population of effector cd4+ cells. these cd56-expressing t cells are expanded in rheumatoid arthritis patients and had features of senescent cells. nkg2d is another nk receptor over expressed on effector cd4+ cells in aav patients. cd 56+ as well as nkg2d + t cells seem to be involved in tissue injury as they are capable of mediating tcr-independent immune activation. it is hypothesized that il-15 is able to up regulate the expression of nk cell receptors. interleukin-15 (il-15) is a proinflammatory cytokine that is over expressed in aav and is linked to the expansion of cd4+ effector memory t cells (tem). in aav in remission a persistent expansion of these cd4+ effector memory t cells has been observed. in the present study we assessed the expression cd56 on cd4+ t cells of aav and if expression of these molecules was influenced by il-15. methods. the distribution of cd4+ tem and the proportion of cd56+cd4+ t cells and nkg2d+ cd4+ t cells were analysed in 52 aav-patients and 30 hcs by facs. in vitro effects of il-15 on the expansion of cd4+ tem and up regulation of cytotoxic markers were assessed in the same way. in addition il-15 serum levels were measured in patients and hc by elisa. results. we observed an increased proportion of circulating cd4+cd56+ t cells in aav as well as nkg2d+ cd4+ t cells in patients in remission compared to hc (13.6 vs 0.6 p<0.0001 and 14 vs 0.7 p<0.0001). 80% to 90% of these cells were cd4+ effector memory t cells. the percentages of the cd56+cd4+ t cells and nkg2d+ cd4+ t cells were constant over time. we also observed elevated il-15 serum levels in patients in remission compared to hc (p=0.001). in vitro stimulation of pbmcs with il-15 increased not only the proportion of cd4+ memory cells (cd45ro+) but also the expression of cd56 and nkg2d on these cells. conclusion. the driving force behind the persistent expansion of a cytotoxic subset of cd4+ effector memory t cells expressing cd56 and nkg2d+ and being tcr -independent is likely the increased il-15 expression in aav patients . ergebnisse. unabhängig von regime der remissionsinduktion und der primären erhaltungstherapie lag am ende der nachbeobachtungsperiode bei 69% der patienten eine renale remission vor (45%; 24% pr). 16% hatten eine persistierende proteinurie von >0,5 g/tag bei stabiler nierenfunktion, 3% eine persistierende niereninsuffizienz mit erhöhtem kreatinin bei inaktivem sle, bei 12% wurden eine persistierende aktive ln und/oder renale rezidive beobachtet. vier patienten verstarben. patienten mit langzeit-cr waren gekennzeichnet durch einen niedrigeren tubulointerstitiellen chronizitätsindex in der initialen nierenbiopsie (0,37±0,40 vs. 1,47±1,13; p=0,001), eine hochsignifikant geringere proteinurie nach 6 cyc-pulsen (0,36±0,36 vs. 1,97±1,57 g/tag; p=0,000) und niedrigere dsdna-ak (61±72 vs. 110±89 u/ml; p<0,05) zum zeitpunkt des beginns der erhaltungstherapie. eine proteinurie von <0,35 g/tag nach 6 pulsen cyc zeigte eine sensitivität von 71% und eine spezifität von 94% für eine langzeit-cr. schlussfolgerung. eine proteinurie von <0.35 g/tag nach remissionsinduktion mit 6 pulsen cyc sowie ein geringer tubulointerstitieller chronizitätsindex in der nierenbiopsie sind prädiktoren einer anhaltenden kompletten renalen remission bei ln. background. to evaluate and compare clinical efficacy of three biomarkers for interferon activity (measured directly and indirectly) and six traditional biomarkers to indicate current disease activity in sle. methods. ifn-α (delfia), ip-10 (elisa) and siglec-1 (flow cytometry) was measured in 79 accurately characterized lupus patients and compared to serum titres of anti-dsdna (elisa and ria), anti-dsdna-ncx elisa, anti-nuc elisa, c3 and c4. disease activity was evaluated using bilag-2004 and a modified sledai-2000 (msle-dai-2k). additionally, 31 clinically quiescent patients were monitored for flares over the course of 180 days. results. increased levels of ifn-α, ip-10 and siglec-1 were found in 32%, 50% and 86% of 66 active sle patients. ifnα (r=0.45; p<0.0001) and siglec-1 (r=0.54; p<0.0001) correlated better with bilag-2004 than ip-10 (r=0.38; p=0.0002), farr assay (r=0.40; p=0.0001), anti-dsdna-ncx elisa (r=0.28; p=0.0061), anti-dsdna elisa (r=0.31; p=0.0025), anti-nuc elisa (r=0.25; p=0.0121), c3 (r=-0.43; p<0.0001) and c4 (r=−0.33; p=0.0013). predictors of sle flares were disease duration ≤92 months, mild clinical activity (in contrast to no activity), complement c3≤89 mg/dl and ifn-α ≥20 pg/ml, while only lymphocyte count and age were independent predictors in multivariate analysis. conclusion. ifn-α, ip-10 and siglec-1 emerged as beneficial biomarkers for disease activity in lupus patients. therefore, implementation of ifn biomarkers in standard lupus diagnostics should be reappraised, especially in view of emerging anti-ifn-directed therapies. .0001) and carried significantly more often other antibodies (71.1%; p<0.0001), which were separated into u1rnp-(22.7%), ro-(16.8%), pmscl-(11.5%) antibodies, followed by 10.8% with rheumatoid factors, 7.5% with la-, 5.8% with dsdna-and 2.8% with jo-1-and 2.6% with ku-antibodies. the kaplan-meier analysis of the onset of organ involvement revealed a clear inclined position of overlap patients between patients suffering from lcssc and dcssc, especially regarding lung fibrosis and heart involvement. patients suffering from pah, oesophagus involvement and kidney involvement, overlap and lcssc patients showed nearly similar curve progression (log rank <0.0001). furthermore musculoskeletal involvement was significantly more frequent and more progressive in patients with overlap disease, followed by patients with dcssc and lcssc (log rank <0.0001). conclusion. these data support the current concept, that ssc-overlap syndromes should be regarded as a separate ssc subset, distinct from lcssc and dcssc, due to a different course of the disease, different proportional distribution of specific autoantibodies and skin/organ involvement. methoden. 18 patienten mit gpa (11 mit aktiver und 7 mit in remission befindlicher gpa) wurden durchflusszytometrisch analysiert und mit 17 gesunden verglichen. eine färbung für cd27, cd20, cd19, igd, iga, cd95, mhcii, wurde mittels flowjo-software analysiert. die statistische auswertung erfolgte mit "graph pad prism" und p-werte<0,05 wurden als signifikant angesehen. die studie wurde von der ethik-kommission der charité genehmigt. ergebnisse. deutliche unterschiede (p=0,0018) wurden sowohl für die absolute zahl als auch die frequenz der plasmazellen im peripheren blut der patienten mit gpa mit krankheitsaktivität (6,4±5,06/µl) im vergleich zu denen mit einem bvas von 0 (2,52±1,6/µl) oder gesunden (2,27±1,15/µl) gefunden, ähnlich wie bei sle. bei patienten mit gpa ist außerdem eine signifikante erhöhte anzahl der plasmazellen igapositiv (p=0,0028). die anzahl der plasmazellen sowie die frequenz der plasmazellen an den b-zellen im blut korrelieren mit dem bvas (r=0,9135; p<0,0001). interessanterweise zeigte sich keine expansion der doppelt negativen memory-zellen, die zum beispiel beim sle beschrieben ist. für die naiven b-zellen fand sich ebenfalls ein signifikanter unterschied zwischen patienten mit aktiver erkrankung im vergleich zu gesunden. bei den t-zellen fanden sich nur diskrete veränderungen. schlussfolgerung. die anzahl der plasmazellen ist bei patienten mit aktiver gpa deutlich erhöht, was eine rolle von plasmazell-vermittelten mechanismen in der pathogenese nahelegt. ein großteil dieser plasmazellen ist iga-positiv, diese könnten eine rolle bei der hno-beteiligung spielen. key: cord-323581-qtasvgtd authors: zhang, yu-dong; dong, zhengchao; wang, shui-hua; yu, xiang; yao, xujing; zhou, qinghua; hu, hua; li, min; jiménez-mesa, carmen; ramirez, javier; martinez, francisco j.; gorriz, juan manuel title: advances in multimodal data fusion in neuroimaging: overview, challenges, and novel orientation date: 2020-07-17 journal: inf fusion doi: 10.1016/j.inffus.2020.07.006 sha: doc_id: 323581 cord_uid: qtasvgtd multimodal fusion in neuroimaging combines data from multiple imaging modalities to overcome the fundamental limitations of individual modalities. neuroimaging fusion can achieve higher temporal and spatial resolution, enhance contrast, correct imaging distortions, and bridge physiological and cognitive information. in this study, we analyzed over 450 references from pubmed, google scholar, ieee, sciencedirect, web of science, and various sources published from 1978 to 2020. we provide a review that encompasses (1) an overview of current challenges in multimodal fusion (2) the current medical applications of fusion for specific neurological diseases, (3) strengths and limitations of available imaging modalities, (4) fundamental fusion rules, (5) fusion quality assessment methods, and (6) the applications of fusion for atlas-based segmentation and quantification. overall, multimodal fusion shows significant benefits in clinical diagnosis and neuroscience research. widespread education and further research amongst engineers, researchers and clinicians will benefit the field of multimodal neuroimaging. neuroimaging has been playing pivotal roles in clinical diagnosis and basic biomedical research in the past decades. as described in the following section, the most widely used imaging modalities are magnetic resonance imaging (mri), computerized tomography (ct), positron emission tomography (pet), and single-photon emission computed tomography (spect). among them, mri itself is a non-radioactive, non-invasive, and versatile technique that has derived many unique imaging modalities, such as diffusion-weighted imaging, diffusion tensor imaging, susceptibility-weighted imaging, and spectroscopic imaging. pet is also versatile, as it may use different radiotracers to target different molecules or to trace different biologic pathways of the receptors in the body. therefore, these individual imaging modalities (the use of one imaging modality), with their characteristics in signal sources, energy levels, spatial resolutions, and temporal resolutions, provide complementary information on anatomical structure, pathophysiology, metabolism, structural connectivity, functional connectivity, etc. over the past decades, everlasting efforts have been made in developing individual modalities and improving their technical performance. directions of improvements include data acquisition and data processing aspects to increase spatial and/or temporal resolutions, improve signal-to-noise ratio and contrast to noise ratio, and reduce scan time. on application aspects, individual modalities have been widely used to meet clinical and scientific challenges. at the same time, technical developments and biomedical applications of the concert, integrated use of multiple neuroimaging modalities are trending up in both research and clinical institutions. the driving force of this trend is twofold. first, all individual modalities have their limitations. for example, some lesions in ms can appear normal in t1-weighted or t2-weighted mr images but show pathological changes in dwi or swi images [1] . second, a disease, disorder, or lesion may manifest itself in different forms, symptoms, or etiology; or on the other hand, different diseases may share some common symptoms or appearances [2, 3] . therefore, an individual image modality may not be able to reveal a complete picture of the disease; and multimodal imaging modality (the use of multiple imaging modalities) may lead to a more comprehensive understanding, identify factors, and develop biomarkers of the disease. in the narrow sense, a multimodal imaging study would mean the use of multiple imaging devices such as pet and mri scanners, different imaging modes such as structural mri, diffusion-weighted imaging, and magnetic resonance spectroscopy, or even different contract mechanism such as with or without contract agents in a single examination or experiment of a subject. this practice has been widely used in clinical diagnosis and medical research. for example, a routine protocol of mri examination of a stroke patient may include t1-weighted, t1-weighted high-resolution structural mri scans, diffusion-weighted imaging, swi, etc [4, 5] . a protocol of an mri study of a psychiatric disorder may contain a combination of structural mri, functional mri, mr spectroscopic imaging, etc [6, 7] . in the broad sense, a multimodal imaging study may mean the use of multimodal imaging data obtained separately, from different subjects, and/or from different clinical or research sites. this practice offers the advantages of large and diverse datasets. however, it also comes with challenges of sophisticated models, complicated data normalization (that includes correction of errors and variations imbedded in data from different institutions), data fusion, and data integration [8, 9] . in recent years, the quantity of peer-reviewed journal articles on neuroimaging has been increasing steadily. a database (pubmed) query using the keywords in titles of "neuroimaging" or "brain imaging" returned more than 39 ,000 articles from 2010 to the present time when this paper was drafted in feb 2020 ( figure 1 ). these publications include not only applications of multimodal neuroimaging in clinical examinations and biomedical research but also methodological studies in imaging processing and fusion of multimodal neuroimaging. therefore, this present paper will focus on the following two main aspects: (1) we will review some of the recent, typical papers that exhibit the strength and limitations of the neuroimaging modalities and the corresponding analysis methods, and in particular, the needs for improved image fusion methods and (2) we will review recent methodological development in data preprocessing and data fusion in multimodal neuroimaging. we note that although we tried to cover all neuroimaging modalities, we inevitably paid more attention to mri modalities. this is not only due to the most practical application and versatility of the mri but also due to the limitations of our expertise. figure 2 shows the taxonomy of this review. the main contents of the paper are organized as follows. chapter 2 will give a brief introduction to neuroimaging, and challenges of multimodal imaging; chapter 3 introduces the commonly used neuroimaging modalities, which include computerized tomography, positron emission tomography, single-proton emission computed tomography, and magnetic resonance imaging, which has many modalities in its own right. for each modality, we will concisely describe its signal source, energy level, spatial resolution, temporal resolution, and major applications; chapter 4 describe applications of neuroimaging in three major areas: the developing brains, the degenerative brains, and mental disorders. in each part, we will first briefly describe what the clinical and/or biomedical problems are, we then review recent papers on how neuroimaging has been used to address these problems, and we point out what the unmet needs and challenges; chapters 5 to 9 are devoted to the multimodal neuroimaging fusion, covering some important procedures in data fusion. the topics are not necessarily complete and their order of presentation is not necessarily coherent with the pipeline of fusion processing. chapter 5 reviews the fundamental methods, which covers types, rules, atlas-based segmentation, decomposition, reconstruction, and quantification; chapter 6 reviews subjective and objective assessment of data fusion in multimodal neuroimaging; chapter 7 reviews the advantages of data fusion in improving the spatial/temporal resolution, distortion correction, and contrast; it also reviews the benefits of these advantages in fusing structural and functional images; chapter 8 reviews atlas-based segmentations in multimodal imaging fusion; chapter 9 reviews the quantification in multimodal neuroimaging fusion. while the focus of this part is given to pet and spect, some of the approaches and principles discussed here, such as partial volume correction and attenuation (relaxation), can be applied to quantitative mri modalities, such as dti, asl, quantitative susceptibility mapping (qsm), etc. chapter 10 concludes the paper. figure 1 numbers of peer-reviewed papers with the keywords of "neuroimaging" or "brain imaging" in titles (the numbers and the bar graph were generated by pubmed in feb 2020). in this part, we will review the current challenges of neuroimaging, including limited spatial/temporal resolution, lack of quantification, and imaging distortions. these challenges often create fundamental limitations on individual modalities of neuroimaging, while some challenges also exist in current multi-modal neuroimaging. this part will mainly cover the challenges of individual neuroimaging modalities that led to the development and ongoing research of multimodal neuroimaging methods. neuroimaging can be divided into structural imaging and functional imaging according to the imaging mode. structural imaging is used to show the structure of the brain to aid the diagnosis of some brain diseases, such as brain tumors or brain trauma. functional imaging is used to show how the brain metabolizes while carrying out certain tasks, including sensory, motor, and cognitive functions. functional imaging is mainly used in neuroscience and psychological research, but it is gradually becoming a new way of clinical-neurological diagnosis [10] . the amount of information obtainable through single-mode imaging is limited and often cannot reflect the complex specificity of organisms. for instance, although ct imaging is effective in identifying normal structures and abnormal diseased tissues according to their density and thus can provide clear anatomical structure information, it cannot image soft tissue well. generally speaking, mri imaging has good soft-tissue contrast resolution for most sequences, but its display of bone structure is relatively poor. pet imaging and spect imaging are not limited by the detection depth, with high imaging sensitivity, and are easy to quantify, but their spatial resolutions are low [11] . optical imaging refers to the detection of fluorescence or bioluminescent dyes using the principle of light emission. this technique has high sensitivity, no radioactivity, good specificity, and low cost. optical imaging allows dynamical monitoring of the replication process of virus bacteria in organisms. however, it has low spatial resolution and limited imaging depth [12, 13] . therefore, it can be observed that various imaging technologies all have both benefits and drawbacks, as shown in figure 3 , and it is difficult to provide comprehensive and accurate information through utilizing individual modality imaging. the nowadays most commonly used noninvasive functional imaging methods and their spatial and temporal range are illustrated in figure 4 . it can be distinctly observed that among these most advanced methods, functional mri (fmri) reaches the highest range of spatial resolution. fmri can assess the whole brain and image the microscopic level hemodynamic processes at the layered and columnar levels of the human cortex, under the condition of a high-intensity magnetic field (i.e., submillimeter level) [14] . however, it has a relatively lower temporal resolution in terms of imaging the neuronal population dynamics. electroencephalogram (eeg) and magnetoencephalography (meg) can both measure electromagnetic changes in the scale of milliseconds. however, their spatial resolution/uncertainty is more than several millimeters [15, 16] . the microscopic level of neuroscience is often beyond the reach of noninvasive imaging techniques due to the requirement of high spatial or temporal resolution. the majority of imaging modalities are non-quantitative and have to gain complement information from other data. this additional information allows the normalization of signals, acquirement of absolute units, and inter-subject comparison. as an example, the fmri signal is a measure of neuronal activity incited hemodynamic changes caused by a combination of complex physical and physiological processes. in different subjects or brain areas, the same level of neuronal activity can evoke different corresponding fmri signals. as a consequence, fmri signals can only be considered as roughly proportional to the activity of neurons. four years later, in 2008, the studies from ances have found that the cerebral blood flow (cbf) is relevant to fmri signal variations in individual's brain regions, patients' age groups, and health conditions. this broad relevance brings fmri signal high sensitivity [17] . various approaches have been proposed to explain the ensuing sensitivity differences. amongst these approaches, the so-called calibrated bold approach proposed and improved by blockley, chiarelli and hoge over the years has been the most widely used [18] [19] [20] . however, the more reliable absolute quantitative results of cbf with improved spatial and temporal resolutions are provided by the arterial spin labeling (asl) technique by the umich fmri lab. [21] some neuroimaging modalities are prone to geometric distortions. echo-planar imaging (epi) is a fast imaging approach that could obtain the completespace data set just in a single acquisition. due to its unmatched acquisition speed, it has revolutionized the field of neuroimaging and has served as the standard readout module for most fmri and dmri acquisition. nevertheless, epi suffers from distortion and intensity loss mainly caused by field inhomogeneities, leading to relatively poor image quality [22] . in general, the imperfection of equipment may result in information loss, noise amplification and artifacts, resulting in the distortion of images. to conclude, in practical application, utilizing individual modality imaging often has limitations, such as low sensitivity and specificity, low spatial/temporal/contrast resolution, distortion and so on. because of these deficiencies, we need to introduce the usage of multimodal neuroimaging to eliminate those shortcomings in some degree. positron emission tomography, shortened as pet, is a combination of nuclear medicine and biochemical analysis that is mostly used for the diagnosis of brain or heart conditions and cancer. instead of detecting the amount of a radioactive substance existing in body tissues of a specific location to check the tissue's function, pet detects the biochemical changes within body tissues. the biochemical changes can reveal the onset of a disease process before other imaging processes can visualize the anatomical changes related to the disease. during pet studies, only a tiny amount of radioactive substance is needed for the examination of targeted tissues. pet scans not only can be used to detect the presence of disease or other conditions of organs or tissues but can also be used to evaluate the function of organs, like the heart or the brain. the most common application of pet scan is cancer detection and treatment. figure 6 (a) shows a pet image of the brain, and figure 6 (b) shows a pet scan of the kidney [27] . (a) brain scan via pet scan (b) kidney scan via pet scan (c) brain scan via spect (d) brain scan via mri figure 6 common scan modalities single-photon emission computed tomography, commonly known as spect, uses gamma rays as the tracer to detect blood flow in organs or tissue. therefore, a gamma-emitting radioisotope, such as isotope gallium, should be injected into the bloodstream of the patient for spect. the computer collects the gamma rays from the tracer and shows it on the ct cross-section. it bears similarity with the traditional nuclear medicine planar imaging but provides 3d information as multiple images of cross-sectional slices through the patient. the information can be manipulated or reformatted freely according to diagnostic or research requirements. besides detecting blood flow, spect scanning is also applied for the presurgical evaluation of medically controlled seizures. figure 6 (c) [27] shows a spect scan of the brain magnetic resonance imaging (mri) utilizes strong magnetic field, magnetic field gradients, and radio waves to generate pictures of the anatomy and the physiological processes of the body [28] . different from pet or ct, mri does not need the injection of ionizing radioisotopes or involve x-rays. as all radiation instances can cause ionization that leads to cancer, mri, without exposing the body to radiation, becomes a better choice than ct and one of the safest medical procedures. mri is widely used in hospitals and clinics for the medical diagnosis of different body regions, including the brain, spinal cord, bones and joints, breasts, heart and blood vessels, and other internal organs, such as the liver, womb or prostate gland [29] [30] [31] . besides, mri can also be used for non-living objects [32] . figure 6 (d) shows an mri brain image [33] . t1, t2 and proton density (pd) are three basic types of mri imaging. t1, t2 and pd, which all vary with sequence parameters, can simultaneously determine the contrast of the mr images [34] . via selecting different pulse sequences with different timings, we can decide the contrast in the region being imaged. there are also other types of sequences, such as fluid attenuates inversion recovery (flair) and short tau inversion recovery (stir). in this section, we will only mention the three main types. figure 7 shows the relationship between and , of which refers to plane [35] . different from t1 and t2, which mainly focuses on the magnetic characteristics of the hydrogen nuclei, pd is more related to the number of nuclei in the region being imaged. pd weighted images are obtained by a short echo time and a long repetition time, which can provide a more apparent distinction between the gray matter and white matter. pd weighted imaging is specifically useful for detecting joint disease and injury. figure 8 (a) and (b) show a t1 weighted brain image and t2 weighted brain image, respectively [27] . (a) t1 weighted brain image (b) t2 weighted brain image figure 8 two types of weighted images of the same brain functional magnetic resonance imaging or functional mri (fmri) measures brain activity by detecting changes associated with blood flow. as it has been proved that when an area of the brain is in use, the blood flow to that area increases, which means that the neuronal activation and cerebral blood flow are matched. fmri is a particular type of imaging technology used to map the neuron activities in the spinal cord and brain of humans or animals by visualizing the change in blood flow, which is related to the energy use by brain cells. fmri also includes resting-state fmri [36] or task-less fmri, which can provide subjects' baseline bold service [37] . diffusion weighted/tensor imaging (dwi) generates image contrast from the differences in the magnitude of diffusion of water molecules within the brain. diffusion in biology is defined as the passive movement of molecules from a higher concentration region to a lower concentration region, which is also known as brownian motion [38] . diffusion within the brain is affected by many factors, such as temperature, type of molecule under investigation, and the microenvironmental architecture in which the diffusion takes place. based on the mri sequences of which diffusion is sensitive to, the image contrast can be generated according to the difference in diffusion rates. dwi is highly effective for the early diagnosis of ischemic tissue injury, even before the pathology can be shown by the traditional mr sequence. therefore, dwi provides the time window for tissue salvaging interventions. perfusion weight imaging (pwi) is defined as a variety of mri techniques that are able to provide insights into the perfusion of tissues by blood [39] . pwi can be used for the evaluation of ischaemic conditions, neoplasms, and neurodegenerative diseases. perfusion mri mainly has three main techniques: dynamic susceptibility contrast (dsc), dynamic contrast-enhanced (dce), and arterial spin labeling (asl). susceptibility weighted imaging (swi), previously known as bold venographic imaging, is a type of mri sequence that is extremely sensitive to venous blood, hemorrhage, and iron storage. as an fmri technique, swi can explore the susceptibility differences between tissues and detect differences based on the phase image. an enhanced contrast magnitude image can be obtained by combing the magnitude and phase data. swi is commonly used in traumatic brain injuries (tbi) and high-resolution brain venographies as it is sensitive to venous blood. magnetic resonance fingerprinting (mrf) [40] is new mri technique that integrates mr physics theory and computer pattern recognition technology and realizes fast and multi-parameter parallel quantization imaging. the technique consists of three modules. first, the fingerprinting signals are excited and acquired from the subject in the mr scanner by the pseudorandom temporal varied pulse sequence to reflect the physiological property of tissue. second, the evolution of fingerprinting signals with different physiological parameter combinations are predicted by the computer simulation using the bloch equation; and a fingerprint dictionary indexed by the quantized parameters is constructed. finally, the pattern recognition technology is applied to find the matched fingerprinting entries for the measured fingerprinting signals, so as to obtain the corresponding quantization parameters and realize quantization mr imaging. different from most of the conventional mri modalities, which provide qualitative contrast-based images that are determined not only by the tissue properties but also by experimental conditions, mrf provides quantitative images of tissue properties that reflects pathological conditions of the subject. figure 9 shows currently, the applications of mrf have been limited to biomedical research and the fusion of mrf with other neuroimaging modalities has not been reported. given its parametric and quantitative features, the mrf technique will play an important role not only in neuroimaging but also in fusion of multimodal neuroimaging. figure 9 digital phantom experiments of conventional t1 weighted and t2 weighted mris, and mrf table 1 lists the main advantages, disadvantages and applications of each neuroimaging technology. in this section, we listed some public databases, as shown in in this part, we will review recent advancements in the application of multimodal neuroimaging in some clinical and research areas such as early brain development, neurodegenerative diseases, psychiatric disorders, and neurological diseases. it is not our intention to cover all aspects or provide a complete review of these areas. instead, we focus on the aspects related to the development and applications of the multimodal neuroimaging techniques that meet the expectations and challenges of biomedicine. as such, each of the areas will begin with a brief description of background information such as clinical features, pathology, diagnosis, treatment of the diseases; then a general introduction of the roles, applications, and current status of the medical imaging techniques to the disease; the major part will be a review of recent papers that used one or more imaging modalities and used image fusion in multiple imaging modalities. recent studies show that the human brain experiences a rapid development in the first eight years and continues to develop and change into adulthood. during this long period, the brain develops in size, neuroanatomy, and functions. this period is significant for a person's physical and mental health, intellectual and emotional development, and learning, working, and life success [41] [42] [43] . many factors have influences on the brain development of young children, which will have an impact on cognitive abilities and mental health in later life. these influencing factors include genes, maternal stress, and drug abuse, exposure to toxic environments, infectious diseases, socioeconomic status of the family, etc. approximately one-third of genes in the human genome are expressed primarily in the brain and will affect brain development. many psychiatric and mental disorders, such as autism, adhd, bipolar, and schizophrenia, are highly heritable or have genetic risk factors. maternal stress and drug abuse are associated with preterm birth and low birth weight and increased risk of neurodevelopmental disorders and mental disorders in children [44] . the nutritional status of a child, which is affected by the socioeconomic status of the family, has a significant impact on neurocognitive development [45] . neuroimaging techniques have been used to study normal and/or abnormal development of the brain, enhancing our understanding of neuroanatomy, connectivity, and functionality of the brain. these techniques also reveal the etiological associations of abnormal brain development with risk factors and contribute to the development of intervention procedures for diseased children [42] . young children are more sensitive to radiation than adults are, so the use of pet and ct is limited. thanks to the in vivo nature and versatility of mri, not only young children but also newborn babies can be imaged, offering the opportunity to study white matter development and cognition in babies [46] [47] [48] . mri has become the most important pediatric neuroimaging modality and has been widely used to study normal and abnormal brain development, allowing repeated longitudinal observation of the changes of brains of the same individuals before and after birth [49] . in the following, our review will focus on the major mri modalities in pediatric imaging, which include structural, functional, and diffusion tensor imaging. early pediatric brain mri studies focused on the anatomical aspects using t1-weighted and t2-weighted images. qualitative studies provided information about changing patterns of gray matter and white matter differentiation and myelination in the first months of birth [50] and early childhood [51] . quantitative studies also revealed the changes in water contents, t1, and t2 relaxation times in both gray matter and white matter; age-related changes in gray matter, white matter, and csf volumes. all these reflect ongoing maturation and remodeling of the central nervous system [52, 53] . compared with adult cohorts, brain mr imaging of young children is challenging because of several factors. young children are less cooperative than adults with scanning procedures, which can be long, noisy, and uncomfortable when lying still for long; the images are often plagued with motion artifacts. the brain changes rapidly with age in early life after birth; the brain is not well myelinated; the contrast between gray matter and white matter is low. these pose difficulties to the optimized parameters for data acquisition protocol and also the standard parameters or criteria for the postprocessing procedures, such as the segmentation of the brain to determine cortical thickness [54] . as a result, the physical properties, such as relaxation times, water content, diffusion coefficients, of the developing brain are not very well characterized. other technical challenges exist to scan young children [55] . knowledge of the variations of biophysical properties, such as t1 and t2 relaxation times, water contents in gm and wm during the early life of children, is of critical importance to the understanding of neurodevelopment of young children and also to the development of diagnostic protocols of abnormal brain development. the measurement of these biophysical properties is challenging due to the prolonged scan time. recent technical development of magnetic resonance fingerprinting (mrf) allows rapid and quantitative analysis of multiple tissue properties [40] . for example, mrf can provide t1, t2, and proton density maps of the brain in contrast to the conventional t1-weighted, t2-weighted, or proton density-weighted images. a recent paper reported an application of the mrf to study the t1, t2, and mwf of children aged from 0 to 5 years old [56] . this study was able to record different patterns of variations of tissue biophysical parameters over different age stages. mrf techniques were also used to parametrically characterize brain tumors in children and young adults [57] . in a broad sense, the parametric information in mrf opened doors to studies of the correlations between brain tissue properties and brain development, impairment, and physiopathology. techniques of image fusion can play an essential role in the processing, interpretation, and application of mrf data. degenerative brain diseases are caused by the decline of neuronal function and the reduction of numbers of neurons in the central nervous system (cns). known degenerative brain diseases include mild cognition impairment, alzheimer's disease (ad), parkinson's disease, etc. the patients of these diseases suffer from losses of functions in memory, speech, movement, etc. most of these diseases (except for some mild cognitive impairment subtypes) are progressive, i.e. the symptoms deteriorate as the brains age. as the population is rapidly aging, degenerative brain diseases post enormous impacts on individuals, families, and society. the etiology of these diseases is still unknown, and there is currently no cure. in the following sessions, we will review advances of neuroimaging on mci, ads, and pds. mild cognitive impairment (mci) is a clinical transition between normal aging and dementia or alzheimer's disease (ad), in which individuals have memory or other cognitive impairments beyond their age, but not to the extent of dementia. patients with mci often only have minor difficulties in functional ability. in studies based on people older than 65 years of age, the incidence of mci is estimated to be at 10-20% [58] , and the mayo clinical study on aging shows an 11.1% incidence of amnestic mci (amci) and 4.9% incidence of non-amnestic mci (namci) in undiagnosed patients aged 70-89 years [59] . several longitudinal studies have shown that most mci patients have a significantly higher risk of developing to dementia compared to the general u.s. population (1-2%/ year) [60] , the community population (5-15%/ year), and the clinical patients (10-15%/ year) [61] [62] [63] . the latter data suggest that cognitive impairment tends to develop more rapidly for the patients that display serious symptoms. although some studies have shown that the incidence of mci reversals to normal cognitive function is as high as 25-30%, recent studies suggest that the incidence may be lower. in addition, cognitive reversals over a short period of follow-up study showed that they did not prevent subsequent disease progression. magnetic resonance imaging magnetic resonance imaging (mri) techniques have been used in the clinical identification of mci and various types of dementia to predict the progression of mci to dementia. for mri measurements of brain structure, linear, area, or volume measurements can be used. the results showed that the area of mci brain atrophy was consistent with ad, but to a lesser extent, between the normal elderly (control group) and ad patients [64] [65] [66] [67] . similar results were found using voxel-based measurement and analysis, with abnormal changes in not only gray matter but also white matter [68, 69] . the previous diagnosis of ad by structural mri was mainly based on the degree of brain atrophy, especially in the medial temporal lobe. the structural mri studies showed the atrophy along the hippocampal pathway (entorhinal cortex, hippocampus and posterior cingulate cortex), which was consistent with the loss of early memory. as the disease progresses, the temporal, frontal, and apical lobes shrink with neuronal loss, causing abnormalities in language, practice, vision, and behavior [70, 71] . however, no definitive biomarkers have been identified by structural mri alone to distinguish mci and ad, to stage mci, and to predict mci conversion to ad or not [72, 73] . mri-based functional imaging has been applied to the understanding of and to the discrimination between ad and mci. these techniques include perfusion-weighted imaging (pwi), diffusion-weighted imaging (dwi), diffusion tensor imaging (dti), and blood oxygen-dependent fmri (including task execution and resting state) [72] . functional mri allows the delineation of microstructural brain changes, which is complementary to structural mri that can depict the global changes of the brain in mci. an mri-based functional imaging study that employed pwi, dti and proton mrs showed significant abnormalities in parameters derived from the three imaging modalities for ad patients. pwi and dti parameters showed a significant, but a lower degree of abnormalities in some areas for mci patients. fmri has also been used to distinguish ad and mci and to predict the transition from cognitive normal to mci and from mci to ad. recent studies show that bold-fmri can detect changes in brain function before mci progresses to ad, making it an important technique to study the neural mechanism of mci [74, 75] . proton magnetic resonance spectroscopy ( 1 hmrs) is a noninvasive imaging method that can detect biochemical and metabolic changes in brain tissue in vivo and conduct quantitative analysis. early mrs studies show abnormal concentrations of n-acetylaspartate (naa), creatine, and choline are associated with the status of memory and cognition impairment and have a promise for assessing cognitive status, evaluating response to medicine, and monitoring progression during treatment [76] [77] [78] . in recent years, with advances in the technical development of mr hardware and pulse sequences, the roles of glutamate, the excitatory neurotransmitter, and gaba, the inhibitory neurotransmitter, in mci patients became the main focus [79] [80] [81] . for example, with ultra-high field 7 tesla mr scanner, abnormal concentrations of gaba, glutamate, naa, glutathione, and myo-inositol (mi) in different brain regions were detected [82] . the manifestations of 1 hmrs in mci patients were mainly shown in decreased naa/cr ratio and increased mi/cr ratio. the pathological results showed neuronal deletion and glial proliferation, and the changes in metabolite concentration were consistent with the pathological results [82, 83] . multimodal imaging pet and spect provide insight into blood perfusion and metabolism in tissues and organs, as well as explore changes in function. the nuclear medical images of amci patients showed decreased perfusion and metabolism in the hippocampus, temporoparietal lobe, and posterior cingulate gyrus. studies using pet, spect, and mri have shown that glucose metabolism in the hippocampus, glucose metabolism rate in the bilateral temporal-parietal lobe, and blood perfusion in patients with amci are lower than those in normal elderly. these studies have also shown that low glucose metabolism in the temporal-parietal lobe is a reliable indicator of conversion to ad [84] [85] [86] . excessive deposition of β-amyloid peptide in the brain and the cascade reaction caused by it are the early onset of ad. therefore, early detection of β-amyloid peptide in the brain can help identify patients with amci, and monitor the progression of the disease and treatment effect. it was found that the 11 c-pib-pet could attach to aβ in the brain. pet imaging showed the amount and location of aβ deposition in the brain, which was expected to be an early diagnostic method for ad [87] [88] [89] . multimodal imaging techniques involving mri-based imaging and pet-based imaging have been frequently used for prediction, characterization, and classification of mci [90, 91] . in facilitating these complex tasks, imaging fusion methods based on artificial intelligence, neural network, deep learning and graph theory have been used [92] [93] [94] . brain network studies based on multimodal mri and graph theory analysis have found that the topological properties of ad and amci affected brain networks have undergone abnormal changes, which mainly manifested as the imbalance between functional differentiation and integration. this approach provided a new way to reveal topological mechanisms and pathophysiological mechanisms of brain networks [93, 95] . in addition, the combination of graph theory analysis and classification analysis suggests that the brain network topology attribute can be used as an imaging marker of ad and has a good clinical application prospect. alzheimer's disease (ad) is a neurodegenerative disorder and the most common cause of dementia. ad is characterized by progressive memory loss, aphasia, loss of use, loss of recognition, impairment of visual-spatial skills, executive dysfunction, and personality and behavior changes [96, 97] . it has become one of the major diseases that seriously threaten the health and quality of life of the elderly [98] . the onset of ad is slow or insidious, with patients and their families often unable to tell when it starts. it is more common in the elderly over the age of 70 (the average male is 73, and the average female is 75 years old), with more females than males (female to male ratio of 3:1) [99] . there is currently no cure for ad, but large numbers of novel compounds are currently under development that have the potential to modify the course of the disease and to assess the efficacy of these proposed treatments. there is a pressing need for imaging biomarkers to improve understanding of the disease and to assess the efficacy of these proposed treatments. magnetic resonance imaging structural mri (smri) is the most widely used imaging modality for the study of ad. the techniques for analyzing smri are classified into volume-based and surface-based methods [100] . previous studies have shown that hippocampal volume atrophy and whole-brain atrophy independently predicted the progression of ad [101] . hippocampal damage or atrophy occurs in the early stage of ad, which is an important structural basis for the clinical manifestations of ad. although global hippocampal atrophy in ad was well accepted, the differences were often detected large sample-size studies [102] . de winter et al. studied 48 elderly ad patients with depression and 52 healthy control elderly people and examined all the subjects with smri and neuropsychology [103] . they found that there was no significant difference in the positive rate of aβ between the depression group and the healthy control group. however, the hippocampal volume in the depression group was significantly smaller than that in the healthy control group. there is significant hippocampal atrophy in elderly depression patients, and hippocampal atrophy has nothing to do with aβ, which challenges the reliability of hippocampal atrophy in the clinical diagnosis of ad. it is suggested that hippocampal atrophy not only occurs in ad but also in senile depression. the study of smri indicates that the brain atrophy shown by brain morphology and structure has reference value for the diagnosis of ad. however, the diagnosis of ad still needs to be confirmed by combining clinical manifestations, neuropsychological assessments, and other examination methods. it also indicates that follow-up is needed for suspected depression in patients with ad. the above studies showed the limitations of structural mri and the necessity of the multimodal approach in the study of ad [104] . other mri modalities, including functional mri, dwi, pwi, have also been widely used in the study of neurodegenerative diseases. we will review recent advances of the resting-state functional magnetic resonance imaging (rs-fmri) as an example. as opposed to the conventional task-based fmri, rs-fmri does not require the subject to perform any task or be subjected to any external excitation. the rs-fmri captures the low-frequency oscillations signals that are related to the spontaneous neural activity of the brain by analyzing the brain blood oxygen level dependent (bold) signal. sophisticated methods of analysis of the rs-fmri data depict the functional connectivity of the brain. the rs-fmri has been used to reveal how the networks of the functional connectivity are correlated to the brain functions of individuals with cognitive impairment. zamboni et al. found that the recognition task of ad patients was related to the increased activation of the lateral prefrontal area, which also overlapped with the functional connection enhancement area indicated by the rs-fmri [105] . zhou et al. predicted the pathological changes of ad by using the calculation model of resting brain function network and studied five different brain regions vulnerable to neurodegenerative diseases through the use of task state fmri [106] . they found that the brain network of ad patients may have the phenomenon of weak functional connectivity and their ability to transmit information of functional brain network decline. wang et al. found that the functional brain network of mci patients had different degrees of functional connectivity disorder. the evaluation of overall functional brain connectivity of patients plays an important role in the early diagnosis and treatment of ad [107] . abnormal brain connectivity can be a biomarker of the disease. many neuropsychiatric diseases and dementia can change the default mode network (dmn) of the brain. identification of the change in the connectivity of dmn is constructive for the early recognition of ad. jin et al. collected 8 patients with amci and 8 healthy people to analyze rs-fmri data by independent component analysis (ica) [108] . they found that the functional activities of the lateral prefrontal cortex, left medial temporal lobe, left middle temporal gyrus and right angular gyrus in amci patients decreased, while the activity of the middle and medial prefrontal cortex and the left parietal cortex increased. further studies found that the functional activities of the left lateral prefrontal cortex, left middle temporal gyrus and right angular gyrus were positively correlated with memory, especially delayed memory [109] . although there was no significant difference between the two groups in the degree of medial temporal lobe atrophy, the functional activities of the left medial temporal lobe decreased. this decrease suggests that the functional changes of dmn may occur in the early stage of ad, i.e. amci, and the functional changes may occur before the obvious change of brain structure. multimodal imaging due to severe overlap in symptoms and findings of individual imaging modalities of the neurodegenerative diseases, it is difficult to identify the biomarkers that could be used to differentiate the types of these diseases and/or to stage the progress of a disease. therefore, multimodal neuroimaging techniques are used to overcome the challenges [110] . as pointed out in [111] , individual modalities of mri and eeg lack precision in ad diagnosis and staging. by employing both imaging modalities, with the mri measuring the cortical thickness and the eeg measuring the rhythmic activities, the authors found joint markers that identified the subjects of alzheimer's disease with an accuracy of 84.7%, a significant increase from those of individual modalities. while some studies of multimodal imaging confirmed correlations of findings among individual modalities as in a study of smri and fmri [112] , multimodal imaging studies can also be used to dissociate the tau deposition and brain atrophy in early ads using pet and mri. the study found that the tau load had little effect on the gray matter atrophy, and this might imply that tau protein deposit precedes and predicts brain atrophy. the multimodal imaging studies require statistical and analytical models, advanced computing algorithms, and especially, novel data fusion methods [113] [114] [115] [116] , which will be reviewed in detail in the following sections. parkinson's disease (pd) is a chronic progressive degenerative disease of the central nervous system, which is commonly seen in elderly patients. typical clinical manifestations of pd include static tremor, myotonia, bradykinesia, and abnormal posture and pace [117] . with the continuous increase of the aging population, the incidence and disability rates of the population are also increasing year by year. the results of epidemiological surveys indicate that the prevalence of pd in people over 65 is about 1.7%, and the prevalence of pd in people over 80 is as high as 4% [118] [119] [120] . pd is more and more harmful to the health of the middle-aged and elderly, especially involving the central nervous system. due to the lack of objective basis and diagnostic criteria for the diagnosis of pd, the previous clinical diagnosis of pd was mainly based on the clinical symptoms, resulting in a low coincidence rate between the clinical diagnosis and pathology of pd and in a significant lag behind the pathological changes of brain microstructure. with the increasingly standardized diagnosis and treatment of pd, neuroimaging examination has become an indispensable part of the diagnosis. this differential diagnosis of pd can help identify different movement disorders, locate anatomical dysfunction sites, and determine the causes of the lesion, which will improve clinical evaluation and prognosis [121, 122] . magnetic resonance imaging structural cranial mri can distinguish white matter from gray matter by setting different imaging parameters while avoiding radiation. it is better than cranial ct in revealing white matter lesions, small infarcts, subacute intracerebral hemorrhage, and lesions in the brain stem, subcortical regions, and posterior fossa. on structural mri such as t1, t2-weighted, and fluid-attenuated inversion recovery (flair) images, pd patients usually exhibit broadening of the ventricles (caused by extrapyramidal atrophy) and widened sulci (diffuse brain cortical atrophy) [123] . the quantitative measurements of cortical atrophy can be measured based on voxel morphometric assessment. when the compact belt of the substantia nigra shrinks and the short t2 signal of the substantia nigra disappears, the width of the dense belt of the substantia nigra, the ratio of the width of the dense belt of the substantia nigra to the diameter of the midbrain, the caudex nucleus, the putamen nucleus, the thalamus and other areas of interest are measured. in evaluating the extent of atrophy, physiological changes such as age increase and relevant clinical supporting evidence should be taken into account [124] . neuromelanin-sensitive mri is used to detect neuromelanin, a surrogate biomarker for the pd. neuromelanin is a dark pigment found in neurons in the substantia nigra pars compacta. the concentration of neuromelanin increases with age but is found to be around 50% higher in pd patients compared with age-matched non-pd subjects, due to the death of cells in the substantia nigra. neuromelanin-sensitive mri allows the visualization of the neuromelanin-containing neurons in the substantia nigra, pars compacta. with the use of morphological analysis and signal intensity (contrast to noise ratio), the width and cnr of the lateral and central substantia nigra were found to be significantly lower in the pd subjects than in the control group and untreated essential tremor (et) group [125, 126] . therefore, this imaging technique can be potentially used as a biomarker to differentiate et from the de novo tremor-dominant pd subtype. the neuromelanin levels were quantitatively assessed using neuromelanin-sensitive mri and quantitative susceptibility mapping (qsm) [127] , an mri modality for measuring the absolute concentrations of iron, calcium, and other substances in tissues based on changes of local susceptibility [128] . while the neuromelanin imaging found significantly lower neuromelanin levels in the pd group than the health controls (hc), which is in agreement with the neuromelanin mri only study, the qsm values were significantly higher in the ps group than in the hc group. this result suggested the usefulness of qsm in detecting pd [127] . resting functional magnetic resonance imaging (fmri) is a technique that collects the blood oxygen level dependent signal changes of patients in the awake and resting states to obtain the functional activity level of the brain in the baseline state. in recent years, fmri has been widely used in clinical studies of all motor disorders or neurodegenerative diseases, including pd [129] [130] [131] . resting-state functional mri (rs-fmri) can calculate a variety of brain activity attributes, such as local consistency, range of low-frequency fluctuation, and amplitude of low-frequency fluctuation etc. by observing the correlation between time-dependent signals of blood oxygen levels in different voxels or areas of interest, we can further evaluate the synchronization of functional activity in different brain areas, i.e. functional connectivity [129, 132, 133] . in recent years, calculation methods based on independent component analysis, granger causality analysis and graph theory can help to find complex pattern changes in the brain network of pd patients. other imaging modalities and multimodal imaging other imaging modalities, including pet, spect, eeg, ct, have been applied to study the functional and structural abnormalities and changes of pd patients, and they provide much complementary information to mr-based imaging modalities mentioned earlier. pet studies investigated cerebral glucose metabolism with or without medications, with or without brain stimulations [134] [135] [136] . metabolic and brain chemical changes related to dopamine neurons in pd patients were also studied using spect, which cannot be assessed by other mri modalities including proton magnetic resonance spectroscopy (mrs) [137] . by jointly applying spect and dti, this study identified regions and connections of the brain that differentiate pd patients and healthy controls. different from the imaging modalities in that study, a recent study employed pet scans with two different tracers and rs-fmri to investigate variations of metabolism and functional connectivity of the pd patients [138] . it identified correlations between motor impairments with hypometabolism and hypoconnectivity in multiple brain regions. with the use of different modalities under similar aims, results from these studies can provide complementary information for the impaired regions. the data from them can be integrated and analyzed using data fusion like the work in [139] , in which data of anatomical mri, rs-fmri, and dti were analyzed for more accurate and reliable biomarkers of pd. mental disorders are conditions that affect a person's thinking, mode, behavior, relationship with others, and depression is a common mood disorder, which can be caused by a variety of reasons. the main clinical feature is marked with persistent depression of mood, which is incompatible with the situation. in severe cases, suicidal thoughts and behaviors may occur. most cases tend to show recurrence; and most can be relieved each time, while some may have residual symptoms or progress to chronic depression. at least 10% of clinical depression patients also show manic episodes and should be diagnosed as bipolar disorder [150, 151] . what we commonly call depression is clinical or major depression, which affects 16% of the population at some point in their lives [152] . in addition to the severe emotional and social costs of depression, the economic costs are also enormous. according to the world health organization, depression has become the fourth most serious disease in the world and is expected to become the second most serious disease after coronary heart disease by 2020 [153] . so far, the etiology and pathogenesis of depression are not clear, and there are no obvious signs or laboratory indicators of abnormality. although there have been many basic and clinical studies on depression, no critical breakthrough has been made in the three most important clinical problems: pathogenesis, objective diagnosis, and efficient treatment. a key breakthrough in these issues is to find and establish a stable biological marker from gene to clinical phenotype and then further study its pathogenesis, establish objective diagnostic methods and develop efficient clinical therapy. magnetic resonance imaging up to now, in the clinical research field of mental illness, especially depression, the most sought after biological markers may potentially be provided by the study of neuroimaging, especially brain mri. brain mri examination have characteristics of good clinical applicability, non-invasive, simple operation, universal, relatively stable results and easy to repeat, but its sensitivity and specificity need to be improved. brain mri research has become an intermediate mechanism from molecular research to clinical phenotype. through this mechanism research, we can not only explore how genes, molecules, and proteins affect the brain structure and function of patients with depression but also use mri as an objective diagnostic tool for the most urgent clinical needs. over the past 20 years, the application of multi-mode mri technology to study the brain structural and functional characteristics of depression, especially to establish clear biological marker targets around the characteristics of emotional circuits, has become one of the major scientific frontiers in the basic and clinical research of neuroscience. many studies have found that patients with depression have abnormalities in brain structure and function of emotional circuits, as well as in neurotransmitters associated with these circuits [149, 154] . mri studies in recent years found that the depressive mood is associated with three brain regions, namely in the amygdala and the ventral striatum as the primary mood areas, the orbital gyrus, medial prefrontal cortex and cingulate gyrus as the emotional auto-regulation areas, and the dorsolateral and ventrolateral prefrontal cortex as the center of the active emotional regulation area [154] [155] [156] . multimodal mri techniques used in mental disorders seek to find correlated, complementary, and/or converging image features from multiple image modalities and applied sophisticated analytical methods to identify robust biomarkers for the types of depression. a study employed dti, magnetic resonance spectroscopy (mrs), rs-fmri, and magnetoencephalography (meg) and revealed patterns of abnormalities of patients with major depressive disorders. these patterns included factors in the neurotransmitters (glutamate concentration), white matter fibers (fractional anisotropy), and functional excitations (fmri) [157] . a multimodal mri study involves structural mri and asl to assess grey matter volume and regional cerebral blood flow in mdd patients. this multimodal study revealed negative correlations between the extent of depressive symptoms and cbf in the bilateral para-hippocampus and between depressive symptoms and cbf in the right middle frontal cortex [158] . in addition to confirming the correlations among findings of individual modalities, some multimodal mri studies, however, found disrelations among individual findings in the mdd group [159] . further multimodal data analysis involving mri imaging data and clinical, neurobiological metrics of the patients may resolve the disparities. among the methods of the multimodal mri image fusion in depressive disorders, support vector machine (svm) [160] and linked independent component analysis [161] was recently used, respectively, to identify biomarkers for the classification and prediction of symptom loads of heterogeneous mdd cohorts. imaging data and neurobiological data were included in the data fusion. in both studies, the results did not show strong support for the hypothesis and did not provide sufficient evidence for the sought biomarkers [160, 161] . obsessive-compulsive disorder (ocd) is a group of neuropsychiatric disorders with obsessive thinking and compulsive behavior as the main clinical manifestations. it is characterized by the co-existence of conscious compulsion and anti-compulsion, and the repeated intrusion of thoughts or impulses into the daily life of patients that are often meaningless and involuntary. although patient perceives that these thoughts or impulses are their own and resist them to the utmost degree, he or she is still unable to control them. the intense conflict between the two causes the patient great anxiety and pain, which affects his other study, work, interpersonal communication, and even daily life. magnetic resonance imaging voxel-based morphometry was widely used in the smri studies of ocd. these studies measure the structures and volumes of regions of interest in various ocd groups and healthy control groups. ocd patients were found to have lower grey matter volumes in specific regions of the brain. for children with ocd, these regions include the bilateral frontal lobe, cingulate cortex, and temporal-parietal junction [162] . for adults with ocd, these regions are the left and right orbitofrontal cortex [67] . lower volumes were also seen in white matter in the cingulate and occipital cortex, right frontal and parietal and left temporal regions [162] and in a small area of the parietal cortex for patients with ocd [163] . fmri studies can provide information about the pathophysiology of ocd [164, 165] . however, whether this information from single fmri modality alone could be of clinical value in the diagnosis of individual patients is not clear [166] . the pathophysiological feature of ocd, as revealed by fmri studies, suggest that abnormal brain metabolites may be implied in ocds. abnormalities in brain metabolite concentrations in patients with ocd were investigated using proton mrs [167] [168] [169] [170] . among about ten detectable metabolites, glutamate, glutamine, and gaba are of particular interest, as they are involved in neurotransmission. recent studies show that ocd patients had an elevated gaba level and a higher gaba/glutamate ratio in the anterior cingulate cortex [171] , and they had lower gaba concentration in the prefrontal lobe, as compared to healthy control groups [172] . the roles of glutamate and glutamine in ocd are in the focus of research interest, but the findings lacked reasonable consistency [173] [174] [175] . the heterogeneity of structural neuroimaging findings of ocd may reflect the heterogeneity of the disease itself. multimodal mri multimodal mri studies in ocd provide complementary, correlated and/or integrated information of findings from individual modalities [176, 177] . early structural mri study suggested that the volume reduction of superior temporal gyrus (stg) is associated with the pathophysiology of ocd [178] . a functional mri study found increased low-frequency fluctuations in neural activities in stg [179] . a correlation between these findings was found in a combined structural mri and fmri study, which shows that the volume of the superior temporal sulcus is strongly correlated with functional connectivity between several brain regions that may form a neuro-network [177, 180] . the simultaneous 1h-mrs and dti study, to investigate metabolic and white matter integrity alterations in ocd, found that the level of glx to cr ratio in the anterior cingulate cortex was higher in the ocd group than the healthy control group [181] . the study also found from dti analysis that the fa values in the left cingulate bundle of the ocd group were significantly higher than the healthy controls. a limitation of this study is that the glx level, which is a combination of glutamate and glutamine, was measured instead of measuring glutamate and glutamine individually. it has been recognized that it is difficult to distinguish these two structurally similar metabolites using 3 tesla scanners and ultra-high magnetic field (e.g. 7t) scanners are required. schizophrenia is a group of serious psychosis with unknown etiology, which usually starts slowly or sub-acute in the young and middle-aged individuals [182] . clinically, it often manifests as a syndrome with different symptoms, including abnormalities in sensory perception, thinking, emotion, and behavior, as well as uncoordinated mental activities [183] . schizophrenia is a multifactor disease [184] . deterioration. some patients eventually show recession and mental disability, but some patients can maintain recovery or basic recovery after treatment [185] . magnetic resonance imaging structural mri was widely used to study the morphology and volumetry of the brains of schizophrenia patients. studies found that the average brain volume of schizophrenia patients was smaller than that of healthy people [186, 187] . the abnormal volume and structure of white matter usually appear before the onset of the disease, and these abnormalities tend to be stable during the development of the disease [188] ; the change of gray matter volume is more evident after the onset of the disease and decreases progressively over time [189] . according to a longitudinal study, gray matter deficiency in schizophrenia mainly occurs in the first five years [190] . quiet complement to the structural mri, dti reveals the abnormalities of white matter microstructure of schizophrenia patients [191] . decreased fractional anisotropy in white matter tracts, different cortical regions, and subcortical regions was found in schizophrenia patients in some studies. however, controversial findings were also reported [192, 193] . these inconsistencies might be attributed, in part, to small sample sizes. a large-scale dti study involving more 4,000 subjects found widespread white matter microstructural differences between schizophrenia patients and healthy controls [194] . significantly reduced fractional anisotropy values were found in 20 of the 25 investigated regions within the white matter. furthermore, significantly higher mean diffusivity and radial diffusivity were also observed in schizophrenia patients than in healthy controls. functional mri techniques are used to detect the deficits in neural networks of patients with schizophrenia [195] . brain network studies show that the functional connectivity of the default mode network (dmn) in schizophrenic patients has changed. although the research structures are inconsistent, most studies show that dmn functional connectivity is enhanced in schizophrenia, and functional connectivity in the prefrontal cortex is weakened (especially in the prefrontal cortex) [196] . in addition, the functional connections of auditory/linguistic networks and basal nuclei are related to auditory hallucinations and delusional symptoms. the study of brain structure networks found that the number of frontal and temporal core nodes decreased and the average shortest path increased, indicating decrease in global efficiency. wang et al constructed a network of dti images of 79 schizophrenia patients and 96 age-matched normal subjects [197] . they found that: compared with the normal subjects, the global efficiency of the schizophrenic group decreased; the local efficiency of the core nodes distributed in the frontal cortex, the paralimbic system, the limbic system and the left putamen decreased; and the global efficiency of the network was negatively correlated with the panss score. research shows that the change in brain structure network started at the beginning of the disease. more severe symptoms indicate lower the global or local efficiency of the network, and the slower the speed of information integration. magnetic resonance spectroscopy studies found that the brain metabolism of schizophrenia patients was abnormal [198] [199] [200] . the levels of n-acetyl-aspartic acid (naa) in the hippocampus, frontal lobe, temporal lobe, and thalamus of schizophrenic patients decreased; the levels of naa in the thalamus of high-risk groups also decreased, while the level of naa in temporal lobe decreased. it was also found that the increase of glutamate level in the hippocampus and medial temporal lobe was related to the decrease of executive function. multimodal imaging the heterogeneities of findings of individual imaging modalities have been driving the multimodal neuroimaging approach to the search of the more consistent and precise biomarkers for the deficits, abnormalities in functions of schizophrenia patients. a concerted use of three mri modalities, namely, resting-state of fmri, structural mri, and diffusion mri, was able to simultaneously reveal abnormalities from these three kinds of mri images and, thereby, identify the cortico-striato-thalamic circuits that might be related the cognitive impairments in schizophrenia [201] . in addition to the multimodal imaging investigation of structural and functional brain abnormalities in schizophrenia, proton mrs has also been used in combination with fmri to investigate cognitive impairment in schizophrenia at both neurometabolic and functional levels [202] . the combined proton mrs and fmri study are particularly useful for short-term longitudinal studies on the effects of medication, which is invariant to brain structural change. in this study [202] , the relationship between glx/cr levels and bold response significantly changed after six weeks of medication for schizophrenia patients, although factors that confound interpretations of the results remain. more examples of multimodal imaging studies on schizophrenia are given in recent review articles [203, 204] . multimodal fusion has gradually entered the center of research interest as an approach to tackle the challenges of neuroimaging. the first main reason is that there exists a great complementarity between different imaging modes. for instance, the images obtained by positron emission tomography imaging (pet) or single-photon emission tomography imaging (spect) do not contain high resolution, three-dimensional anatomical information. on the other hand, high-resolution structural images can be obtained via the use of ct and/or mri. these images complement each other to provide a complete picture of the targeted organs' anatomy, physiology, and pathology. the fusion of these images is of great significance for the relevant clinical and pre-clinical studies. another outstanding merit of utilizing multimodal fusion is that it efficiently enhances the spatial and temporal resolution in the characterization of brain processes. in other words, multimodal imaging may allow the combination of the hyper-temporal resolution of one imaging mode with the hyper-spatial resolution of another, taking advantage of the spatial-temporal complementarity. take a study in 2014 as an example, ke zhang et al have successfully measured the cerebral blood flow with a combination of arterial spin labeling (asl), mri and pet [205] . apart from this, utilizing eeg together with fmri to improve spatial and temporal resolution has also been studied by many scientists in neuroscience [206] [207] [208] [209] it is worth mentioning that, in both narrow and wide senses, multimodal data fusion has a high capacity of generalization. a typical instance is the alignment of functional mri, eeg, and fnirs images to an anatomical coordinate system. the coordinate system can act as a template to standardize reported results. the alignment of the images to a single coordinate system not only allows comparison with other studies but also allows the combination of functional and structural information [210] . pet/ct combination is a multimodal absolute quantification approach where ct provides structural data information on bones, which also serves as the main absorber for the γ-rays in pet. this combination allows decay correction, in which the accumulation of radioactive isotopes in human tissues becomes apparent, and the amount of radioactive decay can be absolutely quantified [211, 212] . multimodal imaging also has the benefit of utilizing data from one modality to improve the data quality of another modality, such as correcting the geometric distortions of epi images by acquiring a b0 field map or obtaining epi with different parameters [213, 214] . another classic case is in a combined mr-pet study, where the motion information provided by high-temporal resolution mri data was used to help the reconstruction of the pet data [10] . the long history of neuroimaging has led to the development of an assortment of imaging technologies and modalities, as seen in section 3. the existing research and apparatus provided a solid foundation for multimodal fusion, leading to the rapid development of many fusion techniques. in this part, we classify reviewed methodologies into four primary forms: multimodal, multi-focus, multi-temporal, and multi-view. modern medical imaging methods aim at revealing possible dysfunctions in patients. for example, neuroimaging methods are often used to image the structure of nervous system on a macroscopic level, which in turn helps explore the neuroglial basis of behavior and cognition of patients. however, how to combine different medical imaging methods to provide images with better quality or clearer structures remains to be the heated research interest in the field. therefore, multimodal image fusion is proposed to minimize the gap. in a narrow sense, multimodal image fusion, a technique to improve the interpretation of the structure and functions of target organ or region, generally combines two or even more images collected from different imaging instruments. in order to achieve the goal of simultaneous acquisition, researchers have developed particular instrumentations to allow data of one modality to be acquired with low or neglectable inference from another modality. for instance, the eeg-fmri combination fuses data acquired from eeg instruments like amplifiers and mri scanners. also, the novel instrumentations range from simple arrangements to relatively complex technological innovations. however, in some combinations, simultaneous acquisition of data was impossible due to the physical interactions of the imaging devices. multimodal image fusion, in a broader sense, also combines data but collected with the same instrument. in this case, mri is widely used due to its versatility in the generation of different tissue contrasts with the well-studied phenomenon of magnetic resonance. there is also research that combines two and more contrasts in the same acquisition, which has been routinely used for many years. multiple contrasts can also be acquired by pet (positron emission tomography) when radioactive compounds injected are different. a region-based method, which incorporated segmentation into the fusion process, was proposed by s. li in and local focus measure comparison. it was pointed out that local features such as dense sift can also be used to match pixels that were misregistered between multiple source images. in methods based on frequency, images are transformed into the frequency-domain for fusion. wavelet-based methods, including discrete wavelet transform (dwt) [221] , haar wavelet [222] and pyramid-based methods such as the laplacian pyramid [223] , fall under the category of frequency-domain methods. a dwt based method was proposed in [224] . principal component analysis (pca) was used for approximating coefficients of input images. the principal components were evaluated to obtain multiscale coefficients. the weights for the fusion rule were then acquired by averaging those components. besides the promising performance, the proposed method was widely applied in medical image fusion for ct and mri images. in [225] , the authors proposed the daubechies complex wavelet transform (dcxwt) to fuse multimodal medical image. by using the maximum selection rule, the complex wavelet coefficients of source images are fused. source images at different levels are decomposed by dcxwt, followed by inverse dcxwt to form the fused image. compared to the other five methods, including dual tree complex wavelet transform (dtcwt) based fusion and pca based fusion, the proposed method achieved the best performance in terms of five measurements, including standard deviation, entropy, edge strength, fusion symmetry, and fusion factor. it was proved that the proposed method was robust to noises, including speckle, salt and pepper, while maintaining the property of shift-invariance. multi-temporal fusion is to fuse images taken at different times but of the same modality. multi-temporal fusion enables easy detection of changes in images by subtracting one or multiple images from another. data acquisition consists of separate recording and simultaneous recording. the choice between separate or simultaneous acquisition should be cautiously considered. compared to separate recordings, where an image from each modality is acquired individually, simultaneous acquisitions have relatively lower data quality and more artifacts. for example, eeg-fmri simultaneously acquires cardio-ballistic artifacts and mri gradients. data acquisition consists of separate recording and simultaneous recording [226] . in the mr-pet scenario, components of the mri scanner would trigger degradation in pet scanning results. therefore, the costs of simultaneous acquisition are higher than separate acquisition due to subject discomfort and long set-up time. however, there are also many cases in which costs are of less concern, given the benefits of simultaneous acquisitions. in multi-view fusion, images of the same modality are taken under different conditions at the same time. this fusion technique is applied to increase the amount of information for the fused images, while source images are taken under different conditions. the choice between asymmetric and symmetric data fusion makes a significant difference in the integration and joint analysis of multimodal data. for integration methods falling under the asymmetric category, information from different modalities is assigned with different weights so that information from one modality could be treated as a constraint on the other modality. for instance, fmri contrast maps limit the source localization of eeg/meg. modalities in symmetric data fusion, however, are treated equally in terms of spatial and temporal resolution as well as the uncertainty in the possible indirect relation to neural activity. hypothesis-driven approaches and data-driven approaches are the two main categories of symmetric fusion approaches. hypothesis-driven approaches, also called model-driven approaches, are usually in model-based setting, while data-driven approaches belong to blind source separation methods [227] . examples of different fusion methods are shown in table 3 . image fusion rules are applied to highlight the features of interest in images while suppressing the unimportant features. generally, fusion rules are mainly comprised of four components: activity-level measurement, coefficient grouping, coefficient combination, and consistency verification [230] . the activity-level measurement rule, as can be subdivided into window-based activity (wba), coefficient-based activity (cba) and region-based activity (rba), characterizes coefficients at different scales. in the coefficient grouping component, there are mainly three typical groupings, including single-scale grouping (sg), multi-scale grouping (mg), and no-grouping (ng). sg indicates that the same strategy is applied to fuse different coefficients between sub-images on the same scale. the coefficient combination component mainly comprises of maximum rules (mr), weighted rules (war), and average rules (ar). mr can be given as: where c f indicates the combined coefficient, 1 and 2 are the coefficients of two input images at the level of . for war, 1 and 2 are combined by multiplying different weights 1 and 2 , that is ar, which has the coefficient of input images averaged, is a special case of war. the consistency verification component ensures that the same rules are applied to fuse the coefficients in the neighborhood. there are three different levels of image fusion: pixel level, feature level, and decision level. this categorization can be seen in table 4 and figure 10 . pixel level rules directly deal with the information acquired from each pixel of source images and then generates pixel values for the fused image correspondingly. feature level rules focus on regional information and features such as texture and salient features. the fused image in the decision level is acquired through rules of fuzzy logic and statistics. before rules in feature level and decision level apply to the source images, segmentation of the source images is needed. compared to the pixel level fusion, feature and decision level fusion shows more advantages are less affected by noises and misregistration. feature and decision level fusion also shows better contrast and lower complexity [231] . in the following sections, we will introduce fusion rules for multi-model image fusion, followed by validation metrics. figure 10 pixel-based and window-based fusion fuzzy logic-based rules belong to decision level fusion. these rules are usually used to solve challenges in blurry fused images. mamdani and t-s models are two fuzzy logic models. the difference between them lies in the consequence parts. t-s models linearly mapped input variables into functions to form the consequence parts, while mamdani models used fuzzy sets. the t-s model is more advantageous than the mamdani model in regard to number of rules and accuracy. in general, feature extraction through fuzzy logic algorithms is performed prior to fusion, which generates pixel-wise features 1 and 2 from two input images. the fusion procedure can be divided into three steps. in the first step, the fuzzy logic, which is usually comprised of four conditional rules, is used to label the individual pixels as following. = { , both of 1 and 2 are high (rule1) , 1 is low but 2 is high (rule2) or 1 is high but 2 is low (rule3) , both of 1 and 2 are low (rule4) then the new pixel-wise feature values can be calculated through: where 1, 2, 3 corresponds to low, medium and high components, respectively. and are the mean and variance of each component. by incorporating the center average defuzzifier to process fuzzy outputs, the weight of fuzzy logic can be obtained. the essence in statistics-based methods lies in the data-driven technique and high order statistics that can reveal the underlying pattern across multiple modes of data. principal component analysis (pca) [232] [233] [234] [235] together with hidden markow tree (hmt) [236] [237] [238] are two typical examples of statistic methods in the field of multi-modal medical image fusion. pca is an orthogonal linear transformation that reveals the most valuable components of the input images. let 1 and 2 be the two coefficients of the input images that can be denoted as: where 1 and 2 (1 ≤ ≤ ) are column vectors of two coefficients 1 and 2 . the importance of components is related to the eigenvalues in the covariance matrix between 1 and 2 . the covariance matrix can be computed through: where is the expectation of vectors, 1 ̅̅̅ and 2 ̅̅̅ corresponds to the average of 1 and 2 respectively, that is given the eigenvalues obtained from the covariance matrix as , the normalized weights 1 and 2 for 1 and 2 can be denoted as: therefore, the fused coefficient can be the combination of two input images: the two-state hmt method, unlike pca methods, can be deployed to model the coefficients. two mixed gaussian random distributions, as well as the hidden states, depict intra-coefficients. the hidden states here refer to the one parent and four children coefficients. given each coefficient denoted as , the coefficient is obtained by probability density function: when the coefficient in the state n (n=0, 1), ( | = ) is the probability density function correspondingly. the fused coefficient is then given by: methods based on the human visual system (hvs) aim at solving the fusion problem in the way of image recognition and comprehension. the system includes components such as visibility, smallest univalve segment assimilating nucleus (susan) [239] , and retina-inspired model (rim) [240, 241] . the sharpness of an image can be quantified by visibility. therefore, the images with higher visibility show lower blurriness. given an image of size × , then the visibility of the can be mathematically expressed as : where µ is acquired by calculating the mean grey value of the image and , the visual constant varying from 0.6 to 0.7. susan, proposed in [242] , is a feature extraction algorithm inspired by hvs. susan computes the feature of a pixel by considering a circular mask around the pixel. in the mask, the area consisting of pixels that have similar brightness to the nucleus, or the central pixel, is selected and is called univalue segment assimilating nucleus (usan). let the input image to be and the circular mask with the radius , then simplest usan can be given as : where 0 is the central pixel, is a nominal depicting surrounding pixels. ( )is the pixel value at and is the brightness difference threshold. the value of , which specifies the range of pixel values to be considered, must be carefully chosen because extracted features are sensitive to it. in order to lower the sensitiveness, the distance between pixels is also taken into consideration, and the extended usan function is: where is the distance scaling factor. for components in intensity-hue saturation (ihs) decomposition methods, the rim model can be used as the fusion rules. there are five layers in rim. the first cone layer outputs an array of high-resolution cone photoreceptors with high resolution. the second layer is the extractor for spatial feature, while the third layers are horizontal cells. the fourth and fifth layers, which combine features, are bipolar and ganglion cells the rim based image fusion rule can be demonstrated as: where 1 and 2 stand for intensity components of two source images. 1 and 2 are the filters of feature extractors. the filter 1 , a high-scale spatial feature extractor, calculates the spatial difference between high-resolution and low-resolution. filter 2 combines the output of horizontal cells. objective evaluation metrics are used to evaluate the efficacy of image fusion rules on improving the quality of the fused image. widely used metrics includes spatial frequency (sf) [243] , the ratio of spatial frequency error (rsfe) [244] , wavelet entropy (we) [245] , signal noise ratio (snr) [246] , mutual information (mi) [247] and directive contrast (dc) [248] . sf metric, which measures images' activity, is generally used for pca integrated his methods in multimodal image fusion. sf can be defined as where and stand for column frequency and row frequency, respectively. based on sf, rsfe compares the sf f ′ of the fused image with 1 ′ and 2 ′ of the input images where sf' can be extended as: where and are the main diagonal sf and the secondary diagonal sf. rsfe can then be formulated as: calculated by multi-scale entropy, we can be given by: where i is the resolution level, is the density distribution derived from the energy of the detail signal and the total energy = in [246] , the authors proposed snr-based image fusion rules. the proposed fusion method can be formulated in the following form. for a specific region . ( ) is the activity level of that, while is the total number of pixels. the probability of pixel activity can be calculated through: where is the weight of snr from the image, is the number of decomposition levels and ( 1 , 2 ) is the detailed wavelet coefficient. mi is deployed as the fusion rule for wt-based multi-modal medical image fusion. mi between the input images , and the fused image , is maximized to give , which is acquired by: dc measures the difference between the pixel and its neighbors. the ratio between the high-frequency intensity and the low-frequency intensity is the intensity contrast dc. for the multi-modal image fusion of neuroimaging, the selection of various decomposition and reconstruction methods influence the fusion procedure and outcomes. in this survey, we shall discuss seven popular methods: (i) rgb-ihs; (ii) pyramid representation; (iii) wavelet-based approach and its variants; (iv) multi-resolution analysis; (v) sparse representation; and (vi) salient features. the intensity-hue-saturation (ihs) model [249] helps transform the original image in rgb color space to hue, saturation, and intensity channels. this rgb to ihs procedure is calculated by simple equations. besides, the reconstruction is carried out by inversed transformation (ihs to rgb). for the rgb->ihs procedure, the intensity of each input image was estimated by the following equations: then, we consider three conditions: c 1 : b